PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sijbrands, EJG				Sijbrands, Eric J. G.			Inhibition of PCSK9 in familial hypercholesterolaemia	LANCET			English	Editorial Material							APOLIPOPROTEIN-B; CONTROLLED-TRIAL; LDL CHOLESTEROL; DOUBLE-BLIND; STATIN; ATHEROSCLEROSIS; MIPOMERSEN; EZETIMIBE; EFFICACY; THERAPY		[Sijbrands, Eric J. G.] Erasmus MC, Pharmacol Vasc & Metab Dis sect, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Sijbrands, Eric J. G.] Erasmus MC, Dept Cardiol & Internal Med, Cardiovasc Genet Sect, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sijbrands, EJG (corresponding author), Erasmus MC, Pharmacol Vasc & Metab Dis sect, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands.	e.sijbrands@erasmusmc.nl	Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389				Akdim F, 2010, J AM COLL CARDIOL, V55, P1611, DOI 10.1016/j.jacc.2009.11.069; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Huijgen R, 2010, CLIN THER, V32, P615, DOI 10.1016/j.clinthera.2010.04.014; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Neefjes LA, 2011, ATHEROSCLEROSIS, V219, P721, DOI 10.1016/j.atherosclerosis.2011.09.052; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	13	4	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2012	380	9836					6	7		10.1016/S0140-6736(12)60814-9	http://dx.doi.org/10.1016/S0140-6736(12)60814-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970GK	22633823				2022-12-28	WOS:000306115900006
J	Bienz, M; He, X				Bienz, Mariann; He, Xi			A Lipid Linchpin for Wnt-Fz Docking	SCIENCE			English	Editorial Material							BINDING; PROTEIN; PATHWAY; DISEASE; LRP6		[Bienz, Mariann] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA	MRC Laboratory Molecular Biology; Harvard University; Boston Children's Hospital; Harvard Medical School	Bienz, M (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	mb2@mrc-lmb.cam.ac.uk; xi.he@childrens.harvard.edu			MRC [MC_U105184273, MC_U105192713] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241, R01GM057603] Funding Source: NIH RePORTER; Medical Research Council [U105192713, MC_U105192713, MC_U105184273] Funding Source: Medline; NIAMS NIH HHS [AR060359, R01 AR060359] Funding Source: Medline; NICHD NIH HHS [P30 HD-18655] Funding Source: Medline; NIGMS NIH HHS [R01 GM074241, R01 GM057603, GM074241, GM057603S1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Hausmann G, 2006, DEV CELL, V11, P751, DOI 10.1016/j.devcel.2006.11.007; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	15	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					44	45		10.1126/science.1224468	http://dx.doi.org/10.1126/science.1224468			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22653728				2022-12-28	WOS:000306053100037
J	Gupta, GR				Gupta, Geeta Rao			Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children	LANCET			English	Editorial Material									UNICEF, New York, NY 10017 USA	UNICEF	Gupta, GR (corresponding author), UNICEF, New York, NY 10017 USA.	hnewby@unicef.org						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Editorial, 1978, LANCET, V312, P300; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; The United Nations Children's Fund (UNICEF) World Health Organization (WHO), 2009, DIARRH WHY CHILDR DY; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF (United Nations International Children's Emergency Fund), 2010, NARR GAPS MEET GOALS; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; WHO and UNICEF, 2012, JOINT MON PROGR WAT; WHO UNICEF, 2009, B WORLD HEALTH ORGAN, V86, P1; World Health Organization, 2012, EQ FOC STRAT IMPR AC	11	20	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2123	2124		10.1016/S0140-6736(12)60907-6	http://dx.doi.org/10.1016/S0140-6736(12)60907-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682449				2022-12-28	WOS:000304990900006
J	Presern, C; Bustreo, F; Droop, J; Fogstad, H; Starrs, A; Axelson, H; Frenk, J				Presern, Carole; Bustreo, Flavia; Droop, James; Fogstad, Helga; Starrs, Ann; Axelson, Henrik; Frenk, Julio			Keeping promises for women and children	LANCET			English	Editorial Material									[Presern, Carole; Axelson, Henrik; Frenk, Julio] Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland; [Bustreo, Flavia] WHO, CH-1211 Geneva 27, Switzerland; [Droop, James] United Kingdom Dept Int Dev, London, England; [Fogstad, Helga] Norwegian Agcy Dev Cooperat, Oslo, Norway; [Starrs, Ann] Family Care Int, New York, NY USA; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA	World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Presern, C (corresponding author), Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland.	presernc@who.int						[Anonymous], 2011, AN COMM ADV GLOB STR; Schrade C, 2011, STRENGTHENING GLOBAL; United Nations, EV WOM EV CHILD COMM; United Nations, 2000, UN MILL DECL GEN ASS; United Nations Secretary-General Ban Ki-moon, 2010, GLOB STRAT WOM CHILD	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2125	2126		10.1016/S0140-6736(12)60653-9	http://dx.doi.org/10.1016/S0140-6736(12)60653-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682450				2022-12-28	WOS:000304990900007
J	Ito, H; Sato, K; Koganezawa, M; Ote, M; Matsumoto, K; Hama, C; Yamamoto, D				Ito, Hiroki; Sato, Kosei; Koganezawa, Masayuki; Ote, Manabu; Matsumoto, Ken; Hama, Chihiro; Yamamoto, Daisuke			Fruitless Recruits Two Antagonistic Chromatin Factors to Establish Single-Neuron Sexual Dimorphism	CELL			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; HISTONE DEACETYLASE; NUCLEAR RECEPTORS; GENE-EXPRESSION; TIF1 FAMILY; LYSINE 9; DOMAIN; MORPHOGENESIS	The Drosophila fruitless (fru) gene encodes a set of putative transcription factors that promote male sexual behavior by controlling the development of sexually dimorphic neuronal circuitry. However, the mechanism whereby fru establishes the sexual fate of neurons remains enigmatic. Here, we show that Fru forms a complex with the transcriptional cofactor Bonus (Bon), which, in turn, recruits either of two chromatin regulators, Histone deacetylase 1 (HDAC1), which masculinizes individual sexually dimorphic neurons, or Heterochromatin protein 1a (HP1a), which demasculinizes them. Manipulations of HDAC1 or HP1a expression change the proportion of male-typical neurons and female-typical neurons rather than producing neurons with intersexual characteristics, indicating that on a single neuron level, this sexual switch operates in an all-or-none manner.	[Ito, Hiroki; Sato, Kosei; Koganezawa, Masayuki; Ote, Manabu; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 9808577, Japan; [Matsumoto, Ken] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan; [Hama, Chihiro] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan	Tohoku University; Japan Advanced Institute of Science & Technology (JAIST); Kyoto Sangyo University	Yamamoto, D (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 9808577, Japan.	daichan@m.tohoku.ac.jp	Sato, Kosei/V-8303-2018; Koganezawa, Masayuki/X-7284-2018; Ito, Hiroki/ABC-9621-2020; Ito, Hiroki/E-4858-2017	Sato, Kosei/0000-0002-4463-1440; Koganezawa, Masayuki/0000-0002-8009-0450; Ito, Hiroki/0000-0003-4745-5750; Ote, Manabu/0000-0003-1480-0319; , Daisuke/0000-0002-4623-0106	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24113502, 23220007, 1802012]; Japan Science and Technology Agency; Tohoku Neuroscience Global COE; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24570082, 23220007] Funding Source: KAKEN	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Tohoku Neuroscience Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Bloomington Stock Center, Kyoto Genetic Resource Center and Vienna Drosophila RNAi Center for numerous stocks, the Developmental Studies Hybridoma Bank for antibodies, B. Baker, H.J. Bellen, L.A. Pile, R. Mottus, J.C. Eissenberg, K. Kimura, J. Levine, J. Bernues, J. Muller, and M. Buszczak for the cDNAs, antibodies, and flies, Y. Ishikawa for help in statistics, and H. Sato and K. Sawaguchi for secretarial assistance. This work was supported in part by Grants-in-Aid for Scientific Research (24113502, 23220007, 1802012) from the Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) to D.Y., a grant from the Strategic Japanese-French Cooperative Program from the Japan Science and Technology Agency to D.Y., a grant from the Tohoku Neuroscience Global COE program to D.Y., and the Life Science Grant from Takeda Science Foundation to D.Y.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Beckstead RB, 2005, GENETICS, V169, P783, DOI 10.1534/genetics.104.037085; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ferri SL, 2008, J NEUROGENET, V22, P17, DOI 10.1080/01677060701671947; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Goto J, 2011, J NEUROSCI, V31, P5454, DOI 10.1523/JNEUROSCI.4861-10.2011; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Mottus R, 2000, GENETICS, V154, P657; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Tea JS, 2010, J NEUROSCI, V30, P9939, DOI 10.1523/JNEUROSCI.1643-10.2010; Toba G, 1999, GENETICS, V151, P725; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	34	65	66	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1327	1338		10.1016/j.cell.2012.04.025	http://dx.doi.org/10.1016/j.cell.2012.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682252	Bronze			2022-12-28	WOS:000305119600016
J	Creager, MA; Kaufman, JA; Conte, MS				Creager, Mark A.; Kaufman, John A.; Conte, Michael S.			Acute Limb Ischemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERIPHERAL ARTERIAL-DISEASE; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; ACUTE LEG ISCHEMIA; LOWER-EXTREMITY; THROMBOLYTIC THERAPY; OCCLUSIVE DISEASE; INITIAL TREATMENT; VASCULAR-SURGERY; MANAGEMENT	A 57-year-old man presents with an acute onset of left foot pain, numbness, and partial loss of motor function. Four months ago, he underwent endovascular treatment for disabling claudication, which included placement of overlapping polytetrafluoroethylene-coated stents in the left superficial femoral and popliteal arteries. His popliteal and pedal pulses are absent, and the foot is cool and mottled. Angiography reveals complete occlusion of the stent, with thrombosis extending distally into the popliteal and tibial arteries below the knee. How should his case be managed?	[Creager, Mark A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Creager, Mark A.] Harvard Univ, Sch Med, Boston, MA USA; [Kaufman, John A.] Oregon Hlth & Sci Univ Hosp, Div Vasc & Intervent Radiol, Dotter Intervent Inst, Portland, OR USA; [Conte, Michael S.] Univ Calif San Francisco, Div Vasc & Endovas Surg, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; University of California System; University of California San Francisco	Creager, MA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	mcreager@partners.org			AstraZeneca; Baxter International; Genzyme; Aastrom Biosciences; Thrombolysis in Myocardial Infarction (TIMI) Study Group; Merck; VIVA Physicians; Humacyte; Talecris Biotherapeutics	AstraZeneca(AstraZeneca); Baxter International; Genzyme(Sanofi-AventisGenzyme Corporation); Aastrom Biosciences; Thrombolysis in Myocardial Infarction (TIMI) Study Group; Merck(Merck & Company); VIVA Physicians; Humacyte; Talecris Biotherapeutics	Dr. Creager reports receiving payment from AstraZeneca and Baxter International for serving as an advisory board member and from Genzyme, Aastrom Biosciences, and the Thrombolysis in Myocardial Infarction (TIMI) Study Group (which is funded by Merck) for serving as a steering committee member; Dr. Kaufman, receiving payment as a board member of VIVA Physicians, a nonprofit educational organization that receives funding from several companies, including device and pharmaceutical companies; and Dr. Conte, receiving payment from Aastrom Biosciences and Humacyte for serving as an advisory board member and from Talecris Biotherapeutics for serving as a member of a data and safety monitoring board and serving as an unpaid advisory-board member for Baxter International. No other potential conflict of interest relevant to this article was reported.	Agle SC, 2010, ANN VASC SURG, V24, P609, DOI 10.1016/j.avsg.2009.12.011; Allie DE, 2004, CATHETER CARDIO INTE, V63, P512, DOI 10.1002/ccd.20216; Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; Berridge DC, 2002, COCHRANE DB SYST REV, V3; Collins R, 2007, BMJ-BRIT MED J, V334, P1257, DOI 10.1136/bmj.39217.473275.55; Comerota AJ, 2009, SEMIN VASC SURG, V22, P41, DOI 10.1053/j.semvascsurg.2009.01.003; Drescher P, 2002, J VASC INTERV RADIOL, V13, P37, DOI 10.1016/S1051-0443(07)60006-2; Earnshaw JJ, 2004, J VASC SURG, V39, P1018, DOI 10.1016/j.jvs.2004.01.019; Eliason JL, 2003, ANN SURG, V238, P382, DOI 10.1097/01.sla.0000086663.49670.d1; FOGARTY TJ, 1963, SURG GYNECOL OBSTET, V116, P241; GRAOR RA, 1994, ANN SURG, V220, P251; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Kessel DO, 2004, COCHRANE DB SYST REV, V1; Kropman RHJ, 2010, EUR J VASC ENDOVASC, V39, P452, DOI 10.1016/j.ejvs.2009.11.010; Kuoppala M, 2011, J THROMB THROMBOLYS, V31, P226, DOI 10.1007/s11239-010-0520-2; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Morrison Harry L, 2006, Semin Intervent Radiol, V23, P258, DOI 10.1055/s-2006-948765; NILSSON L, 1992, EUR J VASCULAR SURG, V6, P189, DOI 10.1016/S0950-821X(05)80239-7; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Ouriel K, 2004, J VASC INTERV RADIOL, V15, P229, DOI 10.1079/01.RVI.0000116193.44877.0F; OURIEL K, 1994, J VASC SURG, V19, P1021, DOI 10.1016/S0741-5214(94)70214-4; Ouriel K, 1996, J VASC SURG, V23, P64, DOI 10.1016/S0741-5214(05)80036-9; Ouriel K, 1998, NEW ENGL J MED, V338, P1105, DOI 10.1056/NEJM199804163381603; Raabe RD, 2010, J VASC INTERV RADIOL, V21, P1165, DOI 10.1016/j.jvir.2010.03.020; Rajan DK, 2005, J VASC INTERV RADIOL, V16, P585, DOI 10.1097/01.RVI.0000156191.83408.B4; Razavi MK, 2004, J VASC INTERV RADIOL, V15, P13, DOI 10.1097/01.RVI.0000112621.22203.12; Robertson I, 2010, COCHRANE DB SYST REV, V3; Robinson WP, 2009, SEMIN VASC SURG, V22, P17, DOI 10.1053/j.semvascsurg.2008.12.005; Rogers JH, 2007, CIRCULATION, V116, P2072, DOI 10.1161/CIRCULATIONAHA.107.715433; Rutherford RB, 2001, J VASC SURG, V33, P805; Sarac TP, 2004, J VASC SURG, V39, P556, DOI 10.1016/j.jvs.2003.10.061; van den Berg JC, 2010, J VASC SURG, V52, P512, DOI 10.1016/j.jvs.2010.01.080	34	177	190	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2198	2206		10.1056/NEJMcp1006054	http://dx.doi.org/10.1056/NEJMcp1006054			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670905				2022-12-28	WOS:000304863400009
J	Bhatnagar, S; Wadhwa, N; Aneja, S; Lodha, R; Kabra, SK; Natchu, UCM; Sommerfelt, H; Dutta, AK; Chandra, J; Rath, B; Sharma, M; Sharma, VK; Kumari, M; Strand, TA				Bhatnagar, Shinjini; Wadhwa, Nitya; Aneja, Satinder; Lodha, Rakesh; Kabra, Sushil Kumar; Natchu, Uma Chandra Mouli; Sommerfelt, Halvor; Dutta, Ashok Kumar; Chandra, Jagdish; Rath, Bimbadhar; Sharma, Mamta; Sharma, Vinod Kumar; Kumari, Mohini; Strand, Tor A.			Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							ORAL ZINC; SUPPLEMENTATION; CHILDREN; PNEUMONIA; DIARRHEA; THERAPY	Background Serious bacterial infections are a major cause of death in early infancy in developing countries. Inexpensive and accessible interventions that can add to the effect of standard antibiotic treatment could reduce infant mortality. We measured the effect of zinc as an adjunct to antibiotics in infants with probable serious bacterial infection. Methods In this randomised, double-blind, placebo-controlled trial, we enrolled infants aged 7-120 days with probable serious bacterial infection at three hospitals in New Delhi, India, between July 6, 2005, and Dec 3, 2008. With computer-generated sequences, we randomly assigned infants in permuted blocks of six, stratified by whether patients were underweight or had diarrhoea at enrolment, to receive either 10 mg of zinc or placebo orally every day in addition to standard antibiotic treatment. The primary outcome was treatment failure, which was defined as a need to change antibiotics within 7 days of randomisation, or a need for intensive care, or death at any time within 21 days. Participants and investigators were masked to treatment allocation. All analyses were done by intention-to-treat. This trial is registered with ClinicalTrials.gov, number NCT00347386. Findings 352 infants were randomly assigned to receive zinc and 348 to placebo. 332 given zinc and 323 given placebo could be assessed for treatment failure. Significantly fewer treatment failures occurred in the zinc group (34 [10%]) than in the placebo group (55 [17%]; relative risk reduction 40%, 95% CI 10-60, p=0.0113; absolute risk reduction 6.8%, 1.5-12.0, p=0.0111). Treatment of 15 (95% CI eight to 67) infants with zinc would prevent one treatment failure. Ten infants receiving zinc died compared with 17 given placebo (relative risk 0.57, 0.27-1.23, p=0.15). Interpretation Zinc could be given as adjunct treatment to reduce the risk of treatment failure in infants aged 7-120 days with probable serious bacterial infection.	[Bhatnagar, Shinjini; Wadhwa, Nitya] All India Inst Med Sci, Ctr Diarrhoeal Dis & Nutr Res, New Delhi, India; [Lodha, Rakesh; Kabra, Sushil Kumar] All India Inst Med Sci, Dept Paediat, New Delhi, India; [Bhatnagar, Shinjini; Wadhwa, Nitya; Natchu, Uma Chandra Mouli] Translat Hlth Sci & Technol Inst, Paediat Biol Ctr, Gurgaon 122016, Haryana, India; [Aneja, Satinder; Dutta, Ashok Kumar; Chandra, Jagdish] Lady Hardinge Med Coll & Hosp, Dept Paediat, New Delhi, India; [Aneja, Satinder; Dutta, Ashok Kumar; Chandra, Jagdish] Kalawati Saran Childrens Hosp, New Delhi, India; [Natchu, Uma Chandra Mouli] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor; Strand, Tor A.] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Sharma, Mamta; Sharma, Vinod Kumar; Kumari, Mohini] Deen Dayal Upadhyay Hosp, Dept Paediat, New Delhi, India; [Strand, Tor A.] Innlandet Hosp Trust, Dept Lab Med, Lillehammer, Norway	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Lady Hardinge Medical College & Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Bergen; Norwegian Institute of Public Health (NIPH); Innlandet Hospital Trust	Bhatnagar, S (corresponding author), Translat Hlth Sci & Technol Inst, Paediat Biol Ctr, Gurgaon 122016, Haryana, India.	shinjini.bhatnagar@thsti.res.in	Sommerfelt, Halvor/ABD-3552-2020; Strand, Tor/D-9836-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Strand, Tor/0000-0002-4038-151X; bhatnagar, shinjini/0000-0003-1703-5296	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR5238/MED/14/610/2004]; European Commission (EU-INCO-DC) [INCO-FP6-003740]; Meltzer Foundation (Bergen, Norway); Research Council of Norway [172226]; Meltzer Foundation; European Commission	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); European Commission (EU-INCO-DC)(European CommissionEuropean Commission Joint Research Centre); Meltzer Foundation (Bergen, Norway); Research Council of Norway(Research Council of Norway); Meltzer Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	Department of Biotechnology, Government of India; the European Commission; the Meltzer Foundation; and the Research Council of Norway.; The study was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR5238/MED/14/610/2004). We also received funding from the European Commission (EU-INCO-DC contract number INCO-FP6-003740), the Meltzer Foundation (Bergen, Norway), and the Research Council of Norway (project number 172226). We thank the medical and nursing staff of the three hospitals for their contribution; the patients and their parents; Ritu Chawla, Uday Pal Singh Kainth, Anil Gulati, Arvind Bagga, and Madhulika Kabra for providing clinical support to patients enrolled in the study at the Deen Dayal Upadhyay Hospital and All India Institute of Medical Sciences; Arti Kapil for supervising the blood cultures; Anil Kumar Sharma for assisting in quality assurance and supervision of the research staff; Savita Saini for undertaking the micronutrient assays and providing technical support for all other laboratory work; Mukesh Juyal for secretarial support; Dharmendra Sharma for data management support and analysis of data; and Olivier Fontaine (WHO) for providing the intervention (zinc and placebo tablets from Nutriset) and periodic reviews of study procedures.	Auriti C, 2012, ARCH DIS CHILD-FETAL, V97, pF488, DOI 10.1136/adc.2010.194100; Bao SY, 2010, AM J PHYSIOL-LUNG C, V298, pL744, DOI 10.1152/ajplung.00368.2009; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Beck FWJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE1002, DOI 10.1152/ajpendo.1997.272.6.E1002; Bhatnagar S, 2004, J PEDIATR GASTR NUTR, V38, P34, DOI 10.1097/00005176-200401000-00010; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; HAMBIDGE KM, 1990, J TRACE ELEM ELECT H, V4, P229; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Lazzerini M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005436.pub2; Lopez AF, 2003, PEDIATR INFECT DIS J, V22, P895, DOI 10.1097/01.inf.0000091360.11784.21; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; MOCCHEGIANI E, 1995, INT J IMMUNOPHARMACO, V17, P719, DOI 10.1016/0192-0561(95)00060-F; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; Natchu UCM, 2008, NUTR REV, V66, P398, DOI 10.1111/j.1753-4887.2008.00049.x; National Center for Health Statistics, 2000, IND GROWTH CHARTS; Palmer A, 2004, ANN TROP PAEDIATR, V24, P205, DOI 10.1179/027249304225018948; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; PRASAD AS, 1988, J CLIN INVEST, V82, P1202, DOI 10.1172/JCI113717; Prasad AS, 1999, AM J HEMATOL, V61, P194, DOI 10.1002/(SICI)1096-8652(199907)61:3<194::AID-AJH6>3.0.CO;2-C; SAZAWAL S, 1997, PEDIATRICS, V34, P589; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Sheikh A, 2010, J NUTR, V140, P1049, DOI 10.3945/jn.109.111492; Smith PG, 1996, FIELD TRIALS HLTH IN, P42; Valentiner-Branth P, 2010, AM J CLIN NUTR, V91, P1667, DOI 10.3945/ajcn.2009.28907; World Health Organization, 2003, INT MAN NEON CHILDH	27	62	62	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2072	2078		10.1016/S0140-6736(12)60477-2	http://dx.doi.org/10.1016/S0140-6736(12)60477-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22656335				2022-12-28	WOS:000304759100032
J	Tsen, AW; Brown, L; Levendorf, MP; Ghahari, F; Huang, PY; Havener, RW; Ruiz-Vargas, CS; Muller, DA; Kim, P; Park, J				Tsen, Adam W.; Brown, Lola; Levendorf, Mark P.; Ghahari, Fereshte; Huang, Pinshane Y.; Havener, Robin W.; Ruiz-Vargas, Carlos S.; Muller, David A.; Kim, Philip; Park, Jiwoong			Tailoring Electrical Transport Across Grain Boundaries in Polycrystalline Graphene	SCIENCE			English	Article							CHEMICAL-VAPOR-DEPOSITION; HIGH-QUALITY; FILMS	Graphene produced by chemical vapor deposition (CVD) is polycrystalline, and scattering of charge carriers at grain boundaries (GBs) could degrade its performance relative to exfoliated, single-crystal graphene. However, the electrical properties of GBs have so far been addressed indirectly without simultaneous knowledge of their locations and structures. We present electrical measurements on individual GBs in CVD graphene first imaged by transmission electron microscopy. Unexpectedly, the electrical conductance improves by one order of magnitude for GBs with better interdomain connectivity. Our study suggests that polycrystalline graphene with good stitching may allow for uniformly high electrical performance rivaling that of exfoliated samples, which we demonstrate using optimized growth conditions and device geometry.	[Brown, Lola; Levendorf, Mark P.; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Tsen, Adam W.; Huang, Pinshane Y.; Havener, Robin W.; Ruiz-Vargas, Carlos S.; Muller, David A.] Cornell Univ, Dept Appl Phys, Ithaca, NY 14853 USA; [Ghahari, Fereshte; Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Muller, David A.; Park, Jiwoong] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Columbia University; Cornell University	Park, J (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jpark@cornell.edu	Muller, David/A-7745-2010; Kim, Philip/N-1886-2013; Park, Jiwoong/C-2327-2013	Muller, David/0000-0003-4129-0473; Kim, Philip/0000-0002-8255-0086; Ghahari Kermani, Fereshte/0000-0003-0317-4009; Huang, Pinshane/0000-0002-1095-1833	Air Force Office of Scientific Research [FA9550-09-1-0691, FA9550-10-1-0410]; NSF through the Cornell Center for Materials Research [NSF DMR-1120296]; Fullbright scholarship; NSF [DGE-0707428]; Consejo Nacional de Ciencia y Tecnologia Mexico	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the Cornell Center for Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Fullbright scholarship; NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank B. Ilic and P. L. McEuen for helpful discussions. This work was mainly supported by Air Force Office of Scientific Research grants (FA9550-09-1-0691 and FA9550-10-1-0410) and the NSF through the Cornell Center for Materials Research (NSF DMR-1120296). L. B. was partially supported by a Fullbright scholarship; P.Y.H. was supported by an NSF Graduate Research Fellowship (DGE-0707428); R. W. H. was supported by an NSF Graduate Research Fellowship; and C.S.R.-V. was partially supported by Consejo Nacional de Ciencia y Tecnologia Mexico. Sample fabrication was performed at the Cornell NanoScale Science and Technology Facility.	Adam S, 2007, P NATL ACAD SCI USA, V104, P18392, DOI 10.1073/pnas.0704772104; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Chen JH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236805; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Gannett W, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599708; Holt DB, 2007, EXTENDED DEFECTS IN SEMICONDUCTORS: ELECTRONIC PROPERTIES, DEVICE EFFECTS AND STRUCTURES, P1, DOI 10.1017/CBO9780511534850; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jauregui LA, 2011, SOLID STATE COMMUN, V151, P1100, DOI 10.1016/j.ssc.2011.05.023; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Li XS, 2011, J AM CHEM SOC, V133, P2816, DOI 10.1021/ja109793s; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Mesaros A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205119; Ni GX, 2012, ACS NANO, V6, P1158, DOI 10.1021/nn203775x; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Robertson AW, 2011, ACS NANO, V5, P6610, DOI 10.1021/nn202051g; Shon NH, 1998, J PHYS SOC JPN, V67, P2421, DOI 10.1143/JPSJ.67.2421; Stauber T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205423; Tan YW, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246803; Tan YW, 2007, EUR PHYS J-SPEC TOP, V148, P15, DOI 10.1140/epjst/e2007-00221-9; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/nmat2830, 10.1038/NMAT2830]; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/NMAT3010, 10.1038/nmat3010]	24	472	483	17	413	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1143	1146		10.1126/science.1218948	http://dx.doi.org/10.1126/science.1218948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654054				2022-12-28	WOS:000304647900045
J	Speirs, V				Speirs, Valerie			PERSPECTIVE Not just for women	NATURE			English	Editorial Material									Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Speirs, V (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England.	v.speirs@leeds.ac.uk	Speirs, Valerie/ABE-7377-2021	Speirs, Valerie/0000-0002-0602-4666				Curtis C, 2012, NATURE          0418, DOI [10.1038/nature10983, DOI 10.1038/NATURE10983]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; White J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2930	6	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S66	S66		10.1038/485S66a	http://dx.doi.org/10.1038/485S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648505				2022-12-28	WOS:000304608000009
J	Szpilman, D; Bierens, JJLM; Handley, AJ; Orlowski, JP				Szpilman, David; Bierens, Joost J. L. M.; Handley, Anthony J.; Orlowski, James P.			CURRENT CONCEPTS Drowning	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HOSPITAL CARDIAC-ARREST; ACCIDENTAL HYPOTHERMIA; UTSTEIN STYLE; RESUSCITATION; MORTALITY; CHILDREN; RESCUE; PREVENTION; GUIDELINES; EXPERIENCE	ACCORDING TO THE WORLD HEALTH ORGANIZATION (WHO), 0.7% OF ALL deaths worldwide - or more than 500,000 deaths each year(1) - are due to unintentional drowning.(2) Since some cases of fatal drowning are not classified as such according to the codes of the International Classification of Disease, this number underestimates the real figures, even for high-income countries,(3) and does not include drownings that occur as a result of floods, tsunamis, and boating accidents. Drowning is a leading cause of death worldwide among boys 5 to 14 years of age.(2) In the United States, drowning is the second leading cause of injury-related death among children 1 to 4 years of age, with a death rate of 3 per 100,000,(4) and in some countries, such as Thailand, the death rate among 2-year-old children is 107 per 100,000.(5) In many countries in Africa and in Central America, the incidence of drowning is 10 to 20 times as high as the incidence in the United States. Key risk factors for drowning are male sex,(4) age of less than 14 years,(6) alcohol use,(7) low income,(1) poor education,(5) rural residency,(5) aquatic exposure,(6,7) risky behavior,(6,7) and lack of supervision.(6) For people with epilepsy, the risk of drowning is 15 to 19 times as high as the risk for those who do not have epilepsy.(8) Exposure-adjusted, person-time estimates for drowning are 200 times as high as such estimates for deaths from traffic accidents.(9) Coastal drownings are estimated to cost more than $273 million per year in the United States(10) and more than $228 million per year (in U. S. dollars) in Brazil.(11) For every person who dies from drowning, another four persons receive care in the emergency department for nonfatal drowning.(12)	[Szpilman, David] Hosp Municipal Miguel Couto, Adult Intens Care Unit, Rio De Janeiro, Brazil; [Szpilman, David] Corpo Bombeiros Militar, Rio De Janeiro, Brazil; [Bierens, Joost J. L. M.] Soc Prevent People Drowning, Amsterdam, Netherlands; [Handley, Anthony J.] Royal Life Saving Soc UK, Broom, Warwick, England; [Orlowski, James P.] Florida Hosp, Tampa, FL USA; [Orlowski, James P.] Univ S Florida, Tampa, FL USA	Adventist Health Services; AdventHealth; (AdventHealth) West Florida Division; West Florida Hospital; AdventHealth Tampa; State University System of Florida; University of South Florida	Szpilman, D (corresponding author), Av Amer 3555,Bloco 2,Sala 302, BR-22631003 Rio De Janeiro, Brazil.	david@szpilman.com	Szpilman, David/F-1682-2013; Bierens, Joost/AAW-8332-2020	Bierens, Joost/0000-0003-4467-8211; Szpilman, David/0000-0003-3961-3640				[Anonymous], 2008, INF SAUD MIN SAUD BR; [Anonymous], 2003, INJ VIOL PREV NONC D; Baker PA, 2011, ANAESTH INTENS CARE, V39, P675, DOI 10.1177/0310057X1103900423; Beerman S, 2006, DROWNING PREVENTION, P331; Bell GS, 2008, NEUROLOGY, V71, P578, DOI 10.1212/01.wnl.0000323813.36193.4d; Borse NNGJ., 2008, CDC CHILDHOOD INJURY; CDC, 2021, CTR DIS CONTROL PREV; Claesson A, 2008, RESUSCITATION, V76, P381, DOI 10.1016/j.resuscitation.2007.09.003; CM Branche, 2001, LIFE GUARD EFFECTIVE; Cubattoli L, 2009, RESUSCITATION, V80, P1088, DOI 10.1016/j.resuscitation.2009.05.017; Cummings P, 2011, INJURY PREV, V17, P156, DOI 10.1136/ip.2010.028688; Diamond W, 2011, PREHOSP EMERG CARE, V15, P288, DOI 10.3109/10903127.2010.545480; EGGINK WF, 1977, NETH J MED, V20, P162; Eich C, 2007, RESUSCITATION, V75, P42, DOI 10.1016/j.resuscitation.2007.03.013; Foex BA, 2001, EMERG MED J, V18, P465, DOI 10.1136/emj.18.6.465; Gauger PG, 1996, CRIT CARE MED, V24, P16, DOI 10.1097/00003246-199601000-00006; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Gregorakos L, 2009, LUNG, V187, P93, DOI 10.1007/s00408-008-9132-4; Grmec S, 2009, INT J EMERG MED, V2, P7, DOI 10.1007/s12245-009-0084-0; Guenther U, 2009, RESUSCITATION, V80, P379, DOI 10.1016/j.resuscitation.2008.11.019; Idris AH, 2003, CIRCULATION, V108, P2565, DOI 10.1161/01.CIR.0000099581.70012.68; International Life Saving Federation Medical Committee, 2008, CLAR STAT CARD RES D; Kapur N, 2009, PEDIATR PULM, V44, P1043, DOI 10.1002/ppul.21088; Kochanek PM, 2010, JAMA-J AM MED ASSOC, V303, P2190, DOI 10.1001/jama.2010.715; Linnan M., 2007, SPECIAL SERIES CHILD; Lu TH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-30; MANOLIOS N, 1988, MED J AUSTRALIA, V148, P165, DOI 10.5694/j.1326-5377.1988.tb112805.x; Mitchell RJ, 2010, INJURY PREV, V16, P261, DOI 10.1136/ip.2009.024307; Modell JH, 2010, SOUTH MED J, V103, P650, DOI 10.1097/SMJ.0b013e3181e10564; MODELL JH, 1976, CHEST, V70, P231, DOI 10.1378/chest.70.2.231; Moran K., 2011, International Journal of Aquatic Research and Education, V5, P251; Oehmichen Manfred, 2008, Legal Medicine, V10, P1, DOI 10.1016/j.legalmed.2007.05.007; ORLOWSKI JP, 1989, ANN EMERG MED, V18, P1044, DOI 10.1016/S0196-0644(89)80927-8; Orlowski JP, 2001, PEDIATR CLIN N AM, V48, P627, DOI 10.1016/S0031-3955(05)70331-X; Peden M, 2002, INJURY CHART BOOK GR; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Quan L., 2007, Handbook of injury and violence prevention, P81, DOI 10.1007/978-0-387-29457-5_5; Quan L, 2003, INJURY PREV, V9, P163, DOI 10.1136/ip.9.2.163; Rafaat KT, 2008, PEDIATR CRIT CARE ME, V9, P567, DOI 10.1097/PCC.0b013e31818c8955; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Spicer ST, 1999, J AM SOC NEPHROL, V10, P382; STERBA JA, 1985, UNDERSEA BIOMED RES, V12, P139; Szpilman D, 2004, RESUSCITATION, V63, P25, DOI 10.1016/j.resuscitation.2004.03.017; Szpilman D, 1997, CHEST, V112, P660, DOI 10.1378/chest.112.3.660; Szpilman D, 2002, WORLD C DROWN AMST J; Szpilman D, 2006, HDB DROWNING PREVENT, P336; Takano Y, 1999, Nihon Kokyuki Gakkai Zasshi, V37, P997; Tipton MJ, 2011, RESUSCITATION, V82, P819, DOI 10.1016/j.resuscitation.2011.02.021; van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853; vanBerkel M, 1996, INTENS CARE MED, V22, P101, DOI 10.1007/BF01720715; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Venema AM, 2010, RESUSCITATION, V81, P434, DOI 10.1016/j.resuscitation.2010.01.005; Warner D, 2006, DROWNING PREVENTION, P436; Watson RS, 2001, J TRAUMA, V51, P658, DOI 10.1097/00005373-200110000-00006; Weiss SJ, 2000, RESUSCITATION, V45, P201, DOI 10.1016/S0300-9572(00)00185-4; Wood C, 2010, EMERG MED J, V27, P393, DOI 10.1136/emj.2010.094888; Youn CS, 2009, RESUSCITATION, V80, P778, DOI 10.1016/j.resuscitation.2009.04.007	57	190	200	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2102	2110		10.1056/NEJMra1013317	http://dx.doi.org/10.1056/NEJMra1013317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646632	Bronze			2022-12-28	WOS:000304613400010
J	Zomer, E; Owen, A; Magliano, DJ; Liew, D; Reid, CM				Zomer, Ella; Owen, Alice; Magliano, Dianna J.; Liew, Danny; Reid, Christopher M.			The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; DEPENDENT VASODILATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; HEALTHY HUMANS; NITRIC-OXIDE; COCOA; HYPERTENSION; METAANALYSIS	Objective To model the long term effectiveness and cost effectiveness of daily dark chocolate consumption in a population with metabolic syndrome at high risk of cardiovascular disease. Design Best case scenario analysis using a Markov model. Setting Australian Diabetes, Obesity and Lifestyle study. Participants 2013 people with hypertension who met the criteria for metabolic syndrome, with no history of cardiovascular disease and not receiving antihypertensive therapy. Main outcome measures Treatment effects associated with dark chocolate consumption derived from published meta-analyses were used to determine the absolute number of cardiovascular events with and without treatment. Costs associated with cardiovascular events and treatments were applied to determine the potential amount of funding required for dark chocolate therapy to be considered cost effective. Results Daily consumption of dark chocolate (polyphenol content equivalent to 100 g of dark chocolate) can reduce cardiovascular events by 85 (95% confidence interval 60 to 105) per 10 000 population treated over 10 years. $A40 (25; pound (sic)31; $42) could be cost effectively spent per person per year on prevention strategies using dark chocolate. These results assume 100% compliance and represent a best case scenario. Conclusions The blood pressure and cholesterol lowering effects of dark chocolate consumption are beneficial in the prevention of cardiovascular events in a population with metabolic syndrome. Daily dark chocolate consumption could be an effective cardiovascular preventive strategy in this population.	[Zomer, Ella; Owen, Alice; Reid, Christopher M.] Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, CCRE Therapeut, Melbourne, Vic 3004, Australia; [Magliano, Dianna J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Liew, Danny] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne EpiCtr, Melbourne, Vic 3010, Australia	Monash University; Baker Heart and Diabetes Institute; Royal Melbourne Hospital; University of Melbourne	Reid, CM (corresponding author), Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, CCRE Therapeut, Melbourne, Vic 3004, Australia.	Chris.Reid@monash.edu	Reid, Christopher M/AAP-8135-2021; Zomer, Ella/AAE-2462-2019	Reid, Christopher/0000-0001-9173-3944; Magliano, Dianna/0000-0002-9507-6096; Zomer, Ella/0000-0002-9993-4297; Liew, Danny/0000-0002-0131-623X; Magliano, Dianna Josephine/0000-0002-6026-5065	Australian Research Council [LP0775329]; Sanofi-Aventis Australia	Australian Research Council(Australian Research Council); Sanofi-Aventis Australia(Sanofi-Aventis)	This research was supported by an Australian Research Council linkage grant (LP0775329) with Sanofi-Aventis Australia.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Institute of Health and Welfare, 2011, NAT GRIM BOOKS; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Egan BM, 2010, HYPERTENSION, V55, P1289, DOI 10.1161/HYPERTENSIONAHA.110.151522; Field DT, 2011, PHYSIOL BEHAV, V103, P255, DOI 10.1016/j.physbeh.2011.02.013; Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016; Fraga CG, 2011, J CLIN BIOCHEM NUTR, V48, P63, DOI 10.3164/jcbn.11-010FR; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Hollenberg N.K., 2004, BRIT J CARDIOLOGY, V11, P379; Huynh Tai, 2004, Physician Exec, V30, P56; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Lippi G, 2009, J THROMB THROMBOLYS, V28, P482, DOI 10.1007/s11239-008-0273-3; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457; Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Ohman EM, 2006, AM HEART J, V295, P180; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Ried K, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-22; Salkeld G, 1997, HEALTH POLICY, V41, P105, DOI 10.1016/S0168-8510(97)00015-8; Serafini M, 2003, NATURE, V424, P1013, DOI 10.1038/4241013a; Severens JL, 2004, VALUE HEALTH, V7, P397, DOI 10.1111/j.1524-4733.2004.74002.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Sun X, 2008, EUR J HEALTH ECON, V9, P313, DOI 10.1007/s10198-007-0078-x; Taubert D, 2003, JAMA-J AM MED ASSOC, V290, P1029, DOI 10.1001/jama.290.8.1029; Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Walker A, 2010, INT J SIMUL PROCESS, V6, P137; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; World Health Organization, 2007, CARD DIS FACT SHEET	39	29	29	0	68	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3657	10.1136/bmj.e3657	http://dx.doi.org/10.1136/bmj.e3657			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22653982	Green Published, hybrid			2022-12-28	WOS:000304857000007
J	Liao, JM				Liao, Joshua M.			Patient safety: an educational competency	LANCET			English	Editorial Material									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Liao, JM (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	jmliao@bcm.edu						Aboumatar HJ, 2012, BMJ QUAL SAF, V21, P416, DOI 10.1136/bmjqs-2011-000463; Agency for Healthcare Research and Quality, AHRQ PAT SAF NETW SA; Nie YL, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-33; Sorokin R, 2011, J PATIENT SAF, V7, P133, DOI 10.1097/PTS.0b013e31822a9c5e; Wetzel AP, 2012, EVAL HEALTH PROF, V35, P221, DOI 10.1177/0163278711414560; Wilson RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e832; Wong BM, 2010, ACAD MED, V85, P1425, DOI 10.1097/ACM.0b013e3181e2d0c6	7	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1933	1933		10.1016/S0140-6736(12)60833-2	http://dx.doi.org/10.1016/S0140-6736(12)60833-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22633024				2022-12-28	WOS:000304757700011
J	Cassel, CK				Cassel, Christine K.			Retail Clinics and Drugstore Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; ILLNESSES		Amer Board Internal Med, Philadelphia, PA 19106 USA	American Board of Internal Medicine	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						Ahmed A, 2010, ANN FAM MED, V8, P117, DOI 10.1370/afm.1052; Ashwood JS, 2011, AM J MANAG CARE, V17, pE443; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; President's Council of Advisors on Science and Technology, 2010, REP PRES REAL FULL P; United States Department of Commerce, 2011, INC POV HLTH INS COV	7	24	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2151	2152		10.1001/jama.2012.3966	http://dx.doi.org/10.1001/jama.2012.3966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618918				2022-12-28	WOS:000304315200020
J	de Waal, FBM				de Waal, Frans B. M.			THE ANTIQUITY OF EMPATHY	SCIENCE			English	Editorial Material							CHIMPANZEES; ALTRUISM; CONSOLATION	The view of humans as violent war-prone apes is poorly supported by archaeological evidence and only partly supported by the behavior of our closest primate relatives, chimpanzees and bonobos. Whereas the first species is marked by xenophobia, the second is relatively peaceful and highly empathic in both behavior and brain organization. Animal empathy is best regarded as a multilayered phenomenon, built around motor mirroring and shared neural representations at basal levels, that develops into more advanced cognitive perspective-taking in large-brained species. As indicated by both observational and experimental studies on our closest relatives, empathy may be the main motivator of prosocial behavior.	[de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [de Waal, Frans B. M.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Emory University; Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	dewaal@emory.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378				Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Boesch C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008901; Boyd R, 2006, SCIENCE, V314, P1555, DOI 10.1126/science.1136841; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Coolidge HJ, 1933, AM J PHYS ANTHROPOL, V18, P1, DOI 10.1002/ajpa.1330180113; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Fry DP., 2006, HUMAN POTENTIAL PEAC; Grossman Dave, 1995, KILLING PSYCHOL COST; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harcourt AH., 1992, COALITIONS ALLIANCES; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Smuts B. B., 1999, SEX FRIENDSHIP BABOO; Thorpe IJN, 2003, WORLD ARCHAEOL, V35, P145, DOI 10.1080/0043824032000079198; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	28	127	133	11	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					874	876		10.1126/science.1220999	http://dx.doi.org/10.1126/science.1220999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605767				2022-12-28	WOS:000304145600053
J	Sambanis, N; Schulhofer-Wohl, J; Shayo, M				Sambanis, Nicholas; Schulhofer-Wohl, Jonah; Shayo, Moses			Parochialism as a Central Challenge in Counterinsurgency	SCIENCE			English	Editorial Material							CIVIL-WAR; INTERGROUP CONFLICT; GROUP LOYALTY; ALTRUISM; TERRORISM; IDENTITY; PARTICIPATION; AFGHANISTAN; PREFERENCES; DIVERSITY		[Sambanis, Nicholas] Yale Univ, Dept Polit Sci, New Haven, CT 06520 USA; [Schulhofer-Wohl, Jonah] Princeton Univ, Woodrow Wilson Sch, Niehaus Ctr Globalizat & Governance, Princeton, NJ 08544 USA; [Shayo, Moses] Hebrew Univ Jerusalem, Dept Econ, IL-91905 Jerusalem, Israel	Yale University; Princeton University; Hebrew University of Jerusalem	Sambanis, N (corresponding author), Yale Univ, Dept Polit Sci, New Haven, CT 06520 USA.	nicholas.sambanis@yale.edu		Schulhofer-Wohl, Jonah/0000-0001-9259-7307				Abadie A, 2006, AM ECON REV, V96, P50, DOI 10.1257/000282806777211847; Alexander M, 2011, SCIENCE, V334, P1392, DOI 10.1126/science.1202599; Beath Andrew, 2012, 201114 MIT; Belasco A., 2011, 33110 RL CRS; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; Berman E, 2011, J POLIT ECON, V119, P766, DOI 10.1086/661983; Berman E, 2011, J CONFLICT RESOLUT, V55, P496, DOI 10.1177/0022002710393920; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bettencourt BA, 2001, PSYCHOL BULL, V127, P520, DOI 10.1037//0033-2909.127.4.520; Biddle S, 2008, PERSPECT POLIT, V6, P347, DOI 10.1017/S1537592708081164; Blattman C, 2009, AM POLIT SCI REV, V103, P231, DOI 10.1017/S0003055409090212; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Bourhis R. Y., 2001, BLACKWELL HDB SOCIAL, V4, P89; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Christia F, 2009, FOREIGN AFF, V88, P34; Costa DL, 2003, Q J ECON, V118, P519, DOI 10.1162/003355303321675446; Crost B., 2011, AID FIRE DEV PROJECT; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Dovidio J.F., 2010, HDB SOCIAL PSYCHOL, P1084, DOI DOI 10.1002/9780470561119.S0CPSY002029; Doyle Michael W., 2006, MAKING WAR BUILDING; Eckel CC, 2005, J ECON BEHAV ORGAN, V58, P371, DOI 10.1016/j.jebo.2004.01.003; Felter, 2010, 16152 NBER; Fong CM, 2009, AM ECON J-APPL ECON, V1, P64, DOI 10.1257/app.1.2.64; Galula David, 1964, COUNTERINSURGENCY WA; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Habyarimana J, 2007, AM POLIT SCI REV, V101, P709, DOI 10.1017/S0003055407070499; Hegre H, 2006, J CONFLICT RESOLUT, V50, P508, DOI 10.1177/0022002706289303; Humphreys M, 2008, AM J POLIT SCI, V52, P436, DOI 10.1111/j.1540-5907.2008.00322.x; Iyengar R., 2011, 17297 NBER; Jaeger DA, 2012, J PUBLIC ECON, V96, P354, DOI 10.1016/j.jpubeco.2011.12.001; Kilcullen D., 2010, COUNTERINSURGENCY; Klor EF, 2010, J PUBLIC ECON, V94, P269, DOI 10.1016/j.jpubeco.2009.12.003; Krueger AB, 2003, J ECON PERSPECT, V17, P119, DOI 10.1257/089533003772034925; Leites Nathan, 1970, REBELLION AUTHORITY; Lyall J., 2011, 17 S FRAS U; Nagl Jonh A., 2002, COUNTERINSURGENCY LE; Petraeus David F., 2006, COUNT, p[1, 5, 72]; Sambanis N., 2012, LEITNER WORKING PAPE; Shayo M, 2011, Q J ECON, V126, P1447, DOI 10.1093/qje/qjr022; Stouffer S. A., 1949, AM SOLDIER COMBAT IT, V2; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; U.S. Department of the Army, 2009, US DEP ARM HDB; Wood E. J., 2003, INSURGENT COLLECTIVE	45	29	29	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					805	808		10.1126/science.1222304	http://dx.doi.org/10.1126/science.1222304			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605736				2022-12-28	WOS:000304145600024
J	Mandrup-Poulsen, T				Mandrup-Poulsen, Thomas			Testing failures	NATURE			English	Editorial Material							ANTAGONIST		[Mandrup-Poulsen, Thomas] Univ Copenhagens, Inst Biomed Sci, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Stockholm, Sweden	Karolinska Institutet	Mandrup-Poulsen, T (corresponding author), Univ Copenhagens, Inst Biomed Sci, Copenhagen, Denmark.	tmpo@sund.ku.dk		Mandrup-Poulsen, Thomas/0000-0002-3215-9273				Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8	5	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S17	S17		10.1038/485S17a	http://dx.doi.org/10.1038/485S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968AT	22616101	Bronze			2022-12-28	WOS:000305950100008
J	Persson, LA; Arifeen, S; Ekstrom, EC; Rasmussen, KM; Frongillo, EA; Yunus, M				Persson, Lars Ake; Arifeen, Shams; Ekstrom, Eva-Charlotte; Rasmussen, Kathleen M.; Frongillo, Edward A.; Yunus, Md		MINIMat Study Team	Effects of Prenatal Micronutrient and Early Food Supplementation on Maternal Hemoglobin, Birth Weight, and Infant Mortality Among Children in Bangladesh The MINIMat Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-INCOME COUNTRIES; MULTIPLE MICRONUTRIENT; FETAL-GROWTH; IRON SUPPLEMENTATION; PREGNANCY; NUTRITION; ENERGY; CONSEQUENCES; METAANALYSIS; DEFICIENCY	Context Nutritional insult in fetal life and small size at birth are common in low-income countries and are associated with serious health consequences. Objectives To test the hypothesis that prenatal multiple micronutrient supplementation (MMS) and an early invitation to food supplementation would increase maternal hemoglobin level and birth weight and decrease infant mortality, and to assess whether a combination of these interventions would further enhance these outcomes. Design, Setting, and Participants A randomized trial with a factorial design in Matlab, Bangladesh, of 4436 pregnant women, recruited between November 11, 2001, and October 30, 2003, with follow-up until June 23, 2009. Interventions Participants were randomized into 6 groups; a double-masked supplementation with capsules of 30 mg of iron and 400 mu g of folic acid, 60 mg of iron and 400 mu g of folic acid, or MMS containing a daily allowance of 15 micronutrients, including 30 mg of iron and 400 mu g of folic acid, was combined with food supplementation (608 kcal 6 days per week) randomized to either early invitation (9 weeks' gestation) or usual invitation (20 weeks' gestation). Main Outcome Measures Maternal hemoglobin level at 30 weeks' gestation, birth weight, and infant mortality. Under 5-year mortality was also assessed. Results Adjusted maternal hemoglobin level at 30 weeks' gestation was 115.0 g/L(95% CI, 114.4-115.5 g/L), with no significant differences among micronutrient groups. Mean maternal hemoglobin level was lower in the early vs usual invitation groups (114.5 vs 115.4 g/L; difference, -0.9 g/L; 95% CI, -1.7 to -0.1; P=.04). There were 3625 live births out of 4436 pregnancies. Mean birth weight among 3267 singletons was 2694 g(95% CI, 2680-2708 g), with no significant differences among groups. The early invitation with MMS group had an infant mortality rate of 16.8 per 1000 live births vs 44.1 per 1000 live births for usual invitation with 60 mg of iron and 400 mu g of folic acid (hazard ratio [HR], 0.38; 95% CI, 0.18-0.78). Early invitation with MMS group had an under 5-year mortality rate of 18 per 1000 live births (54 per 1000 live births for usual invitation with 60 mg of iron and 400 mu g of folic acid; HR, 0.34; 95% CI, 0.18-0.65). Usual invitation with MMS group had the highest incidence of spontaneous abortions and the highest infant mortality rate. Conclusion Among pregnant women in poor communities in Bangladesh, treatment with multiple micronutrients, including iron and folic acid combined with early food supplementation, vs a standard program that included treatment with iron and folic acid and usual food supplementation, resulted in decreased childhood mortality.	[Persson, Lars Ake; Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Arifeen, Shams; Yunus, Md] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Rasmussen, Kathleen M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Frongillo, Edward A.] Univ S Carolina, Dept Hlth Promot Educ & Behav, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Uppsala University; International Centre for Diarrhoeal Disease Research (ICDDR); Cornell University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Persson, LA (corresponding author), Univ Uppsala Hosp, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden.	lars-ake.persson@kbh.uu.se		Arifeen, Shams/0000-0002-5372-5932; Persson, Lars Ake/0000-0003-0710-7954; Raqib, Rubhana/0000-0002-8116-4511; Yunus, Mohammed/0000-0003-1116-4978	ICDDR,B; United Nations Children's Fund; Swedish International Development Cooperation Agency (Sida); UK Medical Research Council; Swedish Research Council; Department for International Development (DFID); Japan Society for the Promotion of Science; Child Health and Nutrition Research Initiative; Uppsala University; US Agency for International Development; Australian Agency for International Development; Canadian International Development Agency; Government of the People's Republic of Bangladesh; Kingdom of the Netherlands; Swiss Agency for Development and Cooperation; Sida	ICDDR,B; United Nations Children's Fund; Swedish International Development Cooperation Agency (Sida); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department for International Development (DFID); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Child Health and Nutrition Research Initiative; Uppsala University; US Agency for International Development(United States Agency for International Development (USAID)); Australian Agency for International Development; Canadian International Development Agency; Government of the People's Republic of Bangladesh; Kingdom of the Netherlands; Swiss Agency for Development and Cooperation; Sida	The MINIMat research study was funded by the ICDDR,B, United Nations Children's Fund, Swedish International Development Cooperation Agency (Sida), UK Medical Research Council, Swedish Research Council, Department for International Development (DFID), Japan Society for the Promotion of Science, Child Health and Nutrition Research Initiative, Uppsala University, and US Agency for International Development. ICDDR,B acknowledges the following donors who provided unrestricted support: Australian Agency for International Development, Canadian International Development Agency, DFID, Government of the People's Republic of Bangladesh, Kingdom of the Netherlands, Swiss Agency for Development and Cooperation, and Sida. Salaries of the MINIMat study team at ICDDR, B were partly supported by the research grants provided to the trial. No other compensations were received by any MINIMat study team member for their contributions.	Ahmed F, 2003, PUBLIC HEALTH NUTR, V6, P447, DOI 10.1079/PHN2002454; Alam DS, 2003, EUR J CLIN NUTR, V57, P151, DOI 10.1038/sj.ejcn.1601514; Allen LH, 2009, FOOD NUTR BULL, V30, pS527, DOI 10.1177/15648265090304S407; Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian PS, 2012, ARCH DIS CHILD-FETAL, V97, pF312, DOI 10.1136/adc.2006.114009; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Ekstrom EC, 2002, AM J CLIN NUTR, V76, P1392, DOI 10.1093/ajcn/76.6.1392; Ekstrom EC, 1996, AM J CLIN NUTR, V64, P368, DOI 10.1093/ajcn/64.3.368; Eneroth H, 2010, J NUTR, V140, P618, DOI 10.3945/jn.109.111740; Fall CHD, 2009, FOOD NUTR BULL, V30, pS533, DOI 10.1177/15648265090304S408; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Hoet JJ, 1999, J PHYSIOL-LONDON, V514, P617, DOI 10.1111/j.1469-7793.1999.617ad.x; Hyder SMZ, 2004, PUBLIC HEALTH NUTR, V7, P1065, DOI 10.1079/PHN2004645; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S17; Kramer M.S., 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000032, 10.1002/14651858]; Lindstrom E, 2011, ACTA OBSTET GYN SCAN, V90, P47, DOI 10.1111/j.1600-0412.2010.01014.x; Margetts BM, 2009, FOOD NUTR BULL, V30, pS517, DOI 10.1177/15648265090304S406; McArdle HJ, 1999, BRIT MED BULL, V55, P499, DOI 10.1258/0007142991902574; Merialdi M, 2003, J NUTR, V133, p1626S, DOI 10.1093/jn/133.5.1626S; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Ronsmans C, 2009, FOOD NUTR BULL, V30, pS547, DOI 10.1177/15648265090304S409; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Shaheen R, 2006, AM J CLIN NUTR, V83, P1355, DOI 10.1093/ajcn/83.6.1355; Shrimpton R, 2009, FOOD NUTR BULL, V30, pS556, DOI 10.1177/15648265090304S410; Tofail F, 2008, AM J CLIN NUTR, V87, P704, DOI 10.1093/ajcn/87.3.704; UNICEF, 2011, STAT WORLD CHILDR 20; UNICEF/WHO/UNU, 1999, COMP MULT MICR SUPPL; World Health Organization, 2007, VERB AUT STAND ASC A	37	131	133	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2050	2059		10.1001/jama.2012.4061	http://dx.doi.org/10.1001/jama.2012.4061			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665104				2022-12-28	WOS:000304048200024
J	Wardlaw, JM; Murray, V; Berge, E; del Zoppo, G; Sandercock, P; Lindley, RL; Cohen, G				Wardlaw, Joanna M.; Murray, Veronica; Berge, Eivind; del Zoppo, Gregory; Sandercock, Peter; Lindley, Richard L.; Cohen, Geoff			Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis	LANCET			English	Article							INTRAVENOUS ALTEPLASE; THROMBOLYTIC THERAPY; CONTROLLED-TRIAL; POOLED ANALYSIS; DOUBLE-BLIND; RT-PA; ATLANTIS; ECASS; EPITHET; NINDS	Background Recombinant tissue plasminogen activator (rt-PA, alteplase) improved functional outcome in patients treated soon after acute ischaemic stroke in randomised trials, but licensing is restrictive and use varies widely. The IST-3 trial adds substantial new data. We therefore assessed all the evidence from randomised trials for rt-PA in acute ischaemic stroke in an updated systematic review and meta-analysis. Methods We searched for randomised trials of intravenous rt-PA versus control given within 6 h of onset of acute ischaemic stroke up to March 30, 2012. We estimated summary odds ratios (ORs) and 95% CI in the primary analysis for prespecified outcomes within 7 days and at the final follow-up of all patients treated up to 6 h after stroke. Findings In up to 12 trials (7012 patients), rt-PA given within 6 h of stroke significantly increased the odds of being alive and independent (modified Rankin Scale, mRS 0-2) at final follow-up (1611/3483 [46.3%] vs 1434/3404 [42.1%], OR 1.17, 95% CI 1.06-1.29; p=0.001), absolute increase of 42 (19-66) per 1000 people treated, and favourable outcome (mRS 0-1) absolute increase of 55 (95% CI 33-77) per 1000. The benefit of rt-PA was greatest in patients treated within 3 h (mRS 0-2, 365/896 [40.7%] vs 280/883 [31.7%], 1.53, 1.26-1.86, p<0.0001), absolute benefit of 90 (46-135) per 1000 people treated, and mRS 0-1 (283/896 [31.6%] vs 202/883 [22.9%], 1.61, 1.30-1.90; p<0.0001), absolute benefit 87 (46-128) per 1000 treated. Numbers of deaths within 7 days were increased (250/2807 [8.9%] vs 174/2728 [6.4%], 1.44, 1.18-1.76; p=0.0003), but by final follow-up the excess was no longer significant (679/3548 [19.1%] vs 640/3464 [18.5%], 1.06, 0.94-1.20; p=0.33). Symptomatic intracranial haemorrhage (272/3548 [7.7%] vs 63/3463 [1.8%], 3.72, 2.98-4.64; p<0.0001) accounted for most of the early excess deaths. Patients older than 80 years achieved similar benefit to those aged 80 years or younger, particularly when treated early. Interpretation The evidence indicates that intravenous rt-PA increased the proportion of patients who were alive with favourable outcome and alive and independent at final follow-up. The data strengthen previous evidence to treat patients as early as possible after acute ischaemic stroke, although some patients might benefit up to 6 h after stroke.	[Wardlaw, Joanna M.; Sandercock, Peter; Cohen, Geoff] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Murray, Veronica] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; [Berge, Eivind] Oslo Univ Hosp, Dept Internal Med, Oslo, Norway; [del Zoppo, Gregory] Univ Washington, Sch Med, Seattle, WA USA; [Lindley, Richard L.] Univ Sydney, Westmead Hosp, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lindley, Richard L.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Edinburgh; Danderyds Hospital; Karolinska Institutet; University of Oslo; University of Washington; University of Washington Seattle; University of Sydney; George Institute for Global Health; University of Sydney	Wardlaw, JM (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Hernandez, María/GYU-3543-2022; Lindley, Richard/B-8148-2013; Wardlaw, Joanna M/Y-3456-2019	Lindley, Richard/0000-0002-0104-5679; Wardlaw, Joanna M/0000-0002-9812-6642; Sandercock, Peter/0000-0001-8484-0135	UK Medical Research Council; Stroke Association; University of Edinburgh; National Health Service Health Technology Assessment Programme; Swedish Heart-Lung Fund; AFA Insurances Stockholm (Arbetsmarknadens Partners Forsakringsbolag); Karolinska Institute; Marianne and Marcus Wallenberg Foundation; Research Council of Norway; Oslo University Hospital; Boehringer Ingelheim; MRC [G0400069, G0800803] Funding Source: UKRI; Medical Research Council [G0400069, G0800803, G0700704B] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038710, R01NS053716] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; University of Edinburgh; National Health Service Health Technology Assessment Programme; Swedish Heart-Lung Fund(Swedish Heart-Lung Foundation); AFA Insurances Stockholm (Arbetsmarknadens Partners Forsakringsbolag); Karolinska Institute(Karolinska Institutet); Marianne and Marcus Wallenberg Foundation; Research Council of Norway(Research Council of Norway); Oslo University Hospital; Boehringer Ingelheim(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	UK Medical Research Council, Stroke Association, University of Edinburgh, National Health Service Health Technology Assessment Programme, Swedish Heart-Lung Fund, AFA Insurances Stockholm (Arbetsmarknadens Partners Forsakringsbolag), Karolinska Institute, Marianne and Marcus Wallenberg Foundation, Research Council of Norway, Oslo University Hospital.; JMW, VM, EB, PS, RIL, and GC are all investigators in the IST-3 trial. JMW was a member of the expert neuroradiological adjudication committee for IST-3 and ECASS 3. GdZ was on the data and safety monitoring committees of the ECASS and ECASS II trials funded by Boehringer Ingelheim. JMW has received reimbursement for expenses for speaking at and attending meetings arranged by Boehringer Ingelheim, is not or has not been on any industry expert panels but did provide independent information to Boehringer Ingelheim to assist with the European license application for rt-PA. RIL has received payment in his role as conference Scientific Committee member and for occasional lectures from Boehringer Ingelheim; he has attended national stroke meetings that were organised and funded by Boehringer Ingelheim; and he is not a member of any industry advisory boards. EB and PS have received payment for lectures at meetings arranged by Boehringer Ingelheim, and reimbursement for costs for attending these meetings.	Albers GW, 2002, STROKE, V33, P493, DOI 10.1161/hs0202.102599; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Bhatnagar P, 2011, J NEUROL NEUROSUR PS, V82, P712, DOI 10.1136/jnnp.2010.223149; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; HALEY EC, 1993, STROKE, V24, P1000, DOI 10.1161/01.STR.24.7.1000; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lorenzano S, 2012, INT J STROKE, V7, P250, DOI 10.1111/j.1747-4949.2011.00747.x; Ma H, 2012, INT J STROKE, V7, P74, DOI 10.1111/j.1747-4949.2011.00730.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mishra NK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6046; MORI E, 1992, NEUROLOGY, V42, P976, DOI 10.1212/WNL.42.5.976; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Wang Shen-yan, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P542; Wardlaw JM, 2003, STROKE, V34, P1437, DOI 10.1161/01.STR.0000072513.72262.7E; WARDLAW JM, 1992, STROKE, V23, P1826, DOI 10.1161/01.STR.23.12.1826; Wardlaw JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Wardlaw JM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4584; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; YAMAGUCHI T, 1993, CEREBROVASC DIS, V3, P269, DOI 10.1159/000108714	26	686	737	3	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2364	2372		10.1016/S0140-6736(12)60738-7	http://dx.doi.org/10.1016/S0140-6736(12)60738-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961ZV	22632907	Green Published			2022-12-28	WOS:000305509600031
J	Blencowe, H; Cousens, S; Oestergaard, MZ; Chou, D; Moller, AB; Narwal, R; Adler, A; Garcia, CV; Rohde, S; Say, L; Lawn, JE				Blencowe, Hannah; Cousens, Simon; Oestergaard, Mikkel Z.; Chou, Doris; Moller, Ann-Beth; Narwal, Rajesh; Adler, Alma; Garcia, Claudia Vera; Rohde, Sarah; Say, Lale; Lawn, Joy E.			National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications	LANCET			English	Article							BODY-MASS INDEX; WEIGHT INFANTS; MORTALITY; SEX; EPIDEMIOLOGY; OUTCOMES; TERM; AGE; STILLBIRTH; RISK	Background Preterm birth is the second largest direct cause of child deaths in children younger than 5 years. Yet, data regarding preterm birth (<37 completed weeks of gestation) are not routinely collected by UN agencies, and no systematic country estimates nor time trend analyses have been done. We report worldwide, regional, and national estimates of preterm birth rates for 184 countries in 2010 with time trends for selected countries, and provide a quantitative assessment of the uncertainty surrounding these estimates. Methods We assessed various data sources according to prespecified inclusion criteria. National Registries (563 datapoints, 51 countries), Reproductive Health Surveys (13 datapoints, eight countries), and studies identified through systematic searches and unpublished data (162 datapoints, 40 countries) were included. 55 countries submitted additional data during WHO's country consultation process. For 13 countries with adequate quality and quantity of data, we estimated preterm birth rates using country-level loess regression for 2010. For 171 countries, two regional multilevel statistical models were developed to estimate preterm birth rates for 2010. We estimated time trends from 1990 to 2010 for 65 countries with reliable time trend data and more than 10 000 livebirths per year. We calculated uncertainty ranges for all countries. Findings In 2010, an estimated 14.9 million babies (uncertainty range 12.3-18.1 million) were born preterm, 11.1% of all livebirths worldwide, ranging from about 5% in several European countries to 18% in some African countries. More than 60% of preterm babies were born in south Asia and sub-Saharan Africa, where 52% of the global livebirths occur. Preterm birth also affects rich countries, for example, USA has high rates and is one of the ten countries with the highest numbers of preterm births. Of the 65 countries with estimated time trends, only three (Croatia, Ecuador, and Estonia), had reduced preterm birth rates 1990-2010. Interpretation The burden of preterm birth is substantial and is increasing in those regions with reliable data. Improved recording of all pregnancy outcomes and standard application of preterm definitions is important. We recommend the addition of a data-quality indicator of the per cent of all live preterm births that are under 28 weeks' gestation. Distinguishing preterm births that are spontaneous from those that are provider-initiated is important to monitor trends associated with increased caesarean sections. Rapid scale up of basic interventions could accelerate progress towards Millennium Development Goal 4 for child survival and beyond.	[Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [Blencowe, Hannah; Cousens, Simon; Narwal, Rajesh; Adler, Alma; Garcia, Claudia Vera] London Sch Hyg & Trop Med, London WC1, England; [Oestergaard, Mikkel Z.; Chou, Doris; Moller, Ann-Beth; Say, Lale] WHO, CH-1211 Geneva, Switzerland; [Rohde, Sarah] Univ Cape Town, ZA-7925 Cape Town, South Africa	Save the Children; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Cape Town	Lawn, JE (corresponding author), Save Children, Saving Newborn Lives, Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020; , lalesay/AAG-1912-2021; Akın, Mustafa Senol/F-5143-2017; Blencowe, Hannah/K-7415-2012	Lawn, Joy/0000-0002-4573-1443; Akın, Mustafa Senol/0000-0003-0055-8277; Blencowe, Hannah/0000-0003-1556-3159	Bill & Melinda Gates Foundation; Save the Children's Saving Newborn Lives programme; March of Dimes; Partnership for Maternal Newborn and Childe Health; WHO, Department of Reproductive Health and Research	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Save the Children's Saving Newborn Lives programme; March of Dimes(March of Dimes); Partnership for Maternal Newborn and Childe Health; WHO, Department of Reproductive Health and Research	Bill & Melinda Gates Foundation through grants to Child Health Epidemiology Reference Group (CHERG) and Save the Children's Saving Newborn Lives programme; March of Dimes; the Partnership for Maternal Newborn and Childe Health; and WHO, Department of Reproductive Health and Research.	Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Barros FC, 2011, REV SAUDE PUBL, V45, P607, DOI 10.1590/S0034-89102011005000019; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blondel A, 2002, BJOG-INT J OBSTET GY, V109, P718; Boerma JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000373; Centre for Disease Control and Prevention, REPR HLTH SURV; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD00; Consultative Council on Obstetric and Paediatric Mortality and Morbidity, 1992, ANN REP YEARS 1991 1; Consultative Council on Obstetric and Paediatric Mortality and Morbidity, 2001, ANN REP YEARS 1991 1; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; CP Howson, 2012, BORN TOO SOON GLOBAL, P78; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Femitha P, 2012, INDIAN J PEDIATR, V79, P1019, DOI 10.1007/s12098-011-0620-9; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-58; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; KHOURY MJ, 1985, AM J OBSTET GYNECOL, V151, P777, DOI 10.1016/0002-9378(85)90518-6; KRAMER MS, 1995, OBSTET GYNECOL, V86, P744, DOI 10.1016/0029-7844(95)00267-U; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2012, BORN TOO SOON GLOBAL, P60; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; March of Dimes PMNCH Save the Children WHO, 2012, BORN TOO SOON GLOBAL, DOI DOI 10.1016/S0140-6736(12)61970-9; Marchant T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-624; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Newnham JP, 2011, AUST NZ J OBSTET GYN, V51, P426, DOI 10.1111/j.1479-828X.2011.01327.x; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; Petrou S, 2006, EARLY HUM DEV, V82, P77, DOI 10.1016/j.earlhumdev.2006.01.002; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Schieve LA, 2000, OBSTET GYNECOL, V96, P194, DOI 10.1016/S0029-7844(00)00883-8; Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Teune MJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.015; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; UN, CHILD HLTH MILL DEV; UN, MAT HLTH MILL DEV IN; UN Statistics Division, INF NAT STAT SYST; United Nations Population Division, 2010, WORLD POP PROSP; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762	66	2699	2850	18	278	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2162	2172		10.1016/S0140-6736(12)60820-4	http://dx.doi.org/10.1016/S0140-6736(12)60820-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955BA	22682464	Green Accepted			2022-12-28	WOS:000304990900032
J	[Anonymous]				[Anonymous]			Sustainable development for health: Rio and beyond	LANCET			English	Editorial Material																			0	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2117	2117						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682444	Bronze			2022-12-28	WOS:000304990900001
J	Cervera, C; Peri, L				Cervera, Carlos; Peri, Luis			Bladder Stone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cervera, Carlos; Peri, Luis] Hosp Clin Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Cervera, C (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.	ccervera@clinic.ub.es	Cervera, Carlos/U-4538-2018	Cervera, Carlos/0000-0002-0161-1749					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					E34	E34						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953JO	22670923				2022-12-28	WOS:000304863400012
J	DeVita, VT; Rosenberg, SA				DeVita, Vincent T., Jr.; Rosenberg, Steven A.			Two Hundred Years of Cancer Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							COMPARING TOTAL MASTECTOMY; NEGATIVE BREAST-CANCER; FOLLOW-UP; COMBINATION CHEMOTHERAPY; LYMPHOCYTES; LUMPECTOMY; THERAPY; IRRADIATION; RADIATION; TUMORS		[DeVita, Vincent T., Jr.] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; [DeVita, Vincent T., Jr.] Yale Univ, Sch Med, Smilow Canc Hosp Yale New Haven, New Haven, CT 06520 USA; [DeVita, Vincent T., Jr.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Rosenberg, Steven A.] NCI, NIH, Bethesda, MD 20892 USA; [Rosenberg, Steven A.] Uniformed Serv Univ Hlth Sci, Sch Med, Bethesda, MD 20814 USA; [Rosenberg, Steven A.] George Washington Univ, Sch Med, Washington, DC USA	Yale University; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; George Washington University	DeVita, VT (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, 333 Cedar St,POB 208028, New Haven, CT 06520 USA.	vincent.devita@yale.edu			NATIONAL CANCER INSTITUTE [ZIABC010984] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adler L., 1912, PRIMARY MALIGNANT GR; [Anonymous], 1964, PUBL PHS; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BONADONNA G, 1976, NEW ENGL J MED, V294, P405, DOI 10.1056/NEJM197602192940801; Boveri T, 1914, FRAGE ENTWICKLUNG MA; Brawley O, STRATEGIC APPROACH C; Byers TE, 2011, DEVITA HELLMAN ROSEN, P261; Byers T, 2006, CANCER-AM CANCER SOC, V107, P396, DOI 10.1002/cncr.21990; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clowes GHA, 1904, FURTHER EVIDENCE IMM; Coutard H, 1932, AM J ROENTGENOL RADI, V28, P313; Curie P., 1898, CR HEBD ACAD SCI, V127, P1215; DeVITA VINCENT T., 1965, PROC AMER ASS CANCER RES, V6, P15; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; FISHER B, 1989, NEW ENGL J MED, V320, P473, DOI 10.1056/NEJM198902233200801; FISHER B, 1993, NEW ENGL J MED, V328, P1581, DOI 10.1056/NEJM199306033282201; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; FISHER B, 1975, NEW ENGL J MED, V292, P117, DOI 10.1056/NEJM197501162920301; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; FISHER B, 1981, NEW ENGL J MED, V305, P1, DOI 10.1056/NEJM198107023050101; FISHER B, 1994, NEW ENGL J MED, V330, P1458; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fisher B, 2007, NEW ENGL J MED, V357, P1051; FREI E, 1965, BLOOD-J HEMATOL, V26, P642, DOI 10.1182/blood.V26.5.642.642; Goodman LS, 1946, JAMA-J AM MED ASSOC, V105, P475; Halsted W S, 1894, Ann Surg, V20, P497, DOI 10.1097/00000658-189407000-00075; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lister J, 1867, Br Med J, V2, P246; Maloney DG, 1997, BLOOD, V90, P2188; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Rontgen WC, 1896, NATURE, V53, P274; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Rous P, 1910, J EXP MED, V12, P696, DOI 10.1084/jem.12.5.696; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; TEMIN HM, 1970, NATURE, V227, P102, DOI 10.1038/227102b0; Virchow R, 1863, CELLULAR PATHOLOGY B; Warren J.C., 1846, BOSTON MED SURG J, V35, P375, DOI [10.1056/NEJM184612090351902, DOI 10.1056/NEJM184612090351902]; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Whipple AO, 1935, ANN SURG, V102, P763, DOI 10.1097/00000658-193510000-00023; WONG VCW, 1984, LANCET, V1, P921; ZURHAUSEN H, 1976, CANCER RES, V36, P794	56	168	183	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2207	2214		10.1056/NEJMra1204479	http://dx.doi.org/10.1056/NEJMra1204479			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22646510	Green Accepted			2022-12-28	WOS:000304863400010
J	Godal, T; Quam, L				Godal, Tore; Quam, Lois			Accelerating the global response to reduce maternal mortality	LANCET			English	Editorial Material									[Godal, Tore] Minist Foreign Affairs, N-0032 Oslo, Norway; [Quam, Lois] US Dept State, Global Hlth Initiat, Washington, DC 20520 USA		Godal, T (corresponding author), Minist Foreign Affairs, N-0032 Oslo, Norway.	Tore.Godal@mfa.no						Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; PEPFAR, 2011, PEPFAR GUID INT PREV; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNFPA UNICEF WHO World Bank, 2012, TRENDS MAT MORT 1990; United Nations, 2012, UN LAUNCH COMM LIF S; United Nations, 2005, END POV 2015 GOAL 5; United Nations Secretary-General Ban Ki-moon, 2010, GLOB STRAT WOM CHILD; WHO, 2005, INCR MED AW MAT CHIL; World Health Organisation, 2007, STRENGTH HLTH SYST I	11	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2025	2026		10.1016/S0140-6736(12)60863-0	http://dx.doi.org/10.1016/S0140-6736(12)60863-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22656873				2022-12-28	WOS:000304759100007
J	Cremades, N; Cohen, SIA; Deas, E; Abramov, AY; Chen, AY; Orte, A; Sandal, M; Clarke, RW; Dunne, P; Aprile, FA; Bertoncini, CW; Wood, NW; Knowles, TPJ; Dobson, CM; Klenerman, D				Cremades, Nunilo; Cohen, Samuel I. A.; Deas, Emma; Abramov, Andrey Y.; Chen, Allen Y.; Orte, Angel; Sandal, Massimo; Clarke, Richard W.; Dunne, Paul; Aprile, Francesco A.; Bertoncini, Carlos W.; Wood, Nicholas W.; Knowles, Tuomas P. J.; Dobson, Christopher M.; Klenerman, David			Direct Observation of the Interconversion of Normal and Toxic Forms of alpha-Synuclein	CELL			English	Article							AMYLOID FIBRIL FORMATION; PARKINSONS-DISEASE; SINGLE-MOLECULE; PROTEIN AGGREGATION; SECONDARY STRUCTURE; COMMON MECHANISM; OLIGOMERS; FIBRILLOGENESIS; POLYMERIZATION; FIBRILLIZATION	Here, we use single-molecule techniques to study the aggregation of alpha-synuclein, the protein whose misfolding and deposition is associated with Parkinson's disease. We identify a conformational change from the initially formed oligomers to stable, more compact proteinase-K-resistant oligomers as the key step that leads ultimately to fibril formation. The oligomers formed as a result of the structural conversion generate much higher levels of oxidative stress in rat primary neurons than do the oligomers formed initially, showing that they are more damaging to cells. The structural conversion is remarkably slow, indicating a high kinetic barrier for the conversion and suggesting that there is a significant period of time for the cellular protective machinery to operate and potentially for therapeutic intervention, prior to the onset of cellular damage. In the absence of added soluble protein, the assembly process is reversed and fibrils disaggregate to form stable oligomers, hence acting as a source of cytotoxic species.	[Cremades, Nunilo; Cohen, Samuel I. A.; Chen, Allen Y.; Orte, Angel; Sandal, Massimo; Clarke, Richard W.; Dunne, Paul; Aprile, Francesco A.; Bertoncini, Carlos W.; Knowles, Tuomas P. J.; Dobson, Christopher M.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Deas, Emma; Abramov, Andrey Y.; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain; [Aprile, Francesco A.] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Bertoncini, Carlos W.] Inst Res Biomed, Barcelona 08028, Spain	University of Cambridge; University of London; University College London; University of Granada; University of Milano-Bicocca; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; dk10012@cam.ac.uk	Wood, Nicholas W/C-2505-2009; Knowles, Tuomas/C-6663-2009; Abramov, Andrey/AAC-6712-2019; Cremades, Nunilo/F-9634-2015; Orte, Angel/J-4810-2012; Abramov, Andrey Y/H-9053-2012	Wood, Nicholas W/0000-0002-9500-3348; Knowles, Tuomas/0000-0002-7879-0140; Abramov, Andrey/0000-0002-7646-7235; Cremades, Nunilo/0000-0002-9138-6687; Orte, Angel/0000-0003-1905-4183; Abramov, Andrey Y/0000-0002-7646-7235; Klenerman, David/0000-0001-7116-6954; Aprile, Francesco Antonio/0000-0002-5040-4420; Bertoncini, Carlos/0000-0001-7695-2882; /0000-0003-0929-0393; Clarke, Richard/0000-0003-3152-0423	Human Frontier Science Program [LT000795/2009]; Schiff Foundation; EU; Gates Cambridge Scholarship; FEBS Fellowship; Italian Ministry of Education; University and Research; Marie Curie IEF; Wellcome/MRC Parkinson's Disease Consortium; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; Augustus Newman Foundation; Wellcome Trust; Leverhulme Trust; Medical Research Council (UK); Engineering and Physical Sciences Research Council; BBSRC [BB/E019927/1]; European Commission [LSHM-CT-2006-037525]; Biotechnology and Biological Sciences Research Council [BB/E019927/1] Funding Source: researchfish; Medical Research Council [MC_G1000734, MC_G1000735] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; MRC [MC_G1000735, MC_G1000734] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); Schiff Foundation; EU(European Commission); Gates Cambridge Scholarship; FEBS Fellowship; Italian Ministry of Education; University and Research; Marie Curie IEF(European Commission); Wellcome/MRC Parkinson's Disease Consortium(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Augustus Newman Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Francisco Mateo and Priyanka Narayan for their helpful comments and discussions. N.C. is the recipient of a Human Frontier Science Program Long-term Fellowship (LT000795/2009). S.I.A.C. is supported by a Schiff Foundation Scholarship, A.O. acknowledges an ERG from the EU 7th FP, A.Y.C. was supported by a Gates Cambridge Scholarship, and M. S. was supported by a FEBS Fellowship. F.A.A. was recipient of a PhD Fellowship from the Italian Ministry of Education, University and Research, and C.W.B. is the recipient of a FP7 Marie Curie IEF grant. E.D., A.Y.A., and N.W.W. are supported by the Wellcome/MRC Parkinson's Disease Consortium grant to UCL/IoN, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (grant number WT089698). C.M.D. and D.K. acknowledge with gratitude support from the Augustus Newman Foundation, the Wellcome Trust, the Leverhulme Trust, BBSRC (BB/E019927/1), the European Commission (project LSHM-CT-2006-037525), the Medical Research Council (UK), and the Engineering and Physical Sciences Research Council.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiou A, 2009, BIOPHYS J, V97, P2306, DOI 10.1016/j.bpj.2009.07.057; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zampagni M, 2011, J CELL MOL MED, V15, P2106, DOI 10.1111/j.1582-4934.2010.01239.x	58	579	589	8	203	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1048	1059		10.1016/j.cell.2012.03.037	http://dx.doi.org/10.1016/j.cell.2012.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632969	hybrid, Green Published			2022-12-28	WOS:000304453900011
J	Freitag, J; Ast, J; Bolker, M				Freitag, Johannes; Ast, Julia; Boelker, Michael			Cryptic peroxisomal targeting via alternative splicing and stop codon read-through in fungi	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEINS; YEAST; IDENTIFICATION; DEHYDROGENASE; COORDINATION; MICROBODIES; TRANSPORT; MEMBRANE; SIGNAL-1	Peroxisomes are eukaryotic organelles important for the metabolism of long-chain fatty acids(1,2). Here we show that in numerous fungal species, several core enzymes of glycolysis, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 3-phosphoglycerate kinase (PGK), reside in both the cytoplasm and peroxisomes. We detected in these enzymes cryptic type 1 peroxisomal targeting signals (PTS1)(3), which are activated by post-transcriptional processes. Notably, the molecular mechanisms that generate the peroxisomal isoforms vary considerably among different species. In the basidiomycete plant pathogen Ustilago maydis, peroxisomal targeting of Pgk1 results from ribosomal read-through, whereas alternative splicing generates the PTS1 of Gapdh. In the filamentous ascomycete Aspergillus nidulans, peroxisomal targeting of these enzymes is achieved by exactly the opposite mechanisms. We also detected PTS1 motifs in the glycolytic enzymes triose-phosphate isomerase and fructose-bisphosphate aldolase. U. maydis mutants lacking the peroxisomal isoforms of Gapdh or Pgk1 showed reduced virulence. In addition, mutational analysis suggests that GAPDH, together with other peroxisomal NADH-dependent dehydrogenases, has a role in redox homeostasis. Owing to its hidden nature, partial peroxisomal targeting of well-studied cytoplasmic enzymes has remained undetected. Thus, we anticipate that further bona fide cytoplasmic proteins exhibit similar dual targeting.	[Freitag, Johannes; Ast, Julia; Boelker, Michael] Univ Marburg, Dept Biol, D-35032 Marburg, Germany	Philipps University Marburg	Bolker, M (corresponding author), Univ Marburg, Dept Biol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	boelker@uni-marburg.de		Bolker, Michael/0000-0002-7366-3855; Freitag, Johannes/0000-0002-8251-4878; Ast, Julia/0000-0002-0039-4762	Deutsche Forschungsgemeinschaft [DFG-GK1216]; Marburg University Research Academy (MARA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marburg University Research Academy (MARA)	We are indebted to J. Heitman and W. K. Holloman for reading of the manuscript. We thank R. Fischer and G. Barth for providing strains and DNA. We acknowledge technical assistance by M. Piscator. We thank D. Lanver and T. Stehlik for discussions. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG-GK1216). J. A. received a fellowship from the Marburg University Research Academy (MARA).	Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Bernhardt K, 2012, PLANT J, V69, P1, DOI 10.1111/j.1365-313X.2011.04775.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Guthrie C., 2002, GUIDE YEAST GENETICS; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; Kabran P, 2012, DNA RES, V19, P231, DOI 10.1093/dnares/dss007; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Loubradou G, 2001, MOL MICROBIOL, V40, P719, DOI 10.1046/j.1365-2958.2001.02424.x; Managadze D, 2010, PROTEOMICS, V10, P3222, DOI 10.1002/pmic.201000095; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Sambrook J., 2001, MOL CLONING LAB MANU; Schink KO, 2009, MOL BIOL CELL, V20, P1081, DOI 10.1091/mbc.E08-03-0280; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Strijbis K, 2012, FEMS YEAST RES, V12, P61, DOI 10.1111/j.1567-1364.2011.00761.x; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352	40	112	112	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					522	U135		10.1038/nature11051	http://dx.doi.org/10.1038/nature11051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622582				2022-12-28	WOS:000304344500047
J	Keller, CB; Schoene, B				Keller, C. Brenhin; Schoene, Blair			Statistical geochemistry reveals disruption in secular lithospheric evolution about 2.5 Gyr ago	NATURE			English	Article							ATMOSPHERIC OXYGEN; OXIDATION-STATE; OCEANIC BASALTS; REDOX STATE; MANTLE; MODEL; MINERALS; GENESIS; MELTS; RISE	The Earth has cooled over the past 4.5 billion years (Gyr) as a result of surface heat loss and declining radiogenic heat production. Igneous geochemistry has been used to understand how changing heat flux influenced Archaean geodynamics(1,2), but records of systematic geochemical evolution are complicated by heterogeneity of the rock record and uncertainties regarding selection and preservation bias(3-5). Here we apply statistical sampling techniques to a geochemical database of about 70,000 samples from the continental igneous rock record to produce a comprehensive record of secular geochemical evolution throughout Earth history. Consistent with secular mantle cooling, compatible and incompatible elements in basalts record gradually decreasing mantle melt fraction through time. Superimposed on this gradual evolution is a pervasive geochemical discontinuity occurring about 2.5 Gyr ago, involving substantial decreases in mantle melt fraction in basalts, and in indicators of deep crustal melting and fractionation, such as Na/K, Eu/Eu* (europium anomaly(4)) and La/Yb ratios in felsic rocks. Along with an increase in preserved crustal thickness across the Archaean/Proterozoic boundary(6,7), these data are consistent with a model in which high-degree Archaean mantle melting produced a thick, mafic lower crust and consequent deep crustal delamination and melting-leading to abundant tonalite-trondhjemite-granodiorite magmatism and a thin preserved Archaean crust. The coincidence of the observed changes in geochemistry and crustal thickness with stepwise atmospheric oxidation(8) at the end of the Archaean eon provides a significant temporal link between deep Earth geochemical processes and the rise of atmospheric oxygen on the Earth.	[Keller, C. Brenhin; Schoene, Blair] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Keller, CB (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall,Washington Rd, Princeton, NJ 08544 USA.	cbkeller@princeton.edu	Schoene, Blair/C-3281-2014	Schoene, Blair/0000-0001-7092-8590; Keller, C Brenhin/0000-0001-7400-9428	Princeton University	Princeton University(Princeton University)	We thank K. Condie and J.-F. Moyen for providing their data sets of granitoid rocks through time; F. Simons for assistance with statistical methods; C.-T. Lee, W. Fischer, A. Maloof, C. Langmuir, O. Muntener, J. Higgins, A. Rubin, T. Duffy, K. Samperton, and B. Dyer for discussions; and W. White for comments. C. B. K. was supported by a Princeton University Centennial Fellowship	Artemieva IM, 2006, TECTONOPHYSICS, V416, P245, DOI 10.1016/j.tecto.2005.11.022; Asimow PD, 1998, AM MINERAL, V83, P1127; Bassin C., 2000, EOS T AM GEOPHYS UN, V81, pF897; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; CANIL D, 1994, EARTH PLANET SC LETT, V123, P205, DOI 10.1016/0012-821X(94)90268-2; Carlson, 2003, TREATISE GEOCHEMISTR, V2, P363, DOI DOI 10.1016/B0-08-043751-6/02008-9; Condie K. C., 2008, DID PLATE TECTONICS; Condie KC, 2008, GEOLOGY, V36, P611, DOI 10.1130/G24793A.1; Condie KC, 2011, GEOL SOC AM BULL, V123, P951, DOI 10.1130/B30344.1; Condie KC, 2010, AM J SCI, V310, P775, DOI 10.2475/09.2010.01; Condie KC, 2010, PRECAMBRIAN RES, V180, P227, DOI 10.1016/j.precamres.2010.03.008; CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; de Wit MJ, 1998, PRECAMBRIAN RES, V91, P181, DOI 10.1016/S0301-9268(98)00043-6; DRUMMOND MS, 1990, J GEOPHYS RES-SOLID, V95, P21503, DOI 10.1029/JB095iB13p21503; DURRHEIM RJ, 1991, GEOLOGY, V19, P606, DOI 10.1130/0091-7613(1991)019<0606:AAPCEE>2.3.CO;2; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Fischer WW, 2009, GEOL SOC AM BULL, V121, P222, DOI 10.1130/B26328.1; Gando A, 2011, NAT GEOSCI, V4, P647, DOI 10.1038/ngeo1205; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Hawkesworth CJ, 2006, NATURE, V443, P811, DOI 10.1038/nature05191; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Hirschmann MM, 1998, J PETROL, V39, P1091, DOI 10.1093/petrology/39.6.1091; HOFMANN AW, 1986, EARTH PLANET SC LETT, V79, P33, DOI 10.1016/0012-821X(86)90038-5; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KAY RW, 1993, TECTONOPHYSICS, V219, P177, DOI 10.1016/0040-1951(93)90295-U; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; Lee CTA, 2010, NATURE, V468, P681, DOI 10.1038/nature09617; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; Maruyama S, 2007, GONDWANA RES, V11, P148, DOI 10.1016/j.gr.2006.06.001; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Moyen J.-F., 2006, AGU MONOGRAPH, P147; Moyen JF, 2011, LITHOS, V123, P21, DOI 10.1016/j.lithos.2010.09.015; Muntener O, 2001, CONTRIB MINERAL PETR, V141, P643; Nikolaev G.S., 1996, GEOCHEM INT, V34, P641; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Petford N, 1996, J PETROL, V37, P1491, DOI 10.1093/petrology/37.6.1491; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; van Aken PA, 2002, PHYS CHEM MINER, V29, P188, DOI 10.1007/s00269-001-0222-6; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0	47	228	234	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					490	U100		10.1038/nature11024	http://dx.doi.org/10.1038/nature11024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622575	Green Submitted			2022-12-28	WOS:000304344500040
J	Hung, WW; Egol, KA; Zuckerman, JD; Siu, AL				Hung, William W.; Egol, Kenneth A.; Zuckerman, Joseph D.; Siu, Albert L.			Hip Fracture Management Tailoring Care for the Older Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; RISK-FACTORS; BIPOLAR HEMIARTHROPLASTY; FUNCTIONAL RECOVERY; HOSPITAL DISCHARGE; ELDERLY-PATIENTS; HOME EXERCISE; FEMORAL-NECK; VITAMIN-D	Hip fracture is a potentially devastating condition for older adults. Hip fracture leads to pain and immobilization with complications ranging from delirium to functional loss and death. Although a mainstay of treatment is orthopedic repair, a multidisciplinary comanagement approach, including medical specialists and rehabilitation, may maximize patient recovery. Using the case of Mr W, an older man who sustained a fall and hip fracture, we present evidence-based components of care both in the hospital and outpatient settings. Preoperatively, clinicians should correct medical abnormalities and consider the appropriateness, timing, and type of surgical repair in the context of the patient's life expectancy and goals of care. Perioperative care should include prophylaxis with antibiotics, chemoprophylaxis for venous thromboembolism, and correction of major clinical abnormalities prior to surgery. Pain control, delirium, and pressure ulcer prevention are important inpatient care elements. Multidisciplinary models incorporating these care elements can decrease complications during inpatient stay. Rehabilitation strategies should be tailored to patient needs; early mobilization followed by rehabilitation exercises in institutional, home, and group settings should be considered to maximize restoration of locomotive abilities. Attention to care transitions is necessary and treatment for osteoporosis should be considered. The road to recovery for hip fracture patients is long and most patients may not regain their prefracture functional status. Understanding and anticipating issues that may arise in the older patient with hip fracture, while delivering evidence-based care components, is necessary to maximize patient recovery.	[Hung, William W.; Siu, Albert L.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Hung, William W.; Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY USA; [Hung, William W.; Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Dev Res Enhancement Award Program, Bronx, NY USA; [Hung, William W.; Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Hlth Serv Res, Bronx, NY USA; [Egol, Kenneth A.; Zuckerman, Joseph D.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Hung, WW (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	william.hung@mssm.edu			Exactech; Orthopaedic Research & Education Foundation; Orthopaedic Trauma Association; New York Academy of Medicine; Claude D. Pepper Older Americans Independence Center at Mount Sinai School of Medicine [P30-AG028741]; SCAN Foundation; NATIONAL INSTITUTE ON AGING [P30AG028741] Funding Source: NIH RePORTER	Exactech; Orthopaedic Research & Education Foundation; Orthopaedic Trauma Association; New York Academy of Medicine; Claude D. Pepper Older Americans Independence Center at Mount Sinai School of Medicine; SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Egol reports receipt of consultancy fees and royalties from Exactech; grants or pending grants from the Orthopaedic Research & Education Foundation and the Orthopaedic Trauma Association; and holding stock/stock options with Johnson & Johnson. The other authors report no disclosures.; Dr Hung is currently supported by the New York Academy of Medicine Hoar Fellowship. This article was supported in part by the Claude D. Pepper Older Americans Independence Center at Mount Sinai School of Medicine (P30-AG028741). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Adunsky A, 2011, J AM MED DIR ASSOC, V12, P439, DOI 10.1016/j.jamda.2010.09.003; Agency for Healthcare Research and Quality, GUID SYNTH PREV PRES; Avenell A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001880.pub5, 10.1002/14651858.CD001880.pub6]; Baumgarten M, 2009, J AM GERIATR SOC, V57, P863, DOI 10.1111/j.1532-5415.2009.02245.x; BENTLEY G, 1980, CLIN ORTHOP RELAT R, P93; Berry SD, 2009, J GERONTOL A-BIOL, V64, P771, DOI 10.1093/gerona/glp019; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Blomfeldt R, 2007, J BONE JOINT SURG BR, V89B, P160, DOI 10.1302/0301-620X.89B2.18576; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Boockvar KS, 2004, J AM GERIATR SOC, V52, P1826, DOI 10.1111/j.1532-5415.2004.52512.x; Boockvar KS, 2003, J AM GERIATR SOC, V51, P399, DOI 10.1046/j.1532-5415.2003.51115.x; Brauer C, 2000, ARCH INTERN MED, V160, P1856, DOI 10.1001/archinte.160.12.1856; Carmeli E, 2006, DISABIL REHABIL, V28, P997, DOI 10.1080/09638280500476154; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Centers for Disease Control and Prevention, INJ PREV CONTR HIP F; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Colon-Emeric C, 2003, OSTEOPOROSIS INT, V14, P879, DOI 10.1007/s00198-003-1460-x; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Crotty M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007624.pub3; Cumming RG, 1996, AUST NZ J PUBL HEAL, V20, P579, DOI 10.1111/j.1467-842X.1996.tb01069.x; CUMMINGS SR, 1990, CLIN ORTHOP RELAT R, P163; Dolan MM, 2000, J GERONTOL A-BIOL, V55, pM527, DOI 10.1093/gerona/55.9.M527; Donnelly J, 2011, J WOUND CARE, V20, P309, DOI 10.12968/jowc.2011.20.7.309; Fletcher AK, 2003, ANN EMERG MED, V41, P227, DOI 10.1067/mem.2003.51; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Gillespie WJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000244.pub2; Gillespie WJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub4; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hagsten B, 2006, ACTA ORTHOP, V77, P114, DOI 10.1080/17453670610045786; Handoll HHG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001704.pub3; Handoll HHG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000337.pub2; Handoll HHG, 2002, COCHRANE DB SYST REV; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Herrick C, 2004, J AM GERIATR SOC, V52, P2062, DOI 10.1111/j.1532-5415.2004.52566.x; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P42; Huang TT, 2005, J CLIN NURS, V14, P1193, DOI 10.1111/j.1365-2702.2005.01260.x; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; Lenze EJ, 2007, J AM GERIATR SOC, V55, P81, DOI 10.1111/j.1532-5415.2006.01017.x; Lundstrom M, 2007, AGING CLIN EXP RES, V19, P178; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; MAGAZINER J, 1990, J GERONTOL, V45, pM101, DOI 10.1093/geronj/45.3.M101; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; McInnes E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001735.pub4; McLaughlin MA, 2006, J GEN INTERN MED, V21, P219, DOI 10.1111/j.1525-1497.2006.00318.x; Michel JP, 2002, AGING CLIN EXP RES, V14, P389; Morrison, 2000, JAMA, V284, P2447; Morrison RS, 2009, J AM GERIATR SOC, V57, P1, DOI 10.1111/j.1532-5415.2008.02063.x; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Naglie G, 2002, CAN MED ASSOC J, V167, P25; Nahm ES, 2010, GERIATR NURS, V31, P254, DOI 10.1016/j.gerinurse.2010.01.003; OBRANT KJ, 1987, ORTHOPEDICS, V10, P1153; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Orwig DL, 2011, ARCH INTERN MED, V171, P323, DOI 10.1001/archinternmed.2011.15; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000086.pub2; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P261, DOI 10.1302/0301-620X.74B2.1544965; Parker MJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000521.PUB2; Pedersen SJ, 2008, J AM GERIATR SOC, V56, P1831, DOI 10.1111/j.1532-5415.2008.01945.x; Penrod JD, 2007, J AM GERIATR SOC, V55, P407, DOI 10.1111/j.1532-5415.2007.01078.x; Samelson EJ, 2002, AM J PUBLIC HEALTH, V92, P858, DOI 10.2105/AJPH.92.5.858; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Sherrington C, 2004, ARCH PHYS MED REHAB, V85, P710, DOI 10.1016/S0003-9993(03)00620-8; Sherrington C, 1997, ARCH PHYS MED REHAB, V78, P208, DOI 10.1016/S0003-9993(97)90265-3; Shyu YIL, 2010, J AM GERIATR SOC, V58, P1081, DOI 10.1111/j.1532-5415.2010.02882.x; Siu AL, 2006, ARCH INTERN MED, V166, P766, DOI 10.1001/archinte.166.7.766; SKELLY JM, 1992, CAN MED ASSOC J, V146, P1185; Stolee P, 2009, J GERONTOL A-BIOL, V64, P403, DOI 10.1093/gerona/gln035; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Vidan MT, 2011, ANN INTERN MED, V155, P226, DOI 10.7326/0003-4819-155-4-201108160-00006; Visschedijk J, 2010, J AM GERIATR SOC, V58, P1739, DOI 10.1111/j.1532-5415.2010.03036.x; Voshaar RCO, 2007, AM J GERIAT PSYCHIAT, V15, P807, DOI 10.1097/JGP.0b013e318098610c; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003376.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Ziden L, 2010, DISABIL REHABIL, V32, P18, DOI 10.3109/09638280902980910; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010	85	134	145	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2185	2194		10.1001/jama.2012.4842	http://dx.doi.org/10.1001/jama.2012.4842			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945YX	22618926				2022-12-28	WOS:000304315200028
J	Merte, LR; Peng, GW; Bechstein, R; Rieboldt, F; Farberow, CA; Grabow, LC; Kudernatsch, W; Wendt, S; Laegsgaard, E; Mavrikakis, M; Besenbacher, F				Merte, Lindsay R.; Peng, Guowen; Bechstein, Ralf; Rieboldt, Felix; Farberow, Carrie A.; Grabow, Lars C.; Kudernatsch, Wilhelmine; Wendt, Stefan; Laegsgaard, Erik; Mavrikakis, Manos; Besenbacher, Flemming			Water-Mediated Proton Hopping on an Iron Oxide Surface	SCIENCE			English	Article							AUGMENTED-WAVE METHOD; HYDROGEN SPILLOVER; FEO(111); FE3O4(111); ADSORPTION; TIO2(110); CATALYSTS; MECHANISM; MOBILITY; ENERGY	The diffusion of hydrogen atoms across solid oxide surfaces is often assumed to be accelerated by the presence of water molecules. Here we present a high-resolution, high-speed scanning tunneling microscopy (STM) study of the diffusion of H atoms on an FeO thin film. STM movies directly reveal a water-mediated hydrogen diffusion mechanism on the oxide surface at temperatures between 100 and 300 kelvin. Density functional theory calculations and isotope-exchange experiments confirm the STM observations, and a proton-transfer mechanism that proceeds via an H3O+-like transition state is revealed. This mechanism differs from that observed previously for rutile TiO2(110), where water dissociation is a key step in proton diffusion.	[Peng, Guowen; Farberow, Carrie A.; Grabow, Lars C.; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Merte, Lindsay R.; Bechstein, Ralf; Rieboldt, Felix; Kudernatsch, Wilhelmine; Wendt, Stefan; Laegsgaard, Erik; Besenbacher, Flemming] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Merte, Lindsay R.; Bechstein, Ralf; Rieboldt, Felix; Kudernatsch, Wilhelmine; Wendt, Stefan; Laegsgaard, Erik; Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	University of Wisconsin System; University of Wisconsin Madison; Aarhus University; Aarhus University	Mavrikakis, M (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	manos@engr.wisc.edu; fbe@inano.au.dk	Grabow, Lars/F-7095-2011; Mavrikakis, Manos/D-5702-2012	Grabow, Lars/0000-0002-7766-8856; Mavrikakis, Manos/0000-0002-5293-5356; Farberow, Carrie/0000-0002-3753-962X; Merte, Lindsay Richard/0000-0002-3213-4199	Danish Research Agency; Strategic Research Council; Villum Kahn Rasmussen Foundation; Carlsberg Foundation; Lundbeck Foundation; Haldor Topsoe A/S; European Research Council; U.S. Department of Energy, Basic Energy Sciences, Chemical Sciences Office; NSF	Danish Research Agency; Strategic Research Council; Villum Kahn Rasmussen Foundation(Villum Fonden); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Haldor Topsoe A/S; European Research Council(European Research Council (ERC)European Commission); U.S. Department of Energy, Basic Energy Sciences, Chemical Sciences Office(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	Supported by the Danish Research Agency, the Strategic Research Council, the Villum Kahn Rasmussen Foundation, the Carlsberg Foundation, the Lundbeck Foundation, Haldor Topsoe A/S, and the European Research Council through an advanced ERC grant. Work at the University of Wisconsin was supported by the U.S. Department of Energy, Basic Energy Sciences, Chemical Sciences Office. C.A.F. thanks NSF for a Graduate Research Fellowship. G.P., C.A.F., L.C.G., and M.M. thank the National Energy Research Scientific Computing Center, Pacific Northwest National Laboratory, Argonne National Laboratory, and Oak Ridge National Laboratory for computational resources and thank J. A. Dumesic for fruitful discussions.	AITICHOU I, 1985, J CATAL, V91, P293, DOI 10.1016/0021-9517(85)90343-4; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cheng HS, 2008, ENERG ENVIRON SCI, V1, P338, DOI 10.1039/b807618a; CONNER WC, 1995, CHEM REV, V95, P759, DOI 10.1021/cr00035a014; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Daiguji H, 2010, NAT NANOTECHNOL, V5, P831, DOI 10.1038/nnano.2010.245; Daschbach JL, 2005, J PHYS CHEM B, V109, P10362, DOI 10.1021/jp058013s; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; GALLOWAY HC, 1993, SURF SCI, V298, P127, DOI 10.1016/0039-6028(93)90089-3; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; HIGAZY AA, 1992, J PHYS CHEM SOLIDS, V53, P549, DOI 10.1016/0022-3697(92)90099-Y; Hilmen AM, 1996, CATAL LETT, V38, P143, DOI 10.1007/BF00806560; Huang WX, 2006, SURF SCI, V600, P793, DOI 10.1016/j.susc.2005.11.026; IOANNIDES T, 1993, J CATAL, V143, P175, DOI 10.1006/jcat.1993.1264; Joseph Y, 1999, CHEM PHYS LETT, V314, P195, DOI 10.1016/S0009-2614(99)01159-8; Jung KD, 2000, J CATAL, V193, P207, DOI 10.1006/jcat.2000.2881; Kanellopoulos J, 2008, J CATAL, V255, P68, DOI 10.1016/j.jcat.2008.01.028; Knudsen J, 2010, SURF SCI, V604, P11, DOI 10.1016/j.susc.2009.10.008; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Leist U, 2003, PHYS CHEM CHEM PHYS, V5, P2435, DOI 10.1039/b212163h; LEVY RB, 1974, J CATAL, V32, P304, DOI 10.1016/0021-9517(74)90080-3; Li SC, 2008, J AM CHEM SOC, V130, P9080, DOI 10.1021/ja8012825; Li SC, 2010, SCIENCE, V328, P882, DOI 10.1126/science.1188328; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; ROZANOV VV, 1997, RUSS CHEM REV, V66, P107, DOI DOI 10.1070/RC1997v066n02ABEH000308; Wendt S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066107; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058	28	205	207	11	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					889	893		10.1126/science.1219468	http://dx.doi.org/10.1126/science.1219468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605771				2022-12-28	WOS:000304145600058
J	Perez, C; Muckle, MT; Zaleski, DP; Seifert, NA; Temelso, B; Shields, GC; Kisiel, Z; Pate, BH				Perez, Cristobal; Muckle, Matt T.; Zaleski, Daniel P.; Seifert, Nathan A.; Temelso, Berhane; Shields, George C.; Kisiel, Zbigniew; Pate, Brooks H.			Structures of Cage, Prism, and Book Isomers of Water Hexamer from Broadband Rotational Spectroscopy	SCIENCE			English	Article							RELATIVE ENERGIES; 1ST PRINCIPLES; CLUSTERS; SPECTRUM; LIQUID; FORM; ICE	Theory predicts the water hexamer to be the smallest water cluster with a three-dimensional hydrogen-bonding network as its minimum energy structure. There are several possible low-energy isomers, and calculations with different methods and basis sets assign them different relative stabilities. Previous experimental work has provided evidence for the cage, book, and cyclic isomers, but no experiment has identified multiple coexisting structures. Here, we report that broadband rotational spectroscopy in a pulsed supersonic expansion unambiguously identifies all three isomers; we determined their oxygen framework structures by means of oxygen-18-substituted water ((H2O)-O-18). Relative isomer populations at different expansion conditions establish that the cage isomer is the minimum energy structure. Rotational spectra consistent with predicted heptamer and nonamer structures have also been identified.	[Temelso, Berhane; Shields, George C.] Bucknell Univ, Coll Arts & Sci, Deans Off, Lewisburg, PA 17837 USA; [Temelso, Berhane; Shields, George C.] Bucknell Univ, Dept Chem, Lewisburg, PA 17837 USA; [Perez, Cristobal; Muckle, Matt T.; Zaleski, Daniel P.; Seifert, Nathan A.; Pate, Brooks H.] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA; [Kisiel, Zbigniew] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland	Bucknell University; Bucknell University; University of Virginia; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Shields, GC (corresponding author), Bucknell Univ, Coll Arts & Sci, Deans Off, Lewisburg, PA 17837 USA.	george.shields@bucknell.edu; kisiel@ifpan.edu.pl; brookspate@virginia.edu	Temelso, Berhane/V-3945-2018; Shields, George C/C-6454-2012; Pérez, Cristóbal/V-4348-2019; Kisiel, Zbigniew/K-8798-2016; Perez, Cristobal/D-2599-2016	Temelso, Berhane/0000-0002-5286-1983; Shields, George C/0000-0003-1287-8585; Pérez, Cristóbal/0000-0001-5248-5212; Kisiel, Zbigniew/0000-0002-2570-3154; Perez, Cristobal/0000-0001-5248-5212; Zaleski, Daniel/0000-0003-0153-9158	U.S. National Science Foundation (NSF) [CHE-0960074, CHE-0848827]; Institute of Physics, Polish Academy of Sciences; NSF [CHE-0116435, CHE-0521063, CHE-0849677]; Texas Advanced Computing Center (TACC) [TG-CHE090095]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Division Of Chemistry [1229354, 1044351] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Institute of Physics, Polish Academy of Sciences; NSF(National Science Foundation (NSF)); Texas Advanced Computing Center (TACC); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by U.S. National Science Foundation (NSF) grants CHE-0960074 and CHE-0848827; the Institute of Physics, Polish Academy of Sciences; and NSF grants CHE-0116435, CHE-0521063, and CHE-0849677 as part of the MERCURY high-performance computer consortium (www.mercuryconsortium.org). This research used the NSF TeraGrid resources provided by the Texas Advanced Computing Center (TACC) under grant TG-CHE090095 and resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231.	Barone V, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1824881; Bates DM, 2009, J PHYS CHEM A, V113, P3555, DOI 10.1021/jp8105919; Brown GG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919120; Bukowski R, 2007, SCIENCE, V315, P1249, DOI 10.1126/science.1136371; Chen YM, 2010, J PHYS CHEM A, V114, P11719, DOI 10.1021/jp104822e; Cruzan JD, 1996, SCIENCE, V271, P59, DOI 10.1126/science.271.5245.59; Dahlke EE, 2008, J PHYS CHEM A, V112, P3976, DOI 10.1021/jp077376k; DELUCIA FC, 1973, PHYS REV A, V8, P2785, DOI 10.1103/PhysRevA.8.2785; Diken EG, 2004, J PHYS CHEM A, V108, P64, DOI 10.1021/jp0309973; Erlekam U, 2007, PHYS CHEM CHEM PHYS, V9, P3786, DOI 10.1039/b703571c; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gora U, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664730; Gregory JK, 1996, J PHYS CHEM-US, V100, P18014, DOI 10.1021/jp9616019; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hincapie G, 2010, J PHYS CHEM A, V114, P7809, DOI 10.1021/jp103683m; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kisiel Z, 2003, J MOL SPECTROSC, V218, P58, DOI 10.1016/S0022-2852(02)00036-X; KRAITCHMAN J, 1953, AM J PHYS, V21, P17, DOI 10.1119/1.1933338; Liu K, 1997, J PHYS CHEM A, V101, P8995, DOI 10.1021/jp9707807; Liu K, 1996, SCIENCE, V271, P62, DOI 10.1126/science.271.5245.62; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; Liu K, 1996, NATURE, V381, P501, DOI 10.1038/381501a0; Nauta K, 2000, SCIENCE, V287, P293, DOI 10.1126/science.287.5451.293; PRIBBLE RN, 1994, SCIENCE, V265, P75, DOI 10.1126/science.265.5168.75; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; Santra B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012573; Steinbach C, 2004, PHYS CHEM CHEM PHYS, V6, P3320, DOI 10.1039/b400664j; Temelso B, 2011, J PHYS CHEM A, V115, P12034, DOI 10.1021/jp2069489; Wang YM, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3579995; Werner HJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2712434; Xantheas SS, 2002, J CHEM PHYS, V116, P1493, DOI 10.1063/1.1423941; ZWART E, 1991, J MOL SPECTROSC, V147, P27, DOI 10.1016/0022-2852(91)90165-7	32	316	324	7	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					897	901		10.1126/science.1220574	http://dx.doi.org/10.1126/science.1220574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605772				2022-12-28	WOS:000304145600060
J	Saykally, RJ; Wales, DJ				Saykally, Richard J.; Wales, David J.			Pinning Down the Water Hexamer	SCIENCE			English	Editorial Material							CLUSTERS; LIQUID; CAGE		[Saykally, Richard J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wales, David J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of California System; University of California Berkeley; University of Cambridge	Saykally, RJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	saykally@cchem.berkeley.edu; dw34@cam.ac.uk		SAYKALLY, RICHARD/0000-0001-8942-3656				Brown GG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2919120; Goldman N, 2005, PHILOS T R SOC A, V363, P493, DOI 10.1098/rsta.2004.1504; Goldman N, 2004, J CHEM PHYS, V120, P4777, DOI 10.1063/1.1645777; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Liu K, 1997, J PHYS CHEM A, V101, P8995, DOI 10.1021/jp9707807; Nilsson A, 2011, CHEM PHYS, V389, P1, DOI 10.1016/j.chemphys.2011.07.021; ODUTOLA JA, 1980, J CHEM PHYS, V72, P5062, DOI 10.1063/1.439795; Perez C, 2012, SCIENCE, V336, P897, DOI 10.1126/science.1220574; Rocher-Casterline BE, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3598339; Wales D. J., 1999, Theory of atomic and molecular clusters. With a glimpse at experiments, P86; Wales D. J., 2000, COMPUTATIONAL MOL SP, P431; Walsh TR, 1996, J CHEM SOC FARADAY T, V92, P2505, DOI 10.1039/ft9969202505; Xantheas SS, 2000, CHEM PHYS, V258, P225, DOI 10.1016/S0301-0104(00)00189-0	13	57	59	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					814	815		10.1126/science.1222007	http://dx.doi.org/10.1126/science.1222007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605742				2022-12-28	WOS:000304145600030
J	Mottl, R; Brennecke, F; Baumann, K; Landig, R; Donner, T; Esslinger, T				Mottl, R.; Brennecke, F.; Baumann, K.; Landig, R.; Donner, T.; Esslinger, T.			Roton-Type Mode Softening in a Quantum Gas with Cavity-Mediated Long-Range Interactions	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; OPTICAL CAVITY	Long-range interactions in quantum gases are predicted to give rise to an excitation spectrum of roton character, similar to that observed in superfluid helium. We investigated the excitation spectrum of a Bose-Einstein condensate with cavity-mediated long-range interactions, which couple all particles to each other. Increasing the strength of the interaction leads to a softening of an excitation mode at a finite momentum, preceding a superfluid-to-supersolid phase transition. We used a variant of Bragg spectroscopy to study the mode softening across the phase transition. The measured spectrum was in very good agreement with ab initio calculations and, at the phase transition, a diverging susceptibility was observed. The work paves the way toward quantum simulation of long-range interacting many-body systems.	[Mottl, R.; Brennecke, F.; Baumann, K.; Landig, R.; Donner, T.; Esslinger, T.] Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Baumann, Kristian/M-9653-2013; Donner, Tobias/A-2845-2011; Esslinger, Tilman/M-9022-2016	Donner, Tobias/0000-0001-7016-587X; Esslinger, Tilman/0000-0002-8333-107X	Synthetic Quantum Many-Body Systems (European Research Council); Nanodesigning of Atomic and Molecular Quantum Matter (European Union, Future and Emerging Technologies open); National Centre of Competence in Research/Quantum Science and Technology; European Science Foundation (POLATOM)	Synthetic Quantum Many-Body Systems (European Research Council)(European Research Council (ERC)); Nanodesigning of Atomic and Molecular Quantum Matter (European Union, Future and Emerging Technologies open); National Centre of Competence in Research/Quantum Science and Technology; European Science Foundation (POLATOM)	We thank H. Tureci, P. Domokos, and H. Ritsch for stimulating discussions. Supported by Synthetic Quantum Many-Body Systems (European Research Council advanced grant), Nanodesigning of Atomic and Molecular Quantum Matter (European Union, Future and Emerging Technologies open), National Centre of Competence in Research/Quantum Science and Technology, and the European Science Foundation (POLATOM).	Asboth JK, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013414; Baumann K, 2010, NATURE, V464, P1301, DOI 10.1038/nature09009; Bismut G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040404; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Cherng RW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.185301; Deiglmayr J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.133004; Domokos P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.253003; Fattori M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.190405; Gopalakrishnan S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.277201; Gopalakrishnan S, 2009, NAT PHYS, V5, P845, DOI 10.1038/NPHYS1403; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Henkel N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195302; Koch T, 2008, NAT PHYS, V4, P218, DOI 10.1038/nphys887; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lahaye T, 2007, NATURE, V448, P672, DOI 10.1038/nature06036; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Maschler C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260401; Munstermann P, 2000, PHYS REV LETT, V84, P4068, DOI 10.1103/PhysRevLett.84.4068; Nagy D, 2008, EUR PHYS J D, V48, P127, DOI 10.1140/epjd/e2008-00074-6; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; NOZIERES P, 1990, THEORY QUANTUM LIQUI, V2; O'Dell DHJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.110402; POMEAU Y, 1994, PHYS REV LETT, V72, P2426, DOI 10.1103/PhysRevLett.72.2426; Santos L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.250403; Slama S, 2008, AIP CONF PROC, V970, P319; Steinhauer J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120407; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; Strack P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.277202; YARNELL JL, 1958, PHYS REV LETT, V1, P9, DOI 10.1103/PhysRevLett.1.9	29	186	187	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1570	1573		10.1126/science.1220314	http://dx.doi.org/10.1126/science.1220314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22604724	Green Submitted			2022-12-28	WOS:000305507500054
J	Perrone, J; Nelson, LS				Perrone, Jeanmarie; Nelson, Lewis S.			Medication Reconciliation for Controlled Substances - An "Ideal" Prescription-Drug Monitoring Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Perrone, Jeanmarie] Univ Penn, Dept Emergency Med, Div Med Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; New York University	Perrone, J (corresponding author), Univ Penn, Dept Emergency Med, Div Med Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA.			Nelson, Lewis/0000-0001-9551-3922				Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Feldman Lance, 2011, J Pain Palliat Care Pharmacother, V25, P313, DOI 10.3109/15360288.2011.606292; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Paulozzi LJ, 2012, PAIN MED, V13, P87, DOI 10.1111/j.1526-4637.2011.01260.x	4	66	66	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2341	2343		10.1056/NEJMp1204493	http://dx.doi.org/10.1056/NEJMp1204493			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961GH	22646509				2022-12-28	WOS:000305451700003
J	Yakubovich, N; Gerstein, HC				Yakubovich, Natalia; Gerstein, Hertzel C.			Is regression to normoglycaemia clinically important?	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; PREVENTION; TRIAL; ROSIGLITAZONE; PIOGLITAZONE; THERAPY		[Yakubovich, Natalia] McMaster Univ, Hamilton, ON L8S 4K1, Canada; Hlth Res Inst, Hamilton Hlth Sci Dept Med & Populat, Hamilton, ON L8S 4K1, Canada	McMaster University	Yakubovich, N (corresponding author), McMaster Univ, Hamilton, ON L8S 4K1, Canada.	natalia.yakubovich@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836				Bosch J, 2006, NEW ENGL J MED, V355, P1551; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Perreault L, 2009, DIABETES CARE, V32, P1583, DOI 10.2337/dc09-0523; Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x; Snehalatha C, 2009, DIABETES CARE, V32, P1796, DOI 10.2337/dc09-0676; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5	13	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2216	2218		10.1016/S0140-6736(12)60828-9	http://dx.doi.org/10.1016/S0140-6736(12)60828-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683127				2022-12-28	WOS:000305511400006
J	Hooper, DU; Adair, EC; Cardinale, BJ; Byrnes, JEK; Hungate, BA; Matulich, KL; Gonzalez, A; Duffy, JE; Gamfeldt, L; O'Connor, MI				Hooper, David U.; Adair, E. Carol; Cardinale, Bradley J.; Byrnes, Jarrett E. K.; Hungate, Bruce A.; Matulich, Kristin L.; Gonzalez, Andrew; Duffy, J. Emmett; Gamfeldt, Lars; O'Connor, Mary I.			A global synthesis reveals biodiversity loss as a major driver of ecosystem change	NATURE			English	Article							SPECIES-DIVERSITY; PLANT DIVERSITY; ELEVATED CO2; TERRESTRIAL ECOSYSTEMS; PRODUCTIVITY; COMMUNITIES; NITROGEN; CONSEQUENCES; GRASSLAND; RESPONSES	Evidence is mounting that extinctions are altering key processes important to the productivity and sustainability of Earth's ecosystems(1-4). Further species loss will accelerate change in ecosystem processes(5-8), but it is unclear how these effects compare to the direct effects of other forms of environmental change that are both driving diversity loss and altering ecosystem function. Here we use a suite of meta-analyses of published data to show that the effects of species loss on productivity and decomposition-two processes important in all ecosystems-are of comparable magnitude to the effects of many other global environmental changes. In experiments, intermediate levels of species loss (21-40%) reduced plant production by 5-10%, comparable to previously documented effects of ultraviolet radiation and climate warming. Higher levels of extinction (41-60%) had effects rivalling those of ozone, acidification, elevated CO2 and nutrient pollution. At intermediate levels, species loss generally had equal or greater effects on decomposition than did elevated CO2 and nitrogen addition. The identity of species lost also had a large effect on changes in productivity and decomposition, generating a wide range of plausible outcomes for extinction. Despite the need for more studies on interactive effects of diversity loss and environmental changes, our analyses clearly show that the ecosystem consequences of local species loss are as quantitatively significant as the direct effects of several global change stressors that have mobilized major international concern and remediation efforts(9).	[Hooper, David U.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Adair, E. Carol; Byrnes, Jarrett E. K.; O'Connor, Mary I.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Adair, E. Carol] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Aiken Ctr, Burlington, VT 05405 USA; [Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Matulich, Kristin L.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Duffy, J. Emmett] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Gamfeldt, Lars] Univ Gothenburg, Dept Biol & Environm Sci, SE-40530 Gothenburg, Sweden; [O'Connor, Mary I.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Western Washington University; National Center for Ecological Analysis & Synthesis; University of Vermont; University of Michigan System; University of Michigan; Northern Arizona University; University of California System; University of California Irvine; McGill University; William & Mary; Virginia Institute of Marine Science; University of Gothenburg; University of British Columbia	Hooper, DU (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	hooper@biol.wwu.edu	Hungate, Bruce/F-8991-2011; O'Connor, Mary I/F-2275-2010; Duffy, J. Emmett/ABF-9200-2020; Cardinale, Bradley J/I-7076-2013; Gonzalez, Andrew/F-2247-2010; O'Connor, Mary/R-2933-2019	Hungate, Bruce/0000-0002-7337-1887; O'Connor, Mary I/0000-0001-9583-1592; Duffy, J. Emmett/0000-0001-8595-6391; Gonzalez, Andrew/0000-0001-6075-8081; Adair, E. Carol/0000-0002-8567-9045; Byrnes, Jarrett/0000-0002-9791-9472; Dolan, Kristin/0000-0003-2642-9406	National Center for Ecological Analysis and Synthesis (NCEAS); University of California Santa Barbara; National Science Foundation [OCE-1031061, DEB-1046121]; Swedish Research Council VR [621-2009-5457]; Canada Research Chair Program; NSERC; Direct For Biological Sciences [1046121] Funding Source: National Science Foundation; Division Of Ocean Sciences [1031061] Funding Source: National Science Foundation	National Center for Ecological Analysis and Synthesis (NCEAS); University of California Santa Barbara(University of California System); National Science Foundation(National Science Foundation (NSF)); Swedish Research Council VR(Swedish Research Council); Canada Research Chair Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the authors of the original data sets, both published and unpublished, who shared data with us. We thank the National Center for Ecological Analysis and Synthesis (NCEAS) for funding the workshop "Biodiversity and the Functioning of Ecosystems: Translating Results from Model Experiments into Functional Reality". Support for NCEAS comes from University of California Santa Barbara and the National Science Foundation. J.E.K.B., E. C. A. and M.I.O. had NCEAS post-doctoral fellowships, J.E.D. had support from NSF OCE-1031061; B.J.C. had support from NSF DEB-1046121; L. G. was supported by grant 621-2009-5457 from the Swedish Research Council VR; A. G. is supported by the Canada Research Chair Program and NSERC.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; Diaz S., 2009, BIODIVERSITY ECOSYST, P149; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JOHNSON NJ, 1978, J AM STAT ASSOC, V73, P536, DOI 10.2307/2286597; Lanta V, 2006, ACTA OECOL, V29, P85, DOI 10.1016/j.actao.2005.08.003; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Maestre FT, 2007, OECOLOGIA, V151, P512, DOI 10.1007/s00442-006-0577-y; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Rixen C, 2005, OECOLOGIA, V146, P287, DOI 10.1007/s00442-005-0196-z; Rixen C, 2008, PERSPECT PLANT ECOL, V10, P51, DOI 10.1016/j.ppees.2007.09.003; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; SMITH A, 1985, J APPL ECOL, V22, P185, DOI 10.2307/2403336; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Striebel M, 2009, ECOLOGY, V90, P2025, DOI 10.1890/08-1409.1; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; von Felten S, 2008, J PLANT ECOL, V1, P33, DOI 10.1093/jpe/rtm006; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; Wang XZ, 2007, OECOLOGIA, V152, P595, DOI 10.1007/s00442-007-0691-5; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005	46	1336	1406	99	2124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					105	U129		10.1038/nature11118	http://dx.doi.org/10.1038/nature11118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678289				2022-12-28	WOS:000304854000036
J	Hekstra, DR; Leibler, S				Hekstra, Doeke R.; Leibler, Stanislas			Contingency and Statistical Laws in Replicate Microbial Closed Ecosystems	CELL			English	Article							SPECIES-DEFINED MICROCOSM; ESCHERICHIA-COLI; FLUORESCENT PROTEIN; TAYLORS LAW; FOOD-WEB; DYNAMICS; EVOLUTION; SYSTEMS; DIVERSIFICATION; COMMUNITIES	Contingency, the persistent influence of past random events, pervades biology. To what extent, then, is each course of ecological or evolutionary dynamics unique, and to what extent are these dynamics subject to a common statistical structure? Addressing this question requires replicate measurements to search for emergent statistical laws. We establish a readily replicated microbial closed ecosystem (CES), sustaining its three species for years. We precisely measure the local population density of each species in many CES replicates, started from the same initial conditions and kept under constant light and temperature. The covariation among replicates of the three species densities acquires a stable structure, which could be decomposed into discrete eigenvectors, or "ecomodes.'' The largest ecomode dominates population density fluctuations around the replicate-average dynamics. These fluctuations follow simple power laws consistent with a geometric random walk. Thus, variability in ecological dynamics can be studied with CES replicates and described by simple statistical laws.	[Hekstra, Doeke R.; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Hekstra, Doeke R.; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Rockefeller University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Hekstra, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	doeke.hekstra@utsouthwestern.edu		Hekstra, Doeke/0000-0003-2332-9223	Training Program in Chemical Biology	Training Program in Chemical Biology	We thank for comments and suggestions: S. Cocco, J. Cohen, S. Dutcher, J. Hopfield, D. Huse, G. Iyengar, A. Libchaber, J. McKinney, R. Monasson, R. Ranganathan, T.N. Siegel, and M.-C. Yao, as well as current and former members of our laboratory; for technical assistance: J. Chuang, Y. Liu, and S. Ram; and for distribution of genetic constructs and strains: the laboratories of C.D. Allis, J. Berman, and R. Tsien and the Yale Coli Genetic Stock Center, the National BioResource Project (NIG, Japan), and the Culture Collection of Algae (UT Austin). D.R.H. acknowledges support from the Training Program in Chemical Biology.	Asai DJ, 2000, METHODS CELL BIOL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bretz M, 2006, EUROPHYS LETT, V74, P1116, DOI 10.1209/epl/i2006-10048-2; Brittain A.M., 1993, THESIS U HAWAII HONO; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; CARLSON JM, 1989, PHYS REV A, V40, P6470, DOI 10.1103/PhysRevA.40.6470; Eisler Z, 2008, ADV PHYS, V57, P89, DOI 10.1080/00018730801893043; Feder J., 1988, FRACTALS; Folsome C. E., 1986, ECOSYSTEM THEORY APP; Frentz Z, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3473937; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gitelson I. I., 2003, MANMADE CLOSED ECOLO; Gould S. J., 1989, WONDERFUL LIFE BURGE; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Hekstra D.R., 2009, THESIS ROCKEFELLER U; HERRNDORF N, 1984, ANN PROBAB, V12, P141, DOI 10.1214/aop/1176993379; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Kantz H., 2004, NONLINEAR TIME SERIE; KAWABATA Z, 1995, J PROTOZOOL RES, V5, P23; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Matsui K, 2000, HYDROBIOLOGIA, V435, P109, DOI 10.1023/A:1004016907260; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Morris SC, 2010, PHILOS T R SOC B, V365, P133, DOI 10.1098/rstb.2009.0154; Mrozek S., 1968, UGUPU BIRD, P39; Nakajima T, 2009, BIOSYSTEMS, V96, P127, DOI 10.1016/j.biosystems.2008.12.006; Niwa HS, 2007, ICES J MAR SCI, V64, P496, DOI 10.1093/icesjms/fsm004; Price JE, 2009, ECOL RES, V24, P587, DOI 10.1007/s11284-008-0529-6; Ramsayer J, 2012, BIOL LETTERS, V8, P316, DOI 10.1098/rsbl.2011.0895; Sait SM, 2000, NATURE, V405, P448, DOI 10.1038/35013045; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; TAUB FB, 1964, LIMNOL OCEANOGR, V9, P61, DOI 10.4319/lo.1964.9.1.0061; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Warren PH, 2003, ECOLOGY, V84, P1001, DOI 10.1890/0012-9658(2003)084[1001:MTAOPC]2.0.CO;2; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	50	68	70	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1164	1173		10.1016/j.cell.2012.03.040	http://dx.doi.org/10.1016/j.cell.2012.03.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632978	Bronze			2022-12-28	WOS:000304453900020
J	Soto, C				Soto, Claudio			Transmissible Proteins: Expanding the Prion Heresy	CELL			English	Review							BETA-AMYLOID DEPOSITION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; IN-VITRO; NEURODEGENERATIVE-DISEASES; SACCHAROMYCES-CEREVISIAE; APLYSIA CPEB; YEAST; PROPAGATION; MECHANISM	The once heretical concept that a misfolded protein is the infectious agent responsible for prion diseases is now widely accepted. Recent exciting research has led not only to the end of the skepticism that proteins can transmit disease, but also to expanding the concept that transmissible proteins might be at the root of some of the most prevalent human illnesses. At the same time, the idea that biological information can be transmitted by propagation of protein (mis) folding raises the possibility that heritable protein agents may be operating as epigenetic factors in normal biological functions and participating in evolutionary adaptation.	Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Soto, C (corresponding author), Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu			NIH [R01 NS49173, R01 GM100453, P01 AI077774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I thank my lab members Rodrigo Morales, Dennisse Gonzalez-Romero, Marcelo Barria, Akihiko Urayama, Abhisek Mukherjee, and Rodrigo Diaz-Espinoza for critical reading of the manuscript and inspiring discussions and Karina Cuanalo-Contreras for help in drafting the figure. This work was partially supported by NIH grants R01 NS49173, R01 GM100453, and P01 AI077774.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; CULLIE J, 1939, CR HEBD ACAD SCI, V208, P1058; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Derkatch IL, 1996, GENETICS, V144, P1375; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korenaga T, 2006, AM J PATHOL, V168, P898, DOI 10.2353/ajpath.2006.050350; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	87	169	172	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					968	977		10.1016/j.cell.2012.05.007	http://dx.doi.org/10.1016/j.cell.2012.05.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632966	Bronze, Green Accepted			2022-12-28	WOS:000304453900005
J	Maloney, DG				Maloney, David G.			Anti-CD20 Antibody Therapy for B-Cell Lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKINS-LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; SINGLE-AGENT RITUXIMAB; LATE-ONSET NEUTROPENIA; MONOCLONAL-ANTIBODY; FOLLICULAR LYMPHOMA; CHOP CHEMOTHERAPY; ELDERLY-PATIENTS; TUMOR BURDEN	A 62-year-old man is evaluated for abdominal pain. Computed tomography (CT) shows a 7-cm mesenteric mass. An incisional biopsy reveals a diffuse large B-cell lymphoma, and immunohistochemical staining is positive for the B-cell antigen CD20. The patient is referred to an oncologist. A positron-emission tomographic-CT (PET-CT) scan reveals involvement of additional nodes in the lower chest and abdomen. The serum level of lactate dehydrogenase is twice the upper limit of the normal range. The results of bone marrow biopsy and aspiration are normal on pathological analysis and flow cytometry. The patient reports an unintentional weight loss of 11 1/2 kg (25 lb) during the previous 6 months but no unexplained fevers or night sweats. He has no history of cardiac disease, and an echocardiogram shows a normal left ventricular ejection fraction. The oncologist recommends treatment with the anti-CD20 monoclonal antibody rituximab in combination with a chemotherapy regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP).	[Maloney, David G.] Fred Hutchinson Canc Res Ctr, Transplantat Biol Program, Div Clin Res, Seattle, WA 98104 USA; [Maloney, David G.] Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Maloney, DG (corresponding author), Fred Hutchinson Canc Res Ctr, Transplantat Biol Program, Div Clin Res, 1100 Fairview Ave N,D1-100, Seattle, WA 98104 USA.	dmaloney@fhcrc.org						Ardeshna KM, 2010, BLOOD, V116, P5, DOI 10.1182/blood.V116.21.6.6; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Brennan PJ, 2009, J ALLERGY CLIN IMMUN, V124, P1259, DOI 10.1016/j.jaci.2009.09.009; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 1998, BLOOD, V92, P1927; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Colombat P, 2001, BLOOD, V97, P101, DOI 10.1182/blood.V97.1.101; Czuczman MS, 1999, SEMIN ONCOL, V26, P88; Fang C, 2010, ANN HEMATOL, V89, P1107, DOI 10.1007/s00277-010-0990-5; Ghielmini M, 2005, J CLIN ONCOL, V23, P705, DOI 10.1200/JCO.2005.04.164; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; Groot MT, 2005, EUR J HAEMATOL, V74, P194, DOI 10.1111/j.1600-0609.2004.00368.x; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hadjinicolaou AV, 2012, RHEUMATOLOGY, V51, P653, DOI 10.1093/rheumatology/ker290; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hornberger JC, 2005, CANCER-AM CANCER SOC, V103, P1644, DOI 10.1002/cncr.20956; Kimby E, 2005, CANCER TREAT REV, V31, P456, DOI 10.1016/j.ctrv.2005.05.007; Knight C, 2004, HEALTH TECHNOL ASSES, V8, P1; Kollmar O, 2002, TRANSPLANTATION, V73, P669, DOI 10.1097/00007890-200202270-00038; Lau GKK, 2008, HEPATOL INT, V2, P152, DOI 10.1007/s12072-008-9056-3; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li SC, 2010, AM J HEMATOL, V85, P810, DOI 10.1002/ajh.21818; Lowndes S, 2002, ANN ONCOL, V13, P1948, DOI 10.1093/annonc/mdf350; Maloney DG, 1997, BLOOD, V90, P2188; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Morschhauser F, 2008, J CLIN ONCOL, V26, P5156, DOI 10.1200/JCO.2008.17.2015; National Comprehensive Cancer Network, NONH LYMPH CLIN PRAC; O'Keefe TL, 1998, IMMUNOGENETICS, V48, P125, DOI 10.1007/s002510050412; Ohmachi K, 2011, ANN ONCOL, V22, P1382, DOI 10.1093/annonc/mdq619; Persky DO, 2008, J CLIN ONCOL, V26, P2258, DOI 10.1200/JCO.2007.13.6929; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; Press OW, 2006, J CLIN ONCOL, V24, P4143, DOI 10.1200/JCO.2006.05.8198; REFF ME, 1994, BLOOD, V83, P435; Robak T, 2009, CURR OPIN INVEST DR, V10, P588; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Salles G, 2011, LANCET, V377, P1154; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Schulz H, 2007, JNCI-J NATL CANCER I, V99, P706, DOI 10.1093/jnci/djk152; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Swerdlow SH, 2008, WHO CLASSIFICATION T; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; Tilly H, 2010, ANN ONCOL, V21, pv172, DOI 10.1093/annonc/mdq203; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; van Oers MHJ, 2006, BLOOD, V108, P3295, DOI 10.1182/blood-2006-05-021113; van Oers MHJ, 2010, J CLIN ONCOL, V28, P2853, DOI 10.1200/JCO.2009.26.5827; Weng WK, 2010, J CLIN ONCOL, V28, P279, DOI 10.1200/JCO.2009.25.0274; Wierda, 2010, J CLIN ONCOL, V28, P3670, DOI 10.1200/JCO.2010.31.3544; Wierda WG, 2010, J CLIN ONCOL, V28, P1749, DOI 10.1200/JCO.2009.25.3187; Wilson W, 2011, HAEMATOLOGICA   1201; Witzens-Harig M, 2011, BLOOD, V118, P1580, DOI 10.1182/blood.V118.21.3700.3700; Wolach O, 2010, MEDICINE, V89, P308, DOI 10.1097/MD.0b013e3181f2caef; Zelenetz AD, 2003, SEMIN ONCOL, V30, P22, DOI 10.1053/sonc.2003.23803; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	61	216	236	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					2008	2016						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621628				2022-12-28	WOS:000304353000011
J	Ramrath, DJF; Yamamoto, H; Rother, K; Wittek, D; Pech, M; Mielke, T; Loerke, J; Scheerer, P; Ivanov, P; Teraoka, Y; Shpanchenko, O; Nierhaus, KH; Spahn, CMT				Ramrath, David J. F.; Yamamoto, Hiroshi; Rother, Kristian; Wittek, Daniela; Pech, Markus; Mielke, Thorsten; Loerke, Justus; Scheerer, Patrick; Ivanov, Pavel; Teraoka, Yoshika; Shpanchenko, Olga; Nierhaus, Knud H.; Spahn, Christian M. T.			The complex of tmRNA-SmpB and EF-G on translocating ribosomes	NATURE			English	Article							TRANSFER-MESSENGER-RNA; BACTERIAL RIBOSOME; HYBRID-STATE; CRYO-EM; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; STALLED RIBOSOME; STRUCTURAL BASIS; 70S RIBOSOME; SYSTEM	Bacterial ribosomes stalled at the 3' end of malfunctioning messenger RNAs can be rescued by transfer-messenger RNA (tmRNA)-mediated trans-translation(1,2). The SmpB protein forms a complex with the tmRNA, and the transfer-RNA-like domain (TLD) of the tmRNA then enters the A site of the ribosome. Subsequently, the TLD-SmpB module is translocated to the P site, a process that is facilitated by the elongation factor EF-G, and translation is switched to the mRNA-like domain (MLD) of the tmRNA. Accurate loading of the MLD into the mRNA path is an unusual initiation mechanism. Despite various snapshots of different ribosome-tmRNA complexes at low to intermediate resolution(3-7), it is unclear how the large, highly structured tmRNA is translocated and how the MLD is loaded. Here we present a cryo-electron microscopy reconstruction of a fusidic-acid-stalled ribosomal 70S-tmRNA-SmpB-EF-G complex (carrying both of the large ligands, that is, EF-G and tmRNA) at 8.3 angstrom resolution. This post-translocational intermediate (TIPOST) presents the TLD-SmpB module in an intrasubunit ap/P hybrid site and a tRNA(fMet) in an intrasubunit pe/E hybrid site. Conformational changes in the ribosome and tmRNA occur in the intersubunit space and on the solvent side. The key underlying event is a unique extra-large swivel movement of the 30S head, which is crucial for both tmRNA-SmpB translocation and MLD loading, thereby coupling translocation to MLD loading. This mechanism exemplifies the versatile, dynamic nature of the ribosome, and it shows that the conformational modes of the ribosome that normally drive canonical translation can also be used in a modified form to facilitate more complex tasks in specialized non-canonical pathways.	[Ramrath, David J. F.; Yamamoto, Hiroshi; Pech, Markus; Mielke, Thorsten; Loerke, Justus; Scheerer, Patrick; Nierhaus, Knud H.; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Yamamoto, Hiroshi; Wittek, Daniela; Pech, Markus; Ivanov, Pavel; Teraoka, Yoshika; Shpanchenko, Olga; Nierhaus, Knud H.] Max Planck Inst Mol Genet, Abt Vingron, AG Ribosomen, D-14195 Berlin, Germany; [Rother, Kristian] Adam Mickiewicz Univ, Coll Biol, Inst Biol & Mol Biotechnol, PL-61614 Poznan, Poland; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Ivanov, Pavel; Shpanchenko, Olga] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Adam Mickiewicz University; Max Planck Society; Lomonosov Moscow State University	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Ziegelstr 5-9, D-10117 Berlin, Germany.	christian.spahn@charite.de	Shpanchenko, Olga/C-7813-2015; Ivanov, Pavel/AAZ-9197-2021; Ivanov, Pavel/F-3339-2016; Yamamoto, Hiroshi/Z-5912-2019	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760; Loerke, Justus/0000-0002-3424-8536; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft DFG [SP 1130/2-1, SFB740]; German Academic Exchange Service [D/09/42768]; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); Alexander-von-Humboldt grant [GAN 1127366 STP-2]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); Alexander-von-Humboldt grant	We thank M. Muhs, T. Budkevich, M. Sommer and A. Korostelev for discussions. The strain for tmRNA overexpression and the plasmid for SmpB were provided by A. Muto. We also thank J. Buerger for his assistance during the cryo-EM data collection, E. Einfeldt for tRNA preparation and R. Albrecht for the preparation of the reassociated 70S ribosomes. This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SP 1130/2-1 to C. M. T. S. and K.H.N., and SFB740 to C. M. T. S.), the German Academic Exchange Service (D/09/42768 to K. R.) and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum) and the Alexander-von-Humboldt grant (GAN 1127366 STP-2 to H.Y.).	Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crandall J, 2010, J BACTERIOL, V192, P553, DOI 10.1128/JB.01178-09; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Felden B, 1997, RNA, V3, P89; Flores S. C., 2010, S BIOCOMPUT, V2010, P216; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Michiels PJA, 2001, J MOL BIOL, V310, P1109, DOI 10.1006/jmbi.2001.4823; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nameki N, 2000, FEBS LETT, V470, P345, DOI 10.1016/S0014-5793(00)01349-1; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHEN LX, 1995, J MOL BIOL, V247, P963, DOI 10.1006/jmbi.1995.0193; Shpanchenko OV, 2005, J BIOL CHEM, V280, P18368, DOI 10.1074/jbc.M409094200; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Weis F, 2010, RNA, V16, P299, DOI 10.1261/rna.1757410; Wower IK, 2009, RNA, V15, P128, DOI 10.1261/rna.1192409; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	42	63	66	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					526	U140		10.1038/nature11006	http://dx.doi.org/10.1038/nature11006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622583				2022-12-28	WOS:000304344500048
J	Siontis, GCM; Tzoulaki, I; Siontis, KC; Ioannidis, JPA				Siontis, George C. M.; Tzoulaki, Ioanna; Siontis, Konstantinos C.; Ioannidis, John P. A.			Comparisons of established risk prediction models for cardiovascular disease: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; INTEGRATED DISCRIMINATION; NET RECLASSIFICATION; EXTERNAL VALIDATION; PRIMARY PREVENTION; SCORING SCHEME; FOLLOW-UP; FRAMINGHAM; POPULATION; EVENTS	Objective To evaluate the evidence on comparisons of established cardiovascular risk prediction models and to collect comparative information on their relative prognostic performance. Design Systematic review of comparative predictive model studies. Data sources Medline and screening of citations and references. Study selection Studies examining the relative prognostic performance of at least two major risk models for cardiovascular disease in general populations. Data extraction Information on study design, assessed risk models, and outcomes. We examined the relative performance of the models (discrimination, calibration, and reclassification) and the potential for outcome selection and optimism biases favouring newly introduced models and models developed by the authors. Results 20 articles including 56 pairwise comparisons of eight models (two variants of the Framingham risk score, the assessing cardiovascular risk to Scottish Intercollegiate Guidelines Network to assign preventative treatment (ASSIGN) score, systematic coronary risk evaluation (SCORE) score, Prospective Cardiovascular Munster (PROCAM) score, QRESEARCH cardiovascular risk (QRISK1 and QRISK2) algorithms, Reynolds risk score) were eligible. Only 10 of 56 comparisons exceeded a 5% relative difference based on the area under the receiver operating characteristic curve. Use of other discrimination, calibration, and reclassification statistics was less consistent. In 32 comparisons, an outcome was used that had been used in the original development of only one of the compared models, and in 25 of these comparisons (78%) the outcome-congruent model had a better area under the receiver operating characteristic curve. Moreover, authors always reported better area under the receiver operating characteristic curves for models that they themselves developed (in five articles on newly introduced models and in three articles on subsequent evaluations). Conclusions Several risk prediction models for cardiovascular disease are available and their head to head comparisons would benefit from standardised reporting and formal, consistent statistical comparisons. Outcome selection and optimism biases apparently affect this literature.	[Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Siontis, George C. M.; Tzoulaki, Ioanna; Siontis, Konstantinos C.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece	Stanford University; University of Ioannina	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	jioannid@stanford.edu	Tzoulaki, Ioanna/ABE-6269-2020; Ioannidis, John P. A./G-9836-2011	Tzoulaki, Ioanna/0000-0002-4275-9328; 				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Bertolini G, 2000, J Epidemiol Biostat, V5, P251; Barroso LC, 2010, SCAND J PRIM HEALTH, V28, P242, DOI 10.3109/02813432.2010.518407; Chalmers I, 2006, LANCET, V367, P449, DOI 10.1016/S0140-6736(06)68153-1; Chen L, 2009, EUR J CARDIOV PREV R, V16, P562, DOI 10.1097/HJR.0b013e32832cd9cb; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Cooper JA, 2005, ATHEROSCLEROSIS, V181, P93, DOI 10.1016/j.atherosclerosis.2004.12.026; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; de la Iglesia B, 2011, HEART, V97, P491, DOI 10.1136/hrt.2010.203364; Dunder K, 2004, AM HEART J, V148, P596, DOI 10.1016/j.ahj.2004.03.021; Empana JP, 2003, EUR HEART J, V24, P1903, DOI 10.1016/j.ehj.2003.09.002; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hurley LP, 2010, CIRC-CARDIOVASC QUAL, V3, P181, DOI 10.1161/CIRCOUTCOMES.108.831073; Ioannidis JPA, 2008, SEMIN HEMATOL, V45, P160, DOI 10.1053/j.seminhematol.2008.04.010; Ioannidis JPA, 2010, JAMA-J AM MED ASSOC, V303, P1646, DOI 10.1001/jama.2010.503; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mainous AG, 2007, AM J CARDIOL, V99, P1236, DOI 10.1016/j.amjcard.2006.12.035; Marcin JP, 2007, CRIT CARE MED, V35, P2212, DOI 10.1097/01.CCM.0000281522.70992.EF; Mosca Lori, 2007, Circulation, V115, P1481, DOI 10.1161/CIRCULATIONAHA.107.181546; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Scheltens T, 2008, EUR J CARDIOV PREV R, V15, P562, DOI 10.1097/HJR.0b013e3283063a65; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; van der Heijden AAWA, 2009, DIABETES CARE, V32, P2094, DOI 10.2337/dc09-0745; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Woodward M, 2009, BRIT J HAEMATOL, V146, P442, DOI 10.1111/j.1365-2141.2009.07778.x; World Health Organization, 2007, PREV CARD DIS GUID A; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	52	158	159	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2012	344								e3318	10.1136/bmj.e3318	http://dx.doi.org/10.1136/bmj.e3318			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QU	22628003	hybrid			2022-12-28	WOS:000304591600005
J	McMillan, AM; Landorf, KB; Gilheany, MF; Bird, AR; Morrow, AD; Menz, HB				McMillan, Andrew M.; Landorf, Karl B.; Gilheany, Mark F.; Bird, Adam R.; Morrow, Adam D.; Menz, Hylton B.			Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEEL PAIN; STEROID INJECTION; PATELLAR TENDON; FOOT; HEALTH; PREVALENCE; INJURIES; CARE	Objective To investigate the effectiveness of ultrasound guided corticosteroid injection in the treatment of plantar fasciitis. Design Randomised, investigator and participant blinded, placebo controlled trial. Setting University clinic in Melbourne, Australia. Participants 82 people with a clinical and ultrasound diagnosis of plantar fasciitis unrelated to systemic inflammatory disease. Interventions Participants were randomly allocated to ultrasound guided injection of the plantar fascia with either 1 mL of 4 mg/mL dexamethasone sodium phosphate (experimental group) or 1 mL normal saline (placebo). Before injection the participants were given an ultrasound guided posterior tibial nerve block with 2% lidocaine (lignocaine). Main outcome measures Primary outcomes were pain, as measured by the foot health status questionnaire (0-100 point scale), and plantar fascia thickness, measured by ultrasound at 4, 8, and 12 weeks. Results Reduction in pain at four weeks favoured the dexamethasone group by 10.9 points (95% confidence interval 1.4 to 20.4, P=0.03). Between group differences for pain scores at eight and 12 weeks were not statistically significant. Plantar fascia thickness measured at four weeks favoured the dexamethasone group by -0.35 mm (95% confidence interval -0.67 to -0.03, P=0.03). At eight and 12 weeks, between group differences for plantar fascia thickness also favoured dexamethasone, at -0.39 mm (-0.73 to -0.05, P=0.02) and -0.43 mm (-0.85 to -0.01, P=0.04), respectively. The number needed to treat with dexamethasone for one successful outcome for pain at four weeks was 2.93 (95% confidence interval 2.76 to 3.12). There were no reported adverse events associated with the intervention. Conclusion A single ultrasound guided dexamethasone injection is a safe and effective short term treatment for plantar fasciitis. It provides greater pain relief than placebo at four weeks and reduces abnormal swelling of the plantar fascia for up to three months. However, clinicians offering this treatment should also note that significant pain relief did not continue beyond four weeks.	[McMillan, Andrew M.; Landorf, Karl B.; Gilheany, Mark F.; Bird, Adam R.; Morrow, Adam D.] La Trobe Univ, Fac Hlth Sci, Dept Podiatry, Bundoora, Vic 3086, Australia; [Menz, Hylton B.] La Trobe Univ, Fac Hlth Sci, Musculoskeletal Res Ctr, Bundoora, Vic 3086, Australia	La Trobe University; La Trobe University	McMillan, AM (corresponding author), La Trobe Univ, Fac Hlth Sci, Dept Podiatry, Bundoora, Vic 3086, Australia.	a.mcmillan@latrobe.edu.au	Landorf, Karl B/H-2829-2014; Menz, Hylton B/B-4508-2013	Landorf, Karl B/0000-0002-3882-5206; Menz, Hylton B/0000-0002-2045-3846	Australian Podiatry Education and Research Foundation; Australian Postgraduate Award	Australian Podiatry Education and Research Foundation; Australian Postgraduate Award(Australian Government)	This study was funded by the Australian Podiatry Education and Research Foundation. AMcM has received an Australian Postgraduate Award scholarship. HBM is a National Health and Medical Research Council senior research fellow (ID: 1020925). Briggate Medical (Victoria, Australia) donated medical consumables used in the trial.	Alfredson H, 2005, SCAND J MED SCI SPOR, V15, P252, DOI 10.1111/j.1600-0838.2005.00466.x; Bennett PJ, 1998, J AM PODIAT MED ASSN, V88, P419, DOI 10.7547/87507315-88-9-419; BLOCKEY NJ, 1956, BRIT MED J, V1, P1277, DOI 10.1136/bmj.1.4978.1277; Brunton LL, 2018, GOODMAN GILMANS PHAR; Buchbinder R, 2004, NEW ENGL J MED, V350, P2159, DOI 10.1056/NEJMcp032745; Centeno L M, 1994, Arthritis Care Res, V7, P151, DOI 10.1002/art.1790070309; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Crawford F, 1999, RHEUMATOLOGY, V38, P974, DOI 10.1093/rheumatology/38.10.974; Crawford F, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000416; Danielson P, 2006, MICROSC RES TECHNIQ, V69, P808, DOI 10.1002/jemt.20351; DiGiovanni BF, 2003, J BONE JOINT SURG AM, V85A, P1270, DOI 10.2106/00004623-200307000-00013; Dunn JE, 2004, AM J EPIDEMIOL, V159, P491, DOI 10.1093/aje/kwh071; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572; Genc H, 2005, JOINT BONE SPINE, V72, P61, DOI 10.1016/j.jbspin.2004.03.006; HASLOCK I, 1995, BRIT J RHEUMATOL, V34, P449; Hill CL, 2008, J FOOT ANKLE RES, V1, DOI 10.1186/1757-1146-1-2; HILL JJ, 1989, CONT ORTHOP, V18, P39; Irving DB, 2008, J AM PODIAT MED ASSN, V98, P283, DOI 10.7547/0980283; Jacobs JW, 2009, BEST PRACT RES CL RH, V23, P193, DOI 10.1016/j.berh.2008.11.002; Jarde O, 2003, ACTA ORTHOP BELG, V69, P274; Johnson JE, 2011, FOOT ANKLE INT, V32, P394, DOI 10.3113/FAI.2011.0394; Khan KM, 2000, BRIT J SPORT MED, V34, P81, DOI 10.1136/bjsm.34.2.81; Koscielniak-Nielsen ZJ, 2008, ACTA ANAESTH SCAND, V52, P727, DOI 10.1111/j.1399-6576.2008.01666.x; Koski JM, 2000, J RHEUMATOL, V27, P2131; Landorf K, 2008, CLIN EVIDENCE, V2, P1111; Landorf KB, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-7; LEACH RE, 1986, FOOT ANKLE, V7, P156, DOI 10.1177/107110078600700305; Lemont H, 2003, J AM PODIAT MED ASSN, V93, P234, DOI 10.7547/87507315-93-3-234; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; Marhofer P, 2005, BRIT J ANAESTH, V94, P7, DOI 10.1093/bja/aei002; McMillan AM, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-15; McMillan AM, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-32; McPoil TG, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0302; Moore GF, 2005, ARTHRITIS ALLIED CON; Pribut SM, 2007, J AM PODIAT MED ASSN, V97, P68, DOI 10.7547/0970068; Redborg KE, 2009, REGION ANESTH PAIN M, V34, P256, DOI 10.1097/AAP.0b013e3181a343a2; Riddle DL, 2004, FOOT ANKLE INT, V25, P303, DOI 10.1177/107110070402500505; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; SCHEPSIS AA, 1991, CLIN ORTHOP RELAT R, P185; Singh D, 1997, BMJ-BRIT MED J, V315, P172, DOI 10.1136/bmj.315.7101.172; Skedros JG, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-63; Smidt N, 2002, PAIN, V96, P23, DOI 10.1016/S0304-3959(01)00388-8; SNIDER MP, 1983, AM J SPORT MED, V11, P215, DOI 10.1177/036354658301100406; Speed CA, 2003, BEST PRACT RES CL RH, V17, P167, DOI 10.1016/S1521-6942(02)00122-5; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Tong Kuo Bianchini, 2010, Am J Orthop (Belle Mead NJ), V39, P227; Tountas AA, 1996, CLIN ORTHOP RELAT R, P170; Tsai WC, 2006, J CLIN ULTRASOUND, V34, P12, DOI 10.1002/jcu.20177; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Wearing SC, 2004, MED SCI SPORT EXER, V36, P1761, DOI 10.1249/01.MSS.0000142297.10881.11	52	84	86	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2012	344								e3260	10.1136/bmj.e3260	http://dx.doi.org/10.1136/bmj.e3260			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QS	22619193	Green Submitted, hybrid			2022-12-28	WOS:000304591400006
J	Roy, H; Kallmeyer, J; Adhikari, RR; Pockalny, R; Jorgensen, BB; D'Hondt, S				Roy, Hans; Kallmeyer, Jens; Adhikari, Rishi Ram; Pockalny, Robert; Jorgensen, Bo Barker; D'Hondt, Steven			Aerobic Microbial Respiration in 86-Million-Year-Old Deep-Sea Red Clay	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; SOUTH-PACIFIC GYRE; MARINE-SEDIMENTS; NORTH PACIFIC; IN-SITU; MATTER; FLOOR; OCEAN; BIOSPHERE; PROFILES	Microbial communities can subsist at depth in marine sediments without fresh supply of organic matter for millions of years. At threshold sedimentation rates of 1 millimeter per 1000 years, the low rates of microbial community metabolism in the North Pacific Gyre allow sediments to remain oxygenated tens of meters below the sea floor. We found that the oxygen respiration rates dropped from 10 micromoles of O-2 liter(-1) year(-1) near the sediment-water interface to 0.001 micromoles of O-2 liter(-1) year(-1) at 30-meter depth within 86 million-year-old sediment. The cell-specific respiration rate decreased with depth but stabilized at around 10(-3) femtomoles of O-2 cell(-1) day(-1) 10 meters below the seafloor. This result indicated that the community size is controlled by the rate of carbon oxidation and thereby by the low available energy flux.	[Roy, Hans; Jorgensen, Bo Barker] Aarhus Univ, Dept Biosci, Cter Geomicrobiol, DK-8000 Aarhus C, Denmark; [Kallmeyer, Jens; Adhikari, Rishi Ram] Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany; [Pockalny, Robert; D'Hondt, Steven] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Aarhus University; University of Potsdam; University of Rhode Island	Roy, H (corresponding author), Aarhus Univ, Dept Biosci, Cter Geomicrobiol, Ny Munkegade 116, DK-8000 Aarhus C, Denmark.	hans.roy@biology.au.dk	Kallmeyer, Jens/I-3554-2012; Jorgensen, Bo B/C-2214-2013; Kallmeyer, Jens/AAF-6906-2020; Pockalny, Rob/HHZ-6845-2022; Røy, Hans/G-3842-2010	Kallmeyer, Jens/0000-0002-6440-1140; Jorgensen, Bo B/0000-0001-9398-8027; Kallmeyer, Jens/0000-0002-6440-1140; Røy, Hans/0000-0002-6477-3091; Adhikari, Rishi Ram/0000-0002-3624-9639	Danish National Research Foundation; German Max Planck Society, Aarhus University; German Federal Ministry of Research and Education; U.S NSF (OCE) [0752336]; U.S NSF; Division Of Ocean Sciences [0752336] Funding Source: National Science Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); German Max Planck Society, Aarhus University; German Federal Ministry of Research and Education; U.S NSF (OCE); U.S NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The assistance from E. Caporelli, B. Costello, and E. Benway at Woods Hole Oceanographic Institution (WHOI) was crucial for our participation in the R/V Knorr cruise. We thank B. Gribsholt, the shipboard science party, the WHOI long-coring team, and the crew of the R/V Knorr for cooperation at sea. Net primary production data were provided by R. O'Malley from Oregon State University (www.science.oregonstate.edu/ocean.productivity/index.php). Our study was funded by the Danish National Research Foundation, the German Max Planck Society, Aarhus University, the German Federal Ministry of Research and Education via the GeoEnergie Project, and the U.S NSF (OCE grant 0752336 and the NSF-funded C-DEBI Science and Technology Center). This is C-DEBI publication number 130.	Antia AN, 2001, GLOBAL BIOGEOCHEM CY, V15, P845, DOI 10.1029/2000GB001376; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Berner A., 1980, C INT CNRS, V293, P35; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Cai WJ, 1996, MAR CHEM, V52, P123, DOI 10.1016/0304-4203(95)00081-X; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Divins D. L., 2009, TOTAL SEDIMENT THICK; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fischer JP, 2009, BIOGEOSCIENCES, V6, P1467, DOI 10.5194/bg-6-1467-2009; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; JAHNKE RA, 1987, NATURE, V329, P621, DOI 10.1038/329621a0; Jorgensen BB, 2006, SCIENCE, V314, P932, DOI 10.1126/science.1133796; Kallmeyer J, 2008, LIMNOL OCEANOGR-METH, V6, P236, DOI 10.4319/lom.2008.6.236; Knoblauch C, 1999, APPL ENVIRON MICROB, V65, P4230; KYTE FT, 1993, GEOCHIM COSMOCHIM AC, V57, P1719, DOI 10.1016/0016-7037(93)90109-A; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wenzhofer F, 2001, DEEP-SEA RES PT I, V48, P1741, DOI 10.1016/S0967-0637(00)00108-4	25	126	131	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					922	925		10.1126/science.1219424	http://dx.doi.org/10.1126/science.1219424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605778				2022-12-28	WOS:000304145600067
J	Scheffran, J; Brzoska, M; Kominek, J; Link, PM; Schilling, J				Scheffran, Juergen; Brzoska, Michael; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter			CLIMATE CHANGE AND VIOLENT CONFLICT	SCIENCE			English	Editorial Material							NATURAL DISASTERS; CIVIL CONFLICT; LAST MILLENNIUM; AFRICA; BLAME; RISK; WAR	Current debates over the relation between climate change and conflict originate in a lack of data, as well as the complexity of pathways connecting the two phenomena.	[Scheffran, Juergen; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter] Univ Hamburg, Inst Geog, Res Grp Climate Change & Secur, D-20144 Hamburg, Germany; [Brzoska, Michael] Univ Hamburg, Inst Peace Res & Secur Policy, D-20144 Hamburg, Germany; [Scheffran, Juergen; Brzoska, Michael; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter] Univ Hamburg, KlimaCampus, D-20144 Hamburg, Germany; [Kominek, Jasmin] Univ Hamburg, Inst Sociol, D-20146 Hamburg, Germany; [Link, P. Michael] Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Res Unit Sustainabil & Global Change, D-20146 Hamburg, Germany; [Schilling, Janpeter] Univ Hamburg, Sch Integrated Climate Syst Sci, D-20144 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg	Scheffran, J (corresponding author), Univ Hamburg, Inst Geog, Res Grp Climate Change & Secur, Grindelberg 5, D-20144 Hamburg, Germany.	juergen.scheffran@zmaw.de	Scheffran, Jürgen/M-6876-2019; Link, Peter Michael/O-1616-2014; Carroll, Joseph/D-1158-2011; Brzoska, Michael/AAX-6310-2020; Link, Peter Michael/AAL-4171-2021	Scheffran, Jürgen/0000-0002-7171-3062; Carroll, Joseph/0000-0003-2656-1378; Brzoska, Michael/0000-0002-5227-1625	German Science Foundation (DFG) [EXC177]	German Science Foundation (DFG)(German Research Foundation (DFG))	Research for this study was funded in part by the German Science Foundation (DFG) through the Cluster of Excellence "CliSAP" (EXC177).	Adano WR, 2012, J PEACE RES, V49, P65, DOI 10.1177/0022343311427344; Bachler G., 1999, ENV CHANGE SECURITY, P107; Benjaminsen TA, 2012, J PEACE RES, V49, P97, DOI 10.1177/0022343311427343; Bergholt D, 2012, J PEACE RES, V49, P147, DOI 10.1177/0022343311426167; Bernauer T, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015601; Bernauer T, 2012, J PEACE RES, V49, P227, DOI 10.1177/0022343311425843; Brochmann M, 2009, INT NEGOT, V14, P393, DOI 10.1163/157180609X432879; Brzoska, 2012, CLIMATE CHANGE HUMAN, DOI 10.1007/978-3-642-28626-1; Brzoska M., 2012, CLIMATE CHANGE HUMAN, P165, DOI DOI 10.1007/978-3-642-28626-1_8; Buhaug H., 2012, CLIMATE CHANGE HUMAN, V8; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Busby J.W., 2012, HEXAGON SERIES HUMAN, P463; De Stefano L, 2012, J PEACE RES, V49, P193, DOI 10.1177/0022343311427416; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; HOMERDIXON TF, 1994, INT SECURITY, V19, P5, DOI 10.2307/2539147; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Intergovernmental Panel on Climate Change IPCC, 2007, CLIM CHANG 2007 CLIM; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Johnstone S, 2011, SURVIVAL, V53, P11, DOI 10.1080/00396338.2011.571006; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Marshall M., 2010, POLITY 4 PROJECT POL; Messer E., 2009, NAPA B, V32, P12; Nardulli P. F., 2012, CLIMATE CHANGE HUMAN, P57; Nel P, 2008, INT STUD QUART, V52, P159, DOI 10.1111/j.1468-2478.2007.00495.x; Opiyo F. E. O., 2012, AFRIC J ENV SCI TECH; Organization for Economic Cooperation and Development, 2012, AN AID MUCH AID IS D; Raleigh C, 2012, J PEACE RES, V49, P51, DOI 10.1177/0022343311427754; Scheffran J., 2012, CLIMATE CHANGE HUMAN, V8, P91; Scheffran J, 2011, REG ENVIRON CHANGE, V11, pS27, DOI 10.1007/s10113-010-0175-8; Slettebak RT, 2012, J PEACE RES, V49, P163, DOI 10.1177/0022343311425693; Themner L, 2011, J PEACE RES, V48, P525, DOI 10.1177/0022343311415302; Tol RSJ, 2010, CLIMATIC CHANGE, V99, P65, DOI 10.1007/s10584-009-9659-2; UCDP-PRIO, 2011, UCDP PRIO ARMED CONF; WBGU, 2008, WORLD TRANS CLIM CHA; Zhang DD, 2007, HUM ECOL, V35, P403, DOI 10.1007/s10745-007-9115-8; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108	37	183	183	8	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					869	871		10.1126/science.1221339	http://dx.doi.org/10.1126/science.1221339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605765				2022-12-28	WOS:000304145600051
J	Mihaylova, B; Emberson, J; Blackwell, L; Keech, A; Simes, J; Barnes, EH; Voysey, M; Gray, A; Collins, R; Baigent, C; de Lemos, J; Braunwald, E; Blazing, M; Murphy, S; Downs, JR; Gotto, A; Clearfield, M; Holdaas, H; Gordon, D; Davis, B; Koren, M; Dahlof, B; Poulter, N; Sever, P; Knopp, RH; Fellstrom, B; Holdaas, H; Jardine, A; Schmieder, R; Zannad, F; Goldbourt, U; Kaplinsky, E; Colhoun, HM; Betteridge, DJ; Durrington, PN; Hitman, GA; Fuller, J; Neil, A; Wanner, C; Krane, V; Sacks, F; Moye, L; Pfeffer, M; Hawkins, CM; Braunwald, E; Kjekshus, J; Wedel, H; Wikstrand, J; Barter, P; Keech, A; Tavazzi, L; Maggioni, A; Marchioli, R; Tognoni, G; Franzosi, MG; Maggioni, A; Bloomfield, H; Robins, S; Collins, R; Armitage, J; Keech, A; Parish, S; Peto, R; Sleight, P; Pedersen, TR; Ridker, PM; Holman, R; Meade, T; Simes, J; Keech, A; MacMahon, S; Marschner, I; Tonkin, A; Shaw, J; Serruys, PW; Nakamura, H; Knatterud, G; Furberg, C; Byington, R; Macfarlane, P; Cobbe, S; Ford, I; Murphy, M; Blauw, GJ; Packard, C; Shepherd, J; Kjekshus, J; Pedersen, T; Wilhelmsen, L; Braunwald, E; Cannon, C; Murphy, S; Collins, R; Armitage, J; Bowman, L; Parish, S; Peto, R; Sleight, P; Baigent, C; Landray, M; Collins, R; La Rosa, J; Rossouw, J; Probstfield, J; Shepherd, J; Cobbe, S; Macfarlane, P; Ford, I				Mihaylova, B.; Emberson, J.; Blackwell, L.; Keech, A.; Simes, J.; Barnes, E. H.; Voysey, M.; Gray, A.; Collins, R.; Baigent, C.; de Lemos, J.; Braunwald, E.; Blazing, M.; Murphy, S.; Downs, J. R.; Gotto, A.; Clearfield, M.; Holdaas, H.; Gordon, D.; Davis, B.; Koren, M.; Dahlof, B.; Poulter, N.; Sever, P.; Knopp, R. H.; Fellstrom, B.; Holdaas, H.; Jardine, A.; Schmieder, R.; Zannad, F.; Goldbourt, U.; Kaplinsky, E.; Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Fuller, J.; Neil, A.; Wanner, C.; Krane, V.; Sacks, F.; Moye, L.; Pfeffer, M.; Hawkins, C. M.; Braunwald, E.; Kjekshus, J.; Wedel, H.; Wikstrand, J.; Barter, P.; Keech, A.; Tavazzi, L.; Maggioni, A.; Marchioli, R.; Tognoni, G.; Franzosi, M. G.; Maggioni, A.; Bloomfield, H.; Robins, S.; Collins, R.; Armitage, J.; Keech, A.; Parish, S.; Peto, R.; Sleight, P.; Pedersen, T. R.; Ridker, P. M.; Holman, R.; Meade, T.; Simes, J.; Keech, A.; MacMahon, S.; Marschner, I.; Tonkin, A.; Shaw, J.; Serruys, P. W.; Nakamura, H.; Knatterud, G.; Furberg, C.; Byington, R.; Macfarlane, P.; Cobbe, S.; Ford, I.; Murphy, M.; Blauw, G. J.; Packard, C.; Shepherd, J.; Kjekshus, J.; Pedersen, T.; Wilhelmsen, L.; Braunwald, E.; Cannon, C.; Murphy, S.; Collins, R.; Armitage, J.; Bowman, L.; Parish, S.; Peto, R.; Sleight, P.; Baigent, C.; Landray, M.; Collins, R.; La Rosa, J.; Rossouw, J.; Probstfield, J.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Ford, I.		Cholesterol Treatment Trialists	The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials	LANCET			English	Article							CORONARY-HEART-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; DIABETES-MELLITUS; CARDIAC OUTCOMES; FOLLOW-UP; EVENTS	Background Statins reduce LDL cholesterol and prevent vascular events, but their net effects in people at low risk of vascular events remain uncertain. Methods This meta-analysis included individual participant data from 22 trials of statin versus control (n=134 537; mean LDL cholesterol difference 1.08 mmol/L; median follow-up 4.8 years) and five trials of more versus less statin (n=39 612; difference 0.51 mmol/L; 5.1 years). Major vascular events were major coronary events (ie,non-fatal myocardial infarction or coronary death), strokes, or coronary revascularisations. Participants were separated into five categories of baseline 5-year major vascular event risk on control therapy (no statin or low-intensity statin) (<5%, >= 5% to <10%, >= 10% to <20%, >= 20% to <30%, >= 30%); in each, the rate ratio (RR) per 1.0 mmol/L LDL cholesterol reduction was estimated. Findings Reduction of LDL cholesterol with a statin reduced the risk of major vascular events (RR 0.79, 95% CI 0.77-0.81, per 1.0 mmol/L reduction), largely irrespective of age, sex, baseline LDL cholesterol or previous vascular disease, and of vascular and all-cause mortality. The proportional reduction in major vascular events was at least as big in the two lowest risk categories as in the higher risk categories (RR per 1.0 mmol/L reduction from lowest to highest risk: 0.62 [99% CI 0.47-0.81], 0.69 [99% CI 0.60-0.79], 0.79 [99% CI 0.74-0.85], 0.81 [99% CI 0.77-0.86], and 0.79 [99% CI 0.74-0.84]; trend p=0.04), which reflected significant reductions in these two lowest risk categories in major coronary events (RR 0.57, 99% CI 0.36-0.89, p=0.0012, and 0.61, 99% CI 0.50-0.74, p<0.0001) and in coronary revascularisations (RR 0.52, 99% CI 0.35-0.75, and 0.63, 99% CI 0.51-0.79; both p<0.0001). For stroke, the reduction in risk in participants with 5-year risk of major vascular events lower than 10% (RR per 1.0 mmol/L LDL cholesterol reduction 0.76, 99% CI 0.61-0.95, p=0.0012) was also similar to that seen in higher risk categories (trend p=0.3). In participants without a history of vascular disease, statins reduced the risks of vascular (RR per 1.0 mmol/L LDL cholesterol reduction 0.85, 95% CI 0.77-0.95) and all-cause mortality (RR 0.91, 95% CI 0.85-0.97), and the proportional reductions were similar by baseline risk. There was no evidence that reduction of LDL cholesterol with a statin increased cancer incidence (RR per 1.0 mmol/L LDL cholesterol reduction 1.00, 95% CI 0.96-1.04), cancer mortality (RR 0.99, 95% CI 0.93-1.06), or other non-vascular mortality. Interpretation In individuals with 5-year risk of major vascular events lower than 10%, each 1 mmol/L reduction in LDL cholesterol produced an absolute reduction in major vascular events of about 11 per 1000 over 5 years. This benefit greatly exceeds any known hazards of statin therapy. Under present guidelines, such individuals would not typically be regarded as suitable for LDL-lowering statin therapy. The present report suggests, therefore, that these guidelines might need to be reconsidered.	[Mihaylova, B.] CTT Secretariat, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Emberson, J.; Keech, A.; Simes, J.; Barnes, E. H.] Univ Sydney, Natl Hlth & Med Res Council NHMRC Clin Trial Ctr, Sydney, NSW 2006, Australia	University of Oxford; University of Sydney	Mihaylova, B (corresponding author), CTT Secretariat, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	ctt@ctsu.ox.ac.uk	Simes, Robert John/P-1497-2014; Ford, Ian/ABE-6145-2020; Collins, Rory/ABA-8487-2020; Zannad, Faiez/K-4649-2019; Blauw, Gerard/GWD-1079-2022; Jardine, Alan/L-5770-2019; Blauw, Gerard/AAW-7904-2021; Maggioni, Aldo Pietro/AAL-5334-2020; de Lemos, James/ABD-6669-2021; Tavazzi, Luigi/ABD-5119-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779; Tavazzi, Luigi/0000-0003-0336-8356; Bhala, Neeraj/0000-0003-2502-1177; Mihaylova, Borislava/0000-0002-0951-1304; MacMahon, Stephen/0000-0003-2064-7699; Emberson, Jonathan/0000-0001-7792-9422; Jardine, Alan/0000-0001-5815-9370; bloomfield, hanna/0000-0002-0756-7064; Herrington, William/0000-0003-1172-8243; Gordon, David/0000-0003-3276-9685; Colhoun, Helen/0000-0002-8345-3288; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Landray, Martin/0000-0001-6646-827X; Buck, Georgina/0000-0001-5909-4265; Voysey, Merryn/0000-0001-6324-6559; Marschner, Ian/0000-0002-6225-1572; Kearney, Patricia/0000-0001-9599-3540; Yusuf, Salim/0000-0003-4776-5601	British Heart Foundation; UK Medical Research Council; Cancer Research UK; European Community Biomed Programme; Australian National Health and Medical Research Council; National Heart Foundation, Australia; British Heart Foundation [PG/08/063/25397]; BHF Centre of Research Excellence, Oxford, UK [RE/08/04]; Medical Research Council [G0701113, MC_U137686849] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish; MRC [MC_U137686849, G0701113] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Community Biomed Programme; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation, Australia(National Heart Foundation of Australia); British Heart Foundation(British Heart Foundation); BHF Centre of Research Excellence, Oxford, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in the UK and the National Health and Medical Research Council Clinical Trials Centre (CTC) in Australia coordinate this collaboration jointly. The present meta-analysis work is supported at the Health Economics Research Centre, University of Oxford (writing committee members B Mihaylova, A Gray) by a British Heart Foundation research grant (Grant No PG/08/063/25397), and at the CTSU (writing committee members J Emberson, L Blackwell, R Collins, C Baigent) by the UK Medical Research Council, British Heart Foundation, Cancer Research UK and, previously, the European Community Biomed Programme. The CTC is supported by a programme grant from the Australian National Health and Medical Research Council, and a grant from the National Heart Foundation, Australia. JE acknowledges support from the BHF Centre of Research Excellence, Oxford, UK (RE/08/04).	Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2000, Ital Heart J, V1, P810; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cheung BMY, 2010, LANCET, V376, P1622, DOI 10.1016/S0140-6736(10)61545-0; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cooper A, 2008, CLIN GUIDELINES EVID; Davidson MH, 2007, J AM COLL CARDIOL, V49, P1753, DOI 10.1016/j.jacc.2007.01.067; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Kerr AJ, 2009, HEART, V95, P125, DOI 10.1136/hrt.2007.140905; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Mihaylova B, 2006, BMJ-BRIT MED J, V333, P1145, DOI 10.1136/bmj.38993.731725.BE; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Redberg RF, 2011, ARCH INTERN MED, V171, P1594, DOI 10.1001/archinternmed.2011.409; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Simes RJ, 2002, LANCET, V359, P1379; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	55	1805	1874	8	247	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					581	590		10.1016/S0140-6736(12)60367-5	http://dx.doi.org/10.1016/S0140-6736(12)60367-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22607822	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000307511400031
J	Osterloh, JM; Yang, J; Rooney, TM; Fox, AN; Adalbert, R; Powell, EH; Sheehan, AE; Avery, MA; Hackett, R; Logan, MA; MacDonald, JM; Ziegenfuss, JS; Milde, S; Hou, YJ; Nathan, C; Ding, AH; Brown, RH; Conforti, L; Coleman, M; Tessier-Lavigne, M; Zuchner, S; Freeman, MR				Osterloh, Jeannette M.; Yang, Jing; Rooney, Timothy M.; Fox, A. Nicole; Adalbert, Robert; Powell, Eric H.; Sheehan, Amy E.; Avery, Michelle A.; Hackett, Rachel; Logan, Mary A.; MacDonald, Jennifer M.; Ziegenfuss, Jennifer S.; Milde, Stefan; Hou, Ying-Ju; Nathan, Carl; Ding, Aihao; Brown, Robert H., Jr.; Conforti, Laura; Coleman, Michael; Tessier-Lavigne, Marc; Zuechner, Stephan; Freeman, Marc R.			dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; WALLERIAN DEGENERATION; SELF-DESTRUCTION; REPEAT PROTEIN; NERVE; GENE; APOPTOSIS; SURVIVAL; ELEGANS; NEURONS	Axonal and synaptic degeneration is a hallmark of peripheral neuropathy, brain injury, and neurodegenerative disease. Axonal degeneration has been proposed to be mediated by an active autodestruction program, akin to apoptotic cell death; however, loss-of-function mutations capable of potently blocking axon self-destruction have not been described. Here, we show that loss of the Drosophila Toll receptor adaptor dSarm (sterile alpha/Armadillo/Toll-Interleukin receptor homology domain protein) cell-autonomously suppresses Wallerian degeneration for weeks after axotomy. Severed mouse Sarm1 null axons exhibit remarkable long-term survival both in vivo and in vitro, indicating that Sarm1 prodegenerative signaling is conserved in mammals. Our results provide direct evidence that axons actively promote their own destruction after injury and identify dSarm/Sarm1 as a member of an ancient axon death signaling pathway.	[Osterloh, Jeannette M.; Rooney, Timothy M.; Fox, A. Nicole; Sheehan, Amy E.; Avery, Michelle A.; Hackett, Rachel; Logan, Mary A.; MacDonald, Jennifer M.; Ziegenfuss, Jennifer S.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Yang, Jing; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Powell, Eric H.; Zuechner, Stephan] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn Dept Human Genet, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Adalbert, Robert; Milde, Stefan; Coleman, Michael] Babraham Inst, Cambridge CB22 3AT, England; [Nathan, Carl; Ding, Aihao] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Conforti, Laura] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	University of Massachusetts System; University of Massachusetts Worcester; Rockefeller University; University of Miami; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cornell University; University of Massachusetts System; University of Massachusetts Worcester; University of Nottingham	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	marc.freeman@umassmed.edu	MacDonald, Jennifer/ABB-1560-2020; Yang, Jing/M-2831-2017	Yang, Jing/0000-0002-2048-735X; Adalbert, Robert/0000-0003-0782-1402; Freeman, Marc/0000-0003-3481-3715; Fox, Nicole/0000-0001-5012-9177	U.S. Department of Defense [BC093796]; National Institute for Neurological Diseases and Stroke (NINDS) [R01NS072248, U54NS065712, R01NS059991]; Alzheimer's Research UK [ART/PG2009/2]; Biotechnology and Biological Sciences Research Council Institute; NIH [AI030165]; Rockefeller University; ALS Therapy Alliance; NINDS ARRA [RC2-NS070-342]; Angel Fund; ALS Association; P2ALS; ALS; Pierre L. de Bourgknecht ALS Research Foundation;  [NINDS5RO1-NS050557-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030165, R01AI030165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712, R01NS072248, R01NS050557, R01NS059991, R37NS053538, RC2NS070342] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2009-2] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C200, BBS/E/B/000C0417] Funding Source: researchfish; BBSRC [BBS/E/B/000C0417] Funding Source: UKRI	U.S. Department of Defense(United States Department of Defense); National Institute for Neurological Diseases and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Biotechnology and Biological Sciences Research Council Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; ALS Therapy Alliance; NINDS ARRA; Angel Fund; ALS Association; P2ALS; ALS; Pierre L. de Bourgknecht ALS Research Foundation; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Gilley for preliminary work with Sarm1 primary cultures and Y. Hsueh for the Sarm1 antibody. We thank J. Patrick, D. Cameron, and D. Weaver for assistance with mouse work. This work was supported by the U.S. Department of Defense grant BC093796 (to T. M. R.); National Institute for Neurological Diseases and Stroke (NINDS) grants R01NS072248 and U54NS065712 (to S.Z.); an Alzheimer's Research UK Grant ART/PG2009/2, a Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant (to M.C.); NIH grant AI030165 to A.D.; support from Rockefeller University (J.Y. and M.T.-L.); and NINDS grant R01NS059991 and the ALS Therapy Alliance (to M.R.F.). M.R.F. is an Early Career Scientist with the Howard Hughes Medical Institute. M.R.F. and S.Z. are inventors on a patent applied for by University of Massachusetts Medical School, University of Miami, and the Howard Hughes Medical Institute covering therapeutic applications that target Sarm1 to block axonal and synaptic degeneration. R.H.B. was supported by NINDS5RO1-NS050557-05, NINDS ARRA Award RC2-NS070-342, the Angel Fund, the ALS Association, P2ALS, Project ALS, Pierre L. de Bourgknecht ALS Research Foundation, and the ALS Therapy Alliance. R.H.B. is cofounder of AviTx, an ALS research company, and serves as a consultant to BiogenIdec and Iperion, is President of the ALS Therapy Alliance, and serves on the advisory boards of Project ALS, P2ALS, and the Angel Fund for ALS research.	Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chang C, 2011, DEVELOPMENT, V138, P3509, DOI 10.1242/dev.069740; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Finn JT, 2000, J NEUROSCI, V20, P1333; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147	22	389	400	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					481	484		10.1126/science.1223899	http://dx.doi.org/10.1126/science.1223899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22678360	Green Accepted			2022-12-28	WOS:000306802300047
J	Steele, A; McCubbin, FM; Fries, M; Kater, L; Boctor, NZ; Fogel, ML; Conrad, PG; Glamoclija, M; Spencer, M; Morrow, AL; Hammond, MR; Zare, RN; Vicenzi, EP; Siljestrom, S; Bowden, R; Herd, CDK; Mysen, BO; Shirey, SB; Amundsen, HEF; Treiman, AH; Bullock, ES; Jull, AJT				Steele, A.; McCubbin, F. M.; Fries, M.; Kater, L.; Boctor, N. Z.; Fogel, M. L.; Conrad, P. G.; Glamoclija, M.; Spencer, M.; Morrow, A. L.; Hammond, M. R.; Zare, R. N.; Vicenzi, E. P.; Siljestrom, S.; Bowden, R.; Herd, C. D. K.; Mysen, B. O.; Shirey, S. B.; Amundsen, H. E. F.; Treiman, A. H.; Bullock, E. S.; Jull, A. J. T.			A Reduced Organic Carbon Component in Martian Basalts	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ALLAN HILLS 84001; ISOTOPIC EVIDENCE; OXYGEN FUGACITY; METEORITE; ORIGIN; MARS; MANTLE; GRAPHITE; IMPACT	The source and nature of carbon on Mars have been a subject of intense speculation. We report the results of confocal Raman imaging spectroscopy on 11 martian meteorites, spanning about 4.2 billion years of martian history. Ten of the meteorites contain abiotic macromolecular carbon (MMC) phases detected in association with small oxide grains included within high-temperature minerals. Polycyclic aromatic hydrocarbons were detected along with MMC phases in Dar al Gani 476. The association of organic carbon within magmatic minerals indicates that martian magmas favored precipitation of reduced carbon species during crystallization. The ubiquitous distribution of abiotic organic carbon in martian igneous rocks is important for understanding the martian carbon cycle and has implications for future missions to detect possible past martian life.	[Steele, A.; McCubbin, F. M.; Boctor, N. Z.; Fogel, M. L.; Glamoclija, M.; Bowden, R.; Mysen, B. O.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [McCubbin, F. M.] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Fries, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Kater, L.] Witec GmbH, D-89081 Ulm, Germany; [Conrad, P. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Spencer, M.; Morrow, A. L.; Hammond, M. R.; Zare, R. N.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Vicenzi, E. P.] Smithsonian Inst, Museum Conservat Inst, Suitland, MD 20746 USA; [Siljestrom, S.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Siljestrom, S.] SP Tech Res Inst Sweden, Dept Chem & Mat, S-50115 Boras, Sweden; [Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Shirey, S. B.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Amundsen, H. E. F.] Earth Explorat Serv, N-0364 Oslo, Norway; [Amundsen, H. E. F.] Planetary Explorat Serv, N-0364 Oslo, Norway; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Bullock, E. S.] Smithsonian Inst, Dept Mineral Sci, Washington, DC 20013 USA; [Jull, A. J. T.] Univ Arizona, Tucson, AZ 85721 USA	Carnegie Institution for Science; University of New Mexico; WITec; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; Smithsonian Institution; Stockholm University; SP Technical Research Institute of Sweden; University of Alberta; Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Arizona	Steele, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	asteele@ciw.edu	Steele, Andrew/A-3573-2013; Bullock, Emma/A-3870-2016; McCubbin, Francis/D-1698-2009; McCubbin, Francis/AAG-1095-2020; Fogel, Marilyn L/M-2395-2015; Glamoclija, Mihaela/GWQ-3360-2022; Vicenzi, Edward P/T-9430-2017	Steele, Andrew/0000-0001-9643-2841; Bullock, Emma/0000-0002-5678-3695; Fogel, Marilyn L/0000-0002-1176-3818; Glamoclija, Mihaela/0000-0003-4327-6480; Vicenzi, Edward P/0000-0003-2085-6546; Zare, Richard/0000-0001-5266-4253; Siljestrom, Sandra/0000-0002-4975-6074; Herd, Christopher/0000-0001-5210-4002	NASA Astrobiology Science and Technology for Exploring Planets [NNX09AB74G]; NASA Mars Fundamental Research Program [NNX08AN61G]; W. M. Keck Foundation [2007-6-29]; NASA Astrobiology Institute [NNA09DA81A]; Carnegie Institution of Washington; NASA Cosmochemistry [NNX11AG76G]; Natural Science and Engineering Research Council of Canada [261740]; Division Of Earth Sciences [0929458] Funding Source: National Science Foundation	NASA Astrobiology Science and Technology for Exploring Planets; NASA Mars Fundamental Research Program(National Aeronautics & Space Administration (NASA)); W. M. Keck Foundation(W.M. Keck Foundation); NASA Astrobiology Institute; Carnegie Institution of Washington; NASA Cosmochemistry(National Aeronautics & Space Administration (NASA)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by NASA Astrobiology Science and Technology for Exploring Planets (NNX09AB74G to A. S., P. G. C., A. H. T., and M. L. F.), NASA Mars Fundamental Research Program (NNX08AN61G to A. S.), the W. M. Keck Foundation (2007-6-29 to M. L. F. and A. S.), NASA Astrobiology Institute (NNA09DA81A to A. S., S. B. S., N.Z.B., B.O.M., and M. L. F.), and the Carnegie Institution of Washington. F. M. M. acknowledges financial support from NASA Cosmochemistry (NNX11AG76G to F. M. M.). A. S. thanks J. Strope for identification of suitable meteorite samples, C. Agee (University of New Mexico) for the Tissint sample, and L. Welzenbach, T. Gooding, and T. Rose for their assistance in thin-sectioning the meteorites and the use of the Scanning Electron Microscope in the Department of Mineral Sciences, National Museum of Natural History, Smithsonian Institution, Washington, DC. C. D. K. H. thanks D. Hnatyshin for assistance with oxygen fugacity calculations. This work was supported by Natural Science and Engineering Research Council of Canada grant 261740 "The Geology of Mars from Studies of Martian Meteorites" to C. D. K. H. L<SUP>2</SUP>MS, <SUP>14</SUP>C, and additional Raman data have been included in the supplementary materials.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Becker L, 1999, EARTH PLANET SC LETT, V167, P71, DOI 10.1016/S0012-821X(99)00014-X; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; ECK RV, 1966, SCIENCE, V153, P628, DOI 10.1126/science.153.3736.628; Fries M, 2008, SCIENCE, V320, P91, DOI 10.1126/science.1153578; Grady MM., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Herd CDK, 2003, METEORIT PLANET SCI, V38, P1793, DOI 10.1111/j.1945-5100.2003.tb00015.x; Hirschmann MM, 2008, EARTH PLANET SC LETT, V270, P147, DOI 10.1016/j.epsl.2008.03.034; Jull A.J.T., 2006, METEORITES EARLY SOL, P889, DOI DOI 10.1038/293433A0; Jull AJT, 2000, GEOCHIM COSMOCHIM AC, V64, P3763, DOI 10.1016/S0016-7037(00)00458-0; Jull AJT, 1998, SCIENCE, V279, P366, DOI 10.1126/science.279.5349.366; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; McCubbin F. M., 2012, P 43 LUN PLAN SCI C, V43, P1121; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McCubbin FM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003165; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Messenger S, 1998, ASTROPHYS J, V502, P284, DOI 10.1086/305874; Michalski JR, 2010, NAT GEOSCI, V3, P751, DOI [10.1038/ngeo971, 10.1038/NGEO971]; Morris RV, 2010, SCIENCE, V329, P421, DOI 10.1126/science.1189667; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Musselwhite DS, 2006, METEORIT PLANET SCI, V41, P1271, DOI 10.1111/j.1945-5100.2006.tb00521.x; Pasteris JD, 2003, ASTROBIOLOGY, V3, P727, DOI 10.1089/153110703322736051; Righter K, 2008, METEORIT PLANET SCI, V43, P1709, DOI 10.1111/j.1945-5100.2008.tb00638.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; Steele A, 2010, SCIENCE, V329, P51, DOI 10.1126/science.1190541; Steele A, 2000, METEORIT PLANET SCI, V35, P237, DOI 10.1111/j.1945-5100.2000.tb01772.x; Stephan T, 2003, METEORIT PLANET SCI, V38, P109, DOI 10.1111/j.1945-5100.2003.tb01049.x; Toporski J, 2007, ASTROBIOLOGY, V7, P389, DOI 10.1089/ast.2006.0009; Treiman AH, 2003, ASTROBIOLOGY, V3, P369, DOI 10.1089/153110703769016451; Wadhwa M, 2001, SCIENCE, V291, P1527, DOI 10.1126/science.1057594; Wadhwa M, 2008, REV MINERAL GEOCHEM, V68, P493, DOI 10.2138/rmg.2008.68.17; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; Zipfel J, 2000, METEORIT PLANET SCI, V35, P95, DOI 10.1111/j.1945-5100.2000.tb01977.x; Zolotov MY, 2000, J GEOPHYS RES-SOL EA, V105, P539, DOI 10.1029/1999JB900369; Zolotov MY, 2000, METEORIT PLANET SCI, V35, P629, DOI 10.1111/j.1945-5100.2000.tb01443.x	38	161	164	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					212	215		10.1126/science.1220715	http://dx.doi.org/10.1126/science.1220715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22628557				2022-12-28	WOS:000306323500053
J	Zimbelman, JR; Scheidt, SP				Zimbelman, James R.; Scheidt, Stephen P.			Hesperian Age for Western Medusae Fossae Formation, Mars	SCIENCE			English	Article							CRATER		[Zimbelman, James R.; Scheidt, Stephen P.] Smithsonian Inst, Natl Air & Space Museum, MRC 315, Ctr Earth & Planetary Studies, Washington, DC 20013 USA	Smithsonian Institution	Zimbelman, JR (corresponding author), Smithsonian Inst, Natl Air & Space Museum, MRC 315, Ctr Earth & Planetary Studies, Washington, DC 20013 USA.	zimbelmanj@si.edu			NASA from the Planetary Geology and Geophysics program [NNX07AP42G]	NASA from the Planetary Geology and Geophysics program	This work was supported by NASA grant NNX07AP42G from the Planetary Geology and Geophysics program.	Bradley BA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001537; Kerber L, 2010, ICARUS, V206, P669, DOI 10.1016/j.icarus.2009.10.001; Mandt KE, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003076; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Werner SC, 2011, ICARUS, V215, P603, DOI 10.1016/j.icarus.2011.07.024; Werner SC, 2009, ICARUS, V201, P44, DOI 10.1016/j.icarus.2008.12.019; Zimbelman J. R., 2012, LUNAR PLANET SCI, V43; Zimbelman JR, 2010, ICARUS, V205, P198, DOI 10.1016/j.icarus.2009.04.003	11	40	41	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1683	1683		10.1126/science.1221094	http://dx.doi.org/10.1126/science.1221094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22628559				2022-12-28	WOS:000305794500043
J	Topalian, SL; Hodi, FS; Brahmer, JR; Gettinger, SN; Smith, DC; McDermott, DF; Powderly, JD; Carvajal, RD; Sosman, JA; Atkins, MB; Leming, PD; Spigel, DR; Antonia, SJ; Horn, L; Drake, CG; Pardoll, DM; Chen, LP; Sharfman, WH; Anders, RA; Taube, JM; McMiller, TL; Xu, HY; Korman, AJ; Jure-Kunkel, M; Agrawal, S; McDonald, D; Kollia, GD; Gupta, A; Wigginton, JM; Sznol, M				Topalian, Suzanne L.; Hodi, F. Stephen; Brahmer, Julie R.; Gettinger, Scott N.; Smith, David C.; McDermott, David F.; Powderly, John D.; Carvajal, Richard D.; Sosman, Jeffrey A.; Atkins, Michael B.; Leming, Philip D.; Spigel, David R.; Antonia, Scott J.; Horn, Leora; Drake, Charles G.; Pardoll, Drew M.; Chen, Lieping; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying; Korman, Alan J.; Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.; Sznol, Mario			Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B7 FAMILY; IMMUNOTHERAPY; B7-H1; GUIDELINES; CRITERIA; THERAPY; MEMBER	BACKGROUND Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1. METHODS We enrolled patients with advanced melanoma, non-small-cell lung cancer, castration-resistant prostate cancer, or renal-cell or colorectal cancer to receive anti-PD-1 antibody at a dose of 0.1 to 10.0 mg per kilogram of body weight every 2 weeks. Response was assessed after each 8-week treatment cycle. Patients received up to 12 cycles until disease progression or a complete response occurred. RESULTS A total of 296 patients received treatment through February 24, 2012. Grade 3 or 4 drug-related adverse events occurred in 14% of patients; there were three deaths from pulmonary toxicity. No maximum tolerated dose was defined. Adverse events consistent with immune-related causes were observed. Among 236 patients in whom response could be evaluated, objective responses (complete or partial responses) were observed in those with non-small-cell lung cancer, melanoma, or renal-cell cancer. Cumulative response rates (all doses) were 18% among patients with non-small-cell lung cancer (14 of 76 patients), 28% among patients with melanoma (26 of 94 patients), and 27% among patients with renal-cell cancer (9 of 33 patients). Responses were durable; 20 of 31 responses lasted 1 year or more in patients with 1 year or more of follow-up. To assess the role of intratumoral PD-1 ligand (PD-L1) expression in the modulation of the PD-1-PD-L1 pathway, immunohistochemical analysis was performed on pretreatment tumor specimens obtained from 42 patients. Of 17 patients with PD-L1-negative tumors, none had an objective response; 9 of 25 patients (36%) with PD-L1-positive tumors had an objective response (P = 0.006). CONCLUSIONS Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use. Preliminary data suggest a relationship between PD-L1 expression on tumor cells and objective response. (Funded by Bristol-Myers Squibb and others; ClinicalTrials.gov number, NCT00730639.)	[Topalian, Suzanne L.] Johns Hopkins Univ, Dept Surg, Sch Med, Baltimore, MD 21287 USA; [Topalian, Suzanne L.; Brahmer, Julie R.; Drake, Charles G.; Pardoll, Drew M.; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [McDermott, David F.; Atkins, Michael B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Gettinger, Scott N.; Chen, Lieping; Sznol, Mario] Yale Univ, Sch Med, New Haven, CT USA; [Gettinger, Scott N.; Chen, Lieping; Sznol, Mario] Yale Canc Ctr, New Haven, CT USA; [Smith, David C.] Univ Michigan, Ann Arbor, MI 48109 USA; [Powderly, John D.] Carolina BioOncol Inst, Huntersville, NC USA; [Carvajal, Richard D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Sosman, Jeffrey A.; Horn, Leora] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Spigel, David R.] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA; [Leming, Philip D.] Cincinnati Hematol Oncol, Cincinnati, OH USA; [Antonia, Scott J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Korman, Alan J.] Bristol Myers Squibb Co, Milpitas, CA USA; [Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.] Bristol Myers Squibb Co, Princeton, NJ USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Yale University; Yale University; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Sarah Cannon Research Institute; Tennessee Oncology; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Bristol-Myers Squibb; Bristol-Myers Squibb	Topalian, SL (corresponding author), Johns Hopkins Univ, Dept Surg, Sch Med, 1550 Orleans St,CRB 2,Rm 508, Baltimore, MD 21287 USA.	stopali1@jhmi.edu	Carvajal, Richard/ABA-3285-2021	Smith, David/0000-0002-9465-988X; Sznol, Mario/0000-0002-4359-8749	Bristol-Myers Squibb; Ono Pharmaceutical; National Institutes of Health [5R01 CA142779]; Melanoma Research Alliance; Genentech; Pfizer; Novartis; Synta Pharmaceuticals; MedImmune; Regeneron; Merck; Eli Lilly; Prometheus Laboratories; Roche/Genentech; Celldex; Amplimmune; ImClone; Genoptix; Veridex; Dendreon; Millennium; Morphotek; Florida Society of Dermatology and Dermatologic Surgery and Imedex; CureTech; Nektar; AstraZeneca; Aduro Biotech; Immune Design; NexImmune; ImmuneXcite; GlaxoSmithKline; Abbott; Jennerex; Anza Therapeutics; BioSante; Amplimmune on behalf of Johns Hopkins University; Yale University; Bristol-Myers Squibb [B7-H1]; Center for Bio-medical Continuing Education; Institute for Medical Education and Research; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA142779] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Genentech(Roche HoldingGenentech); Pfizer(Pfizer); Novartis(Novartis); Synta Pharmaceuticals; MedImmune(AstraZenecaMedimmune); Regeneron(Regeneron); Merck(Merck & Company); Eli Lilly(Eli Lilly); Prometheus Laboratories; Roche/Genentech(Roche HoldingGenentech); Celldex; Amplimmune; ImClone; Genoptix; Veridex; Dendreon; Millennium(Takeda Pharmaceutical Company Ltd); Morphotek; Florida Society of Dermatology and Dermatologic Surgery and Imedex; CureTech; Nektar; AstraZeneca(AstraZeneca); Aduro Biotech; Immune Design; NexImmune; ImmuneXcite; GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Jennerex; Anza Therapeutics; BioSante; Amplimmune on behalf of Johns Hopkins University; Yale University; Bristol-Myers Squibb(Bristol-Myers Squibb); Center for Bio-medical Continuing Education; Institute for Medical Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb, Ono Pharmaceutical, and grants from the National Institutes of Health (5R01 CA142779, to Drs. Topalian and Pardoll) and the Melanoma Research Alliance (to Drs. Topalian and Pardoll).; Dr. Topalian reports receiving grant support and reimbursement for travel expenses from Bristol-Myers Squibb. Dr. Hodi reports receiving reimbursement for travel expenses from BristolMyers Squibb and funding for clinical trials from Bristol-Myers Squibb, Genentech, Pfizer, Novartis, and Synta Pharmaceuticals on behalf of his institution. Dr. Brahmer reports receiving grant support from MedImmune, Regeneron, Merck, and Synta Pharmaceuticals, consulting fees and reimbursement for travel expenses from Genentech, consulting fees from Eli Lilly, reimbursement for travel expenses from Bristol-Myers Squibb, and payment for the development of educational presentations from Quintiles and the Network for Continuing Medical Education. Dr. Smith reports receiving grant support from Bristol-Myers Squibb. Dr. McDermott reports receiving grant support and consulting fees from Prometheus Laboratories and consulting fees from Bristol-Myers Squibb and Roche/Genentech. Dr. Powderly reports receiving grant support (including for the development of educational presentations) and lecture fees from Bristol-Myers Squibb; receiving grant support, consulting fees, and lecture fees from Genentech; receiving grant support and consulting fees from Celldex; receiving grant support and consulting fees from Amplimmune; receiving grant support from ImClone; receiving consulting fees and lecture fees from Genoptix; receiving consulting fees from Veridex; receiving lecture fees from Dendreon; and being the founder of and holding stock in BioCytics, which has received contract work from Genentech and Millennium. Dr. Carvajal reports receiving consulting fees from Morphotek and Novartis and lecture fees from the Florida Society of Dermatology and Dermatologic Surgery and Imedex. Dr. Atkins reports receiving consulting fees from Bristol-Myers Squibb, Genentech, CureTech, Merck, Prometheus Laboratories, Nektar, and AstraZeneca. Dr. Spigel reports receiving consulting fees from Bristol-Myers Squibb on behalf of his institution. Dr. Drake reports receiving consulting fees and payment for the development of educational presentations from Bristol-Myers Squibb, receiving consulting fees from Dendreon and Pfizer, holding stock or stock options in Amplimmune, holding patents regarding the blockade of lymphocyte checkpoint molecules, and receiving patent royalties from Bristol-Myers Squibb and Amplimmune on behalf of his institution. Dr. Pardoll reports receiving consulting fees from Aduro Biotech, Immune Design, NexImmune, ImmuneXcite, Amplimmune, GlaxoSmithKline, Abbott, Jennerex, Pfizer, and Anza Therapeutics; receiving reimbursement for travel expenses from Bristol-Myers Squibb; holding patents regarding immunotherapy with the B7-DC gene and its products, combinatorial therapy of cancer with vaccines plus anti-B7-H1 antibodies, vaccine strategies, and the blockade of lymphocyte checkpoint molecules; and receiving patent royalties from Bristol-Myers Squibb, Amplimmune, GlaxoSmithKline, Aduro Biotech, and BioSante on behalf of his institution. Dr.; Chen reports serving as a board observer of, receiving consulting fees from, and holding stock options in Amplimmune; receiving patent licensing payment and research funding from Amplimmune on behalf of Johns Hopkins University and Yale University; receiving patent licensing payment regarding B7-H1-related technologies from Bristol-Myers Squibb on behalf of the Mayo Clinic; receiving funding for research on B7-H1 immunohistochemistry from Bristol-Myers Squibb; and receiving patent licensing payment from ImmuNext on behalf of the Mayo Clinic. Dr. Sharfman reports receiving consulting fees from Genentech and Merck and lecture fees from Prometheus Laboratories. Dr. Anders reports receiving grant support and reimbursement for travel expenses from Bristol-Myers Squibb. Dr. Taube reports receiving grant support from Bristol-Myers Squibb on behalf of her institution. Ms. McMiller reports receiving compensation for sponsored laboratory research from Bristol-Myers Squibb on behalf of her institution. Dr. Korman reports being an employee of, holding stock or stock options in, and receiving reimbursement for travel expenses from Bristol-Myers Squibb. Drs. Jure-Kunkel, Agrawal, Kollia, Gupta, and Wigginton report being employees of and holding stock or stock options in Bristol-Myers Squibb. Mr. McDonald reports being an employee of, holding stock or stock options in, and receiving reimbursement for travel expenses from Bristol-Myers Squibb. Dr. Sznol reports receiving consulting fees from and owning stock options in Genesis Biopharma; receiving consulting fees from Bristol-Myers Squibb, Anaeropharma Science, Prometheus Laboratories, Nektar, and Abbott; and receiving lecture fees from the Center for Bio-medical Continuing Education and Institute for Medical Education and Research, both of which are sponsored in part by Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gridelli C, 2008, J THORAC ONCOL, V3, P430, DOI 10.1097/JTO.0b013e318168c815; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Miller VA, 2006, SEMIN ONCOL, V33, pS25, DOI 10.1053/j.seminoncol.2005.12.005; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ribas A, 2009, CLIN CANCER RES, V15, P7116, DOI 10.1158/1078-0432.CCR-09-2376; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Scagliotti G, 2011, J THORAC ONCOL, V6, P64, DOI 10.1097/JTO.0b013e3181f7c6d4; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	26	8687	9269	91	2267	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2443	2454		10.1056/NEJMoa1200690	http://dx.doi.org/10.1056/NEJMoa1200690			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22658127	Green Accepted			2022-12-28	WOS:000305747000004
J	Haiser, HJ; Turnbaugh, PJ				Haiser, Henry J.; Turnbaugh, Peter J.			Is It Time for a Metagenomic Basis of Therapeutics?	SCIENCE			English	Editorial Material							INTESTINAL MICROBIOTA; GUT FLORA; IDENTIFICATION; METABOLISM; BACTERIA	The trillions of microbes associated with the human body are a key part of a comprehensive view of pharmacology. A mechanistic understanding of how the gut microbiota directly and indirectly affects drug metabolism is beginning to emerge.	[Haiser, Henry J.; Turnbaugh, Peter J.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University	Turnbaugh, PJ (corresponding author), Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	Haiser, Henry/AAN-5187-2020	Turnbaugh, Peter/0000-0002-0888-2875	Canadian Institutes of Health Research [MFE-112991] Funding Source: Medline; NIGMS NIH HHS [P50 GM068763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; DOBKIN JF, 1983, SCIENCE, V220, P325; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	14	85	94	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1253	1255		10.1126/science.1224396	http://dx.doi.org/10.1126/science.1224396			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674325				2022-12-28	WOS:000304905300033
J	Tanner, KE				Tanner, K. Elizabeth			Small But Extremely Tough	SCIENCE			English	Editorial Material							BEHAVIOR		Univ Glasgow, Sch Engn, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Tanner, KE (corresponding author), Univ Glasgow, Sch Engn, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	elizabeth.tanner@glasgow.ac.uk	Tanner, Elizabeth/E-9242-2010	Tanner, Elizabeth/0000-0003-2257-0218				Barthelat F, 2011, J MECH PHYS SOLIDS, V59, P829, DOI 10.1016/j.jmps.2011.01.001; Bishop M. C., 1993, ROMAN MILITARY EQUIP; Burghard Z, 2009, NANO LETT, V9, P4103, DOI 10.1021/nl902324x; Cusack M, 2008, J STRUCT BIOL, V164, P96, DOI 10.1016/j.jsb.2008.06.010; Fernandez JG, 2012, ADV MATER, V24, P480, DOI 10.1002/adma.201104051; Simmons LM, 2011, EUR J ORAL SCI, V119, P19, DOI 10.1111/j.1600-0722.2011.00909.x; Tasdemirci A, 2012, INT J IMPACT ENG, V44, P1, DOI 10.1016/j.ijimpeng.2011.12.005; Ubeyli M, 2008, J MATER PROCESS TECH, V196, P356, DOI 10.1016/j.jmatprotec.2007.05.050; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Zlotnikov I, 2010, COLLOID SURFACE A, V361, P138, DOI 10.1016/j.colsurfa.2010.03.013	10	11	11	7	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1237	1238		10.1126/science.1222642	http://dx.doi.org/10.1126/science.1222642			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679085				2022-12-28	WOS:000304905300023
J	Gler, MT; Skripconoka, V; Sanchez-Garavito, E; Xiao, HP; Cabrera-Rivero, JL; Vargas-Vasquez, DE; Gao, MQ; Awad, M; Park, SK; Shim, TS; Suh, GY; Danilovits, M; Ogata, H; Kurve, A; Chang, J; Suzuki, K; Tupasi, T; Koh, WJ; Seaworth, B; Geiter, LJ; Wells, CD				Gler, Maria Tarcela; Skripconoka, Vija; Sanchez-Garavito, Epifanio; Xiao, Heping; Cabrera-Rivero, Jose L.; Vargas-Vasquez, Dante E.; Gao, Mengqiu; Awad, Mohamed; Park, Seung-Kyu; Shim, Tae Sun; Suh, Gee Young; Danilovits, Manfred; Ogata, Hideo; Kurve, Anu; Chang, Joon; Suzuki, Katsuhiro; Tupasi, Thelma; Koh, Won-Jung; Seaworth, Barbara; Geiter, Lawrence J.; Wells, Charles D.			Delamanid for Multidrug-Resistant Pulmonary Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EARLY BACTERICIDAL ACTIVITY; TREATMENT OUTCOMES; MYCOBACTERIUM; METAANALYSIS; OPC-67683	BACKGROUND Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new anti-tuberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis. METHODS In this randomized, placebo-controlled, multinational clinical trial, we assigned 481 patients (nearly all of whom were negative for the human immunodeficiency virus) with pulmonary multidrug-resistant tuberculosis to receive delamanid, at a dose of 100 mg twice daily (161 patients) or 200 mg twice daily (160 patients), or placebo (160 patients) for 2 months in combination with a background drug regimen developed according to World Health Organization guidelines. Sputum cultures were assessed weekly with the use of both liquid broth and solid medium; sputum-culture conversion was defined as a series of five or more consecutive cultures that were negative for growth of M. tuberculosis. The primary efficacy end point was the proportion of patients with sputum-culture conversion in liquid broth medium at 2 months. RESULTS Among patients who received a background drug regimen plus 100 mg of delamanid twice daily, 45.4% had sputum-culture conversion in liquid broth at 2 months, as compared with 29.6% of patients who received a background drug regimen plus placebo (P=0.008). Likewise, as compared with the placebo group, the group that received the background drug regimen plus 200 mg of delamanid twice daily had a higher proportion of patients with sputum-culture conversion (41.9%, P=0.04). The findings were similar with assessment of sputum-culture conversion in solid medium. Most adverse events were mild to moderate in severity and were evenly distributed across groups. Although no clinical events due to QT prolongation on electrocardiography were observed, QT prolongation was reported significantly more frequently in the groups that received delamanid. CONCLUSIONS Delamanid was associated with an increase in sputum-culture conversion at 2 months among patients with multidrug-resistant tuberculosis. This finding suggests that delamanid could enhance treatment options for multidrug-resistant tuberculosis. (Funded by Otsuka Pharmaceutical Development and Commercialization; ClinicalTrials.gov number, NCT00685360.)	[Gler, Maria Tarcela] Makati Med Ctr, Manila, Philippines; [Gler, Maria Tarcela; Tupasi, Thelma] Trop Dis Fdn, Makati, Philippines; [Skripconoka, Vija] State Agcy TB & Lung Dis, Riga, Latvia; [Sanchez-Garavito, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru; [Cabrera-Rivero, Jose L.] Hosp Nacl Daniel A Carrion, Unidad Invest, Lima, Peru; [Vargas-Vasquez, Dante E.] Hosp Nacl Hipolito Unanue, Lima, Peru; [Xiao, Heping] Shanghai Pulm Hosp, Shanghai, Peoples R China; [Gao, Mengqiu] Beijing Chest Hosp, Beijing, Peoples R China; [Awad, Mohamed] Sadr Abassia Hosp, Cairo, Egypt; [Park, Seung-Kyu] Natl Masan Hosp, Masan, South Korea; [Shim, Tae Sun] Asan Med Ctr, Seoul, South Korea; [Suh, Gee Young; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Chang, Joon] Yonsei Univ, Med Ctr, Severance Hosp, Seoul 120749, South Korea; [Danilovits, Manfred] Univ Tartu, Lung Hosp, EE-50090 Tartu, Estonia; [Kurve, Anu] N Estonian Med Ctr Fdn, Ctr Pulmonol, Tallinn, Estonia; [Ogata, Hideo] Fukujuji Hosp, Tokyo, Japan; [Suzuki, Katsuhiro] Natl Hosp Org Kinki Chuo Chest Med Ctr, Osaka, Japan; [Seaworth, Barbara] Univ Texas Hlth Ctr Tyler, Tyler, TX USA; [Geiter, Lawrence J.; Wells, Charles D.] Otsuka Pharmaceut Dev & Commercializat, Rockville, MD USA	Makati Medical Center; Capital Medical University; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; University of Tartu; Fukujuji Hospital; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Otsuka Pharmaceutical	Geiter, LJ (corresponding author), Otsuka Novel Prod OPDC, 2440 Res Blvd, Rockville, MD 20850 USA.	lawrence.geiter@otsuka-us.com	Suh, Gee Young/O-3676-2019; Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011	Suh, Gee Young/0000-0001-5473-1712; Koh, Won-Jung/0000-0002-4756-3527; Chang, Joon/0000-0003-4542-6841				[Anonymous], 2007, M48P CLSI; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2008, 4 WHO; Barry PJ, 2007, CURR MED CHEM, V14, P2000; Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Gammino VM, 2011, INT J TUBERC LUNG D, V15, P1315, DOI 10.5588/ijtld.10.0221; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Leimane V, 2010, EUR RESPIR J, V36, P584, DOI 10.1183/09031936.00003710; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; National Committee for Clinical Laboratory Standards, 2004, M22A3 NCCLS; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Shin SY, 2004, CHEST, V125, P974, DOI 10.1378/chest.125.3.974; Srisuwanvilai LO, 2008, DIAGN MICR INFEC DIS, V61, P402, DOI 10.1016/j.diagmicrobio.2008.02.015; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5	20	526	548	1	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2151	2160		10.1056/nejmoa1112433	http://dx.doi.org/10.1056/nejmoa1112433			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670901				2022-12-28	WOS:000304863400004
J	Vela, C				Vela, Carmen			Turn Spain's budget crisis into an opportunity	NATURE			English	Editorial Material												secretaria.seidi@mineco.es							0	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					7	7		10.1038/486007a	http://dx.doi.org/10.1038/486007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GD	22678244	Bronze			2022-12-28	WOS:000304854000002
J	Henderson, TO; Oeffinger, KC; Whitton, J; Leisenring, W; Neglia, J; Meadows, A; Crotty, C; Rubin, DT; Diller, L; Inskip, P; Smith, SA; Stovall, M; Constine, LS; Hammond, S; Armstrong, GT; Robison, LL; Nathan, PC				Henderson, Tara O.; Oeffinger, Kevin C.; Whitton, John; Leisenring, Wendy; Neglia, Joseph; Meadows, Anna; Crotty, Catherine; Rubin, David T.; Diller, Lisa; Inskip, Peter; Smith, Susan A.; Stovall, Marilyn; Constine, Louis S.; Hammond, Sue; Armstrong, Greg T.; Robison, Leslie L.; Nathan, Paul C.			Secondary Gastrointestinal Cancer in Childhood Cancer Survivors A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							2ND MALIGNANT NEOPLASMS; LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; HODGKINS-DISEASE; SUBSEQUENT NEOPLASMS; COLORECTAL-CANCER; FOLLOW-UP; RISK; GUIDELINES; SURVEILLANCE	Background: Childhood cancer survivors develop gastrointestinal cancer more frequently and at a younger age than the general population, but the risk factors have not been well-characterized. Objective: To determine the risk and associated risk factors for gastrointestinal subsequent malignant neoplasms (SMNs) in childhood cancer survivors. Design: Retrospective cohort study. Setting: The Childhood Cancer Survivor Study, a multicenter study of childhood cancer survivors diagnosed between 1970 and 1986. Patients: 14 358 survivors of cancer diagnosed when they were younger than 21 years of age who survived for 5 or more years after the initial diagnosis. Measurements: Standardized incidence ratios (SIRs) for gastrointestinal SMNs were calculated by using age-specific population data. Multivariate Cox regression models identified associations between risk factors and gastrointestinal SMN development. Results: At median follow-up of 22.8 years (range, 5.5 to 30.2 years), 45 cases of gastrointestinal cancer were identified. The risk for gastrointestinal SMNs was 4.6-fold higher in childhood cancer survivors than in the general population (95% CI, 3.4 to 6.1). The SIR for colorectal cancer was 4.2 (CI, 2.8 to 6.3). The highest risk for gastrointestinal SMNs was associated with abdominal radiation (SIR, 11.2 [CI, 7.6 to 16.4]). However, survivors not exposed to radiation had a significantly increased risk (SIR, 2.4 [CI, 1.4 to 3.9]). In addition to abdominal radiation, high-dose procarbazine (relative risk, 3.2 [CI, 1.1 to 9.4]) and platinum drugs (relative risk, 7.6 [CI, 2.3 to 25.5]) independently increased the risk for gastrointestinal SMNs. Limitation: This cohort has not yet attained an age at which risk for gastrointestinal cancer is greatest. Conclusion: Childhood cancer survivors, particularly those exposed to abdominal radiation, are at increased risk for gastrointestinal SMNs. These findings suggest that surveillance of at-risk childhood cancer survivors should begin at a younger age than that recommended for the general population.	[Henderson, Tara O.] Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Minnesota, Minneapolis, MN USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; NCI, Bethesda, MD 20892 USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Rochester, Rochester, NY USA; Nationwide Childrens Hosp, Columbus, OH USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Chicago; Fred Hutchinson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Rochester; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Henderson, TO (corresponding author), Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, 5841 S Maryland Ave,MC 4060, Chicago, IL 60637 USA.	thenderson@peds.bsd.uchicago.edu	Armstrong, Gregory/N-8096-2018; Robison, Leslie/N-8122-2018; Nathan, Paul/GRR-2377-2022	Leisenring, Wendy/0000-0001-7405-0906; Nathan, Paul/0000-0003-0334-0871; Neglia, Joseph/0000-0002-5525-0598	National Cancer Institute [U24 CA55727, K07CA134935]; National Institutes of Health; American Lebanese-Syrian Associated Charities; NATIONAL CANCER INSTITUTE [U24CA055727, K07CA134935, P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese-Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: National Cancer Institute.; By the NCI through grant U24 CA55727 awarded to Dr. Robison. Additional support was provided by the Intramural Research Program of the National Institutes of Health and NCI and by the American Lebanese-Syrian Associated Charities. Dr. Henderson received support from the NCI through grant K07CA134935.	Bassal M, 2006, J CLIN ONCOL, V24, P476, DOI 10.1200/JCO.2005.02.7235; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; de Vathaire F, 1999, BRIT J CANCER, V79, P1884, DOI 10.1038/sj.bjc.6690300; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Kalbfleisch J, 1980, STAT ANAL FAILURE TI, P168; Krapcho M, 2011, SEER CANC STAT REV 1; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Metayer C, 2000, J CLIN ONCOL, V18, P2435, DOI 10.1200/JCO.2000.18.12.2435; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Smith RA, 2001, CA CANC J CLIN, V51; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; van den Belt-Dusebout AW, 2007, J CLIN ONCOL, V25, P4370, DOI 10.1200/JCO.2006.10.5296; van den Belt-Dusebout AW, 2009, INT J RADIAT ONCOL, V75, P1420, DOI 10.1016/j.ijrobp.2009.01.073; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Yasui Y, 2003, AM J EPIDEMIOL, V158, P1108, DOI 10.1093/aje/kwg278	29	96	99	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					757	+		10.7326/0003-4819-156-11-201206050-00002	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	954ZK	22665813				2022-12-28	WOS:000304986500001
J	Vecchio, M; Malaguarnera, G; Giordano, M; Malaguarnera, M; Volti, GL; Galvano, F; Drago, F; Basile, F; Malaguarnera, M				Vecchio, Michele; Malaguarnera, Giulia; Giordano, Maria; Malaguarnera, Michele; Volti, Giovanni Li; Galvano, Fabio; Drago, Filippo; Basile, Francesco; Malaguarnera, Mariano			A musician's dystonia	LANCET			English	Editorial Material									[Giordano, Maria; Malaguarnera, Mariano] Cannizzaro Hosp, Dept Internal Med & Geriatr, I-95100 Catania, Italy; [Vecchio, Michele] Vittorio Emanuele Hosp, Ctr Phys Med & Rehabil, Catania, Italy; [Malaguarnera, Giulia; Drago, Filippo] Univ Catania, Int PhD Program Neuropharmacol, Sch Med, Catania, Italy; [Malaguarnera, Michele; Volti, Giovanni Li; Galvano, Fabio] Univ Catania, Dept Biol Chem Med Chem & Mol Biol, Catania, Italy; [Basile, Francesco] Univ Catania, Dept Gen Surg, Catania, Italy	Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; University of Catania; University of Catania	Malaguarnera, M (corresponding author), Cannizzaro Hosp, Dept Internal Med & Geriatr, Via Messina 829, I-95100 Catania, Italy.	malaguar@unict.it; malaguar@unict.it	Galvano, Fabio/F-8122-2010; Malaguarnera, Giulia/ABD-4968-2020; Malaguarnera, Michele/A-1376-2019; Volti, Giovanni Li/A-2435-2008; Drago, Francesco/H-7563-2019; Drago, Filippo/AAC-5090-2022; Drago, Filippo/K-5619-2018	Galvano, Fabio/0000-0003-0644-0755; Malaguarnera, Giulia/0000-0003-3655-4307; Malaguarnera, Michele/0000-0002-7145-6377; Volti, Giovanni Li/0000-0002-8678-2183; Drago, Filippo/0000-0003-2887-5223; Vecchio, Michele/0000-0001-5254-3283; MALAGUARNERA, Lucia/0000-0002-5171-7963; Basile, Francesco/0000-0001-6831-5840				Jankovic J, 2006, LANCET NEUROL, V5, P864, DOI 10.1016/S1474-4422(06)70574-9; Jankovic J, 2009, LANCET NEUROL, V8, P844, DOI 10.1016/S1474-4422(09)70183-8; Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b; Oppenheim H., 1911, NEUROL CENTRALBL, V30, P1090; Phukan J, 2011, LANCET NEUROL, V10, P1074, DOI 10.1016/S1474-4422(11)70232-0	5	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2116	2116		10.1016/S0140-6736(12)60315-8	http://dx.doi.org/10.1016/S0140-6736(12)60315-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22656885				2022-12-28	WOS:000304759100035
J	Yang, H; Heo, J; Park, S; Song, HJ; Seo, DH; Byun, KE; Kim, P; Yoo, I; Chung, HJ; Kim, K				Yang, Heejun; Heo, Jinseong; Park, Seongjun; Song, Hyun Jae; Seo, David H.; Byun, Kyung-Eun; Kim, Philip; Yoo, InKyeong; Chung, Hyun-Jong; Kim, Kinam			Graphene Barristor, a Triode Device with a Gate-Controlled Schottky Barrier	SCIENCE			English	Article							LARGE-AREA; FILMS; DIODES	Despite several years of research into graphene electronics, sufficient on/off current ratio I-on/I-off in graphene transistors with conventional device structures has been impossible to obtain. We report on a three-terminal active device, a graphene variable-barrier "barristor" (GB), in which the key is an atomically sharp interface between graphene and hydrogenated silicon. Large modulation on the device current (on/off ratio of 10(5)) is achieved by adjusting the gate voltage to control the graphene-silicon Schottky barrier. The absence of Fermi-level pinning at the interface allows the barrier's height to be tuned to 0.2 electron volt by adjusting graphene's work function, which results in large shifts of diode threshold voltages. Fabricating GBs on respective 150-mm wafers and combining complementary p- and n-type GBs, we demonstrate inverter and half-adder logic circuits.	[Yang, Heejun; Heo, Jinseong; Park, Seongjun; Song, Hyun Jae; Seo, David H.; Byun, Kyung-Eun; Yoo, InKyeong; Chung, Hyun-Jong] Samsung Adv Inst Technol, Graphene Res Ctr, Yongin 446712, South Korea; [Kim, Philip] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Kim, Kinam] Samsung Adv Inst Technol, Yongin 446712, South Korea	Samsung; Columbia University; Samsung	Chung, HJ (corresponding author), Samsung Adv Inst Technol, Graphene Res Ctr, Yongin 446712, South Korea.	hyunjong.chung@samsung.com	Kim, Philip/N-1886-2013; YANG, Heejun/A-8468-2010; Chung, Hyun-Jong/AAJ-7950-2021	Kim, Philip/0000-0002-8255-0086; Chung, Hyun-Jong/0000-0002-8840-6296; Heo, Jinseong/0000-0003-2530-488X				Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; BARDEEN J, 1948, PHYS REV, V74, P230, DOI 10.1103/PhysRev.74.230; BELL LD, 1988, APPL PHYS LETT, V52, P278, DOI 10.1063/1.99493; Boettcher SW, 2007, NAT MATER, V6, P592, DOI 10.1038/nmat1943; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Chen CC, 2011, NANO LETT, V11, P1863, DOI 10.1021/nl104364c; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Heo J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035421; HIMPSEL FJ, 1983, PHYS REV B, V28, P7014, DOI 10.1103/PhysRevB.28.7014; Jeon I, 2011, ACS NANO, V5, P1915, DOI 10.1021/nn102916c; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Lee JU, 2004, APPL PHYS LETT, V85, P145, DOI 10.1063/1.1769595; Li XM, 2010, ADV MATER, V22, P2743, DOI 10.1002/adma.200904383; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Lin YM, 2011, IEEE ELECTR DEVICE L, V32, P1343, DOI 10.1109/LED.2011.2162934; Liu CH, 2011, NANO LETT, V11, P1782, DOI 10.1021/nl200371z; Lonergan MC, 1997, SCIENCE, V278, P2103, DOI 10.1126/science.278.5346.2103; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Seyller T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213928; Tongay S, 2011, CARBON, V49, P2033, DOI 10.1016/j.carbon.2011.01.029; Tongay S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3268788; Xia FN, 2011, NAT NANOTECHNOL, V6, P179, DOI [10.1038/nnano.2011.6, 10.1038/NNANO.2011.6]; Xu Y, 2011, NANO LETT, V11, P2735, DOI 10.1021/nl201022t; Yabuta H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2353811; Yu YJ, 2009, NANO LETT, V9, P3430, DOI 10.1021/nl901572a; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	29	774	787	28	697	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1140	1143		10.1126/science.1220527	http://dx.doi.org/10.1126/science.1220527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22604723				2022-12-28	WOS:000304647900044
J	Jeon, SM; Chandel, NS; Hay, N				Jeon, Sang-Min; Chandel, Navdeep S.; Hay, Nissim			AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress	NATURE			English	Article							FATTY-ACID SYNTHASE; ACTIVATED PROTEIN-KINASE; REDUCED PYRIDINE-NUCLEOTIDES; CANCER-CELLS; PROSTATE-CANCER; LUNG-CANCER; APOPTOSIS; METABOLISM; INHIBITION; GROWTH	Overcoming metabolic stress is a critical step for solid tumour growth(1,2). However, the underlying mechanisms of cell death and survival under metabolic stress are not well understood. A key signalling pathway involved in metabolic adaptation is the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway(2,3). Energy stress conditions that decrease intracellular ATP levels below a certain level promote AMPK activation by LKB1. Previous studies showed that LKB1-deficient or AMPK-deficient cells are resistant to oncogenic transformation and tumorigenesis(4-6), possibly because of the function of AMPK in metabolic adaptation. However, the mechanisms by which AMPK promotes metabolic adaptation in tumour cells are not fully understood. Here we show that AMPK activation, during energy stress, prolongs cell survival by redox regulation. Under these conditions, NADPH generation by the pentose phosphate pathway is impaired, but AMPK induces alternative routes to maintain NADPH and inhibit cell death. The inhibition of the acetyl-CoA carboxylases ACC1 and ACC2 by AMPK maintains NADPH levels by decreasing NADPH consumption in fatty-acid synthesis and increasing NADPH generation by means of fatty-acid oxidation. Knockdown of either ACC1 or ACC2 compensates for AMPK activation and facilitates anchorage-independent growth and solid tumour formation in vivo, whereas the activation of ACC1 or ACC2 attenuates these processes. Thus AMPK, in addition to its function in ATP homeostasis, has a key function in NADPH maintenance, which is critical for cancer cell survival under energy stress conditions, such as glucose limitations, anchorage-independent growth and solid tumour formation in vivo.	[Jeon, Sang-Min; Hay, Nissim] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Chandel, Navdeep S.] Northwestern Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Hay, N (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	nhay@uic.edu	Jeon, Sang-Min/I-7917-2018	Jeon, Sang-Min/0000-0002-0132-925X	National Institutes of Health [CA090764, AG016927, AG025953]; Chicago Biomedical Consortium; Chicago Community;  [P60DK20595]; NATIONAL CANCER INSTITUTE [R01CA090764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025953, R01AG016927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Chicago Community; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Viollet for the AMPK-KO MEFs, M. R. Montminy for the ACC complementary DNA, and G. Hatzivassiliou for comments on the manuscript. This work was supported by grants CA090764, AG016927 and AG025953 from the National Institutes of Health, by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community, and by grant P60DK20595 to the Diabetes Research and Training Center, University of Chicago (to N. H.).	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chhipa RR, 2010, CELL SIGNAL, V22, P1554, DOI 10.1016/j.cellsig.2010.05.024; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Jang TC, 2011, INT J CANCER, V128, P2230, DOI 10.1002/ijc.25558; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim Hyun Sook, 2010, Korean Journal of Internal Medicine, V25, P399, DOI 10.3904/kjim.2010.25.4.399; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Le Goffe C, 2002, BIOCHEM J, V364, P349, DOI 10.1042/BJ20011856; Li DY, 2009, CANCER BIOTHER RADIO, V24, P81, DOI 10.1089/cbr.2008.0494; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhou WB, 2003, CANCER RES, V63, P7330	36	786	822	6	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					661	+		10.1038/nature11066	http://dx.doi.org/10.1038/nature11066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660331	Green Accepted			2022-12-28	WOS:000304608000052
J	Edgar, RS; Green, EW; Zhao, YW; van Ooijen, G; Olmedo, M; Qin, XM; Xu, Y; Pan, M; Valekunja, UK; Feeney, KA; Maywood, ES; Hastings, MH; Baliga, NS; Merrow, M; Millar, AJ; Johnson, CH; Kyriacou, CP; O'Neill, JS; Reddy, AB				Edgar, Rachel S.; Green, Edward W.; Zhao, Yuwei; van Ooijen, Gerben; Olmedo, Maria; Qin, Ximing; Xu, Yao; Pan, Min; Valekunja, Utham K.; Feeney, Kevin A.; Maywood, Elizabeth S.; Hastings, Michael H.; Baliga, Nitin S.; Merrow, Martha; Millar, Andrew J.; Johnson, Carl H.; Kyriacou, Charalambos P.; O'Neill, John S.; Reddy, Akhilesh B.			Peroxiredoxins are conserved markers of circadian rhythms	NATURE			English	Article							SUPRACHIASMATIC NUCLEUS; 2-CYS PEROXIREDOXIN; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; REDOX STATE; CLOCK; GENE; EVOLUTION; TIME; METABOLISM	Cellular life emerged similar to 3.7 billion years ago. With scant exception, terrestrial organisms have evolved under predictable daily cycles owing to the Earth's rotation. The advantage conferred on organisms that anticipate such environmental cycles has driven the evolution of endogenous circadian rhythms that tune internal physiology to external conditions. The molecular phylogeny of mechanisms driving these rhythms has been difficult to dissect because identified clock genes and proteins are not conserved across the domains of life: Bacteria, Archaea and Eukaryota. Here we show that oxidation-reduction cycles of peroxiredoxin proteins constitute a universal marker for circadian rhythms in all domains of life, by characterizing their oscillations in a variety of model organisms. Furthermore, we explore the interconnectivity between these metabolic cycles and transcription-translation feedback loops of the clockwork in each system. Our results suggest an intimate co-evolution of cellular timekeeping with redox homeostatic mechanisms after the Great Oxidation Event similar to 2.5 billion years ago.	[Edgar, Rachel S.; Valekunja, Utham K.; Feeney, Kevin A.; O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, NIHR Biomed Res Ctr, Inst Metab Sci,Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Green, Edward W.; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Zhao, Yuwei; Qin, Ximing; Xu, Yao; Johnson, Carl H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [van Ooijen, Gerben; Millar, Andrew J.] Synthet & Syst Biol SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland; [Olmedo, Maria; Merrow, Martha] Univ Groningen, Ctr Life Sci, Dept Mol Chronobiol, NL-9700 CC Groningen, Netherlands; [Pan, Min; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98109 USA; [Maywood, Elizabeth S.; Hastings, Michael H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Leicester; Vanderbilt University; University of Groningen; Institute for Systems Biology (ISB); MRC Laboratory Molecular Biology; University of Edinburgh	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, NIHR Biomed Res Ctr, Inst Metab Sci,Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	jso22@medschl.cam.ac.uk; areddy@cantab.net	van Ooijen, Gerben/E-9371-2013; Qin, Ximing/J-6485-2012; Olmedo, Maria/N-3708-2019; Olmedo, Maria/E-1824-2012; Johnson, Carl H/I-4655-2014; Millar, Andrew J/G-2423-2012	van Ooijen, Gerben/0000-0001-7967-0637; Olmedo, Maria/0000-0002-5701-2665; Olmedo, Maria/0000-0002-5701-2665; Millar, Andrew J/0000-0003-1756-3654; Hastings, Michael Harvey/0000-0001-8576-6651; Edgar, Rachel/0000-0002-3348-0851; Valekunja, Utham Kashyap/0000-0003-2385-4239; Qin, Ximing/0000-0003-2496-2434; O'Neill, John Stuart/0000-0003-2204-6096; baliga, nitin/0000-0001-9157-5974	Wellcome Trust [083643/Z/07/Z, 093734/Z/10/Z]; European Research Council (ERC) [281348]; EMBO; Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; European Commission [018741]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C006941/1]; Engineering and Physical Sciences Research Council (EPSRC) [BB/D019621]; ENIGMA; US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health (NIH) [P50GM076547, R01GM088595, R01GM067152, R21HL102492]; Netherlands Organisation for Scientific Research (NWO); Dutch Science Foundation VICI; University of Groningen; BBSRC [BB/D019621/1] Funding Source: UKRI; MRC [MC_U105170643, MC_UP_1201/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1, BB/C006941/1] Funding Source: researchfish; Medical Research Council [MC_U105170643, G0600717B, MC_UP_1201/4] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088595, R37GM067152, P50GM076547, R01GM067152] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ENIGMA(European Commission); US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Science Foundation VICI; University of Groningen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily supported by the Wellcome Trust (083643/Z/07/Z and 093734/Z/10/Z), the European Research Council (ERC Starting Grant No. 281348, MetaCLOCK), and EMBO Young Investigators Programme, as well as the Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD), and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. C. P. K. and M. H. H. acknowledge European Commission grant EUCLOCK (no. 018741) and Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/C006941/1. SynthSys is funded by BBSRC and Engineering and Physical Sciences Research Council (EPSRC) award BB/D019621 to A.J.M. and others. N.S.B. was supported by ENIGMA, US Department of Energy, under contract no. DE-AC02-05CH11231, and by a grant from the National Institutes of Health (NIH; P50GM076547). C.H.J. was supported by the NIH (R01GM088595, R01GM067152 and R21HL102492). M. M. was supported by the Netherlands Organisation for Scientific Research (NWO; Dutch Science Foundation VICI award and Open Programma) and the University of Groningen (Rosalind Franklin Fellowship Program). We thank M. Jain, G. O'Neill and J. Chambers for discussion about the manuscript, and S. G. Rhee, F. Rouyer and R. Stanewsky for the gifts of antisera.	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAMFORTH SS, 1962, LIMNOL OCEANOGR, V7, P348, DOI 10.4319/lo.1962.7.3.0348; Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Ditty JL, 2005, MICROBIOL-SGM, V151, P2605, DOI 10.1099/mic.0.28030-0; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Granshaw T, 2003, J BIOL RHYTHM, V18, P287, DOI 10.1177/0748730403255934; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hastings MH, 2005, METHOD ENZYMOL, V393, P579, DOI 10.1016/S0076-6879(05)93030-9; House SB, 1998, J NEUROENDOCRINOL, V10, P849; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mulholland PJ, 2005, ECOL INDIC, V5, P243, DOI 10.1016/j.ecolind.2005.03.004; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ochoa D, 2010, BIOINFORMATICS, V26, P1370, DOI 10.1093/bioinformatics/btq137; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P939, DOI 10.1016/j.fgb.2010.08.001; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; PEIXOTO AA, 1993, MOL BIOL EVOL, V10, P127; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shima S, 2004, BIOCHEM SOC T, V32, P269, DOI 10.1042/BST0320269; Stork T, 2009, ARCH MICROBIOL, V191, P141, DOI 10.1007/s00203-008-0438-7; Venkiteswaran JJ, 2007, OECOLOGIA, V153, P385, DOI 10.1007/s00442-007-0744-9; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2010, METHODS IN REDOX SIGNALING, P19; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Xu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007509; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028227; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	67	570	589	12	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					459	U65		10.1038/nature11088	http://dx.doi.org/10.1038/nature11088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622569	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000304344500034
J	Fry, DP				Fry, Douglas P.			LIFE WITHOUT WAR	SCIENCE			English	Review							BLOOD REVENGE; HISTORIES	An emerging evolutionary perspective suggests that nature and human nature are less "red in tooth and claw" than generally acknowledged by a competition-based view of the biological world. War is not always present in human societies. Peace systems, defined as groups of neighboring societies that do not make war on each other, exist on different continents. A comparison of three peace systems-the Upper Xingu River basin tribes of Brazil, the Iroquois Confederacy of upper New York State, and the European Union-highlight six features hypothesized to be important in the creation and maintenance of intersocietal peace: (i) an overarching social identity, (ii) interconnections among subgroups, (iii) interdependence, (iv) nonwarring values, (v) symbolism and ceremonies that reinforce peace, and (vi) superordinate institutions for conflict management. The existence of peace systems demonstrates that it is possible to create social systems free of war.	[Fry, Douglas P.] Abo Akad Univ Vasa, Dept Social Sci, FIN-65100 Vaasa, Finland; [Fry, Douglas P.] Sch Anthropol, Bur Appl Res Anthropol, Tucson, AZ 85721 USA		Fry, DP (corresponding author), Abo Akad Univ Vasa, Dept Social Sci, POB 311, FIN-65100 Vaasa, Finland.	dfry@abo.fi	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378	National Science Foundation [03-13670]	National Science Foundation(National Science Foundation (NSF))	I thank M. Dennis for graciously sharing his knowledge about the Iroquois Confederacy, my colleagues and students at Abo Akademi University for fruitful discussions, and three anonymous reviewers for their input. Some of the data reported in this paper were collected during research funded by the National Science Foundation (grant 03-13670).	[Anonymous], TREAT LISB EUR RIGHT; Beckerman S, 2009, P NATL ACAD SCI USA, V106, P8134, DOI 10.1073/pnas.0901431106; Bekoff Marc, 2009, WILD JUSTICE; Black D, 1993, SOCIAL STRUCTURE RIG; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; De Waal, 1989, PEACEMAKING PRIMATES; de Waal Frans, 2009, THE AGE OF EMPATHY; Dennis M., 1993, CREATING LANDSCAPE P; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Endicott KM., 2008, HEADMAN WAS WOMAN; Ferguson RB, 2011, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/978-1-4419-9520-9_14; Fry D.P., 2000, NATURAL CONFLICT RES, P334; Fry DP, 2011, DEV PRIMATOL-PROG PR, P227, DOI 10.1007/978-1-4419-9520-9_13; Fry DP, 2009, PEACE PSYCHOL BOOK S, P11, DOI 10.1007/978-0-387-09575-2_2; Fry DP, 2009, J AGGRESS CONFL PEAC, V1, P4, DOI 10.1108/17596599200900008; Fry Douglas P., 2010, NONKILLING SOC, P101; Fry DP., 2006, HUMAN POTENTIAL PEAC; Gregor T., 1990, ANTHR WAR, P105; Grossman D., 2009, KILLING; Haas J., 1999, ANCIENT WARFARE, P11; Hart D, 2011, DEV PRIMATOL-PROG PR, P19, DOI 10.1007/978-1-4419-9520-9_3; Hill S., 2010, EUROPES PROMISE; Hrdy, 2009, MOTHERS OTHERS; Hudgens T., 1986, WE NEED LAW; Johnson A., 1983, ADAPTIVE RESPONSES N, P61; Koch K.-F., 1974, WAR PEACE JALEMO; KUPCHAN CHARLES A, 2010, ENEMIES BECOME FRIEN; Marshall S., 2000, MEN FIRE; Miklikowska M., 2012, NONKILLING PSYCHOL, P43; Miklikowska Marta, 2010, BELIEFS VALUES, V2, P124; Nowak M. A., 2011, SUPERCOOPERATORS; Pinker S., 2011, BETTER ANGELS OUR NA; Reid T. R., 2004, US EUROPE; Rilling JK, 2011, DEV PRIMATOL-PROG PR, P295, DOI 10.1007/978-1-4419-9520-9_17; Roscoe P, 2007, AM ANTHROPOL, V109, P485, DOI 10.1525/AA.2007.109.3.485; Rubin J., 1994, SOCIAL CONFLICT, V2; Sachs J. D., 2008, COMMON WEALTH; Sherif M., 1988, ROBBERS CAVE EXPT IN; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sponsel Leslie E, 1994, ANTHR PEACE NONVIOLE; Staab A., 2008, EUROPEAN UNION EXPLA; Sussman RW, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-9520-9; Tonkinson Robert, 2004, KEEPING PEACE CONFLI, P89; Verbeek P, 2008, BEHAVIOUR, V145, P1497, DOI 10.1163/156853908786131270; Wallace P., 1994, WHITE ROOTS PEACE; Weiss K., 2009, MERMAIDS TALE; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wrangham R., 1996, DEMONIC MALES; Wright Quincy, 1942, STUDY WAR	51	32	32	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					879	884		10.1126/science.1217987	http://dx.doi.org/10.1126/science.1217987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605769				2022-12-28	WOS:000304145600055
J	Marmot, MG				Marmot, Michael G.			Policy Making With Health Equity at Its Heart	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UCL, UCL Inst Hlth Equ, London WC1E 6BT, England	University of London; University College London	Marmot, MG (corresponding author), UCL, UCL Inst Hlth Equ, 1-19 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G0902037, G8802774, G19/35] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, UPDATE WORLD BANKS E; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Hope K, 2012, FINANCIAL TIMES 0216; Marmot M, 2012, LANCET, V379, P181, DOI 10.1016/S0140-6736(11)61506-7; Stiglitz J., REPORT COMMISSION ME; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; The London Health Observatory and UCL Institute of Health Equity, 2012, MARM IND LOC AUTH EN	8	23	23	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2033	2034		10.1001/jama.2012.3534	http://dx.doi.org/10.1001/jama.2012.3534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665099				2022-12-28	WOS:000304048200019
J	Stein, EA; Gipe, D; Bergeron, J; Gaudet, D; Weiss, R; Dufour, R; Wu, R; Pordy, R				Stein, Evan A.; Gipe, Dan; Bergeron, Jean; Gaudet, Daniel; Weiss, Robert; Dufour, Robert; Wu, Richard; Pordy, Robert			Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial	LANCET			English	Article							RECEPTOR; PROTEIN	Background Inhibition of proprotein convertase subtilisin/kexin type 9 serine protease (PCSK9) resulted in large reductions of low-density lipoprotein cholesterol (LDL-C) in phase 1 trials. We assessed the efficacy and safety of various doses and dosing intervals of REGN727, a monoclonal antibody to PCSK9, added to statins, to further lower LDL-C in patients with heterozygous familial hypercholesterolaemia. Methods This multicentre, randomised, placebo-controlled phase 2 trial was done at 16 lipid clinics in the USA and Canada. Between Jan 18, 2011, and Nov 7, 2011, we enrolled adults with heterozygous familial hypercholesterolaemia and LDL-C concentrations of 2.6 mmol/L or higher on stable diet and statin dose, with or without ezetimibe. Patients were randomly assigned to receive REGN727 150 mg, 200 mg, or 300 mg every 4 weeks, or 150 mg every 2 weeks, or placebo every 2 weeks (ratio 1:1:1:1:1). Randomisation was stratified by concomitant use of ezetimibe at baseline. Investigators, study staff, and patients were masked to treatment group. Blinding was maintained by administration of placebo alternating with REGN727 for the groups of 4 week dosing. The primary endpoint was mean percent reduction in LDL-C from baseline at week 12 and was analysed in the modified intention-to-treat population with an analysis of covariance (ANCOVA) model with treatment group. This trial is registered in ClinicalTrials.gov, number NCT 01266876. Findings 77 patients were randomly assigned to study groups (15-16 patients per group) and all were analysed. Least-squares (LS) mean LDL-C reduction from baseline to week 12 was 28.9% (SE 5.08) for 150 mg every 4 weeks (p=0.0113), 31.54% (4.91) for 200 mg every 4 weeks (p=0.0035), 42.53% (5.09) for 300 mg every 4 weeks (p<0.0001), and 67.90% (4.85) for 150 mg every 2 weeks (p<0.0001), compared with 10.65% (5.04) with placebo. One serious adverse event was reported with placebo and none with REGN727. No increases of more than three times the upper limit of normal were reported for hepatic transaminases or creatinine kinase. The most common adverse event was injection-site reaction with one patient in the group of 300 mg REGN727 terminating treatment. Interpretation REGN727 was well tolerated and achieved substantial further LDL-C reduction in patients with heterozygous familial hypercholesterolaemia and elevated LDL-C treated with high-dose statins, with or without ezetimibe. REGN727 has the potential to provide optimum control of LDL-C in patients with this disorder.	[Stein, Evan A.] Metab & Atherosclerosis Res Ctr, Cincinnati, OH 45212 USA; [Gipe, Dan; Wu, Richard; Pordy, Robert] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Bergeron, Jean] Clin Malad Lipid Quebec, Quebec City, PQ, Canada; [Gaudet, Daniel] ECOGENE 21 Clin Trial Ctr, Chicoutimi, PQ, Canada; [Weiss, Robert] Maine Res Associates, Auburn, ME USA; [Dufour, Robert] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	Regeneron; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Stein, EA (corresponding author), Metab & Atherosclerosis Res Ctr, 4685 Forest Ave, Cincinnati, OH 45212 USA.	esteinmrl@aol.com			Sanofi US; Regeneron Pharmaceuticals Incorporated; Amgen; Adnexus Therapeutics; Sanofi; Regeneron; Sanofi US, Bridgewater, New Jersey; Regeneron Pharmaceuticals Incorporated, Tarrytown, NY, USA	Sanofi US; Regeneron Pharmaceuticals Incorporated(Regeneron); Amgen(Amgen); Adnexus Therapeutics; Sanofi; Regeneron(Regeneron); Sanofi US, Bridgewater, New Jersey; Regeneron Pharmaceuticals Incorporated, Tarrytown, NY, USA(Regeneron)	Sanofi US and Regeneron Pharmaceuticals Incorporated.; EAS has received consulting fees from Amgen, Adnexus Therapeutics, and Sanofi related to PCSK9 inhibitors and his institution has received research funding related to PCSK9 clinical trials from Amgen, Sanofi, and Regeneron. DGi, RWu, and RP are employees of Regeneron Pharmaceuticals, Inc. The other authors declare that they have no conflicts of interest.; This study was financially supported by Sanofi US, Bridgewater, New Jersey, and Regeneron Pharmaceuticals Incorporated, Tarrytown, NY, USA. We thank all the study investigators, the Data Monitoring Committee members, Anders Olsson, David Waters, Dominique Larrey, Robert S Rosenson, and Geert Molenberghs, for assisting with the statistical analyses; and Sola Neunie, of PPSI, for editorial support in the formatting of the report, funded by Sanofi and Regeneron.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Akdim F, 2010, AM J CARDIOL, V105, P1413, DOI 10.1016/j.amjcard.2010.01.003; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Elis A, 2011, AM J CARDIOL, V108, P223, DOI 10.1016/j.amjcard.2011.03.027; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; McKenney JM, 2012, J AM COLL CARDIOL; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Sachais BS, 2005, J CLIN APHERESIS, V20, P252, DOI 10.1002/jca.20036; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Stein E, 2004, AM HEART J, V148, P447, DOI 10.1016/j.ahj.2004.03.052; Stein EA, 2007, J CLIN LIPIDOL, V1, P280, DOI 10.1016/j.jacl.2007.07.003; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Thompson GR, 2008, ATHEROSCLEROSIS, V198, P247, DOI 10.1016/j.atherosclerosis.2008.02.009; THOROGOOD M, 1991, BRIT MED J, V303, P893; WHO, WHOHGNFHCONS992	19	472	509	0	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					29	36		10.1016/S0140-6736(12)60771-5	http://dx.doi.org/10.1016/S0140-6736(12)60771-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970GK	22633824				2022-12-28	WOS:000306115900030
J	Victora, C; Bryce, J; Requejo, J; Bhutta, Z; Chopra, M; Berman, P; Daelmans, B; de Francisco, A; Lawn, J; Mason, E; Newby, H; Presern, C; Starrs, A				Victora, Cesar; Bryce, Jennifer; Requejo, Jennifer; Bhutta, Zulfiqar; Chopra, Mickey; Berman, Peter; Daelmans, Bernadette; de Francisco, Andres; Lawn, Joy; Mason, Elizabeth; Newby, Holly; Presern, Carole; Starrs, Ann		Countdown 2012 Report Writing Grp	Building a future for women and children	LANCET			English	Editorial Material												jrequejo@jhsph.edu	Lawn, Joy/ABE-6382-2020; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Lawn, Joy/0000-0002-4573-1443; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180				[Anonymous], 2010, COUNTD 2015 COUNTD 2; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Commission on Information and Accountability for Women's and Children's Health, 2011, COMM INF ACC WOM CHI; *UNICEF, 2008, COUNTD 2015 TRACK PR; UNICEF, 2005, COUNTD 2015 TRACK PR; World Health Organization/United Nations Children's Fund, 2012, COUNTD 2015 BUILD FU	6	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2121	2122						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682448				2022-12-28	WOS:000304990900005
J	Sonnenberg, GF; Monticelli, LA; Alenghat, T; Fung, TC; Hutnick, NA; Kunisawa, J; Shibata, N; Grunberg, S; Sinha, R; Zahm, AM; Tardif, MR; Sathaliyawala, T; Kubota, M; Farber, DL; Collman, RG; Shaked, A; Fouser, LA; Weiner, DB; Tessier, PA; Friedman, JR; Kiyono, H; Bushman, FD; Chang, KM; Artis, D				Sonnenberg, Gregory F.; Monticelli, Laurel A.; Alenghat, Theresa; Fung, Thomas C.; Hutnick, Natalie A.; Kunisawa, Jun; Shibata, Naoko; Grunberg, Stephanie; Sinha, Rohini; Zahm, Adam M.; Tardif, Melanie R.; Sathaliyawala, Taheri; Kubota, Masaru; Farber, Donna L.; Collman, Ronald G.; Shaked, Abraham; Fouser, Lynette A.; Weiner, David B.; Tessier, Philippe A.; Friedman, Joshua R.; Kiyono, Hiroshi; Bushman, Frederic D.; Chang, Kyong-Mi; Artis, David			Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria	SCIENCE			English	Article							ALCALIGENES-XYLOSOXIDANS; INTESTINAL BACTERIA; HOST-DEFENSE; MICROBIOTA; ACHROMOBACTER; INFLAMMATION; HOMEOSTASIS; IDENTIFICATION; IMMUNITY; SYSTEM	The mammalian intestinal tract is colonized by trillions of beneficial commensal bacteria that are anatomically restricted to specific niches. However, the mechanisms that regulate anatomical containment remain unclear. Here, we show that interleukin-22 (IL-22)-producing innate lymphoid cells (ILCs) are present in intestinal tissues of healthy mammals. Depletion of ILCs resulted in peripheral dissemination of commensal bacteria and systemic inflammation, which was prevented by administration of IL-22. Disseminating bacteria were identified as Alcaligenes species originating from host lymphoid tissues. Alcaligenes was sufficient to promote systemic inflammation after ILC depletion in mice, and Alcaligenes-specific systemic immune responses were associated with Crohn's disease and progressive hepatitis C virus infection in patients. Collectively, these data indicate that ILCs regulate selective containment of lymphoid-resident bacteria to prevent systemic inflammation associated with chronic diseases.	[Sonnenberg, Gregory F.; Monticelli, Laurel A.; Alenghat, Theresa; Fung, Thomas C.; Grunberg, Stephanie; Sinha, Rohini; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.; Monticelli, Laurel A.; Alenghat, Theresa; Fung, Thomas C.; Grunberg, Stephanie; Sinha, Rohini; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Hutnick, Natalie A.; Weiner, David B.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kunisawa, Jun; Shibata, Naoko; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo 1088639, Japan; [Kunisawa, Jun; Shibata, Naoko; Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778562, Japan; [Zahm, Adam M.; Friedman, Joshua R.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat,Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Tardif, Melanie R.; Tessier, Philippe A.] Univ Laval, Fac Med, CHU Laval, Ctr Rech Infectiol, Quebec City, PQ G1K 7P4, Canada; [Sathaliyawala, Taheri; Kubota, Masaru; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Sathaliyawala, Taheri; Kubota, Masaru; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Collman, Ronald G.; Chang, Kyong-Mi] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaked, Abraham] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Fouser, Lynette A.] Pfizer Worldwide R&D, Inflammat & Immunol Res Unit, Biotherapeut Res & Dev, Cambridge, MA 02140 USA; [Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Chang, Kyong-Mi] Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; University of Tokyo; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Laval University; Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pfizer; Japan Science & Technology Agency (JST); University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Weiner, David B/H-8579-2014; Kiyono, Hiroshi/AAC-6735-2022	Farber, Donna/0000-0001-8236-9183; Artis, David/0000-0002-1753-4100; Tessier, Philippe/0000-0001-7177-7763; Bushman, Frederic/0000-0003-4740-4056; Collman, Ronald/0000-0002-0508-3701; Friedman, Joshua/0000-0001-9382-8429; Chang, Kyong-Mi/0000-0001-6811-9364	NIH [AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, T32-AI007532, T32-AI055428, T32-RR007063, K08-DK093784, AI47619, P30 AI 045008]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Philadelphia VA Medical Research and Merit Review; American Gastroenterological Association; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Matthew J. Ryan Veterinary Hospital Pathology Lab, the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core [P30DK50306]; National Cancer Institute (NCI) Comprehensive Cancer Center [2-P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R01AI074878, R01AI095466, P30AI045008, R21AI087990, U01AI095608, T32AI055428, R01AI102942, T32AI007532, R21AI083480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK093784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Philadelphia VA Medical Research and Merit Review; American Gastroenterological Association; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry; Matthew J. Ryan Veterinary Hospital Pathology Lab, the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core; National Cancer Institute (NCI) Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Artis laboratory for discussions and critical reading of the manuscript. We also thank S. Olland, R. Zollner, K. Lam, and A. Root at Pfizer for the preparation of IL-22 cytokine and antibodies. The research is supported by the NIH (grants AI061570, AI087990, AI074878, AI083480, AI095466, and AI095608 to D. A.; T32-AI007532 to G. F. S and L. A. M.; T32-AI055428 to G. F. S.; T32-RR007063 and K08-DK093784 to T. A.; and AI47619 to K.-M. C.); the NIH-funded Penn Center for AIDS Research (grant P30 AI 045008 to G. F. S. and D. A.); the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (to D. A.); the Philadelphia VA Medical Research and Merit Review and American Gastroenterological Association (to K.-M. C.); the Ministry of Education, Culture, Sports, Science and Technology of Japan (to J.K., N.S., and H. K); and the Program for Promotion of Basic and Applied Researches for Innovations in Bio-Oriented Industry (to J.K.). We also thank the Matthew J. Ryan Veterinary Hospital Pathology Lab, the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core (grant P30DK50306), the Penn Microarray Facility, and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory [partially supported by National Cancer Institute (NCI) Comprehensive Cancer Center Support grant # 2-P30 CA016520] for technical advice and support. Several human tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the NCI. The data presented in the paper are tabulated in the main paper and in the supplementary materials.	Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Busse HJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P675, DOI 10.1007/0-387-30745-1_28; Duggan JM, 1996, CLIN INFECT DIS, V23, P569, DOI 10.1093/clinids/23.3.569; Espinoza-Gomez F, 2007, BRAZ J INFECT DIS, V11, P603, DOI 10.1590/S1413-86702007000600015; Funke G, 1998, J CLIN MICROBIOL, V36, P1948, DOI 10.1128/JCM.36.7.1948-1952.1998; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; LESCUT D, 1990, GASTROEN CLIN BIOL, V14, P811; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Liu LX, 2002, J CLIN MICROBIOL, V40, P1210, DOI 10.1128/JCM.40.4.1210-1213.2002; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Ryckman C, 2002, J IMMUNOL, V169, P3307, DOI 10.4049/jimmunol.169.6.3307; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	29	517	546	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1321	1325		10.1126/science.1222551	http://dx.doi.org/10.1126/science.1222551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674331	Green Accepted			2022-12-28	WOS:000304905300051
J	Iglehart, JK				Iglehart, John K.			Primary Care Update - Light at the End of the Tunnel?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ABIM Foundation, 2012, WORKB PRIM CAR INN I; Dentzer S, 2012, HEALTH AFFAIR, V31, P341, DOI 10.1377/hlthaff.2012.0077; MCCARTY DJ, 1987, NEW ENGL J MED, V317, P567, DOI 10.1056/NEJM198708273170909; Medicare Payment Advisory Commission, 2012, REP C MED PAYM POL; PETERSDORF RG, 1992, NEW ENGL J MED, V326, P408, DOI 10.1056/NEJM199202063260610	5	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2144	2146		10.1056/NEJMp1205537	http://dx.doi.org/10.1056/NEJMp1205537			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953JO	22621420				2022-12-28	WOS:000304863400002
J	Relton, C; Strong, M; Holdsworth, M				Relton, Clare; Strong, Mark; Holdsworth, Michelle			Plastic food packaging encourages obesity	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Relton, Clare; Strong, Mark; Holdsworth, Michelle] Univ Sheffield, Fac Med, Sect Publ Hlth, ScHARR Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Relton, C (corresponding author), Univ Sheffield, Fac Med, Sect Publ Hlth, ScHARR Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England.	c.relton@sheffield.ac.uk	holdsworth, michelle/AAH-5400-2020; Strong, Mark/A-4638-2010	holdsworth, michelle/0000-0001-6028-885X; Strong, Mark/0000-0003-1486-8233; Relton, Clare/0000-0001-8530-5011				Bix L, PACKAGING MATRIX LIN; Tang-Peronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x	2	1	1	1	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 1	2012	344								e3824	10.1136/bmj.e3824	http://dx.doi.org/10.1136/bmj.e3824			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HK	22661726				2022-12-28	WOS:000304857600006
J	Dixon, SJ; Lemberg, KM; Lamprecht, MR; Skouta, R; Zaitsev, EM; Gleason, CE; Patel, DN; Bauer, AJ; Cantley, AM; Yang, WS; Morrison, B; Stockwell, BR				Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay, III; Stockwell, Brent R.			Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death	CELL			English	Article							SMALL-MOLECULE; ORGANOTYPIC CULTURES; CANCER-CELLS; IN-VITRO; K-RAS; PROTEIN; GROWTH; NEURODEGENERATION; IDENTIFICATION; TRANSPORTER	Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathological states. The oncogenic RAS-selective lethal small molecule erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis. Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphologically, biochemically, and genetically distinct from apoptosis, necrosis, and autophagy. We identify the small molecule ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes. Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system x(c)(-)), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death. Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.	[Dixon, Scott J.; Lemberg, Kathryn M.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Lamprecht, Michael R.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Stockwell, BR (corresponding author), Columbia Univ, Dept Biol Sci, 550 W 120th St,NW Corner Bldg,MC 4846, New York, NY 10027 USA.	bstockwell@columbia.edu	Morrison, Barclay/B-7132-2008; Skouta, Rachid/M-2690-2019; Skouta, Rachid/Q-7132-2016; Stockwell, Brent R/AAE-7200-2019	Morrison, Barclay/0000-0001-7676-0864; Stockwell, Brent R/0000-0002-3532-3868; Skouta, Rachid/0000-0003-3324-4362; Dixon, Scott/0000-0001-6230-8199	NSF [CHE-0840451]; Columbia University; Canadian Institutes of Health Research; US National Institutes of Health [5R01CA097061, 5R01GM085081, R01CA161061]; Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE [R01CA097061, R00CA166517, R01CA161061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Columbia University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Vamsi Mootha, Joshua Baughman, and David Root for sharing the custom shRNA library; Kristy Brown and Elma Zaganjor for assistance with electron microscopy; Darnelle Delva for help with qPCR; Rohitha SriRamaratnam for help with cell death assays; Eric Schon for providing the 143B cell lines; Craig Thompson for providing Bax<SUP>-/-</SUP> Bak<SUP>-/-</SUP> MEFs; and Patrick Page (GenKyoTex S.A.) for providing GKT137831. We thank David Clarke for comments on the manuscript. Certain shRNA collections used in this work were generated with the assistance of the Scientific Planning and Allocation of Resources Committee (SPARC, to Vamsi Mootha). NSF grant CHE-0840451 supported the purchase and operation of equipment used in the chemical characterization of ferrostatin-1. M.R.L. was supported by a fellowship from the National Science Foundation. K.M.L. was supported by the Medical Scientist Training Program (Columbia University). S.J.D. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. This research was supported by grants from the US National Institutes of Health (5R01CA097061, 5R01GM085081, and R01CA161061), the Arnold and Mabel Beckman Foundation, and NYSTAR. B.R.S. is an Early Career Scientist of the Howard Hughes Medical Institute.	Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; ISHII T, 1981, J BIOL CHEM, V256, P2387; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kanai Yoshikatsu, 2003, J Toxicol Sci, V28, P1, DOI 10.2131/jts.28.1; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; RATAN RR, 1994, J NEUROCHEM, V62, P376; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yonezawa M, 1996, J NEUROCHEM, V67, P566	47	4900	5167	351	1731	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1060	1072		10.1016/j.cell.2012.03.042	http://dx.doi.org/10.1016/j.cell.2012.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632970	Green Accepted, Bronze			2022-12-28	WOS:000304453900012
J	Ahrens, MB; Li, JM; Orger, MB; Robson, DN; Schier, AF; Engert, F; Portugues, R				Ahrens, Misha B.; Li, Jennifer M.; Orger, Michael B.; Robson, Drew N.; Schier, Alexander F.; Engert, Florian; Portugues, Ruben			Brain-wide neuronal dynamics during motor adaptation in zebrafish	NATURE			English	Article							FUNCTIONAL GROUND PLAN; CELLULAR RESOLUTION; ODOR REPRESENTATIONS; NEURAL ACTIVITY; HINDBRAIN; BEHAVIOR; DROSOPHILA; MOTION; CEREBELLUM; EXPRESSION	A fundamental question in neuroscience is how entire neural circuits generate behaviour and adapt it to changes in sensory feedback. Here we use two-photon calcium imaging to record the activity of large populations of neurons at the cellular level, throughout the brain of larval zebrafish expressing a genetically encoded calcium sensor, while the paralysed animals interact fictively with a virtual environment and rapidly adapt their motor output to changes in visual feedback. We decompose the network dynamics involved in adaptive locomotion into four types of neuronal response properties, and provide anatomical maps of the corresponding sites. A subset of these signals occurred during behavioural adjustments and are candidates for the functional elements that drive motor learning. Lesions to the inferior olive indicate a specific functional role for olivocerebellar circuitry in adaptive locomotion. This study enables the analysis of brain-wide dynamics at single-cell resolution during behaviour.	[Ahrens, Misha B.; Li, Jennifer M.; Robson, Drew N.; Schier, Alexander F.; Engert, Florian; Portugues, Ruben] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahrens, Misha B.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Orger, Michael B.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	Harvard University; University of Cambridge; Fundacao Champalimaud	Engert, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	florian@mcb.harvard.edu	Portugues, Ruben/N-4900-2019; Portugues, Ruben/C-3600-2012	Portugues, Ruben/0000-0002-1495-9314; Portugues, Ruben/0000-0002-1495-9314; Schier, Alexander Franz/0000-0001-7645-5325; Orger, Michael/0000-0002-9763-8902; Robson, Drew/0000-0002-0150-1515	Wellcome Trust; K99 [5K99NS62780-2]; National Institutes of Health [5R01EY014429, RC2NS069407]; NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS082121, RC2NS069407, K99NS062780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030304] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); K99; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to D. Schoppik for teaching M. B. A. the fictive swimming preparation, to K.-H. Huang for carrying out spinal calcium green injections, and to M. Concha, R. Baker and L.-H. Ma for advice on anatomy. We thank M. Meister, B. Olveczky, D. Wolpert, E. Mukamel, M. Yartsev, D. Schoppik, D. Hildebrand, E. Naumann, A. Kampff, P. Latham, T. Dunn and members of the Engert laboratory for useful discussions and comments on the manuscript. We thank P. Oteiza and R. Hellmiss for help with anatomy and figures, and A. Viel for use of laboratory space. M. B. A. thanks D. Wolpert and E. Santos for support. This work was supported by a Sir Henry Wellcome Fellowship from the Wellcome Trust (M. B. A.), a K99 grant no. 5K99NS62780-2 (M.B.O.) and National Institutes of Health grants 5R01EY014429 and RC2NS069407 (F.E.).	Aizenberg M, 2011, J NEUROSCI, V31, P8708, DOI 10.1523/JNEUROSCI.6565-10.2011; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; BENNETT AF, 1985, J EXP BIOL, V115, P333; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Chong M, 2007, DEV NEUROBIOL, V67, P933, DOI 10.1002/dneu.20398; COHEN AH, 1980, EXP BRAIN RES, V41, P11; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hieber V, 1998, J NEUROBIOL, V37, P429, DOI 10.1002/(SICI)1097-4695(19981115)37:3<429::AID-NEU8>3.0.CO;2-N; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; ITO M, 1974, BRAIN RES, V65, P170, DOI 10.1016/0006-8993(74)90344-8; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Koyama M, 2011, P NATL ACAD SCI USA, V108, P1170, DOI 10.1073/pnas.1012189108; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Matsumoto N, 2007, BRAIN BEHAV EVOLUT, V70, P105, DOI 10.1159/000102972; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miri A, 2011, NAT NEUROSCI, V14, P1150, DOI 10.1038/nn.2888; MOHL B, 1988, J COMP PHYSIOL A, V163, P803, DOI 10.1007/BF00604057; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Portugues R, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00072; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROBERTS BL, 1992, J EXP BIOL, V167, P171; ROCK I, 1986, PERCEPTION, V15, P497, DOI 10.1068/p150497; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Volkmann K, 2010, J COMP NEUROL, V518, P2794, DOI 10.1002/cne.22364; WALL PD, 1967, EXP NEUROL, V19, P519, DOI 10.1016/0014-4886(67)90172-0; WOLF R, 1992, PHILOS T R SOC B, V337, P261, DOI 10.1098/rstb.1992.0104; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288	52	399	401	7	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					471	U80		10.1038/nature11057	http://dx.doi.org/10.1038/nature11057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622571	Green Accepted			2022-12-28	WOS:000304344500036
J	Chotirmall, SH; Smith, SG; Gunaratnam, C; Cosgrove, S; Dimitrov, BD; O'Neill, SJ; Harvey, BJ; Greene, CM; McElvaney, NG				Chotirmall, Sanjay H.; Smith, Stephen G.; Gunaratnam, Cedric; Cosgrove, Sonya; Dimitrov, Borislav D.; O'Neill, Shane J.; Harvey, Brian J.; Greene, Catherine M.; McElvaney, Noel G.			Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG INFECTION; AERUGINOSA INFECTION; GENDER-DIFFERENCES; HYDROGEN-PEROXIDE; MOUSE MODEL; ALGINATE; 17-BETA-ESTRADIOL; MORTALITY; SURVIVORSHIP; PREVALENCE	Background Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contributes to a sexual dichotomy in disease severity. Methods We evaluated the effects of estradiol and its metabolite estriol on P. aeruginosa in vitro and in vivo and determined the effect of estradiol on disease exacerbations in women with cystic fibrosis. Results Estradiol and estriol induced alginate production in P. aeruginosa strain 01 and in clinical isolates obtained from patients with and those without cystic fibrosis. After prolonged exposure to estradiol, P. aeruginosa adopted early mucoid morphology, whereas short-term exposure inhibited bacterial catalase activity and increased levels of hydrogen peroxide, which is potentially damaging to DNA. Consequently, a frameshift mutation was identified in mucA, a key regulator of alginate biosynthesis in P. aeruginosa. In vivo levels of estradiol correlated with infective exacerbations in women with cystic fibrosis, with the majority occurring during the follicular phase (P<0.05). A review of the Cystic Fibrosis Registry of Ireland revealed that the use of oral contraceptives was associated with a decreased need for antibiotics. Predominantly nonmucoid P. aeruginosa was isolated from sputum during exacerbations in the luteal phase (low estradiol). Increased proportions of mucoid bacteria were isolated during exacerbations occurring in the follicular phase (high estradiol), with a variable P. aeruginosa phenotype evident in vivo during the course of the menstrual cycle corresponding to fluctuating estradiol levels. Conclusions Estradiol and estriol induced mucoid conversion of P. aeruginosa in women with cystic fibrosis through a mutation of mucA in vitro and were associated with selectivity for mucoid isolation, increased exacerbations, and mucoid conversion in vivo.	[Greene, Catherine M.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Med,Resp Res Div, Dublin 9, Ireland; [Dimitrov, Borislav D.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Gen Practice, Dublin, Ireland; [Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin, Ireland; [Chotirmall, Sanjay H.; Gunaratnam, Cedric; O'Neill, Shane J.; McElvaney, Noel G.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Resp Med, Dublin, Ireland; [Smith, Stephen G.] Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin	Greene, CM (corresponding author), Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Med,Resp Res Div, Dublin 9, Ireland.	cmgreene@rcsi.ie	Smith, Stephen/C-8523-2014; Harvey, Brian J/A-5120-2010; McElvaney, Noel/A-6809-2010; Harvey, Brian/AAJ-4085-2020; Chotirmall, Sanjay Haresh/K-4127-2015; Greene, Catherine M/D-3513-2012; Dimitrov, Borislav D/A-1246-2010	Smith, Stephen/0000-0001-7807-2176; Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Chotirmall, Sanjay Haresh/0000-0003-0417-7607; Greene, Catherine M/0000-0003-2549-2569; Dimitrov, Borislav D/0000-0002-5896-2072; mcelvaney, Noel/0000-0002-0152-4370	Molecular Medicine Ireland Clinician-Scientist Fellowship Programme; Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme	Molecular Medicine Ireland Clinician-Scientist Fellowship Programme; Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme	Funded by the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme.; Supported by the Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 through a grant (2008-2011) from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme.	BAKER ME, 1989, FASEB J, V3, P2086, DOI 10.1096/fasebj.3.9.2663583; BENISEK WF, 1982, BIOCHEMISTRY-US, V21, P5816, DOI 10.1021/bi00266a015; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; FISHMAN J, 1960, J BIOL CHEM, V235, P3104; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gosselin D, 1998, AM J RESP CRIT CARE, V157, P1253, DOI 10.1164/ajrccm.157.4.9702081; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; HOIBY N, 1975, ACTA PATH MICRO IM B, V83, P549; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; KRIEG DP, 1986, J CLIN MICROBIOL, V24, P986, DOI 10.1128/JCM.24.6.986-990.1986; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LIEHR JG, 1990, FREE RADICAL BIO MED, V8, P415, DOI 10.1016/0891-5849(90)90108-U; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Maselli JH, 2003, PEDIATR PULM, V35, P257, DOI 10.1002/ppul.10230; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Olesen HV, 2010, PEDIATR PULM, V45, P959, DOI 10.1002/ppul.21265; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pier GB, 2007, J IMMUNOL, V178, P7485, DOI 10.4049/jimmunol.178.11.7485; Pier GB, 2004, J IMMUNOL, V173, P5671, DOI 10.4049/jimmunol.173.9.5671; Pittman JE, 2011, PEDIATR PULM, V46, P497, DOI 10.1002/ppul.21397; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; ROWLAND SS, 1992, J STEROID BIOCHEM, V42, P721, DOI 10.1016/0960-0760(92)90113-W; Schallreuter KU, 2006, J INVEST DERMATOL, V126, P1036, DOI 10.1038/sj.jid.5700257; Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; SUGARMAN B, 1990, J MED MICROBIOL, V32, P227, DOI 10.1099/00222615-32-4-227; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]	42	125	128	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1978	1986		10.1056/NEJMoa1106126	http://dx.doi.org/10.1056/NEJMoa1106126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22607135	Green Published			2022-12-28	WOS:000304353000008
J	Leschziner, G; Gringras, P				Leschziner, Guy; Gringras, Paul			Restless legs syndrome	BRITISH MEDICAL JOURNAL			English	Review							LIMB MOVEMENT-DISORDER; QUALITY-OF-LIFE; DOUBLE-BLIND; POPULATION; HEALTH; PREVALENCE; PREGABALIN; FREQUENCY; PREGNANCY; DIAGNOSIS		[Leschziner, Guy] Guys & St Thomas NHS Fdn Trust, Dept Neurol, London SE1 7EH, England; [Leschziner, Guy] Guys & St Thomas NHS Fdn Trust, Sleep Disorders Ctr, London SE1 7EH, England; [Gringras, Paul] Evelina Childrens Hosp, Dept Pediat Neurosci, London, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Leschziner, G (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Neurol, London SE1 7EH, England.	guy.leschziner@gstt.nhs.uk						Allen R, 2010, SLEEP MED, V11, P512, DOI 10.1016/j.sleep.2010.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Byrne Ruth, 2006, Neuropsychiatr Dis Treat, V2, P155, DOI 10.2147/nedt.2006.2.2.155; Cesnik E, 2010, NEUROLOGY, V75, P2117, DOI 10.1212/WNL.0b013e318200d779; Chervin RD, 2002, SLEEP, V25, P213; Connor JR, 2003, NEUROLOGY, V61, P304, DOI 10.1212/01.WNL.0000078887.16593.12; Cornelius JR, 2010, SLEEP, V33, P81; Dzaja A, 2009, SLEEP, V32, P169, DOI 10.1093/sleep/32.2.169; Earley CJ, 2000, J NEUROSCI RES, V62, P623, DOI 10.1002/1097-4547(20001201)62:5<623::AID-JNR1>3.3.CO;2-8; Ekbom KA, 1945, ACTA MED SCAND, V158, P1; Garcia-Borreguero D, 2010, NEUROLOGY, V74, P1897, DOI 10.1212/WNL.0b013e3181e1ce73; Garcia-Borreguero D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-28; Garcia-Borreguero D, 2010, SLEEP MED REV, V14, P339, DOI 10.1016/j.smrv.2009.11.006; Happe S, 2009, SLEEP MED, V10, P295, DOI 10.1016/j.sleep.2008.01.002; Hornyak M, 2012, SLEEP MED; Innes KE, 2011, SLEEP MED REV; Michaud M, 2000, MOVEMENT DISORD, V15, P289, DOI 10.1002/1531-8257(200003)15:2<289::AID-MDS1012>3.0.CO;2-E; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Ohayon MM, 2011, SLEEP MED REV; Perez-Diaz H, 2011, NEUROLOGY, V77, P1283, DOI 10.1212/WNL.0b013e318230207a; Picchietti D, 2007, PEDIATRICS, V120, P253, DOI 10.1542/peds.2006-2767; Picchietti DL, 2009, SLEEP MED, V10, P925, DOI 10.1016/j.sleep.2008.10.006; Rangarajan S, 2007, SLEEP MED, V9, P88, DOI 10.1016/j.sleep.2006.11.004; Salas RE, 2010, CURR OPIN NEUROL, V23, P401, DOI 10.1097/WCO.0b013e32833bcdd8; Scholz H, 2011, COCHRANE DB SYST REV, V3; Trenkwalder C, 2008, MOVEMENT DISORD, V23, P2267, DOI 10.1002/mds.22254; Trenkwalder C, 2008, SLEEP MED, V9, P572, DOI 10.1016/j.sleep.2007.07.020; Vignatelli L, 2006, EUR J NEUROL, V13, P1049, DOI 10.1111/J.1468-1331.2006.01410.x; Vogl FD, 2006, MOVEMENT DISORD, V21, P1189, DOI 10.1002/mds.20922; Voon V, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-117; Walters AS, 2002, SLEEP MED, V3, P93, DOI 10.1016/S1389-9457(01)00164-2; Winkelman JW, 2006, EUR J NEUROL, V13, P8, DOI 10.1111/j.1468-1331.2006.01586.x; Winkelman JW, 2009, SLEEP, V32, P772, DOI 10.1093/sleep/32.6.772; Winkelmann J, 2000, SLEEP, V23, P597; Yeh P., 2011, SLEEP BREATH	36	26	26	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 24	2012	344								e3056	10.1136/bmj.e3056	http://dx.doi.org/10.1136/bmj.e3056			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QU	22623643				2022-12-28	WOS:000304591600003
J	Dlouhy, BJ; Greenlee, JDW				Dlouhy, Brian J.; Greenlee, Jeremy D. W.			Progressive Confusion, Memory Loss, and Gait Ataxia in an Adult	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLOID CYSTS; VENTRICLE		[Dlouhy, Brian J.; Greenlee, Jeremy D. W.] Univ Iowa, Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA	University of Iowa	Dlouhy, BJ (corresponding author), Univ Iowa, Hosp & Clin, Dept Neurosurg, 200 Hawkins Dr, Iowa City, IA 52242 USA.	brian-dlouhy@uiowa.edu		Dlouhy, Brian/0000-0001-6724-688X; Greenlee, Jeremy/0000-0002-8481-8517				AKKARAJU V, 1982, CT-J COMPUT TOMOGR, V6, P26, DOI 10.1016/0149-936X(82)90006-6; CAMACHO A, 1989, NEUROSURGERY, V24, P693, DOI 10.1227/00006123-198905000-00006; Dandaleh NS, 2012, J CLIN NEUROSCI, V19, P612, DOI 10.1016/j.jocn.2011.06.021; Dlouhy BJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS10312; Greenlee JDW, 2008, NEUROSURGERY, V63, P51, DOI [10.1227/01.NEU.0000297004.20222.ED, 10.1227/01.neu.0000317373.00018.6f]; Humphries Roger L, 2011, J Emerg Med, V40, pe5, DOI 10.1016/j.jemermed.2007.11.110; LITTLE JR, 1974, J NEUROSURG, V40, P230, DOI 10.3171/jns.1974.40.2.0230; MATHIESEN T, 1993, J NEUROSURG, V78, P748, DOI 10.3171/jns.1993.78.5.0748; MORRISON G, 1984, RADIOLOGY, V153, P435, DOI 10.1148/radiology.153.2.6333046; Rekate HL, 2011, CHILD NERV SYST, V27, P1535, DOI 10.1007/s00381-011-1558-y	10	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2195	2196		10.1001/jama.2012.3447	http://dx.doi.org/10.1001/jama.2012.3447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618927				2022-12-28	WOS:000304315200029
J	Turnbull, AMJ; Mayfield, MP				Turnbull, Andrew M. J.; Mayfield, Martin P.			10-MINUTE CONSULTATION Blepharitis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Turnbull, Andrew M. J.] Bournemouth Eye Unit, Bournemouth BH7 7DW, Dorset, England		Turnbull, AMJ (corresponding author), Bournemouth Eye Unit, Bournemouth BH7 7DW, Dorset, England.	andyt@doctors.org.uk							0	0	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 23	2012	344								e3328	10.1136/bmj.e3328	http://dx.doi.org/10.1136/bmj.e3328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QT	22623633				2022-12-28	WOS:000304591500003
J	Drolet, BC; Christopher, DA; Fischer, SA				Drolet, Brian C.; Christopher, Derrick A.; Fischer, Staci A.			Residents' Response to Duty-Hour Regulations - A Follow-up National Survey	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORK HOURS		[Drolet, Brian C.] Brown Univ, Warren Alpert Med Sch, Dept Plast Surg, Providence, RI 02912 USA; [Drolet, Brian C.] Brown Univ, Warren Alpert Med Sch, Dept Gen Surg, Providence, RI 02912 USA; [Fischer, Staci A.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Drolet, Brian C.; Fischer, Staci A.] Rhode Isl Hosp, Providence, RI USA; [Christopher, Derrick A.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Vanderbilt University	Drolet, BC (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Plast Surg, Providence, RI 02912 USA.							[Anonymous], 2011, ACGME DAT RES BOOK A; Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Blum AB, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-33; Drolet BC, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1011413; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406	5	81	81	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24							e35	10.1056/NEJMp1202848	http://dx.doi.org/10.1056/NEJMp1202848			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22646511				2022-12-28	WOS:000305174100004
J	Castello, A; Fischer, B; Eichelbaum, K; Horos, R; Beckmann, BM; Strein, C; Davey, NE; Humphreys, DT; Preiss, T; Steinmetz, LM; Krijgsveld, J; Hentze, MW				Castello, Alfredo; Fischer, Bernd; Eichelbaum, Katrin; Horos, Rastislav; Beckmann, Benedikt M.; Strein, Claudia; Davey, Norman E.; Humphreys, David T.; Preiss, Thomas; Steinmetz, Lars M.; Krijgsveld, Jeroen; Hentze, Matthias W.			Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins	CELL			English	Article							NUCLEIC-ACIDS; CROSS-LINKING; IRE-BP; CYCLOPHILIN; DEHYDROGENASE; EXPRESSION; IDENTIFICATION; INTERACTS; ACONITASE; DISORDER	RNA-binding proteins (RBPs) determine RNA fate from synthesis to decay. Employing two complementary protocols for covalent UV crosslinking of RBPs to RNA, we describe a systematic, unbiased, and comprehensive approach, termed "interactome capture,'' to define the mRNA interactome of proliferating human HeLa cells. We identify 860 proteins that qualify as RBPs by biochemical and statistical criteria, adding more than 300 RBPs to those previously known and shedding light on RBPs in disease, RNA-binding enzymes of intermediary metabolism, RNA-binding kinases, and RNA-binding architectures. Unexpectedly, we find that many proteins of the HeLa mRNA interactome are highly intrinsically disordered and enriched in short repetitive amino acid motifs. Interactome capture is broadly applicable to study mRNA interactome composition and dynamics in varied biological settings.	[Castello, Alfredo; Fischer, Bernd; Eichelbaum, Katrin; Horos, Rastislav; Beckmann, Benedikt M.; Strein, Claudia; Davey, Norman E.; Steinmetz, Lars M.; Krijgsveld, Jeroen; Hentze, Matthias W.] EMBL, D-69117 Heidelberg, Germany; [Humphreys, David T.; Preiss, Thomas; Hentze, Matthias W.] Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW 2010, Australia; [Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genome Biol Dept, Canberra, ACT 0200, Australia	European Molecular Biology Laboratory (EMBL); Victor Chang Cardiac Research Institute; Australian National University; John Curtin School of Medical Research	Krijgsveld, J (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jeroen.krijgsveld@embl.de; hentze@embl.de	Davey, Norman E/D-5362-2013; Castello, Alfredo/U-6317-2018; Palomares, Alfredo Castello/K-8062-2019; Fischer, Bernd/E-7461-2011; Krijgsveld, Jeroen/F-5974-2011; Hentze, Matthias W/V-3980-2017; Preiss, Thomas/F-7355-2010	Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Fischer, Bernd/0000-0001-9437-2099; Hentze, Matthias W/0000-0002-4023-7876; Preiss, Thomas/0000-0001-6273-784X; Beckmann, Benedikt/0000-0001-7566-4408; Steinmetz, Lars/0000-0002-3962-2865; Humphreys, David/0000-0003-4140-0089; Davey, Norman/0000-0001-6988-4850; Horos, Rastislav/0000-0001-7730-9557; Krijgsveld, Jeroen/0000-0001-7549-9326	National Health and Medical Research Council [514904, 573731, 632757]; Australian Research Council [DP0878224]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank Drs. Toby Gibson, Teresa Carlomagno, Wolfgang Huber, and Maria Moreno (EMBL) for expert advice and helpful discussions, and we also thank Dr. Markus Landthaler (MCD, Berlin) for generously sharing his expertise on PAR-CL. We are grateful to Drs. Jan Ellenberg, Rainer Pepperkok (EMBL), Stefan Pusch, and Andreas von Deimling (Universitatsklinikum Heidelberg) for plasmids; Dr. Iain Mattaj (EMBL) for the rabbit GFP antibody; and Dr. Matthias Gromeier (Duke University Medical Center, Durham, USA) for the HeLa Flip-In TRex cell line. We acknowledge Alexis Perez and the EMBL Flow Cytometry Core Facility for FACS experiments and EMBL Gene Core Facility for support throughout this work. This work was supported by grants 514904, 573731, and 632757 from the National Health and Medical Research Council and was also supported by DP0878224 from the Australian Research Council awarded to T.P.A.C. is the beneficiary of a Marie Curie postdoctoral fellowship (FP7).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, CANCER RES TREAT, V42, P125, DOI 10.4143/crt.2010.42.3.125; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ELZINGA SDJ, 1993, NUCLEIC ACIDS RES, V21, P5328, DOI 10.1093/nar/21.23.5328; Elzinga SDJ, 2000, CURR GENET, V38, P87, DOI 10.1007/s002940000132; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hentze MW, 2010, TRENDS BIOCHEM SCI, V35, P423, DOI 10.1016/j.tibs.2010.05.009; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kiri A, 2002, J MUSCLE RES CELL M, V23, P119, DOI 10.1023/A:1020211729728; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Pioli PA, 2002, J BIOL CHEM, V277, P35738, DOI 10.1074/jbc.M204002200; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Shetty S, 2004, AM J RESP CELL MOL, V31, P100, DOI 10.1165/rcmb.2003-0104OC; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; WETZEL R, 1977, NUCLEIC ACIDS RES, V4, P1681, DOI 10.1093/nar/4.5.1681; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zeng L, 2001, CYTOGENET CELL GENET, V95, P43, DOI 10.1159/000057015	62	1301	1331	9	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1393	1406		10.1016/j.cell.2012.04.031	http://dx.doi.org/10.1016/j.cell.2012.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22658674	Bronze			2022-12-28	WOS:000305119600021
J	Mueller, K; Ash, C; Pennisi, E; Smith, O				Mueller, Kristen; Ash, Caroline; Pennisi, Elizabeth; Smith, Orla			The Gut Microbiota INTRODUCTION	SCIENCE			English	Editorial Material																		BLUMBERG, SCI TRANSL MED, V4; HOLMES, SCI TRANSL MED, V4; SCI TRANSL MED, V4; SCI TRANSL MED, V4	4	24	29	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1245	1245						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674336				2022-12-28	WOS:000304905300029
J	DeKlotz, C; DeKlotz, T				DeKlotz, Cynthia; DeKlotz, Timothy			Scrofuloderma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[DeKlotz, Cynthia; DeKlotz, Timothy] Georgetown Univ Hosp, Washington Hosp Ctr, Washington, DC 20007 USA	Georgetown University; MedStar Washington Hospital Center	DeKlotz, C (corresponding author), Georgetown Univ Hosp, Washington Hosp Ctr, Washington, DC 20007 USA.	cyndee.carver@gmail.com		DeKlotz, Cynthia/0000-0002-6410-8710					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2215	2215						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953JO	22670906				2022-12-28	WOS:000304863400011
J	Williams, LA; Davis-Dusenbery, BN; Eggan, KC				Williams, Luis A.; Davis-Dusenbery, Brandi N.; Eggan, Kevin C.			SnapShot: Directed Differentiation of Pluripotent Stem Cells	CELL			English	Editorial Material							MOUSE		[Williams, Luis A.; Davis-Dusenbery, Brandi N.; Eggan, Kevin C.] Harvard Univ, HHMI, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Williams, LA (corresponding author), Harvard Univ, HHMI, Cambridge, MA 02138 USA.		Davis-Dusenbery, Brandi/N-2798-2013; Eggan, Kevin/P-7119-2018	Davis-Dusenbery, Brandi/0000-0001-7811-8613; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Shi Y, 2012, NAT NEUROSCI, V15, pS1, DOI DOI 10.1038/NN.3041.; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691	11	45	47	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1174	U236	1174.e1	10.1016/j.cell.2012.05.015	http://dx.doi.org/10.1016/j.cell.2012.05.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632979	Bronze			2022-12-28	WOS:000304453900021
J	Maehara, H; Shibayama, T; Notsu, S; Notsu, Y; Nagao, T; Kusaba, S; Honda, S; Nogami, D; Shibata, K				Maehara, Hiroyuki; Shibayama, Takuya; Notsu, Shota; Notsu, Yuta; Nagao, Takashi; Kusaba, Satoshi; Honda, Satoshi; Nogami, Daisaku; Shibata, Kazunari			Superflares on solar-type stars	NATURE			English	Article							X-RAY FLARE; STELLAR; ROTATION	Solar flares are caused by the sudden release of magnetic energy stored near sunspots. They release 10(29) to 10(32) ergs of energy on a timescale of hours(1). Similar flares have been observed on many stars, with larger 'superflares' seen on a variety of stars(2,3), some of which are rapidly rotating(4,5) and some of which are of ordinary solar type(3,6). The small number of superflares observed on solar-type stars has hitherto precluded a detailed study of them. Here we report observations of 365 superflares, including some from slowly rotating solar-type stars, from about 83,000 stars observed over 120 days. Quasi-periodic brightness modulations observed in the solar-type stars suggest that they have much larger starspots than does the Sun. The maximum energy of the flare is not correlated with the stellar rotation period, but the data suggest that superflares occur more frequently on rapidly rotating stars. It has been proposed that hot Jupiters may be important in the generation of superflares on solar-type stars(7), but none have been discovered around the stars that we have studied, indicating that hot Jupiters associated with superflares are rare.	[Maehara, Hiroyuki; Shibayama, Takuya; Notsu, Shota; Notsu, Yuta; Nagao, Takashi; Kusaba, Satoshi; Honda, Satoshi; Nogami, Daisaku; Shibata, Kazunari] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kyoto 6078471, Japan; [Maehara, Hiroyuki; Shibayama, Takuya; Notsu, Shota; Notsu, Yuta; Nagao, Takashi; Kusaba, Satoshi; Honda, Satoshi; Nogami, Daisaku; Shibata, Kazunari] Kyoto Univ, Hida Observ, Yamashina Ku, Kyoto 6078471, Japan	Kyoto University; Kyoto University	Maehara, H (corresponding author), Kyoto Univ, Kwasan Observ, Yamashina Ku, 17 Ohmine Cho Kita Kazan, Kyoto 6078471, Japan.	maehara@kwasan.kyoto-u.ac.jp	Nogami, Daisaku/Q-8582-2019	Nagao, Takashi/0000-0002-3933-7861; Notsu, Shota/0000-0003-2493-912X; Notsu, Yuta/0000-0002-0412-0849	NASA Science Mission Directorate; Ministry of Education, Culture, Sports, Science and Technology of Japan	NASA Science Mission Directorate(National Aeronautics & Space Administration (NASA)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Kepler was selected as NASA's tenth Discovery mission. Funding for the mission is provided by the NASA Science Mission Directorate. The data presented in this paper were obtained from the Multimission Archive at STScI. This work was supported by the Grant-in-Aid for the Global COE Program 'The Next Generation of Physics, Spun from Universality and Emergence' and the Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are grateful to K. Sekiguchi and A. Hillier for suggestions.	Baker DN, 2005, LECT NOTES PHYS, V656, P3; Barnes SA, 2003, ASTROPHYS J, V586, P464, DOI 10.1086/367639; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Carrington R. C., 1859, MONTHLY NOTICES ROY, V20, P13, DOI [10.1093/mnras/20.1.13, DOI 10.1093/MNRAS/20.1.13]; CROSBY NB, 1993, SOL PHYS, V143, P275, DOI 10.1007/BF00646488; Cuntz M, 2000, ASTROPHYS J, V533, pL151, DOI 10.1086/312609; Debosscher J, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015647; Gershberg R. E., 2005, SOLAR TYPE ACTIVITY, P191; Howard A. W., 2011, PLANET OCCURRENCE 0; Ip WH, 2004, ASTROPHYS J, V602, pL53, DOI 10.1086/382274; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Kopal Z., 1959, CLOSE BINARY SYSTEMS, P147; Kretzschmar M, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015930; LANDINI M, 1986, ASTRON ASTROPHYS, V157, P217; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; PALLAVICINI R, 1981, ASTROPHYS J, V248, P279, DOI 10.1086/159152; PARKER EN, 1979, COSMICAL MAGNETIC FI, P532; Randich S, 2000, ASTR SOC P, V198, P401; RODONO M, 1986, ASTRON ASTROPHYS, V165, P135; Rubenstein EP, 2000, ASTROPHYS J, V529, P1031, DOI 10.1086/308326; SCHAEFER BE, 1989, ASTROPHYS J, V337, P927, DOI 10.1086/167162; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; SHAKHOVSKAYA NI, 1989, SOL PHYS, V121, P375; Shea MA, 2006, ADV SPACE RES-SERIES, V38, P232, DOI 10.1016/j.asr.2005.02.100; Shibata K, 2002, ASTROPHYS J, V577, P422, DOI 10.1086/342141; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; Tsurutani BT, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009504; Unno W., 1989, NONRADIAL OSCILLATIO, P237	29	353	358	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					478	481		10.1038/nature11063	http://dx.doi.org/10.1038/nature11063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622572				2022-12-28	WOS:000304344500037
J	van Honk, J; Montoya, ER; Bos, PA; van Vugt, M; Terburg, D				van Honk, Jack; Montoya, Estrella R.; Bos, Peter A.; van Vugt, Mark; Terburg, David			Newevidence on testosterone and cooperation	NATURE			English	Letter							4TH DIGIT LENGTH; RATIO; 2ND; WOMEN; HYPOTHESIS; BEHAVIOR; HORMONE		[van Honk, Jack; Montoya, Estrella R.; Bos, Peter A.; Terburg, David] Univ Utrecht, Dept Expt Psychol, NL-3584 CS Utrecht, Netherlands; [van Honk, Jack; Bos, Peter A.; Terburg, David] Univ Cape Town, Dept Psychiat, ZA-7925 Cape Town, South Africa; [van Vugt, Mark] Vrije Univ Amsterdam, Dept Social & Org Psychol, NL-1081 BT Amsterdam, Netherlands	Utrecht University; University of Cape Town; Vrije Universiteit Amsterdam	van Honk, J (corresponding author), Univ Utrecht, Dept Expt Psychol, NL-3584 CS Utrecht, Netherlands.	j.vanhonk@uu.nl		Terburg, David/0000-0003-2356-8734; Bos, Peter A/0000-0001-8944-0181				Bos PA, 2012, FRONT NEUROENDOCRIN, V33, P17, DOI 10.1016/j.yfrne.2011.01.002; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Dabbs J. M., 2000, ROGUES LOVERS TESTOS; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Millet K, 2006, BIOL PSYCHOL, V71, P111, DOI 10.1016/j.biopsycho.2005.06.001; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Tuiten A, 2000, ARCH GEN PSYCHIAT, V57, P149, DOI 10.1001/archpsyc.57.2.149; van Honk J, 2004, PSYCHONEUROENDOCRINO, V29, P937, DOI 10.1016/j.psyneuen.2003.08.007; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	15	109	112	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					E4	E5		10.1038/nature11136	http://dx.doi.org/10.1038/nature11136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622587				2022-12-28	WOS:000304344500001
J	Raviglione, M; Marais, B; Floyd, K; Lonnroth, K; Getahun, H; Migliori, GB; Harries, AD; Nunn, P; Lienhardt, C; Graham, S; Chakaya, J; Weyer, K; Cole, S; Kaufmann, SHE; Zumla, A				Raviglione, Mario; Marais, Ben; Floyd, Katherine; Loennroth, Knut; Getahun, Haileyesus; Migliori, Giovanni B.; Harries, Anthony D.; Nunn, Paul; Lienhardt, Christian; Graham, Steve; Chakaya, Jeremiah; Weyer, Karin; Cole, Stewart; Kaufmann, Stefan H. E.; Zumla, Alimuddin			Scaling up interventions to achieve global tuberculosis control: progress and new developments	LANCET			English	Review							DRUG-RESISTANT TUBERCULOSIS; XPERT MTB/RIF TEST; ISONIAZID PREVENTIVE THERAPY; HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; DIAGNOSTIC-ACCURACY	Tuberculosis is still one of the most important causes of death worldwide. The 2010 Lancet tuberculosis series provided a comprehensive overview of global control efforts and challenges. In this update we review recent progress. With improved control efforts, the world and most regions are on track to achieve the Millennium Development Goal of decreasing tuberculosis incidence by 2015, and the Stop TB Partnership target of halving 1990 mortality rates by 2015; the exception is Africa. Despite these advances, full scale-up of tuberculosis and HIV collaborative activities remains challenging and emerging drug-resistant tuberculosis is a major threat. Recognition of the effect that non-communicable diseases-such as smoking-related lung disease, diet-related diabetes mellitus, and alcohol and drug misuse-have on individual vulnerability, as well as the contribution of poor living conditions to community vulnerability, shows the need for multidisciplinary approaches. Several new diagnostic tests are being introduced in endemic countries and for the first time in 40 years a coordinated portfolio of promising new tuberculosis drugs exists. However, none of these advances off er easy solutions. Achievement of international tuberculosis control targets and maintenance of these gains needs optimum national health policies and services, with ongoing investment into new approaches and strategies. Despite growing funding in recent years, a serious shortfall persists. International and national financial uncertainty places gains at serious risk. Perseverance and renewed commitment are needed to achieve global control of tuberculosis, and ultimately, its elimination.	[Raviglione, Mario; Floyd, Katherine; Loennroth, Knut; Getahun, Haileyesus; Nunn, Paul; Lienhardt, Christian; Weyer, Karin] WHO, STOP TB Dept, CH-1211 Geneva, Switzerland; [Marais, Ben] Univ Sydney, Sydney Inst Emerging Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Marais, Ben] Univ Sydney, Sydney Med Sch, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Migliori, Giovanni B.] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, Tradate, Italy; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Graham, Steve] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Graham, Steve] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya; [Cole, Stewart] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Berlin, Germany; [Zumla, Alimuddin] UCL, Div Infect & Immun, Dept Infect, London WC1E 6AJ, England; [Zumla, Alimuddin] Univ Zambia, Univ Coll London Med Sch, Res & Training Project, Univ Teaching Hosp, Lusaka, Zambia	World Health Organization; University of Sydney; University of Sydney; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Kenya Medical Research Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; University of London; University College London; University of Zambia	Zumla, A (corresponding author), UCL, Div Infect & Immun, Dept Infect, London WC1E 6AJ, England.	a.zumla@ucl.ac.uk	Rivet, Catherine A/M-7978-2014; Migliori, Giovanni Battista/AAB-8589-2020; Marais, Ben/AAX-2626-2021; Lienhardt, Christian/AAU-4969-2021; Lönnroth, Knut/L-2339-2014; Trajman, Anete/C-7679-2016; Graham, Steve/AAR-2339-2020; ZUMLA, Alimuddin/ABA-8208-2020; Getahun, Haileyesus/ABC-5181-2020; Lonnroth, Knut/H-5470-2017; Kaufmann, Stefan HE/I-5454-2014	Migliori, Giovanni Battista/0000-0002-2597-574X; Lienhardt, Christian/0000-0003-0233-893X; Lönnroth, Knut/0000-0001-5054-8240; Trajman, Anete/0000-0002-4000-4984; ZUMLA, Alimuddin/0000-0002-5111-5735; Lonnroth, Knut/0000-0001-6944-0256; RAVIGLIONE, Mario/0000-0002-9331-2067; Kaufmann, Stefan HE/0000-0001-9866-8268	UBS Optimus Foundation (Zurich, Switzerland); UK NIHR UCLH-CBRC; UCL Hospitals NHS Foundation Trust; EuropeAID-ADAT; UK MRC; EDCTP-TB-NEAT; EDCTP-PANACEA; EDCTP (TB-TEA); Bill & Melinda Gates Foundation [74]; EU; German Ministry for Science and Education; European Commission [FP7-223681]	UBS Optimus Foundation (Zurich, Switzerland); UK NIHR UCLH-CBRC; UCL Hospitals NHS Foundation Trust; EuropeAID-ADAT; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EDCTP-TB-NEAT; EDCTP-PANACEA; EDCTP (TB-TEA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EU(European Commission); German Ministry for Science and Education; European Commission(European CommissionEuropean Commission Joint Research Centre)	AZ receives grant support from the UBS Optimus Foundation (Zurich, Switzerland), UK NIHR UCLH-CBRC, the UCL Hospitals NHS Foundation Trust, EuropeAID-ADAT, UK MRC, EDCTP-TB-NEAT, and EDCTP-PANACEA. SHEK acknowledges grant support from the EDCTP (TB-TEA), the Bill & Melinda Gates Foundation Grand Challenges in Global Health (GC6-#74), EU-FP7 (NEWTBVAC), and the German Ministry for Science and Education. GBM receives support from the European Commission through the FP7 TB PAN-NET project, grant FP7-223681. Peter Andersen, Ingrid Kromann, Jerry Sadoff, Helen McShane, Tom Evans, Bernd Eisele, and Opokua Ofori-Anyinam provided information on vaccine candidates.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2011, GLOB TUB CONTR; [Anonymous], GUID INT TUB CAS FIN; Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Axelsson-Robertson R, 2012, J INFECT DIS, V205, pS301, DOI 10.1093/infdis/jis198; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cole ST, 2011, CURR OPIN MICROBIOL, V14, P570, DOI 10.1016/j.mib.2011.07.022; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; ECDC, 2011, US INT GAMM REL ASS; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gomes VF, 2011, THORAX, V66, P163, DOI 10.1136/thx.2010.141309; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Gupta A, 2011, J INFECT DIS, V203, P358, DOI [10.1093/infdis/jiq064, 10.1093/jinfdis/jiq064]; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Harries AD, 2011, INT J TUBERC LUNG D, V15, P144; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; John SH, 2012, BIOMARKERS, V17, P1, DOI 10.3109/1354750X.2011.628048; Kabali C, 2011, INT J TUBERC LUNG D, V15, P1515, DOI 10.5588/ijtld.10.0788; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kim JH, 2011, NUCLEIC ACIDS RES, V39, P2210, DOI 10.1093/nar/gkq1149; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Loeliger A, 2012, INT J TUBERC LUNG D, V16, P6, DOI 10.5588/ijtld.10.0626; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; McNeeley DF, 2011, PROG RESPIR RES, V40, P235; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Menzies HJ, 2010, AM J PUBLIC HEALTH, V100, P1724, DOI 10.2105/AJPH.2009.181289; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Migliori GB, 2012, EUR RESPIR J, V39, P807, DOI 10.1183/09031936.00203811; Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461; Phillips PPJ, 2012, J INFECT DIS, V205, pS250, DOI 10.1093/infdis/jis041; Phillips PPJ, 2010, FUTURE MED CHEM, V2, P1273, DOI 10.4155/FMC.10.221; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Raviglione M, 2012, LANCET, V379, P1077, DOI 10.1016/S0140-6736(12)60373-0; Rio de Janeiro, 2011, WORLD C SOC DET HLTH; Sala C, 2010, ANTIMICROB AGENTS CH, V54, P4150, DOI 10.1128/AAC.00821-10; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sandgren A, 2011, EUROSURVEILLANCE, V16, P8; Seddon JA, 2012, TUBERCULOSIS, V92, P9, DOI 10.1016/j.tube.2011.11.001; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Skrahina A, 2012, EUR RESPIR J, V39, P1425, DOI 10.1183/09031936.00145411; Sotgiu G, 2011, EUR RESPIR J, V38, P1221, DOI 10.1183/09031936.00029311; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Stop TB Partnership, 2011, INT ROADM TUB RES; Stop TB Partnership, 2011, STOP TB PARTN GLOB F; Stop TB Partnership World Health Organization, 2011, STOP TB PARTN WHO GL; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; TAG, 2011, TUB RES DEV 2011 REP; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Uplekar S, 2011, INFECT IMMUN, V79, P4042, DOI 10.1128/IAI.05344-11; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2010, ANT THER HIV INF AD; WHO, EV BAS TUB DIAGN WHO; WHO, 2005, PRACT APPR LUNG HLTH; WHO, 2010, WHO POL COLL TB HIV; WHO, 2009, TREATM TUB GUID; WHO, 2008, WHO UN MON TB TOB CO; WHO, 2009, WHO POL INF CONTR HL; Working Group on New TB Drugs, STOP TB PARTN; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2010, RAP ADV TREATM TUB C; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P1426, DOI 10.5588/ijtld.11.0316; Zumla A, 2012, EUR RESPIR J, V39, P802, DOI 10.1183/09031936.00171611; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858; Zumla A, 2012, INT J TUBERC LUNG D, V16, P285, DOI 10.5588/ijtld.12.0066	102	257	269	5	95	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1902	1913		10.1016/S0140-6736(12)60727-2	http://dx.doi.org/10.1016/S0140-6736(12)60727-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22608339				2022-12-28	WOS:000304194200032
J	Boutet, S; Lomb, L; Williams, GJ; Barends, TRM; Aquila, A; Doak, RB; Weierstall, U; DePonte, DP; Steinbrener, J; Shoeman, RL; Messerschmidt, M; Barty, A; White, TA; Kassemeyer, S; Kirian, RA; Seibert, MM; Montanez, PA; Kenney, C; Herbst, R; Hart, P; Pines, J; Haller, G; Gruner, SM; Philipp, HT; Tate, MW; Hromalik, M; Koerner, LJ; van Bakel, N; Morse, J; Ghonsalves, W; Arnlund, D; Bogan, MJ; Caleman, C; Fromme, R; Hampton, CY; Hunter, MS; Johansson, LC; Katona, G; Kupitz, C; Liang, MN; Martin, AV; Nass, K; Redecke, L; Stellato, F; Timneanu, N; Wang, DJ; Zatsepin, NA; Schafer, D; Defever, J; Neutze, R; Fromme, P; Spence, JCH; Chapman, HN; Schlichting, I				Boutet, Sebastien; Lomb, Lukas; Williams, Garth J.; Barends, Thomas R. M.; Aquila, Andrew; Doak, R. Bruce; Weierstall, Uwe; DePonte, Daniel P.; Steinbrener, Jan; Shoeman, Robert L.; Messerschmidt, Marc; Barty, Anton; White, Thomas A.; Kassemeyer, Stephan; Kirian, Richard A.; Seibert, M. Marvin; Montanez, Paul A.; Kenney, Chris; Herbst, Ryan; Hart, Philip; Pines, Jack; Haller, Gunther; Gruner, Sol M.; Philipp, Hugh T.; Tate, Mark W.; Hromalik, Marianne; Koerner, Lucas J.; van Bakel, Niels; Morse, John; Ghonsalves, Wilfred; Arnlund, David; Bogan, Michael J.; Caleman, Carl; Fromme, Raimund; Hampton, Christina Y.; Hunter, Mark S.; Johansson, Linda C.; Katona, Gergely; Kupitz, Christopher; Liang, Mengning; Martin, Andrew V.; Nass, Karol; Redecke, Lars; Stellato, Francesco; Timneanu, Nicusor; Wang, Dingjie; Zatsepin, Nadia A.; Schafer, Donald; Defever, James; Neutze, Richard; Fromme, Petra; Spence, John C. H.; Chapman, Henry N.; Schlichting, Ilme			High-Resolution Protein Structure Determination by Serial Femtosecond Crystallography	SCIENCE			English	Article							DIFFRACTION DATA; LYSOZYME	Structure determination of proteins and other macromolecules has historically required the growth of high-quality crystals sufficiently large to diffract x-rays efficiently while withstanding radiation damage. We applied serial femtosecond crystallography (SFX) using an x-ray free-electron laser (XFEL) to obtain high-resolution structural information from microcrystals (less than 1 micrometer by 1 micrometer by 3 micrometers) of the well-characterized model protein lysozyme. The agreement with synchrotron data demonstrates the immediate relevance of SFX for analyzing the structure of the large group of difficult-to-crystallize molecules.	[Boutet, Sebastien; Bogan, Michael J.; Hampton, Christina Y.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Lomb, Lukas; Barends, Thomas R. M.; Steinbrener, Jan; Shoeman, Robert L.; Kassemeyer, Stephan; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Lomb, Lukas; Barends, Thomas R. M.; Steinbrener, Jan; Shoeman, Robert L.; Kassemeyer, Stephan; Schlichting, Ilme] Ctr Free Electron Laser Sci, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Aquila, Andrew; DePonte, Daniel P.; Barty, Anton; White, Thomas A.; Caleman, Carl; Liang, Mengning; Martin, Andrew V.; Stellato, Francesco; Chapman, Henry N.] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Doak, R. Bruce; Weierstall, Uwe; Kirian, Richard A.; Wang, Dingjie; Zatsepin, Nadia A.; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Gruner, Sol M.; Philipp, Hugh T.; Tate, Mark W.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Cornell High Energy Synchrotron Source, Wilson Lab, Ithaca, NY 14853 USA; [Hromalik, Marianne] SUNY Coll Oswego, Oswego, NY 13126 USA; [Koerner, Lucas J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [van Bakel, Niels] Natl Inst Subatom Phys, Nikhef, NL-1098 XG Amsterdam, Netherlands; [Morse, John] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Arnlund, David; Johansson, Linda C.; Katona, Gergely; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Fromme, Raimund; Hunter, Mark S.; Kupitz, Christopher; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-22761 Hamburg, Germany; [Redecke, Lars] Univ Lubeck, Inst Biochem, DESY, Hamburg, Germany; [Redecke, Lars] Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany; [Timneanu, Nicusor] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Arizona State University; Arizona State University-Tempe; Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; FOM National Institute for Subatomic Physics; European Synchrotron Radiation Facility (ESRF); University of Gothenburg; Arizona State University; Arizona State University-Tempe; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck; German Center for Infection Research; University of Lubeck; Uppsala University	Boutet, S (corresponding author), SLAC Natl Accelerator Lab, PULSE Inst, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	sboutet@slac.stanford.edu	Johansson, Linda/O-6893-2019; Nass, Karol/K-1970-2012; Fromme, Raimund/C-8885-2012; Fromme, Raimund/AAG-6578-2019; van Bakel, Niels/B-6233-2015; Fromme, Raimund/W-5838-2019; Messerschmidt, Marc/F-3796-2010; Zatsepin, Nadia/AAF-2451-2019; Redecke, Lars/A-5611-2013; Gruner, Sol/G-2924-2010; Stellato, Francesco/AAZ-4379-2020; Messerschmidt, Marc/Y-8929-2019; Arnlund, David/B-1246-2011; FRS, Henry N Chapman/G-2153-2010; Schlichting, Ilme/I-1339-2013; Williams, Garth/H-1606-2012; Neutze, Richard/A-7573-2010; Kirian, Richard/M-3750-2013; Bogan, Mike/I-6962-2012; Katona, Gergely/B-3491-2008; Timneanu, Nicusor/C-7691-2012; Barty, Anton/K-5137-2014; Johansson, Linda/B-1240-2011	Johansson, Linda/0000-0003-4776-5142; Nass, Karol/0000-0001-8843-1566; Fromme, Raimund/0000-0003-4835-1080; van Bakel, Niels/0000-0002-4053-7588; Fromme, Raimund/0000-0003-4835-1080; Messerschmidt, Marc/0000-0002-8641-3302; Gruner, Sol/0000-0002-1171-4426; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Neutze, Richard/0000-0003-0986-6153; Bogan, Mike/0000-0001-9318-3333; Katona, Gergely/0000-0002-2031-8716; Timneanu, Nicusor/0000-0001-7328-0400; Barty, Anton/0000-0003-4751-2727; Johansson, Linda/0000-0003-4776-5142; Aquila, Andrew/0000-0003-0358-2774; MARTIN, ANDREW/0000-0003-3704-1829; Zatsepin, Nadia/0000-0003-1757-0205; Seibert, Mark Marvin/0000-0003-0251-0744; Johansson, Linda/0000-0002-8931-0683; White, Thomas/0000-0002-8407-0270; Kirian, Richard/0000-0001-7197-3086; Koerner, Lucas/0000-0002-7236-7202	LCLS Ultrafast Science Instruments (LUSI) project; DOE, OBES; Max Planck Society; Hamburg Ministry of Science and Research; Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection; U.S. NSF [0417142, MCB-1021557]; NIH [1R01GM095583]; German Federal Ministry for Education and Research [01KX0806, 01KX0807]; Deutsche Forschungsgemeinschaft Cluster of Excellence [EXC 306]; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education; Direct For Biological Sciences [1021557, 1120997] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	LCLS Ultrafast Science Instruments (LUSI) project; DOE, OBES(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Hamburg Ministry of Science and Research; Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection; U.S. NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft Cluster of Excellence(German Research Foundation (DFG)); AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE(United States Department of Energy (DOE)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the LCLS, a National User Facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences (OBES) and at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. The CXI instrument was funded by the LCLS Ultrafast Science Instruments (LUSI) project funded by DOE, OBES. We acknowledge support from the Max Planck Society, the Hamburg Ministry of Science and Research, and the Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics in Infection; the U.S. NSF (awards 0417142 and MCB-1021557); the NIH (award 1R01GM095583); the German Federal Ministry for Education and Research (grants 01KX0806 and 01KX0807); the Deutsche Forschungsgemeinschaft Cluster of Excellence EXC 306; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE; the Swedish Research Council; the Swedish Foundation for International Cooperation in Research and Higher Education. We thank A. Meinhart and E. Hofmann for collecting the synchrotron data set, M. Gebhart for help preparing the crystals, and M. Hayes and the technical staff of SLAC and the LCLS for their great support in carrying out these experiments. Special thanks to G. M. Stewart, T. Anderson, and SLAC Infomedia for generating Fig. 1. The structure factors and coordinates have been deposited with the Protein Data Bank (accession codes 4ET8, 4ET9, 4ETA, 4ETB, 4ETC, 4ETD, and 4ETE). The diffraction patterns have been deposited with the Coherent X-ray Imaging Data Bank cxidb.org (accession code ID-17). The Arizona Board of Regents, acting for and on behalf of Arizona State University and in conjunction with R. B. D., U. W., D. P. D., and J.C.H.S., has filed U.S. and international patent applications on the nozzle technology applied herein.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Holton JM, 2010, ACTA CRYSTALLOGR D, V66, P393, DOI 10.1107/S0907444910007262; Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/NMETH.1867, 10.1038/nmeth.1867]; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Lomb L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214111; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Wang JW, 2007, ACTA CRYSTALLOGR D, V63, P1254, DOI 10.1107/S0907444907054224; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	21	613	623	14	441	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					362	364		10.1126/science.1217737	http://dx.doi.org/10.1126/science.1217737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22653729	Green Accepted, Green Published			2022-12-28	WOS:000306542600057
J	Baicker, K; Chandra, A				Baicker, Katherine; Chandra, Amitabh			The Health Care Jobs Fallacy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Chandra, Amitabh] Harvard Kennedy Sch Govt, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Baicker K, 2012, ANNU REV ECON, V4, P33, DOI 10.1146/annurev-economics-080511-110942; Bureau of Labor Statistics, NAT EMPL DAT DAT TAB; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Garber AA, 2008, J ECON PERSPECT, V22, P27, DOI 10.1257/jep.22.4.27	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2433	2435		10.1056/NEJMp1204891	http://dx.doi.org/10.1056/NEJMp1204891			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965DP	22670868				2022-12-28	WOS:000305747000001
J	Prowell, TM; Pazdur, R				Prowell, Tatiana M.; Pazdur, Richard			Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOTHERAPY; TRASTUZUMAB		[Prowell, Tatiana M.; Pazdur, Richard] US FDA, Off Hematol Oncol Prod, Silver Spring, MD USA; [Prowell, Tatiana M.] Johns Hopkins Univ, Breast Canc Program, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Medicine	Prowell, TM (corresponding author), US FDA, Off Hematol Oncol Prod, Silver Spring, MD USA.							Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Prowell T, DRAFT GUIDANCE FOR I; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	6	253	267	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2438	2441		10.1056/NEJMp1205737	http://dx.doi.org/10.1056/NEJMp1205737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965DP	22646508				2022-12-28	WOS:000305747000003
J	Davies, HE; Mishra, EK; Kahan, BC; Wrightson, JM; Stanton, AE; Guhan, A; Davies, CWH; Grayez, J; Harrison, R; Prasad, A; Crosthwaite, N; Lee, YCG; Davies, RJO; Miller, RF; Rahman, NM				Davies, Helen E.; Mishra, Eleanor K.; Kahan, Brennan C.; Wrightson, John M.; Stanton, Andrew E.; Guhan, Anur; Davies, Christopher W. H.; Grayez, Jamal; Harrison, Richard; Prasad, Anjani; Crosthwaite, Nicola; Lee, Y. C. Gary; Davies, Robert J. O.; Miller, Robert F.; Rahman, Najib M.			Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion The TIME2 Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTPATIENT MANAGEMENT; DISEASE	Context Malignant pleural effusion causes disabling dyspnea in patients with a short life expectancy. Palliation is achieved by fluid drainage, but the most effective firstline method has not been determined. Objective To determine whether indwelling pleural catheters (IPCs) are more effective than chest tube and talc slurry pleurodesis (talc) at relieving dyspnea. Design Unblinded randomized controlled trial (Second Therapeutic Intervention in Malignant Effusion Trial [TIME2]) comparing IPC and talc (1:1) for which 106 patients with malignant pleural effusion who had not previously undergone pleurodesis were recruited from 143 patients who were treated at 7 UK hospitals. Patients were screened from April 2007-February 2011 and were followed up for a year. Intervention Indwelling pleural catheters were inserted on an outpatient basis, followed by initial large volume drainage, education, and subsequent home drainage. The talc group were admitted for chest tube insertion and talc for slurry pleurodesis. Main Outcome Measure Patients completed daily 100-mm line visual analog scale (VAS) of dyspnea over 42 days after undergoing the intervention (0 mm represents no dyspnea and 100 mm represents maximum dyspnea; 10 mm represents minimum clinically significant difference). Mean difference was analyzed using a mixed-effects linear regression model adjusted for minimization variables. Results Dyspnea improved in both groups, with no significant difference in the first 42 days with a mean VAS dyspnea score of 24.7 in the IPC group (95% CI, 19.3-30.1 mm) and 24.4 mm (95% CI, 19.4-29.4 mm) in the talc group, with a difference of 0.16 mm (95% CI, -6.82 to 7.15; P=.96). There was a statistically significant improvement in dyspnea in the IPC group at 6 months, with a mean difference in VAS score between the IPC group and the talc group of -14.0 mm (95% CI, -25.2 to -2.8 mm; P=.01). Length of initial hospitalization was significantly shorter in the IPC group with a median of 0 days (interquartile range [IQR], 0-1 day) and 4 days (IQR, 2-6 days) for the talc group, with a difference of -3.5 days (95% CI, -4.8 to -1.5 days; P<.001). There was no significant difference in quality of life. Twelve patients (22%) in the talc group required further pleural procedures compared with 3 (6%) in the IPC group (odds ratio [OR], 0.21; 95% CI, 0.04-0.86; P=.03). Twenty-one of the 52 patients in the catheter group experienced adverse events vs 7 of 54 in the talc group (OR, 4.70; 95% CI, 1.75-12.60; P=.002). Conclusion Among patients with malignant pleural effusion and no previous pleurodesis, there was no significant difference between IPCs and talc pleurodesis at relieving patient-reported dyspnea.	[Mishra, Eleanor K.; Wrightson, John M.; Crosthwaite, Nicola; Davies, Robert J. O.; Rahman, Najib M.] Univ Oxford, Churchill Hosp, Oxford Resp Trials Unit, Oxford OX3 7LJ, England; [Davies, Helen E.] Univ Wales Hosp, Dept Resp Med, Cardiff CF4 4XW, S Glam, Wales; [Mishra, Eleanor K.; Wrightson, John M.; Crosthwaite, Nicola; Davies, Robert J. O.; Rahman, Najib M.] Oxford Ctr Resp Med, Oxford, England; [Kahan, Brennan C.] MRC, Clin Trials Unit, London, England; [Wrightson, John M.; Davies, Robert J. O.; Rahman, Najib M.] Univ Oxford, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX1 2JD, England; [Stanton, Andrew E.] Great Western Hosp, Swindon, Wilts, England; [Guhan, Anur] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Guhan, Anur] Univ Hosp Ayr, Ayr, Scotland; [Davies, Christopher W. H.] Royal Berkshire Hosp, Reading, Wales; Horton Hosp, Banbury, Oxon, England; [Prasad, Anjani] Buckinghamshire Healthcare Natl Hlth Serv Trust, Amersham, Bucks, England; [Lee, Y. C. Gary] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Miller, Robert F.] UCL, Res Dept Infect & Populat Hlth, London WC1E 6BT, England	University of Oxford; Cardiff University; Medical Research Council Clinical Trials Unit; University of Oxford; James Cook University Hospital; University of Western Australia; University of Western Australia; University of London; University College London	Rahman, NM (corresponding author), Univ Oxford, Churchill Hosp, Oxford Resp Trials Unit, S Parks Rd, Oxford OX3 7LJ, England.	najib.rahman@ndm.ox.ac.uk	Stanton, Andrew/AAX-1664-2021; Lee, Y C Gary/H-5264-2014	Wrightson, John Matthew/0000-0002-3036-9672; Miller, Robert/0000-0003-2067-4291; Rahman, Najib M/0000-0003-1195-1680; Davies, Helen/0000-0001-6102-256X; Mishra, Eleanor/0000-0002-5903-3005; Lee, Yun Chor Gary/0000-0002-0036-511X	British Lung Foundation; Robert Luff Foundation, London, England; University of Oxford; Boehringer Ingelheim	British Lung Foundation; Robert Luff Foundation, London, England; University of Oxford; Boehringer Ingelheim(Boehringer Ingelheim)	All authors completed and submitted the ICMJE Form for Disclosure and Potential Conflicts of Interest. Dr Wrightson reported that he has received honoraria, grant support to attend a conference from Boehringer Ingelheim. Dr Guhan reported receiving support from Medico for expert testimony; having served on the speakers' bureau for AstraZeneca, GlaxoSmithKline, and Chiesi; and receiving support for conference attendance from Chiesi and GlaxoSmithKline. Dr C. Davies reported serving on the speakers' bureau for AstraZeneca. Dr Lee reported receiving honoraria from CareFusion and Sequana Medical as an advisory board member. Dr Miller reported receiving support for lectures on HIV infection from Merck and Gilead. Dr Rahman reported that he acts as a consultant to Rocket Medical for device development. No other conflicts of interest were reported.; This study was supported with an unrestricted education grant from the British Lung Foundation and the Robert Luff Foundation, London, England The study was sponsored by the University of Oxford. The IPCs and drainage bottles were provided by Rocket Medical, Washington, England.	Antevil JL, 2007, ANN SURG ONCOL, V14, P2698, DOI 10.1245/s10434-007-9371-2; Bausewein C, 2007, RESP MED, V101, P399, DOI 10.1016/j.rmed.2006.07.003; Burrows CM, 2000, CHEST, V117, P73, DOI 10.1378/chest.117.1.73; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; Ferlay JSH, 2008, INT AGENCY RES CANC; Fysh ETH, 2012, CHEST, V142, P394, DOI 10.1378/chest.11-2657; Janes SM, 2007, CHEST, V131, P1232, DOI 10.1378/chest.06-2353; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Maringwa J, 2011, ANN ONCOL, V22, P2107, DOI 10.1093/annonc/mdq726; Musani AI, 2004, RESPIRATION, V71, P559, DOI 10.1159/000081755; Office for National Statistics, 2011, CANC STAT REG REG CA; Olden AM, 2010, J PALLIAT MED, V13, P59, DOI 10.1089/jpm.2009.0220; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Putnam JB, 2000, ANN THORAC SURG, V69, P369, DOI 10.1016/S0003-4975(99)01482-4; Putnam JB, 1999, CANCER, V86, P1992, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M; Ries Andrew L, 2005, COPD, V2, P105; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; RODRIGUEZPANADERO F, 1989, EUR RESPIR J, V2, P366; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Tan C, 2006, EUR J CARDIO-THORAC, V29, P829, DOI 10.1016/j.ejcts.2005.12.025; Tremblay A, 2007, EUR RESPIR J, V30, P759, DOI 10.1183/09031936.00164706; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Van Meter MEM, 2011, J GEN INTERN MED, V26, P70, DOI 10.1007/s11606-010-1472-0; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981	24	389	397	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2383	2389		10.1001/jama.2012.5535	http://dx.doi.org/10.1001/jama.2012.5535			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22610520				2022-12-28	WOS:000305115900023
J	Holmes, D				Holmes, David			Profile Zulfiqar Bhutta: patriotics and paediatrics	LANCET			English	Biographical-Item																		BHUTTA Z, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2141	2141		10.1016/S0140-6736(12)60932-5	http://dx.doi.org/10.1016/S0140-6736(12)60932-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955BA	22682453	Bronze			2022-12-28	WOS:000304990900017
J	Gowrishankar, K; Ghosh, S; Saha, S; Rumamol, C; Mayor, S; Rao, M				Gowrishankar, Kripa; Ghosh, Subhasri; Saha, Suvrajit; Rumamol, C.; Mayor, Satyajit; Rao, Madan			Active Remodeling of Cortical Actin Regulates Spatiotemporal Organization of Cell Surface Molecules	CELL			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; NANOCLUSTERS; RECEPTOR; BINDING; POLYMERIZATION; FILAMENTS; DYNAMICS; TRACKING	Many lipid-tethered proteins and glycolipids exist as monomers and nanoclusters on the surface of living cells. The spatial distribution and dynamics of formation and breakup of nanoclusters does not reflect thermal and chemical equilibrium and is controlled by active remodeling of the underlying cortical actin. We propose a model for nanoclustering based on active hydrodynamics, wherein cell surface molecules bound to dynamic actin are actively driven to form transient clusters. This consistently explains all of our experimental observations. Using FCS and TIRF microscopy, we provide evidence for the existence of short, dynamic, polymerizing actin filaments at the cortex, a key assumption of the theoretical framework. Our theory predicts that lipid-anchored proteins that interact with dynamic actin must exhibit anomalous concentration fluctuations, and a cell membrane protein capable of binding directly to actin can form nanoclusters. These we confirm experimentally, providing an active mechanism for molecular organization and its spatiotemporal regulation on the plasma membrane.	[Saha, Suvrajit; Rumamol, C.; Mayor, Satyajit; Rao, Madan] Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Gowrishankar, Kripa; Ghosh, Subhasri; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI)	Mayor, S (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in; madan@ncbs.res.in	Saha, Suvrajit/D-4638-2014; Rao, Madan/E-2927-2012	Saha, Suvrajit/0000-0001-6631-0464; Ghosh, Subhasri/0000-0002-3907-6366	CEFIPRA [3504-2]; HFSP; DST	CEFIPRA; HFSP(Human Frontier Science Program); DST(Department of Science & Technology (India))	We thank S. Ramaswamy and J. Toner for critical reading of the manuscript and Drs. Thomas Lecuit, Helen Morrison, and Antonio Sechi for their generous gifts of the actin-binding constructs. We thank P. Srivastava and K. Hussain for help in quantifying the FCS data, Balaji Ramalingam for help with SMPT, and the Central Imaging Facility at NCBS. M. R. acknowledges grants from CEFIPRA (3504-2) and HFSP, and S. M. acknowledges support from a JC Bose fellowship from the DST.	Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; CAO LG, 1993, J CELL BIOL, V123, P173, DOI 10.1083/jcb.123.1.173; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; De Gennes P.-G., 1993, PHYS LIQUID CRYSTALS; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K., 2009, THESIS J NEHRU U BAN; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Howard J, 2001, MECH MOTOR PROTEINS; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Press W.H., 2007, NUMERICAL RECIPES, V3; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPUDICH A, 1988, CELL MOTIL CYTOSKEL, V9, P85, DOI 10.1002/cm.970090109; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; Wan C, 2008, BIOCHEMISTRY-US, V47, P2190, DOI 10.1021/bi7021552; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108	43	276	278	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1353	1367		10.1016/j.cell.2012.05.008	http://dx.doi.org/10.1016/j.cell.2012.05.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682254	Bronze			2022-12-28	WOS:000305119600018
J	Li, TY; Kon, N; Jiang, L; Tan, MJ; Ludwig, T; Zhao, YM; Baer, R; Gu, W				Li, Tongyuan; Kon, Ning; Jiang, Le; Tan, Minjia; Ludwig, Thomas; Zhao, Yingming; Baer, Richard; Gu, Wei			Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence	CELL			English	Article							P53 TARGET GENE; P53-INDUCIBLE REGULATOR; GLUCOSE-METABOLISM; DNA-BINDING; ACETYLATION; PUMA; TUMORIGENESIS; MICE; ACTIVATION; COMPLEXES	Cell-cycle arrest, apoptosis, and senescence are widely accepted as the major mechanisms by which p53 inhibits tumor formation. Nevertheless, it remains unclear whether they are the rate-limiting steps in tumor suppression. Here, we have generated mice bearing lysine to arginine mutations at one (p53(K117R)) or three (p53(3KR); K117R+K161R+K162R) of p53 acetylation sites. Although p53(K117R/K117R) cells are competent for p53-mediated cell-cycle arrest and senescence, but not apoptosis, all three of these processes are ablated in p53(3KR/3KR) cells. Surprisingly, unlike p53 null mice, which rapidly succumb to spontaneous thymic lymphomas, early-onset tumor formation does not occur in either p53(K117R/K117R) or p53(3KR/3KR) animals. Notably, p53(3KR) retains the ability to regulate energy metabolism and reactive oxygen species production. These findings underscore the crucial role of acetylation in differentially modulating p53 responses and suggest that unconventional activities of p53, such as metabolic regulation and antioxidant function, are critical for suppression of early-onset spontaneous tumorigenesis.	[Li, Tongyuan; Kon, Ning; Jiang, Le; Ludwig, Thomas; Baer, Richard; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Li, Tongyuan; Kon, Ning; Jiang, Le; Ludwig, Thomas; Baer, Richard; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tan, Minjia; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Columbia University; Columbia University; University of Chicago	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu	Tan, Minjia/C-4491-2014; Ludwig, Thomas/Q-6484-2016	Tan, Minjia/0000-0002-6784-9653; Ludwig, Thomas/0000-0003-3461-2585	NIH/NCI [RO1-CA085533, RO1-CA098821]; Leukemia and Lymphoma Society; NCI [PO1-CA97403]; NATIONAL CANCER INSTITUTE [R01CA098821, P01CA080058, P01CA097403, R01CA085533] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Victor Lin from HICCC Mouse Facility for excellent services in developing p53 knockin mice and Dr. M. Szabolcs for mouse pathology analysis. We thank Dr. Z.H. Feng from UMDNJ for providing the reagents. This publication was made possible by grants from NIH/NCI (RO1-CA085533 and RO1-CA098821) and the Leukemia and Lymphoma Society to W.G. This study was also supported by Grant PO1-CA97403 from NCI to R.B., W.G., and T. Ludwig.	ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berger SL, 2010, CELL, V142, P17, DOI 10.1016/j.cell.2010.06.026; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gottlieb E., 2010, PERSPECT BIOL, V2; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Van Nguyen T, 2007, J EXP MED, V204, P1453, DOI 10.1084/jem.20062453; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	627	648	6	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1269	1283		10.1016/j.cell.2012.04.026	http://dx.doi.org/10.1016/j.cell.2012.04.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682249	Bronze, Green Accepted			2022-12-28	WOS:000305119600012
J	Nancy, P; Tagliani, E; Tay, CS; Asp, P; Levy, DE; Erlebacher, A				Nancy, Patrice; Tagliani, Elisa; Tay, Chin-Siean; Asp, Patrik; Levy, David E.; Erlebacher, Adrian			Chemokine Gene Silencing in Decidual Stromal Cells Limits T Cell Access to the Maternal-Fetal Interface	SCIENCE			English	Article							PREGNANT UTERUS; KAPPA-B; ACTIVATION; SITE; EXPRESSION; LIGAND; GAMMA; CD4; IFN	The chemokine-mediated recruitment of effector T cells to sites of inflammation is a central feature of the immune response. The extent to which chemokine expression levels are limited by the intrinsic developmental characteristics of a tissue has remained unexplored. We show in mice that effector T cells cannot accumulate within the decidua, the specialized stromal tissue encapsulating the fetus and placenta. Impaired accumulation was in part attributable to the epigenetic silencing of key T cell-attracting inflammatory chemokine genes in decidual stromal cells, as evidenced by promoter accrual of repressive histone marks. These findings give insight into mechanisms of fetomaternal immune tolerance, as well as reveal the epigenetic modification of tissue stromal cells as a modality for limiting effector T cell trafficking.	[Nancy, Patrice; Tagliani, Elisa; Tay, Chin-Siean; Levy, David E.; Erlebacher, Adrian] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Asp, Patrik; Levy, David E.; Erlebacher, Adrian] NYU, Sch Med, Inst Canc, New York, NY 10016 USA	New York University; New York University	Erlebacher, A (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	adrian.erlebacher@nyumc.org	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019; Tagliani, Elisa/AAN-1955-2020	Levy, David/0000-0002-7320-7788; 	NIH, National Cancer Institute [P30CA016087]; NIH [RO1AI062980]; American Cancer Society [RSG-10-158-01-LIB]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062980] Funding Source: NIH RePORTER	NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. K. Dey and K. Johnson for advice, and A. Frey and J. Ernst for comments on the manuscript. The Histopathology and Vaccine and Cell Therapy core facilities of the New York University Cancer Institute provided histology services and tetramer reagents and were supported by NIH, National Cancer Institute (P30CA016087). P.N., E.T., and C.-S. T. performed experiments; P.A. and D.E.L. provided critical expertise and reagents; P.N. and A.E. analyzed data; and P.N. and A.E. designed experiments and wrote the manuscript. The data reported in the manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by grants from NIH (RO1AI062980) and the American Cancer Society to A.E. (RSG-10-158-01-LIB).	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Erlebacher A, 2004, J CLIN INVEST, V114, P39, DOI 10.1172/JC1200420645; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marlin R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-58; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317	18	271	277	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1317	1321		10.1126/science.1220030	http://dx.doi.org/10.1126/science.1220030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679098	Green Accepted			2022-12-28	WOS:000304905300050
J	Hoppa, MB; Lana, B; Margas, W; Dolphin, AC; Ryan, TA				Hoppa, Michael B.; Lana, Beatrice; Margas, Wojciech; Dolphin, Annette C.; Ryan, Timothy A.			alpha 2 delta expression sets presynaptic calcium channel abundance and release probability	NATURE			English	Article							GATED CA2+ CHANNELS; FACTOR-A DOMAIN; SYNAPTIC-TRANSMISSION; NEUROTRANSMITTER RELEASE; ALPHA(2)DELTA SUBUNITS; FUNCTIONAL-PROPERTIES; FLUORESCENT PROTEINS; PLASMA-MEMBRANE; TRAFFICKING; CA(V)2.1	Synaptic neurotransmitter release is driven by Ca2+ influx through active zone voltage-gated calcium channels (VGCCs)(1,2). Control of active zone VGCC abundance and function remains poorly understood. Here we show that a trafficking step probably sets synaptic VGCC levels in rats, because overexpression of the pore-forming alpha 1(A) VGCC subunit fails to change synaptic VGCC abundance or function. alpha 2 delta s are a family of glycosylphosphatidylinositol (GPI)-anchored VGCC-associated subunits(3) that, in addition to being the target of the potent neuropathic analgesics gabapentin and pregabalin (alpha 2 delta-1 and alpha 2 delta-2)(4,5), were also identified in a forward genetic screen for pain genes (alpha 2 delta-3)(6). We show that these proteins confer powerful modulation of presynaptic function through two distinct molecular mechanisms. First, alpha 2 delta subunits set synaptic VGCC abundance, as predicted from their chaperone-like function when expressed in non-neuronal cells(3,7). Second, alpha 2 delta s configure synaptic VGCCs to drive exocytosis through an extracellular metal ion-dependent adhesion site (MIDAS), a conserved set of amino acids within the predicted von Willebrand A domain of alpha 2 delta. Expression of alpha 2 delta with an intact MIDAS motif leads to an 80% increase in release probability, while simultaneously protecting exocytosis from blockade by an intracellular Ca2+ chelator. alpha 2 delta s harbouring MIDAS site mutations still drive synaptic accumulation of VGCCs; however, they no longer change release probability or sensitivity to intracellular Ca2+ chelators. Our data reveal dual functionality of these clinically important VGCC subunits, allowing synapses to make more efficient use of Ca2+ entry to drive neurotransmitter release.	[Hoppa, Michael B.; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10023 USA; [Lana, Beatrice; Margas, Wojciech; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, Lab Cellular & Mol Neurosci, London WC1E 6BT, England	Cornell University; University of London; University College London	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10023 USA.	taryan@med.cornell.edu	Dolphin, Annette C/F-7416-2010; Ryan, Timothy/AAO-8286-2020; Tuluc, Petronel/C-2527-2011	Dolphin, Annette C/0000-0003-4626-4856; Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783] Funding Source: NIH RePORTER; MRC [G0901758, G0801756, G0700368] Funding Source: UKRI; Medical Research Council [G0801756, G0700368, G0901758] Funding Source: Medline; NIMH NIH HHS [R01 MH085783, R01 MH085783-03, R01 MH085783-02, R01 MH085783-01A1, R01 MH085783-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ariel P, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00018; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Brown JT, 2005, SYNAPSE, V55, P262, DOI 10.1002/syn.20115; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Gao BN, 2000, J BIOL CHEM, V275, P12237, DOI 10.1074/jbc.275.16.12237; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; LLINAS R, 1976, P NATL ACAD SCI USA, V73, P2918, DOI 10.1073/pnas.73.8.2918; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Watschinger K, 2008, CHANNELS, V2, P461, DOI 10.4161/chan.2.6.6793; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637	34	233	237	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					122	U149		10.1038/nature11033	http://dx.doi.org/10.1038/nature11033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678293	Green Accepted			2022-12-28	WOS:000304854000040
J	Drmanac, R				Drmanac, Radoje			The Ultimate Genetic Test	SCIENCE			English	Editorial Material							GENOME; MUTATIONS; PATIENT		Complete Genom Inc, Mountain View, CA 94043 USA		Drmanac, R (corresponding author), Complete Genom Inc, Mountain View, CA 94043 USA.	rdrmanac@completegenomics.com						[Anonymous], DAT SEQ; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Ciszkowski C, 2009, NEW ENGL J MED, V361, P827, DOI 10.1056/NEJMc0904266; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Drmanac R., 2006, international patent bibliographic data, Patent No. [WO/2006/138284, 2006138284, 2006/138284 A2]; Drmanac R, 2011, GENET MED, V13, P188, DOI 10.1097/GIM.0b013e31820f16e6; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Evans JP, 2011, JAMA-J AM MED ASSOC, V306, P2376, DOI 10.1001/jama.2011.1788; Gatke MR, 2001, ANESTHESIOLOGY, V95, P600; Kegel CAT, 2011, MIND BRAIN EDUC, V5, P71, DOI 10.1111/j.1751-228X.2011.01112.x; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	27	25	25	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1110	1112		10.1126/science.1221037	http://dx.doi.org/10.1126/science.1221037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	950KK	22654043				2022-12-28	WOS:000304647900030
J	Petherick, A				Petherick, Anna			ENVIRONMENT AND GENETICS Making sense of the noise	NATURE			English	Editorial Material							BREAST-CANCER; SUSCEPTIBILITY; RISK											Antonova L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2836; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Morris DH, 2011, MENOPAUSE, V18, P956, DOI 10.1097/gme.0b013e31820ed6d2; Ritter HD, 2012, MOL CANCER RES, V10, P558, DOI 10.1158/1541-7786.MCR-11-0423-T	9	2	2	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S64	S65		10.1038/485S64a	http://dx.doi.org/10.1038/485S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648504	Bronze			2022-12-28	WOS:000304608000008
J	Steeg, PS				Steeg, Patricia S.			PERSPECTIVE The right trials	NATURE			English	Editorial Material							METASTASIS		NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Steeg, PS (corresponding author), NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	steegp@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIASC000892] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333	5	62	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S58	S59		10.1038/485S58a	http://dx.doi.org/10.1038/485S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648501	Bronze			2022-12-28	WOS:000304608000005
J	Lepper, PM; Ott, S; Nuesch, E; von Eynatten, M; Schumann, C; Pletz, MW; Mealing, NM; Welte, T; Bauer, TT; Suttorp, N; Juni, P; Bals, R; Rohde, G				Lepper, Philipp M.; Ott, Sebastian; Nueesch, Eveline; von Eynatten, Maximilian; Schumann, Christian; Pletz, Mathias W.; Mealing, Nicole M.; Welte, Tobias; Bauer, Torsten T.; Suttorp, Norbert; Jueni, Peter; Bals, Robert; Rohde, Gernot		German Community Acquired Pneumoni	Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE INSULIN THERAPY; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; GLYCEMIC CONTROL; RISK-FACTORS; HYPERGLYCEMIA; MORTALITY; OUTCOMES; ICU	Objective To examine whether acute dysglycaemia predicts death in people admitted to hospital with community acquired pneumonia. Design Multicentre prospective cohort study. Setting Hospitals and private practices in Germany, Switzerland, and Austria. Participants 6891 patients with community acquired pneumonia included in the German community acquired pneumonia competence network (CAPNETZ) study between 2003 and 2009. Main outcome measures Univariable and multivariable hazard ratios adjusted for sex, age, current smoking status, severity of community acquired pneumonia using the CRB-65 score (confusion, respiratory rate >30/min, systolic blood pressure <= 90 mm Hg or diastolic blood pressure <= 60 mm Hg, and age >= 65 years), and various comorbidities for death at 28, 90, and 180 days according to serum glucose levels on admission. Results An increased serum glucose level at admission to hospital in participants with community acquired pneumonia and no pre-existing diabetes was a predictor of death at 28 and 90 days. Compared with participants with normal serum glucose levels on admission, those with mild acute hyperglycaemia (serum glucose concentration 6-10.99 mmol/L) had a significantly increased risk of death at 90 days (1.56, 95% confidence interval 1.22 to 2.01; P<0.001), and this risk increased to 2.37 (1.62 to 3.46; P<0.001) when serum glucose concentrations were >= 14 mmol/L. In sensitivity analyses the predictive value of serum glucose levels on admission for death was confirmed at 28 days and 90 days. Patients with pre-existing diabetes had a significantly increased overall mortality compared with those without diabetes (crude hazard ratio 2.47, 95% confidence interval 2.05 to 2.98; P<0.001). This outcome was not significantly affected by serum glucose levels on admission (P=0.18 for interaction). Conclusions Serum glucose levels on admission to hospital can predict death in patients with community acquired pneumonia without pre-existing diabetes. Acute hyperglycaemia may therefore identify patients in need of intensified care to reduce the risk of death from community acquired pneumonia.	[Lepper, Philipp M.; Bals, Robert] Univ Hosp Saarland, Dept Internal Med 5, D-66421 Homburg, Germany; [Ott, Sebastian] Inselspital Bern, Univ Hosp Bern, Dept Pneumol, CH-3010 Bern, Switzerland; [Nueesch, Eveline; Mealing, Nicole M.; Jueni, Peter] Inselspital Bern, Univ Hosp Bern, Clin Trials Unit, CH-3010 Bern, Switzerland; [Nueesch, Eveline; Mealing, Nicole M.; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [von Eynatten, Maximilian] Univ Heidelberg Hosp, Dept Diabet Endocrinol & Clin Chem, Heidelberg, Germany; [Schumann, Christian] Univ Hosp Ulm, Dept Internal Med 2, Ulm, Germany; [Pletz, Mathias W.] Jena Univ Hosp, Div Gastroenterol Hepatol & Infect Dis, Jena, Germany; [Welte, Tobias] Leibniz Univ Hannover, Hannover Med Sch, Dept Pneumol, Hannover, Germany; [Bauer, Torsten T.] Klinikum Emil von Behring, Lungenklin Heckeshorn, Dept Pneumol, Berlin, Germany; [Suttorp, Norbert] Charite, Univ Hosp Berlin, Dept Pneumol & Infect Dis, Berlin, Germany; [Rohde, Gernot] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Universitatsklinikum des Saarlandes; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; Ruprecht Karls University Heidelberg; Ulm University; Friedrich Schiller University of Jena; Hannover Medical School; Leibniz University Hannover; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maastricht University	Lepper, PM (corresponding author), Univ Hosp Saarland, Dept Internal Med 5, D-66421 Homburg, Germany.	philipp.lepper@uks.eu	Pletz, Mathias Wilhelm/H-9782-2019; Rohde, Gernot GU/F-3060-2013; Juni, Peter/Q-8700-2016	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Rohde, Gernot GU/0000-0002-5193-7755; Juni, Peter/0000-0002-5985-0670; Stolz, Daiana/0000-0003-0099-882X; Suttorp, Norbert/0000-0002-3958-1151	German Ministry of Education and Research, BundesministeriumfurBildung und Forschung [01KI07145]	German Ministry of Education and Research, BundesministeriumfurBildung und Forschung(Federal Ministry of Education & Research (BMBF))	CAPNETZ is funded by the German Ministry of Education and Research, BundesministeriumfurBildung und Forschung (grant No 01KI07145).	Abourizk NN, 2004, J GEN INTERN MED, V19, P466, DOI 10.1111/j.1525-1497.2004.30133.x; Akbar DH, 2001, ACTA DIABETOL, V38, P77, DOI 10.1007/s005920170017; Aliberti S, 2008, CHEST, V134, P955, DOI 10.1378/chest.08-0334; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; *CDCP, 2005, NAT DIAB FACT SHEET; Eurich DT, 2010, DIABETOLOGIA, V53, P497, DOI 10.1007/s00125-009-1598-y; Falguera K, 2005, CHEST, V128, P3233, DOI 10.1378/chest.128.5.3233; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Genuth S, 2003, DIABETES CARE, V26, P3160; Godar Desiree A, 2011, WMJ, V110, P14; Gornik I, 2010, CRIT CARE, V14, DOI 10.1186/cc9101; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; KOZIEL H, 1995, INFECT DIS CLIN N AM, V9, P65; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rueda AM, 2010, J INFECTION, V60, P99, DOI 10.1016/j.jinf.2009.12.003; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Singanayagam A, 2009, EUR RESPIR J, V34, P932, DOI 10.1183/09031936.00197008; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Spencer EA, 2008, EUR J EPIDEMIOL, V23, P793, DOI 10.1007/s10654-008-9298-3; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2006, ENDOCRIN METAB CLIN, V35, P859, DOI 10.1016/j.ecl.2006.09.002; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Welte T, 2004, INFECTION, V32, P234, DOI 10.1007/s15010-004-3107-z	40	89	93	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2012	344								e3397	10.1136/bmj.e3397	http://dx.doi.org/10.1136/bmj.e3397			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645184	Green Published, hybrid			2022-12-28	WOS:000304855700003
J	Levinson, SC				Levinson, Stephen C.			Kinship and Human Thought	SCIENCE			English	Editorial Material							LANGUAGES		[Levinson, Stephen C.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Levinson, Stephen C.] Donders Inst, NL-6500 HE Nijmegen, Netherlands	Max Planck Society	Levinson, SC (corresponding author), Max Planck Inst Psycholinguist, PB 310, NL-6500 AH Nijmegen, Netherlands.	stephen.levinson@mpi.nl						Frank MC, 2012, SCIENCE, V336, P998, DOI 10.1126/science.1218633; Jones D, 2003, AM ANTHROPOL, V105, P501, DOI 10.1525/aa.2003.105.3.501; Jones D, 2010, BEHAV BRAIN SCI, V33, P367, DOI 10.1017/S0140525X10000890; Jordan FM, 2011, HUM BIOL, V83, P297, DOI 10.3378/027.083.0209; Kemp C, 2012, SCIENCE, V336, P1049, DOI 10.1126/science.1218811; Levinson SC, 2012, TRENDS COGN SCI, V16, P167, DOI 10.1016/j.tics.2012.01.007; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Morgan LewisHenry., 1871, SYSTEMS CONSANGUINIT; MURDOCK GP, 1970, ETHNOLOGY, V9, P165, DOI 10.2307/3772782; Murdock GPM, 1949, SOCIAL STRUCTURE; Read DW, 2007, ETHNOLOGY, V46, P329, DOI 10.2307/20456635; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Scott-Phillips TC, 2010, TRENDS COGN SCI, V14, P411, DOI 10.1016/j.tics.2010.06.006; Trautmann Thomas, 2008, LH MORGAN INVENTION	14	12	12	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					988	989		10.1126/science.1222691	http://dx.doi.org/10.1126/science.1222691			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628642	Green Published			2022-12-28	WOS:000304406800029
J	Owen, R; Jobling, S				Owen, Richard; Jobling, Susan			The hidden costs of flexible fertility	NATURE			English	Editorial Material							FISH		[Owen, Richard] Univ Exeter, Sch Business, Exeter EX4 4PU, Devon, England; [Jobling, Susan] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	University of Exeter; Brunel University	Owen, R (corresponding author), Univ Exeter, Sch Business, Exeter EX4 4PU, Devon, England.	r.j.owen@exeter.ac.uk		Owen, Richard/0000-0002-1767-3901				European Commission, 2000, COMMUNICATION; Gross-Sorokin MY, 2006, ENVIRON HEALTH PERSP, V114, P147, DOI 10.1289/ehp.8068; Jobling S., LATE LESSON IN PRESS; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Royal Commission on Environmental Pollution, 1998, 21 RCEP	5	55	56	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					441	441		10.1038/485441a	http://dx.doi.org/10.1038/485441a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622553	Bronze			2022-12-28	WOS:000304344500018
J	White, PD; Rickards, H; Zeman, AZJ				White, P. D.; Rickards, H.; Zeman, A. Z. J.			Time to end the distinction between mental and neurological illnesses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS; DISORDER; BRAIN; SCHIZOPHRENIA; HIPPOCAMPAL; DEPRESSION; VOLUME		[White, P. D.] Queen Mary Univ London, Barts & London Sch Med, London, England; [Rickards, H.] Univ Birmingham, Dept Neuropsychiat, Birmingham B15 2TT, W Midlands, England; [Zeman, A. Z. J.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX4 4QJ, Devon, England	University of London; Queen Mary University London; University of Birmingham; University of Exeter; University of Plymouth	White, PD (corresponding author), St Bartholomews Hosp, Dept Psychol Med, London EC1A 7BE, England.	p.d.white@qmul.ac.uk		Zeman, Adam/0000-0003-4875-658X; White, Peter/0000-0002-8193-5355				Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Bullmore ET, 2009, BRIT J PSYCHIAT, V194, P293, DOI 10.1192/bjp.bp.108.058479; Butler C, 2005, J NEUROL NEUROSUR PS, V76, pI31, DOI 10.1136/jnnp.2004.060459; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Demertzi A, 2009, ANN NY ACAD SCI, V1157, P1, DOI 10.1111/j.1749-6632.2008.04117.x; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Goldberg D, 2010, BRIT J PSYCHIAT, V196, P255, DOI 10.1192/bjp.bp.109.072405; Hamilton WT, 2009, PSYCHOL MED, V39, P1913, DOI 10.1017/S0033291709005601; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kendell RE, 2001, BRIT J PSYCHIAT, V178, P490, DOI 10.1192/bjp.178.6.490; Kupfer DJ, 2010, JAMA-J AM MED ASSOC, V303, P1974, DOI 10.1001/jama.2010.646; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Schatzberg AF, 2009, TXB PSYCHOPHARMACOLO; Searle J.R., 2004, MIND BRIEF INTRO; Smith GD., 2005, BIOPSYCHOSOC MED; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	26	56	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2012	344								e3454	10.1136/bmj.e3454	http://dx.doi.org/10.1136/bmj.e3454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QU	22628005				2022-12-28	WOS:000304591600007
J	Holmes, D				Holmes, David			Lisa Bero: taking the path of most resistance	LANCET			English	Biographical-Item																		BERO L, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1869	1869		10.1016/S0140-6736(12)60797-1	http://dx.doi.org/10.1016/S0140-6736(12)60797-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22608326				2022-12-28	WOS:000304194200014
J	Greeley, JP				Greeley, Jeffrey P.			Active Site of an Industrial Catalyst	SCIENCE			English	Editorial Material									Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Greeley, JP (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA.	jgreeley@anl.gov						Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Cuesta A, 2006, J AM CHEM SOC, V128, P13332, DOI 10.1021/ja0644172; Dahl S, 1999, PHYS REV LETT, V83, P1814, DOI 10.1103/PhysRevLett.83.1814; Ferrin P, 2009, J AM CHEM SOC, V131, P14381, DOI 10.1021/ja904010u; Greeley J, 2002, ANNU REV PHYS CHEM, V53, P319, DOI 10.1146/annurev.physchem.53.100301.131630; Hansen J.B., 2008, HDB HETEROGENEOUS CA; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Neurock M, 2003, J CATAL, V216, P73, DOI 10.1016/S0021-9517(02)00115-X; Somorjai G.A., 2010, INTRO SURFACE CHEM C	10	32	33	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					810	811		10.1126/science.1222974	http://dx.doi.org/10.1126/science.1222974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605738				2022-12-28	WOS:000304145600026
J	Kress, M				Kress, Moshe			MODELING ARMED CONFLICTS	SCIENCE			English	Review							LANCHESTER; OPERATIONS; DEFENSE; GAMES; COUNTERINSURGENCY; OPTIMIZATION; INTELLIGENCE; INSURGENT; SECURITY; ARDENNES	Armed conflicts have been prevalent throughout history, in some cases having very great consequences. To win, one needs to understand the characteristics of an armed conflict and be prepared with resources and capabilities for responding to its specific challenges. An important tool for understanding these characteristics and challenges is a model-an abstraction of the field of conflict. Models have evolved through the years, addressing different conflict scenarios with varying techniques.	USN, Postgrad Sch, Monterey, CA 93943 USA	United States Department of Defense; United States Navy; Naval Postgraduate School	Kress, M (corresponding author), USN, Postgrad Sch, Monterey, CA 93943 USA.	mkress@nps.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378				Atkinson MP, 2012, J OPER RES SOC, V63, P1363, DOI 10.1057/jors.2011.146; BARFOOT CB, 1974, OPER RES, V22, P318, DOI 10.1287/opre.22.2.318; BELLMAN R, 1969, SIAM REV, V11, P66, DOI 10.1137/1011006; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Bonder S, 2002, OPER RES, V50, P25, DOI 10.1287/opre.50.1.25.17804; Brown G, 2005, OPER RES, V53, P745, DOI 10.1287/opre.1050.0231; Brown G., 2005, TUTORIALS OPERATIONS, P102; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Citino R. M., 2005, GERMAN WAY WAR 30 YE, P150; Commission on Physical Sciences Mathematics and Applications the National Academies, 1997, TECHN US NAV MAR COR; DEITCHMAN SJ, 1962, OPER RES, V10, P818, DOI 10.1287/opre.10.6.818; Dresher M., 2007, GAMES STRATEGY THEOR; EADSIM, BROWN ENG; Fowler C. A., 2006, ASYMMETRIC WARFARE P; Fricker RD, 1998, NAV RES LOG, V45, P1, DOI 10.1002/(SICI)1520-6750(199802)45:1<1::AID-NAV1>3.0.CO;2-D; Gaver DP, 2006, NAV RES LOG, V53, P588, DOI 10.1002/nav.20162; Henscheid Z. A., 2010, 104822 MITRE; Hughes Jr. W. P., 1996, WARFARE MODELING, P121; Ilachinski A, 2004, ARTIFICIAL WAR MULTI; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Johnson DDP, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P159; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Kaplan EH, 2011, INTELLIGENCE ANALYSIS: BEHAVIORAL AND SOCIAL SCIENTIFIC FOUNDATIONS, P31; Kaplan EH, 2010, OPER RES, V58, P773, DOI 10.1287/opre.1100.0831; Kaplan EH, 2010, OPER RES, V58, P329, DOI 10.1287/opre.1090.0728; Kaplan EH, 2005, P NATL ACAD SCI USA, V102, P10399, DOI 10.1073/pnas.0500567102; Kimball G. F., 1951, METHODS OPERATIONS R; Kocher MA, 2011, AM J POLIT SCI, V55, P201, DOI 10.1111/j.1540-5907.2010.00498.x; Kress M, 2005, NAV RES LOG, V52, P22, DOI 10.1002/nav.20049; Kress M, 1999, J OPER RES SOC, V50, P733, DOI 10.1057/palgrave.jors.2600758; Kress M, 2008, MIL OPER RES, V13, P23, DOI 10.5711/morj.13.1.23; Kress M, 2009, OPER RES, V57, P578, DOI 10.1287/opre.1090.0700; KURAN T, 1989, PUBLIC CHOICE, V61, P41, DOI 10.1007/BF00116762; Laffont J.-J., 2002, THEORY INCENTIVES PR, DOI [10.1515/9781400829453, DOI 10.1515/9781400829453]; Lanchester, 1916, AIRCRAFT WARFARE DAW; Leppingwell J. W. R., 1987, INT SECURITY, V12, P89; Lucas TW, 2004, NAV RES LOG, V51, P95, DOI 10.1002/nav.10101; Lyall J, 2009, J CONFLICT RESOLUT, V53, P331, DOI 10.1177/0022002708330881; MacKay N, 2011, HISTORY, V96, P304, DOI 10.1111/j.1468-229X.2011.00521.x; National Research Council of the National Academies, 2006, DEF MOD SIM AN; Newman AM, 2011, NAV RES LOG, V58, P281, DOI 10.1002/nav.20377; RAVID I, 1989, OPER RES, V37, P700, DOI 10.1287/opre.37.5.700; Rose-Ackerman Susan., 1978, CORRUPTION STUDY POL, P1, DOI [10.1016/B978-0-12-596350-3.50005-3, DOI 10.1016/B978-0-12-596350-3.50005-3]; Sandler T, 2009, SIMULAT GAMING, V40, P164, DOI 10.1177/1046878108314772; SCHREIBER TS, 1964, OPER RES, V12, P507, DOI 10.1287/opre.12.3.507; Subrahmanian VS, 2009, SCIENCE, V326, P1201, DOI 10.1126/science.1182660; Thomas C. J., 1997, MILITARY MODELS DECI, P333; United States Department of Defense, 2010, IRR WARF COUNT IRR T, P9; von Neumann J, 1928, MATH ANN, V100, P295; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Washburn A, 2011, NAV RES LOG, V58, P180, DOI 10.1002/nav.20374; Washburn A, 2009, INT SER OPER RES MAN, V134, P1, DOI 10.1007/978-1-4419-0790-5_1; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weidmann NB, 2008, SOC SCI COMPUT REV, V26, P510, DOI 10.1177/0894439307313516; Wein LM, 2009, OPER RES, V57, P801, DOI 10.1287/opre.1090.0695	55	25	25	6	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					865	869		10.1126/science.1217724	http://dx.doi.org/10.1126/science.1217724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605764				2022-12-28	WOS:000304145600050
J	Levine, DI; Toffel, MW; Johnson, MS				Levine, David I.; Toffel, Michael W.; Johnson, Matthew S.			Randomized Government Safety Inspections Reduce Worker Injuries with No Detectable Job Loss	SCIENCE			English	Article							OSHA; COMPENSATION; PRODUCTIVITY; IMPACT; RATES	Controversy surrounds occupational health and safety regulators, with some observers claiming that workplace regulations damage firms' competitiveness and destroy jobs and others arguing that they make workplaces safer at little cost to employers and employees. We analyzed a natural field experiment to examine how workplace safety inspections affected injury rates and other outcomes. We compared 409 randomly inspected establishments in California with 409 matched-control establishments that were eligible, but not chosen, for inspection. Compared with controls, randomly inspected employers experienced a 9.4% decline in injury rates (95% confidence interval = -0.177 to -0.021) and a 26% reduction in injury cost (95% confidence interval = -0.513 to -0.083). We find no evidence that these improvements came at the expense of employment, sales, credit ratings, or firm survival.	[Toffel, Michael W.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Levine, David I.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Johnson, Matthew S.] Boston Univ, Dept Econ, Boston, MA 02215 USA	Harvard University; University of California System; University of California Berkeley; Boston University	Toffel, MW (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.	mtoffel@hbs.edu	Toffel, Michael/G-2555-2011	Toffel, Michael/0000-0002-1224-9159	California's Commission on Health and Safety and Workers' Compensation; Workers' Compensation Insurance Rating Board; California's Division of Occupational Safety and Health; Harvard Business School's Division of Research and Faculty Development; Kauffman Foundation; University of California at Berkeley's Institute; University of California	California's Commission on Health and Safety and Workers' Compensation; Workers' Compensation Insurance Rating Board; California's Division of Occupational Safety and Health; Harvard Business School's Division of Research and Faculty Development; Kauffman Foundation; University of California at Berkeley's Institute; University of California(University of California System)	We appreciate the support of C. Baker and I. Nemirovsky of California's Commission on Health and Safety and Workers' Compensation, D. Bellusci and T. Basuino of the Workers' Compensation Insurance Rating Board, and G. Murphy of California's Division of Occupational Safety and Health and helpful comments from F. Neuhauser and J. Sum; A. Nguyen-Chyung and M. Ouellet provided outstanding research assistance. We are grateful for financial support from the Commission on Health and Safety and Workers' Compensation, Harvard Business School's Division of Research and Faculty Development, Kauffman Foundation, University of California at Berkeley's Institute for Research on Labor and Employment, and University of California's Labor and Employment Relations Fund. The publicly accessible portion of the data set analyzed in this study is available at http://hdl.handle.net/1902.1/17936 in the Murray Research Archive at Harvard University (study identifier: 1902.1/17936). That data set contains the following variables: a scrambled establishment ID that uniquely identifies each establishment, the establishment's city, industry, year, year of random inspection, treated (has been randomly inspected), sales, employment, PAYDEX score, and Composite Credit Appraisal. It does not contain the following variables used in the analysis because of the confidentiality conditions under which they were obtained: establishment name, street address, ZIP Code, DUNS number; annual payroll, injury count, injury cost, and average occupational riskiness. Details on how to access all data used in this analysis are provided in the supplementary materials.	Biddle J, 1998, J OCCUP ENVIRON MED, V40, P325, DOI 10.1097/00043764-199804000-00006; California Department of Industrial Relations, 2005, 2005 REP HIGH HAZ EN; Dufour C, 1998, J PROD ANAL, V9, P233, DOI 10.1023/A:1018387021327; Feldman J., 2011, OSHA INACTION ONEROU; GRAY WB, 1987, AM ECON REV, V77, P998; GRAY WB, 1993, LAW SOC REV, V27, P177, DOI 10.2307/3053754; Haviland A, 2010, J SAFETY RES, V41, P339, DOI 10.1016/j.jsr.2010.03.005; Haviland AM, 2012, AM J IND MED, V55, P964, DOI 10.1002/ajim.22062; Leigh JP, 2004, J OCCUP ENVIRON MED, V46, P10, DOI 10.1097/01.jom.0000105909.66435.53; Mendeloff J., 2005, LAW POLICY, V27, P219, DOI [10.1111/j.1467-9930.2005.00198.x, DOI 10.1111/J.1467-9930.2005.00198.X]; MSDSonline, 2011, MSDSONLINE NEW SAFET; Pelley S., 2008, 60 MINUTES CBS  0608; Rosenman KD, 2000, J OCCUP ENVIRON MED, V42, P25, DOI 10.1097/00043764-200001000-00008; Ruser JW, 1995, J RISK INSUR, V62, P67, DOI 10.2307/253693; RUSER JW, 1991, J HUM RESOUR, V26, P212, DOI 10.2307/145921; Sherk J., 2011, 112 C HER FDN WASH D; SMITH RS, 1979, IND LABOR RELAT REV, V32, P339, DOI 10.2307/2522263; SMITH RS, 1979, J HUM RESOUR, V14, P145, DOI 10.2307/145640; VISCUSI WK, 1979, BELL J ECON, V10, P117, DOI 10.2307/3003322	19	88	90	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					907	911		10.1126/science.1215191	http://dx.doi.org/10.1126/science.1215191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605775				2022-12-28	WOS:000304145600063
J	Polikanov, YS; Blaha, GM; Steitz, TA				Polikanov, Yury S.; Blaha, Gregor M.; Steitz, Thomas A.			How Hibernation Factors RMF, HPF, and YfiA Turn Off Protein Synthesis	SCIENCE			English	Article							RIBOSOME-RECYCLING FACTOR; ESCHERICHIA-COLI; STATIONARY-PHASE; MESSENGER-RNA; TRANSLATION INITIATION; STRUCTURAL BASIS; 100S RIBOSOME; FACTOR RRF; SUBUNIT; STRESS	Eubacteria inactivate their ribosomes as 100S dimers or 70S monomers upon entry into stationary phase. In Escherichia coli, 100S dimer formation is mediated by ribosome modulation factor (RMF) and hibernation promoting factor (HPF), or alternatively, the YfiA protein inactivates ribosomes as 70S monomers. Here, we present high-resolution crystal structures of the Thermus thermophilus 70S ribosome in complex with each of these stationary-phase factors. The binding site of RMF overlaps with that of the messenger RNA (mRNA) Shine-Dalgarno sequence, which prevents the interaction between the mRNA and the 16S ribosomal RNA. The nearly identical binding sites of HPF and YfiA overlap with those of the mRNA, transfer RNA, and initiation factors, which prevents translation initiation. The binding of RMF and HPF, but not YfiA, to the ribosome induces a conformational change of the 30S head domain that promotes 100S dimer formation.	[Polikanov, Yury S.; Blaha, Gregor M.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Polikanov, Yury S.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu			NIH [GM022778]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the National Synchrotron Light Source (beamlines X29 and X25) and at the Advanced Photon Source (beamline 24ID) for help during data collection, the staff at the Center for Structural Biology at Yale University for computational support, and S. Seetharaman and M. Gagnon for valuable discussions. This work was supported by NIH grant GM022778 awarded to T.A.S. The structure factors and coordinates for both copies of the 70S ribosome in the asymmetric unit of all complexes have been deposited in the Research Collaboration for Structural Biology Protein Data Bank with the following accession codes: 3V22, 3V23, 3V24, and 3V25 for the RMF-ribosome complex; 3V26, 3V27, 3V28, and 3V29 for the HPF-ribosome complex; and 3V2C, 3V2D, 3V2F, and 3V2E for the YfiA-ribosome complex. T.A.S. owns stock in and is on the advisory board of Rib-X Pharmaceuticals, Inc., which does structure-based drug design targeted at the ribosome.	Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Agafonov DE, 2001, EMBO REP, V2, P399; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Karamyshev AL, 2004, BIOCHIMIE, V86, P933, DOI 10.1016/j.biochi.2004.08.006; Kato T, 2010, STRUCTURE, V18, P719, DOI 10.1016/j.str.2010.02.017; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2010, J BIOL CHEM, V285, P4006, DOI 10.1074/jbc.M109.062299; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; TISSIERES A, 1959, J MOL BIOL, V1, P221, DOI 10.1016/S0022-2836(59)80029-2; Ueta M, 2005, GENES CELLS, V10, P1103, DOI 10.1111/j.1365-2443.2005.00903.x; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yoshida H, 2004, GENES CELLS, V9, P271, DOI 10.1111/j.1356-9597.2004.00723.x; Yoshida H, 2002, J BIOCHEM, V132, P983, DOI 10.1093/oxfordjournals.jbchem.a003313; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	25	136	143	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					915	918		10.1126/science.1218538	http://dx.doi.org/10.1126/science.1218538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605777	Green Accepted			2022-12-28	WOS:000304145600065
J	Seifert, F; Rudelius, M; Ring, J; Gutermuth, J; Andres, C				Seifert, Florian; Rudelius, Martina; Ring, Johannes; Gutermuth, Jan; Andres, Christian			Bilateral axillary ectopic breast tissue	LANCET			English	Editorial Material									[Gutermuth, Jan] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80802 Munich, Germany; [Seifert, Florian; Andres, Christian] Tech Univ Munich, Dept Dermatol & Allergy Biederstein, D-80802 Munich, Germany; [Rudelius, Martina] Tech Univ Munich, Inst Pathol, D-80802 Munich, Germany; [Ring, Johannes] Christine Kuhne Ctr Allergy Res & Educ, Davos, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Gutermuth, J (corresponding author), Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80802 Munich, Germany.	jan.gutermuth@lrz.tum.de	Ring, Johannes/GLN-4341-2022	Ring, Johannes/0000-0001-8236-3152					0	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 1	2012	380	9844					835	835		10.1016/S0140-6736(12)60316-X	http://dx.doi.org/10.1016/S0140-6736(12)60316-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22608194				2022-12-28	WOS:000308396300032
J	Gari, K; Ortiz, AML; Borel, V; Flynn, H; Skehel, JM; Boulton, SJ				Gari, Kerstin; Ortiz, Ana Maria Leon; Borel, Valerie; Flynn, Helen; Skehel, J. Mark; Boulton, Simon J.			MMS19 Links Cytoplasmic Iron-Sulfur Cluster Assembly to DNA Metabolism	SCIENCE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN; TFIIH; GENE; TRANSCRIPTION; HELICASES; COMPLEX; XPD	The function of many DNA metabolism proteins depends on their ability to coordinate an iron-sulfur (Fe-S) cluster. Biogenesis of Fe-S proteins is a multistep process that takes place in mitochondria and the cytoplasm, but how it is linked to nuclear Fe-S proteins is not known. Here, we demonstrate that MMS19 forms a complex with the cytoplasmic Fe-S assembly (CIA) proteins CIAO1, IOP1, and MIP18. Cytoplasmic MMS19 also binds to multiple nuclear Fe-S proteins involved in DNA metabolism. In the absence of MMS19, a failure to transfer Fe-S clusters to target proteins is associated with Fe-S protein instability and preimplantation death of mice in which Mms19 has been knocked out. We propose that MMS19 functions as a platform to facilitate Fe-S cluster transfer to proteins critical for DNA replication and repair.	[Gari, Kerstin; Ortiz, Ana Maria Leon; Borel, Valerie; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Flynn, Helen; Skehel, J. Mark] Canc Res UK, London Res Inst, Prot Anal & Prote Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Gari, Kerstin/D-1261-2014	Gari, Kerstin/0000-0003-1276-8941; Flynn, Helen/0000-0001-7002-9130	Cancer Research UK; European Research Council; Royal Society; Federation of European Biochemical Societies; Human Frontier Science Program; Cancer Research UK [11581] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Federation of European Biochemical Societies; Human Frontier Science Program(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	Research in the laboratories of S.J.B. and M.J.S. is supported by Cancer Research UK. The laboratory of S.J.B. is also funded by a European Research Council Advanced Investigator Grant (RecMitMei). S.J.B. is a recipient of a Royal Society Wolfson Research Merit Award. K. G. is funded by long-term fellowships from the Federation of European Biochemical Societies and the Human Frontier Science Program. The authors declare no conflict of interest.	Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; PRAKASH L, 1979, MOL GEN GENET, V176, P351, DOI 10.1007/BF00333097; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seroz T, 2000, NUCLEIC ACIDS RES, V28, P4506, DOI 10.1093/nar/28.22.4506; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	19	154	164	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					243	245		10.1126/science.1219664	http://dx.doi.org/10.1126/science.1219664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22678361				2022-12-28	WOS:000306323500061
J	Elkayam, E; Kuhn, CD; Tocilj, A; Haase, AD; Greene, EM; Hannon, GJ; Joshua-Tor, L				Elkayam, Elad; Kuhn, Claus-D.; Tocilj, Ante; Haase, Astrid D.; Greene, Emily M.; Hannon, Gregory J.; Joshua-Tor, Leemor			The Structure of Human Argonaute-2 in Complex with miR-20a	CELL			English	Article							CRYSTAL-STRUCTURE; SILENCING COMPLEX; RNA RECOGNITION; GUIDE RNA; DOMAIN; RISC; MICRORNAS; BINDING	Argonaute proteins lie at the heart of the RNA-induced silencing complex (RISC), wherein they use small RNA guides to recognize targets. Initial insight into the architecture of Argonautes came from studies of prokaryotic proteins, revealing a crescent-shaped base made up of the amino-terminal, PAZ, middle, and PIWI domains. The recently reported crystal structure of human Argonaute-2 (hAgo2), the "slicer" in RNA interference, in complex with a mixed population of RNAs derived from insect cells provides insight into the architecture of a eukaryotic Argonaute protein with defined biochemical and biological functions. Here, we report the structure of human Ago2 bound to a physiologically relevant microRNA, microRNA-20a, at 2.2 angstrom resolution. The miRNA is anchored at both ends by the Mid and PAZ domains and makes several kinks and turns along the binding groove. Interestingly, miRNA binding confers remarkable stability on hAgo2, locking this otherwise flexible enzyme into a stable conformation.	[Elkayam, Elad; Kuhn, Claus-D.; Tocilj, Ante; Greene, Emily M.; Joshua-Tor, Leemor] WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; [Elkayam, Elad; Greene, Emily M.; Hannon, Gregory J.; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Joshua-Tor, L (corresponding author), WM Keck Struct Biol Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Elkayam, Elad/AAF-6433-2021; Hannon, Gregory/AAB-3568-2019; Kuhn, Claus D./U-3438-2019; @haase_astrid, Astrid D/HHS-1635-2022	Kuhn, Claus D./0000-0002-4244-3219; @haase_astrid, Astrid D/0000-0003-1120-9013; Joshua-Tor, Leemor/0000-0001-8185-8049; Elkayam, Elad/0000-0001-9266-7002	Department of Energy, Office of Basic Energy Sciences; Jane Coffin Childs Memorial Fund for Medical Research Fellowship; Louis Morin Charitable Trust;  [GM062534]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534, R01GM062534] Funding Source: NIH RePORTER	Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Jane Coffin Childs Memorial Fund for Medical Research Fellowship; Louis Morin Charitable Trust; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Deanna Bahel for technical support; Chris Faehnle, Thomas Schalch, and members of the Joshua-Tor and Hannon laboratories for discussions and advice; Howard Robinson and Neil Whelan for help at the National Synchrotron Light Source, which is supported by the Department of Energy, Office of Basic Energy Sciences. C.-D.K. was supported by a Jane Coffin Childs Memorial Fund for Medical Research Fellowship. This work was supported by the Louis Morin Charitable Trust (to L.J.) and by GM062534 to G.J.H. L.J. and G.J.H. are Howard Hughes Medical Institute Investigators.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bricogne G, 1997, METHOD ENZYMOL, V277, P14, DOI 10.1016/S0076-6879(97)77004-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rizzo M, 2010, J CELL MOL MED, V14, P2633, DOI 10.1111/j.1582-4934.2010.01173.x; Schalch T, 2011, NAT STRUCT MOL BIOL, V18, P1351, DOI 10.1038/nsmb.2151; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	41	386	404	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					100	110		10.1016/j.cell.2012.05.017	http://dx.doi.org/10.1016/j.cell.2012.05.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22682761	Green Accepted, Bronze			2022-12-28	WOS:000306115000010
J	Clevers, H; Nusse, R				Clevers, Hans; Nusse, Roel			Wnt/beta-Catenin Signaling and Disease	CELL			English	Review							RECEPTOR-RELATED PROTEIN-5; CANCER STEM-CELLS; GLYCOGEN-SYNTHASE KINASE-3; SMALL-MOLECULE INHIBITORS; NUCLEAR BETA-CATENIN; HAIR FOLLICLE; REQUIRES RETROMER; GENE-PRODUCT; WNT PROTEINS; COLORECTAL-CANCER	The WNT signal transduction cascade controls myriad biological phenomena throughout development and adult life of all animals. In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans. In this Review, we provide an update of the core Wnt/beta-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.	[Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Nusse, Roel] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Stanford University; Stanford University	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; BERGER W, 2001, METABOLIC MOL BASES, P5977; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chang MV, 2008, CURR BIOL, V18, P1877, DOI 10.1016/j.cub.2008.10.047; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Christodoulides C, 2006, DIABETOLOGIA, V49, P678, DOI 10.1007/s00125-006-0144-4; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Janda CY, 2012, SCIENCE; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Parker DS, 2002, DEVELOPMENT, V129, P2565; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Regimbald-Dumas Y, 2011, EMBO J, V30, P1415, DOI 10.1038/emboj.2011.101; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Schwab KR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-15; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Strand M, 2011, P NATL ACAD SCI USA, V108, P17696, DOI 10.1073/pnas.1109794108; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Sugioka K, 2011, CELL, V146, P941, DOI 10.1016/j.cell.2011.07.043; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Wang YK, 1999, GENOMICS, V57, P235, DOI 10.1006/geno.1999.5773; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	176	3826	4055	28	746	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1192	1205		10.1016/j.cell.2012.05.012	http://dx.doi.org/10.1016/j.cell.2012.05.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682243	Bronze			2022-12-28	WOS:000305119600006
J	Jain, RK; Carmeliet, P				Jain, Rakesh K.; Carmeliet, Peter			SnapShot: Tumor Angiogenesis	CELL			English	Editorial Material							ANTIANGIOGENIC THERAPY; VASCULATURE; VESSELS		[Jain, Rakesh K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Carmeliet, Peter] VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, B-3000 Louvain, Belgium	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); KU Leuven	Jain, RK (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Carmeliet, Peter/AAQ-5140-2020; Jain, Rakesh K/I-1384-2017	Carmeliet, Peter/0000-0001-7961-1821; Jain, Rakesh K/0000-0001-7571-3548				Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cascone T, 2012, J CLIN ONCOL, V30, P441, DOI 10.1200/JCO.2011.38.7621; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gerstner E. R., 2012, ASCO; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464	10	97	102	3	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1408	U257	1408.e1	10.1016/j.cell.2012.05.025	http://dx.doi.org/10.1016/j.cell.2012.05.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682256	Bronze			2022-12-28	WOS:000305119600022
J	Yu, M; Hon, GC; Szulwach, KE; Song, CX; Zhang, L; Kim, A; Li, XK; Dai, Q; Shen, Y; Park, B; Min, JH; Jin, P; Ren, B; He, C				Yu, Miao; Hon, Gary C.; Szulwach, Keith E.; Song, Chun-Xiao; Zhang, Liang; Kim, Audrey; Li, Xuekun; Dai, Qing; Shen, Yin; Park, Beomseok; Min, Jung-Hyun; Jin, Peng; Ren, Bing; He, Chuan			Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome	CELL			English	Article							DNA METHYLATION; THYMINE DNA; CELLS; REPLICATION; PLURIPOTENT; GLYCOSYLASE; ARABIDOPSIS; EXPRESSION; EPIGENOME; BINDING	The study of 5-hydroxylmethylcytosines (5hmC) has been hampered by the lack of a method to map it at single-base resolution on a genome-wide scale. Affinity purification-based methods cannot precisely locate 5hmC nor accurately determine its relative abundance at each modified site. We here present a genome-wide approach, Tet-assisted bisulfite sequencing (TAB-Seq), that when combined with traditional bisulfite sequencing can be used for mapping 5hmC at base resolution and quantifying the relative abundance of 5hmC as well as 5mC. Application of this method to embryonic stem cells not only confirms widespread distribution of 5hmC in the mammalian genome but also reveals sequence bias and strand asymmetry at 5hmC sites. We observe high levels of 5hmC and reciprocally low levels of 5mC near but not on transcription factor-binding sites. Additionally, the relative abundance of 5hmC varies significantly among distinct functional sequence elements, suggesting different mechanisms for 5hmC deposition and maintenance.	[Szulwach, Keith E.; Li, Xuekun; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Yu, Miao; Song, Chun-Xiao; Zhang, Liang; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; Song, Chun-Xiao; Zhang, Liang; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hon, Gary C.; Kim, Audrey; Shen, Yin; Ren, Bing] Univ Calif San Diego, San Diego Sch Med, UCSD Moores Canc Canc, Dept Cellular & Mol Med,Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Hon, Gary C.; Kim, Audrey; Shen, Yin; Ren, Bing] Univ Calif San Diego, Inst Genome Med, San Diego Sch Med, La Jolla, CA 92093 USA; [Park, Beomseok; Min, Jung-Hyun] Univ Illinois, Dept Chem, Chicago, IL 60606 USA	Emory University; University of Chicago; University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	peng.jin@emory.edu; biren@ucsd.edu; chuanhe@uchicago.edu	Dai, Qing/ABD-8444-2021; Jin, Peng/B-5977-2012; Zhang, Liang/F-8064-2013	Jin, Peng/0000-0001-6137-6659; Zhang, Liang/0000-0002-7672-1168; Song, Chun-Xiao/0000-0002-7781-6521; Min, Jung-Hyun/0000-0002-4221-9321	National Institutes of Health [GM071440, NS051630, P50AG025688, U01ES017166]; Chicago Biomedical Consortium; The Chicago Community Trust; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; Autism Speaks grant [7660]; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH076090, R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067461, R01NS051630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; The Chicago Community Trust; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; Autism Speaks grant; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (GM071440 to C.H., NS051630 and P50AG025688 to P.J., U01ES017166 to B.R.), a Catalyst Award (C.H. and J.-H.M.) from the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, the Emory Genetics Discovery Fund (P.J.), the Simons Foundation Autism Research Initiative (P.J.), the Autism Speaks grant (#7660 to X.L.), and the Ludwig Institute for Cancer Research (B.R.).	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2011, J MOL BIOL, V409, P47, DOI 10.1016/j.jmb.2011.01.056; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pelizzola M, 2011, FEBS LETT, V585, P1994, DOI 10.1016/j.febslet.2010.10.061; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Robertson AB, 2012, NAT PROTOC, V7, P340, DOI 10.1038/nprot.2011.443; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	55	729	768	5	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1368	1380		10.1016/j.cell.2012.04.027	http://dx.doi.org/10.1016/j.cell.2012.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22608086	Green Accepted, Bronze			2022-12-28	WOS:000305119600019
J	Mukhopadhyay, S				Mukhopadhyay, Sujoy			Early differentiation and volatile accretion recorded in deep-mantle neon and xenon	NATURE			English	Article							RARE-GAS SYSTEMATICS; EARTHS MANTLE; NOBLE-GASES; HELIUM; EVOLUTION; ISOTOPES; ATMOSPHERE; ORIGIN; HETEROGENEITY; CONVECTION	The isotopes Xe-129, produced from the radioactive decay of extinct I-129, and Xe-136, produced from extinct Pu-244 and extant U-238, have provided important constraints on early mantle outgassing and volatile loss from Earth(1,2). The low ratios of radiogenic to non-radiogenic xenon (Xe-129/Xe-130) in ocean island basalts (OIBs) compared with mid-ocean-ridge basalts (MORBs) have been used as evidence for the existence of a relatively undegassed primitive deep-mantle reservoir(1). However, the low Xe-129/Xe-130 ratios in OIBs have also been attributed to mixing between subducted atmospheric Xe and MORB Xe, which obviates the need for a less degassed deep-mantle reservoir(3,4). Here I present new noble gas (He, Ne, Ar, Xe) measurements from an Icelandic OIB that reveal differences in elemental abundances and Ne-20/Ne-22 ratios between the Iceland mantle plume and the MORB source. These observations show that the lower Xe-129/Xe-130 ratios in OIBs are due to a lower I/Xe ratio in the OIB mantle source and cannot be explained solely by mixing atmospheric Xe with MORB-type Xe. Because I-129 became extinct about 100 million years after the formation of the Solar System, OIB and MORB mantle sources must have differentiated by 4.45 billion years ago and subsequent mixing must have been limited. The Iceland plume source also has a higher proportion of Pu- to U-derived fission Xe, requiring the plume source to be less degassed than MORBs, a conclusion that is independent of noble gas concentrations and the partitioning behaviour of the noble gases with respect to their radiogenic parents. Overall, these results show that Earth's mantle accreted volatiles from at least two separate sources and that neither the Moon-forming impact nor 4.45 billion years of mantle convection has erased the signature of Earth's heterogeneous accretion and early differentiation.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Mukhopadhyay, S (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	sujoy@eps.harvard.edu			NSF [EAR 0911363]; Directorate For Geosciences [0911363] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	I thank D. Graham for supplying the Iceland sample, and K. Zahnle, C. Langmuir, S. Stewart and R. Parai for comments. Reviews by C. Ballentine, B. Marty and D. Porcelli helped to improve the paper. This work was supported by NSF grant EAR 0911363.	Albarede F, 2008, SCIENCE, V319, P943, DOI 10.1126/science.1150060; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; Brandenburg JP, 2008, EARTH PLANET SC LETT, V276, P1, DOI 10.1016/j.epsl.2008.08.027; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; Caro G, 2011, ANNU REV EARTH PL SC, V39, P31, DOI 10.1146/annurev-earth-040610-133400; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Gonnermann HM, 2009, NATURE, V459, P560, DOI 10.1038/nature08018; Harrison D, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000325; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Honda M, 1998, GEOPHYS RES LETT, V25, P1951, DOI 10.1029/98GL01329; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Lee CTA, 2010, NATURE, V463, P930, DOI 10.1038/nature08824; MARTY B, 1989, EARTH PLANET SC LETT, V94, P45, DOI 10.1016/0012-821X(89)90082-4; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Pepin RO, 2002, REV MINERAL GEOCHEM, V47, P191, DOI 10.2138/rmg.2002.47.7; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Pujol M, 2011, EARTH PLANET SC LETT, V308, P298, DOI 10.1016/j.epsl.2011.05.053; Raquin A, 2008, EARTH PLANET SC LETT, V274, P142, DOI 10.1016/j.epsl.2008.07.007; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; Trieloff M, 2005, PHYS EARTH PLANET IN, V148, P13, DOI 10.1016/j.pepi.2004.07.007; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Yokochi R, 2005, EARTH PLANET SC LETT, V238, P17, DOI 10.1016/j.epsl.2005.07.020; Yokochi R, 2004, EARTH PLANET SC LETT, V225, P77, DOI 10.1016/j.epsl.2004.06.010	30	242	243	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					101	U124		10.1038/nature11141	http://dx.doi.org/10.1038/nature11141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678288				2022-12-28	WOS:000304854000035
J	Brunham, LR; Hayden, MR				Brunham, Liam R.; Hayden, Michael R.			Whole-Genome Sequencing: The New Standard of Care?	SCIENCE			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS; MUTATION		[Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Brunham, Liam R.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 4H4, Canada; [Hayden, Michael R.] Natl Univ Singapore, Dept Med, TLGM, Singapore 117609, Singapore; [Hayden, Michael R.] ASTAR, Singapore 117609, Singapore	Child & Family Research Institute; University of British Columbia; University of British Columbia; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Hayden, MR (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mayer AN, 2011, GENET MED, V13, P195, DOI 10.1097/GIM.0b013e3182095089; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Wade N, 2010, NY TIMES, pA1; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wright C., 2011, NEXT STEPS SEQUENCE	17	53	57	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1112	1113		10.1126/science.1220967	http://dx.doi.org/10.1126/science.1220967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	950KK	22654044				2022-12-28	WOS:000304647900031
J	Jankowski, P; McKellar, ARW; Szalewicz, K				Jankowski, Piotr; McKellar, A. R. W.; Szalewicz, Krzysztof			Theory Untangles the High-Resolution Infrared Spectrum of the ortho-H-2-CO van der Waals Complex	SCIENCE			English	Article							WEAKLY-BOUND COMPLEX; ROTATIONAL-EXCITATION; MOLECULAR-COMPLEX; ENERGY SURFACE; SPECTROSCOPY; CO-ORTHOD(2); POTENTIALS; H-2-CO; DIMER; CO	Rovibrational spectroscopy of molecules boasts extremely high precision, but its usefulness relies on the assignment of spectral features to corresponding quantum mechanical transitions. In the case of ortho-H-2-CO, a weakly bound complex abundant in the interstellar medium (although not yet observed there), the rather complex spectrum has been unexplained for more than a decade. We assigned this spectrum by comparison with a purely ab initio calculation. For most lines, agreement to within 0.01 centimeter(-1) between experiment and theory was achieved. Our results show that the applicability of rovibrational spectroscopy can be extended with the assistance of high-accuracy quantum mechanical computations.	[Jankowski, Piotr] Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland; [McKellar, A. R. W.] CNR, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Szalewicz, Krzysztof] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA	Nicolaus Copernicus University; National Research Council Canada; University of Delaware	Jankowski, P (corresponding author), Nicholas Copernicus Univ, Fac Chem, Gagarina 7, PL-87100 Torun, Poland.	teojan@chem.umk.pl	Jankowski, Piotr/AFG-8206-2022; Jankowski, Piotr/O-5874-2015	Jankowski, Piotr/0000-0002-2023-5849; Jankowski, Piotr/0000-0002-2023-5849	NSF [CHE-0848589]	NSF(National Science Foundation (NSF))	Supported by NSF grant CHE-0848589.	Bukowski R, 1999, J CHEM PHYS, V110, P3785, DOI 10.1063/1.479108; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; GREEN S, 1976, ASTROPHYS J, V205, P766, DOI 10.1086/154333; Huber K.P., 1979, MOL SPECTRA MOL STRU; Hutson M., 1993, BOUND COMPUTER CODE; Jankowski P, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2008216; Jankowski P, 2004, J CHEM PHYS, V121, P1655, DOI 10.1063/1.1766293; Jankowski P, 1998, J CHEM PHYS, V108, P3554, DOI 10.1063/1.475347; Jankowski P, 2008, CHEM PHYS LETT, V459, P60, DOI 10.1016/j.cplett.2008.05.047; Jankowski P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2906130; Jeziorska M, 2000, J CHEM PHYS, V113, P2957, DOI 10.1063/1.1287058; Jeziorska M, 2003, COLLECT CZECH CHEM C, V68, P463, DOI 10.1135/cccc20030463; McKellar ARW, 2000, J CHEM PHYS, V112, P9282, DOI 10.1063/1.481549; McKellar ARW, 1998, J CHEM PHYS, V108, P1811, DOI 10.1063/1.475558; Pak I, 1999, CHEM PHYS LETT, V304, P145, DOI 10.1016/S0009-2614(99)00312-7; Potapov AV, 2009, ASTROPHYS J, V703, P2108, DOI 10.1088/0004-637X/703/2/2108; Potapov AV, 2009, OPT SPECTROSC+, V106, P655, DOI 10.1134/S0030400X09050051; Surin LA, 2000, J CHEM PHYS, V113, P9351, DOI 10.1063/1.1319349; Wernli M, 2006, ASTRON ASTROPHYS, V446, P367, DOI 10.1051/0004-6361:20053919; Ziolkowski M., 2006, THESIS N COPERNICUS	20	68	68	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1147	1150		10.1126/science.1221000	http://dx.doi.org/10.1126/science.1221000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654055				2022-12-28	WOS:000304647900046
J	Li, DS; Nielsen, MH; Lee, JRI; Frandsen, C; Banfield, JF; De Yoreo, JJ				Li, Dongsheng; Nielsen, Michael H.; Lee, Jonathan R. I.; Frandsen, Cathrine; Banfield, Jillian F.; De Yoreo, James J.			Direction-Specific Interactions Control Crystal Growth by Oriented Attachment	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; NANOCRYSTAL GROWTH; AGGREGATION	The oriented attachment of molecular clusters and nanoparticles in solution is now recognized as an important mechanism of crystal growth in many materials, yet the alignment process and attachment mechanism have not been established. We performed high-resolution transmission electron microscopy using a fluid cell to directly observe oriented attachment of iron oxyhydroxide nanoparticles. The particles undergo continuous rotation and interaction until they find a perfect lattice match. A sudden jump to contact then occurs over less than 1 nanometer, followed by lateral atom-by-atom addition initiated at the contact point. Interface elimination proceeds at a rate consistent with the curvature dependence of the Gibbs free energy. Measured translational and rotational accelerations show that strong, highly direction-specific interactions drive crystal growth via oriented attachment.	[Li, Dongsheng; Nielsen, Michael H.; De Yoreo, James J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Nielsen, Michael H.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Lee, Jonathan R. I.] Lawrence Livermore Natl Lab, Phys Sci Directorate, Livermore, CA 94551 USA; [Frandsen, Cathrine] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [De Yoreo, James J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Denmark; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	De Yoreo, JJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	jjdeyoreo@lbl.gov	Frandsen, Cathrine/A-5729-2011; Frandsen, Cathrine/O-5656-2019; Nielsen, Michael/D-1881-2015; Lee, Jonathan/M-5442-2017	Frandsen, Cathrine/0000-0001-5006-924X; Lee, Jonathan/0000-0001-7316-7643; Banfield, Jill/0000-0001-8203-8771	U.S. Department of Energy, Office of Basic Energy Sciences (OBES), by LBNL [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory (LLNL) [DE-AC52-07NA27344]; Department of Defense; Air Force Office of Scientific Research; National Defense Science and Engineering Graduate Fellowship [32 CFR 168a]; Danish Council for Independent Research	U.S. Department of Energy, Office of Basic Energy Sciences (OBES), by LBNL; Lawrence Livermore National Laboratory (LLNL); Department of Defense(United States Department of Defense); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Defense Science and Engineering Graduate Fellowship; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	We thank V. Altoe and S. Aloni for their assistance with electron microscopy and L. Zhang for his help with analysis of the data. This research was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (OBES), by LBNL under contract no. DE-AC02-05CH11231 and Lawrence Livermore National Laboratory (LLNL) under contract DE-AC52-07NA27344. Development of the TEM fluid cell was supported by the OBES, Division of Chemical, Biological and Geological Sciences; analysis of iron oxide formation was supported by the OBES, Division of Materials Science and Engineering; and cell fabrication and TEM analysis were performed at the Molecular Foundry, LLNL, which is supported by the OBES, Scientific User Facilities Division. M.H.N. acknowledges government support under and awarded by the Department of Defense, the Air Force Office of Scientific Research, and a National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a. C. F. acknowledges support from The Danish Council for Independent Research. Data are available in the supplementary materials.	BALLUFFI RW, 1972, SURF SCI, V31, P68, DOI 10.1016/0039-6028(72)90254-3; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Cao G., 2004, NANOSTRUCTURES NANOM; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Deo N, 1998, INT J MINER PROCESS, V55, P41, DOI 10.1016/S0301-7516(98)00020-9; Frandsen C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214406; HACKNEY SA, 1986, SCRIPTA METALL MATER, V20, P937, DOI 10.1016/0036-9748(86)90470-9; HASSON G, 1972, SURF SCI, V31, P115, DOI 10.1016/0039-6028(72)90256-7; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Janney DE, 2000, CLAY CLAY MINER, V48, P111, DOI 10.1346/CCMN.2000.0480114; Joubert JC, 1997, AN QUIM-INT, V93, pS70; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; Mann S., 2001, BIOMINERALIZATION PR; Passchier C. W., 1998, MICROTECTONICS; Penn RL, 2004, J PHYS CHEM B, V108, P12707, DOI 10.1021/jp036490+; Penn RL, 2001, GEOLOGY, V29, P843, DOI 10.1130/0091-7613(2001)029<0843:IOCOSG>2.0.CO;2; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Penn RL, 1998, AM MINERAL, V83, P1077; Penn RL, 2001, J PHYS CHEM B, V105, P2177, DOI 10.1021/jp003570u; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Randle V, 1996, ROLE CONINCIDENCE SI; Ribeiro C, 2005, CHEMPHYSCHEM, V6, P690, DOI 10.1002/cphc.200400505; Yadong Y., 2005, NATURE, V437, P7059; Yang Y, 2011, INORG CHEM, V50, P10143, DOI 10.1021/ic201104w; Yuwono VM, 2010, J AM CHEM SOC, V132, P2163, DOI 10.1021/ja909769a; Zhang J, 2010, NANOSCALE, V2, P18, DOI 10.1039/b9nr00047j; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	29	803	820	50	947	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1014	1018		10.1126/science.1219643	http://dx.doi.org/10.1126/science.1219643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628650				2022-12-28	WOS:000304406800040
J	Nik-Zainal, S; Alexandrov, LB; Wedge, DC; Van Loo, P; Greenman, CD; Raine, K; Jones, D; Hinton, J; Marshall, J; Stebbings, LA; Menzies, A; Martin, S; Leung, K; Chen, L; Leroy, C; Ramakrishna, M; Rance, R; Lau, KW; Mudie, LJ; Varela, I; McBride, DJ; Bignell, GR; Cooke, SL; Shlien, A; Gamble, J; Whitmore, I; Maddison, M; Tarpey, PS; Davies, HR; Papaemmanuil, E; Stephens, PJ; McLaren, S; Butler, AP; Teague, JW; Jonsson, G; Garber, JE; Silver, D; Miron, P; Fatima, A; Boyault, S; Langerod, A; Tutt, A; Martens, JWM; Aparicio, SAJR; Borg, A; Salomon, AV; Thomas, G; Borresen-Dale, AL; Richardson, AL; Neuberger, MS; Futreal, PA; Campbell, PJ; Stratton, MR				Nik-Zainal, Serena; Alexandrov, Ludmil B.; Wedge, David C.; Van Loo, Peter; Greenman, Christopher D.; Raine, Keiran; Jones, David; Hinton, Jonathan; Marshall, John; Stebbings, Lucy A.; Menzies, Andrew; Martin, Sancha; Leung, Kenric; Chen, Lina; Leroy, Catherine; Ramakrishna, Manasa; Rance, Richard; Lau, King Wai; Mudie, Laura J.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Cooke, Susanna L.; Shlien, Adam; Gamble, John; Whitmore, Ian; Maddison, Mark; Tarpey, Patrick S.; Davies, Helen R.; Papaemmanuil, Elli; Stephens, Philip J.; McLaren, Stuart; Butler, Adam P.; Teague, Jon W.; Jonsson, Goran; Garber, Judy E.; Silver, Daniel; Miron, Penelope; Fatima, Aquila; Boyault, Sandrine; Langerod, Anita; Tutt, Andrew; Martens, John W. M.; Aparicio, Samuel A. J. R.; Borg, Ake; Salomon, Anne Vincent; Thomas, Gilles; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Neuberger, Michael S.; Futreal, P. Andrew; Campbell, Peter J.; Stratton, Michael R.		Int Canc Genome Consortium	Mutational Processes Molding the Genomes of 21 Breast Cancers	CELL			English	Article							DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; SOMATIC HYPERMUTATION; P53 MUTATIONS; GENE; PATTERNS; REARRANGEMENT; TRANSVERSIONS; SIGNATURES; PROGRESS	All cancers carry somatic mutations. The patterns of mutation in cancer genomes reflect the DNA damage and repair processes to which cancer cells and their precursors have been exposed. To explore these mechanisms further, we generated catalogs of somatic mutation from 21 breast cancers and applied mathematical methods to extract mutational signatures of the underlying processes. Multiple distinct single- and double-nucleotide substitution signatures were discernible. Cancers with BRCA1 or BRCA2 mutations exhibited a characteristic combination of substitution mutation signatures and a distinctive profile of deletions. Complex relationships between somatic mutation prevalence and transcription were detected. A remarkable phenomenon of localized hypermutation, termed "kataegis,'' was observed. Regions of kataegis differed between cancers but usually colocalized with somatic rearrangements. Base substitutions in these regions were almost exclusively of cytosine at TpC dinucleotides. The mechanisms underlying most of these mutational signatures are unknown. However, a role for the APOBEC family of cytidine deaminases is proposed.	[Nik-Zainal, Serena; Alexandrov, Ludmil B.; Wedge, David C.; Van Loo, Peter; Greenman, Christopher D.; Raine, Keiran; Jones, David; Hinton, Jonathan; Marshall, John; Stebbings, Lucy A.; Menzies, Andrew; Martin, Sancha; Leung, Kenric; Chen, Lina; Leroy, Catherine; Ramakrishna, Manasa; Rance, Richard; Lau, King Wai; Mudie, Laura J.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Cooke, Susanna L.; Shlien, Adam; Gamble, John; Whitmore, Ian; Maddison, Mark; Tarpey, Patrick S.; Davies, Helen R.; Papaemmanuil, Elli; Stephens, Philip J.; McLaren, Stuart; Butler, Adam P.; Teague, Jon W.; Futreal, P. Andrew; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Greenman, Christopher D.] Univ E Anglia, Dept Comp, Norwich NR4 7TJ, Norfolk, England; [Greenman, Christopher D.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Garber, Judy E.; Silver, Daniel; Miron, Penelope; Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Boyault, Sandrine; Thomas, Gilles] Ctr Leon Berard, INCa Synergie, Fac Med, Lyon 08, France; [Langerod, Anita; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Martens, John W. M.] Erasmus MC, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Jonsson, Goran; Borg, Ake] Lund Univ, Dept Oncol, SE-22184 Lund, Sweden; [Salomon, Anne Vincent] Inst Curie, Dept Pathol, F-75248 Paris 05, France; [Salomon, Anne Vincent] INSERM, U830, F-75248 Paris 05, France; [Borresen-Dale, Anne-Lise] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Inst Clin Med, Fac Med, N-0310 Oslo, Norway; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Neuberger, Michael S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of British Columbia; Harvard University; Dana-Farber Cancer Institute; Institut National du Cancer (INCA) France; UNICANCER; Centre Leon Berard; University of Oslo; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; British Columbia Cancer Agency; Lund University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Wedge, David/AAC-4977-2021; Nik-Zainal, Serena/ABD-4437-2020; Silver, Daniel/P-3443-2019; Jönsson, Göran/D-1212-2014; Van Loo, Peter/A-3287-2012; Alexandrov, Ludmil/AAS-1454-2021; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; Alexandrov, Ludmil/B-6582-2014	Alexandrov, Ludmil/0000-0003-3596-4515; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Alexandrov, Ludmil/0000-0003-3596-4515; Tutt, Andrew/0000-0001-8715-2901; Aparicio, Samuel/0000-0002-0487-9599; Nik-Zainal, Serena/0000-0001-5054-1727; Martin, Sancha/0000-0001-6213-5259; Raine, Keiran/0000-0002-5634-1539; Van Loo, Peter/0000-0003-0292-1949; Wedge, David/0000-0002-7572-3196	Wellcome Trust [098051]; Breakthrough Breast Cancer Research [ICGC 08/09]; Wellcome Trust Clinical Research; Wellcome Trust Senior Clinical Research [WT088340MA]; Research Foundation - Flanders [FWO]; National Research Council Canada; EMBO; International Human Frontier Science Program Organization; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research; Norwegian Research Council; The Norwegian Cancer Society; The Radium Hospital Foundation; Health Region South-East; European Community [242006]; Breast Cancer Somatic Genetics Study [BASIS]; Wellcome Trust Sanger Institute; Breakthrough Breast Cancer Unit; ICGC Breast Cancer Working Group; Oslo University Hospital; United States National Cancer Institute Specialized Program Of Research Excellence [CA089393]; Centre for Translational Genomics (CTAG); Department of Health via NIHR comprehensive Biomedical Research Centre; NHS Foundation Trust, King's College London; King's College Hospital NHS Foundation Trust; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MC_U105178806] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Medical Research Council [MC_U105178806] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer Research; Wellcome Trust Clinical Research; Wellcome Trust Senior Clinical Research(Wellcome Trust); Research Foundation - Flanders [FWO](FWO); National Research Council Canada; EMBO(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Norwegian Research Council(Research Council of NorwayEuropean Commission); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); The Radium Hospital Foundation; Health Region South-East; European Community(European Commission); Breast Cancer Somatic Genetics Study [BASIS]; Wellcome Trust Sanger Institute(Wellcome Trust); Breakthrough Breast Cancer Unit; ICGC Breast Cancer Working Group; Oslo University Hospital; United States National Cancer Institute Specialized Program Of Research Excellence; Centre for Translational Genomics (CTAG); Department of Health via NIHR comprehensive Biomedical Research Centre; NHS Foundation Trust, King's College London; King's College Hospital NHS Foundation Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant reference 098051) and Breakthrough Breast Cancer Research (ICGC 08/09). Individual support: S.N.Z. (Wellcome Trust Clinical Research Training Fellow); P.J.C. (Wellcome Trust Senior Clinical Research Fellow grant reference WT088340MA); P.V.L. (Research Foundation - Flanders [FWO]); A.S. (National Research Council Canada [HL Holmes Award] and EMBO); I.V. (International Human Frontier Science Program Organization); J.W.M.M. (Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research); A.L.B.D. and A.L. (Norwegian Research Council, The Norwegian Cancer Society, The Radium Hospital Foundation and Health Region South-East); S.M (European Community's Seventh Framework Programme [FP7/2010-2014] grant reference 242006 Breast Cancer Somatic Genetics Study [BASIS]). We thank Nancy Miller for her activities related to the curation and collection of the clinical data associated with this study. We acknowledge the Core Sequencing Facility and IT groups of the Wellcome Trust Sanger Institute, the Breakthrough Breast Cancer Unit, members of the ICGC Breast Cancer Working Group, the OSBREAC Consortium of Oslo University Hospital, the United States National Cancer Institute Specialized Program Of Research Excellence (grant reference CA089393) and Dr. Peter Watson of the BCCA Tumour Tissue Repository and the Centre for Translational Genomics (CTAG). The authors acknowledge financial support from the Department of Health via NIHR comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust, King's College London, and King's College Hospital NHS Foundation Trust. We thank George Vassiliou for pointing us to the term "kataegis.'' J.E.G. is a consultant for Generation Health.	Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen JM, 2012, MUTAT RES-REV MUTAT, V750, P52, DOI 10.1016/j.mrrev.2011.10.002; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Hori M, 2011, MUTAT RES-FUND MOL M, V714, P11, DOI 10.1016/j.mrfmmm.2011.05.015; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Mace K, 1997, CARCINOGENESIS, V18, P1291, DOI 10.1093/carcin/18.7.1291; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Palacios J, 2008, PATHOBIOLOGY, V75, P85, DOI 10.1159/000123846; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spencer WA, 2012, CHEM RES TOXICOL, V25, P305, DOI 10.1021/tx200356v; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	60	1210	1233	4	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					979	993		10.1016/j.cell.2012.04.024	http://dx.doi.org/10.1016/j.cell.2012.04.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22608084	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000304453900006
J	Schmidt, EF; Warner-Schmidt, JL; Otopalik, BG; Pickett, SB; Greengard, P; Heintz, N				Schmidt, Eric F.; Warner-Schmidt, Jennifer L.; Otopalik, Benjamin G.; Pickett, Sarah B.; Greengard, Paul; Heintz, Nathaniel			Identification of the Cortical Neurons that Mediate Antidepressant Responses	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; NEURAL CIRCUITS; ANIMAL-MODELS; DEPRESSION; P11; ABNORMALITIES; STIMULATION; MOOD; DISORDERS	Our understanding of current treatments for depression, and the development of more specific therapies, is limited by the complexity of the circuits controlling mood and the distributed actions of antidepressants. Although the therapeutic efficacy of serotonin-specific reuptake inhibitors (SSRIs) is correlated with increases in cortical activity, the cell types crucial for their action remain unknown. Here we employ bacTRAP translational profiling to show that layer 5 corticostriatal pyramidal cells expressing p11 (S100a10) are strongly and specifically responsive to chronic antidepressant treatment. This response requires p11 and includes the specific induction of Htr4 expression. Cortex-specific deletion of p11 abolishes behavioral responses to SSRIs, but does not lead to increased depression-like behaviors. Our data identify corticostriatal projection neurons as critical for the response to antidepressants, and suggest that the regulation of serotonergic tone in this single cell type plays a pivotal role in antidepressant therapy.	[Schmidt, Eric F.; Otopalik, Benjamin G.; Pickett, Sarah B.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Warner-Schmidt, Jennifer L.; Greengard, Paul] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@rockefeller.edu	Schmidt, Eric F./AAE-8723-2019	Schmidt, Eric F./0000-0002-7869-0270; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute; NIH/NIDA ARRA [PHS DA028968]; Conte Center [PHS MH090963]; USAMRAA [W81XWH-09-0401]; JPB Foundation; Fisher Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028968] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIDA ARRA; Conte Center; USAMRAA; JPB Foundation; Fisher Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute (N.H.), NIH/NIDA ARRA Grand Opportunity Grant PHS DA028968 (N.H., P.G.), Conte Center PHS MH090963 (P.G., N.H.), USAMRAA grant W81XWH-09-0401 (J.W.S.), the JPB Foundation (P.G.), and the Fisher Foundation (P.G.). We thank the Rockefeller University Genomics Resource Center, and Neuroscience Associates. We would further like to thank Tanya Stevens, Sujata Bupp, and George Skabardonis for their excellent advice and assistance, and Joseph Dougherty for providing the Snap25 bacTRAP mice. N.H. and P.G. are cofounders of, and consults for, Envoy Therapeutics.	Anisman H, 2008, J PSYCHIATR NEUROSCI, V33, P131; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Egeland M, 2011, NEUROPHARMACOLOGY, V61, P442, DOI 10.1016/j.neuropharm.2011.01.046; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108; Warner-Schmidt JL, 2010, BIOL PSYCHIAT, V68, P528, DOI 10.1016/j.biopsych.2010.04.029; Warner-Schmidt JL, 2009, J NEUROSCI, V29, P1937, DOI 10.1523/JNEUROSCI.5343-08.2009	31	92	94	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1152	1163		10.1016/j.cell.2012.03.038	http://dx.doi.org/10.1016/j.cell.2012.03.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632977	Green Accepted, Bronze			2022-12-28	WOS:000304453900019
J	Bonser, RS; Taylor, R; Collett, D; Thomas, HL; Dark, JH; Neuberger, J				Bonser, Robert S.; Taylor, Rhiannon; Collett, David; Thomas, Helen L.; Dark, John H.; Neuberger, James		Cardiothoracic Advisory Grp NHS; Assoc Lung Transplant Phys UK	Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry	LANCET			English	Article							OFFICIAL ADULT LUNG; INTERNATIONAL SOCIETY; RISK-FACTORS; OUTCOMES; CRITERIA; IMPACT; DEATH; HEART; EXPERIENCE; MANAGEMENT	Background The risk that a positive smoking history in lung donors could adversely affect survival of transplant recipients causes concern. Conversely, reduction of the donor pool by exclusion of donors with positive smoking histories could compromise survival of patients waiting to receive a transplant. We examined the consequences of donor smoking on post-transplantation survival, and the potential effect of not transplanting lungs from such donors. Methods We analysed the effect of donor smoking on 3 year survival after first adult lung transplantation from brain-dead donors done between July 1, 1999, and Dec 31, 2010, by Cox regression modelling of data from the UK Transplant Registry. We estimated the effect of acceptance of lungs from donors with positive smoking histories on survival and compared it with the effect of remaining on the waiting list for a potential transplant from a donor with a negative smoking history donor, by analysing all waiting-list registrations during the same period with a risk-adjusted sequentially stratified Cox regression model. Findings Of 1295 lung transplantations, 510 (39%) used lungs from donors with positive smoking histories. Recipients of such lungs had worse 3 year survival after transplantation than did those who received lungs from donors with negative smoking histories (unadjusted hazard ratio [HR] 1.46, 95% CI 1.20-1.78; adjusted HR 1.36, 1.11-1.67). Independent factors affecting survival were recipient's age, donor-recipient cytomegalovirus matching, donor-recipient height difference, donor's sex, and total ischaemic time. Of 2181 patients registered on the waiting list, 802 (37%) died or were removed from the list without receiving a transplant. Patients receiving lungs from donors with positive smoking histories had a lower unadjusted hazard of death after registration than did those who remained on the waiting list (0.79, 95% CI 0.70-0.91). Patients with septic or fibrotic lung disease registered in 1999-2003 had risk-adjusted hazards of 0.60 (95% CI 0.42-0.87) and 0.39 (0.28-0.55), respectively. Interpretation In the UK, an organ selection policy that uses lungs from donors with positive smoking histories improves overall survival of patients registered for lung transplantation, and should be continued. Although lungs from such donors are associated with worse outcomes, the individual probability of survival is greater if they are accepted than if they are declined and the patient chooses to wait for a potential transplant from a donor with a negative smoking history. This situation should be fully explained to and discussed with patients who are accepted for lung transplantation.	[Bonser, Robert S.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Bonser, Robert S.] Univ Birmingham, Birmingham, W Midlands, England; [Bonser, Robert S.] Cardiothorac Advisory Grp NHS Blood & Transplant, Bristol, Avon, England; [Taylor, Rhiannon; Collett, David; Thomas, Helen L.; Neuberger, James] NHS Blood & Transplant, Bristol, Avon, England; [Dark, John H.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Birmingham; University of Birmingham; Newcastle University - UK	Bonser, RS (corresponding author), Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England.	robert.bonser@uhb.nhs.uk	Neuberger, James/ABG-3010-2020	Thompson, Richard/0000-0003-1523-0944; Collett, David/0000-0003-4861-7627; Townend, Jonathan/0000-0002-5881-5806	National Health Service Blood and Transplant	National Health Service Blood and Transplant	National Health Service Blood and Transplant.	Aigner C, 2005, EUR J CARDIO-THORAC, V27, P757, DOI 10.1016/j.ejcts.2005.01.024; Alvarez A, 2010, EUR J CARDIO-THORAC, V37, P432, DOI 10.1016/j.ejcts.2009.08.011; Angel LF, 2006, AM J RESP CRIT CARE, V174, P710, DOI 10.1164/rccm.200603-432OC; Berman M, 2010, ANN THORAC SURG, V90, P1786, DOI 10.1016/j.athoracsur.2010.07.073; Bhorade SM, 2000, J HEART LUNG TRANSPL, V19, P1199, DOI 10.1016/S1053-2498(00)00215-1; Botha P, 2006, J THORAC CARDIOV SUR, V131, P1154, DOI 10.1016/j.jtcvs.2005.12.037; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Christie JD, 2009, J HEART LUNG TRANSPL, V28, P1031, DOI 10.1016/j.healun.2009.08.004; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; de Perrot M, 2007, J THORAC CARDIOV SUR, V133, P525, DOI 10.1016/j.jtcvs.2006.09.054; EGAN TM, 1992, TRANSPLANTATION, V53, P420, DOI 10.1097/00007890-199202010-00029; Gabbay E, 1999, AM J RESP CRIT CARE, V160, P265, DOI 10.1164/ajrccm.160.1.9811017; Ganesh JS, 2007, J HEART LUNG TRANSPL, V26, pS183, DOI 10.1016/j.healun.2006.11.362; Ganesh JS, 2005, J HEART LUNG TRANSPL, V24, P1544, DOI 10.1016/j.healun.2004.11.316; GROSSMAN RF, 1990, NEW ENGL J MED, V322, P727, DOI 10.1056/NEJM199003153221104; Mason DP, 2009, J THORAC CARDIOV SUR, V137, P1234, DOI 10.1016/j.jtcvs.2008.10.024; NHS Blood and Transplant-British Transplantation Society, GUID CONS SOL ORG TR; Office for National Statistics, GEN LIF SURV 2009; Oto T, 2004, TRANSPLANTATION, V78, P599, DOI 10.1097/01.TP.0000131975.98323.13; Oto T, 2007, ANN THORAC SURG, V83, P257, DOI 10.1016/j.athoracsur.2006.07.040; Pierre AF, 2002, J THORAC CARDIOV SUR, V123, P421, DOI 10.1067/mtc.2002.120345; Reyes KG, 2010, ANN THORAC SURG, V89, P1756, DOI 10.1016/j.athoracsur.2010.02.056; Schaubel DE, 2006, BIOMETRICS, V62, P910, DOI 10.1111/j.1541-0420.2006.00527.x; Shigemura N, 2011, J HEART LUNG TRANSPL, V30, pS109, DOI 10.1016/j.healun.2011.01.322; Snell GI, 2008, J HEART LUNG TRANSPL, V27, P662, DOI 10.1016/j.healun.2008.03.009; SUNDARESAN S, 1995, J THORAC CARDIOV SUR, V109, P1075, DOI 10.1016/S0022-5223(95)70190-7; SUNDARESAN S, 1993, ANN THORAC SURG, V56, P1409, DOI 10.1016/0003-4975(93)90699-I; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Van Raemdonck Dirk, 2009, Proc Am Thorac Soc, V6, P28, DOI 10.1513/pats.200808-098GO; Wald N, 1991, US SMOKING STAT; Wang Q, 2011, TRANSPLANTATION, V91, P921, DOI 10.1097/TP.0b013e31821060b5; Wauters S, 2011, EUR J CARDIO-THORAC, V39, pE68, DOI 10.1016/j.ejcts.2010.11.049; Whitson BA, 2006, J THORAC CARDIOV SUR, V131, P73, DOI 10.1016/j.jtcvs.2005.08.039	34	103	106	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					747	755		10.1016/S0140-6736(12)60160-3	http://dx.doi.org/10.1016/S0140-6736(12)60160-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22647758				2022-12-28	WOS:000308001300032
J	Shim, SB; Kwan, KY; Li, MF; Lefebvre, V; Sestan, N				Shim, Sungbo; Kwan, Kenneth Y.; Li, Mingfeng; Lefebvre, Veronique; Sestan, Nenad			Cis-regulatory control of corticospinal system development and evolution	NATURE			English	Article							DEVELOPING CEREBRAL-CORTEX; SUBCORTICAL PROJECTION NEURONS; REELIN SIGNALING PATHWAY; ZINC-FINGER GENE; EXPRESSION PATTERNS; MAMMALIAN NEOCORTEX; DESCENDING PATHWAYS; LAMINAR IDENTITY; PYRAMIDAL TRACT; AXON GUIDANCE	The co-emergence of a six-layered cerebral neocortex and its corticospinal output system is one of the evolutionary hallmarks of mammals. However, the genetic programs that underlie their development and evolution remain poorly understood. Hereweidentify a conserved non-exonic element (E4) that acts as a cortex-specific enhancer for the nearby gene Fezf2 (also known as Fezl and Zfp312), which is required for the specification of corticospinal neuron identity and connectivity. We find that SOX4 and SOX11 functionally compete with the repressor SOX5 in the transactivation of E4. Cortex-specific double deletion of Sox4 and Sox11 leads to the loss of Fezf2 expression, failed specification of corticospinal neurons and, independent of Fezf2, a reeler-like inversion of layers. We show evidence supporting the emergence of functional SOX-binding sites in E4 during tetrapod evolution, and their subsequent stabilization in mammals and possibly amniotes. These findings reveal that SOX transcription factors converge onto a cis-acting element of Fezf2 and form critical components of a regulatory network controlling the identity and connectivity of corticospinal neurons.	[Shim, Sungbo; Kwan, Kenneth Y.; Li, Mingfeng; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Shim, Sungbo; Kwan, Kenneth Y.; Li, Mingfeng; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Orthopaed & Rheumatol Res Ctr, Cleveland, OH 44195 USA	Yale University; Yale University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Kwan, Kenneth/AAI-2841-2021; Kwan, Kenneth Y/F-8489-2011	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X	National Institutes of Health [NS054273, MH081896, AR54153]; March of Dimes Foundation; McDonnell Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); McDonnell Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Han, Y. Imamura Kawasawa, D. Liu and T. Nottoli for technical help; A. Giraldez and A. M. M. Sousa for reagents; and the Sestan laboratory for discussions. This work was supported by the National Institutes of Health (NS054273, MH081896, AR54153), the March of Dimes Foundation and a McDonnell Scholar Award (N.S.).	Bar I, 2000, TRENDS NEUROSCI, V23, P633, DOI 10.1016/S0166-2236(00)01675-1; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Butler AB, 2011, ANN NY ACAD SCI, V1225, P14, DOI 10.1111/j.1749-6632.2011.06006.x; Canty AJ, 2008, PROG NEUROBIOL, V85, P214, DOI 10.1016/j.pneurobio.2008.02.001; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; Hobert O, 2010, TRENDS NEUROSCI, V33, P435, DOI 10.1016/j.tins.2010.05.006; Inoue K, 2004, EUR J NEUROSCI, V20, P2909, DOI 10.1111/j.1460-9568.2004.03763.x; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Joosten EAJ, 1999, J ANAT, V194, P15, DOI 10.1046/j.1469-7580.1999.19410015.x; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lo-Castro A, 2009, EUR J MED GENET, V52, P67, DOI 10.1016/j.ejmg.2008.09.004; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; NUDO RJ, 1990, J COMP NEUROL, V296, P584, DOI 10.1002/cne.902960406; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Penzo-Mendez A, 2007, GENESIS, V45, P776, DOI 10.1002/dvg.20358; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; STEINDLER DA, 1976, BRAIN RES, V113, P386, DOI 10.1016/0006-8993(76)90949-5; ten Donkelaar HJ, 2004, J NEUROL, V251, P1429, DOI 10.1007/s00415-004-0653-3; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wild JM, 2000, J COMP NEUROL, V416, P429; Williamson I, 2011, DEV CELL, V21, P17, DOI 10.1016/j.devcel.2011.06.008; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	55	129	131	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					74	U177		10.1038/nature11094	http://dx.doi.org/10.1038/nature11094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678282	Green Accepted			2022-12-28	WOS:000304854000029
J	Spence, D				Spence, Des			Bad medicine: dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Alzheimer's Disease International, ANN REP 2010 2011; ALZselftest, 2012, SELFT; [Anonymous], WORLD ALZH REP 2011; Bentham P, 2004, LANCET, V363, P2105; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Chan A, 2011, HUFFINGTON POST 1114; Kmietowicz Z, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2347; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; National Institute for Health and Care Excellence [NICE], 2011, DON GAL RIV MEM TREA; Schrag A, 2012, J NEUROL NEUROSUR PS, V83, P171, DOI 10.1136/jnnp-2011-300881	10	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2012	344								e3859	10.1136/bmj.e3859	http://dx.doi.org/10.1136/bmj.e3859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HK	22661738				2022-12-28	WOS:000304857600018
J	McCartney, M				McCartney, Margaret			The rise of the pop psychologists	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, CBS NEWS        0427; British Psychological Society, ETH MED INF MEMB; Hemmings Jo, CELEBRITY PSYCHOL; ITV, SAM BRICK ITV THIS M; Moise K, 2012, ABC NEWS        0427; Netmums Coffee House Chat, 2011, WEBCH POTT TRAIN EXP; Wessely S, 2012, LANCET, V379, P1563, DOI 10.1016/S0140-6736(12)60655-2	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 30	2012	344								e3541	10.1136/bmj.e3541	http://dx.doi.org/10.1136/bmj.e3541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HA	22613875				2022-12-28	WOS:000304856400001
J	Moynihan, R; Doust, J; Henry, D				Moynihan, Ray; Doust, Jenny; Henry, David			Preventing overdiagnosis: how to stop harming the healthy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INVASIVE BREAST-CANCER; CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; CLASSIFICATION; DIAGNOSIS; SATISFACTION; PERFORMANCE; DEFINITION; ATTENTION; TIME		[Moynihan, Ray; Doust, Jenny] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Robina, Qld, Australia; [Henry, David] Inst Clin Evaluat Sci, Toronto, ON, Canada	Bond University; University of Toronto	Moynihan, R (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Robina, Qld, Australia.	raymoynihan@bond.edu.au	Henry, David/AAJ-4332-2020; Henry, David/AAU-4650-2020; Doust, Jenny/AGI-8773-2022; Moynihan, Ray/ABC-3010-2020	Henry, David/0000-0003-2934-2242; Henry, David/0000-0001-7169-7704; Doust, Jenny/0000-0002-4024-9308; 				Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Abramson J., 2004, OVERDOSED AM BROKEN; Ahmed AIH, 1997, OSTEOPOROSIS INT, V7, P432, DOI 10.1007/s001980050029; Angell M, 2011, NEW YORK REV BO 0623; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Black WC, 1998, EUR J RADIOL, V27, P116, DOI 10.1016/S0720-048X(97)00160-5; Brownlee S., 2007, OVERTREATED WHY TOO; Carrier M, 2011, STUDY EVALUATE SAFET; Cundy T, 2012, DIABETIC MED, V29, P176, DOI 10.1111/j.1464-5491.2011.03407.x; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Eknoyan G, 2007, KIDNEY INT, V72, P1183, DOI 10.1038/sj.ki.5002576; Elmore JG, 2012, ANN INTERN MED, V156, P536, DOI 10.7326/0003-4819-156-7-201204030-00012; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; Glassock RJ, 2009, KIDNEY INT, V75, P1001, DOI 10.1038/ki.2009.38; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; Healy D, 2006, PLOS MED, V3, P441, DOI 10.1371/journal.pmed.0030185; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Herndon MB, 2007, HEALTH AFFAIR, V26, P1702, DOI 10.1377/hlthaff.26.6.1702; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Kramer B, 2012, CURRENT FUTURE PERSP; Lauer MS, 2011, ARCH INTERN MED, V171, P1268, DOI 10.1001/archinternmed.2011.205; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucas AEM, 2008, FAM PRACT, V25, P86, DOI 10.1093/fampra/cmn006; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Morrow RL, 2012, CAN MED ASSOC J, V184, P755, DOI 10.1503/cmaj.111619; Moynihan, 2005, SELLING SICKNESS WOR; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2010, BMJ-BRIT MED J, V341, pc5050; Moynihan R, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2548; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Prasad V, 2012, ARCH INTERN MED  APR; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Reich JM, 2008, THORAX, V63, P377, DOI 10.1136/thx.2007.079673; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; Schwartz L M, 1999, Eff Clin Pract, V2, P76; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Taylor BC, 2011, J GEN INTERN MED, V26, P685, DOI 10.1007/s11606-011-1660-6; Thomas R, 2012, OV M COOL 29 30 APR; Welch GH, 2011, OVER DIAGNOSED MAKIN; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Winearls CG, 2010, NEFROLOGIA, V30, P493, DOI 10.3265/Nefrologia.pre2010.Jul.10501; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013; Woolf SH, 2012, JAMA-J AM MED ASSOC, V307, P565, DOI 10.1001/jama.2012.100; 2002, AM J KIDNEY DIS S1, V39, pS17	54	421	429	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2012	344								e3502	10.1136/bmj.e3502	http://dx.doi.org/10.1136/bmj.e3502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645185				2022-12-28	WOS:000304855700005
J	Karaberopoulos, D; Karamanou, M; Androutsos, G				Karaberopoulos, Demetrios; Karamanou, Marianna; Androutsos, George			The art of medicine The theriac in antiquity	LANCET			English	Editorial Material									[Karaberopoulos, Demetrios; Karamanou, Marianna; Androutsos, George] Univ Athens, Sch Med, Hist Med Dept, Athens 14564, Greece	Athens Medical School; National & Kapodistrian University of Athens	Karamanou, M (corresponding author), Univ Athens, Sch Med, Hist Med Dept, Athens 14564, Greece.	mkaramanou@med.uoa.gr	Karamanou, Marianna/AAA-3497-2020; Androutsos, Georges/AAA-3504-2020	Karamanou, Marianna/0000-0002-1307-7707; 				Galen, 1965, THERIACA AD PISONEM; Mattern S. P., 2008, GALEN RHETORIC HEALI; Porter Roy, 1995, DRUGS NARCOTICS HIST; Thompson C.J.S, 1929, MYSTERY ART APOTHECA; Watson G, 1966, THERIAC MITHRIDATUM	5	16	16	6	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1942	1943		10.1016/S0140-6736(12)60846-0	http://dx.doi.org/10.1016/S0140-6736(12)60846-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	951YV	22645742				2022-12-28	WOS:000304757700017
J	Tomita, M; Kami, K				Tomita, Masaru; Kami, Kenjiro			Systems Biology, Metabolomics, and Cancer Metabolism	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY; HIGH-THROUGHPUT; CELL; GLYCINE		[Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan; Human Metabolome Technol Inc, Tsuruoka, Yamagata 9970052, Japan	Keio University; Keio University	Tomita, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970035, Japan.	mt@sfc.keio.ac.jp						Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; WEINBERG JM, 1987, J CLIN INVEST, V80, P1446, DOI 10.1172/JCI113224; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	15	63	66	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					990	991		10.1126/science.1223066	http://dx.doi.org/10.1126/science.1223066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628644				2022-12-28	WOS:000304406800031
J	Yudkin, JS				Yudkin, John S.			PERSONAL VIEW The drug industry is a barrier to diabetes care in poor countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TIME		UCL, London WC1E 6BT, England	University of London; University College London	Yudkin, JS (corresponding author), UCL, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008					18th Expert Committee on the Selection and Use of Essential Medicines, 2011, REV EV COMP INS HUM; Access To Medicine Index, IND 2010; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Lincoln P, 2011, LANCET, V378, pE6, DOI 10.1016/S0140-6736(11)61463-3; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; NovoNordisk, 2012, OUR TRIPL BOTT LIN; Preiss D, 2011, LANCET, V378, P106, DOI 10.1016/S0140-6736(11)60819-2; World Health Organization, 2011, UN REP 18 EXP COMM S; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; Yudkin JS, 2011, IDF DEB WORLD DIAB C	17	3	3	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2012	344								e3018	10.1136/bmj.e3018	http://dx.doi.org/10.1136/bmj.e3018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QV	22636786				2022-12-28	WOS:000304591800001
J	Falchook, GS; Long, GV; Kurzrock, R; Kim, KB; Arkenau, TH; Brown, MP; Hamid, O; Infante, JR; Millward, M; Pavlick, AC; O'Day, SJ; Blackman, SC; Curtis, CM; Lebowitz, P; Ma, B; Ouellet, D; Kefford, RF				Falchook, Gerald S.; Long, Georgina V.; Kurzrock, Razelle; Kim, Kevin B.; Arkenau, Tobias H.; Brown, Michael P.; Hamid, Omid; Infante, Jeffrey R.; Millward, Michael; Pavlick, Anna C.; O'Day, Steven J.; Blackman, Samuel C.; Curtis, C. Martin; Lebowitz, Peter; Ma, Bo; Ouellet, Daniele; Kefford, Richard F.			Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial	LANCET			English	Article							RAF INHIBITOR RESISTANCE; B-RAF; SURVIVAL; BRAF(V600E); PATHWAY; VEMURAFENIB; IRRADIATION; MUTATIONS; CANCER	Background Dabrafenib is an inhibitor of BRAF kinase that is selective for mutant BRAF. We aimed to assess its safety and tolerability and to establish a recommended phase 2 dose in patients with incurable solid tumours, especially those with melanoma and untreated, asymptomatic brain metastases. Methods We undertook a phase 1 trial between May 27, 2009, and March 20, 2012, at eight study centres in Australia and the USA. Eligible patients had incurable solid tumours, were 18 years or older, and had adequate organ function. BRAF mutations were mandatory for inclusion later in the study because of an absence of activity in patients with wild-type BRAF. We used an accelerated dose titration method, with the first dose cohort receiving 12 mg dabrafenib daily in a 21-day cycle. Once doses had been established, we expanded the cohorts to include up to 20 patients. On the basis of initial data, we chose a recommended phase 2 dose. Efficacy at the recommended phase 2 dose was studied in patients with BRAF-mutant tumours, including those with non-Val600Glu mutations, in three cohorts: metastatic melanoma, melanoma with untreated brain metastases, and non-melanoma solid tumours. This study is registered with ClinicalTrials.gov, number NCT00880321. Findings We enrolled 184 patients, of whom 156 had metastatic melanoma. The most common treatment-related adverse events of grade 2 or worse were cutaneous squamous-cell carcinoma (20 patients, 11%), fatigue (14, 8%), and pyrexia (11, 6%). Dose reductions were necessary in 13 (7%) patients. No deaths or discontinuations resulted from adverse events, and 140 (76%) patients had no treatment-related adverse events worse than grade 2. Doses were increased to 300 mg twice daily, with no maximum tolerated dose recorded. On the basis of safety, pharmacokinetic, and response data, we selected a recommended phase 2 dose of 150 mg twice daily. At the recommended phase 2 dose in 36 patients with Val600 BRAF-mutant melanoma, responses were reported in 25 (69%, 95% CI 51.9-83.7) and confirmed responses in 18 (50%, 32.9-67.1). 21 (78%, 57.7-91.4) of 27 patients with Val600Glu BRAF-mutant melanoma responded and 15 (56%, 35.3-74.5) had a confirmed response. In Val600 BRAF-mutant melanoma, responses were durable, with 17 patients (47%) on treatment for more than 6 months. Responses were recorded in patients with non-Val600Glu BRAF mutations. In patients with melanoma and untreated brain metastases, nine of ten patients had reductions in size of brain lesions. In 28 patients with BRAF-mutant non-melanoma solid tumours, apparent antitumour activity was noted in a gastrointestinal stromal tumour, papillary thyroid cancers, non-small-cell lung cancer, ovarian cancer, and colorectal cancer. Interpretation Dabrafenib is safe in patients with solid tumours, and an active inhibitor of Val600-mutant BRAF with responses noted in patients with melanoma, brain metastases, and other solid tumours.	[Falchook, Gerald S.; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA; [Kim, Kevin B.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Long, Georgina V.; Kefford, Richard F.] Univ Sydney, Melanoma Inst Australia, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; [Long, Georgina V.; Kefford, Richard F.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Long, Georgina V.; Kefford, Richard F.] Univ Sydney, Dept Med Oncol, Westmead Hosp, Sydney, NSW 2006, Australia; [Arkenau, Tobias H.] Prince Wales Hosp, GlaxoSmithKline Med Res Unit, Randwick, NSW 2031, Australia; [Brown, Michael P.] Univ Adelaide, Adelaide, SA, Australia; [Brown, Michael P.] Royal Adelaide Hosp, Canc Clin Trials Unit, Adelaide, SA 5000, Australia; [Hamid, Omid; O'Day, Steven J.] Angeles Clin & Res Inst, Los Angeles, CA USA; [Infante, Jeffrey R.] Sarah Cannon Res Inst, Drug Dev Unit, Nashville, TN USA; [Millward, Michael] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Millward, Michael] Univ Western Australia, Perth, WA 6009, Australia; [Pavlick, Anna C.] NYU, Sch Med, Div Med Oncol, New York, NY USA; [Blackman, Samuel C.; Curtis, C. Martin; Lebowitz, Peter; Ma, Bo; Ouellet, Daniele] GlaxoSmithKline Res & Dev Ltd, Philadelphia, PA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Melanoma Institute Australia; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Adelaide; Royal Adelaide Hospital; Angeles Clinic & Research Institute; Sarah Cannon Research Institute; University of Western Australia; University of Western Australia; New York University; GlaxoSmithKline	Falchook, GS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA.	gfalchoo@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020; Millward, Michael/H-5456-2014; Long, Georgina V/C-1771-2013; Brown, Michael/C-2081-2014	Long, Georgina V/0000-0001-8894-3545; Kefford, Richard/0000-0001-9251-9229; Brown, Michael/0000-0002-5796-1932	GlaxoSmithKline; Merck; Sharp; Dohme; Pfizer; Roche; Genentech; Bristol-Myers Squibb; Arqule; Cancer Institute NSW; Royal Australasian College of Physicians; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sharp; Dohme; Pfizer(Pfizer); Roche(Roche Holding); Genentech(Roche HoldingGenentech); Bristol-Myers Squibb(Bristol-Myers Squibb); Arqule; Cancer Institute NSW; Royal Australasian College of Physicians(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding GlaxoSmithKline.; GSF has received support for congress attendance from GlaxoSmithKline. The Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas received research funds from GlaxoSmithKline on behalf of GSF and RK. GVL has received honoraria from GlaxoSmithKline and Roche; support for congress attendance from GlaxoSmithKline; and payment for lectures from Merck, Sharp and Dohme, and Pfizer. The Melanoma Institute Australia received educational grants from Roche. MPB received consultancy fees from GlaxoSmithKline. OH received payment for lectures from Genentech and Bristol-Myers Squibb; and The Angeles Clinic received grants for clinical trials from Arqule, Bristol-Myers Squibb, Genentech, and Roche. The Drug Development Unit (Sarah Cannon Research Institute, Nashville, TN, USA) received consulting fees and support for congress attendance on behalf of JRI, who has no additional conflicts of interest. MM has received consultancy fees, and the Cancer Council Trials, and Sir Charles Gairdner Hospital, and University of Western Australia have received research funding, from GlaxoSmithKline. SCB, CMC, BM, and DO are employees of GlaxoSmithKline and hold stock options. PL was an employee of GlaxoSmithKline at the time of the study and holds stock options. RFK has received consultancy fees and support for travel from GlaxoSmithKline, and payment for lectures and board membership from Merck, Sharp and Dohme, Pfizer, and Roche. The Melanoma Institute Australia, University of Sydney, and Westmead Institute for Cancer Research have received fees for board membership from Merck, Sharp and Dohme, and Roche; and support for congress attendance and research grants from Roche. KBK, THA, AP, and SJO'D declare that they have no conflicts of interest.; GlaxoSmithKline funded and sponsored this study. GVL was supported by Fellowships from the Cancer Institute NSW (2009, 2011) and the Royal Australasian College of Physicians (2010). We thank the patients and their families for their participation; and Vicky Wegener, Natalie Byrne, Peter Carr, Arthur Clements, Matteo Carlino, Alexander Menzies, Pablo Fernandez-Penas, Rachael Anforth, Julie Howle, Deirdre d'Souza, Catriona McNeil, Sayed Ali, Lydia Visintin, John Thompson, Michael Hughes, Peter Barry, Jonathon Stretch, Robyn Saw, Andrew Spillane, Kerwin Shannon, Michael Quinn, Raghwa Sharma, Richard Scolyer, Cliff Meldrum, Sandie Grierson, Candace Carter, Valerie Jakrot, Emma Zhang, Melvin Chin, Robyn Ward, Franziska Loehrer, Haby Henary, Judith Christmas, Catrina Coverdale, Colleen Fitzgerald, Rebecca Tunstall, John Sullivan, Francine McCarty, Christine Smith, Susannah Chang, Jolly Mazumdar, Monica Barbee, Vicki Goodman, Jeff Legos, Bill Bell, and Mary Richardson for their contributions to the study's operation. Editorial support in the form of comment collation, checking of facts, and graphic services was provided by Alison Scott at MediTech Media and was funded by GlaxoSmithKline.	Agarwala SS, 2004, J CLIN ONCOL, V22, P2101, DOI 10.1200/JCO.2004.11.044; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Carlino MS, 2010, PIGM CELL MELANOMA R, V23, P874; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2011, CANCER-AM CANCER SOC, V117, P1687, DOI 10.1002/cncr.25634; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Laquerre S, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B88; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; Mornex F, 2003, MELANOMA RES, V13, P97, DOI 10.1097/00008390-200302000-00016; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Simon P, 1997, J NATL CANCER I, V89, P1138; Skibber JM, 1996, ANN SURG ONCOL, V3, P118, DOI 10.1007/BF02305789; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellcome Trust Sanger Institute, 2011, CAT SOM MUT CANC; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	34	693	711	3	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1893	1901		10.1016/S0140-6736(12)60398-5	http://dx.doi.org/10.1016/S0140-6736(12)60398-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22608338	Green Accepted			2022-12-28	WOS:000304194200031
J	Wardill, TJ; List, O; Li, XF; Dongre, S; McCulloch, M; Ting, CY; O'Kane, CJ; Tang, SM; Lee, CH; Hardie, RC; Juusola, M				Wardill, Trevor J.; List, Olivier; Li, Xiaofeng; Dongre, Sidhartha; McCulloch, Marie; Ting, Chun-Yuan; O'Kane, Cahir J.; Tang, Shiming; Lee, Chi-Hon; Hardie, Roger C.; Juusola, Mikko			Multiple Spectral Inputs Improve Motion Discrimination in the Drosophila Visual System	SCIENCE			English	Article							PHOTORECEPTOR CELLS; WILD-TYPE; COLOR; MELANOGASTER; RHODOPSIN; PATHWAYS; CHANNEL; STIMULATION; DISSECTION; BEHAVIOR	Color and motion information are thought to be channeled through separate neural pathways, but it remains unclear whether and how these pathways interact to improve motion perception. In insects, such as Drosophila, it has long been believed that motion information is fed exclusively by one spectral class of photoreceptor, so-called R1 to R6 cells; whereas R7 and R8 photoreceptors, which exist in multiple spectral classes, subserve color vision. Here, we report that R7 and R8 also contribute to the motion pathway. By using electrophysiological, optical, and behavioral assays, we found that R7/R8 information converge with and shape the motion pathway output, explaining flies' broadly tuned optomotor behavior by its composite responses. Our results demonstrate that inputs from photoreceptors of different spectral sensitivities improve motion discrimination, increasing robustness of perception.	[Wardill, Trevor J.; List, Olivier; Li, Xiaofeng; Dongre, Sidhartha; McCulloch, Marie; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Li, Xiaofeng; Tang, Shiming; Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Ting, Chun-Yuan; Lee, Chi-Hon] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB3 2EG, England	University of Sheffield; Beijing Normal University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cambridge; University of Cambridge	Juusola, M (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011; O'Kane, Cahir/Q-6681-2019; List, Olivier/F-3049-2011; Ting, chun-yuan/F-6448-2013; Lee, Chi-Hon/G-9190-2012	O'Kane, Cahir/0000-0002-3488-2078; List, Olivier/0000-0002-8302-8089; Ting, chun-yuan/0000-0002-2302-4203; Lee, Chi-Hon/0000-0002-6138-711X; Dongre, Sidhartha/0000-0003-2575-4362; Hardie, Roger/0000-0001-5531-3264; Wardill, Trevor/0000-0002-2049-113X; Juusola, Mikko/0000-0002-4428-5330	Gatsby Charitable Foundation [GAT2839]; State Key Laboratory of Cognitive Neuroscience and Learning; Biotechnology and Biological Sciences Research Council [BB/H013849/1, BB/F012071/1, BB/G006865/1, BB/D007585/1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD008776-06]; NSFC [30810103906]; Biotechnology and Biological Sciences Research Council [BB/D001900/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008776] Funding Source: NIH RePORTER; BBSRC [BB/H013849/1, BB/G006865/1, BB/F012071/1, BB/D001900/1] Funding Source: UKRI	Gatsby Charitable Foundation; State Key Laboratory of Cognitive Neuroscience and Learning; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSFC(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. de Polavieja and people of the Juusola lab for discussions and I. Meinertzhagen and P. Gonzalez Bellido for assistance with electron microscopy. The work was supported by the Gatsby Charitable Foundation (GAT2839: M.J.), the open research fund of the State Key Laboratory of Cognitive Neuroscience and Learning (M.J. and S.T.), the Biotechnology and Biological Sciences Research Council grants (BB/H013849/1 and BB/F012071/1: M.J.) and (BB/G006865/1 and BB/D007585/1: R.C.H.), and the Intramural Research Program of Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD008776-06: C.H.L.), the NSFC project (30810103906: S.T. and M.J.). The authors declare no competing financial interests. Supplementary materials accompany the paper on Science Online. Author contributions: Project initiation: M.J.; genetics: T.J.W., O.L., C.H.L., R.C.H., C.J.O'K., X.L.; electrophysiology: X.L., M.J., R.C.H., T.J.W.; behavior: S.D., M.M.C., T.J.W., M.J., S.T.; imaging: O.L., T.J.W., S.D., M.J.; electronmicroscopy: T.J.W.; immunohistochemistry: C.Y.T.; wrote the paper: M.J., with contributions from all authors.	Barlow H, 2001, BEHAV BRAIN SCI, V24, P602, DOI 10.1017/S0140525X01000024; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; de Polavieja GG, 2006, NEURAL COMPUT, V18, P2102, DOI 10.1162/neco.2006.18.9.2102; Derrington AM, 2000, CURR BIOL, V10, pR268, DOI 10.1016/S0960-9822(00)00403-6; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; FEILER R, 1992, J NEUROSCI, V12, P3862; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gegenfurtner KR, 1996, TRENDS NEUROSCI, V19, P394, DOI 10.1016/S0166-2236(96)10036-9; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gonzalez-Bellido PT, 2011, P NATL ACAD SCI USA, V108, P4224, DOI 10.1073/pnas.1014438108; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAISER W, 1974, J COMP PHYSIOL, V89, P391, DOI 10.1007/BF00695355; Kaiser W., 1975, P359; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; Schiller PH, 2010, P NATL ACAD SCI USA, V107, P17087, DOI 10.1073/pnas.1011782107; SHAW SR, 1984, J EXP BIOL, V112, P225; SHAW SR, 1989, CELL TISSUE RES, V257, P295, DOI 10.1007/BF00261833; SRINIVASAN MV, 1985, VISION RES, V25, P997, DOI 10.1016/0042-6989(85)90210-X; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takeuchi T, 2003, VISION RES, V43, P1159, DOI 10.1016/S0042-6989(03)00086-5; VANHATEREN JH, 1986, J COMP PHYSIOL A, V158, P795, DOI 10.1007/BF01324822; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105	42	83	84	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					925	931		10.1126/science.1215317	http://dx.doi.org/10.1126/science.1215317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605779	Green Accepted			2022-12-28	WOS:000304145600068
J	Jonietz, E				Jonietz, Erika			Cause and effect	NATURE			English	Editorial Material																		Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746	3	9	9	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S10	S11		10.1038/485S10a	http://dx.doi.org/10.1038/485S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616098	Bronze			2022-12-28	WOS:000305950100005
J	Solimini, NL; Xu, QK; Mermel, CH; Liang, AC; Schlabach, MR; Luo, J; Burrows, AE; Anselmo, AN; Bredemeyer, AL; Li, MZ; Beroukhim, R; Meyerson, M; Elledge, SJ				Solimini, Nicole L.; Xu, Qikai; Mermel, Craig H.; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Beroukhim, Rameen; Meyerson, Matthew; Elledge, Stephen J.			Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential	SCIENCE			English	Article							LINEAGE-SURVIVAL ONCOGENE; LIVER-CANCER; IDENTIFICATION; PRINCIPLES; MUTATIONS; GENES	Tumors exhibit numerous recurrent hemizygous focal deletions that contain no known tumor suppressors and are poorly understood. To investigate whether these regions contribute to tumorigenesis, we searched genetically for genes with cancer-relevant properties within these hemizygous deletions. We identified STOP and GO genes, which negatively and positively regulate proliferation, respectively. STOP genes include many known tumor suppressors, whereas GO genes are enriched for essential genes. Analysis of their chromosomal distribution revealed that recurring deletions preferentially overrepresent STOP genes and underrepresent GO genes. We propose a hypothesis called the cancer gene island model, whereby gene islands encompassing high densities of STOP genes and low densities of GO genes are hemizygously deleted to maximize proliferative fitness through cumulative haploinsufficiencies. Because hundreds to thousands of genes are hemizygously deleted per tumor, this mechanism may help to drive tumorigenesis across many cancer types.	[Solimini, Nicole L.; Xu, Qikai; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Solimini, Nicole L.; Xu, Qikai; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02141 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Mermel, Craig/AAZ-7322-2020; Meyerson, Matthew L/E-7123-2012	Mermel, Craig/0000-0002-0816-3395; Meyerson, Matthew/0000-0002-9133-8108; Bredemeyer, Andrea/0000-0003-2970-5998	National Human Genome Research Institute; NIH [U54CA143798]; U.S. Department of Defense; Susan G. Komen for the Cure Foundation [KG080087]; American Cancer Society [116410-PF-09-078-01-MGO]; National Institute of General Medical Sciences Medical Scientist Training Program [T32GM07753]; NIH, Stand Up to Cancer; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); National Institute of General Medical Sciences Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, Stand Up to Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Forbes, A. Futreal, and M. Stratton for generously providing the whole-genome sequencing data from the COSMIC database, and C. Shaw, D. MacPherson, M. Emanuele, C. Thoma, T. Westbrook, and members of the Elledge lab for helpful discussions and critical reading of this manuscript. Supported by grants from the National Human Genome Research Institute-funded Cancer Genome Atlas project (M. M.); NIH grant U54CA143798 (R. B.); NIH, Stand Up to Cancer, and the U.S. Department of Defense (S.J.E.); Susan G. Komen for the Cure Foundation postdoctoral fellowship KG080087 (N.L.S.); American Cancer Society postdoctoral fellowship 116410-PF-09-078-01-MGO (Q. X.); and National Institute of General Medical Sciences Medical Scientist Training Program award T32GM07753 (C. H. M.). S.J.E. is an investigator of the Howard Hughes Medical Institute.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	25	137	152	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					104	109		10.1126/science.1219580	http://dx.doi.org/10.1126/science.1219580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628553	Green Accepted			2022-12-28	WOS:000306053100054
J	Rubin, AE				Rubin, Alan E.			Fragments of the Lunar Cataclysm	SCIENCE			English	Editorial Material							CHONDRITE; ORDOVICIAN; MOON		Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Rubin, AE (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	aerubin@ucla.edu						Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; Joy KH, 2012, SCIENCE, V336, P1426, DOI 10.1126/science.1219633; KIRSTEN T, 1973, P LUNAR PLANET SCI C, V4, P1757; Korochantseva EV, 2007, METEORIT PLANET SCI, V42, P113, DOI 10.1111/j.1945-5100.2007.tb00221.x; Kring D. A., 2002, J GEOPHYS RES, V107; Mojzsis SJ, 2000, GSA TODAY, V10, P1; Quaide W., 1970, P LUNAR PLANET SCI C, V1, P711; Rubin AE, 1997, METEORIT PLANET SCI, V32, P135, DOI 10.1111/j.1945-5100.1997.tb01248.x; Ryder G., 1990, EOS, V71, P322; Schmitz B, 2001, EARTH PLANET SC LETT, V194, P1, DOI 10.1016/S0012-821X(01)00559-3; Swindle TD, 2009, METEORIT PLANET SCI, V44, P747, DOI 10.1111/j.1945-5100.2009.tb00766.x; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; WOOD JA, 1970, 307 SMITHS ASTR OBS; Zolensky ME, 1997, METEORIT PLANET SCI, V32, P15, DOI 10.1111/j.1945-5100.1997.tb01235.x	17	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1390	1391		10.1126/science.1224184	http://dx.doi.org/10.1126/science.1224184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22604721				2022-12-28	WOS:000305211700029
J	Lai, MS; Foiani, M				Lai, Mong Sing; Foiani, Marco			Dna2 Offers Support for Stalled Forks	CELL			English	Editorial Material							REPLICATION FORKS; GENOME STABILITY; REVERSAL	The ATR and ATM checkpoint kinases preserve the integrity of replicating chromosomes by preventing the reversal of stalled and terminal replication forks. Hu et al. now show that the ATR pathway targets the Dna2 nuclease to process stalled forks and counteract fork reversal.	[Lai, Mong Sing; Foiani, Marco] IFOM IEO Campus, IFOM Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy; [Foiani, Marco] Univ Milan, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Foiani, M (corresponding author), IFOM IEO Campus, IFOM Fdn Ist FIRC Oncol Mol, Via Adamello 16, I-20139 Milan, Italy.	marco.foiani@ifom-ieo-campus.it	Foiani, Marco/M-8234-2014	Foiani, Marco/0000-0003-4795-834X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Budd ME, 2011, CELL CYCLE, V10, P1690, DOI 10.4161/cc.10.10.15643; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Peng G., 2012, CANC RES; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435	10	10	10	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1181	1183		10.1016/j.cell.2012.05.021	http://dx.doi.org/10.1016/j.cell.2012.05.021			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682239	Bronze			2022-12-28	WOS:000305119600002
J	Li, VSW; Ng, SS; Boersema, PJ; Low, TY; Karthaus, WR; Gerlach, JP; Mohammed, S; Heck, AJR; Maurice, MM; Mahmoudi, T; Clevers, H				Li, Vivian S. W.; Ng, Ser Sue; Boersema, Paul J.; Low, Teck Y.; Karthaus, Wouter R.; Gerlach, Jan P.; Mohammed, Shabaz; Heck, Albert J. R.; Maurice, Madelon M.; Mahmoudi, Tokameh; Clevers, Hans			Wnt Signaling through Inhibition of beta-Catenin Degradation in an Intact Axin1 Complex	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; DUAL-KINASE MECHANISM; TUMOR-SUPPRESSOR APC; DESTRUCTION COMPLEX; COLORECTAL-CANCER; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; STEM-CELLS; PATHWAY; PROTEIN	Degradation of cytosolic beta-catenin by the APC/Axin1 destruction complex represents the key regulated step of the Wnt pathway. It is incompletely understood how the Axin1 complex exerts its Wnt-regulated function. Here, we examine the mechanism of Wnt signaling under endogenous levels of the Axin1 complex. Our results demonstrate that beta-catenin is not only phosphorylated inside the Axin1 complex, but also ubiquinated and degraded via the proteasome, all within an intact Axin1 complex. In disagreement with current views, we find neither a disassembly of the complex nor an inhibition of phosphorylation of Axin1-bound beta-catenin upon Wnt signaling. Similar observations are made in primary intestinal epithelium and in colorectal cancer cell lines carrying activating Wnt pathway mutations. Wnt signaling suppresses beta-catenin ubiquitination normally occurring within the complex, leading to complex saturation by accumulated phospho-beta-catenin. Subsequently, newly synthesized b-catenin can accumulate in a free cytosolic form and engage nuclear TCF transcription factors.	[Li, Vivian S. W.; Ng, Ser Sue; Karthaus, Wouter R.; Mahmoudi, Tokameh; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Boersema, Paul J.; Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Boersema, Paul J.; Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Boersema, Paul J.; Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Boersema, Paul J.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Gerlach, Jan P.; Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Mahmoudi, Tokameh] Erasmus Univ, Med Ctr, Dept Biochem, NL-3000 CA Rotterdam, Netherlands; [Mahmoudi, Tokameh; Clevers, Hans] Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Max Planck Society; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Mahmoudi, T (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	t.mahmoudi@erasmusmc.nl; h.clevers@hubrecht.eu	Low, Teck Yew/J-4403-2014; Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011; Mohammed, Shabaz/D-1042-2010; 高, 雨莉/HGU-8187-2022; Mohammed, Shabaz/AAY-6313-2020	Low, Teck Yew/0000-0001-7878-7534; Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Maurice, Madelon/0000-0001-6885-5361; Li, Vivian/0000-0003-2041-0085; Karthaus, Wouter R./0000-0002-9234-9044; Ng, Ser Sue/0000-0001-9873-9433; Gerlach, Jan/0000-0002-4445-3138	Marie Curie Incoming International Fellowship [PIIF-GA-2008-221108]; Erasmus MC Fellowship; KWF [PF-HUBR 2007-3956]; NPCII;  [EU/TORNADO-KBBE-222720]	Marie Curie Incoming International Fellowship(European Commission); Erasmus MC Fellowship; KWF; NPCII; 	We would like to thank Haleh Rafati and Eline van Kappel for technical assistance. Tokameh Mahmoudi was supported by a Marie Curie Incoming International Fellowship (PIIF-GA-2008-221108) and an Erasmus MC Fellowship. V.S.W.L. was supported by KWF (PF-HUBR 2007-3956). S.S.N. was supported by NPCII. W.R.K. was supported by EU/TORNADO-KBBE-222720.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; van Amerongen R, 2005, CELL CYCLE, V4, pE89; van Amerongen R, 2005, GENE DEV, V19, P425, DOI 10.1101/gad.326705; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2001, CANCER RES, V61, P278; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	61	615	643	5	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1245	1256		10.1016/j.cell.2012.05.002	http://dx.doi.org/10.1016/j.cell.2012.05.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682247	Bronze			2022-12-28	WOS:000305119600010
J	Zhao, YL; Xu, SF; Wang, LX; Chin, DP; Wang, SF; Jiang, GL; Xia, H; Zhou, Y; Li, Q; Ou, XC; Pang, Y; Song, YY; Zhao, B; Zhang, HT; He, GX; Guo, J; Wang, Y				Zhao, Yanlin; Xu, Shaofa; Wang, Lixia; Chin, Daniel P.; Wang, Shengfen; Jiang, Guanglu; Xia, Hui; Zhou, Yang; Li, Qiang; Ou, Xichao; Pang, Yu; Song, Yuanyuan; Zhao, Bing; Zhang, Hongtao; He, Guangxue; Guo, Jing; Wang, Yu			National Survey of Drug-Resistant Tuberculosis in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; TREATMENT OUTCOMES; PREVALENCE; TRENDS	BACKGROUND The available information on the epidemic of drug-resistant tuberculosis in China is based on local or regional surveys. In 2007, we carried out a national survey of drug-resistant tuberculosis in China. METHODS We estimated the proportion of tuberculosis cases in China that were resistant to drugs by means of cluster-randomized sampling of tuberculosis cases in the public health system and testing for resistance to the first-line antituberculosis drugs isoniazid, rifampin, ethambutol, and streptomycin and the second-line drugs ofloxacin and kanamycin. We used the results from this survey and published estimates of the incidence of tuberculosis to estimate the incidence of drug-resistant tuberculosis. Information from patient interviews was used to identify factors linked to drug resistance. RESULTS Among 3037 patients with new cases of tuberculosis and 892 with previously treated cases, 5.7% (95% confidence interval [CI], 4.5 to 7.0) and 25.6% (95% CI, 21.5 to 29.8), respectively, had multidrug-resistant (MDR) tuberculosis (defined as disease that was resistant to at least isoniazid and rifampin). Among all patients with tuberculosis, approximately 1 of 4 had disease that was resistant to isoniazid, rifampin, or both, and 1 of 10 had MDR tuberculosis. Approximately 8% of the patients with MDR tuberculosis had extensively drug-resistant (XDR) tuberculosis (defined as disease that was resistant to at least isoniazid, rifampin, ofloxacin, and kanamycin). In 2007, there were 110,000 incident cases (95% CI, 97,000 to 130,000) of MDR tuberculosis and 8200 incident cases (95% CI, 7200 to 9700) of XDR tuberculosis. Most cases of MDR and XDR tuberculosis resulted from primary transmission. Patients with multiple previous treatments who had received their last treatment in a tuberculosis hospital had the highest risk of MDR tuberculosis (adjusted odds ratio, 13.3; 95% CI, 3.9 to 46.0). Among 226 previously treated patients with MDR tuberculosis, 43.8% had not completed their last treatment; most had been treated in the hospital system. Among those who had completed treatment, tuberculosis developed again in most of the patients after their treatment in the public health system. CONCLUSIONS China has a serious epidemic of drug-resistant tuberculosis. MDR tuberculosis is linked to inadequate treatment in both the public health system and the hospital system, especially tuberculosis hospitals; however, primary transmission accounts for most cases. (Funded by the Chinese Ministry of Health.)	[Zhao, Yanlin; Wang, Lixia; Wang, Shengfen; Xia, Hui; Zhou, Yang; Li, Qiang; Ou, Xichao; Pang, Yu; Song, Yuanyuan; Zhao, Bing; He, Guangxue; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhao, Yanlin; Xu, Shaofa; Jiang, Guanglu; Zhang, Hongtao] Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China; [Chin, Daniel P.] China Off, Bill & Melinda Gates Fdn, Beijing 100027, Peoples R China; [Guo, Jing] Peoples Univ, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Renmin University of China	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	daniel.chin@gatesfoundation.org; wangyu@chinacdc.cn						Aguiar F, 2009, INT J TUBERC LUNG D, V13, P54; Barclay E, 2009, LANCET, V373, P15, DOI 10.1016/S0140-6736(08)61938-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boonsarngsuk V, 2009, SINGAP MED J, V50, P378; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Clark CM, 2005, INT J TUBERC LUNG D, V9, P964; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Kliiman K, 2009, ANN INTERN MED, V150, P766, DOI 10.7326/0003-4819-150-11-200906020-00004; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Moniruzzaman A, 2006, INT J TUBERC LUNG D, V10, P631; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WHO, 2011, AUT REAL TIM NUCL AC; WHO, 2009, WHOHTMTB2009422; WHO, TUB TB; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTMTB2006360; World Health Organization, 2010, WHOHTMTB20103; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31	31	474	574	17	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2161	2170						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670902	Bronze			2022-12-28	WOS:000304863400005
J	Schouten, HJ; Koek, HL; Oudega, R; Geersing, GJ; Janssen, KJM; van Delden, JJM; Moons, KGM				Schouten, Henrike J.; Koek, H. L. (Dineke); Oudega, Ruud; Geersing, Geert-Jan; Janssen, Kristel J. M.; van Delden, Johannes J. M.; Moons, Karel G. M.			Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis	BRITISH MEDICAL JOURNAL			English	Article							PULMONARY-EMBOLISM; VENOUS THROMBOSIS; CLINICAL PROBABILITY; PREDICTION RULES; THROMBOEMBOLISM; IMPACT; SPECIFICITY; SENSITIVITY; OUTPATIENTS; STRATEGIES	Objective To determine whether the use of age adapted D-dimer cut-off values can be translated to primary care patients who are suspected of deep vein thrombosis. Design Retrospective, cross sectional diagnostic study. Setting 110 primary care doctors affiliated with three hospitals in the Netherlands. Participants 1374 consecutive patients (936 (68.1%) aged >50 years) with clinically suspected deep vein thrombosis. Main outcome measures Proportion of patients with D-dimer values below two proposed age adapted cut-off levels (age in years x 10 mu g/L in patients aged >50 years, or 750 mu g/L in patients aged >= 60 years), in whom deep vein thrombosis could be excluded; and the number of false negative results. Results Using the Wells score, 647 patients had an unlikely clinical probability of deep vein thrombosis. In these patients (at all ages), deep vein thrombosis could be excluded in 309 (47.8%) using the age dependent cut-off value compared with 272 (42.0%) using the conventional cut-off value of 500 mu g/L (increase 5.7%, 95% confidence interval 4.1% to 7.8%). This exclusion rate resulted in 0.5% and 0.3% false negative cases, respectively (increase 0.2%, 0.004% to 8.6%). The increase in exclusion rate by using the age dependent cut-off value was highest in the oldest patients. In patients older than 80 years, deep vein thrombosis could be safely excluded in 22 (35.5%) patients using the age dependent cut-off value compared with 13 (21.0%) using the conventional cut-off value (increase 14.5%, 6.8% to 25.8%). Compared with the age dependent cut-off value, the cut-off value of 750 mu g/L had a similar exclusion rate (307 (47.4%) patients) and false negative rate (0.3%). Conclusions Combined with a low clinical probability of deep vein thrombosis, use of the age dependent D-dimer cut-off value for patients older than 50 years or the cut-off value of 750 mu g/L for patients aged 60 years and older resulted in a considerable increase in the proportion of patients in primary care in whom deep vein thrombosis could be safely excluded, compared with the conventional cut-off value of 500 mu g/L.	[Schouten, Henrike J.; Oudega, Ruud; Geersing, Geert-Jan; Janssen, Kristel J. M.; van Delden, Johannes J. M.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Schouten, Henrike J.; Koek, H. L. (Dineke)] Univ Med Ctr Utrecht, Dept Geriatr, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schouten, HJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	h.j.schouten-3@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021		Netherlands Organization for Scientific Research [17088-2502, 917-46-360, 945-04-009]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The study received financial support from the Netherlands Organization for Scientific Research (ZonMw project numbers 17088-2502, 917-46-360, and 945-04-009). The funding source had no influence on any aspect of this study.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Fraser JD, 1999, RADIOLOGY, V211, P9, DOI 10.1148/radiology.211.1.r99ap459; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Girard P, 1999, CHEST, V116, P903, DOI 10.1378/chest.116.4.903; Haas FJLM, 2009, AM J HEMATOL, V84, P488, DOI 10.1002/ajh.21455; Harper PL, 2007, INTERN MED J, V37, P607, DOI 10.1111/j.1445-5994.2007.01388.x; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Johnson SA, 2010, JAMA-J AM MED ASSOC, V303, P454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002; Oudega R, 2006, THROMB HAEMOSTASIS, V95, P744, DOI 10.1160/TH05-07-0474; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Rothman KJ, 1979, EPIDEMIOLOGIC ANAL P; Schutgens REG, 2005, BRIT J HAEMATOL, V129, P653, DOI 10.1111/j.1365-2141.2005.05515.x; Siccama RN, 2011, AGEING RES REV, V10, P304, DOI 10.1016/j.arr.2010.10.005; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Toll DB, 2008, FAM PRACT, V25, P3, DOI 10.1093/fampra/cmm075; Toll DB, 2006, J FAM PRACTICE, V55, P613; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	30	48	49	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 6	2012	344								e2985	10.1136/bmj.e2985	http://dx.doi.org/10.1136/bmj.e2985			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957TC	22674922	hybrid, Green Published			2022-12-28	WOS:000305184700003
J	Weiss, R; Bourgeois, J				Weiss, Robert; Bourgeois, Joanne			Understanding Sediments-Reducing Tsunami Risk	SCIENCE			English	Editorial Material							DEPOSITS		[Weiss, Robert; Bourgeois, Joanne] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Weiss, R (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.	weiszr@vt.edu		Weiss, Robert/0000-0002-7168-5401				[Anonymous], 2012, COASTAL ENG J, V54; Apotsos A, 2011, EARTH-SCI REV, V107, P1, DOI 10.1016/j.earscirev.2010.11.001; Chague-Goff C, 2011, EARTH-SCI REV, V107, P107, DOI 10.1016/j.earscirev.2011.03.007; Choi BH, 2007, COAST ENG, V54, P618, DOI 10.1016/j.coastaleng.2007.02.001; Goff J, 2012, SEDIMENT GEOL, V243, P70, DOI 10.1016/j.sedgeo.2011.11.002; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Huntington K., 2007, EOS T AM GEOPHYS UN, V88, P577, DOI DOI 10.1029/2007EO520001; Kim DH, 2009, OCEAN MODEL, V27, P198, DOI 10.1016/j.ocemod.2009.01.005; LeVeque RJ, 2011, ACTA NUMER, V20, P211, DOI 10.1017/S0962492911000043; Lynett PJ, 2012, EARTH PLANET SC LETT, V327, P68, DOI 10.1016/j.epsl.2012.02.002; MacInnes BT, 2010, B SEISMOL SOC AM, V100, P1695, DOI 10.1785/0120090376; Martin ME, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032349; MINOURA K, 1991, J GEOL, V99, P265, DOI 10.1086/629488; Normile D, 2011, SCIENCE, V334, P1341, DOI 10.1126/science.334.6061.1341; Normile D, 2011, SCIENCE, V332, P22, DOI 10.1126/science.332.6025.22; Satake K, 2008, EARTH PLANETS SPACE, V60, P925, DOI 10.1186/BF03352848; Sugawara D, 2013, PURE APPL GEOPHYS, V170, P831, DOI 10.1007/s00024-012-0460-1; Weiss R., 2010, P 32 C COAST ENG SHA; Witter RC, 2012, NAT HAZARDS, V63, P223, DOI 10.1007/s11069-011-9912-7; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493	20	14	14	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1117	1118		10.1126/science.1221452	http://dx.doi.org/10.1126/science.1221452			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654047				2022-12-28	WOS:000304647900034
J	Grayson, M				Grayson, Michelle			BREAST CANCER	NATURE			English	Editorial Material																			0	35	40	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S49	S49		10.1038/485S49a	http://dx.doi.org/10.1038/485S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22648496	Bronze			2022-12-28	WOS:000304608000055
J	Kozorovitskiy, Y; Saunders, A; Johnson, CA; Lowell, BB; Sabatini, BL				Kozorovitskiy, Yevgenia; Saunders, Arpiar; Johnson, Caroline A.; Lowell, Bradford B.; Sabatini, Bernardo L.			Recurrent network activity drives striatal synaptogenesis	NATURE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DENDRITIC SPINES; CORTEX; ORGANIZATION; GABA; PATHWAYS; CIRCUITS; INPUT; LIGHT	Neural activity during development critically shapes postnatal wiring of the mammalian brain. This is best illustrated by the sensory systems, in which the patterned feed-forward excitation provided by sensory organs and experience drives the formation of mature topographic circuits capable of extracting specific features of sensory stimuli(1,2). In contrast, little is known about the role of early activity in the development of the basal ganglia, a phylogenetically ancient group of nuclei fundamentally important for complex motor action and reward-based learning(3,4). These nuclei lack direct sensory input and are only loosely topographically organized(5,6), forming interlocking feed-forward and feed-back inhibitory circuits without laminar structure. Here we use transgenic mice and viral gene transfer methods to modulate neurotransmitter release and neuronal activity in vivo in the developing striatum. We find that the balance of activity between the two inhibitory and antagonist pathways in the striatum regulates excitatory innervation of the basal ganglia during development. These effects indicate that the propagation of activity through a multi-stage network regulates the wiring of the basal ganglia, revealing an important role of positive feedback in driving network maturation.	[Kozorovitskiy, Yevgenia; Saunders, Arpiar; Johnson, Caroline A.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484; Johnson, Caroline/0000-0001-5770-6176	NINDS [NS046579]; W.F. Milton Fund Award; Leonard and Isabelle Goldenson Research Fellowship; NIH [F31 NS074842]; Shapiro predoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, F31NS074842] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); W.F. Milton Fund Award; Leonard and Isabelle Goldenson Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shapiro predoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Sabatini laboratory members for comments on the manuscript; B. Roth, K. Deisseroth and M. During for AAV backbones encoding hM4D, ChR2 and Cre, respectively; and C. Gerfen for the Rbp4-Cre mouse line. Confocal imaging was done through the Harvard NeuroDiscovery and Olympus Imaging Centers. This work was supported by grants from NINDS (NS046579, B. L. S); the W.F. Milton Fund Award and the Leonard and Isabelle Goldenson Research Fellowship (Y.K.); and NIH (F31 NS074842) and Shapiro predoctoral fellowship (A.S.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cho JW, 1997, BRAIN RES, V756, P241, DOI 10.1016/S0006-8993(97)00143-1; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Kelly R. M., 2004, PROG BRAIN RES, V143, P447; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOMOGYI P, 1981, J COMP NEUROL, V195, P567, DOI 10.1002/cne.901950403; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	30	109	109	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					646	+		10.1038/nature11052	http://dx.doi.org/10.1038/nature11052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660328	Green Accepted, Green Submitted			2022-12-28	WOS:000304608000049
J	Patadia, S; Vasanawala, SS				Patadia, Sasha; Vasanawala, Shreyas S.			Splenic Spirals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patadia, Sasha; Vasanawala, Shreyas S.] Stanford Univ, Palo Alto, CA 94304 USA	Stanford University	Patadia, S (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.		Vasanawala, Shreyas/AAW-4385-2020	Vasanawala, Shreyas/0000-0002-1999-6595					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2111	2111						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646633				2022-12-28	WOS:000304613400011
J	Sato, S; Tabata, S; Hirakawa, H; Asamizu, E; Shirasawa, K; Isobe, S; Kaneko, T; Nakamura, Y; Shibata, D; Aoki, K; Egholm, M; Knight, J; Bogden, R; Li, CB; Shuang, Y; Xu, X; Pan, SK; Cheng, SF; Liu, X; Ren, YY; Wang, J; Albiero, A; Dal Pero, F; Todesco, S; Van Eck, J; Buels, RM; Bombarely, A; Gosselin, JR; Huang, MY; Leto, JA; Menda, N; Strickler, S; Mao, LY; Gao, S; Tecle, IY; York, T; Zheng, Y; Vrebalov, JT; Lee, J; Zhong, SL; Mueller, LA; Stiekema, WJ; Ribeca, P; Alioto, T; Yang, WC; Huang, SW; Du, YC; Zhang, ZH; Gao, JC; Guo, YM; Wang, XX; Li, Y; He, J; Li, CY; Cheng, ZK; Zuo, JR; Ren, JF; Zhao, JH; Yan, LH; Jiang, HL; Wang, B; Li, HS; Li, ZJ; Fu, FY; Chen, BT; Han, B; Feng, Q; Fan, DL; Wang, Y; Ling, HQ; Xue, YBA; Ware, D; McCombie, WR; Lippman, ZB; Chia, JM; Jiang, K; Pasternak, S; Gelley, L; Kramer, M; Anderson, LK; Chang, SB; Royer, SM; Shearer, LA; Stack, SM; Rose, JKC; Xu, YM; Eannetta, N; Matas, AJ; McQuinn, R; Tanksley, SD; Camara, F; Guigo, R; Rombauts, S; Fawcett, J; Van de Peer, Y; Zamir, D; Liang, CB; Spannagl, M; Gundlach, H; Bruggmann, R; Mayer, K; Jia, ZQ; Zhang, JH; Ye, ZBA; Bishop, GJ; Butcher, S; Lopez-Cobollo, R; Buchan, D; Filippis, I; Abbott, J; Dixit, R; Singh, M; Singh, A; Pal, JK; Pandit, A; Singh, PK; Mahato, AK; Dogra, V; Gaikwad, K; Sharma, TR; Mohapatra, T; Singh, NK; Causse, M; Rothan, C; Schiex, T; Noirot, C; Bellec, A; Klopp, C; Delalande, C; Berges, H; Mariette, J; Frasse, P; Vautrin, S; Zouine, M; Latche, A; Rousseau, C; Regad, F; Pech, JC; Philippot, M; Bouzayen, M; Pericard, P; Osorio, S; del Carmen, AF; Monforte, A; Granell, A; Fernandez-Munoz, R; Conte, M; Lichtenstein, G; Carrari, F; De Bellis, G; Fuligni, F; Peano, C; Grandillo, S; Termolino, P; Pietrella, M; Fantini, E; Falcone, G; Fiore, A; Giuliano, G; Lopez, L; Facella, P; Perrotta, G; Daddiego, L; Bryan, G; Orozco, M; Pastor, X; Torrents, D; van Schriek, KNVMGM; Feron, RMC; van Oeveren, J; de Heer, P; daPonte, L; Jacobs-Oomen, S; Cariaso, M; Prins, M; van Eijk, MJT; Janssen, A; van Haaren, MJJ; Jo, SH; Kim, J; Kwon, SY; Kim, S; Koo, DH; Lee, S; Hur, CG; Clouser, C; Rico, A; Hallab, A; Gebhardt, C; Klee, K; Jocker, A; Warfsmann, J; Gobel, U; Kawamura, S; Yano, K; Sherman, JD; Fukuoka, H; Negoro, S; Bhutty, S; Chowdhury, P; Chattopadhyay, D; Datema, E; Smit, S; Schijlen, EWM; van de Belt, J; van Haarst, JC; Peters, SA; van Staveren, MJ; Henkens, MHC; Mooyman, PJW; Hesselink, T; van Ham, RCHJ; Jiang, GY; Droege, M; Choi, D; Kang, BC; Kim, BD; Park, M; Kim, S; Yeom, SI; Lee, YH; Choi, YD; Li, GC; Gao, JW; Liu, YS; Huang, SX; Fernandez-Pedrosa, V; Collado, C; Zuniga, S; Wang, GP; Cade, R; Dietrich, RA; Rogers, J; Knapp, S; Fei, ZJ; White, RA; Thannhauser, TW; Giovannoni, JJ; Botella, MA; Gilbert, L; Gonzalez, R; Goicoechea, JL; Yu, Y; Kudrna, D; Collura, K; Wissotski, M; Wing, R; Schoof, H; Meyers, BC; Gurazada, AB; Green, PJ; Mathur, S; Vyas, S; Solanke, AU; Kumar, R; Gupta, V; Sharma, AK; Khurana, P; Khurana, JP; Tyagi, AK; Dalmay, T; Mohorianu, I; Walts, B; Chamala, S; Barbazuk, WB; Li, JP; Guo, H; Lee, TH; Wang, YP; Zhang, D; Paterson, AH; Wang, XY; Tang, HB; Barone, A; Chiusano, ML; Ercolano, MR; D'Agostino, N; Di Filippo, M; Traini, A; Sanseverino, W; Frusciante, L; Seymour, GB; Elharam, M; Fu, Y; Hua, A; Kenton, S; Lewis, J; Lin, SP; Najar, F; Lai, HS; Qin, BF; Qu, CM; Shi, RH; White, D; White, J; Xing, YB; Yang, KQ; Yi, J; Yao, ZY; Zhou, LP; Roe, BA; Vezzi, A; D'Angelo, M; Zimbello, R; Schiavon, R; Caniato, E; Rigobello, C; Campagna, D; Vitulo, N; Valle, G; Nelson, DR; De Paoli, E; Szinay, D; de Jong, HH; Bai, YL; Visser, RGF; Lankhorst, RMK; Beasley, H; McLaren, K; Nicholson, C; Riddle, C; Gianese, G				Sato, Shusei; Tabata, Satoshi; Hirakawa, Hideki; Asamizu, Erika; Shirasawa, Kenta; Isobe, Sachiko; Kaneko, Takakazu; Nakamura, Yasukazu; Shibata, Daisuke; Aoki, Koh; Egholm, Michael; Knight, James; Bogden, Robert; Li, Changbao; Shuang, Yang; Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Liu, Xin; Ren, Yuanyuan; Wang, Jun; Albiero, Alessandro; Dal Pero, Francesca; Todesco, Sara; Van Eck, Joyce; Buels, Robert M.; Bombarely, Aureliano; Gosselin, Joseph R.; Huang, Minyun; Leto, Jonathan A.; Menda, Naama; Strickler, Susan; Mao, Linyong; Gao, Shan; Tecle, Isaak Y.; York, Thomas; Zheng, Yi; Vrebalov, Julia T.; Lee, JeMin; Zhong, Silin; Mueller, Lukas A.; Stiekema, Willem J.; Ribeca, Paolo; Alioto, Tyler; Yang, Wencai; Huang, Sanwen; Du, Yongchen; Zhang, Zhonghua; Gao, Jianchang; Guo, Yanmei; Wang, Xiaoxuan; Li, Ying; He, Jun; Li, Chuanyou; Cheng, Zhukuan; Zuo, Jianru; Ren, Jianfeng; Zhao, Jiuhai; Yan, Liuhua; Jiang, Hongling; Wang, Bao; Li, Hongshuang; Li, Zhenjun; Fu, Fuyou; Chen, Bingtang; Han, Bin; Feng, Qi; Fan, Danlin; Wang, Ying; Ling, Hongqing; Xue, Yongbiao; Ware, Doreen; McCombie, W. Richard; Lippman, Zachary B.; Chia, Jer-Ming; Jiang, Ke; Pasternak, Shiran; Gelley, Laura; Kramer, Melissa; Anderson, Lorinda K.; Chang, Song-Bin; Royer, Suzanne M.; Shearer, Lindsay A.; Stack, Stephen M.; Rose, Jocelyn K. C.; Xu, Yimin; Eannetta, Nancy; Matas, Antonio J.; McQuinn, Ryan; Tanksley, Steven D.; Camara, Francisco; Guigo, Roderic; Rombauts, Stephane; Fawcett, Jeffrey; Van de Peer, Yves; Zamir, Dani; Liang, Chunbo; Spannagl, Manuel; Gundlach, Heidrun; Bruggmann, Remy; Mayer, Klaus; Jia, Zhiqi; Zhang, Junhong; Ye, Zhibiao; Bishop, Gerard J.; Butcher, Sarah; Lopez-Cobollo, Rosa; Buchan, Daniel; Filippis, Ioannis; Abbott, James; Dixit, Rekha; Singh, Manju; Singh, Archana; Pal, Jitendra Kumar; Pandit, Awadhesh; Singh, Pradeep Kumar; Mahato, Ajay Kumar; Dogra, Vivek; Gaikwad, Kishor; Sharma, Tilak Raj; Mohapatra, Trilochan; Singh, Nagendra Kumar; Causse, Mathilde; Rothan, Christophe; Schiex, Thomas; Noirot, Celine; Bellec, Arnaud; Klopp, Christophe; Delalande, Corinne; Berges, Helene; Mariette, Jerome; Frasse, Pierre; Vautrin, Sonia; Zouine, Mohamed; Latche, Alain; Rousseau, Christine; Regad, Farid; Pech, Jean-Claude; Philippot, Murielle; Bouzayen, Mondher; Pericard, Pierre; Osorio, Sonia; Fernandez del Carmen, Asuncion; Monforte, Antonio; Granell, Antonio; Fernandez-Munoz, Rafael; Conte, Mariana; Lichtenstein, Gabriel; Carrari, Fernando; De Bellis, Gianluca; Fuligni, Fabio; Peano, Clelia; Grandillo, Silvana; Termolino, Pasquale; Pietrella, Marco; Fantini, Elio; Falcone, Giulia; Fiore, Alessia; Giuliano, Giovanni; Lopez, Loredana; Facella, Paolo; Perrotta, Gaetano; Daddiego, Loretta; Bryan, Glenn; Orozco, Modesto; Pastor, Xavier; Torrents, David; van Schriek, Keygene N. V. Marco G. M.; Feron, Richard M. C.; van Oeveren, Jan; de Heer, Peter; daPonte, Lorena; Jacobs-Oomen, Saskia; Cariaso, Mike; Prins, Marcel; van Eijk, Michiel J. T.; Janssen, Antoine; van Haaren, Mark J. J.; Jo, Sung-Hwan; Kim, Jungeun; Kwon, Suk-Yoon; Kim, Sangmi; Koo, Dal-Hoe; Lee, Sanghyeob; Hur, Cheol-Goo; Clouser, Christopher; Rico, Alain; Hallab, Asis; Gebhardt, Christiane; Klee, Kathrin; Joecker, Anika; Warfsmann, Jens; Goebel, Ulrike; Kawamura, Shingo; Yano, Kentaro; Sherman, Jamie D.; Fukuoka, Hiroyuki; Negoro, Satomi; Bhutty, Sarita; Chowdhury, Parul; Chattopadhyay, Debasis; Datema, Erwin; Smit, Sandra; Schijlen, Eliog. W. M.; van de Belt, Jose; van Haarst, Jan C.; Peters, Sander A.; van Staveren, Marjo J.; Henkens, Marleen H. C.; Mooyman, Paul J. W.; Hesselink, Thamara; van Ham, Roeland C. H. J.; Jiang, Guoyong; Droege, Marcus; Choi, Doil; Kang, Byung-Cheol; Kim, Byung Dong; Park, Minkyu; Kim, Seungill; Yeom, Seon-In; Lee, Yong-Hwan; Choi, Yang-Do; Li, Guangcun; Gao, Jianwei; Liu, Yongsheng; Huang, Shengxiong; Fernandez-Pedrosa, Victoria; Collado, Carmen; Zuniga, Sheila; Wang, Guoping; Cade, Rebecca; Dietrich, Robert A.; Rogers, Jane; Knapp, Sandra; Fei, Zhangjun; White, Ruth A.; Thannhauser, Theodore W.; Giovannoni, James J.; Angel Botella, Miguel; Gilbert, Louise; Gonzalez, Ramon; Goicoechea, Jose Luis; Yu, Yeisoo; Kudrna, David; Collura, Kristi; Wissotski, Marina; Wing, Rod; Schoof, Heiko; Meyers, Blake C.; Gurazada, Aishwarya Bala; Green, Pamela J.; Mathur, Saloni; Vyas, Shailendra; Solanke, Amolkumar U.; Kumar, Rahul; Gupta, Vikrant; Sharma, Arun K.; Khurana, Paramjit; Khurana, Jitendra P.; Tyagi, Akhilesh K.; Dalmay, Tamas; Mohorianu, Irina; Walts, Brandon; Chamala, Srikar; Barbazuk, W. Brad; Li, Jingping; Guo, Hui; Lee, Tae-Ho; Wang, Yupeng; Zhang, Dong; Paterson, Andrew H.; Wang, Xiyin; Tang, Haibao; Barone, Amalia; Chiusano, Maria Luisa; Ercolano, Maria Raffaella; D'Agostino, Nunzio; Di Filippo, Miriam; Traini, Alessandra; Sanseverino, Walter; Frusciante, Luigi; Seymour, Graham B.; Elharam, Mounir; Fu, Ying; Hua, Axin; Kenton, Steven; Lewis, Jennifer; Lin, Shaoping; Najar, Fares; Lai, Hongshing; Qin, Baifang; Qu, Chunmei; Shi, Ruihua; White, Douglas; White, James; Xing, Yanbo; Yang, Keqin; Yi, Jing; Yao, Ziyun; Zhou, Liping; Roe, Bruce A.; Vezzi, Alessandro; D'Angelo, Michela; Zimbello, Rosanna; Schiavon, Riccardo; Caniato, Elisa; Rigobello, Chiara; Campagna, Davide; Vitulo, Nicola; Valle, Giorgio; Nelson, David R.; De Paoli, Emanuele; Szinay, Dora; de Jong, Hans H.; Bai, Yuling; Visser, Richard G. F.; Lankhorst, Rene M. Klein; Beasley, Helen; McLaren, Karen; Nicholson, Christine; Riddle, Claire; Gianese, Giulio		Tomato Genome Consortium	The tomato genome sequence provides insights into fleshy fruit evolution	NATURE			English	Article							LYCOPERSICON-ESCULENTUM; GENE; DIVERSIFICATION; ARABIDOPSIS; PATTERNS; ORTHOLOG; HISTORY; SORGHUM; POTATO	Tomato (Solanum lycopersicum) is a major crop plant and a model system for fruit development. Solanum is one of the largest angiosperm genera(1) and includes annual and perennial plants from diverse habitats. Here we present a high-quality genome sequence of domesticated tomato, a draft sequence of its closest wild relative, Solanum pimpinellifolium(2), and compare them to each other and to the potato genome (Solanum tuberosum). The two tomato genomes show only 0.6% nucleotide divergence and signs of recent admixture, but show more than 8% divergence from potato, with nine large and several smaller inversions. In contrast to Arabidopsis, but similar to soybean, tomato and potato small RNAs map predominantly to gene-rich chromosomal regions, including gene promoters. The Solanum lineage has experienced two consecutive genome triplications: one that is ancient and shared with rosids, and a more recent one. These triplications set the stage for the neofunctionalization of genes controlling fruit characteristics, such as colour and fleshiness.	[Sato, Shusei; Tabata, Satoshi; Hirakawa, Hideki; Asamizu, Erika; Shirasawa, Kenta; Isobe, Sachiko; Kaneko, Takakazu; Nakamura, Yasukazu; Shibata, Daisuke; Aoki, Koh] Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan; [Egholm, Michael; Knight, James] 454 Life Sci, Branford, CT 06405 USA; [Bogden, Robert] Amplicon Express Inc, Pullman, WA 99163 USA; [Li, Changbao] Beijing Acad Agr & Forestry Sci, Beijing Vegetable Res Ctr, Beijing 100097, Peoples R China; [Shuang, Yang; Xu, Xun; Pan, Shengkai; Cheng, Shifeng; Liu, Xin; Ren, Yuanyuan; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Changbao; Han, Bin; Feng, Qi; Fan, Danlin] Chinese Acad Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China; [Albiero, Alessandro; Dal Pero, Francesca; Todesco, Sara] BMR Genom SrL, I-35131 Padua, Italy; [Van Eck, Joyce; Buels, Robert M.; Bombarely, Aureliano; Gosselin, Joseph R.; Huang, Minyun; Leto, Jonathan A.; Menda, Naama; Strickler, Susan; Mao, Linyong; Gao, Shan; Tecle, Isaak Y.; York, Thomas; Zheng, Yi; Vrebalov, Julia T.; Lee, JeMin; Zhong, Silin; Mueller, Lukas A.; Fei, Zhangjun; White, Ruth A.; Thannhauser, Theodore W.; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Stiekema, Willem J.] Ctr BioSyst Genom, NL-6700 AB Wageningen, Netherlands; [Ribeca, Paolo; Alioto, Tyler] CNAG, Barcelona 08028, Spain; [Yang, Wencai] China Agr Univ, Coll Agron & Biotechnol, Dept Vegetable Sci, Beijing 100193, Peoples R China; [Huang, Sanwen; Du, Yongchen; Zhang, Zhonghua; Gao, Jianchang; Guo, Yanmei; Wang, Xiaoxuan; Li, Ying; He, Jun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sinodutch Joint Lab Hort Genom Technol, Key Lab Hort Crops Genet Improvement,Minist Agr, Beijing 100081, Peoples R China; [Li, Chuanyou; Cheng, Zhukuan; Zuo, Jianru; Ren, Jianfeng; Zhao, Jiuhai; Yan, Liuhua; Jiang, Hongling; Wang, Bao; Li, Hongshuang; Li, Zhenjun; Fu, Fuyou; Chen, Bingtang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Li, Chuanyou; Cheng, Zhukuan; Zuo, Jianru; Ren, Jianfeng; Zhao, Jiuhai; Yan, Liuhua; Jiang, Hongling; Wang, Bao; Li, Hongshuang; Li, Zhenjun; Fu, Fuyou; Chen, Bingtang; Ling, Hongqing; Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China; [Wang, Ying] Chinese Acad Sci, Wuhan Bot Garden, Wuhan 430074, Peoples R China; [Ling, Hongqing] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing 100101, Peoples R China; [Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Mol & Dev Biol Lab, Beijing 100080, Peoples R China; [Ware, Doreen; McCombie, W. Richard; Lippman, Zachary B.; Chia, Jer-Ming; Jiang, Ke; Pasternak, Shiran; Gelley, Laura; Kramer, Melissa] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Anderson, Lorinda K.; Royer, Suzanne M.; Shearer, Lindsay A.; Stack, Stephen M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Chang, Song-Bin] Natl Taiwan Univ, Dept Agron, Taipei 107, Taiwan; [Rose, Jocelyn K. C.; Xu, Yimin; Eannetta, Nancy; Matas, Antonio J.; McQuinn, Ryan; Tanksley, Steven D.; Giovannoni, James J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Camara, Francisco; Guigo, Roderic] Univ Pompeu Fabra, CRG, Genome Bioinformat Lab, GRIB IMIM, Barcelona 08003, Spain; [Rombauts, Stephane; Fawcett, Jeffrey; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Biotechnol & Bioinformat, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel; [Liang, Chunbo] Heilongjiang Acad Agr Sci, Inst Ind Crops, Harbin 150086, Peoples R China; [Spannagl, Manuel; Gundlach, Heidrun; Bruggmann, Remy; Mayer, Klaus] Helmholtz Ctr Hlth & Environm, Inst Bioinformat & Syst Biol MIPS, D-85764 Neuherberg, Germany; [Jia, Zhiqi] Henan Agr Univ, Coll Hort, Zhengzhou 450002, Peoples R China; [Zhang, Junhong; Ye, Zhibiao] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Bishop, Gerard J.; Butcher, Sarah; Lopez-Cobollo, Rosa; Buchan, Daniel; Filippis, Ioannis; Abbott, James] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 1AZ, England; [Dixit, Rekha; Singh, Manju; Singh, Archana; Pal, Jitendra Kumar; Pandit, Awadhesh; Singh, Pradeep Kumar; Mahato, Ajay Kumar; Dogra, Vivek; Gaikwad, Kishor; Sharma, Tilak Raj; Mohapatra, Trilochan; Singh, Nagendra Kumar] Indian Agr Res Inst, NRC Plant Biotechnol, New Delhi 110012, India; [Causse, Mathilde] INRA, Genet & Ameliorat Fruits & Legumes UR1052, F-84143 Montfavet, France; [Rothan, Christophe] INRA, Biol Fruit & Pathol, F-33883 Villenave Dornon, France; [Schiex, Thomas; Noirot, Celine] INRA, Unite Biometrie & Intelligence Artificielle UR 87, F-31320 Castanet Tolosan, France; [Bellec, Arnaud; Berges, Helene; Vautrin, Sonia] INRA CNRGV, F-31326 Castanet Tolosan, France; [Klopp, Christophe; Mariette, Jerome] INRA, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Delalande, Corinne; Frasse, Pierre; Zouine, Mohamed; Latche, Alain; Rousseau, Christine; Regad, Farid; Pech, Jean-Claude; Philippot, Murielle; Bouzayen, Mondher] Univ Toulouse, Inst Natl Polytech Toulouse ENSAT, F-31326 Castanet Tolosan, France; [Pericard, Pierre; Osorio, Sonia; Fernandez del Carmen, Asuncion; Monforte, Antonio; Granell, Antonio] Inst Biol Mol & Celular Plantas CSIC UPV, Valencia 46022, Spain; [Fernandez-Munoz, Rafael] Univ Malaga, CSIC, UMA, IHSM,Inst Hortofruticultura Subtrop & Mediterrane, Algarrobo Costa 29750, Malaga, Spain; [De Bellis, Gianluca; Fuligni, Fabio; Peano, Clelia] Natl Res Council Italy, Inst Biomed Technol, I-20090 Milan, Italy; [Grandillo, Silvana; Termolino, Pasquale] Natl Res Council Italy, Inst Plant Genet, Res Div Portici, I-80055 Naples, Italy; [Pietrella, Marco; Fantini, Elio; Falcone, Giulia; Fiore, Alessia; Giuliano, Giovanni] ENEA, Casaccia Res Ctr, I-00123 Rome, Italy; [Pietrella, Marco] Scuola Super Sant Anna, I-56127 Pisa, Italy; [Lopez, Loredana; Facella, Paolo; Perrotta, Gaetano; Daddiego, Loretta] ENEA, Trisaia Res Ctr, I-75026 Rotondella, Matera, Italy; [Bryan, Glenn] James Hutton Inst, Dundee DD2 5DA, Scotland; [Orozco, Modesto; Pastor, Xavier; Torrents, David] Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Orozco, Modesto] Inst Biomed Res, Barcelona 08028, Spain; [Torrents, David] Pg Lluis Co, ICREA, Barcelona 08010, Spain; [van Schriek, Keygene N. V. Marco G. M.; Feron, Richard M. C.; van Oeveren, Jan; de Heer, Peter; daPonte, Lorena; Jacobs-Oomen, Saskia; Cariaso, Mike; Prins, Marcel; van Eijk, Michiel J. T.; Janssen, Antoine; van Haaren, Mark J. J.; Datema, Erwin; van Ham, Roeland C. H. J.] Keygene NV, NL-6708 PW Wageningen, Netherlands; [Jo, Sung-Hwan; Kim, Jungeun; Kwon, Suk-Yoon; Kim, Sangmi; Koo, Dal-Hoe; Lee, Sanghyeob; Hur, Cheol-Goo] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon 305806, South Korea; [Clouser, Christopher] Life Technol, Beverly, MA 01915 USA; [Rico, Alain] Life Technol, F-91943 Courtaboeuf 3, France; [Hallab, Asis; Gebhardt, Christiane; Klee, Kathrin; Joecker, Anika; Warfsmann, Jens; Goebel, Ulrike] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Kawamura, Shingo; Yano, Kentaro] Meiji Univ, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Sherman, Jamie D.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Fukuoka, Hiroyuki; Negoro, Satomi] NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan; [Bhutty, Sarita; Chowdhury, Parul; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi 110067, India; [Datema, Erwin; Smit, Sandra; Schijlen, Eliog. W. M.; van de Belt, Jose; van Haarst, Jan C.; Peters, Sander A.; van Staveren, Marjo J.; Henkens, Marleen H. C.; Mooyman, Paul J. W.; Hesselink, Thamara; van Ham, Roeland C. H. J.] Plant Res Int, Business Unit Biosci, NL-6708 PB Wageningen, Netherlands; [Jiang, Guoyong] Qingdao Agr Univ, Inst Plant Genet Engn, Qingdao 266109, Peoples R China; [Droege, Marcus] Roche Appl Sci, D-82377 Penzberg, Germany; [Choi, Doil; Kang, Byung-Cheol; Kim, Byung Dong; Park, Minkyu; Kim, Seungill; Yeom, Seon-In] Seoul Natl Univ, Dept Plant Sci, Seoul 151921, South Korea; [Choi, Doil; Kang, Byung-Cheol; Kim, Byung Dong; Park, Minkyu; Kim, Seungill; Yeom, Seon-In] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Choi, Yang-Do] Seoul Natl Univ, Crop Funct Genom Ctr, Coll Agr & Life Sci, Seoul 151921, South Korea; [Li, Guangcun] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan 250000, Shandong, Peoples R China; [Gao, Jianwei] Shandong Acad Agr Sci, Inst Vegetables, Jinan 250100, Shandong, Peoples R China; [Liu, Yongsheng; Huang, Shengxiong] Sichuan Univ, Sch Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Fernandez-Pedrosa, Victoria; Collado, Carmen; Zuniga, Sheila] Sistemas Genom, Paterna 46980, Valencia, Spain; [Wang, Guoping] S China Agr Univ, Coll Hort, Guangzhou 510642, Guangdong, Peoples R China; [Cade, Rebecca; Dietrich, Robert A.] Syngenta Biotechnol Inc, Res Triangle Pk, NC 27709 USA; [Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Knapp, Sandra] Nat Hist Museum, Dept Bot, London SW7 5BD, England; [Fei, Zhangjun; White, Ruth A.; Thannhauser, Theodore W.; Giovannoni, James J.] USDA ARS, Robert W Holley Ctr, Ithaca, NY 14853 USA; [Angel Botella, Miguel; Gilbert, Louise] Inst Hortofruticultura Subtrop & Mediterranea, Dept Biol Mol & Bioquim, Malaga 29071, Spain; [Gonzalez, Ramon] Univ Pompeu Fabra, Ctr Regulacio Genom, E-08003 Barcelona, Spain; [Goicoechea, Jose Luis; Yu, Yeisoo; Kudrna, David; Collura, Kristi; Wissotski, Marina; Wing, Rod] Univ Arizona, Sch Plant Sci, Inst Collaborat Res BIO 5, Arizona Genom Inst, Tucson, AZ 85721 USA; [Schoof, Heiko] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany; [Meyers, Blake C.; Gurazada, Aishwarya Bala; Green, Pamela J.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19711 USA; [Meyers, Blake C.; Gurazada, Aishwarya Bala; Green, Pamela J.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Mathur, Saloni; Vyas, Shailendra; Solanke, Amolkumar U.; Kumar, Rahul; Gupta, Vikrant; Sharma, Arun K.; Khurana, Paramjit; Khurana, Jitendra P.; Tyagi, Akhilesh K.] Univ Delhi S Campus, Interdisciplinary Ctr Plant Genom, New Delhi 110021, India; [Mathur, Saloni; Vyas, Shailendra; Solanke, Amolkumar U.; Kumar, Rahul; Gupta, Vikrant; Sharma, Arun K.; Khurana, Paramjit; Khurana, Jitendra P.; Tyagi, Akhilesh K.] Univ Delhi S Campus, Dept Plant Mol Biol, New Delhi 110021, India; [Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mohorianu, Irina] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Walts, Brandon; Chamala, Srikar; Barbazuk, W. Brad] UF Genet Inst, Gainesville, FL 32610 USA; [Walts, Brandon; Chamala, Srikar; Barbazuk, W. Brad] Dept Biol, Gainesville, FL 32610 USA; [Li, Jingping; Guo, Hui; Lee, Tae-Ho; Wang, Yupeng; Zhang, Dong; Paterson, Andrew H.; Wang, Xiyin; Tang, Haibao] Univ Georgia, Plan Genome Mapping Lab, Athens, GA 30602 USA; [Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Wang, Xiyin] Hebei United Univ, Sch Sci, Tangshan 063000, Hebei, Peoples R China; [Tang, Haibao] J Craig Venter Inst, Rockville, MD 20850 USA; [Barone, Amalia; Chiusano, Maria Luisa; Ercolano, Maria Raffaella; D'Agostino, Nunzio; Di Filippo, Miriam; Traini, Alessandra; Sanseverino, Walter; Frusciante, Luigi] Univ Naples Federico II, Dept Soil Plant Environm & Anim Prod Sci, I-80055 Naples, Italy; [Seymour, Graham B.] Univ Nottingham, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England; [Elharam, Mounir; Fu, Ying; Hua, Axin; Kenton, Steven; Lewis, Jennifer; Lin, Shaoping; Najar, Fares; Lai, Hongshing; Qin, Baifang; Qu, Chunmei; Shi, Ruihua; White, Douglas; White, James; Xing, Yanbo; Yang, Keqin; Yi, Jing; Yao, Ziyun; Zhou, Liping; Roe, Bruce A.] Univ Oklahoma, Dept Chem & Biochem, Stephenson Res & Technol Ctr, Norman, OK 73019 USA; [Vezzi, Alessandro; D'Angelo, Michela; Zimbello, Rosanna; Schiavon, Riccardo; Caniato, Elisa; Rigobello, Chiara; Campagna, Davide; Vitulo, Nicola; Valle, Giorgio] Univ Padua, CRIBI, I-35131 Padua, Italy; [Nelson, David R.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [De Paoli, Emanuele] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Szinay, Dora; de Jong, Hans H.] Wageningen Univ, Genet Lab, NL-6708 PB Wageningen, Netherlands; [Szinay, Dora; Bai, Yuling; Visser, Richard G. F.] Wageningen Univ, Lab Plant Breeding, NL-6708 PB Wageningen, Netherlands; [Beasley, Helen; McLaren, Karen; Nicholson, Christine; Riddle, Claire] Wellcome Trust Sanger Inst Hinxton, Cambridge CB10 1SA, England; [Gianese, Giulio] Ylichron SrL, Casaccia Res Ctr, I-00123 Rome, Italy	Kazusa DNA Research Institute; Beijing Academy of Agriculture & Forestry; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cornell University; Boyce Thompson Institute for Plant Research; Centre for BioSystems Genomics; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Cold Spring Harbor Laboratory; Colorado State University; National Taiwan University; Cornell University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Flanders Institute for Biotechnology (VIB); Ghent University; Hebrew University of Jerusalem; Heilongjiang Academy of Agricultural Sciences; Henan Agricultural University; Huazhong Agricultural University; Imperial College London; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; INRAE; INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Italian National Agency New Technical Energy & Sustainable Economics Development; Scuola Superiore Sant'Anna; Italian National Agency New Technical Energy & Sustainable Economics Development; James Hutton Institute; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Keygene N.V.; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Thermo Fisher Scientific; Thermo Fisher Scientific; Max Planck Society; Meiji University; Montana State University System; Montana State University Bozeman; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Qingdao Agricultural University; Roche Holding; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; Sichuan University; South China Agricultural University; Syngenta; The Genome Analysis Centre (TGAC); Natural History Museum London; United States Department of Agriculture (USDA); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Arizona; University of Bonn; University of Delaware; University of Delaware; University of Delhi; University of Delhi; University of East Anglia; University of East Anglia; University System of Georgia; University of Georgia; North China University of Science & Technology; North China University of Science & Technology; J. Craig Venter Institute; University of Naples Federico II; University of Nottingham; University of Oklahoma System; University of Oklahoma - Norman; University of Padua; University of Tennessee System; University of Tennessee Health Science Center; University of Udine; Wageningen University & Research; Wageningen University & Research; Wellcome Trust Sanger Institute; Italian National Agency New Technical Energy & Sustainable Economics Development	Sato, S (corresponding author), Kazusa DNA Res Inst, 2-6-7 Kazusa Kamatari, Kisarazu, Chiba 2920818, Japan.		Fantini, Elio/AAX-7859-2020; Sato, Shusei/A-3616-2015; Wang, Jun/A-7261-2013; Tang, Haibao/A-6715-2011; Botella, Miguel A/B-5734-2012; Pericard, Pierre/AAH-1451-2019; Guigo, Roderic/D-1303-2010; Visser, Richard GF/B-3423-2012; Alioto, Tyler/AAF-6342-2020; Xu, Xun/AAI-6763-2020; Meyers, Blake/B-6535-2012; Nakamura, Yasukazu/T-9038-2019; Causse, Mathilde/AAF-6555-2020; Knapp, Sandra/A-4856-2011; Bouzayen, Mondher/AFQ-0802-2022; D'Agostino, Nunzio/A-6071-2017; Van de Peer, Yves/AAE-7666-2019; Bombarely, Aureliano/C-6580-2009; Kim, Seungill/AAR-1099-2021; Wang, Yupeng/B-7986-2009; VEZZI, ALESSANDRO/AAB-7686-2022; De Bellis, Gianluca/H-9725-2013; Botella, Miguel Ángel/S-3676-2019; Seymour, Graham B/N-4539-2014; Shirasawa, Kenta/L-9141-2019; Giuliano, Giovanni/A-2701-2012; Peano, Clelia/C-4015-2018; luisa, chiusano maria/AAQ-3064-2021; Choi, Doil/F-5002-2011; Rombauts, Stephane M/D-7640-2014; Termolino, Pasquale/B-7668-2015; Singh, Nouratan/N-9377-2017; zhong, silin/O-7029-2015; Wing, Rod A/Z-2885-2019; Schoof, Heiko/Y-7073-2018; He, Jun/ABC-9997-2021; Yeom, Seon-In/D-5420-2013; Granell, Antonio/G-3664-2010; Facella, Paolo/HHC-1895-2022; Huang, Sanwen/ABE-9053-2020; kumar, rahul/GZG-2171-2022; Fei, Zhangjun/H-5152-2012; Lee, Sanghyeob/AAC-6805-2020; Filippis, Ioannis/D-7687-2013; Mohorianu, Irina/J-2549-2019; Klein Lankhorst, René/HGD-0360-2022; Ercolano, Maria/AAJ-8129-2020; Pietrella, Marco/ABE-3613-2020; Li, Chuanyou/ABF-4143-2020; Mayer, Klaus FX/M-7941-2015; Rombauts, Stephane/P-2420-2019; Smit, Sandra/E-6787-2010; Fernandez-Munoz, Rafael/F-3714-2010; Zheng, Yi/F-6150-2016; Osorio, Sonia/M-2258-2014; Lee, Je Min/AAE-7496-2020; Sanseverino, Walter/AAX-5254-2021; Ferreira, Francisco Câmara/G-9841-2015; Ling, Hong-Qing/ABC-9451-2020; Menda, Naama/G-2915-2012; Van de Peer, Yves/D-4388-2009; Klopp, Christophe/J-3164-2019; Alioto, Tyler/K-7267-2015; MONFORTE, Antonio José/B-4784-2009; Yang, Wencai/G-6517-2011; huang, shengxiong/E-8111-2012; Matas, Antonio J./A-9325-2008; Fu, Fuyou/B-9754-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Torrents, David/G-5785-2015; Dalmay, Tamas/E-1377-2011	Fantini, Elio/0000-0001-6481-7560; Sato, Shusei/0000-0002-0293-5366; Tang, Haibao/0000-0002-3460-8570; Botella, Miguel A/0000-0002-8867-1831; Pericard, Pierre/0000-0001-8167-6448; Guigo, Roderic/0000-0002-5738-4477; Visser, Richard GF/0000-0002-0213-4016; Alioto, Tyler/0000-0002-2960-5420; Xu, Xun/0000-0002-5338-5173; Meyers, Blake/0000-0003-3436-6097; Knapp, Sandra/0000-0001-7698-3945; D'Agostino, Nunzio/0000-0001-9840-3817; Van de Peer, Yves/0000-0003-4327-3730; Bombarely, Aureliano/0000-0001-6257-8914; Kim, Seungill/0000-0001-6287-8693; Wang, Yupeng/0000-0002-3002-8069; VEZZI, ALESSANDRO/0000-0002-8629-6644; De Bellis, Gianluca/0000-0002-1622-4477; Botella, Miguel Ángel/0000-0002-8867-1831; Shirasawa, Kenta/0000-0001-7880-6221; Giuliano, Giovanni/0000-0002-2486-0510; Peano, Clelia/0000-0001-7055-3629; luisa, chiusano maria/0000-0002-6296-7132; Rombauts, Stephane M/0000-0002-3985-4981; Termolino, Pasquale/0000-0003-0272-0901; Singh, Nouratan/0000-0002-8063-8375; zhong, silin/0000-0002-0198-7383; Wing, Rod A/0000-0001-6633-6226; Schoof, Heiko/0000-0002-1527-3752; He, Jun/0000-0003-3733-0241; Yeom, Seon-In/0000-0002-8385-0179; Facella, Paolo/0000-0001-9076-3754; Huang, Sanwen/0000-0002-8547-5309; Lee, Sanghyeob/0000-0001-7684-2325; Mayer, Klaus FX/0000-0001-6484-1077; Rombauts, Stephane/0000-0002-3985-4981; Fernandez-Munoz, Rafael/0000-0002-4054-8949; Zheng, Yi/0000-0002-8042-7770; Osorio, Sonia/0000-0002-0159-6091; Lee, Je Min/0000-0002-0446-1336; Sanseverino, Walter/0000-0003-3324-5912; Ferreira, Francisco Câmara/0000-0002-1971-5466; Van de Peer, Yves/0000-0003-4327-3730; Klopp, Christophe/0000-0001-7126-5477; Alioto, Tyler/0000-0002-2960-5420; MONFORTE, Antonio José/0000-0003-3461-3094; Yang, Wencai/0000-0001-5369-2555; Matas, Antonio J./0000-0003-4348-3930; Pietrella, Marco/0000-0002-8789-6860; VALLE, GIORGIO/0000-0003-4377-5685; Spannagl, Manuel/0000-0003-0701-7035; Fu, Fuyou/0000-0002-5020-4496; Perrotta, Gaetano/0000-0003-2037-1063; Wang, Jun/0000-0002-8540-8931; Gupta, Vikrant/0000-0002-3479-8749; McQuinn, Ryan/0000-0002-5549-5181; Fawcett, Jeffrey/0000-0003-3907-2135; barone, amalia/0000-0002-5555-1999; Wang, Jun/0000-0002-2113-5874; Nakamura, Yasukazu/0000-0002-6782-5715; ROTHAN, Christophe/0000-0002-6831-2823; Huang, Shengxiong/0000-0003-2268-3001; Lippman, Zachary/0000-0001-7668-9025; Klee, Kathrin/0000-0003-2408-1282; Kumar, Rahul/0000-0002-4298-5130; Liu, Xin/0000-0003-3256-2940; Audran, Corinne/0000-0002-3083-8088; Seymour, Graham/0000-0001-8365-4947; Chamala, Srikar/0000-0001-6367-7615; ZHAO, JIUHAI/0000-0003-4606-7182; van Haarst, Jan/0000-0003-0307-1245; Van Eck, Joyce/0000-0002-8005-365X; Kwon, Suk-Yoon/0000-0002-5787-4898; Guo, Hui/0000-0001-7830-8564; De Paoli, Emanuele/0000-0003-3646-7692; Barbazuk, William/0000-0002-0909-4563; York, Thomas/0000-0002-6829-5816; Fernandez-del-Carmen, Maria Asuncion/0000-0002-9202-4960; Causse, Mathilde/0000-0002-0407-4985; Chattopadhyay, Debasis/0000-0002-5754-4987; Nelson, David/0000-0003-0583-5421; Lopez-Cobollo, Rosa/0000-0002-4392-5893; Walts, Brandon/0000-0002-0215-0745; Orozco Lopez, Modesto/0000-0002-8608-3278; LICHTENSTEIN, GABRIEL/0000-0002-2974-6717; Sander, Peters/0000-0002-2663-5149; Choi, Yang Do/0000-0003-4706-5154; Smit, Sandra/0000-0001-5239-5321; Dal Molin, Alessandra/0000-0001-6281-9589; Torrents, David/0000-0002-6086-9037; MAHATO, AJAY KUMAR/0000-0003-1359-6643; Vitulo, Nicola/0000-0002-9571-0747; Abbott, James/0000-0001-7701-4249; Gundlach, Heidrun/0000-0002-6757-0943; Pastor, Xavier/0000-0003-2089-3777; zhang, zhonghua/0000-0002-1034-227X; McCombie, W. Richard/0000-0003-1899-0682; Dalmay, Tamas/0000-0003-1492-5429; Zuniga, Sheila/0000-0002-3272-7605; Bruggmann, Remy/0000-0001-5629-6363; Mohorianu, Irina/0000-0003-4863-761X; Sharma, Arun/0000-0002-2777-8731	Argentina: INTA; Argentina: CONICET; Belgium: Flemish Institute for Biotechnology; Belgium: Ghent University; China: The State Key Laboratory of Plant Genomics, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences; Ministry of Science and Technology [2006AA10A116, 2004CB720405, 2006CB101907, 2007DFB30080]; Ministry of Agriculture [2007-Z5]; National Natural Science Foundation [36171319]; Postdoctoral Science Foundation [20070420446]; European Union [EU-SOL PL 016214]; France: Institute National de la Recherche Agronomique; France: Agence Nationale de la Recherche; Germany: the Max Planck Society; India: Department of Biotechnology, Government of India; Indian Council of Agricultural Research; Italy: Ministry of Research; Ministry of Agriculture; FILAS foundation; ENEA; CNR-ENEA [L. 191/2009]; Japan: Kazusa DNA Research Institute Foundation; Japan: National Institute of Vegetable and Tea Science; Korea: KRIBB; Korea: Crop Functional Genomics Research Center (CFGC), MEST; Netherlands: Centre for BioSystemsGenomics, Netherlands Organization for Scientific Research; Spain: Fundacion Genoma Espana; Cajamar; FEPEX; Fundacion Seneca; ICIA; IFAPA; Fundacion Manrique de Lara; Instituto Nacional de Bioinformatica; UK: BBSRC [BB/C509731/1]; DEFRA; SEERAD; USA: NSF [DBI-0116076, DBI-0421634, DBI-0606595, IOS-0923312, DBI-0820612, DBI-0605659, DEB-0316614, DBI 0849896, MCB 1021718]; USDA [2007-02773, 2007-35300-19739]; USDA-ARS; NSF; BBSRC [BB/G02491X/1, BB/G006199/1, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006199/1, BB/C509731/1, BBS/E/T/000PR6193, BB/G02491X/1] Funding Source: researchfish; ICREA Funding Source: Custom	Argentina: INTA; Argentina: CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Belgium: Flemish Institute for Biotechnology; Belgium: Ghent University; China: The State Key Laboratory of Plant Genomics, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation(China Postdoctoral Science Foundation); European Union(European Commission); France: Institute National de la Recherche Agronomique; France: Agence Nationale de la Recherche(French National Research Agency (ANR)); Germany: the Max Planck Society; India: Department of Biotechnology, Government of India; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); Italy: Ministry of Research; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); FILAS foundation; ENEA(ENEA, Italy); CNR-ENEA; Japan: Kazusa DNA Research Institute Foundation; Japan: National Institute of Vegetable and Tea Science; Korea: KRIBB; Korea: Crop Functional Genomics Research Center (CFGC), MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Netherlands: Centre for BioSystemsGenomics, Netherlands Organization for Scientific Research; Spain: Fundacion Genoma Espana; Cajamar; FEPEX; Fundacion Seneca(Fundacion Seneca); ICIA; IFAPA; Fundacion Manrique de Lara(French National Research Agency (ANR)); Instituto Nacional de Bioinformatica; UK: BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); SEERAD; USA: NSF(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICREA(ICREA)	This work was supported by: Argentina: INTA and CONICET. Belgium: Flemish Institute for Biotechnology and Ghent University. China: The State Key Laboratory of Plant Genomics, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences; Ministry of Science and Technology (2006AA10A116, 2004CB720405, 2006CB101907, 2007DFB30080) Ministry of Agriculture ('948' Program: 2007-Z5); National Natural Science Foundation (36171319); Postdoctoral Science Foundation (20070420446). European Union: FP6 Integrated Project EU-SOL PL 016214. France: Institute National de la Recherche Agronomique and Agence Nationale de la Recherche. Germany: the Max Planck Society. India: Department of Biotechnology, Government of India; Indian Council of Agricultural Research. Italy: Ministry of Research (FIRB-SOL, FIRB-Parallelomics, ItaLyco and GenoPOM projects); Ministry of Agriculture (Agronanotech and Biomassval projects); FILAS foundation; ENEA; CNR-ENEA project L. 191/2009. Japan: Kazusa DNA Research Institute Foundation and National Institute of Vegetable and Tea Science. Korea: KRIBB Basic Research Fund and Crop Functional Genomics Research Center (CFGC), MEST. Netherlands: Centre for BioSystemsGenomics, Netherlands Organization for Scientific Research. Spain: Fundacion Genoma Espana; Cajamar; FEPEX; Fundacion Seneca; ICIA; IFAPA; Fundacion Manrique de Lara; Instituto Nacional de Bioinformatica. UK: BBSRC grant BB/C509731/1; DEFRA; SEERAD. USA: NSF (DBI-0116076; DBI-0421634; DBI-0606595; IOS-0923312; DBI-0820612; DBI-0605659; DEB-0316614; DBI 0849896 and MCB 1021718); USDA (2007-02773 and 2007-35300-19739); USDA-ARS. We acknowledge the Potato Genome Sequencing Consortium for sharing data before publication; potato RNA-Seq data was provided by C. R. Buell from the NSF-funded Potato Genome Sequence and Annotation project; tomato RNA-Seq data by the USDA-funded SolCAP project, N. Sinha and J. Maloof; the Amplicon Express team for BAC pooling services; construction of the Whole Genome Profiling (WGP) physical map was supported by EnzaZaden, RijkZwaan, Vilmorin&Cie, and Takii & Co. Keygene N. V. owns patents and patent applications covering its AFLP and Whole Genome Profiling technologies; AFLP and Keygene are registered trademarks of Keygene N. V. The following individuals are also acknowledged for their contribution to the work described: J. Park, B. Wang, C. Niu, D. Liu, F. Cojutti, S. Pescarolo, A. Zambon, G. Xiao, J. Chen, J. Shi, L. Zhang, L. Zeng, M. Caccamo, D. Bolser, D. Martin, M. Gonzalez, P. A. Bedinger, P. A. Covey, P. Pachori, R. R. Pousada, S. Hakim, S. Sims, V. Cahais, W. Long, X. Zhou, Y. Lu, W. Haso, C. Lai, S. Lepp, C. Peluso, H. Teramu, H. De Jong, R. Lizarralde, E. R. May and Z. Li. M. Zabeau is thanked for his support and encouragement and S. van den Brink for her secretarial support. We dedicate this work to the late C. Rick who pioneered tomato genetics, collection of wild germplasm and the distribution of seed and knowledge.	Aagaard JE, 2006, J MOL EVOL, V63, P493, DOI 10.1007/s00239-005-0306-x; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; MICHAELSON MJ, 1991, AM J BOT, V78, P183, DOI 10.2307/2445241; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Ozminkowski R., 2004, REPORT TOMATO GENET, P26; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peralta I. E., 2008, Systematic Botany Monographs, V84; Peterson DG, 1998, GENOME, V41, P346, DOI 10.1139/gen-41-3-346; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; RICK CM, 1960, P NATL ACAD SCI USA, V46, P78, DOI 10.1073/pnas.46.1.78; RICK CM, 1978, SCI AM, V239, P77; Stockey RA, 2009, AM J BOT, V96, P3, DOI 10.3732/ajb.0800402; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Vicente AR, 2007, J SCI FOOD AGR, V87, P1435, DOI 10.1002/jsfa.2837; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; ZAMIR D, 1988, MOL GEN GENET, V213, P254, DOI 10.1007/BF00339589	28	1942	2092	51	1160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					635	641		10.1038/nature11119	http://dx.doi.org/10.1038/nature11119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660326	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000304608000047
J	Lewis, K				Lewis, Kim			Recover the lost art of drug discovery	NATURE			English	Editorial Material							RESISTANCE		[Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Lewis, Kim] NovoBiot Pharmaceut, Cambridge, MA USA; [Lewis, Kim] Arietis Corp, Boston, MA USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu						Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87	4	174	180	4	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					439	440		10.1038/485439a	http://dx.doi.org/10.1038/485439a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622552	Bronze			2022-12-28	WOS:000304344500017
J	Ker, K; Edwards, P; Perel, P; Shakur, H; Roberts, I				Ker, Katharine; Edwards, Phil; Perel, Pablo; Shakur, Haleema; Roberts, Ian			Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REDUCES BLOOD-LOSS; TOTAL HIP-ARTHROPLASTY; EPSILON-AMINOCAPROIC ACID; TOTAL KNEE ARTHROPLASTY; BYPASS GRAFT-SURGERY; COAGULATION-FACTOR USE; LOW-DOSE APROTININ; DOUBLE-BLIND; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS	Objective To assess the effect of tranexamic acid on blood transfusion, thromboembolic events, and mortality in surgical patients. Design Systematic review and meta-analysis. Data sources Cochrane central register of controlled trials, Medline, and Embase, from inception to September 2011, the World Health Organization International Clinical Trials Registry Platform, and the reference lists of relevant articles. Study selection Randomised controlled trials comparing tranexamic acid with no tranexamic acid or placebo in surgical patients. Outcome measures of interest were the number of patients receiving a blood transfusion; the number of patients with a thromboembolic event (myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism); and the number of deaths. Trials were included irrespective of language or publication status. Results 129 trials, totalling 10 488 patients, carried out between 1972 and 2011 were included. Tranexamic acid reduced the probability of receiving a blood transfusion by a third (risk ratio 0.62, 95% confidence interval 0.58 to 0.65; P<0.001). This effect remained when the analysis was restricted to trials using adequate allocation concealment (0.68, 0.62 to 0.74; P<0.001). The effect of tranexamic acid on myocardial infarction (0.68, 0.43 to 1.09; P=0.11), stroke (1.14, 0.65 to 2.00; P=0.65), deep vein thrombosis (0.86, 0.53 to 1.39; P=0.54), and pulmonary embolism (0.61, 0.25 to 1.47; P=0.27) was uncertain. Fewer deaths occurred in the tranexamic acid group (0.61, 0.38 to 0.98; P=0.04), although when the analysis was restricted to trials using adequate concealment there was considerable uncertainty (0.67, 0.33 to 1.34; P=0.25). Cumulative meta-analysis showed that reliable evidence that tranexamic acid reduces the need for transfusion has been available for over 10 years. Conclusions Strong evidence that tranexamic acid reduces blood transfusion in surgery has been available for many years. Further trials on the effect of tranexamic acid on blood transfusion are unlikely to add useful new information. However, the effect of tranexamic acid on thromboembolic events and mortality remains uncertain. Surgical patients should be made aware of this evidence so that they can make an informed choice.	[Ker, Katharine; Edwards, Phil; Perel, Pablo; Shakur, Haleema; Roberts, Ian] Univ London London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Ker, K (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.	katharine.ker@lshtm.ac.uk		/0000-0002-2342-301X; Edwards, Phil/0000-0003-4431-8822; Shakur-Still, Haleema/0000-0002-6511-109X; Ker, Katharine/0000-0002-1514-5005				Alshryda S, 2011, J BONE JOINT SURG BR, V93B, P1577, DOI 10.1302/0301-620X.93B12.26989; Alvarez JC, 2008, TRANSFUSION, V48, P519, DOI 10.1111/j.1537-2995.2007.01564.x; Andreasen JJ, 2004, EUR J CARDIO-THORAC, V26, P311, DOI 10.1016/j.ejcts.2004.03.012; [Anonymous], 2011, REV MAN REVMAN COMP; Armellin G, 2001, J CARDIOTHOR VASC AN, V15, P331, DOI 10.1053/jcan.2001.23284; AUVINEN O, 1987, KLIN WOCHENSCHR, V65, P253, DOI 10.1007/BF01773442; Barrons Robert W., 1996, Am J Ther, V3, P821, DOI 10.1097/00045391-199612000-00007; Benoni G, 1996, J BONE JOINT SURG BR, V78B, P434, DOI 10.1302/0301-620X.78B3.0780434; Benoni G, 2000, ACTA ORTHOP SCAND, V71, P250, DOI 10.1080/000164700317411834; Benoni G, 2001, ACTA ORTHOP SCAND, V72, P442, DOI 10.1080/000164701753532754; BLAUHUT B, 1994, J THORAC CARDIOV SUR, V108, P1083, DOI 10.1016/S0022-5223(12)70192-7; Boylan JF, 1996, ANESTHESIOLOGY, V85, P1043, DOI 10.1097/00000542-199611000-00012; Boylan JF, 1996, ANESTHESIOLOGY, V85, pA30; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Brown RS, 1997, ANESTH ANALG, V85, P963, DOI 10.1097/00000539-199711000-00003; Bulutcu FS, 2005, PEDIATR ANESTH, V15, P41, DOI 10.1111/j.1460-9592.2004.01366.x; Caglar GS, 2008, EUR J OBSTET GYN R B, V137, P227, DOI 10.1016/j.ejogrb.2007.04.003; Casati V, 2004, J THORAC CARDIOV SUR, V128, P83, DOI 10.1016/j.jtcvs.2003.10.034; Casati V, 2002, J THORAC CARDIOV SUR, V123, P1084, DOI 10.1067/mtc.2002.120717; Casati V, 2001, ANESTHESIOLOGY, V94, P8, DOI 10.1097/00000542-200101000-00007; CASTELLI G, 1977, SCHWEIZ MED WSCHR, V107, P780; Chauhan S, 2004, J CARDIOTHOR VASC AN, V18, P141, DOI 10.1053/j.jvca.2004.01.016; Chauhan S, 2003, INDIAN J MED RES, V118, P86; Chauhan Sandeep, 2004, Asian Cardiovasc Thorac Ann, V12, P121; Chen CC, 2008, OTOLARYNG HEAD NECK, V138, P762, DOI 10.1016/j.otohns.2008.02.022; Choi WS, 2009, J ORAL MAXIL SURG, V67, P125, DOI 10.1016/j.joms.2008.08.015; Cid J, 2005, TRANSFUSION, V45, P1302, DOI 10.1111/j.1537-2995.2005.00204.x; Claeys MA, 2007, ACTA CHIR BELG, V107, P397, DOI 10.1080/00015458.2007.11680081; COFFEY A, 1995, AM SURGEON, V61, P566; CORBEAU JJ, 1995, ANN FR ANESTH, V14, P154, DOI 10.1016/S0750-7658(95)70013-2; Crescenti A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5701; Dadure C, 2011, ANESTHESIOLOGY, V114, P856, DOI 10.1097/ALN.0b013e318210f9e3; Dalmau A, 2000, ANESTH ANALG, V91, P29, DOI 10.1097/00000539-200007000-00006; Demeyere R, 2006, CRIT CARE S1, V10; DEPEPPO AP, 1995, TEX HEART I J, V22, P231; Diprose P, 2005, BRIT J ANAESTH, V94, P271, DOI 10.1093/bja/aei044; Dryden PJ, 1997, CAN J ANAESTH, V44, P934, DOI 10.1007/BF03011964; Duran de la Fuente P, 2003, Rev Esp Anestesiol Reanim, V50, P388; Ekback G, 2000, ANESTH ANALG, V91, P1124; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Elwatidy S, 2008, SPINE, V33, P2577, DOI 10.1097/BRS.0b013e318188b9c5; Engel JM, 2001, ANESTH ANALG, V92, P775; Erstad BL, 2001, ANN PHARMACOTHER, V35, P1075; Erstad BL, 2001, ANN PHARMACOTHER, V35, P925, DOI 10.1345/aph.10337; FREMES SE, 1994, ANN THORAC SURG, V58, P1580, DOI 10.1016/0003-4975(94)91636-5; Gai MY, 2004, EUR J OBSTET GYN R B, V112, P154, DOI 10.1016/S0301-2115(03)00287-2; Garneti N, 2004, J ARTHROPLASTY, V19, P488, DOI 10.1016/j.arth.2003.12.073; Gill JB, 2008, J BONE JOINT SURG AM, V90A, P2399, DOI 10.2106/JBJS.G.01179; Gill JB, 2006, J ARTHROPLASTY, V21, P869, DOI 10.1016/j.arth.2005.09.009; Gill JB, 2009, CURR ORTHOP PRACT, V20, P152, DOI 10.1097/BCO.0b013e318191ebc0; Gobbur VR, 2011, 54 ALL IND C OBST GY, P92; Gohel M, 2007, J OBSTET GYNAECOL IN, V57, P228; Goobie SM, 2011, ANESTHESIOLOGY, V114, P862, DOI 10.1097/ALN.0b013e318210fd8f; Good L, 2003, BRIT J ANAESTH, V90, P596, DOI 10.1093/bja/aeg111; Greiff G, 2012, J CARDIOTHOR VASC AN, V26, P232, DOI 10.1053/j.jvca.2011.07.010; GRUNDSELL H, 1984, OBSTET GYNECOL, V64, P573; Guay J, 2006, CAN J ANAESTH, V53, pS59, DOI 10.1007/BF03022253; Gungorduk K, 2011, AM J PERINAT, V28, P233, DOI 10.1055/s-0030-1268238; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008085; Hardy JF, 1998, ANN THORAC SURG, V65, P371, DOI 10.1016/S0003-4975(97)01016-3; Henry DA, 2001, COCHRANE DB SYST REV, V1; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; HIIPPALA S, 1995, BRIT J ANAESTH, V74, P534, DOI 10.1093/bja/74.5.534; Hiippala ST, 1997, ANESTH ANALG, V84, P839, DOI 10.1097/00000539-199704000-00026; Ho KM, 2003, ANAESTH INTENS CARE, V31, P529, DOI 10.1177/0310057X0303100507; HORROW JC, 1990, J THORAC CARDIOV SUR, V99, P70; HORROW JC, 1995, ANESTHESIOLOGY, V82, P383, DOI 10.1097/00000542-199502000-00009; HORROW JC, 1991, CIRCULATION, V84, P2063, DOI 10.1161/01.CIR.84.5.2063; Husted H, 2003, ACTA ORTHOP SCAND, V74, P665, DOI 10.1080/00016470310018171; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Isetta C., 1993, European Heart Journal, V14, P424; Jansen AJ, 1999, BRIT J ANAESTH, V83, P596, DOI 10.1093/bja/83.4.596; Jares M, 2003, J CARDIOVASC SURG, V44, P205; Jimenez JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6173; Johansson T, 2005, ACTA ORTHOP, V76, P314, DOI 10.1080/00016470510030751; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Kakar PN, 2009, INDIAN J ANAESTH, V53, P667; Karski J, 2005, J THORAC CARDIOV SUR, V130, P309, DOI 10.1016/j.jtcvs.2004.11.015; KARSKI JM, 1995, J THORAC CARDIOV SUR, V110, P835, DOI 10.1016/S0022-5223(95)70118-4; Kaspar M, 1997, ANESTH ANALG, V85, P281, DOI 10.1097/00000539-199708000-00007; Katoh J, 1997, J THORAC CARDIOV SUR, V113, P802, DOI 10.1016/S0022-5223(97)70244-7; Katsaros D, 1996, ANN THORAC SURG, V61, P1131, DOI 10.1016/0003-4975(96)00022-7; Kazemi Seyyed Morteza, 2010, Orthopedics, V33, P17, DOI 10.3928/01477447-20091124-30; KLINCK JR, 1993, HEPATOLOGY, V18, P728, DOI 10.1016/0270-9139(93)90395-4; Kojima T, 2001, THROMB RES, V104, P301, DOI 10.1016/S0049-3848(01)00379-6; Kongnyuy EJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005355.pub3; Kuitunen A, 2005, ACTA ANAESTH SCAND, V49, P1272, DOI 10.1111/j.1399-6576.2005.00809.x; Kuitunen AH, 2006, BLOOD COAGUL FIBRIN, V17, P639, DOI 10.1097/01.mbc.0000252598.25024.68; Kulkarni AP, 2011, ASA ABSTR, pA484; Later AFL, 2009, EUR J CARDIO-THORAC, V36, P322, DOI 10.1016/j.ejcts.2008.11.038; Laupacis A, 1997, ANESTH ANALG, V85, P1258, DOI 10.1097/00000539-199712000-00014; Leelahanon S, 2002, THAI J SURG, V23, P138; Lemay E, 2004, CAN J ANAESTH, V51, P31, DOI 10.1007/BF03018543; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Lin PC, 2011, CLIN ORTHOP RELAT R, V469, P1995, DOI 10.1007/s11999-011-1789-y; Liu Jia-ming, 2010, Zhonghua Wai Ke Za Zhi, V48, P937; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Ma SCA, 2011, J CARDIOTHOR VASC AN, V25, P26, DOI 10.1053/j.jvca.2010.08.012; MacGillivray RG, 2011, J ARTHROPLASTY, V26, P24, DOI 10.1016/j.arth.2009.11.013; Maddali Madan M, 2007, Asian Cardiovasc Thorac Ann, V15, P313; Makwana J, 2010, INDIAN J ANAESTH, V54, P489, DOI 10.4103/0019-5049.72636; Malhotra R, 2011, EUR J ORTHOP SURG TR, V21, P101, DOI 10.1007/s00590-010-0671-z; Mansour EE, 2004, EGYPTIAN J ANAESTHES, V20, P229; Martin-Hirsch PPL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001421.pub2; McConnell JS, 2011, ACTA ORTHOP, V82, P660, DOI 10.3109/17453674.2011.623568; Mehr-Aein Aflatoon, 2007, Asian Cardiovasc Thorac Ann, V15, P49; Menichetti A, 1996, J CARDIOVASC SURG, V37, P401; MILLER RA, 1980, BRIT J UROL, V52, P26, DOI 10.1111/j.1464-410X.1980.tb02914.x; Misfeld M, 1998, ANN THORAC SURG, V66, P792, DOI 10.1016/S0003-4975(98)00646-8; Molenaar IQ, 2007, AM J TRANSPLANT, V7, P185, DOI 10.1111/j.1600-6143.2006.01591.x; Molloy DO, 2007, J BONE JOINT SURG BR, V89B, P306, DOI 10.1302/0301-620X.89B3.17565; Moret F, 2006, TRANSFUS ALTERN T S1, V8, P93; Movafegh A, 2011, INT J GYNECOL OBSTET, V115, P224, DOI 10.1016/j.ijgo.2011.07.015; Murphy GJ, 2006, J THORAC CARDIOV SUR, V132, P475, DOI 10.1016/j.jtcvs.2006.01.064; Myles PS, 2008, AM HEART J, V155, P224, DOI 10.1016/j.ahj.2007.10.003; Neilipovitz DT, 2001, ANESTH ANALG, V93, P82; Ngaage DL, 2010, EUR J CARDIO-THORAC, V37, P1375, DOI 10.1016/j.ejcts.2009.11.055; Niskanen RO, 2005, ACTA ORTHOP, V76, P829, DOI 10.1080/17453670510045444; Novikova N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007872.pub2; Nuttall GA, 2000, ANESTHESIOLOGY, V92, P674, DOI 10.1097/00000542-200003000-00010; OERTLI D, 1994, BRIT J SURG, V81, P856, DOI 10.1002/bjs.1800810621; Orpen NM, 2006, KNEE, V13, P106, DOI 10.1016/j.knee.2005.11.001; Ozal E, 2002, J THORAC CARDIOV SUR, V123, P539, DOI 10.1067/mtc.2002.117281; Pfizer, 2011, STUD TRAN AC RED BLO; Pinosky ML, 1997, J CARDIAC SURG, V12, P330, DOI 10.1111/j.1540-8191.1997.tb00147.x; Pleym H, 2003, ANESTH ANALG, V96, P923, DOI 10.1213/01.ANE.0000054001.37346.03; PUGH SC, 1995, J CARDIOTHOR VASC AN, V9, P240, DOI 10.1016/S1053-0770(05)80314-3; Rannikko A, 2004, UROLOGY, V64, P955, DOI 10.1016/j.urology.2004.07.008; Reid RW, 1997, ANESTH ANALG, V84, P990, DOI 10.1097/00000539-199705000-00008; Risch A, 2000, ANAESTHESIST, V49, P279, DOI 10.1007/s001010050829; RYBO G, 1972, ACTA OBSTET GYN SCAN, V51, P347, DOI 10.3109/00016347209156871; Sadeghi M., 2007, ACTA MED IRANICA, V45, P437; Santos ATL, 2006, BRAZ J MED BIOL RES, V39, P63, DOI 10.1590/S0100-879X2006000100007; Schouten ES, 2009, PEDIATR CRIT CARE ME, V10, P182, DOI 10.1097/PCC.0b013e3181956d61; Sekhavat L, 2009, J MATERN-FETAL NEO M, V22, P72, DOI 10.1080/14767050802353580; Sethna NF, 2005, ANESTHESIOLOGY, V102, P727, DOI 10.1097/00000542-200504000-00006; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; ShoreLesserson L, 1996, ANESTH ANALG, V83, P18, DOI 10.1097/00000539-199607000-00005; Sorin A, 1999, J BONE JOINT SURG BR, V81-B, P234; SPEEKENBRINK RGH, 1995, ANN THORAC SURG, V59, P438, DOI 10.1016/0003-4975(94)00865-5; StataCorp, 2009, STAT STAT SOFTW REL; Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; Taghaddomi RJ, 2009, IRAN RED CRESCENT ME, V11, P265; Taghaddomi RJ, 2009, J CARDIOTHOR VASC AN, V23, P312, DOI 10.1053/j.jvca.2008.09.018; Tanaka N, 2001, J BONE JOINT SURG BR, V83B, P702, DOI 10.1302/0301-620X.83B5.11745; Tsutsumimoto T, 2011, SPINE, V36, P1913, DOI 10.1097/BRS.0b013e3181fb3a42; Tzortzopoulou A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006883.pub2; Umscheid CA, 2007, CURR OPIN HEMATOL, V14, P455, DOI 10.1097/MOH.0b013e328270b89e; Uozaki Y, 2001, Jpn J Thorac Cardiovasc Surg, V49, P273; Vanek T, 2005, EUR J CARDIO-THORAC, V28, P563, DOI 10.1016/j.ejcts.2005.06.027; Veien M, 2002, ACTA ANAESTH SCAND, V46, P1206, DOI 10.1034/j.1399-6576.2002.461007.x; Wang G, 2011, ANESTH ANALG; Wei MX, 2006, SCAND CARDIOVASC J, V40, P105, DOI 10.1080/14017430500519864; Wong J, 2008, ANESTH ANALG, V107, P1479, DOI 10.1213/ane.0b013e3181831e44; Wu CC, 2006, ANN SURG, V243, P173, DOI 10.1097/01.sla.0000197561.70972.73; Yang H, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P590; YASSEN K, 1993, CLIN TRANSPLANT, V7, P453; Yepes JF, 2002, ORAL SURG ORAL MED O, V93, P419; Zabeeda D, 2002, ANN THORAC SURG, V74, P733, DOI 10.1016/S0003-4975(02)03784-0; Zhang Fujiang, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1302; Zhang H, 2011, KNEE SURG SPORTS TRA, P2011; Zheng SR, 2000, BLOOD, V96, p846A; Zohar E, 2004, ANESTH ANALG, V99, P1679, DOI 10.1213/01.ANE.0000136770.75805.19; Zonis Z, 1996, J THORAC CARDIOV SUR, V111, P982, DOI 10.1016/S0022-5223(96)70374-4; Zufferey PJ, 2010, BRIT J ANAESTH, V104, P23, DOI 10.1093/bja/aep314; Zufferey P, 2006, ANESTHESIOLOGY, V105, P1034, DOI 10.1097/00000542-200611000-00026	166	531	549	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2012	344								e3054	10.1136/bmj.e3054	http://dx.doi.org/10.1136/bmj.e3054			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QQ	22611164	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000304591200001
J	Pang, T; Weatherall, D				Pang, Tikki; Weatherall, David			Genomics and world health: a decade on	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; DISEASES; PROGRESS; MALARIA; CHINA		[Pang, Tikki] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 259772, Singapore; [Weatherall, David] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	National University of Singapore; University of Oxford	Pang, T (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 259772, Singapore.	spptep@nus.edu.sg						Berns KI, 2012, NATURE, V482, P153, DOI DOI 10.1038/482153A; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Evans JP, 2011, SCIENCE, V331, P861, DOI 10.1126/science.1198039; Hayden EC, 2009, NATURE, V461, P458, DOI 10.1038/461458a; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Normile D, 2012, SCIENCE, V335, P516, DOI 10.1126/science.335.6068.516; Qadir Z, 2011, LANCET, V378, P1838, DOI 10.1016/S0140-6736(11)61797-2; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Sgaier SK, 2007, SCIENCE, V318, P1074, DOI 10.1126/science.1149157; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Weatherall DJ, 2010, ANN NY ACAD SCI, V1202, P17, DOI 10.1111/j.1749-6632.2010.05546.x; WHO, 2002, GEN WORLD HLTH; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; 2002, LANCET, V359, P1535	19	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1853	1854		10.1016/S0140-6736(12)60562-5	http://dx.doi.org/10.1016/S0140-6736(12)60562-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	944IW	22608321				2022-12-28	WOS:000304194200004
J	Ellemers, N				Ellemers, Naomi			THE GROUP SELF	SCIENCE			English	Review							AFRICAN-AMERICANS; STEREOTYPE THREAT; GROUP-LEVEL; IDENTITY; GENDER; MODEL; DISCRIMINATION; IDENTIFICATION; COMPETENCE; CHALLENGE	Although people often tend to consider themselves and others as unique individuals, there are many situations in which they think, feel, and act primarily as group members. This can bring out the best in them, as when they are inspired to help fellow citizens in need, or the worst, as when they show hostility against others simply because they represent another religious or ethnic group. Understanding when and why the group self becomes more important than the individual self, and how this affects people's thoughts, feelings, and behaviors, can help to prevent and redirect unwelcome aspects of human behavior by addressing them at the appropriate level of self.	Leiden Univ, Inst Psychol Res, Dept Social & Org Psychol, NL-2300 RB Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Ellemers, N (corresponding author), Leiden Univ, Inst Psychol Res, Dept Social & Org Psychol, POB 9555, NL-2300 RB Leiden, Netherlands.	Ellemers@fsw.leidenuniv.nl	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; Ellemers, Naomi/0000-0001-9810-1165	Leiden University Institute of Psychological Research	Leiden University Institute of Psychological Research	This work was supported by the Leiden University Institute of Psychological Research. I thank D. de Gilder and two anonymous reviewers for their helpful comments.	BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bijleveld E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033681; Blascovich J, 2001, PSYCHOL SCI, V12, P225, DOI 10.1111/1467-9280.00340; Brambilla M, 2012, BRIT J SOC PSYCHOL, V51, P149, DOI 10.1111/j.2044-8309.2010.02011.x; Branscombe N., 2010, REDISCOVERING SOCIAL, P341; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; Branscombe Nyla R., 2004, COLLECTIVE GUILT; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Brown LM, 2006, BIOL PSYCHOL, V71, P303, DOI 10.1016/j.biopsycho.2005.06.003; Danaer K, 2008, J APPL SOC PSYCHOL, V38, P1639, DOI 10.1111/j.1559-1816.2008.00362.x; Derks B, 2011, PSYCHOL SCI, V22, P1243, DOI 10.1177/0956797611417258; Derks B, 2011, J EXP SOC PSYCHOL, V47, P178, DOI 10.1016/j.jesp.2010.08.016; Derks B, 2007, SOC ISS POLICY REV, V1, P217, DOI 10.1111/j.1751-2409.2007.00008.x; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ellemers N, 2002, ANNU REV PSYCHOL, V53, P161, DOI 10.1146/annurev.psych.53.100901.135228; Ellemers N., 2010, HDB PREJUDICE STEREO, P561; Ellemers N., 2011, HDB THEORIES SOCIAL, P379; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Frable DES, 1998, J PERS SOC PSYCHOL, V74, P909, DOI 10.1037/0022-3514.74.4.909; Grace DM, 2008, CHILD DEV, V79, P1928, DOI 10.1111/j.1467-8624.2008.01234.x; Gutsell J. N., 2011, SOC COGN AFFECT NEUR; Gutsell JN, 2010, J EXP SOC PSYCHOL, V46, P841, DOI 10.1016/j.jesp.2010.03.011; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Jetten J., 2011, REVELS GROUPS DISSEN; Jetten J., 2012, SOCIAL CURE IDENTITY; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Leary M.R., 2003, HDB SELF IDENTITY; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; Marques J.M., 1994, EUR REV SOC PSYCHOL, V5, P37, DOI [10.1080/14792779543000011, DOI 10.1080/14792779543000011]; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Mendes WB, 2002, PERS SOC PSYCHOL B, V28, P939; Mullen E, 2006, J PERS SOC PSYCHOL, V90, P629, DOI 10.1037/0022-3514.90.4.629; OPOTOW S, 1993, J SOC ISSUES, V49, P71, DOI 10.1111/j.1540-4560.1993.tb00909.x; Quinn KA, 1999, PERS SOC PSYCHOL B, V25, P1430, DOI 10.1177/0146167299259008; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Scheepers D, 2009, J EXP SOC PSYCHOL, V45, P228, DOI 10.1016/j.jesp.2008.09.011; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Shapiro JR, 2012, SEX ROLES, V66, P175, DOI 10.1007/s11199-011-0051-0; Smart L, 2000, SOCIAL PSYCHOLOGY OF STIGMA, P220; Smith ER, 2007, J PERS SOC PSYCHOL, V93, P431, DOI 10.1037/0022-3514.93.3.431; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Turner J.C., 2012, THEORIES SOCIAL PSYC, P399, DOI [10.4135/9781446249222.n46, DOI 10.4135/9781446249222.N46]; Tyler TR, 1999, RES ORGAN BEHAV, V21, P201; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Young SD, 2009, HEALTH PSYCHOL, V28, P675, DOI 10.1037/a0016395; Young SG, 2010, J PERS SOC PSYCHOL, V99, P964, DOI 10.1037/a0020400; Yzerbyt VY, 2006, BRIDGING SOCIAL PSYCHOLOGY: BENEFITS OF TRANSDISCIPLINARY APPROACHES, P391	53	116	117	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					848	852		10.1126/science.1220987	http://dx.doi.org/10.1126/science.1220987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605760				2022-12-28	WOS:000304145600046
J	Edwards, SP				Edwards, Scott P.			Nipped in the bud	NATURE			English	Editorial Material							DIABETES PREVENTION; BARIATRIC SURGERY; MEDICAL THERAPY											Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; Wang LM, 2012, DIABETES CARE, V35, P465, DOI 10.2337/dc11-1236	6	0	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S18	S19		10.1038/485S18a	http://dx.doi.org/10.1038/485S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616102				2022-12-28	WOS:000305950100009
J	Bellomo, R; Kellum, JA; Ronco, C				Bellomo, Rinaldo; Kellum, John A.; Ronco, Claudio			Acute kidney injury	LANCET			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; CONTRAST-INDUCED NEPHROPATHY; CRITICALLY-ILL PATIENTS; REPLACEMENT THERAPY; SODIUM-BICARBONATE; CORONARY-ANGIOGRAPHY; HEPATORENAL-SYNDROME; INTENSIVE-CARE; TERLIPRESSIN THERAPY	Acute kidney injury (formerly known as acute renal failure) is a syndrome characterised by the rapid loss of the kidney's excretory function and is typically diagnosed by the accumulation of end products of nitrogen metabolism (urea and creatinine) or decreased urine output, or both. It is the clinical manifestation of several disorders that affect the kidney acutely. Acute kidney injury is common in hospital patients and very common in critically ill patients. In these patients, it is most often secondary to extrarenal events. How such events cause acute kidney injury is controversial. No specific therapies have emerged that can attenuate acute kidney injury or expedite recovery; thus, treatment is supportive. New diagnostic techniques (eg, renal biomarkers) might help with early diagnosis. Patients are given renal replacement therapy if acute kidney injury is severe and biochemical or volume-related, or if uraemic-toxaemia-related complications are of concern. If patients survive their illness and do not have premorbid chronic kidney disease, they typically recover to dialysis independence. However, evidence suggests that patients who have had acute kidney injury are at increased risk of subsequent chronic kidney disease.	[Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3181, Australia; [Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Ronco, Claudio] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Int Renal Res Inst IRRIV, Vicenza, Italy	Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Bellomo, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3181, Australia.	rinaldo.bellomo@austin.org.au	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Ronco, Claudio/0000-0002-6697-4065; Sajgure, Atul/0000-0003-1746-9801; Bellomo, Rinaldo/0000-0002-1650-8939	Alere; Abbott Diagnostics; Gambro; Fresenius; B Braun; Edwards Lifesciences; Baxter	Alere; Abbott Diagnostics(Abbott Laboratories); Gambro; Fresenius; B Braun; Edwards Lifesciences; Baxter	RB and CR have received consultancy and speaking fees from Alere, Abbott Diagnostics, Gambro, Fresenius, B Braun, and Edwards Lifesciences. JAK has received consultancy and speaking fees from Alere, Abbott Diagnostics, Gambro, Baxter, and Fresenius.	Ahlstrom A, 2004, CLIN NEPHROL, V62, P344; ALEJANDRO V, 1995, J CLIN INVEST, V95, P820, DOI 10.1172/JCI117732; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2008, CRIT CARE MED, V36, P610, DOI 10.1097/01.CCM.0B013E3181611F552; Bagshaw Sean M, 2007, Crit Care Resusc, V9, P60; Bagshaw SM, 2007, CRIT CARE MED, V35, P1592, DOI 10.1097/01.CCM.0000266684.17500.2F; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P695, DOI 10.1053/j.ajkd.2006.07.017; Bagshaw SM, 2012, NEPHROL DIAL TRANSPL, V27, P582, DOI 10.1093/ndt/gfr331; Bagshaw SM, 2010, CONTRIB NEPHROL, V165, P274, DOI 10.1159/000313767; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc8037; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Bagshaw SM, 2009, NAT REV NEPHROL, V5, P185, DOI 10.1038/nrneph.2009.23; Bagshaw SM, 2009, J CRIT CARE, V24, P129, DOI 10.1016/j.jcrc.2007.12.017; Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Bell M, 2007, INTENS CARE MED, V33, P773, DOI 10.1007/s00134-007-0590-6; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2005, CURR OPIN CRIT CARE, V11, P542, DOI 10.1097/01.ccx.0000184165.02498.14; Bellomo R, 2000, LANCET, V356, P2139; Bellomo R, 2003, INTENS CARE MED, V29, P1222, DOI 10.1007/s00134-003-1796-x; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2007, CONTRIB NEPHROL, V156, P1; Bentley ML, 2010, CRIT CARE MED, V38, pS169, DOI 10.1097/CCM.0b013e3181de0c60; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038; Brown JR, 2009, JACC-CARDIOVASC INTE, V2, P1116, DOI 10.1016/j.jcin.2009.07.015; Chung SA, 2010, RHEUM DIS CLIN N AM, V36, P545, DOI 10.1016/j.rdc.2010.04.003; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Conger DJ, 2001, ACUTE RENAL FAILURE, P13; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; Damman K, 2007, EUR J HEART FAIL, V9, P872, DOI 10.1016/j.ejheart.2007.05.010; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Devarajan P, 2010, AM J KIDNEY DIS, V56, P632, DOI 10.1053/j.ajkd.2010.04.014; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Falk RJ, 2010, J AM SOC NEPHROL, V21, P745, DOI 10.1681/ASN.2009121238; Feehally J, 2005, OXFORD TXB CLIN NEPH, P363; Fiaccadori E, 2008, J NEPHROL, V21, P645; Firth JD, 2005, OXFORD TXB CLIN NEPH, P1465; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Gluud LL, 2010, HEPATOLOGY, V51, P576, DOI 10.1002/hep.23286; Golestaneh L, 2009, KIDNEY INT, V76, P813, DOI 10.1038/ki.2009.314; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Grunfeld J.P., 2005, OXFORD TXB CLIN NEPH, V3rd ed., P1445; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2011, CURR OPIN HEMATOL, V18, P11, DOI 10.1097/MOH.0b013e3283411517; Haase M, 2010, CONTRIB NEPHROL, V165, P33, DOI 10.1159/000313742; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Heyman Samuel N, 2002, Curr Opin Crit Care, V8, P526, DOI 10.1097/00075198-200212000-00008; Heyman SN, 2010, KIDNEY INT, V77, P9, DOI 10.1038/ki.2009.347; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hoste EAJ, 2010, NEPHROL DIAL TRANSPL, V25, P747, DOI 10.1093/ndt/gfp389; House AA, 2010, AM J KIDNEY DIS, V56, P759, DOI 10.1053/j.ajkd.2010.04.012; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Huber W, 2003, AM J CARDIOL, V91, P1157, DOI 10.1016/S0002-9149(03)00259-5; Huber W, 2002, RADIOLOGY, V223, P772, DOI 10.1148/radiol.2233010609; Ishikawa K, 2010, CONTRIB NEPHROL, V165, P18, DOI 10.1159/000313740; Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047; Kandula P, 2010, NEPHROLOGY, V15, P165, DOI 10.1111/j.1440-1797.2009.01204.x; Kato N, 2009, J AM SOC NEPHROL, V20, P1565, DOI 10.1681/ASN.2008090957; Koyner JL, 2008, KIDNEY INT, V74, P1059, DOI 10.1038/ki.2008.341; Kwon O, 2009, AM J PHYSIOL-RENAL, V296, pF25, DOI 10.1152/ajprenal.90531.2008; Lameire N, 2005, LANCET, V365, P417; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Langenberg C, 2009, CRITICAL CARE NEPHRO, P237; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Lewis J, 2000, AM J KIDNEY DIS, V36, P767, DOI 10.1053/ajkd.2000.17659; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lightstone L, 2010, CURR OPIN RHEUMATOL, V22, P252, DOI 10.1097/BOR.0b013e3283386512; Lin J, 2005, CURR OPIN NEPHROL HY, V14, P105, DOI 10.1097/00041552-200503000-00004; Liu YL, 2009, NEPHROL DIAL TRANSPL, V24, P504, DOI 10.1093/ndt/gfn490; Loutzenhiser R, 2006, AM J PHYSIOL-REG I, V290, pR1153, DOI 10.1152/ajpregu.00402.2005; Macedo E, 2011, NEPHROL DIAL TRANSPL, V26, P509, DOI 10.1093/ndt/gfq332; Macedo E, 2009, CURR OPIN CRIT CARE, V15, P467, DOI 10.1097/MCC.0b013e328332f6e3; Maisel AS, 2011, NEPHROL DIAL TRANSPL, V26, P62, DOI 10.1093/ndt/gfq647; Marenzi G, 2003, NEW ENGL J MED, V349, P1333, DOI 10.1056/NEJMoa023204; Masuda M, 2008, CIRC J, V72, P1610, DOI 10.1253/circj.CJ-08-0368; McCullough PA, 2008, NEPHRON PHYSIOL, V109, pP61, DOI 10.1159/000142938; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Moore E, 2010, MINERVA ANESTESIOL, V76, P425; Moore E, 2010, CURR OPIN CRIT CARE, V16, P523, DOI 10.1097/MCC.0b013e32834008ea; Moreau R, 2008, NEPHRON PHYSIOL, V109, pP73, DOI 10.1159/000142939; Muirhead N, 2010, ANN INTERN MED, V152, P721, DOI 10.7326/0003-4819-152-11-201006010-00243; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Novelli G, 2011, TRANSPL P, V43, P1085, DOI 10.1016/j.transproceed.2011.01.150; Oliver JA, 2010, KIDNEY INT, V77, P669, DOI 10.1038/ki.2010.4; Ortega R, 2002, HEPATOLOGY, V36, P941, DOI 10.1053/jhep.2002.35819; Ozhan H, 2010, ANGIOLOGY, V61, P711, DOI 10.1177/0003319710364216; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Parikh CR, 2009, AM J KIDNEY DIS, V54, P987, DOI 10.1053/j.ajkd.2009.10.004; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Perazella MA, 2010, CLIN J AM SOC NEPHRO, V5, P402, DOI 10.2215/CJN.06960909; PLATELL C, 1990, INTENS CARE MED, V16, P328, DOI 10.1007/BF01706359; Prowle JR, 2010, CONTRIB NEPHROL, V165, P329, DOI 10.1159/000313774; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Prowle JR, 2009, BLOOD PURIFICAT, V28, P216, DOI 10.1159/000230813; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Ramchandra R, 2009, AM J PHYSIOL-REG I, V297, pR1247, DOI 10.1152/ajpregu.00437.2009; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Sagi SV, 2010, J GASTROEN HEPATOL, V25, P880, DOI 10.1111/j.1440-1746.2009.06132.x; Saikumar P, 2003, SEMIN NEPHROL, V23, P511, DOI 10.1053/S0270-9295(03)00130-X; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Saotome T, 2010, INTENS CARE MED, V36, P533, DOI 10.1007/s00134-009-1740-9; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Solomon R, 2005, KIDNEY INT, V68, P2256, DOI 10.1111/j.1523-1755.2005.00684.x; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Srisawat N, 2011, CLIN J AM SOC NEPHRO, V6, P1815, DOI 10.2215/CJN.11261210; Srisawat N, 2010, CRIT CARE, V14, DOI 10.1186/cc8933; Stoegeman CA, 2005, OXFORD TXB CLIN NEPH, P741; ten Dam MAGJ, 2008, NETH J MED, V66, P416; Thuillier R, 2010, TRANSPLANTATION, V90, P612, DOI 10.1097/TP.0b013e3181d72117; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Tumlin J, 2008, J AM SOC NEPHROL, V19, P1034, DOI 10.1681/ASN.2007080895; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Uchino S, 2010, CURR OPIN CRIT CARE, V16, P562, DOI 10.1097/MCC.0b013e32833ea7f3; Uchino S, 2009, CRIT CARE MED, V37, P2576, DOI 10.1097/CCM.0b013e3181a38241; Versteilen AMG, 2011, NEPHRON EXP NEPHROL, V118, pE79, DOI 10.1159/000322605; Waikar SS, 2009, NEPHROL DIAL TRANSPL, V24, P3263, DOI 10.1093/ndt/gfp428; Waikar SS, 2009, JAMA-J AM MED ASSOC, V302, P1227, DOI 10.1001/jama.2009.1364; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; Wong F, 2011, GUT, V60, P702, DOI 10.1136/gut.2010.236133; Zuk A, 1998, AM J PHYSIOL-CELL PH, V275, pC711, DOI 10.1152/ajpcell.1998.275.3.C711	140	963	1042	21	201	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					756	766		10.1016/S0140-6736(11)61454-2	http://dx.doi.org/10.1016/S0140-6736(11)61454-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22617274				2022-12-28	WOS:000308001300033
J	Flaherty, KT; Robert, C; Hersey, P; Nathan, P; Garbe, C; Milhem, M; Demidov, LV; Hassel, JC; Rutkowski, P; Mohr, P; Dummer, R; Trefzer, U; Larkin, JMG; Utikal, J; Dreno, B; Nyakas, M; Middleton, MR; Becker, JC; Casey, M; Sherman, LJ; Wu, FS; Ouellet, D; Martin, AM; Patel, K; Schadendorf, D				Flaherty, Keith T.; Robert, Caroline; Hersey, Peter; Nathan, Paul; Garbe, Claus; Milhem, Mohammed; Demidov, Lev V.; Hassel, Jessica C.; Rutkowski, Piotr; Mohr, Peter; Dummer, Reinhard; Trefzer, Uwe; Larkin, James M. G.; Utikal, Jochen; Dreno, Brigitte; Nyakas, Marta; Middleton, Mark R.; Becker, Juergen C.; Casey, Michelle; Sherman, Laurie J.; Wu, Frank S.; Ouellet, Daniele; Martin, Anne-Marie; Patel, Kiran; Schadendorf, Dirk		METRIC Study Grp	Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MUTATIONS; PATHWAY; CANCER; KINASE; RESISTANCE; CRITERIA	BACKGROUND Activating mutations in serine-threonine protein kinase B-RAF (BRAF) are found in 50% of patients with advanced melanoma. Selective BRAF-inhibitor therapy improves survival, as compared with chemotherapy, but responses are often short-lived. In previous trials, MEK inhibition appeared to be promising in this population. METHODS In this phase 3 open-label trial, we randomly assigned 322 patients who had metastatic melanoma with a V600E or V600K BRAF mutation to receive either trametinib, an oral selective MEK inhibitor, or chemotherapy in a 2: 1 ratio. Patients received trametinib (2 mg orally) once daily or intravenous dacarbazine (1000 mg per square meter of body-surface area) or paclitaxel (175 mg per square meter) every 3 weeks. Patients in the chemotherapy group who had disease progression were permitted to cross over to receive trametinib. Progression-free survival was the primary end point, and overall survival was a secondary end point. RESULTS Median progression-free survival was 4.8 months in the trametinib group and 1.5 months in the chemotherapy group (hazard ratio for disease progression or death in the trametinib group, 0.45; 95% confidence interval [CI], 0.33 to 0.63; P<0.001). At 6 months, the rate of overall survival was 81% in the trametinib group and 67% in the chemotherapy group despite crossover (hazard ratio for death, 0.54; 95% CI, 0.32 to 0.92; P=0.01). Rash, diarrhea, and peripheral edema were the most common toxic effects in the trametinib group and were managed with dose interruption and dose reduction; asymptomatic and reversible reduction in the cardiac ejection fraction and ocular toxic effects occurred infrequently. Secondary skin neoplasms were not observed. CONCLUSIONS Trametinib, as compared with chemotherapy, improved rates of progression-free and overall survival among patients who had metastatic melanoma with a BRAF V600E or V600K mutation. (Funded by GlaxoSmithKline; METRIC ClinicalTrials.gov number, NCT01245062.)	[Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Robert, Caroline] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France; [Robert, Caroline] Inst Gustave Roussy, Dept Dermatol, Villejuif, France; [Hersey, Peter] Univ Sydney, Kolling Inst, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Nathan, Paul] Mt Vernon Canc Ctr, Northwood, Middx, England; [Nathan, Paul] Natl Inst Canc Res, Melanoma Clin Studies Grp, London, England; [Larkin, James M. G.] Royal Marsden Hosp, London SW3 6JJ, England; [Middleton, Mark R.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Dept Oncol, Oxford OX3 7LJ, England; [Garbe, Claus] Univ Tubingen Hosp, Tubingen, Germany; [Becker, Juergen C.] Univ Heidelberg Hosp, Dept Dermatol, Natl Ctr Tumor Dis, Heidelberg, Germany; [Mohr, Peter] Elbekliniken Buxtehude, Buxtehude, Germany; [Trefzer, Uwe] Charite, D-13353 Berlin, Germany; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, D-6900 Heidelberg, Germany; [Utikal, Jochen] Univ Med Ctr, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Utikal, Jochen] Univ Heidelberg, D-6800 Mannheim, Germany; [Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Milhem, Mohammed] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA; [Demidov, Lev V.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Rutkowski, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland; [Rutkowski, Piotr] Inst Oncol, Warsaw, Poland; [Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Nyakas, Marta] Oslo Univ Hosp, Dept Clin Canc Res, Oslo, Norway; [Becker, Juergen C.] Univ Klin Dermatol & Venerol, Graz, Austria; [Casey, Michelle; Sherman, Laurie J.; Wu, Frank S.; Ouellet, Daniele; Martin, Anne-Marie; Patel, Kiran] GlaxoSmithKline, Collegeville, PA USA; [Dreno, Brigitte] Hop Hotel Dieu, Dept Dermatooncol, CHU Nantes, Nantes, France	Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Mount Vernon Cancer Centre; Royal Marsden NHS Foundation Trust; University of Oxford; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Duisburg Essen; University of Iowa; N.N. Blokhin Russian Cancer Research Center; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Zurich; University Zurich Hospital; University of Oslo; GlaxoSmithKline; Nantes Universite; CHU de Nantes	Flaherty, KT (corresponding author), 55 Fruit St,Yawkey 9E, Boston, MA 02114 USA.	kflaherty@partners.org	Schadendorf, Dirk/AAE-8206-2019; Cebon, Jonathan S/H-1643-2013; Rutkowski, Piotr/B-3907-2013; Lorigan, Paul/J-6898-2015; Robert, Caroline/G-6157-2018; Del Vecchio, Michele/K-1584-2016; Krajsova, Ivana/I-4505-2017; Garbe, Claus/ABH-2128-2021; Ottensmeier, Christian H/E-8131-2012	Rutkowski, Piotr/0000-0002-8920-5429; Lorigan, Paul/0000-0002-8875-2164; Robert, Caroline/0000-0002-9493-0238; Del Vecchio, Michele/0000-0001-9060-2512; Krajsova, Ivana/0000-0002-1599-6424; Garbe, Claus/0000-0001-8530-780X; Ottensmeier, Christian H/0000-0003-3619-1657; Leccia, M.Therese/0000-0003-1222-0396; Milhem, Mohammed/0000-0003-4663-6824; Larkin, James/0000-0001-5569-9523; Neyns, Bart/0000-0003-0658-5903; Utikal, Jochen/0000-0001-5316-0241; Cebon, Jonathan/0000-0002-3898-950X; Nathan, Paul/0000-0002-2327-3250	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Supported by GlaxoSmithKline.	Arnault JP, 2012, CLIN CANCER RES, V18, P263, DOI 10.1158/1078-0432.CCR-11-1344; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Infante JR, 2010, ANN M AM SOC CLIN ON; *INT AG RES CANC, 2008, WORLD CANC REP 2008; Jakob JA, 2011, CANCER          1216; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kim KB, 2011, PIGM CELL MELANOMA R, V24, P102; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verma S, 2012, CLIN ONCOL R CO 0113	23	2566	2628	4	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2012	367	2					107	114		10.1056/NEJMoa1203421	http://dx.doi.org/10.1056/NEJMoa1203421			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972IO	22663011	Green Published			2022-12-28	WOS:000306270800007
J	Drell, SD; Shultz, GP; Andreasen, SP				Drell, Sidney D.; Shultz, George P.; Andreasen, Steven P.			A Safer Nuclear Enterprise	SCIENCE			English	Editorial Material									[Drell, Sidney D.; Shultz, George P.] Stanford Univ, Stanford, CA 94305 USA; [Andreasen, Steven P.] Univ Minnesota, Minneapolis, MN 55455 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Drell, SD (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	drell@slac.stanford.edu	Ley, Sarah/Y-9216-2019					[Anonymous], 2011, PRINC REC AR NUCL EN; IAEA, REG BUDG 2012; Shultz G. P., 2011, WALL STREET J   0307, pA15; Shultz G.P., 2008, REYKJAVIK REVISITED; Shultz George P., 2011, DETERRENCE ITS FUTUR; Shultz George P., 2008, WALL STREET J   0115, pA13; SHULTZ GP, 2007, WALL STREET J   0104, pA15; US Department of Defense, NARR SUMM ACC INV US	8	2	2	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1236	1236		10.1126/science.1221842	http://dx.doi.org/10.1126/science.1221842			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953WV	22679084				2022-12-28	WOS:000304905300022
J	Dar, AC; Das, TK; Shokat, KM; Cagan, RL				Dar, Arvin C.; Das, Tirtha K.; Shokat, Kevan M.; Cagan, Ross L.			Chemical genetic discovery of targets and anti-targets for cancer polypharmacology	NATURE			English	Article							CELL-PROLIFERATION; DROSOPHILA MODEL; TYROSINE KINASE; INHIBITOR; PATHWAYS; CARCINOMA; RET; CHROMOSOME; PD-0325901; SORAFENIB	The complexity of cancer has led to recent interest in polypharmacological approaches for developing kinase-inhibitor drugs; however, optimal kinase-inhibition profiles remain difficult to predict. Using a Ret-kinase-driven Drosophila model of multiple endocrine neoplasia type 2 and kinome-wide drug profiling, here we identify that AD57 rescues oncogenic Ret-induced lethality, whereas related Ret inhibitors imparted reduced efficacy and enhanced toxicity. Drosophila genetics and compound profiling defined three pathways accounting for the mechanistic basis of efficacy and dose-limiting toxicity. Inhibition of Ret plus Raf, Src and S6K was required for optimal animal survival, whereas inhibition of the 'anti-target' Tor led to toxicity owing to release of negative feedback. Rational synthetic tailoring to eliminate Tor binding afforded AD80 and AD81, compounds featuring balanced pathway inhibition, improved efficacy and low toxicity in Drosophila and mammalian multiple endocrine neoplasia type 2 models. Combining kinase-focused chemistry, kinome-wide profiling and Drosophila genetics provides a powerful systems pharmacology approach towards developing compounds with a maximal therapeutic index.	[Dar, Arvin C.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Dar, Arvin C.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Das, Tirtha K.; Cagan, Ross L.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	shokat@cmp.ucsf.edu	Cagan, Ross Leigh/AAV-9528-2021	Cagan, Ross/0000-0001-5297-450X	National Institutes of Health [R01CA109730, R01CA084309, R01EB001987, P01 CA081403-11]; American Cancer Society [120616-RSGM-11-018-01-CDD, 120886-PFM-11-137-01-DDC]; NATIONAL CANCER INSTITUTE [R01CA109730, R01CA084309, P01CA081403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the Bloomington Stock Center, Vienna Drosophila RNAi Center and C. Pfleger for reagents. T. K. D. and R. C. were supported by National Institutes of Health grants R01CA109730 and R01CA084309 and American Cancer Society Grant 120616-RSGM-11-018-01-CDD. T. K. D. was also supported by American Cancer Society Grant 120886-PFM-11-137-01-DDC. We thank members of the Shokat and Cagan laboratories for discussions. We thank members of the SelectScreen team at Invitrogen, in particular K. Vogel, for performing kinase-profiling services. K. M. S. thanks NIH R01EB001987, P01 CA081403-11 and The Waxman Foundation.	Ahmad T, 2004, CLIN CANCER RES, V10, p6388S, DOI 10.1158/1078-0432.CCR-040028; Almeida MQ, 2010, CANCER GENET CYTOGEN, V203, P30, DOI 10.1016/j.cancergencyto.2010.09.006; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Brachmann CB, 2000, CURR BIOL, V10, P547, DOI 10.1016/S0960-9822(00)00474-7; Carlomagno F, 2002, CANCER RES, V62, P7284; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dar AC, 2008, CHEM BIOL, V15, P1015, DOI 10.1016/j.chembiol.2008.09.007; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guichard A, 1999, DEVELOPMENT, V126, P2663; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; LAIRMORE TC, 1993, P NATL ACAD SCI USA, V90, P492, DOI 10.1073/pnas.90.2.492; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Read RD, 2005, GENETICS, V171, P1057, DOI 10.1534/genetics.104.038018; Sawamoto K, 1996, DEV BIOL, V178, P13, DOI 10.1006/dbio.1996.0194; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vidal M, 2005, CANCER RES, V65, P3538, DOI 10.1158/0008-5472.CAN-04-4561; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	34	259	261	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					80	U101		10.1038/nature11127	http://dx.doi.org/10.1038/nature11127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678283	Green Accepted			2022-12-28	WOS:000304854000030
J	Batchelor, TT; Sorensen, AG; Louis, DN				Batchelor, Tracy T.; Sorensen, A. Gregory; Louis, David N.			Case 17-2012: A 54-Year-Old Man with Visual-Field Loss and a Mass in the Brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; PROMOTER METHYLATION STATUS; TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT; ADJUVANT; SURGERY; GLIOMAS; TRIAL		[Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sorensen, A. Gregory] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Batchelor, Tracy T.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Sorensen, A. Gregory] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Louis, David N.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Batchelor, TT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.				Millennium; Pfizer; AstraZeneca; Merck; Imedex; Educational Concepts Group; Strategic Edge Communications; BayerScheringPharma; Bristol-Myers Squibb; BiogenIdec; Merrimack Pharmaceuticals; Olea Medical; Mitsubishi Pharma; GE Healthcare; Regeneron; Novartis; Roche; Siemens Healthcare; Takeda; ACR-Image Metrix; Bayer	Millennium(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Merck(Merck & Company); Imedex; Educational Concepts Group; Strategic Edge Communications; BayerScheringPharma(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); BiogenIdec(Biogen); Merrimack Pharmaceuticals; Olea Medical; Mitsubishi Pharma; GE Healthcare(General ElectricGE Healthcare); Regeneron(Regeneron); Novartis(Novartis); Roche(Roche Holding); Siemens Healthcare(Siemens AG); Takeda(Takeda Pharmaceutical Company Ltd); ACR-Image Metrix(General Electric); Bayer(Bayer AG)	Dr. Batchelor reports receiving payment for advisory board membership from Roche, Spectrum, and Amgen; consulting fees from Millennium; grant support from Pfizer and AstraZeneca; lecture fees from Merck, Imedex, Educational Concepts Group, and Strategic Edge Communications; and payment for the development of educational presentations from UpToDate. Dr. Sorensen reports being an employee of Siemens Healthcare; receiving consulting fees from BayerScheringPharma, Bristol-Myers Squibb, BiogenIdec, Merrimack Pharmaceuticals, Olea Medical, Mitsubishi Pharma, GE Healthcare, Regeneron, Novartis, Roche, Siemens Healthcare, Takeda, and AstraZeneca; receiving lecture fees from ACR-Image Metrix; receiving income from patents (owned by Massachusetts General Hospital) for neuroradiology-related image acquisition and analysis; receiving royalties from Massachusetts General Hospital for licensure of brain perfusion software; serving as an expert witness for Kit regarding the imaging appearance of carbon monoxide poisoning; receiving payment from the International Center for Postgraduate Medical Education for preparation of an online course on the use of MRI contrast agents, supported by a grant from Bayer; and owning stock in Catalyst Medical. Dr. Louis reports receiving payment for expert opinion on the results of genetic testing in brain tumors from Rohm and Haas. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1990, N ENGL J MED, V322, P1866; BARNARD RO, 1987, CANCER, V60, P1519, DOI 10.1002/1097-0142(19871001)60:7<1519::AID-CNCR2820600719>3.0.CO;2-1; BATZDORF U, 1963, J NEUROSURG, V20, P122, DOI 10.3171/jns.1963.20.2.0122; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gerstner ER, 2011, J NEURO-ONCOL, V103, P325, DOI 10.1007/s11060-010-0390-7; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330	13	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2112	2120		10.1056/NEJMcpc1111574	http://dx.doi.org/10.1056/NEJMcpc1111574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646634				2022-12-28	WOS:000304613400013
J	Nuila, R				Nuila, Ricardo			Home: Palliation for Dying Undocumented Immigrants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE; TRENDS		Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Nuila, R (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.							Brotman B, 2011, CHICAGO TRIBUNE 0102; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1774; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1085, DOI 10.1001/jama.297.10.1085; Gawande A, 2010, NEW YORKER      0802; Okie S, 2007, NEW ENGL J MED, V357, P525, DOI 10.1056/NEJMp078113; Stimpson JP, 2010, HEALTH AFFAIR, V29, P544, DOI 10.1377/hlthaff.2009.0400	6	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2047	2048						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949YE	22646628	Bronze			2022-12-28	WOS:000304613400002
J	Ramsden, S; Richardson, FM; Josse, G; Thomas, MSC; Ellis, C; Shakeshaft, C; Seghier, ML; Price, CJ				Ramsden, Sue; Richardson, Fiona M.; Josse, Goulven; Thomas, Michael S. C.; Ellis, Caroline; Shakeshaft, Clare; Seghier, Mohamed L.; Price, Cathy J.			Verbal and non-verbal intelligence changes in the teenage brain (vol 479, pg 113, 2011)	NATURE			English	Correction													Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed L/0000-0002-1146-8800; Price, Catherine/0000-0001-7448-4835; Thomas, Michael/0000-0002-8231-6011	Medical Research Council [G0300188] Funding Source: Medline; Wellcome Trust [091593] Funding Source: Medline; MRC [G0300188] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Leeb H, 2008, BERNOULLI, V14, P661, DOI 10.3150/08-BEJ127; Martens HA, 1998, CHEMOMETR INTELL LAB, V44, P99, DOI 10.1016/S0169-7439(98)00167-1; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594	4	5	5	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					666	666		10.1038/nature11113	http://dx.doi.org/10.1038/nature11113			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660332	Bronze			2022-12-28	WOS:000304608000053
J	Shankaran, S; Pappas, A; McDonald, SA; Vohr, BR; Hintz, SR; Epi, MS; Yolton, K; Gustafson, KE; Leach, TM; Green, C; Bara, R; Huitema, CMP; Ehrenkranz, RA; Tyson, JE; Das, A; Hammond, J; Peralta-Carcelen, M; Evans, PW; Heyne, RJ; Wilson-Costello, DE; Vaucher, YE; Bauer, CR; Dusick, AM; Adams-Chapman, I; Goldstein, RF; Guillet, R; Papile, LA; Higgins, RD				Shankaran, Seetha; Pappas, Athina; McDonald, Scott A.; Vohr, Betty R.; Hintz, Susan R.; Epi, M. S.; Yolton, Kimberly; Gustafson, Kathryn E.; Leach, Theresa M.; Green, Charles; Bara, Rebecca; Huitema, Carolyn M. Petrie; Ehrenkranz, Richard A.; Tyson, Jon E.; Das, Abhik; Hammond, Jane; Peralta-Carcelen, Myriam; Evans, Patricia W.; Heyne, Roy J.; Wilson-Costello, Deanne E.; Vaucher, Yvonne E.; Bauer, Charles R.; Dusick, Anna M.; Adams-Chapman, Ira; Goldstein, Ricki F.; Guillet, Ronnie; Papile, Lu-Ann; Higgins, Rosemary D.		Eunice Kennedy Shriver NICHD Neona	Childhood Outcomes after Hypothermia for Neonatal Encephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; EMERGENCY CARDIOVASCULAR CARE; WHOLE-BODY HYPOTHERMIA; CEREBRAL-PALSY; CARDIOPULMONARY-RESUSCITATION; SYSTEMIC HYPOTHERMIA; PERINATAL ASPHYXIA; SCHOOL-AGE; TERM; ASSOCIATION	BACKGROUND We previously reported early results of a randomized trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy showing a significant reduction in the rate of death or moderate or severe disability at 18 to 22 months of age. Long-term outcomes are now available. METHODS In the original trial, we assigned infants with moderate or severe encephalopathy to usual care (the control group) or whole-body cooling to an esophageal temperature of 33.5 degrees C for 72 hours, followed by slow rewarming (the hypothermia group). We evaluated cognitive, attention and executive, and visuospatial function; neurologic outcomes; and physical and psychosocial health among participants at 6 to 7 years of age. The primary outcome of the present analyses was death or an IQ score below 70. RESULTS Of the 208 trial participants, primary outcome data were available for 190. Of the 97 children in the hypothermia group and the 93 children in the control group, death or an IQ score below 70 occurred in 46 (47%) and 58 (62%), respectively (P = 0.06); death occurred in 27 (28%) and 41 (44%) (P = 0.04); and death or severe disability occurred in 38 (41%) and 53 (60%) (P = 0.03). Other outcome data were available for the 122 surviving children, 70 in the hypothermia group and 52 in the control group. Moderate or severe disability occurred in 24 of 69 children (35%) and 19 of 50 children (38%), respectively (P = 0.87). Attention-executive dysfunction occurred in 4% and 13%, respectively, of children receiving hypothermia and those receiving usual care (P = 0.19), and visuospatial dysfunction occurred in 4% and 3% (P = 0.80). CONCLUSIONS The rate of the combined end point of death or an IQ score of less than 70 at 6 to 7 years of age was lower among children undergoing whole-body hypothermia than among those undergoing usual care, but the differences were not significant. However, hypothermia resulted in lower death rates and did not increase rates of severe disability among survivors. (Funded by the National Institutes of Health and the Eunice Kennedy Shriver NICHD Neonatal Research Network; ClinicalTrials.gov number, NCT00005772.)	[Shankaran, Seetha; Pappas, Athina; Bara, Rebecca] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [McDonald, Scott A.; Das, Abhik; Hammond, Jane] Res Triangle Inst, Stat & Epidemiol Unit, Res Triangle Pk, NC 27709 USA; [Huitema, Carolyn M. Petrie] Res Triangle Inst, Stat & Epidemiol Unit, Rockville, MD USA; [Vohr, Betty R.; Leach, Theresa M.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Hintz, Susan R.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Yolton, Kimberly] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Gustafson, Kathryn E.; Goldstein, Ricki F.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Green, Charles; Tyson, Jon E.; Evans, Patricia W.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Peralta-Carcelen, Myriam] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Heyne, Roy J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Wilson-Costello, Deanne E.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Vaucher, Yvonne E.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Bauer, Charles R.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Dusick, Anna M.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Adams-Chapman, Ira] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Adams-Chapman, Ira] Childrens Healthcare Atlanta, Atlanta, GA USA; [Guillet, Ronnie] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Papile, Lu-Ann] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neonatal Res Network, NIH, Bethesda, MD USA	Wayne State University; Research Triangle Institute; Research Triangle Institute; Brown University; Women & Infants Hospital Rhode Island; Stanford University; University System of Ohio; University of Cincinnati; Duke University; University of Texas System; University of Texas Health Science Center Houston; Yale University; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of California System; University of California San Diego; University of Miami; Indiana University System; Indiana University Bloomington; Emory University; Children's Healthcare of Atlanta (CHOA); University of Rochester; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shankaran, S (corresponding author), Childrens Hosp Michigan, Div Neonatal Perinatal Med, 3901 Beaubien Blvd, Detroit, MI 48201 USA.	sshankar@med.wayne.edu	Yunkunis, Kimberly/AAO-5605-2021; Das, Abhik/AAF-1883-2020	Das, Abhik/0000-0003-2722-0479; McDonald, Scott/0000-0002-0054-1099; Shankaran, Seetha/0000-0001-5512-9571; Hintz, Susan/0000-0001-7023-4433	National Institutes of Health; Eunice Kennedy Shriver NICHD Neonatal Research Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021373, U10HD027856, U10HD021385, U10HD040461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149, UL1RR024148, UL1RR025008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD Neonatal Research Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Institutes of Health and the Eunice Kennedy Shriver NICHD Neonatal Research Network.	Arnaud C, 2008, PEDIATRICS, V121, P54, DOI 10.1542/peds.2007-0854; Azzopardi DV, 2010, NEW ENGL J MED, V362, P1056; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gonzalez FF, 2006, ARCH DIS CHILD-FETAL, V91, pF454, DOI 10.1136/adc.2005.092445; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Kattwinkel J, 2011, PEDIATRICS, V128, P176, DOI 10.1542/peds.2011-1260; Kattwinkel J, 2010, PEDIATRICS, V126, pE1400, DOI 10.1542/peds.2010-2972E; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Moster D, 2002, ARCH DIS CHILD-FETAL, V86, pF16, DOI 10.1136/fn.86.1.F16; Palisano RJ, 2006, DEV MED CHILD NEUROL, V48, P424, DOI 10.1017/S0012162206000934; Perlman JM, 2010, PEDIATRICS, V126, pE1319, DOI 10.1542/peds.2010-2972B; Robertson CMT., 2003, FETAL NEONATAL BRAIN, V3. Ed, P829; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Wake M, 2003, DEV MED CHILD NEUROL, V45, P194, DOI 10.1017/S0012162203000379; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	20	456	472	2	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2085	2092		10.1056/NEJMoa1112066	http://dx.doi.org/10.1056/NEJMoa1112066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646631	Green Accepted			2022-12-28	WOS:000304613400008
J	Deng, HX; Grunder, S; Cordova, KE; Valente, C; Furukawa, H; Hmadeh, M; Gandara, F; Whalley, AC; Liu, Z; Asahina, S; Kazumori, H; O'Keeffe, M; Terasaki, O; Stoddart, JF; Yaghi, OM				Deng, Hexiang; Grunder, Sergio; Cordova, Kyle E.; Valente, Cory; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; Whalley, Adam C.; Liu, Zheng; Asahina, Shunsuke; Kazumori, Hiroyoshi; O'Keeffe, Michael; Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.			Large-Pore Apertures in a Series of Metal-Organic Frameworks	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BUILDING UNITS; CATALYSIS; STORAGE; DESIGN; POROSITY; PLATFORM; LIGAND; SITES; CAGES	We report a strategy to expand the pore aperture of metal-organic frameworks (MOFs) into a previously unattained size regime (>32 angstroms). Specifically, the systematic expansion of a well-known MOF structure, MOF-74, from its original link of one phenylene ring (I) to two, three, four, five, six, seven, nine, and eleven (II to XI, respectively), afforded an isoreticular series of MOF-74 structures (termed IRMOF-74-I to XI) with pore apertures ranging from 14 to 98 angstroms. All members of this series have non-interpenetrating structures and exhibit robust architectures, as evidenced by their permanent porosity and high thermal stability (up to 300 degrees C). The pore apertures of an oligoethylene glycol-functionalized IRMOF-74-VII and IRMOF-74-IX are large enough for natural proteins to enter the pores.	[Deng, Hexiang; Cordova, Kyle E.; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Ctr Global Mentoring, Ctr Reticular Chem, US Dept Energy DOE,Inst Genom & Prote, Los Angeles, CA 90095 USA; [Deng, Hexiang; Cordova, Kyle E.; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Grunder, Sergio; Valente, Cory; Whalley, Adam C.; Stoddart, J. Fraser] Northwestern Univ, Dept Chem, Ctr Chem Integrated Syst, Evanston, IL 60208 USA; [Liu, Zheng] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3050046, Japan; [Asahina, Shunsuke; Kazumori, Hiroyoshi] JEOL, SMBU, Tokyo 1968558, Japan; [Terasaki, Osamu] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden; [Terasaki, Osamu] Stockholm Univ, EXSELENT, S-10691 Stockholm, Sweden; [Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.] World Class Univ, NanoCentury KAIST Inst, Taejon 305701, South Korea; [Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.] World Class Univ, Grad Sch Energy Environm Water & Sustainabil, Taejon 305701, South Korea	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; National Institute of Advanced Industrial Science & Technology (AIST); Jeol Ltd; JEOL Japan; Stockholm University; Stockholm University; Korea Advanced Institute of Science & Technology (KAIST)	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu	Stoddart, James Fraser/H-1518-2011; Furukawa, Hiroyasu/C-5910-2008; Gandara, Felipe/H-3168-2017; Cordova, Kyle/I-2556-2014; Gándara, Felipe/B-9198-2013; Deng, Hexiang/N-5616-2017; Terasaki, Osamu/Y-1137-2018; Liu, Zheng/E-6119-2018; Yaghi, Omar M/C-6749-2013; EFRC, CGS/I-6680-2012; Stangl, Kristin/D-1502-2015	Stoddart, James Fraser/0000-0003-3161-3697; Furukawa, Hiroyasu/0000-0002-6082-1738; Gandara, Felipe/0000-0002-1671-6260; Cordova, Kyle/0000-0002-4988-0497; Gándara, Felipe/0000-0002-1671-6260; Deng, Hexiang/0000-0002-9398-7996; Terasaki, Osamu/0000-0001-5803-0817; Liu, Zheng/0000-0001-9095-7647; Yaghi, Omar/0000-0002-5611-3325; Hmadeh, Mohamad/0000-0003-3027-3192	BASF SE (Ludwigshafen, Germany); Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC); DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES) [DE-SC0001015]; U.S. Department of Defense, Defense Threat Reduction Agency [HDTRA11-1-0018]; Non-equilibrium Energy Research Center, EFRC; U.S. DOE-BES [DE-SC0000989]; World Class University [R-31-2008-000-10055-0]; NIH-National Center for Research Resources [CJX1-443835-WS-29646]; NSF [CHE-0722519]; Swiss National Science Foundation; Spanish Ministry of Education	BASF SE (Ludwigshafen, Germany)(BASF); Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC); DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES)(United States Department of Energy (DOE)); U.S. Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Non-equilibrium Energy Research Center, EFRC; U.S. DOE-BES(United States Department of Energy (DOE)); World Class University; NIH-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Education(Spanish Government)	The research at UCLA was funded by BASF SE (Ludwigshafen, Germany) (synthesis of MOFs), the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC) funded by the DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES) for adsorption (DE-SC0001015), and the U.S. Department of Defense, Defense Threat Reduction Agency for inclusion studies (HDTRA11-1-0018). The research conducted at Northwestern University was supported in part by the Non-equilibrium Energy Research Center, which is an EFRC funded by the U.S. DOE-BES (DE-SC0000989). We acknowledge the World Class University Program (R-31-2008-000-10055-0). We thank M. Zhao and D. Li from D. S. Eisenberg's group at UCLA for providing GFP and helpful discussions. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U. S. DOE-BES. Confocal laser scanning microscopy was performed at the California NanoSystems Institute Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding from NIH-National Center for Research Resources shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). We acknowledge JEOL for providing their latest LV-HRSEM instrument. We thank M. Schibler, S. Wan, L. Wang, A. Sue, C. Stevens, C. Knobler, and J. Brown for their invaluable assistance. Z.L. acknowledges K. Suenaga at AIST, Tsukuba, Japan, for his encouragement. S. G. acknowledges the Swiss National Science Foundation for financial support. F. G. acknowledges funding by the Spanish Ministry of Education through the "Programa de Movilidad de Recursos Humanos del Plan Nacional de I-D+i 2008-2011." All data and images are available in the body of the paper or as supplementary materials. Crystallographic data for the reported crystal structures have been deposited at the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk with codes 841642 to 841651 (IRMOF-74-II to -XI, respectively).	BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242; Bradshaw D, 2005, ACCOUNTS CHEM RES, V38, P273, DOI 10.1021/ar0401606; Chandler BD, 2008, NAT MATER, V7, P229, DOI 10.1038/nmat2101; Dietzel PDC, 2008, EUR J INORG CHEM, P3624, DOI 10.1002/ejic.200701284; Dinca M, 2006, J AM CHEM SOC, V128, P16876, DOI 10.1021/ja0656853; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]; Furukawa H, 2006, J AM CHEM SOC, V128, P8398, DOI 10.1021/ja062491e; Furukawa H, 2011, INORG CHEM, V50, P9147, DOI 10.1021/ic201376t; Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160; Hanss D, 2009, EUR J INORG CHEM, P3778, DOI 10.1002/ejic.200900396; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Lin MJ, 2011, CRYSTENGCOMM, V13, P776, DOI 10.1039/c0ce00777c; Lin X, 2009, J AM CHEM SOC, V131, P2159, DOI 10.1021/ja806624j; Lykourinou V, 2011, J AM CHEM SOC, V133, P10382, DOI 10.1021/ja2038003; Ma LQ, 2010, NAT CHEM, V2, P838, DOI [10.1038/NCHEM.738, 10.1038/nchem.738]; O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j; Park YK, 2007, ANGEW CHEM INT EDIT, V46, P8230, DOI 10.1002/anie.200702324; Pasco ST, 1997, SYNTHETIC MET, V84, P275, DOI 10.1016/S0379-6779(97)80749-7; ROSI N L, 2002, ANGEW CHEM, V114, P294; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Shekhah O, 2011, CHEM SOC REV, V40, P1081, DOI 10.1039/c0cs00147c; Sonnauer A, 2009, ANGEW CHEM INT EDIT, V48, P3791, DOI 10.1002/anie.200805980; Wang B, 2008, NATURE, V453, P207, DOI 10.1038/nature06900; Wang XS, 2006, J AM CHEM SOC, V128, P16474, DOI 10.1021/ja066616r; Wang ZQ, 2007, J AM CHEM SOC, V129, P12368, DOI 10.1021/ja074366o; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhang XJ, 2011, ANGEW CHEM INT EDIT, V50, P5728, DOI 10.1002/anie.201007277; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	33	1431	1480	116	2638	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1018	1023		10.1126/science.1220131	http://dx.doi.org/10.1126/science.1220131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628651				2022-12-28	WOS:000304406800041
J	Evans, P				Evans, Phil			Resolving Some Old Problems in Protein Crystallography	SCIENCE			English	Editorial Material							DATA QUALITY		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Evans, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	pre@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105178845] Funding Source: Medline; MRC [MC_U105178845] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227	10	53	53	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					986	987		10.1126/science.1222162	http://dx.doi.org/10.1126/science.1222162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628641				2022-12-28	WOS:000304406800028
J	Berger, MF; Hodis, E; Heffernan, TP; Deribe, YL; Lawrence, MS; Protopopov, A; Ivanova, E; Watson, IR; Nickerson, E; Ghosh, P; Zhang, HL; Zeid, R; Ren, XJ; Cibulskis, K; Sivachenko, AY; Wagle, N; Sucker, A; Sougnez, C; Onofrio, R; Ambrogio, L; Auclair, D; Fennell, T; Carter, SL; Drier, Y; Stojanov, P; Singer, MA; Voet, D; Jing, R; Saksena, G; Barretina, J; Ramos, AH; Pugh, TJ; Stransky, N; Parkin, M; Winckler, W; Mahan, S; Ardlie, K; Baldwin, J; Wargo, J; Schadendorf, D; Meyerson, M; Gabriel, SB; Golub, TR; Wagner, SN; Lander, ES; Getz, G; Chin, L; Garraway, LA				Berger, Michael F.; Hodis, Eran; Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Lawrence, Michael S.; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Nickerson, Elizabeth; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Cibulskis, Kristian; Sivachenko, Andrey Y.; Wagle, Nikhil; Sucker, Antje; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Drier, Yotam; Stojanov, Petar; Singer, Meredith A.; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Wargo, Jennifer; Schadendorf, Dirk; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Wagner, Stephan N.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.			Melanoma genome sequencing reveals frequent PREX2 mutations	NATURE			English	Article							HUMAN CANCER; MALIGNANT-MELANOMA; SOMATIC MUTATIONS; INHIBITION; PATTERNS; BRAF; REARRANGEMENTS; SPECIFICITY; ACTIVATION; SURVIVAL	Melanoma is notable for its metastatic propensity, lethality in the advanced setting and association with ultraviolet exposure early in life(1). To obtain a comprehensive genomic view of melanoma in humans, we sequenced the genomes of 25 metastatic melanomas and matched germline DNA. A wide range of point mutation rates was observed: lowest in melanomas whose primaries arose on non-ultraviolet-exposed hairless skin of the extremities (3 and 14 per megabase (Mb) of genome), intermediate in those originating from hair-bearing skin of the trunk (5-55 per Mb), and highest in a patient with a documented history of chronic sun exposure (111 per Mb). Analysis of whole-genome sequence data identified PREX2 (phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2)-a PTEN-interacting protein and negative regulator of PTEN in breast cancer(2)-as a significantly mutated gene with a mutation frequency of approximately 14% in an independent extension cohort of 107 human melanomas. PREX2 mutations are biologically relevant, as ectopic expression of mutant PREX2 accelerated tumour formation of immortalized human melanocytes in vivo. Thus, whole-genome sequencing of human melanoma tumours revealed genomic evidence of ultraviolet pathogenesis and discovered a new recurrently mutated gene in melanoma.	[Berger, Michael F.; Hodis, Eran; Lawrence, Michael S.; Nickerson, Elizabeth; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Stojanov, Petar; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Wagle, Nikhil; Singer, Meredith A.; Pugh, Trevor J.; Meyerson, Matthew; Chin, Lynda; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wagle, Nikhil; Ramos, Alex H.; Pugh, Trevor J.; Meyerson, Matthew; Chin, Lynda; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Sucker, Antje; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Wargo, Jennifer] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; [Wagner, Stephan N.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Duisburg Essen; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT); Whitehead Institute	Chin, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77030 USA.	LChin@mdanderson.org; levi_garraway@dfci.harvard.edu	Wagle, Nikhil/Q-7428-2019; Stojanov, Petar/GQI-4462-2022; Pugh, Trevor/Y-2535-2019; Lawrence, Michael/AAC-8202-2020; Meyerson, Matthew L/E-7123-2012; Drier, Yotam/K-5208-2012; Cibulskis, Kristian/AAC-7380-2019; Schadendorf, Dirk/AAE-8206-2019; Barretina, Jordi/A-7192-2013	Stojanov, Petar/0000-0001-7815-776X; Pugh, Trevor/0000-0002-8073-5888; Drier, Yotam/0000-0003-1725-2995; Ivanova, Elena/0000-0002-5069-4974; Cibulskis, Kristian/0000-0003-1343-1582; Wagner, Stephan/0000-0003-4941-7029; Meyerson, Matthew/0000-0002-9133-8108; Barretina, Jordi/0000-0002-3478-4080; Watson, Ian/0000-0002-6025-3080	National Human Genome Research Institute; National Cancer Institute; FWF-Austrian Science Fund; NIH; Melanoma Research Alliance; Starr Cancer Consortium; Burroughs-Wellcome Fund; Austrian Science Fund (FWF) [L 590] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009172, R33CA126674, R33CA155554] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FWF-Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Starr Cancer Consortium; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Illumina sequencing was performed at the Broad Institute and array-based genomic characterization and functional studies were performed at the Belfer Institute of DFCI. We are grateful to the Broad Institute Genome Sequencing Platform, Genome Analysis Platform and Biological Samples Platform. This work was supported by the National Human Genome Research Institute (S. B. G., E. S. L.), National Cancer Institute (M. M., L. C.), FWF-Austrian Science Fund (S.N.W.), NIH Director's New Innovator Award (L. A. G.), Melanoma Research Alliance (L. A. G., L. C.), Starr Cancer Consortium (L.A.G.) and the Burroughs-Wellcome Fund (L.A.G.).	Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DROBETSKY EA, 1987, P NATL ACAD SCI USA, V84, P9103, DOI 10.1073/pnas.84.24.9103; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flaherty KT, 2010, CURR OPIN ONCOL, V22, P178, DOI 10.1097/CCO.0b013e32833888ee; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; VRIELING H, 1991, NUCLEIC ACIDS RES, V19, P2411, DOI 10.1093/nar/19.9.2411; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810	29	523	545	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					502	506		10.1038/nature11071	http://dx.doi.org/10.1038/nature11071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622578	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000304344500043
J	Harrison, EM; O'Neill, S; Meurs, TS; Wong, PL; Duxbury, M; Paterson-Brown, S; Wigmore, SJ; Garden, OJ				Harrison, Ewen M.; O'Neill, Stephen; Meurs, Thomas S.; Wong, Pang L.; Duxbury, Mark; Paterson-Brown, Simon; Wigmore, Stephen J.; Garden, O. James			Hospital volume and patient outcomes after cholecystectomy in Scotland: retrospective, national population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY IMPROVEMENT; SURGICAL VOLUME; MORTALITY; SURGERY; OPERATIONS; IMPACT	Objectives To define associations between hospital volume and outcomes following cholecystectomy, after adjustment for case mix using a national database. Design Retrospective, national population based study using multilevel modelling and simulation. Setting Locally validated administrative dataset covering all NHS hospitals in Scotland. Participants All patients undergoing cholecystectomy between 1 January 1998 and 31 December 2007. Main outcome measures Mortality, 30 day reoperation rate, 30 day readmission rate, and length of stay. Results We identified 59 918 patients who had a cholecystectomy in one of 37 hospitals: five hospitals had high volumes (>244 cholecystectomies/year), 10 had medium volumes (173-244), and 22 had low volumes (<173). Compared with low and medium volume hospitals, high volume hospitals performed more procedures non-electively (17.1% and 19.5% v 32.8%), completed more procedures laparoscopically (64.7% and 73.8% v 80.9%), and used more operative cholangiography (11.2% and 6.3% v 21.2%; chi(2) test, all P<0.001). In a well performing multivariable analysis with bias correction for a low event rate, the odds ratio for death was greater in both the low volume (odds ratio 1.45, 95% confidence interval 1.06 to 2.00, P=0.022) and medium volume (1.52, 1.11 to 2.08, P=0.010) groups than in the high volume group. However, in simulation studies, absolute risk differences between volume groups were clinically negligible for patients with average risk (number needed to treat to harm, low v high volume, 3871, 1963 to 17 118), but were significant in patients with higher risk. In models accounting for the hierarchical structure of patients in hospitals, those in medium volume hospitals were more likely to undergo reoperation (odds ratio 1.74, 1.31 to 2.30, P<0.001) or be readmitted (1.17, 1.04 to 1.31, P=0.008) after cholecystectomy than those in high volume hospitals. Length of stay was shorter in high volume hospitals than in low (hazard ratio for discharge 0.78, 0.76 to 0.79, P<0.001) or medium volume hospitals (0.75, 0.74 to 0.77, P<0.001). These differences were also only of clinical significance in patients at higher risk. Conclusions There is wide variation among hospitals in the management of gallstone disease and an association between higher hospital volume and better outcome after a cholecystectomy. The relative risk of death is lower in high volume centres, and although absolute risk differences between volume groups are significant for elderly patients and patients with comorbidity, they are clinically negligible for those at average risk.	[Harrison, Ewen M.; O'Neill, Stephen; Wong, Pang L.; Duxbury, Mark; Paterson-Brown, Simon; Wigmore, Stephen J.; Garden, O. James] Univ Edinburgh, Royal Infirm Edinburgh, Dept Clin Surg, Edinburgh EH16 4SA, Midlothian, Scotland; [Meurs, Thomas S.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Royal Infirmary of Edinburgh; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Harrison, EM (corresponding author), Univ Edinburgh, Royal Infirm Edinburgh, Dept Clin Surg, Edinburgh EH16 4SA, Midlothian, Scotland.	mail@ewenharrison.com	Wigmore, Stephen/AAF-3562-2019; O'Neill, Stephen/L-4515-2013	Wigmore, Stephen/0000-0002-3614-8002; O'Neill, Stephen/0000-0002-3252-340X; Harrison, Ewen/0000-0002-5018-3066	University of Edinburgh; Chief Scientist Office [CZB/4/693] Funding Source: researchfish	University of Edinburgh; Chief Scientist Office	The study was funded by the University of Edinburgh, which had no direct role in the study. The corresponding author had full independence from the funding source.	Austin PC, 2002, HLTH SERV OUTCOME RE, V3, P107, DOI DOI 10.1023/A:1024260023851; Bateson MC, 2000, POSTGRAD MED J, V76, P700, DOI 10.1136/pmj.76.901.700; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Buanes T, 1998, SURG ENDOSC-ULTRAS, V12, P852, DOI 10.1007/s004649900728; Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714; Csikesz NG, 2010, DIGEST DIS SCI, V55, P2398, DOI 10.1007/s10620-009-1035-6; David GG, 2008, BRIT J SURG, V95, P472, DOI 10.1002/bjs.5984; ESCARCE JJ, 1995, JAMA-J AM MED ASSOC, V273, P1581, DOI 10.1001/jama.273.20.1581; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Harboe KM, 2011, INT J QUAL HEALTH C, V23, P565, DOI 10.1093/intqhc/mzr041; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Imai Kosuke, 2007, ZELIG EVERYONES STAT; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Kim SH, 2007, ANN SURG, V245, P201, DOI 10.1097/01.sla.0000245516.10349.c5; KING G, 2000, AM J POLIT SCI, V0044; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mayer EK, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1128; McMahon AJ, 2000, LANCET, V356, P1632, DOI 10.1016/S0140-6736(00)03156-1; Murphy MM, 2010, J AM COLL SURGEONS, V211, P73, DOI 10.1016/j.jamcollsurg.2010.02.050; Rosenmuller M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-35; Schilling PL, 2008, J AM COLL SURGEONS, V207, P698, DOI 10.1016/j.jamcollsurg.2008.06.138; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	27	61	63	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e3330	10.1136/bmj.e3330	http://dx.doi.org/10.1136/bmj.e3330			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QT	22623634	hybrid, Green Submitted			2022-12-28	WOS:000304591500004
J	Akl, EA; Briel, M; You, JJ; Sun, X; Johnston, BC; Busse, JW; Mulla, S; Lamontagne, F; Bassler, D; Vera, C; Alshurafa, M; Katsios, CM; Zhou, Q; Cukierman-Yaffe, T; Gangji, A; Mills, EJ; Walter, SD; Cook, DJ; Schunemann, HJ; Altman, DG; Guyatt, GH				Akl, Elie A.; Briel, Matthias; You, John J.; Sun, Xin; Johnston, Bradley C.; Busse, Jason W.; Mulla, Sohail; Lamontagne, Francois; Bassler, Dirk; Vera, Claudio; Alshurafa, Mohamad; Katsios, Christina M.; Zhou, Qi; Cukierman-Yaffe, Tali; Gangji, Azim; Mills, Edward J.; Walter, Stephen D.; Cook, Deborah J.; Schuenemann, Holger J.; Altman, Douglas G.; Guyatt, Gordon H.			Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENTION-TO-TREAT; ANTIRETROVIRAL TREATMENT; METHODOLOGICAL QUALITY; MISSING-DATA; PROGRAMS; OUTCOMES; BIAS; METAANALYSIS	Objective To assess the reporting, extent, and handling of loss to follow-up and its potential impact on the estimates of the effect of treatment in randomised controlled trials. Design Systematic review. We calculated the percentage of trials for which the relative risk would no longer be significant under a number of assumptions about the outcomes of participants lost to follow-up. Data sources Medline search of five top general medical journals, 2005-07. Eligibility criteria Randomised controlled trials that reported a significant binary primary patient important outcome. Results Of the 235 eligible reports identified, 31 (13%) did not report whether or not loss to follow-up occurred. In reports that did give the relevant information, the median percentage of participants lost to follow-up was 6% (interquartile range 2-14%). The method by which loss to follow-up was handled was unclear in 37 studies (19%); the most commonly used method was survival analysis (66, 35%). When we varied assumptions about loss to follow-up, results of 19% of trials were no longer significant if we assumed no participants lost to follow-up had the event of interest, 17% if we assumed that all participants lost to follow-up had the event, and 58% if we assumed a worst case scenario (all participants lost to follow-up in the treatment group and none of those in the control group had the event). Under more plausible assumptions, in which the incidence of events in those lost to follow-up relative to those followed-up is higher in the intervention than control group, results of 0% to 33% trials were no longer significant. Conclusion Plausible assumptions regarding outcomes of patients lost to follow-up could change the interpretation of results of randomised controlled trials published in top medical journals.	[Akl, Elie A.] SUNY Buffalo, Dept Med, ECMC CC 142, Buffalo, NY 14215 USA; [Akl, Elie A.] SUNY Buffalo, Dept Family Med, Buffalo, NY 14215 USA; [Akl, Elie A.; Briel, Matthias; You, John J.; Sun, Xin; Johnston, Bradley C.; Busse, Jason W.; Mulla, Sohail; Alshurafa, Mohamad; Zhou, Qi; Walter, Stephen D.; Cook, Deborah J.; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostatist, CH-4031 Basel, Switzerland; [You, John J.; Katsios, Christina M.; Cukierman-Yaffe, Tali; Gangji, Azim; Cook, Deborah J.; Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Sun, Xin] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA; [Johnston, Bradley C.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Busse, Jason W.] Inst Work & Hlth, Toronto, ON, Canada; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Dept Neonatol, Tubingen, Germany; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Ctr Paediat Clin Studies, Tubingen, Germany; [Vera, Claudio] Pontificia Univ Catolica Chile, Div Obstet & Gynecol, Santiago, Chile; [Cukierman-Yaffe, Tali] Tel Aviv Univ, Sackler Sch Med, Sheba Med Ctr,Endocrinl Inst, Gertner Inst Epidemiol & Hlth Policy Res, IL-69978 Tel Aviv, Israel; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Schuenemann, Holger J.] Univ Freiburg, Inst Med Informat & Biomet, D-79106 Freiburg, Germany; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McMaster University; University of Basel; McMaster University; Kaiser Permanente; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institute for Work & Health; University of Sherbrooke; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Pontificia Universidad Catolica de Chile; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Ottawa; University of Freiburg; University of Oxford	Akl, EA (corresponding author), SUNY Buffalo, Dept Med, ECMC CC 142, 462 Grider St, Buffalo, NY 14215 USA.	elieakl@buffalo.edu	Busse, Jason/CAH-3696-2022; Akl, Elie/K-5269-2019; Vera, Claudio/H-9579-2013; Zhou, Qi/GSM-9583-2022; Briel, Matthias/AAT-9284-2021; Walter, Stephen/AAB-5548-2022; Akl, Elie A/R-2079-2016	Busse, Jason/0000-0002-0178-8712; Vera, Claudio/0000-0003-3376-304X; Walter, Stephen/0000-0003-4157-8928; Akl, Elie A/0000-0002-3444-8618; Bassler, Dirk/0000-0003-2358-4419; Schunemann, Holger/0000-0003-3211-8479; Briel, Matthias/0000-0002-2070-5230; Alshurafa, Mohamad/0000-0002-2817-0410	Pfizer; Swiss National Foundation [PASMA-112951/1]; Roche Research Foundation; Ontario Ministry of Health and Long-Term Care; National Natural Science Foundation of China [70703025]; SickKids Foundation; CIHR; Canadian Chiropractic Research Foundation; Kidney Foundation of Canada/Canadian Society of Nephrology; Cancer Research UK	Pfizer(Pfizer); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Roche Research Foundation; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SickKids Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; Kidney Foundation of Canada/Canadian Society of Nephrology; Cancer Research UK(Cancer Research UK)	This study was funded by Pfizer. The funder had no role in the study design, in the writing of the manuscript, or in the decision to submit this or future manuscripts for publication. MB is supported by a scholarship for advanced researchers from the Swiss National Foundation (PASMA-112951/1) and the Roche Research Foundation. JJY is supported by a career scientist award from the Ontario Ministry of Health and Long-Term Care. XS is supported by the National Natural Science Foundation of China (70703025). BCJ is supported by a SickKids Foundation postdoctoral fellowship. JWB is funded by a new investigator award from the CIHR and Canadian Chiropractic Research Foundation. AG is supported by the Kidney Foundation of Canada/Canadian Society of Nephrology fellowship award. DJC and EJM are supported by research chairs from CIHR. DGA is supported by Cancer Research UK.	Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Akl EA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-40; ALTMAN DG, 2009, OPEN MED, V3, pE21; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Baron G, 2005, ARTHRITIS RHEUM, V52, P1858, DOI 10.1002/art.21116; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; EDDY DM, 1990, MED DECIS MAKING, V10, P15, DOI 10.1177/0272989X9001000104; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Greenland S, 2009, INT J EPIDEMIOL, V38, P1662, DOI 10.1093/ije/dyp278; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Hershberger RE, 2005, NEW ENGL J MED, V352, P2705, DOI 10.1056/NEJMoa032953; Hewitt CE, 2010, J CLIN EPIDEMIOL, V63, P1264, DOI 10.1016/j.jclinepi.2010.01.010; Higgins JPT, 2008, CLIN TRIALS, V5, P225, DOI 10.1177/1740774508091600; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Riele WWT, 2010, BRIT J SURG, V97, P1535, DOI 10.1002/bjs.7130; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Twardella D, 2008, NICOTINE TOB RES, V10, P891, DOI 10.1080/14622200802027149; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Wood Angela M, 2004, Clin Trials, V1, P368	34	192	194	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2012	344								e2809	10.1136/bmj.e2809	http://dx.doi.org/10.1136/bmj.e2809			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946NV	22611167	hybrid			2022-12-28	WOS:000304359600008
J	Bach, PB; Mirkin, JN; Oliver, TK; Azzoli, CG; Berry, DA; Brawley, OW; Byers, T; Colditz, GA; Gould, MK; Jett, JR; Sabichi, AL; Smith-Bindman, R; Wood, DE; Qaseem, A; Detterbeck, FC				Bach, Peter B.; Mirkin, Joshua N.; Oliver, Thomas K.; Azzoli, Christopher G.; Berry, Donald A.; Brawley, Otis W.; Byers, Tim; Colditz, Graham A.; Gould, Michael K.; Jett, James R.; Sabichi, Anita L.; Smith-Bindman, Rebecca; Wood, Douglas E.; Qaseem, Amir; Detterbeck, Frank C.			Benefits and Harms of CT Screening for Lung Cancer A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SPIRAL COMPUTED-TOMOGRAPHY; LOW-DOSE CT; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; QUANTITATIVE MICROSCOPY; COST-EFFECTIVENESS; CHEST RADIOGRAPH; HOSPITAL VOLUME; ACTION PROJECT; MORTALITY	Context Lung cancer is the leading cause of cancer death. Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of death from lung cancer. Objective To conduct a systematic review of the evidence regarding the benefits and harms of lung cancer screening using low-dose computed tomography (LDCT). A multisociety collaborative initiative (involving the American Cancer Society, American College of Chest Physicians, American Society of Clinical Oncology, and National Comprehensive Cancer Network) was undertaken to create the foundation for development of an evidence-based clinical guideline. Data Sources MEDLINE (Ovid: January 1996 to April 2012), EMBASE (Ovid: January 1996 to April 2012), and the Cochrane Library (April 2012). Study Selection Of 591 citations identified and reviewed, 8 randomized trials and 13 cohort studies of LDCT screening met criteria for inclusion. Primary outcomes were lung cancer mortality and all-cause mortality, and secondary outcomes included nodule detection, invasive procedures, follow-up tests, and smoking cessation. Data Extraction Critical appraisal using predefined criteria was conducted on individual studies and the overall body of evidence. Differences in data extracted by reviewers were adjudicated by consensus. Results Three randomized studies provided evidence on the effect of LDCT screening on lung cancer mortality, of which the National Lung Screening Trial was the most informative, demonstrating that among 53 454 participants enrolled, screening resulted in significantly fewer lung cancer deaths (356 vs 443 deaths; lung cancer-specific mortality, 274 vs 309 events per 100000 person-years for LDCT and control groups, respectively; relative risk, 0.80; 95% CI, 0.73-0.93; absolute risk reduction, 0.33%; P=. 004). The other 2 smaller studies showed no such benefit. In terms of potential harms of LDCT screening, across all trials and cohorts, approximately 20% of individuals in each round of screening had positive results requiring some degree of follow-up, while approximately 1% had lung cancer. There was marked heterogeneity in this finding and in the frequency of follow-up investigations, biopsies, and percentage of surgical procedures performed in patients with benign lesions. Major complications in those with benign conditions were rare. Conclusion Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results. JAMA. 2012;307(22):2418-2429 Published online May 20, 2012. doi: 10.1001/jama.2012.5521 www.jama.com	[Bach, Peter B.; Azzoli, Christopher G.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Mirkin, Joshua N.] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Oliver, Thomas K.] Amer Soc Clin Oncol, Alexandria, VA USA; [Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Brawley, Otis W.] Emory Univ, Atlanta, GA 30322 USA; [Brawley, Otis W.] Amer Canc Soc, Atlanta, GA 30329 USA; [Byers, Tim] Colorado Sch Publ Hlth, Denver, CO USA; [Colditz, Graham A.] Washington Univ, Sch Med, St Louis, MO USA; [Gould, Michael K.] Kaiser Permanente So Calif, Pasadena, CA USA; [Jett, James R.] Natl Jewish Hlth Ctr, Denver, CO USA; [Sabichi, Anita L.] Baylor Coll Med, Houston, TX 77030 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wood, Douglas E.] Univ Washington, Seattle, WA 98195 USA; [Qaseem, Amir] Amer Board Internal Med, Philadelphia, PA USA; [Detterbeck, Frank C.] Yale Univ, Sch Med, New Haven, CT USA	Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; American Society of Clinical Oncology; University of Texas System; UTMD Anderson Cancer Center; Emory University; American Cancer Society; Colorado School of Public Health; Washington University (WUSTL); Kaiser Permanente; National Jewish Health; Baylor College of Medicine; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; American Board of Internal Medicine; Yale University	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,POB 44, New York, NY 10065 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Mirkin, Joshua/0000-0002-6712-8717	Genentech; National Cancer Institute; Covidien; NATIONAL CANCER INSTITUTE [K24CA125036, P30CA014089, P30CA016672, R21CA131698] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Covidien; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICJME form for Disclosure of Potential Conflicts of Interest. Dr Bach reported that he has received speaking fees from Genentech. Dr Berry reported that he is co-owner of Berry Consultants LLC, which designs adaptive clinical trials for pharmaceutical companies, medical device companies, and National Institutes of Health cooperative groups. To the best of his knowledge, none of these parties have any interest in lung cancer screening. Dr Gould reported that he receives grant support from the National Cancer Institute. Dr Jett reported that he has grants pending for work related to screening and early detection of lung cancer with Oncimmune and Isense. Dr Sabichi reported being a member of the National Cancer Institute's PDQ Prevention and Screening Editorial Board and possessing a pending patent for a test for the detection of bladder cancer. Dr Wood reported his participation in the development of the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening in his role as Chair of the NCCN Lung Cancer Screening Panel. Dr Detterbeck reported that he was reimbursed for travel costs associated with his work on the Oncimmune advisory board and has participated without compensation in a symposium on CT screening sponsored by Covidien. No other conflicts were reported.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; American Cancer Society, 2012, CANC FACTS FIG 2012; [Anonymous], LUNG CANC RISK ASS T; [Anonymous], MAMM STAND ACT PROGR; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Bach PB, 2008, THORAX, V63, P298, DOI 10.1136/thx.2007.082990; Bastarrika G, 2005, AM J RESP CRIT CARE, V171, P1378, DOI 10.1164/rccm.200411-1479OC; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Black C, 2006, HEALTH TECHNOL ASSES, V10, pIII; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; BRETT GZ, 1968, THORAX, V23, P414, DOI 10.1136/thx.23.4.414; Callol L, 2007, LUNG CANCER, V56, P217, DOI 10.1016/j.lungcan.2007.01.010; Castleberry AW, 2009, BRIT J CANCER, V101, P882, DOI 10.1038/sj.bjc.6605253; Charles M, 2001, J Radiol Prot, V21, P83, DOI 10.1088/0952-4746/21/1/609; Clark MM, 2004, LUNG CANCER-J IASLC, V44, P13, DOI 10.1016/j.lungcan.2003.10.001; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Diederich S, 2002, RADIOLOGY, V222, P773, DOI 10.1148/radiol.2223010490; Diederich S, 2000, CANCER, V89, P2483, DOI 10.1002/1097-0142(20001201)89:11+<2483::AID-CNCR27>3.0.CO;2-1; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; Garg K, 2002, RADIOLOGY, V225, P506, DOI 10.1148/radiol.2252011851; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2001, ANN NY ACAD SCI, V952, P124, DOI 10.1111/j.1749-6632.2001.tb02733.x; Howlander N, SEER CANC STAT REV 1; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; International Commission on Radiological Protection (ICRP) , 1996, ANN ICRP, V26; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Kubik AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.0.CO;2-W; MacRedmond R, 2004, THORAX, V59, P237, DOI 10.1136/thx.2003.008821; MacRedmond R, 2006, THORAX, V61, P54, DOI 10.1136/thx.2004.037580; MAO L, 1994, CANCER RES, V54, P1634; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; Melamed MR, 2000, CANCER, V89, P2356, DOI 10.1002/1097-0142(20001201)89:11+<2356::AID-CNCR8>3.3.CO;2-Q; Menezes RJ, 2010, LUNG CANCER, V67, P177, DOI 10.1016/j.lungcan.2009.03.030; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Miozzo M, 1996, CANCER RES, V56, P2285; Novello S, 2005, ANN ONCOL, V16, P1662, DOI 10.1093/annonc/mdi314; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Palmisano WA, 2000, CANCER RES, V60, P5954; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Payne PW, 1997, MAYO CLIN PROC, V72, P697; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Picozzi G, 2005, RADIOL MED, V109, P17; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Reich JM, 2009, BRIT J CANCER, V101, P879, DOI 10.1038/sj.bjc.6605260; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Schnoll RA, 2002, LUNG CANCER, V37, P257, DOI 10.1016/S0169-5002(02)00106-X; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; TOCKMAN MS, 1986, CHEST, V89, pS324, DOI 10.1378/chest.89.4_Supplement.324S-a; Tockman MS, 1997, MAYO CLIN PROC, V72, P788, DOI 10.1016/S0025-6196(11)63601-X; van den Bergh KAM, 2008, CANCER, V113, P396, DOI 10.1002/cncr.23590; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC	74	836	889	8	201	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2418	2429		10.1001/jama.2012.5521	http://dx.doi.org/10.1001/jama.2012.5521			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22610500	Green Accepted			2022-12-28	WOS:000305115900027
J	Frost, A; Elgort, MG; Brandman, O; Ives, C; Collins, SR; Miller-Vedam, L; Weibezahn, J; Hein, MY; Poser, I; Mann, M; Hyman, AA; Weissman, JS				Frost, Adam; Elgort, Marc G.; Brandman, Onn; Ives, Clinton; Collins, Sean R.; Miller-Vedam, Lakshmi; Weibezahn, Jimena; Hein, Marco Y.; Poser, Ina; Mann, Matthias; Hyman, Anthony A.; Weissman, Jonathan S.			Functional Repurposing Revealed by Comparing S-pombe and S-cerevisiae Genetic Interactions	CELL			English	Article							SPINDLE-POLE BODY; CELL-DIVISION; NUCLEAR-ENVELOPE; MESSENGER-RNAS; YEAST; PROTEINS; COMPLEX; GENOME; NETWORKS; MAP	We present a genetic interaction map of pairwise measures including similar to 40% of nonessential S. pombe genes. By comparing interaction maps for fission and budding yeast, we confirmed widespread conservation of genetic relationships within and between complexes and pathways. However, we identified an important subset of orthologous complexes that have undergone functional "repurposing'': the evolution of divergent functions and partnerships. We validated three functional repurposing events in S. pombe and mammalian cells and discovered that (1) two lumenal sensors of misfolded ER proteins, the kinase/ nuclease Ire1 and the glucosyltransferase Gpt1, act together to mount an ER stress response; (2) ESCRT factors regulate spindle-pole-body duplication; and (3) a membrane-protein phosphatase and kinase complex, the STRIPAK complex, bridges the cis-Golgi, the centrosome, and the outer nuclear membrane to direct mitotic progression. Each discovery opens new areas of inquiry and-together-have implications for model organism-based research and the evolution of genetic systems.	[Frost, Adam; Elgort, Marc G.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Frost, Adam; Elgort, Marc G.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Brandman, Onn; Ives, Clinton; Miller-Vedam, Lakshmi; Weibezahn, Jimena; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Brandman, Onn; Ives, Clinton; Miller-Vedam, Lakshmi; Weibezahn, Jimena; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Brandman, Onn; Ives, Clinton; Miller-Vedam, Lakshmi; Weibezahn, Jimena; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Collins, Sean R.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Max Planck Society; Max Planck Society; Stanford University	Frost, A (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	frost@biochem.utah.edu	Hein, Marco/C-2994-2014; Hyman, Anthony A/B-3917-2017; Mann, Matthias/A-3454-2013; Hyman, Tony/F-1923-2011	Hein, Marco/0000-0002-9490-2261; Hyman, Anthony A/0000-0003-3664-154X; Mann, Matthias/0000-0003-1292-4799; Weissman, Jonathan/0000-0003-2445-670X; Frost, Adam/0000-0003-2231-2577; Collins, Sean/0000-0002-4276-5840	HHMI; NIH [5T32 CA93247-9]; German National Genome Research Network [01GS0861]; Huntsman Cancer Institute Center [P30 CA042014]; International Human Frontier Science Program [LT 00821/2007-L]; University of Utah; NATIONAL CANCER INSTITUTE [P30CA042014, T32CA093247] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Genome Research Network; Huntsman Cancer Institute Center; International Human Frontier Science Program(Human Frontier Science Program); University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Roguev, N. Krogan, C. Ryan, P. Espenshade, W. Sundquist, D. Ward, and T. Formosa for helpful discussions, reagents, and protocols; N. Elde, J. Kaplan, L. Colf, and M. Karen for critical discussions of the manuscript; and J. Rutter and J. Shaw for microscope access. This work was support by funds from HHMI (J.S.W.), NIH MCRTP 5T32 CA93247-9 (M.G.E.), the German National Genome Research Network grant (01GS0861, A.A.H., M.M.), and the Huntsman Cancer Institute Center Grant (P30 CA042014, A.F.). O.B. and S.R.C. are HHMI fellows of the Helen Hay Whitney Foundation. J.W. was supported by a long-term fellowship from the International Human Frontier Science Program (LT 00821/2007-L). A.F. was an HHMI Fellow of the Life Science Research Foundation and is supported by the University of Utah.	Aslett M, 2006, YEAST, V23, P913, DOI 10.1002/yea.1420; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kowalski D, 2008, MOL PHARMACOL, V74, P1092, DOI 10.1124/mol.108.048256; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Niwa N, 2010, EVOL DEV, V12, P168, DOI 10.1111/j.1525-142X.2010.00402.x; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Sutterlin C, 2010, J CELL BIOL, V188, P621, DOI 10.1083/jcb.200910001; Tallada VA, 2009, J CELL BIOL, V185, P875, DOI 10.1083/jcb.200812108; Tamm T, 2011, J CELL BIOL, V195, P467, DOI 10.1083/jcb.201106076; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Toya M, 2007, NAT CELL BIOL, V9, P646, DOI 10.1038/ncb1593; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Wood V, 2006, TOP CURR GENET, V15, P233, DOI 10.1007/4735_97; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	61	110	110	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1339	1352		10.1016/j.cell.2012.04.028	http://dx.doi.org/10.1016/j.cell.2012.04.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682253	Bronze, Green Accepted			2022-12-28	WOS:000305119600017
J	Hooper, LV; Littman, DR; Macpherson, AJ				Hooper, Lora V.; Littman, Dan R.; Macpherson, Andrew J.			Interactions Between the Microbiota and the Immune System	SCIENCE			English	Review							INNATE LYMPHOID-CELLS; SEGMENTED FILAMENTOUS BACTERIA; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL DENDRITIC CELLS; LECTIN REGIII-GAMMA; GUT MICROBIOTA; CROHNS-DISEASE; SYMBIOTIC BACTERIA; SUSCEPTIBILITY LOCI; COMMENSAL BACTERIA	The large numbers of microorganisms that inhabit mammalian body surfaces have a highly coevolved relationship with the immune system. Although many of these microbes carry out functions that are critical for host physiology, they nevertheless pose the threat of breach with ensuing pathologies. The mammalian immune system plays an essential role in maintaining homeostasis with resident microbial communities, thus ensuring that the mutualistic nature of the host-microbial relationship is maintained. At the same time, resident bacteria profoundly shape mammalian immunity. Here, we review advances in our understanding of the interactions between resident microbes and the immune system and the implications of these findings for human health.	[Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs, Univ Clin Visceral Surg & Med, Bern, Switzerland	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; New York University; New York University; University of Bern; University Hospital of Bern	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu			NIH [DK070855, AI080885]; Burroughs Wellcome Foundation; Howard Hughes Medical Institute; Swiss National Science Foundation [310030-1247324, CRSII3_136286]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L.V.H. is supported by NIH grant DK070855, a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases Award, and the Howard Hughes Medical Institute. D. R. L. is supported by NIH grant AI080885 and the Howard Hughes Medical Institute. A.J.M. is supported by Swiss National Science Foundation grants 310030-1247324 and CRSII3_136286.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; Cummings J. H, 2004, NOVART FDN SYMP, V263, P211; Cummings J. H, 2004, NOVART FDN SYMP, V263; Cummings John H, 2004, Novartis Found Symp, V263, P99; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Henderson C, 2010, CURR OPIN RHEUMATOL, V22, P567, DOI 10.1097/BOR.0b013e32833ceff4; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Leiter EH, 1990, ROLE MICROORGANISMS, P39; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Macpherson A. J., 2009, ENCY MICROBIOLOGY, V156, P237; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OHSUGI T, 1994, LAB ANIM SCI, V44, P386; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schmidt D, 1999, J IMMUNOL, V162, P4627; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371; Zhang YQ, 2010, J IMMUNOL, V184, P5645, DOI 10.4049/jimmunol.0901814	84	2502	2663	71	1258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1268	1273		10.1126/science.1223490	http://dx.doi.org/10.1126/science.1223490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674334	Green Accepted			2022-12-28	WOS:000304905300036
J	Vanharanta, S; Massague, J				Vanharanta, Sakari; Massague, Joan			Field Cancerization: Something New Under the Sun	CELL			English	Editorial Material							SKIN-CANCER; P53; FIBROBLASTS	Mutations in keratinocyte and melanocyte precursors that are caused by extensive sun exposure are well-established contributors to skin cancer. Now Hu et al. provide evidence that the sun's harmful rays may also cause tumor-promoting epigenetic modifications in dermal fibroblasts, high-lighting further the importance of tumor-stroma interactions in cancer.	[Vanharanta, Sakari; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	massaguj@mskcc.org		Massague, Joan/0000-0001-9324-8408				Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Oskarsson T, 2012, EMBO J, V31, P254, DOI 10.1038/emboj.2011.469; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	10	29	29	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1179	1181		10.1016/j.cell.2012.05.013	http://dx.doi.org/10.1016/j.cell.2012.05.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682238	Bronze			2022-12-28	WOS:000305119600001
J	Kalirai, JS				Kalirai, Jason S.			The age of the Milky Way inner halo	NATURE			English	Article							DIGITAL SKY SURVEY; DA WHITE-DWARFS; GLOBULAR-CLUSTERS; SPECTROSCOPIC ANALYSIS; STELLAR EVOLUTION; GALACTIC HALO; ACS SURVEY; BRANCH; MASSES; STARS	The Milky Way galaxy has several components, such as the bulge, disk and halo. Unravelling the assembly history of these stellar populations is often restricted because of difficulties in measuring accurate ages for low-mass, hydrogen-burning stars(1,2). Unlike these progenitors, white dwarf stars(3), the 'cinders' of stellar evolution, are remarkably simple objects and their fundamental properties can be measured with little ambiguity(4,5). Here I report observations of newly formed white dwarf stars in the halo of the Milky Way, and a separate analysis of archival data in the well studied 12.5-billion-year-old globular cluster Messier 4. I measure the mass distribution of the remnant stars and invert the stellar evolution process to develop a mathematical relation that links this final stellar mass to the mass of their immediate progenitors, and therefore to the age of the parent population. By applying this technique to a small sample of four nearby and kinematically confirmed halo white dwarf stars, I calculate the age of local field halo stars to be 11.4 +/- 0.7 billion years. The oldest globular clusters formed 13.5 billion years ago. Future observations of newly formed white dwarf stars in the halo could be used to reduce the uncertainty, and to probe relative differences between the formation times of the youngest globular clusters and the inner halo.	[Kalirai, Jason S.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kalirai, Jason S.] Johns Hopkins Univ, Ctr Astrophys Sci, Baltimore, MD 21218 USA	Space Telescope Science Institute; Johns Hopkins University	Kalirai, JS (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	jkalirai@stsci.edu			W. M. Keck Foundation	W. M. Keck Foundation(W.M. Keck Foundation)	The data presented in this paper were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. I acknowledge the significant cultural role and reverence that the summit of Mauna Kea has within the indigenous Hawaiian community. I am fortunate to have had the opportunity to conduct observations from this mountain. This work was also based on observations obtained at the Paranal Observatory of the European Southern Observatory. I thank A. Dotter, P. Bergeron, and P.-E. Tremblay for discussions related to stellar evolution and ages. I also thank U. Heber for providing us reduced spectra from the SPY Survey.	Bedin LR, 2009, ASTROPHYS J, V697, P965, DOI 10.1088/0004-637X/697/2/965; Beers TC, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/34; BERGERON P, 1992, ASTROPHYS J, V394, P228, DOI 10.1086/171575; Carollo D, 2007, NATURE, V450, P1020, DOI 10.1038/nature06460; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Dotter A, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/74; Dotter A, 2010, ASTROPHYS J, V708, P698, DOI 10.1088/0004-637X/708/1/698; Font AS, 2011, MON NOT R ASTRON SOC, V416, P2802, DOI 10.1111/j.1365-2966.2011.19227.x; Gates E, 2004, ASTROPHYS J, V612, pL129, DOI 10.1086/424568; Jofre P, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117131; Kalirai JS, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/1/11; Kalirai JS, 2009, ASTROPHYS J, V705, P408, DOI 10.1088/0004-637X/705/1/408; Kalirai JS, 2008, ASTROPHYS J, V676, P594, DOI 10.1086/527028; Kalirai JS, 2007, ASTROPHYS J, V671, P748, DOI 10.1086/521922; Kilic M, 2010, ASTROPHYS J LETT, V715, pL21, DOI 10.1088/2041-8205/715/1/L21; Moehler S, 2004, ASTRON ASTROPHYS, V420, P515, DOI 10.1051/0004-6361:20035819; Napiwotzki R, 2001, ASTRON NACHR, V322, P411, DOI 10.1002/1521-3994(200112)322:5/6<411::AID-ASNA411>3.0.CO;2-I; Oppenheimer BR, 2001, SCIENCE, V292, P698, DOI 10.1126/science.1059954; Paczynski B., 1970, Acta Astronomica, V20, P47; Pauli EM, 2006, ASTRON ASTROPHYS, V447, P173, DOI 10.1051/0004-6361:20052730; RENZINI A, 1988, ANNU REV ASTRON ASTR, V26, P199; Sarajedini A, 2007, ASTRON J, V133, P1658, DOI 10.1086/511979; Shapiro S. L., 1983, WHITE DWARFS NEUTRON, V663; Soderblom DR, 2010, ANNU REV ASTRON ASTR, V48, P581, DOI 10.1146/annurev-astro-081309-130806; Tremblay PE, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/128; Tremblay PE, 2009, ASTROPHYS J, V696, P1755, DOI 10.1088/0004-637X/696/2/1755; Wegner G., 1981, Astronomy & Astrophysics Supplement Series, V43, P473; Zolotov A, 2009, ASTROPHYS J, V702, P1058, DOI 10.1088/0004-637X/702/2/1058	28	70	70	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					90	92		10.1038/nature11062	http://dx.doi.org/10.1038/nature11062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678285	Green Submitted			2022-12-28	WOS:000304854000032
J	Lee, DS; Stitt, A; Austin, PC; Stukel, TA; Schull, MJ; Chong, A; Newton, GE; Lee, JS; Tu, JV				Lee, Douglas S.; Stitt, Audra; Austin, Peter C.; Stukel, Therese A.; Schull, Michael J.; Chong, Alice; Newton, Gary E.; Lee, Jacques S.; Tu, Jack V.			Prediction of Heart Failure Mortality in Emergent Care A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							OUTCOMES; MANAGEMENT; ADMISSION; PRESSURE; MODEL; TRIAL	Background: Heart failure contributes to millions of emergency department (ED) visits, but hospitalization-versus-discharge decisions are often not accompanied by prognostic risk quantification. Objective: To derive and validate a model for acute heart failure mortality applicable in the ED. Design: Clinical data abstraction with development of a broadly applicable multivariate risk index for 7-day death using initial vital signs, clinical and presentation features, and readily available laboratory tests. Setting: Multicenter study of 86 hospitals in Ontario, Canada. Patients: Population-based random sample of 12 591 patients presenting to the ED from 2004 to 2007. Measurements: Death within 7 days of presentation. Results: In the derivation cohort (n = 7433; mean age, 75.4 years [SD, 11.4]; 51.5% men), mortality risk increased with higher triage heart rate (adjusted odds ratio [OR], 1.15 [95% CI, 1.03 to 1.30] per 10 beats/min) and creatinine concentration (OR, 1.35 [CI, 1.14 to 1.60] per 1 mg/dL [88.4 mu mol/L]), and lower triage systolic blood pressure (OR, 1.52 [CI, 1.31 to 1.77] per 20 mm Hg) and initial oxygen saturation (OR, 1.16 [CI, 1.01 to 1.33] per 5%). Nonnormal serum troponin levels (OR, 2.75 [CI, 1.86 to 4.07]) were associated with increased mortality risk. Areas under the receiver-operating characteristic curves of the multivariate model were 0.805 for the derivation data set (bootstrap-corrected, 0.811) and 0.826 for validation data set (n = 5158; mean age, 75.7 years [SD, 11.4]; 51.6% men). In the derivation cohort, a multivariate index score stratified 7-day mortality with rates of 0.3%, 0.3%, 0.7%, and 1.9% in quintiles 1 to 4, respectively. Mortality rates in the 2 highest risk groups were 3.5% and 8.2% in deciles 9 and 10, respectively. Limitation: Left ventricular ejection fraction was not included in the model. Conclusion: A multivariate index comprising routinely collected variables stratified mortality risk with high discrimination in a broad group of patients with acute heart failure presenting to the ED.	[Lee, Douglas S.; Newton, Gary E.] Univ Toronto, Inst Clin Evaluat Sci, Univ Hlth Network, Dalla Lana Sch Publ Hlth, Toronto, ON M4N 3M5, Canada; [Schull, Michael J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Lee, DS (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, Univ Hlth Network, Dalla Lana Sch Publ Hlth, Room G-106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dlee@ices.on.ca	Lee, Jacques/CAF-4380-2022; Schull, Michael J/A-7955-2013	Lee, Jacques/0000-0002-9143-6285; Schull, Michael J/0000-0002-1318-6364; Stukel, Therese/0000-0002-2951-1360; Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X; Lee, Douglas/0000-0001-7078-745X	Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research (CIHR) [MOP 114937]; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research Applied Chair in Health Services and Policy Research; Canada Research Chair in Health Services Research	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research Applied Chair in Health Services and Policy Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research(Canada Research Chairs)	Primary Funding Source: Canadian Institutes of Health Research.; The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health and Long-Term Care. This research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR MOP 114937), a Canadian Institutes of Health Research clinician-scientist award (Dr. D. S. Lee), a Career Investigator Award from the Heart and Stroke Foundation of Ontario (Dr. Austin, Dr. Tu), a Canadian Institutes of Health Research Applied Chair in Health Services and Policy Research (Dr. Schull), and a Canada Research Chair in Health Services Research (Dr. Tu).	Abdel-Qadir HM, 2010, AM HEART J, V160, P264, DOI 10.1016/j.ahj.2010.05.032; Auble TE, 2005, ACAD EMERG MED, V12, P514, DOI 10.1197/j.aem.2004.11.026; Butler J, 1998, AM J CARDIOL, V81, P41, DOI 10.1016/S0002-9149(97)00851-5; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Chin MH, 1996, ARCH INTERN MED, V156, P1814, DOI 10.1001/archinte.156.16.1814; Collins SP, 2009, AM J EMERG MED, V27, P293, DOI 10.1016/j.ajem.2008.02.025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2011, JAMA-J AM MED ASSOC, V305, P1702, DOI 10.1001/jama.2011.515; GUTTMANN A, 2011, BMJ-BRIT MED J, V342, P2983, DOI [10.1136/bmj.d2983, DOI 10.1136/BMJ.D2983]; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lee DS, 2010, CIRC-HEART FAIL, V3, P228, DOI 10.1161/CIRCHEARTFAILURE.109.885285; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; PACKER M, 1990, AM J CARDIOL, V65, pE45, DOI 10.1016/0002-9149(90)90251-U; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Peacock WF, 2010, J AM COLL CARDIOL, V56, P343, DOI 10.1016/j.jacc.2010.03.051; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; PERRY JJ, 2010, BMJ-BRIT MED J, V341, P5204; Sanderson JE, 2003, HEART, V89, P585, DOI 10.1136/heart.89.6.585; Schneider HG, 2009, ANN INTERN MED, V150, P365, DOI 10.7326/0003-4819-150-6-200903170-00004; Singer AJ, 2009, CIRC-HEART FAIL, V2, P287, DOI 10.1161/CIRCHEARTFAILURE.108.826685; Steyerberg E., 2009, CLIN PREDICTION MODE; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Thygesen K, 2011, EUR HEART J; Tu JV, 2009, JAMA-J AM MED ASSOC, V302, P2330, DOI 10.1001/jama.2009.1731; Van Spall HGC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023065	36	189	192	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					767	+		10.7326/0003-4819-156-11-201206050-00003	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	954ZK	22665814				2022-12-28	WOS:000304986500002
J	Barrett, PJ; Song, YL; Van Horn, WD; Hustedt, EJ; Schafer, JM; Hadziselimovic, A; Beel, AJ; Sanders, CR				Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Hustedt, Eric J.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.			The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol	SCIENCE			English	Article							C-TERMINAL DOMAIN; GAMMA-SECRETASE; DIMER; APP; SEQUENCE; MODEL	C99 is the transmembrane carboxyl-terminal domain of the amyloid precursor protein that is cleaved by gamma-secretase to release the amyloid-beta polypeptides, which are associated with Alzheimer's disease. Nuclear magnetic resonance and electron paramagnetic resonance spectroscopy show that the extracellular amino terminus of C99 includes a surface-embedded "N-helix" followed by a short "N-loop" connecting to the transmembrane domain (TMD). The TMD is a flexibly curved alpha helix, making it well suited for processive cleavage by gamma-secretase. Titration of C99 reveals a binding site for cholesterol, providing mechanistic insight into how cholesterol promotes amyloidogenesis. Membrane-buried GXXXG motifs (G, Gly; X, any amino acid), which have an established role in oligomerization, were also shown to play a key role in cholesterol binding. The structure and cholesterol binding properties of C99 may aid in the design of Alzheimer's therapeutics.	[Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.] Vanderbilt Univ, Sch Med, Dept Biochem, Struct Biol Ctr, Nashville, TN 37232 USA; [Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.] Vanderbilt Univ, Sch Med, Inst Biol Chem, Nashville, TN 37232 USA; [Hustedt, Eric J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Sanders, CR (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA.	chuck.sanders@vanderbilt.edu	Song, Yuanli/B-1798-2014; Van Horn, Wade/GSN-2667-2022	Van Horn, Wade/0000-0002-2493-5578	Alzheimer's Association [IIRG-07-59379]; NIH [PO1 GM080513, T32 GM08320]; American Heart Association [AHA10POST4210008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM080513, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077681] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Alzheimer's Association grant IIRG-07-59379, NIH grants PO1 GM080513 (C. R. S. and E.J.H.) and T32 GM08320 (P.J.B.), and by an American Heart Association grant AHA10POST4210008 (W. D. V. H.). We thank S. Howell for technical assistance and F. Sonnichsen, K. Mittendorf, B. Carter, E. Stanley, and C. Deatherage for comments on this manuscript. Coordinates for the structure of C99 have been deposited in the Protein Data Bank (accession code 2LP1).	Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Fonseca ACRG, 2010, EXP NEUROL, V223, P282, DOI 10.1016/j.expneurol.2009.09.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J., 2012, ALZHEIMER RES FORUM; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lu JX, 2011, BIOPHYS J, V100, P711, DOI 10.1016/j.bpj.2010.12.3696; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2011, ACTA NATURAE, V3, P69, DOI 10.32607/20758251-2011-3-1-69-76; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yanagisawa K, 2005, SUB CELL BIOCHEM, V38, P179	33	356	363	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1168	1171		10.1126/science.1219988	http://dx.doi.org/10.1126/science.1219988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654059	Green Accepted			2022-12-28	WOS:000304647900052
J	O'Connell, LA; Hofmann, HA				O'Connell, Lauren A.; Hofmann, Hans A.			Evolution of a Vertebrate Social Decision-Making Network	SCIENCE			English	Article							RECEPTOR-MESSENGER-RNA; BEHAVIOR NETWORK; ESTROGEN-RECEPTOR; BRAIN; REWARD; NEUROANATOMY; VASOPRESSIN; EXPRESSION; VASOTOCIN; ANDROGEN	Animals evaluate and respond to their social environment with adaptive decisions. Revealing the neural mechanisms of such decisions is a major goal in biology. We analyzed expression profiles for 10 neurochemical genes across 12 brain regions important for decision-making in 88 species representing five vertebrate lineages. We found that behaviorally relevant brain regions are remarkably conserved over 450 million years of evolution. We also find evidence that different brain regions have experienced different selection pressures, because spatial distribution of neuroendocrine ligands are more flexible than their receptors across vertebrates. Our analysis suggests that the diversity of social behavior in vertebrates can be explained, in part, by variations on a theme of conserved neural and gene expression networks.	[O'Connell, Lauren A.; Hofmann, Hans A.] Univ Texas UT Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [O'Connell, Lauren A.; Hofmann, Hans A.] Univ Texas UT Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hofmann, HA (corresponding author), Univ Texas UT Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	hans@mail.utexas.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X; O'Connell, Lauren/0000-0002-2706-4077	NSF [1011253, 0843712]; Alfred P. Sloan Foundation; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems [0843712] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The data reported in this paper are tabulated in the supplementary materials. We thank M. Cummings, S. Phelps, A. Pollen, M. Ryan, and R. Wong for helpful comments on earlier versions of this manuscript; members of the Hofmann laboratory, the Center for Brain, Behavior, and Evolution at UT Austin, and the Sociogenomics Initiative, especially G. Robinson, for discussions; and D. Canatella, E. Martins, and T. Streelman for advice on the evolutionary analysis. The work was supported by NSF Doctoral Dissertation Improvement Grant 1011253 to L.A.O. and NSF grant 0843712, the Alfred P. Sloan Foundation, a Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology, and an Institute for Cellular and Molecular Biology Fellowship to H. A. H. The authors declare no competing financial interests. L.A.O. gathered all data for analysis; L.A.O. and H. A. H. conceived of the project, analyzed data, and wrote the paper.	Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Butler AB, 2011, ANN NY ACAD SCI, V1225, P14, DOI 10.1111/j.1749-6632.2011.06006.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chakraborty M, 2010, HORM BEHAV, V58, P619, DOI 10.1016/j.yhbeh.2010.06.013; CREWS D, 1986, ANN NY ACAD SCI, V474, P187, DOI 10.1111/j.1749-6632.1986.tb28010.x; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Harris-Warrick RM, 2000, J COMP PHYSIOL A, V186, P605, DOI 10.1007/s003590000133; INSEL TR, 1994, J NEUROSCI, V14, P5381; KIM YS, 1978, AM ZOOL, V18, P425; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Leung CH, 2011, ENDOCRINOLOGY, V152, P4865, DOI 10.1210/en.2011-1394; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Moore FL, 1998, COMP BIOCHEM PHYS C, V119, P251, DOI 10.1016/S0742-8413(98)00014-0; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; Ophir AG, 2008, P NATL ACAD SCI USA, V105, P1249, DOI 10.1073/pnas.0709116105; Parent A., 1984, Handbook of Chemical Neuroanatomy, V2, P409; Pollen AA, 2008, BRAIN BEHAV EVOLUT, V72, P145, DOI 10.1159/000151474; Porges SW, 2011, POLYVAGAL THEORY NEU; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; Striedter G. F., 2005, PRINCIPLES BRAIN EVO; Wickens JR, 2007, ANN NY ACAD SCI, V1104, P192, DOI 10.1196/annals.1390.016; Wood RI, 1998, ANN NY ACAD SCI, V855, P362, DOI 10.1111/j.1749-6632.1998.tb10594.x; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; YOUNG LJ, 1995, J NEUROENDOCRINOL, V7, P567, DOI 10.1111/j.1365-2826.1995.tb00793.x	30	368	369	7	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1154	1157		10.1126/science.1218889	http://dx.doi.org/10.1126/science.1218889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654056				2022-12-28	WOS:000304647900048
J	Brewer, C				Brewer, Colin			Psychoanalysis can seriously damage your health	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.	brewerismo@gmail.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 31	2012	344								e3857	10.1136/bmj.e3857	http://dx.doi.org/10.1136/bmj.e3857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HG	22654070				2022-12-28	WOS:000304857000016
J	Hardy, J; Revesz, T				Hardy, John; Revesz, Tamas			The Spread of Neurodegenerative Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ALZHEIMERS-DISEASE; PATHOLOGY		[Hardy, John] UCL, Inst Neurol, Reta Lila Weston Labs, London WC1E 6BT, England; UCL, Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hardy, J (corresponding author), UCL, Inst Neurol, Reta Lila Weston Labs, Queen Sq, London WC1E 6BT, England.		Revesz, Tamas/A-8732-2010; Hardy, John/C-2451-2009	Revesz, Tamas/0000-0003-2501-0259; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075] Funding Source: Medline; Parkinson&apos;s UK [G-0907] Funding Source: Medline; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Collinge J, 2008, PHILOS T R SOC B, V363, P3607, DOI 10.1098/rstb.2008.0103; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302	6	68	68	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2126	2128						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646635				2022-12-28	WOS:000304613400016
J	Wallace, DJ; Angus, DC; Barnato, AE; Kramer, AA; Kahn, JM				Wallace, David J.; Angus, Derek C.; Barnato, Amber E.; Kramer, Andrew A.; Kahn, Jeremy M.			Nighttime Intensivist Staffing and Mortality among Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH-OF-STAY; CARE-UNIT; HOSPITAL VOLUME; OUTCOMES; SERVICES; DOCTORS; SEPSIS; HOUSE	BACKGROUND Hospitals are increasingly adopting 24-hour intensivist physician staffing as a strategy to improve intensive care unit (ICU) outcomes. However, the degree to which nighttime intensivists are associated with improvements in the quality of ICU care is unknown. METHODS We conducted a retrospective cohort study involving ICUs that participated in the Acute Physiology and Chronic Health Evaluation (APACHE) clinical information system from 2009 through 2010, linking a survey of ICU staffing practices with patient-level outcomes data from adult ICU admissions. Multivariate models were used to assess the relationship between nighttime intensivist staffing and in-hospital mortality among ICU patients, with adjustment for daytime intensivist staffing, severity of illness, and case mix. We conducted a confirmatory analysis in a second, population-based cohort of hospitals in Pennsylvania from which less detailed data were available. RESULTS The analysis with the use of the APACHE database included 65,752 patients admitted to 49 ICUs in 25 hospitals. In ICUs with low-intensity daytime staffing, nighttime intensivist staffing was associated with a reduction in risk-adjusted in-hospital mortality (adjusted odds ratio for death, 0.62; P = 0.04). Among ICUs with high-intensity daytime staffing, nighttime intensivist staffing conferred no benefit with respect to risk-adjusted in-hospital mortality (odds ratio, 1.08; P = 0.78). In the verification cohort, there was a similar relationship among daytime staffing, nighttime staffing, and in-hospital mortality. The interaction between nighttime staffing and daytime staffing was not significant (P = 0.18), yet the direction of the findings were similar to those in the APACHE cohort. CONCLUSIONS The addition of nighttime intensivist staffing to a low-intensity daytime staffing model was associated with reduced mortality. However, a reduction in mortality was not seen in ICUs with high-intensity daytime staffing. (Funded by the National Heart, Lung, and Blood Institute.)	[Wallace, David J.; Angus, Derek C.; Barnato, Amber E.; Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Investigat & Syst Modeling Acute Illness, Pittsburgh, PA 15261 USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Internal Med, Div Gen Internal Med,Ctr Res Hlth Care, Pittsburgh, PA 15261 USA; [Angus, Derek C.; Barnato, Amber E.; Kahn, Jeremy M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; [Kramer, Andrew A.] Cerner, Kansas City, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Investigat & Syst Modeling Acute Illness, 602-B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kahnjm@upmc.edu	Angus, Derek C/E-9671-2012; Kramer, Andrew/AAI-9086-2020	Kramer, Andrew/0000-0002-5681-5781; Kahn, Jeremy/0000-0001-9688-5576	National Heart, Lung, and Blood Institute [K23-HL096651, T32-HL07820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096651, T32HL007820] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (K23-HL096651 and T32-HL07820) from the National Heart, Lung, and Blood Institute.	Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Blunt MC, 2000, LANCET, V356, P735, DOI 10.1016/S0140-6736(00)02634-9; Boucher KM, 1998, J CLIN EPIDEMIOL, V51, P1223, DOI 10.1016/S0895-4356(98)00129-2; Burnham EL, 2010, AM J RESP CRIT CARE, V181, P1159, DOI 10.1164/rccm.201004-0651ED; Cartin-Ceba R, 2010, AM J RESP CRIT CARE, V181, P1279, DOI 10.1164/rccm.201004-0676ED; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Gajic O, 2008, CRIT CARE MED, V36, P36, DOI 10.1097/01.CCM.0000297887.84347.85; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; Haupt MT, 2003, CRIT CARE MED, V31, P2677, DOI 10.1097/01.CCM.0000094227.89800.93; Jones SF, 2010, AM J RESP CRIT CARE, V181, P1280, DOI 10.1164/rccm.201005-0681ED; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2010, AM J RESP CRIT CARE, V181, P1160, DOI 10.1164/rccm.201004-0557ED; Kahn JM, 2009, HEALTH SERV RES, V44, P862, DOI 10.1111/j.1475-6773.2009.00959.x; Kim, 2010, ARCH INTERN MED, V170, P867; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lilly CM, 2011, JAMA-J AM MED ASSOC, V305, P2175, DOI 10.1001/jama.2011.697; Lin CY, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030056; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Lindell KO, 2010, AM J RESP CRIT CARE, V182, P1338, DOI 10.1164/rccm.201007-1129ED; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Wallace DJ, 2011, AM J RESP CRIT CARE, V183; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zimmerman JE, 2010, J CRIT CARE, V25, P205, DOI 10.1016/j.jcrc.2009.06.010; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	30	216	223	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2093	2101		10.1056/NEJMsa1201918	http://dx.doi.org/10.1056/NEJMsa1201918			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22612639	Green Accepted			2022-12-28	WOS:000304613400009
J	Hunter, JD				Hunter, John D.			Ventilator associated pneumonia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NOSOCOMIAL PNEUMONIA; ANTIBIOTIC-THERAPY; NEUTROPHIL DYSFUNCTION; DIAGNOSTIC-ACCURACY; IMPACT; INFECTIONS; PREVENTION; GUIDELINES; MANAGEMENT; RISK		Macclesfield Hosp, Dept Anaesthet & Crit Care, Macclesfield SK10 3BL, Cheshire, England		Hunter, JD (corresponding author), Macclesfield Hosp, Dept Anaesthet & Crit Care, Macclesfield SK10 3BL, Cheshire, England.	john.hunter4@nhs.net						Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Babcock HM, 2003, INFECT CONT HOSP EP, V24, P853, DOI 10.1086/502149; Berton DC, 2012, COCHRANE DB SYST REV, V1; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Dezfulian C, 2005, AM J MED, V118, P11, DOI 10.1016/j.amjmed.2004.07.051; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Dullenkopf A, 2003, INTENS CARE MED, V29, P1849, DOI 10.1007/s00134-003-1933-6; Dupont H, 2001, INTENS CARE MED, V27, P355, DOI 10.1007/s001340000640; Ely EW, 2001, CHEST, V120, p454S, DOI 10.1378/chest.120.6_suppl.454S; ESTES RJ, 1995, INTENS CARE MED, V21, P365, DOI 10.1007/BF01705418; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036; Kollef MH, 2008, JAMA-J AM MED ASSOC, V300, P805, DOI 10.1001/jama.300.7.805; KOLLEF MH, 1995, ANN INTERN MED, V122, P743, DOI 10.7326/0003-4819-122-10-199505150-00002; KOLLEF MH, 1994, CHEST, V105, P1101, DOI 10.1378/chest.105.4.1101; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lisboa T, 2008, CRIT CARE MED, V36, P166, DOI 10.1097/01.CCM.0000297886.32564.CF; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; MARQUETTE CH, 1995, AM J RESP CRIT CARE, V151, P1878, DOI 10.1164/ajrccm.151.6.7767535; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; Melsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33; Miller MA, 2011, J CRIT CARE, V26, P280, DOI 10.1016/j.jcrc.2010.05.035; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Morris AC, 2011, BLOOD, V117, P5178, DOI 10.1182/blood-2010-08-304667; Morris AC, 2009, AM J RESP CRIT CARE, V180, P19, DOI 10.1164/rccm.200812-1928OC; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; National Institute for Health and Clinical Excellence, 2008, TECHN PAT SAF SOL VE; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Palazzo SJ, 2011, HEART LUNG, V40, P293, DOI 10.1016/j.hrtlng.2010.11.003; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Stolz D, 2009, EUR RESPIR J, V34, P1364, DOI 10.1183/09031936.00053209; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; TORRES A, 1995, AM J RESP CRIT CARE, V152, P137, DOI 10.1164/ajrccm.152.1.7599812; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Walkey AJ, 2011, CHEST, V139, P1148, DOI 10.1378/chest.10-1556; Zolfaghari PS, 2011, CRIT CARE, V15, DOI 10.1186/cc10352	47	123	125	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2012	344								e3325	10.1136/bmj.e3325	http://dx.doi.org/10.1136/bmj.e3325			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645207				2022-12-28	WOS:000304855700001
J	Fernandez-Gonzalez, R; Zallen, JA				Fernandez-Gonzalez, Rodrigo; Zallen, Jennifer A.			Feeling the Squeeze: Live-Cell Extrusion Limits Cell Density in Epithelia	CELL			English	Editorial Material							GROWTH	Tissues develop in confined volumes that can impose mechanical constraints on their growth, but it is unclear how cells respond to these limits to regulate tissue size and shape. Two papers show that overcrowding and cell deformation lead to the shedding of live cells to maintain homeostasis in epithelial cell sheets.	[Zallen, Jennifer A.] Sloan Kettering Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Fernandez-Gonzalez, Rodrigo] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Fernandez-Gonzalez, Rodrigo] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G9, Canada; [Fernandez-Gonzalez, Rodrigo] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Zallen, Jennifer A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Memorial Sloan Kettering Cancer Center	Zallen, JA (corresponding author), Sloan Kettering Inst, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	zallenj@mskcc.org	Fernandez-Gonzalez, Rodrigo/F-6145-2012	Fernandez-Gonzalez, Rodrigo/0000-0003-0770-744X	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM079340] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079340] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blankenship JT, 2001, DEVELOPMENT, V128, P5129; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025	10	7	8	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					965	967		10.1016/j.cell.2012.05.006	http://dx.doi.org/10.1016/j.cell.2012.05.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632965	Bronze, Green Accepted			2022-12-28	WOS:000304453900004
J	Bennett, MI; Graham, J; Schmidt-Hansen, M; Prettyjohns, M; Arnold, S				Bennett, Michael I.; Graham, John; Schmidt-Hansen, Mia; Prettyjohns, Matthew; Arnold, Stephanie		Guideline Dev Grp	GUIDELINES Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; CANCER		[Bennett, Michael I.] Univ Leeds, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England; [Graham, John; Schmidt-Hansen, Mia; Prettyjohns, Matthew; Arnold, Stephanie] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	University of Leeds	Bennett, MI (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England.	m.i.bennett@leeds.ac.uk	Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Taubert, Mark/0000-0003-0454-5609; Graham, John/0000-0003-3381-9787				Bennett MI, 2009, PAIN, V143, P192, DOI 10.1016/j.pain.2009.01.016; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; National Institute for Health and Clinical Excellence, 2012, SAF EFF PRESCR STRON; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007	6	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e2806	10.1136/bmj.e2806	http://dx.doi.org/10.1136/bmj.e2806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QT	22623631				2022-12-28	WOS:000304591500001
J	Kopke, S; Muhlhauser, I; Gerlach, A; Haut, A; Haastert, B; Mohler, R; Meyer, G				Koepke, Sascha; Muehlhauser, Ingrid; Gerlach, Anja; Haut, Antonie; Haastert, Burkhard; Moehler, Ralph; Meyer, Gabriele			Effect of a Guideline-Based Multicomponent Intervention on Use of Physical Restraints in Nursing Homes A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE; SINGLE-BLIND; RESIDENTS; DEMENTIA; REDUCE; STAFF; CARE; ATTITUDES	Context Despite unambiguous legal regulation and evidence for lack of effectiveness and safety, physical restraints are still frequently administered in nursing homes. Objective To reduce physical restraint prevalence in nursing homes using a guideline- and theory-based multicomponent intervention. Design, Setting, and Participants Cluster randomized controlled trial of 6 months' duration conducted in 2 German cities between February 2009 and April 2010. Nursing homes were eligible if they had 20% or more residents with physical restraints. Using external concealed randomization, 18 nursing home clusters were included in the intervention group (2283 residents) and 18 in the control group (2166 residents). Intervention The intervention was based on a specifically developed evidence-based guideline and applied the theory of planned behavior. Components were group sessions for all nursing staff; additional training for nominated key nurses; and supportive material for nurses, residents, relatives, and legal guardians. Control group clusters received standard information. Main Outcomes Measures Primary outcome was percentage of residents with physical restraints (bilateral bed rails, belts, fixed tables, and other measures limiting free body movement) at 6 months, assessed through direct unannounced observation by blinded investigators on 3 occasions during 1 day. Secondary outcomes included restraint use at 3 months, falls, fall-related fractures, and psychotropic medication prescriptions. Results All nursing homes completed the study and all residents were included in the analysis. At baseline, 30.6% of control group residents had physical restraints vs 31.5% of intervention group residents. At 6 months, rates were 29.1% vs 22.6%, respectively, a difference of 6.5% (95% CI, 0.6% to 12.4%; cluster-adjusted odds ratio, 0.71; 95% CI, 0.52 to 0.97; P = .03). All physical restraint measures were used less frequently in the intervention group. Rates were stable from 3 to 6 months. There were no statistically significant differences in falls, fall-related fractures, and psychotropic medication prescriptions. Conclusion A guideline- and theory-based multicomponent intervention compared with standard information reduced physical restraint use in nursing homes.	[Koepke, Sascha] Univ Lubeck, Inst Social Med, Nursing Res Grp, D-23538 Lubeck, Germany; [Koepke, Sascha; Muehlhauser, Ingrid; Gerlach, Anja] Univ Hamburg, Unit Hlth Sci & Educ, Hamburg, Germany; [Muehlhauser, Ingrid] Univ Hamburg, Fac Med, Hamburg, Germany; [Haut, Antonie; Moehler, Ralph; Meyer, Gabriele] Univ Witten Herdecke, Fac Hlth, Sch Nursing Sci, Witten, Germany	University of Lubeck; University of Hamburg; University of Hamburg; Witten Herdecke University	Kopke, S (corresponding author), Univ Lubeck, Inst Social Med, Nursing Res Grp, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	sascha.koepke@uksh.de	Möhler, Ralph/AAG-6862-2019	Mohler, Ralph/0000-0001-8637-7818	German Federal Ministry of Education and Research within the Nursing Research Network Northern Germany [01GT0606, 01GT0608]; German Ministry of Education and Research	German Federal Ministry of Education and Research within the Nursing Research Network Northern Germany; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by a grant from the German Federal Ministry of Education and Research within the Nursing Research Network Northern Germany (projects 01GT0606 and 01GT0608).; We thank the study coordinators, nursing staff, and participating residents of 36 nursing homes and the members of the guideline development group. We also thank research assistants Britta Blotenberg, BScN (Witten/Herdecke University), Christiane Brinkmann (University of Hamburg), Pia von Lutzau, MScN (Witten/Herdecke University), and Eva Schmidt (University of Hamburg), whose work was funded by the German Ministry of Education and Research, for assistance in data collection and administration. None of the practice partners received compensation for the contributions.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Castle NG, 2009, MED CARE, V47, P1164, DOI 10.1097/MLR.0b013e3181b58a69; Ceccato NE, 2007, J CONTIN EDUC HEALTH, V27, P201, DOI 10.1002/chp.138; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P722, DOI 10.1111/j.1532-5415.1986.tb04303.x; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dalichau G, 2002, SGB 11 STATUTORY CAR; Driessen MT, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-65; Engberg J, 2008, GERONTOLOGIST, V48, P442, DOI 10.1093/geront/48.4.442; Evans D, 2003, J ADV NURS, V41, P274, DOI 10.1046/j.1365-2648.2003.02501.x; Evans D, 2002, J ADV NURS, V40, P616, DOI 10.1046/j.1365-2648.2002.02422.x; Evans LK, 1997, J AM GERIATR SOC, V45, P675, DOI 10.1111/j.1532-5415.1997.tb01469.x; Flaherty JH, 2004, J GERONTOL A-BIOL, V59, P919; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Gulpers MJM, 2011, J AM GERIATR SOC, V59, P2029, DOI 10.1111/j.1532-5415.2011.03662.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hamers JPH, 2009, INT J NURS STUD, V46, P248, DOI 10.1016/j.ijnurstu.2008.06.007; Hamers JPH, 2005, Z GERONTOL GERIATR, V38, P19, DOI 10.1007/s00391-005-0286-x; Haut A, 2010, J NURS SCHOLARSHIP, V42, P448, DOI 10.1111/j.1547-5069.2010.01341.x; Haut Antonie, 2009, BMC Geriatr, V9, P42, DOI 10.1186/1471-2318-9-42; Haut Antonie, 2007, Pflege Z, V60, P206; Huizing AR, 2009, J AM GERIATR SOC, V57, P1139, DOI 10.1111/j.1532-5415.2009.02309.x; Kerry SM, 2001, STAT MED, V20, P377, DOI 10.1002/1097-0258(20010215)20:3<377::AID-SIM799>3.0.CO;2-N; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Koczy P, 2011, J AM GERIATR SOC, V59, P333, DOI 10.1111/j.1532-5415.2010.03278.x; Kopke S, 2008, Z EVIDENZ FORTBILD Q, V102, P45, DOI 10.1016/j.zgesun.2007.12.003; Luo HB, 2011, AM J ALZHEIMERS DIS, V26, P44, DOI 10.1177/1533317510387585; Mann Eva, 2009, BMC Geriatr, V9, P18, DOI 10.1186/1471-2318-9-18; Meyer G, 2009, J CLIN NURS, V18, P981, DOI 10.1111/j.1365-2702.2008.02460.x; Mohler R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007546.pub2; Morley JE, 2010, J NUTR HEALTH AGING, V14, P586, DOI 10.1007/s12603-010-0039-4; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; Richter T, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.03.007; Scottish Intercollegiate Guidelines Network, SIGN 50 GUID DEV HDB; Testad I, 2005, INT J GERIATR PSYCH, V20, P587, DOI 10.1002/gps.1329; Testad I, 2010, J CLIN PSYCHIAT, V71, P80, DOI 10.4088/JCP.09m05486oli; Weyerer S, 2005, Z GERONTOL GERIATR, V38, P85, DOI 10.1007/s00391-005-0293-y; World Health Organization, 2005, AN THER CHEM CLASS I	37	91	97	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2177	2184		10.1001/jama.2012.4517	http://dx.doi.org/10.1001/jama.2012.4517			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945YX	22618925	Bronze			2022-12-28	WOS:000304315200027
J	Bick, AG; Calvo, SE; Mootha, VK				Bick, Alexander G.; Calvo, Sarah E.; Mootha, Vamsi K.			Evolutionary Diversity of the Mitochondrial Calcium Uniporter	SCIENCE			English	Article							RAT KIDNEY MITOCHONDRIA; PROTEIN		[Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Broad Inst, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		Bick, Alexander/0000-0001-5824-9595	NIH [R01GM077465, R01GM097136, T32GM007753-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097136, T32GM007753, R01GM077465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Pringle, K. Zimmerman, E. Koonin, and E. Lander for critical reading of the manuscript. Protein sequences were obtained from the KEGG Organisms Database, Release 58, or the Origins of Multicellularity Sequencing Project at the Broad Institute. This work was supported by NIH funds (R01GM077465 and R01GM097136 to V.K.M. and T32GM007753-33 to A.G.B.). Alignments and tree available at TreeBASE (accession S12416).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670	7	124	128	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					886	886		10.1126/science.1214977	http://dx.doi.org/10.1126/science.1214977			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605770	Green Accepted			2022-12-28	WOS:000304145600056
J	Kesselheim, AS; Karlawish, J				Kesselheim, Aaron S.; Karlawish, Jason			Biomarkers Unbound - The Supreme Court's Ruling on Diagnostic-Test Patents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Karlawish, Jason] Univ Penn, Dept Med, Ctr Neurosci & Soc, Alzheimers Dis Ctr, Philadelphia, PA 19104 USA; [Karlawish, Jason] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Kesselheim AS, 2006, NEW ENGL J MED, V355, P2036, DOI 10.1056/NEJMhpr063626; Williams H. L., 2010, W16213 NAT BUR EC RE	2	10	10	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2338	2340		10.1056/NEJMp1204164	http://dx.doi.org/10.1056/NEJMp1204164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961GH	22621421	Green Published			2022-12-28	WOS:000305451700002
J	Walker, G; Venkatachalam, P; Bird, J; Wilson, D; Probert, C				Walker, Gareth; Venkatachalam, Prathima; Bird, Jennifer; Wilson, David; Probert, Chris			Mixed fortunes in the treatment of Crohn's disease	LANCET			English	Editorial Material									[Walker, Gareth; Probert, Chris] Univ Hosp Bristol Trust, Bristol Royal Infirm, Dept Gastroenterol, Bristol, Avon, England; [Venkatachalam, Prathima; Bird, Jennifer] Univ Hosp Bristol Trust, Bristol Royal Infirm, Dept Haematol, Bristol, Avon, England; [Wilson, David] Univ Hosp Bristol Trust, Bristol Royal Infirm, Dept Radiol, Bristol, Avon, England	Bristol Royal Infirmary; Bristol Royal Infirmary; Bristol Royal Infirmary	Walker, G (corresponding author), Frenchay Hosp, Dept Gastroenterol, Frenchay Pk Rd, Bristol BS16 1LE, Avon, England.	gareth.walker@nhs.net		Probert, Christopher/0000-0003-4550-0239				Behr MA, 2010, LANCET, V376, P202, DOI 10.1016/S0140-6736(10)60282-6; Burt RK, 2010, BLOOD, V116, P6123, DOI 10.1182/blood-2010-06-292391; LARVOL L, 1994, NEW ENGL J MED, V331, P883, DOI 10.1056/NEJM199409293311321; Leiper K, 2011, GUT, V60, P1520, DOI 10.1136/gut.2010.225482; Papadakis KA, 2003, GASTROENTEROLOGY, V124, P583, DOI 10.1053/gast.2003.50081	5	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2212	2212		10.1016/S0140-6736(12)60359-6	http://dx.doi.org/10.1016/S0140-6736(12)60359-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682468				2022-12-28	WOS:000304990900038
J	Wilken, T; Lo Curto, G; Probst, RA; Steinmetz, T; Manescau, A; Pasquini, L; Hernandez, JIG; Rebolo, R; Hansch, TW; Udem, T; Holzwarth, R				Wilken, Tobias; Lo Curto, Gaspare; Probst, Rafael A.; Steinmetz, Tilo; Manescau, Antonio; Pasquini, Luca; Gonzalez Hernandez, Jonay I.; Rebolo, Rafael; Haensch, Theodor W.; Udem, Thomas; Holzwarth, Ronald			A spectrograph for exoplanet observations calibrated at the centimetre-per-second level	NATURE			English	Article							EXTRA-SOLAR PLANETS; RADIAL-VELOCITY MEASUREMENTS; LASER FREQUENCY COMBS; ASTRONOMICAL SPECTROGRAPHS; HARPS SEARCH; ASTRO-COMB; PRECISION; DECELERATION; METROLOGY	The best spectrographs are limited in stability by their calibration light source(1). Laser frequency combs are the ideal calibrators for astronomical spectrographs(2). They emit a spectrum of lines that are equally spaced in frequency(3) and that are as accurate and stable as the atomic clock relative to which the comb is stabilized. Absolute calibration(4) provides the radial velocity of an astronomical object relative to the observer (on Earth). For the detection of Earth-mass exoplanets(5,6) in Earth-like orbits around solar-type stars, or of cosmic acceleration(7-9), the observable is a tiny velocity change of less than 10 cm s(-1), where the repeatability of the calibration-the variation in stability across observations-is important. Hitherto, only laboratory systems(10-12) or spectrograph calibrations of limited performance(4,13,14) have been demonstrated. Here we report the calibration of an astronomical spectrograph with a short-term Doppler shift repeatability of 2.5 cm s(-1), and use it to monitor the star HD75289 and recompute the orbit of its planet. This repeatability should make it possible to detect Earth-like planets in the habitable zone of star or even to measure the cosmic acceleration directly.	[Wilken, Tobias; Probst, Rafael A.; Steinmetz, Tilo; Haensch, Theodor W.; Udem, Thomas; Holzwarth, Ronald] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Wilken, Tobias; Steinmetz, Tilo; Holzwarth, Ronald] Menlo Syst GmbH, D-82152 Martinsried, Germany; [Lo Curto, Gaspare; Manescau, Antonio; Pasquini, Luca] European So Observ, D-85748 Garching, Germany; [Gonzalez Hernandez, Jonay I.; Rebolo, Rafael] Inst Astrofis Canarias, E-38205 San Cristobal la Laguna, Spain; [Gonzalez Hernandez, Jonay I.; Rebolo, Rafael] Univ La Laguna, Dept Astrofis, E-38206 San Cristobal la Laguna, Spain; [Rebolo, Rafael] CSIC, E-28006 Madrid, Spain	Max Planck Society; Menlo Systems GmbH; European Southern Observatory; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC)	Wilken, T (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	tobias.wilken@mpq.mpg.de; rlh@mpq.mpg.de	Rebolo, Rafael/S-1563-2019; Hernández, Jonay I. González/L-3556-2014; Curto, Gaspare Lo/AAB-2630-2021	Hernández, Jonay I. González/0000-0002-0264-7356; Rebolo, Rafael/0000-0003-3767-7085	Max Planck Foundation	Max Planck Foundation(Max Planck Society)	We would like to thank the staff at La Silla Observatory for their support during our campaigns; S. Stark, H. Hundertmark and P. St J. Russell for supplying us with the tapered PCF; C. Lovis, B. Chazelas and F. Pepe for discussions and help with the data reduction; and C. Buggle and A. Thaller for engineering support. T. W. H. acknowledges support from the Max Planck Foundation.	Baranne A, 1996, ASTRON ASTROPHYS SUP, V119, P373, DOI 10.1051/aas:1996251; BARNES JA, 1971, IEEE T INSTRUM MEAS, VIM20, P105, DOI 10.1109/TIM.1971.5570702; Benedick AJ, 2010, OPT EXPRESS, V18, P19175, DOI 10.1364/OE.18.019175; Braje DA, 2008, EUR PHYS J D, V48, P57, DOI 10.1140/epjd/e2008-00099-9; Chang GQ, 2010, OPT EXPRESS, V18, P12736, DOI 10.1364/OE.18.012736; Drever R. W., 1983, APPL PHYS B, V31, P97; Li CH, 2008, NATURE, V452, P610, DOI 10.1038/nature06854; Liske J, 2008, MON NOT R ASTRON SOC, V386, P1192, DOI 10.1111/j.1365-2966.2008.13090.x; Lo Curto G, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913523; Loeb A, 1998, ASTROPHYS J, V499, pL111, DOI 10.1086/311375; Lovis C, 2007, ASTRON ASTROPHYS, V468, P1115, DOI 10.1051/0004-6361:20077249; Mayor M., 2003, MESSENGER, V114, P20; Murphy MT, 2007, MON NOT R ASTRON SOC, V380, P839, DOI 10.1111/j.1365-2966.2007.12147.x; Quinlan F, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3436638; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; SANDAGE A, 1962, ASTROPHYS J, V136, P319, DOI 10.1086/147385; Stark SP, 2011, OPT EXPRESS, V19, P15690, DOI 10.1364/OE.19.015690; Steinmetz T, 2009, APPL PHYS B-LASERS O, V96, P251, DOI 10.1007/s00340-009-3374-6; Steinmetz T, 2008, SCIENCE, V321, P1335, DOI 10.1126/science.1161030; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; Udry S, 2000, ASTRON ASTROPHYS, V356, P590; Wilken T, 2010, MON NOT R ASTRON SOC, V405, pL16, DOI 10.1111/j.1745-3933.2010.00850.x; Wilken T., 2011, P 2011 C LAS EL IEEE	24	180	189	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					611	614		10.1038/nature11092	http://dx.doi.org/10.1038/nature11092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660320				2022-12-28	WOS:000304608000041
J	Jain, M; Nilsson, R; Sharma, S; Madhusudhan, N; Kitami, T; Souza, AL; Kafri, R; Kirschner, MW; Clish, CB; Mootha, VK				Jain, Mohit; Nilsson, Roland; Sharma, Sonia; Madhusudhan, Nikhil; Kitami, Toshimori; Souza, Amanda L.; Kafri, Ran; Kirschner, Marc W.; Clish, Clary B.; Mootha, Vamsi K.			Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation	SCIENCE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; EXPRESSION SIGNATURE; DEPENDENCE; PATHWAY; SCREEN	Metabolic reprogramming has been proposed to be a hallmark of cancer, yet a systematic characterization of the metabolic pathways active in transformed cells is currently lacking. Using mass spectrometry, we measured the consumption and release ( CORE) profiles of 219 metabolites from media across the NCI-60 cancer cell lines, and integrated these data with a preexisting atlas of gene expression. This analysis identified glycine consumption and expression of the mitochondrial glycine biosynthetic pathway as strongly correlated with rates of proliferation across cancer cells. Antagonizing glycine uptake and its mitochondrial biosynthesis preferentially impaired rapidly proliferating cells. Moreover, higher expression of this pathway was associated with greater mortality in breast cancer patients. Increased reliance on glycine may represent a metabolic vulnerability for selectively targeting rapid cancer cell proliferation.	[Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Souza, Amanda L.; Clish, Clary B.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Kafri, Ran; Kirschner, Marc W.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jain, Mohit] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Nilsson, Roland] Karolinska Inst, Dept Med, Unit Computat Med, S-17176 Stockholm, Sweden; [Sharma, Sonia] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; La Jolla Institute for Immunology	Mootha, VK (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Clish, Clary/AAB-7124-2019; Kitami, Toshimori/N-7460-2019; Clish, Clary B/ABB-9374-2021; Nilsson, Roland/AAJ-3519-2021	Kitami, Toshimori/0000-0001-8418-5230; Clish, Clary B/0000-0001-8259-9245; Nilsson, Roland/0000-0002-6020-7498	NIH [K08HL107451, R01DK081457]; Knut & Alice Wallenberg Foundation; Stockholm County (SLL) [01626-2009]; Leukemia & Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County (SLL); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. R. Golub, O. Shaham, S. B. Vafai, and L. Strittmatter for scientific discussions and feedback; X. Cao for assistance with glucose and lactate measurements; the Broad Institute RNAi Platform for shRNA reagents; D. Gomez-Cabrero for assistance with multidimensional scaling; A. Ploner and P. Dickman for assistance with survival analysis; W. C. Kopp, S. L. Holbeck, K. Gill, and P. Sellers of the Developmental Therapeutics Program, National Cancer Institute, for reagents and assistance with cell culture; and T. Hasaka of the Broad Institute for assistance with imaging studies. Supported by NIH grant K08HL107451 (M.J.), a postdoctoral scholarship from the Knut & Alice Wallenberg Foundation and Stockholm County (SLL) grant 01626-2009 (R.N.), a Special Fellow award from the Leukemia & Lymphoma Society (S. S.), and NIH grant R01DK081457 and a gift from the Nestle Research Center (V. K. M.). The full metabolite CORE profiling data set is available in the supplementary materials as well as through the NCI Molecular Targets data repository (http://dtp.nci.nih.gov/mtargets/download.html). M.J. and R.N. conceived and performed all experiments, collected and analyzed experimental data, and prepared the manuscript. S. S. assisted with cell culture, RNAi, and T lymphocyte experiments. N.M. and T. K. assisted with cell culture and imaging-based experiments. A. L. S. and C. B. C. performed LC-MS/MS profiling experiments and provided experimental feedback. R. K. and M. W. K. performed cell cycle studies. V. K. M. conceived all experiments, reviewed all experimental data, and prepared the manuscript. All authors have discussed the results and reviewed the manuscript. All authors declare no competing financial interests.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OConnor PM, 1997, CANCER RES, V57, P4285; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	29	936	988	10	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1040	1044		10.1126/science.1218595	http://dx.doi.org/10.1126/science.1218595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628656	Green Accepted			2022-12-28	WOS:000304406800047
J	Ghorob, A; Bodenheimer, T				Ghorob, Amireh; Bodenheimer, Thomas			Sharing the Care to Improve Access to Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ghorob, Amireh; Bodenheimer, Thomas] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ghorob, A (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.							[Anonymous], 2011, ACC HLTH CAR MASS IM; [Anonymous], 2011, WHY NOT BEST; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Murray Mark, 2007, Fam Pract Manag, V14, P44; Yarnall KSH, 2009, PREV CHRONIC DIS, V6	5	93	93	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1955	1957		10.1056/NEJMp1202775	http://dx.doi.org/10.1056/NEJMp1202775			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946LL	22621625				2022-12-28	WOS:000304353000005
J	Gibney, GT; Sondak, VK				Gibney, Geoffrey T.; Sondak, Vernon K.			Extending the reach of BRAF-targeted cancer therapy	LANCET			English	Editorial Material							METASTATIC MELANOMA; SURVIVAL; VEMURAFENIB		[Gibney, Geoffrey T.; Sondak, Vernon K.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA; [Gibney, Geoffrey T.; Sondak, Vernon K.] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL USA; [Sondak, Vernon K.] Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sondak, VK (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA.	vernon.sondak@moffitt.org						Agarwala SS, 2004, J CLIN ONCOL, V22, P2101, DOI 10.1200/JCO.2004.11.044; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies MA, 2011, CANCER-AM CANCER SOC, V117, P1687, DOI 10.1002/cncr.25634; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Ewend Matthew G, 2008, J Natl Compr Canc Netw, V6, P505; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Guirguis LM, 2002, J IMMUNOTHER, V25, P82, DOI 10.1097/00002371-200201000-00009; Hong JJ, 2010, CLIN CANCER RES, V16, P4892, DOI 10.1158/1078-0432.CCR-10-1507; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; Mornex F, 2003, MELANOMA RES, V13, P97, DOI 10.1097/00008390-200302000-00016; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302	12	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1858	1859		10.1016/S0140-6736(12)60610-2	http://dx.doi.org/10.1016/S0140-6736(12)60610-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22608322				2022-12-28	WOS:000304194200007
J	Atran, S; Ginges, J				Atran, Scott; Ginges, Jeremy			RELIGIOUS AND SACRED IMPERATIVES IN HUMAN CONFLICT	SCIENCE			English	Editorial Material							EVOLUTION; VALUES; BELIEF	Religion, in promoting outlandish beliefs and costly rituals, increases ingroup trust but also may increase mistrust and conflict with outgroups. Moralizing gods emerged over the last few millennia, enabling large-scale cooperation, and sociopolitical conquest even without war. Whether for cooperation or conflict, sacred values, like devotion to God or a collective cause, signal group identity and operate as moral imperatives that inspire nonrational exertions independent of likely outcomes. In conflict situations, otherwise mundane sociopolitical preferences may become sacred values, acquiring immunity to material incentives. Sacred values sustain intractable conflicts that defy "business-like" negotiation, but also provide surprising opportunities for resolution.	[Atran, Scott] Inst Jean Nicod, CNRS, F-75005 Paris, France; [Atran, Scott] Univ Michigan, Ann Arbor, MI 48106 USA; [Atran, Scott] CUNY John Jay Coll Criminal Justice, New York, NY 10019 USA; [Ginges, Jeremy] New Sch Social Res, New York, NY 10011 USA	Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); The New School	Atran, S (corresponding author), Inst Jean Nicod, CNRS, 29 Rue Ulm, F-75005 Paris, France.	satran@umich.edu; gingesj@newschool.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378	U.S. Department of Defense (Air Force Office of Scientific Research, Office of Naval Research, Army Research Office); NSF; Direct For Social, Behav & Economic Scie [0827313] Funding Source: National Science Foundation	U.S. Department of Defense (Air Force Office of Scientific Research, Office of Naval Research, Army Research Office); NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the U.S. Department of Defense (Air Force Office of Scientific Research, Office of Naval Research, Army Research Office) and NSF for support.	[Anonymous], 2011, US GOV EFF COUNT VIO; Atran S, 2008, NEGOTIATION J, V24, P221, DOI 10.1111/j.1571-9979.2008.00182.x; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Atran Scott., 2008, NATIVE MIND CULTURAL; Bader C, 1999, J SCI STUD RELIG, V38, P119, DOI 10.2307/1387588; Berns GS, 2012, PHILOS T R SOC B, V367, P754, DOI 10.1098/rstb.2011.0262; Bloom P, 2012, ANNU REV PSYCHOL, V63, P179, DOI 10.1146/annurev-psych-120710-100334; Boyd R, 2005, ORIGIN EVOLUTION CUL; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Bulbulia J, 2011, RELIGION, V41, P363, DOI 10.1080/0048721X.2011.604508; Dawkins R., 2007, 4 HORSEMEN; Dehghani M, 2010, JUDGM DECIS MAK, V5, P540; Ginges J, 2011, AM PSYCHOL, V66, P507, DOI 10.1037/a0024715; Ginges J, 2009, PSYCHOL SCI, V20, P224, DOI 10.1111/j.1467-9280.2009.02270.x; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Kay AC, 2010, PERS SOC PSYCHOL REV, V14, P37, DOI 10.1177/1088868309353750; Marcus J, 2004, P NATL ACAD SCI USA, V101, P18257, DOI 10.1073/pnas.0408551102; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norris P., 2004, SECULAR SACRED; Phillips C., 2007, ENCY WARS; Roes FL, 2003, EVOL HUM BEHAV, V24, P126, DOI 10.1016/S1090-5138(02)00134-4; Schama S., 2009, AM FUTURE; Sheikh H, 2012, JUDGM DECIS MAK, V7, P110; Stark R., 1997, RISE CHRISTIANITY; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; Whitehouse Harvey, 2004, MODES RELIG; Wilson David Sloan., 2002, DARWINS CATHEDRAL	27	157	160	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					855	857		10.1126/science.1216902	http://dx.doi.org/10.1126/science.1216902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605762				2022-12-28	WOS:000304145600048
J	Shaw, RJ; Cantley, LC				Shaw, Reuben J.; Cantley, Lewis C.			Ancient Sensor for Ancient Drug	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; ENERGY SENSOR; AMPK; MECHANISM; A-769662		[Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Howard Hughes Medical Institute; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	shaw@salk.edu; lewis_cantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA172229] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA172229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2012, SCIENCE, V335, P29, DOI 10.1126/science.335.6064.29; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	14	13	14	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					813	814		10.1126/science.1223140	http://dx.doi.org/10.1126/science.1223140			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605741				2022-12-28	WOS:000304145600029
J	Marrero, SL; Bloom, DE; Adashi, EY				Marrero, Shannon L.; Bloom, David E.; Adashi, Eli Y.			Noncommunicable Diseases A Global Health Crisis in a New World Order	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Dept Med Sci, Providence, RI 02905 USA; [Bloom, David E.] Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Brown University; Harvard University; Harvard T.H. Chan School of Public Health	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Med Sci, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu						[Anonymous], 2011, COMMUNICATION    SEP; Bloom DE, 2011, GLOBAL EC BURDEN NON; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nugent RA, 2010, 228 CTR GLOB DEV; Organization WH, 2016, GLOBAL STATUS REPORT; United Nations, 2011, 1 M UN FUNDS PROGR A; United Nations General Assembly (UNGA), 2011, POL DECL HIGH LEV M; United Nations General Assembly (UNGA), HIGH LEV M PREV CONT; United Nations Security Council, 2000, SEC COUNC 4172 M JUL; World Health Organization, DOH DECL TRIPS AGR P	10	44	44	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2037	2038		10.1001/jama.2012.3546	http://dx.doi.org/10.1001/jama.2012.3546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665101				2022-12-28	WOS:000304048200021
J	Schindewolf, M; Lindhoff-Last, E; Ludwig, RJ; Boehncke, WH				Schindewolf, Marc; Lindhoff-Last, Edelgard; Ludwig, Ralf J.; Boehncke, Wolf-Henning			Heparin-induced skin lesions	LANCET			English	Review							LOW-MOLECULAR-WEIGHT; DELAYED-TYPE HYPERSENSITIVITY; INDUCED THROMBOCYTOPENIA; SUBCUTANEOUS INJECTIONS; IN-VITRO; VENOUS THROMBOEMBOLISM; CALCINOSIS CUTIS; INTRAVENOUS CHALLENGE; CROSS-REACTIVITY; RECALL URTICARIA	Heparins are widely used for prophylaxis and treatment of thromboembolic diseases. Besides bleeding complications, heparin-induced skin lesions are the most frequent unwanted adverse effects of subcutaneous heparin treatment. Evidence suggests that these lesions are more common than previously thought. Lesions are most frequently due to either allergic reactions or to possibly life-threatening heparin-induced thrombocytopenia. Early recognition and adequate treatment are highly important, because although both complications initially show a similar clinical picture, their treatment should be fundamentally different. Furthermore, risk factors associated with the patient, drug, and treatment regimen have been identified. We review the clinical range of heparin-induced skin lesions, emphasise evidence and controversies in epidemiology, diagnosis, and differential diagnosis, and discuss the management of patients with these skin lesions.	[Ludwig, Ralf J.] Med Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany; [Schindewolf, Marc; Lindhoff-Last, Edelgard] Hosp Johann Wolfgang Goethe Univ, Div Vasc Med & Haemostaseol, Dept Internal Med, Frankfurt, Germany; [Boehncke, Wolf-Henning] Hosp Johann Wolfgang Goethe Univ, Dept Dermatol, Frankfurt, Germany	University of Lubeck; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Ludwig, RJ (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany.	ralf.ludwig@uksh.de	Ludwig, Ralf J/A-2629-2008; Ludwig, Ralf/F-3996-2018	Ludwig, Ralf J/0000-0002-1394-1737; Ludwig, Ralf/0000-0002-1394-1737	GlaxoSmithKline; Bayer; Boehringer Ingelheim; Sanofi-Aventis; Biogen-Idec; Biotest AG; Abbott-Germany; Dompe pharma; Eroimmun AG	GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Biogen-Idec(Biogen); Biotest AG; Abbott-Germany(Abbott Laboratories); Dompe pharma; Eroimmun AG	MS has received a speaking fee from GlaxoSmithKline. ELL has received consulting fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Sanofi-Aventis. RJL has received consulting fees and grants from Biogen-Idec, Biotest AG, Abbott-Germany, and grants from Dompe pharma and Eroimmun AG. WHB declares that he has no conflicts of interest.	Aberer W, 2003, ALLERGY, V58, P854, DOI 10.1034/j.1398-9995.2003.00279.x; Alban S, 2005, EUR J CLIN INVEST, V35, P12, DOI 10.1111/j.0960-135X.2005.01452.x; ALERYANI AY, 1995, THROMB RES, V79, P523, DOI 10.1016/0049-3848(95)00142-E; Bank I, 2003, J THROMB HAEMOST, V1, P859, DOI 10.1046/j.1538-7836.2003.t01-7-00115.x; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Beltraminelli H, 2009, BRIT J DERMATOL, V161, P191, DOI 10.1111/j.1365-2133.2009.09163.x; Berkun Y, 2004, CLIN EXP ALLERGY, V34, P1916, DOI 10.1111/j.1365-2222.2004.02129.x; BERNSTEIN IL, 1956, JAMA-J AM MED ASSOC, V161, P1379, DOI 10.1001/jama.1956.62970140005009b; Bertrand PM, 2011, INTENS CARE MED, V37, P172, DOI 10.1007/s00134-010-2027-x; Bircher AJ, 2006, ALLERGY, V61, P1432, DOI 10.1111/j.1398-9995.2006.01227.x; BIRCHER AJ, 1995, BRIT J DERMATOL, V132, P461, DOI 10.1111/j.1365-2133.1995.tb08684.x; BIRCHER AJ, 1994, LANCET, V343, P861, DOI 10.1016/S0140-6736(94)92067-2; Boccara O, 2010, AM J DERMATOPATH, V32, P52, DOI 10.1097/DAD.0b013e3181aec116; Boehncke WH, 1996, CONTACT DERMATITIS, V35, P73, DOI 10.1111/j.1600-0536.1996.tb02293.x; Bonnecarrere L, 2009, J MAL VASCUL, V34, P366, DOI 10.1016/j.jmv.2009.08.001; Brenner B, 2005, J THROMB HAEMOST, V3, P227, DOI 10.1111/j.1538-7836.2004.01090.x; Caliskaner Z, 2005, J INVEST ALLERG CLIN, V15, P78; Campanelli A, 2005, BRIT J DERMATOL, V153, P657, DOI 10.1111/j.1365-2133.2005.06748.x; Dave S, 2008, J CARDIAC SURG, V23, P394, DOI 10.1111/j.1540-8191.2008.00583.x; Dempfle CEH, 2004, NEW ENGL J MED, V350, P1914, DOI 10.1056/NEJM200404293501825; Deruelle P, 2006, EUR J OBSTET GYN R B, V127, P73, DOI 10.1016/j.ejogrb.2005.09.010; DUX S, 1981, LANCET, V1, P149; Eich D, 2004, J AM ACAD DERMATOL, V50, P210, DOI 10.1016/j.jaad.2003.07.018; Ensom MHH, 1999, PHARMACOTHERAPY, V19, P1013, DOI 10.1592/phco.19.13.1013.31588; Erpenbeck L, 2010, BLOOD, V115, P3427, DOI 10.1182/blood-2009-10-247296; Gaigl Z, 2005, BRIT J HAEMATOL, V128, P389, DOI 10.1111/j.1365-2141.2004.05321.x; Gallais V, 1996, PRESSE MED, V25, P1040; Garcia-Ortega P, 2010, BRIT J HAEMATOL, V151, P84, DOI 10.1111/j.1365-2141.2010.08290.x; Gerhardt A, 2007, THROMB HAEMOSTASIS, V97, P496, DOI 10.1160/TH06-10-0577; Giorgini S, 2005, INT J DERMATOL, V44, P855, DOI 10.1111/j.1365-4632.2005.02310.x; GIUSTOLISI R, 1993, LANCET, V342, P1371, DOI 10.1016/0140-6736(93)92284-Z; Grassegger A, 2001, DERMATOL SURG, V27, P47; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247; GREINACHER A, 2004, HEPARIN INDUCED THRO, P335; Grims RH, 2007, BRIT J DERMATOL, V157, P514, DOI 10.1111/j.1365-2133.2007.08007.x; Groger M, 1996, J IMMUNOL, V156, P1549; Gunukula S, 2011, COCHRANE DATABASE SY; Handschin AE, 2005, BRIT J SURG, V92, P177, DOI 10.1002/bjs.4809; Harenberg J, 1999, ALLERGY, V54, P473, DOI 10.1034/j.1398-9995.1999.00048.x; Harenberg J, 1982, PHLEBOL PROKTOL, V11, P195; Harr T, 2006, ALLERGY, V61, P787, DOI 10.1111/j.1398-9995.2006.01063.x; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hirsh J, 2008, CHEST, V133, p141S, DOI 10.1378/chest.08-0689; Hochart H, 2006, BRIT J HAEMATOL, V133, P62, DOI 10.1111/j.1365-2141.2006.05959.x; JACKSON AM, 1981, BRIT MED J, V283, P1087, DOI 10.1136/bmj.283.6299.1087-a; Jappe U, 2006, BLOOD COAGUL FIBRIN, V17, P605, DOI 10.1097/01.mbc.0000198992.18384.5a; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Koch P, 2000, CONTACT DERMATITIS, V42, P278; KOCH P, 1991, CONTACT DERMATITIS, V25, P205, DOI 10.1111/j.1600-0536.1991.tb01842.x; Koch P, 2000, J AM ACAD DERMATOL, V42, P612, DOI 10.1016/S0190-9622(00)90173-7; Komericki P, 2007, J AM ACAD DERMATOL, V57, P718, DOI 10.1016/j.jaad.2007.05.025; Lagrange F, 2002, THROMB HAEMOSTASIS, V87, P831; LEUNG A, 1985, JAMA-J AM MED ASSOC, V253, P201, DOI 10.1001/jama.1985.03350260047017; Liew Gerald, 2004, ANZ J Surg, V74, P1020, DOI 10.1111/j.1445-1433.2004.03233.x; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Lopez S, 2009, BRIT J DERMATOL, V160, P259, DOI 10.1111/j.1365-2133.2008.08875.x; Ludwig RJ, 2006, THROMB HAEMOSTASIS, V96, P611, DOI 10.1160/TH06-0B4-0210; Ludwig Ralf J, 2009, Curr Drug Discov Technol, V6, P281; Ludwig RJ, 2006, THROMB HAEMOSTASIS, V95, P535, DOI 10.1160/TH05-07-0515; Ludwig RJ, 2005, THROMB HAEMOSTASIS, V94, P1265, DOI 10.1160/TH05-05-0318; Ludwig RJ, 2003, CONTACT DERMATITIS, V49, P158, DOI 10.1111/j.0105-1873.2003.0185a.x; Nadir Y, 2006, EUR J HAEMATOL, V77, P166, DOI 10.1111/j.1600-0609.2006.00668.x; Ojukwu C, 1996, BRIT J OBSTET GYNAEC, V103, P934, DOI 10.1111/j.1471-0528.1996.tb09919.x; Parekh K, 2005, J THORAC CARDIOV SUR, V130, P1455, DOI 10.1016/j.jtcvs.2005.05.023; PATRIARCA G, 1994, ALLERGY, V49, P292, DOI 10.1111/j.1398-9995.1994.tb02663.x; Peitsch WK, 2004, HAUTARZT, V55, P410, DOI 10.1007/s00105-003-0682-3; Perrinaud A, 2006, J AM ACAD DERMATOL, V54, pS5, DOI 10.1016/j.jaad.2005.01.098; PFEIFF B, 1991, DTSCH DERMATOLOGE, V39, P559; PHILLIPS JK, 1993, BRIT J HAEMATOL, V84, P349, DOI 10.1111/j.1365-2141.1993.tb03080.x; Posadas SJ, 2007, CLIN EXP ALLERGY, V37, P989, DOI 10.1111/j.1365-2222.2007.02742.x; SANDERS MN, 1995, INT J DERMATOL, V34, P443, DOI 10.1111/j.1365-4362.1995.tb04452.x; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550; Schiffner R, 2000, CONTACT DERMATITIS, V42, P49; Schindewolf M, 2008, J EUR ACAD DERMATOL, V22, P378, DOI 10.1111/j.1468-3083.2007.02333.x; Schindewolf M, 2007, Hamostaseologie, V27, P89; Schindewolf M, 2010, PHLEBOLOGIE, V39, P226; Schindewolf M, 2010, J THROMB HAEMOST, V8, P1486, DOI 10.1111/j.1538-7836.2010.03795.x; Schindewolf M, 2010, VASA, V39, P61; Schindewolf M, 2010, MAYO CLIN PROC, V85, P913, DOI 10.4065/mcp.2010.0346; Schindewolf M, 2009, CAN MED ASSOC J, V181, P477, DOI 10.1503/cmaj.081729; Singh Sarabjeet, 2007, Am J Ther, V14, P408, DOI 10.1097/MJT.0b013e3180325905; Smith KJ, 2001, ARCH PATHOL LAB MED, V125, P1585; Taylor AA, 2001, BRIT J OBSTET GYNAEC, V108, P1011, DOI 10.1111/j.1471-0528.2001.00215.x; Thuillier D, 2009, ANN DERMATOL VENER, V136, P705, DOI 10.1016/j.annder.2008.10.037; Trautmann A, 1998, CONTACT DERMATITIS, V39, P43, DOI 10.1111/j.1600-0536.1998.tb05823.x; van Haren FMP, 2001, NEPHRON, V87, P279, DOI 10.1159/000045927; VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713; Verdonkschot A. E. M., 2005, Archives of Gynecology and Obstetrics, V271, P163, DOI 10.1007/s00404-004-0615-0; Warkentin TE, 2010, J THROMB HAEMOST, V8, P1483, DOI 10.1111/j.1538-7836.2010.03880.x; Warkentin TE, 1996, BRIT J HAEMATOL, V92, P494, DOI 10.1046/j.1365-2141.1996.d01-1481.x; Warkentin TE, 2001, ANN INTERN MED, V135, P502, DOI 10.7326/0003-4819-135-7-200110020-00009; Warkentin TE, 2005, CHEST, V127, P1857, DOI 10.1378/chest.127.5.1857; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; Warkentin TE, 2004, HEPARIN INDUCED THRO, P53; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Warkentin TE, 2006, BLOOD, V108, P2937, DOI 10.1182/blood-2005-11-012450; Warkentin TE, 2009, EXPERT OPIN DRUG SAF, V8, P129, DOI [10.1517/14740330902778180, 10.1517/14740330902778180 ]; Weber HO, 2009, BRIT J DERMATOL, V161, P187, DOI 10.1111/j.1365-2133.2009.09150.x	101	62	64	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1867	1879		10.1016/S0140-6736(12)60409-7	http://dx.doi.org/10.1016/S0140-6736(12)60409-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	22642893				2022-12-28	WOS:000311435000033
J	Rao, CPV; Suarez, JI				Rao, Chethan P. Venkatasubba; Suarez, Jose I.			Magnesium and neuroprotection in subarachnoid haemorrhage	LANCET			English	Editorial Material							DELAYED CEREBRAL-ISCHEMIA; SULFATE		[Rao, Chethan P. Venkatasubba; Suarez, Jose I.] Baylor Coll Med, Dept Neurol, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA	Baylor College of Medicine	Suarez, JI (corresponding author), Baylor Coll Med, Dept Neurol, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA.	jisuarez@bcm.edu						Al-Tamimi YZ, 2010, WORLD NEUROSURG, V73, P654, DOI 10.1016/j.wneu.2010.02.005; Bruder N, 2011, NEUROCRIT CARE, V15, P257, DOI 10.1007/s12028-011-9598-4; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000277.pub3; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2004, MAGNESIUM RES, V17, P301; Vespa P, 2011, NEUROCRIT CARE, V15, P361, DOI 10.1007/s12028-011-9587-7; Vespa P, 2011, NEUROCRIT CARE, V15, P295, DOI 10.1007/s12028-011-9599-3; Washington CW, 2011, NEUROCRIT CARE, V15, P312, DOI 10.1007/s12028-011-9594-8; Wong GKC, 2011, CRIT CARE, V15, DOI 10.1186/cc10017	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					9	11		10.1016/S0140-6736(12)60784-3	http://dx.doi.org/10.1016/S0140-6736(12)60784-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970GK	22633826				2022-12-28	WOS:000306115900008
J	Iliev, ID; Funari, VA; Taylor, KD; Nguyen, Q; Reyes, CN; Strom, SP; Brown, J; Becker, CA; Fleshner, PR; Dubinsky, M; Rotter, JI; Wang, HLL; McGovern, DPB; Brown, GD; Underhill, DM				Iliev, Iliyan D.; Funari, Vincent A.; Taylor, Kent D.; Quoclinh Nguyen; Reyes, Christopher N.; Strom, Samuel P.; Brown, Jordan; Becker, Courtney A.; Fleshner, Phillip R.; Dubinsky, Marla; Rotter, Jerome I.; Wang, Hanlin L.; McGovern, Dermot P. B.; Brown, Gordon D.; Underhill, David M.			Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDA-ALBICANS; GUT MICROBIOTA; INDUCTION; SUSCEPTIBILITY; RECOGNITION; RESPONSES; CELLS; MICE	The intestinal microflora, typically equated with bacteria, influences diseases such as obesity and inflammatory bowel disease. Here, we show that the mammalian gut contains a rich fungal community that interacts with the immune system through the innate immune receptor Dectin-1. Mice lacking Dectin-1 exhibited increased susceptibility to chemically induced colitis, which was the result of altered responses to indigenous fungi. In humans, we identified a polymorphism in the gene for Dectin-1 (CLEC7A) that is strongly linked to a severe form of ulcerative colitis. Together, our findings reveal a eukaryotic fungal community in the gut (the "mycobiome") that coexists with bacteria and substantially expands the repertoire of organisms interacting with the intestinal immune system to influence health and disease.	[Iliev, Iliyan D.; Reyes, Christopher N.; Becker, Courtney A.; Dubinsky, Marla; McGovern, Dermot P. B.; Underhill, David M.] Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Funari, Vincent A.; Taylor, Kent D.; Quoclinh Nguyen; Strom, Samuel P.; Brown, Jordan; Rotter, Jerome I.; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Fleshner, Phillip R.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Wang, Hanlin L.; Underhill, David M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Div Appl Med, Sect Immunol & Infect, Aberdeen AB24 2ZD, Scotland; [Brown, Gordon D.] Univ Aberdeen, Aberdeen Fungal Grp, Aberdeen AB24 2ZD, Scotland; [Underhill, David M.] Cedars Sinai Med Ctr, Div Immunol Res, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Aberdeen; University of Aberdeen; Cedars Sinai Medical Center	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	Strom, Samuel/C-8692-2014; Rotter, Jerome/AAY-6598-2021; UNDERHILL, DAVID/ABE-2185-2021	Strom, Samuel/0000-0003-3254-7564; brown, gordon/0000-0002-0287-5383; Underhill, David/0000-0002-2989-658X	National Institute of Allergy and Infectious Diseases, NIH [AI071116]; Janis and William Wetsman Family Chair in Inflammatory Bowel Disease Research; Crohn's and Colitis Foundation of America [3064]; National Institute of Diabetes and Digestive and Kidney Diseases, NIH [P01-DK046763]; UCLA Clinical and Translational Science Institute [UL1RR033176]; Cedars-Sinai Medical Center Inflammatory Bowel and Immunobiology Research Institute; Feintech Family Chair in IBD; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Abe and Claire Levine Chair in Pediatric IBD; Joshua L. and Lisa Z. Greer Chair in IBD Genetics; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R01DK093426] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Janis and William Wetsman Family Chair in Inflammatory Bowel Disease Research; Crohn's and Colitis Foundation of America; National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCLA Clinical and Translational Science Institute; Cedars-Sinai Medical Center Inflammatory Bowel and Immunobiology Research Institute; Feintech Family Chair in IBD; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Abe and Claire Levine Chair in Pediatric IBD; Joshua L. and Lisa Z. Greer Chair in IBD Genetics; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by the National Institute of Allergy and Infectious Diseases, NIH (AI071116 to D.M.U.) and the Janis and William Wetsman Family Chair in Inflammatory Bowel Disease Research (D.M.U.). I.D.I. held a Research Fellowship Award (3064) from the Crohn's and Colitis Foundation of America. Further support came from National Institute of Diabetes and Digestive and Kidney Diseases, NIH, grant P01-DK046763; UCLA Clinical and Translational Science Institute grant UL1RR033176; Cedars-Sinai Medical Center Inflammatory Bowel and Immunobiology Research Institute Funds; The Feintech Family Chair in IBD (S. R. Targan); The Cedars-Sinai Board of Governors' Chair in Medical Genetics (J.I.R.); The Abe and Claire Levine Chair in Pediatric IBD (M.D.); and The Joshua L. and Lisa Z. Greer Chair in IBD Genetics (D.M.). G.D.B. is supported by the Wellcome Trust. Clec7a<SUP>-/-</SUP> mice are available through a Material Transfer Agreement with the University of Aberdeen. The data presented in this paper are tabulated in the main paper and in the supplementary materials. All sequences generated in this study have been deposited in the National Center for Biotechnology Information, NIH, Short Read Archive (www.ncbi.nlm.nih.gov/Traces/sra, accession no. SRA051853.1). G.D.B. is an advisory board member of MiniVax and Fiberbiotics. M.D. is a consultant for Prometheus Labs.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Haritunians T, 2010, INFLAMM BOWEL DIS, V16, P1830, DOI 10.1002/ibd.21293; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Joossens S, 2002, GASTROENTEROLOGY, V122, P1242, DOI 10.1053/gast.2002.32980; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049	25	691	717	8	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1314	1317		10.1126/science.1221789	http://dx.doi.org/10.1126/science.1221789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674328	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000304905300049
J	Martin, SJ; Highfield, AC; Brettell, L; Villalobos, EM; Budge, GE; Powell, M; Nikaido, S; Schroeder, DC				Martin, Stephen J.; Highfield, Andrea C.; Brettell, Laura; Villalobos, Ethel M.; Budge, Giles E.; Powell, Michelle; Nikaido, Scott; Schroeder, Declan C.			Global Honey Bee Viral Landscape Altered by a Parasitic Mite	SCIENCE			English	Article							DEFORMED-WING-VIRUS; APIS-MELLIFERA L.; COLONY COLLAPSE DISORDER; VARROA-DESTRUCTOR; TRANSMISSION; POPULATIONS; PREVALENCE; INFECTION	Emerging diseases are among the greatest threats to honey bees. Unfortunately, where and when an emerging disease will appear are almost impossible to predict. The arrival of the parasitic Varroa mite into the Hawaiian honey bee population allowed us to investigate changes in the prevalence, load, and strain diversity of honey bee viruses. The mite increased the prevalence of a single viral species, deformed wing virus (DWV), from similar to 10 to 100% within honey bee populations, which was accompanied by a millionfold increase in viral titer and a massive reduction in DWV diversity, leading to the predominance of a single DWV strain. Therefore, the global spread of Varroa has selected DWV variants that have emerged to allow it to become one of the most widely distributed and contagious insect viruses on the planet.	[Martin, Stephen J.; Brettell, Laura] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Highfield, Andrea C.; Schroeder, Declan C.] Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England; [Villalobos, Ethel M.; Nikaido, Scott] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Budge, Giles E.; Powell, Michelle] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England	University of Sheffield; Marine Biological Association United Kingdom; University of Hawaii System; University of Hawaii Manoa; Food & Environment Research Agency	Martin, SJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	s.j.martin@sheffield.ac.uk; dsch@mba.ac.uk	martin, stephen/B-5254-2009; Schroeder, Declan C./O-9131-2019	Schroeder, Declan C./0000-0001-5991-2838; Martin, Stephen/0000-0001-9418-053X; Brettell, Laura/0000-0002-6050-4804	Natural Environment Research Council [NE/H013164/1]; Organisation for Economic Co-operation and Development; C. B. Dennis Trust; Waterloo foundation; Defra; Welsh Assembly Government; U.S. Department of Agriculture's National Institute of Food and Agriculture Tropical and Subtropical Agricultural Research (TSTAR) [2010-34135-21499]; Hawaii Department of Agriculture; Natural Environment Research Council [MBA010001] Funding Source: researchfish; NERC [NE/H013164/1, MBA010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Organisation for Economic Co-operation and Development; C. B. Dennis Trust; Waterloo foundation; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Welsh Assembly Government; U.S. Department of Agriculture's National Institute of Food and Agriculture Tropical and Subtropical Agricultural Research (TSTAR); Hawaii Department of Agriculture; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all the Hawaiian beekeepers that participated in this study and D. Jackson of Sheffield University and C. Godfray of Oxford University for comments. S.J.M. and L.B. were funded by a Natural Environment Research Council urgency grant (NE/H013164/1), an Organisation for Economic Co-operation and Development fellowship, and the C. B. Dennis Trust. G.E.B. and M.P. were funded by a grant from the Waterloo foundation with support from Defra and the Welsh Assembly Government. D.C.S. and A.C.H. were funded by the C. B. Dennis Trust. S.N. and E.M.V. were funded by the U.S. Department of Agriculture's National Institute of Food and Agriculture Tropical and Subtropical Agricultural Research (TSTAR) Program (grant no. 2010-34135-21499) and by support from the Hawaii Department of Agriculture. The data are available in the DRYAD depository at http://dx.doi.org/10.5061/dryad.d54cc.	Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Blaustein AR, 2010, NATURE, V465, P881, DOI 10.1038/465881a; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Martin S, 1998, APIDOLOGIE, V29, P369, DOI 10.1051/apido:19980407; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2010, AM BEE J, V150, P381; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Roddy K.M., 1997, J HAWAIIAN PACIFIC A, V8, P59; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Waage JK, 2008, PHILOS T R SOC B, V363, P863, DOI 10.1098/rstb.2007.2188; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	27	421	439	12	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1304	1306		10.1126/science.1220941	http://dx.doi.org/10.1126/science.1220941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679096				2022-12-28	WOS:000304905300046
J	Nicholson, JK; Holmes, E; Kinross, J; Burcelin, R; Gibson, G; Jia, W; Pettersson, S				Nicholson, Jeremy K.; Holmes, Elaine; Kinross, James; Burcelin, Remy; Gibson, Glenn; Jia, Wei; Pettersson, Sven			Host-Gut Microbiota Metabolic Interactions	SCIENCE			English	Review							DIET-INDUCED OBESITY; CHAIN FATTY-ACIDS; HEALTH; MODULATION; MICROFLORA; MICE; INFLAMMATION; FERMENTATION; TRYPTOPHAN; ADAPTATION	The composition and activity of the gut microbiota codevelop with the host from birth and is subject to a complex interplay that depends on the host genome, nutrition, and life-style. The gut microbiota is involved in the regulation of multiple host metabolic pathways, giving rise to interactive host-microbiota metabolic, signaling, and immune-inflammatory axes that physiologically connect the gut, liver, muscle, and brain. A deeper understanding of these axes is a prerequisite for optimizing therapeutic strategies to manipulate the gut microbiota to combat disease and improve health.	[Nicholson, Jeremy K.; Holmes, Elaine; Kinross, James] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW7 2AZ, England; [Burcelin, Remy] INSERM, U1048, F-31432 Toulouse, France; [Burcelin, Remy] Hop Rangueil, Inst Malad Metab & Cardiovasc I2MC, F-31432 Toulouse, France; [Gibson, Glenn] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Jia, Wei] Univ N Carolina Greensboro, Dept Nutr, Kannapolis, NC 28081 USA; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-11777 Stockholm, Sweden; [Pettersson, Sven] Nanyang Technol Univ, Sch Biol Sci, Singapore 169610, Singapore; [Pettersson, Sven] Natl Canc Ctr, Singapore 169610, Singapore	Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; University of Reading; University of North Carolina; University of North Carolina Greensboro; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Cancer Centre Singapore (NCCS)	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Exhibit Rd, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk; sven.pettersson@ki.se	Nicholson, Jeremy K/B-3395-2012; Jia, Wei/AAN-5102-2020; Holmes, Elaine/ABE-6606-2020; burcelin, remy/M-6013-2014; Holmes, Elaine/A-2189-2015; Pettersson, Sven/F-9511-2015	Nicholson, Jeremy K/0000-0002-8123-8349; Jia, Wei/0000-0002-3739-8994; Holmes, Elaine/0000-0002-0556-8389; Kinross, James/0000-0002-0427-7643	Imperial College Healthcare Trust Biomedical Research Centre; Bill and Melinda Gates Foundation; UK Medical Research Council; Wellcome Trust; Fondation Merrieux; UK Biotechnology and Biological Sciences Research Council; Tate + Lyle; Proctor and Gamble; Ganeden; Clasado; Swedish Medical Research Council; COMBINE; EU; Karolinska Institutet Inflammation Consortium; Millennium Foundation Singapore; National Cancer Centre Singapore; Nanyang Technical University; Agence Nationale de la Recherche; European Framework Program FP7; U.S. NIH [R01AA020212]; Medical Research Council [G0801056B] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020212] Funding Source: NIH RePORTER	Imperial College Healthcare Trust Biomedical Research Centre; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fondation Merrieux; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tate + Lyle; Proctor and Gamble(Procter & Gamble); Ganeden; Clasado; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); COMBINE; EU(European Commission); Karolinska Institutet Inflammation Consortium; Millennium Foundation Singapore(Singapore Millennium Foundation); National Cancer Centre Singapore; Nanyang Technical University; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Framework Program FP7; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors acknowledge funding from the following: Imperial College Healthcare Trust Biomedical Research Centre, Bill and Melinda Gates Foundation, UK Medical Research Council, The Wellcome Trust, and Fondation Merrieux (J.K.N., E.H., J.K.); UK Biotechnology and Biological Sciences Research Council, Tate + Lyle, Proctor and Gamble, Ganeden, and Clasado (G.G.); Swedish Medical Research Council, COMBINE, EU-project TORNADO, Karolinska Institutet Inflammation Consortium, The Millennium Foundation Singapore, The National Cancer Centre Singapore, and Nanyang Technical University (S.P.); Agence Nationale de la Recherche and European Framework Program FP7 (R.B.); U.S. NIH grant no. R01AA020212 (W.J.).	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; BONE E, 1976, AM J CLIN NUTR, V29, P1448, DOI 10.1093/ajcn/29.12.1448; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; GIBSON GR, 1993, FEMS MICROBIOL ECOL, V12, P117; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Grider JR, 2007, AM J PHYSIOL-GASTR L, V292, pG429, DOI 10.1152/ajpgi.00376.2006; GROH H, 1993, J BASIC MICROB, V33, P59, DOI 10.1002/jobm.3620330115; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lord RS, 2008, ALTERN MED REV, V13, P292; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Mitsou EK, 2008, ANAEROBE, V14, P94, DOI 10.1016/j.anaerobe.2007.11.002; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Qi Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011072; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ryan RP, 2009, MOL MICROBIOL, V73, P760, DOI 10.1111/j.1365-2958.2009.06822.x; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Trevisi P, 2008, NUTRITION, V24, P1023, DOI 10.1016/j.nut.2008.04.008; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yeretssian G., 2012, IMMUNOL RES; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945	69	2683	2875	102	1471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1262	1267		10.1126/science.1223813	http://dx.doi.org/10.1126/science.1223813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674330				2022-12-28	WOS:000304905300035
J	Azoulay, L; Yin, H; Filion, KB; Assayag, J; Majdan, A; Pollak, MN; Suissa, S				Azoulay, Laurent; Yin, Hui; Filion, Kristian B.; Assayag, Jonathan; Majdan, Agnieszka; Pollak, Michael N.; Suissa, Samy			The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; ACTIVATED RECEPTOR-GAMMA; URINARY-BLADDER; VALIDATION; MELLITUS; INFORMATION; AGONIST; EVENTS	Objective To determine if the use of pioglitazone is associated with an increased risk of incident bladder cancer in people with type 2 diabetes. Design Retrospective cohort study using a nested case-control analysis. Setting Over 600 general practices in the United Kingdom contributing to the general practice research database. Participants The cohort consisted of people with type 2 diabetes who were newly treated with oral hypoglycaemic agents between 1 January 1988 and 31 December 2009. All incident cases of bladder cancer occurring during follow-up were identified and matched to up to 20 controls on year of birth, year of cohort entry, sex, and duration of follow-up. Exposure was defined as ever use of pioglitazone, along with measures of duration and cumulative dosage. Main outcome measure Risk of incident bladder cancer associated with use of pioglitazone. Results The cohort included 115 727 new users of oral hypoglycaemic agents, with 470 patients diagnosed as having bladder cancer during follow-up (rate 89.4 per 100 000 person years). The 376 cases of bladder cancer that were diagnosed beyond one year of follow-up were matched to 6699 controls. Overall, ever use of pioglitazone was associated with an increased rate of bladder cancer (rate ratio 1.83, 95% confidence interval 1.10 to 3.05). The rate increased as a function of duration of use, with the highest rate observed in patients exposed for more than 24 months (1.99, 1.14 to 3.45) and in those with a cumulative dosage greater than 28 000 mg (2.54, 1.05 to 6.14). Conclusion The use of pioglitazone is associated with an increased risk of incident bladder cancer among people with type 2 diabetes.	[Azoulay, Laurent; Yin, Hui; Filion, Kristian B.; Assayag, Jonathan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Azoulay, Laurent; Pollak, Michael N.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Filion, Kristian B.] McGill Univ, Div Clin Epidemiol, Montreal, PQ, Canada; [Majdan, Agnieszka] McGill Univ, Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada; [Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine,H-425-1, Montreal, PQ H3T 1E2, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Pollak, Michael/0000-0003-3047-0604; Azoulay, Laurent/0000-0001-5162-3556; Filion, Kristian/0000-0001-6055-0088	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Novo Nordisk	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Novo Nordisk(Novo Nordisk)	This study was supported by grants from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation. The funding sources had no role in the design, analysis, and interpretation of the results, and thus the authors were independent from the funding source.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MNP served as a consultant for Novo Nordisk and Sanofi-Aventis and received research funding from Novo Nordisk; no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Caisse nationale de l'assurance maladie Paris France, 2011, RISQ CANC VESS CHEZ; Cancer Research UK, 2012, BLADD CANC C67 AV NU; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Dominick MA, 2006, TOXICOL PATHOL, V34, P903, DOI 10.1080/01926230601072327; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; Edwards KL, 2008, PHARMACOTHERAPY, V28, P506, DOI 10.1592/phco.28.4.506; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; European Medicines Agency, 2011, QUEST ANSW REV PIOGL; Food and Drug Administration,, 2011, FDA DRUG SAF COMM UP; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Health Canada, 2011, HLTH CAN REV DIAB DR; Hillaire-Buys D, 2011, LANCET, V378, P1543, DOI 10.1016/S0140-6736(11)61662-0; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; MacKenzie T, 2011, CANCER-AM CANCER SOC, V117, P1552, DOI 10.1002/cncr.25641; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Sato K, 2011, TOXICOL APPL PHARM, V251, P234, DOI 10.1016/j.taap.2011.01.006; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suzuki S, 2010, TOXICOL SCI, V113, P349, DOI 10.1093/toxsci/kfp256; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yoshimura R, 2003, INT J CANCER, V104, P597, DOI 10.1002/ijc.10980	38	201	205	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3645	10.1136/bmj.e3645	http://dx.doi.org/10.1136/bmj.e3645			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22653981	Green Published, hybrid			2022-12-28	WOS:000304857000006
J	Corliss, J				Corliss, Julie			EXERCISE Powering up	NATURE			English	Editorial Material							AEROBIC EXERCISE; MECHANISMS											Friedenreich CM, 2011, RECENT RESULTS CANC, V188, P125, DOI 10.1007/978-3-642-10858-7_11; Ibrahim EM, 2011, MED ONCOL, V28, P753, DOI 10.1007/s12032-010-9536-x; Irwin ML, 2009, CANCER EPIDEM BIOMAR, V18, P306, DOI 10.1158/1055-9965.EPI-08-0531; Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774; Zeng HM, 2012, BREAST CANCER RES TR, V133, P127, DOI 10.1007/s10549-011-1716-7	5	0	0	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S62	S63		10.1038/485S62a	http://dx.doi.org/10.1038/485S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648503	Bronze			2022-12-28	WOS:000304608000007
J	Naeraa, T; Schersten, A; Rosing, MT; Kemp, AIS; Hoffmann, JE; Kokfelt, TF; Whitehouse, MJ				Naeraa, T.; Schersten, A.; Rosing, M. T.; Kemp, A. I. S.; Hoffmann, J. E.; Kokfelt, T. F.; Whitehouse, M. J.			Hafnium isotope evidence for a transition in the dynamics of continental growth 3.2Gyr ago	NATURE			English	Article							SOUTHERN WEST GREENLAND; PLASMA-MASS SPECTROMETRY; ITSAQ GNEISS COMPLEX; JACK HILLS ZIRCONS; SITU U-PB; LU-HF; CRUSTAL EVOLUTION; PLATE-TECTONICS; GREENSTONE-BELT; CONSTRAINTS	Earth's lithosphere probably experienced an evolution towards the modern plate tectonic regime, owing to secular changes in mantle temperature(1,2). Radiogenic isotope variations are interpreted as evidence for the declining rates of continental crustal growth over time(3-5), with some estimates suggesting that over 70% of the present continental crustal reservoir was extracted by the end of the Archaean eon(3,5). Patterns of crustal growth and reworking in rocks younger than three billion years (Gyr) are thought to reflect the assembly and break-up of supercontinents by Wilson cycle processes and mark an important change in lithosphere dynamics(6). In southern West Greenland numerous studies have, however, argued for subduction settings and crust growth by arc accretion back to 3.8 Gyr ago(7-9), suggesting that modern-day tectonic regimes operated during the formation of the earliest crustal rock record. Here we report in situ uranium-lead, hafnium and oxygen isotope data from zircons of basement rocks in southern West Greenland across the critical time period during which modern-like tectonic regimes could have initiated. Our data show pronounced differences in the hafnium isotope-time patterns across this interval, requiring changes in the characteristics of the magmatic protolith. The observations suggest that 3.9-3.5-Gyr-old rocks differentiated from a >3.9-Gyr-old source reservoir with a chondritic to slightly depleted hafnium isotope composition. In contrast, rocks formed after 3.2 Gyr ago register the first additions of juvenile depleted material (that is, new mantle-derived crust) since 3.9 Gyr ago, and are characterized by striking shifts in hafnium isotope ratios similar to those shown by Phanerozoic subduction-related orogens(10-12). These data suggest a transitional period 3.5-3.2 Gyr ago from an ancient (3.9-3.5 Gyr old) crustal evolutionary regime unlike that of modern plate tectonics to a geodynamic setting after 3.2 Gyr ago that involved juvenile crust generation by plate tectonic processes.	[Naeraa, T.; Kokfelt, T. F.] Geol Survey Denmark & Greenland GEUS, DK-1350 Copenhagen K, Denmark; [Naeraa, T.; Rosing, M. T.] Univ Copenhagen, Nat Hist Museum Denmark, Nord Ctr Earth Evolut NordCEE, DK-1350 Copenhagen K, Denmark; [Schersten, A.] Lund Univ, Dept Geol, S-22362 Lund, Sweden; [Kemp, A. I. S.] Univ Western Australia, Sch Earth & Environm, Ctr Explorat Targeting, Crawley, WA 6009, Australia; [Kemp, A. I. S.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Hoffmann, J. E.] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Hoffmann, J. E.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Whitehouse, M. J.] Swedish Museum Nat Hist, SE-10405 Stockholm, Sweden	Geological Survey Of Denmark & Greenland; University of Copenhagen; Lund University; University of Western Australia; James Cook University; University of Cologne; University of Bonn; Swedish Museum of Natural History	Naeraa, T (corresponding author), Geol Survey Denmark & Greenland GEUS, Oster Voldgade 10, DK-1350 Copenhagen K, Denmark.	tomn@geus.dk	Kemp, Anthony/H-5179-2014; Rosing, Minik/A-9977-2013; Hoffmann, Elis/AAF-1473-2020; Kokfelt, Thomas Find/J-2736-2018; Whitehouse, Martin J/E-1425-2013	Rosing, Minik/0000-0001-7559-661X; Kokfelt, Thomas Find/0000-0003-1941-920X; Whitehouse, Martin J/0000-0003-2227-577X; Hoffmann, J. Elis/0000-0001-6670-1393; Schersten, Anders/0000-0002-2105-6172; Kemp, Anthony/0000-0003-1642-0360	Geocenter Denmark [7-2006]; Swedish research council [2008-3447]; Danish National Research Foundation; Deutsche Forschungsgemeinschaft (DFG) [Mu 1406/8, HO 4794/1-1]; Australian Research Council [DP0773029, FT100100059]; Geological Survey of Finland; Swedish Museum of Natural History; Geological Survey of Denmark; Geological Survey of Greenland	Geocenter Denmark; Swedish research council(Swedish Research CouncilEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); Geological Survey of Finland; Swedish Museum of Natural History; Geological Survey of Denmark; Geological Survey of Greenland	This work was financed through grants from the Geocenter Denmark (Geocenterbevilling 7-2006 to T.N. and A. S.), the Swedish research council (research grant number 2008-3447 to A. S.) and the Danish National Research Foundation to NordCEE. J.E.H. was financed by the Deutsche Forschungsgemeinschaft (DFG) under grant numbers Mu 1406/8 and HO 4794/1-1. A. I. S. K. acknowledges support from the Australian Research Council fellowships DP0773029 and FT100100059. Y. Hu provided technical assistance during Hf isotope measurement in the Advanced Analytical Centre, James Cook University. The NordSIM laboratory is operated under an agreement between the research funding agencies of Denmark, Norway and Sweden, the Geological Survey of Finland and the Swedish Museum of Natural History; this is NordSIM contribution number 309. We are grateful for logistical and financial support given by the Geological Survey of Denmark and Greenland. This paper is published with permission from the Geological Survey of Denmark and Greenland.	ALLEGRE CJ, 1984, EARTH PLANET SC LETT, V67, P19, DOI 10.1016/0012-821X(84)90035-9; Amelin Y, 2011, CAN J EARTH SCI, V48, P141, DOI 10.1139/E10-091; Belousova EA, 2010, LITHOS, V119, P457, DOI 10.1016/j.lithos.2010.07.024; Blichert-Toft J, 2008, EARTH PLANET SC LETT, V265, P686, DOI 10.1016/j.epsl.2007.10.054; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Cawood PA, 2005, EARTH-SCI REV, V69, P249, DOI 10.1016/j.earscirev.2004.09.001; DAVIES GF, 1992, GEOLOGY, V20, P963, DOI 10.1130/0091-7613(1992)020<0963:OTEOPT>2.3.CO;2; DeCelles PG, 2009, NAT GEOSCI, V2, P251, DOI 10.1038/NGEO469; Frei D, 2009, CHEM GEOL, V261, P261, DOI 10.1016/j.chemgeo.2008.07.025; Friend CRL, 2009, CHEM GEOL, V261, P61, DOI 10.1016/j.chemgeo.2008.09.019; Friend CRL, 2005, J GEOL, V113, P375, DOI 10.1086/430239; Friend CRL, 2005, J GEOL SOC LONDON, V162, P147, DOI 10.1144/0016-764903-161; Garde AA, 2007, J GEOL SOC LONDON, V164, P565, DOI 10.1144/0016-76492005-107; Gerdes A, 2006, EARTH PLANET SC LETT, V249, P47, DOI 10.1016/j.epsl.2006.06.039; Griffin WL, 2007, DEV PREC G, V15, P1013, DOI 10.1016/S0166-2635(07)15082-9; Hiess J, 2009, GEOCHIM COSMOCHIM AC, V73, P4489, DOI 10.1016/j.gca.2009.04.019; Jackson SE, 2004, CHEM GEOL, V211, P47, DOI 10.1016/j.chemgeo.2004.06.017; Kamber BS, 1998, CHEM GEOL, V150, P19, DOI 10.1016/S0009-2541(98)00059-X; Kamber BS, 2003, CONTRIB MINERAL PETR, V145, P25, DOI 10.1007/s00410-002-0429-7; Kemp AIS, 2010, EARTH PLANET SC LETT, V296, P45, DOI 10.1016/j.epsl.2010.04.043; Kemp AIS, 2009, EARTH PLANET SC LETT, V284, P455, DOI 10.1016/j.epsl.2009.05.011; Kemp AIS, 2009, CHEM GEOL, V261, P244, DOI 10.1016/j.chemgeo.2008.06.019; Labrosse S, 2007, EARTH PLANET SC LETT, V260, P465, DOI 10.1016/j.epsl.2007.05.046; MCLENNAN SM, 1982, J GEOL, V90, P347, DOI 10.1086/628690; Miskovic A, 2009, EARTH PLANET SC LETT, V279, P303, DOI 10.1016/j.epsl.2009.01.002; Nemchin AA, 2006, GEOCHIM COSMOCHIM AC, V70, P1864, DOI 10.1016/j.gca.2005.12.009; Nutman AP, 2009, PRECAMBRIAN RES, V172, P212, DOI 10.1016/j.precamres.2009.03.019; Nutman AP, 2004, J GEOL SOC LONDON, V161, P421, DOI 10.1144/0016-764903-043; Polat A, 2007, GONDWANA RES, V11, P69, DOI 10.1016/j.gr.2006.02.004; Polat A, 2010, CHEM GEOL, V277, P1, DOI 10.1016/j.chemgeo.2010.06.016; Ranero CR, 2000, NATURE, V404, P748, DOI 10.1038/35008046; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Schersten A, 2012, PRECAMBRIAN RES, V200, P149, DOI 10.1016/j.precamres.2011.12.014; Segal I, 2003, J ANAL ATOM SPECTROM, V18, P1217, DOI 10.1039/b307016f; Shirey SB, 2011, SCIENCE, V333, P434, DOI 10.1126/science.1206275; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; VALLEY JW, 1994, EARTH PLANET SC LETT, V126, P187, DOI 10.1016/0012-821X(94)90106-6; Van Kranendonk MJ, 2011, SCIENCE, V333, P413, DOI 10.1126/science.1208766; Vervoort JD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000721; Whitehouse MJ, 2009, CHEM GEOL, V261, P31, DOI 10.1016/j.chemgeo.2008.09.009; Wiedenbeck M, 2004, GEOSTAND GEOANAL RES, V28, P9, DOI 10.1111/j.1751-908X.2004.tb01041.x; Woodhead JD, 2005, GEOSTAND GEOANAL RES, V29, P183, DOI 10.1111/j.1751-908X.2005.tb00891.x	43	212	218	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					627	+		10.1038/nature11140	http://dx.doi.org/10.1038/nature11140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660324				2022-12-28	WOS:000304608000045
J	Wei, B; Dai, MJ; Yin, P				Wei, Bryan; Dai, Mingjie; Yin, Peng			Complex shapes self-assembled from single-stranded DNA tiles	NATURE			English	Article							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; DESIGN; CRYSTALS; LATTICES; ARRAYS; RNA	Programmed self-assembly of strands of nucleic acid has proved highly effective for creating a wide range of structures with desired shapes(1-25). A particularly successful implementation is DNA origami, in which a long scaffold strand is folded by hundreds of short auxiliary strands into a complex shape(9,14-16,18-21,25). Modular strategies are in principle simpler and more versatile and have been used to assemble DNA(2-5,8,10-13,17,23) or RNA(7,22) tiles into periodic(3,4,7,22) and algorithmic(5) two-dimensional lattices, extended ribbons(10,12) and tubes(4,12,13), three-dimensional crystals(17), polyhedra(11) and simple finite two-dimensional shapes(7,8). But creating finite yet complex shapes from a large number of uniquely addressable tiles remains challenging. Here we solve this problem with the simplest tile form, a 'single-stranded tile' (SST) that consists of a 42-base strand of DNA composed entirely of concatenated sticky ends and that binds to four local neighbours during self-assembly(12). Although ribbons and tubes with controlled circumferences(12) have been created using the SST approach, we extend it to assemble complex two-dimensional shapes and tubes from hundreds (in some cases more than one thousand) distinct tiles. Our main design feature is a self-assembled rectangle that serves as a molecular canvas, with each of its constituent SST strands-folded into a 3 nm-by-7 nm tile and attached to four neighbouring tiles-acting as a pixel. A desired shape, drawn on the canvas, is then produced by one-pot annealing of all those strands that correspond to pixels covered by the target shape; the remaining strands are excluded. We implement the strategy with a master strand collection that corresponds to a 310-pixel canvas, and then use appropriate strand subsets to construct 107 distinct and complex two-dimensional shapes, thereby establishing SST assembly as a simple, modular and robust framework for constructing nanostructures with prescribed shapes from short synthetic DNA strands.	[Wei, Bryan; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wei, Bryan; Dai, Mingjie; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Dai, Mingjie] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Yin, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	py@hms.harvard.edu	Dai, Mingjie/A-7612-2013	Dai, Mingjie/0000-0002-8665-4966	Office of Naval Research [N000141110914, N000141010827]; NSF [CCF1054898]; NIH [1DP2OD007292]; Wyss Institute for Biologically Inspired Engineering; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1054898] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute for Biologically Inspired Engineering; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank S. Chandarasekaran, X. Lim, W. Sun and R. Conturie for technical assistance; A. Marblestone, R. Barish, W. Shih, Y. Ke, E. Winfree, S. Woo, P. Rothemund and D. Woods for discussions; and J. Aliperti for help with preparation of the draft. This work was funded by Office of Naval Research Young Investigator Program Award N000141110914, Office of Naval Research Grant N000141010827, NSF CAREER Award CCF1054898, NIH Director's New Innovator Award 1DP2OD007292 and a Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund (to P.Y.).	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; O'Neill P, 2006, NANO LETT, V6, P1379, DOI 10.1021/nl0603505; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Rajendran A, 2011, J AM CHEM SOC, V133, P14488, DOI 10.1021/ja204546h; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Wei B, 2007, J COMPUT THEOR NANOS, V4, P133; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	32	654	693	17	600	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					623	+		10.1038/nature11075	http://dx.doi.org/10.1038/nature11075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660323	Green Accepted, Green Submitted			2022-12-28	WOS:000304608000044
J	Park, PG; Frankl, FEK				Park, Peter G., Jr.; Frankl, Fiona E. Karet			Gitelman syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Frankl, Fiona E. Karet] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Frankl, Fiona E. Karet] Addenbrookes Hosp, Cambridge Inst Med Res, Div Renal Med, Cambridge CB2 0XY, England; [Park, Peter G., Jr.] RAF Molesworth, Huntingdon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Frankl, FEK (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	fek1000@cam.ac.uk		Karet, Fiona/0000-0002-2457-2869					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3590	10.1136/bmj.e3590	http://dx.doi.org/10.1136/bmj.e3590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645210	Bronze			2022-12-28	WOS:000304855700013
J	Cima, RFF; Maes, IH; Joore, MA; Scheyen, DJWM; El Refaie, A; Baguley, DM; Anteunis, LJC; van Breukelen, GJP; Vlaeyen, JWS				Cima, Rilana F. F.; Maes, Iris H.; Joore, Manuela A.; Scheyen, Dyon J. W. M.; El Refaie, Amr; Baguley, David M.; Anteunis, Lucien J. C.; van Breukelen, Gerard J. P.; Vlaeyen, Johan W. S.			Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; SCALE; PAIN; ANXIETY; FEAR; ILLUSTRATION; DEPRESSION; VALIDATION; DUTCH	Background Up to 21% of adults will develop tinnitus, which is one of the most distressing and debilitating audiological problems. The absence of medical cures and standardised practice can lead to costly and prolonged treatment. We aimed to assess effectiveness of a stepped-care approach, based on cognitive behaviour therapy, compared with usual care in patients with varying tinnitus severity. Methods In this randomised controlled trial, undertaken at the Adelante Department of Audiology and Communication (Hoensbroek, Netherlands), we enrolled previously untreated Dutch speakers (aged >18 years) who had a primary complaint of tinnitus but no health issues precluding participation. An independent research assistant randomly allocated patients by use of a computer-generated allocation sequence in a 1:1 ratio, stratified by tinnitus severity and hearing ability, in block sizes of four to receive specialised care of cognitive behaviour therapy with sound-focused tinnitus retraining therapy or usual care. Patients and assessors were masked to treatment assignment. Primary outcomes were health-related quality of life (assessed by the health utilities index score), tinnitus severity (tinnitus questionnaire score), and tinnitus impairment (tinnitus handicap inventory score), which were assessed before treatment and at 3 months, 8 months, and 12 months after randomisation. We used multilevel mixed regression analyses to assess outcomes in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT00733044. Findings Between September, 2007 and January, 2011, we enrolled and treated 492 (66%) of 741 screened patients. Compared with 247 patients assigned to usual care, 245 patients assigned to specialised care improved in health-related quality of life during a period of 12 months (between-group difference 0.059, 95% CI 0.025 to 0.094; effect size of Cohen's d=0.24; p=0.0009), and had decreased tinnitus severity (-8.062, -10.829 to -5.295; d=0.43; p<0.0001) and tinnitus impairment (-7.506, -10.661 to -4.352; d=0.45; p<0.0001). Treatment seemed effective irrespective of initial tinnitus severity, and we noted no adverse events in this trial. Interpretation Specialised treatment of tinnitus based on cognitive behaviour therapy could be suitable for widespread implementation for patients with tinnitus of varying severity.	[Cima, Rilana F. F.; van Breukelen, Gerard J. P.] Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands; [Maes, Iris H.; Joore, Manuela A.] Univ Hosp Maastricht, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Anteunis, Lucien J. C.] Univ Hosp Maastricht, Dept Otorhinolaryngol & Head & Neck Surg, Maastricht, Netherlands; [Cima, Rilana F. F.] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Cima, Rilana F. F.; Scheyen, Dyon J. W. M.] Adelante, Dept Audiol & Commun, Hoensbroek, Netherlands; [El Refaie, Amr] Univ Bristol, Ctr Hearing & Balance Studies, Bristol, Avon, England; [Baguley, David M.] Addenbrookes Hosp, Dept Otolaryngol, Cambridge CB2 2QQ, England; [Baguley, David M.] Addenbrookes Hosp, Dept Audiol, Cambridge, England; [Vlaeyen, Johan W. S.] Katholieke Univ Leuven, Res Ctr Hlth Psychol, Louvain, Belgium	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; KU Leuven	Cima, RFF (corresponding author), Maastricht Univ, Dept Methodol & Stat, POB 616, NL-6200 MD Maastricht, Netherlands.	r.cima@maastrichtuniversity.nl	Vlaeyen, Johan W.S./A-2555-2009; van+Breukelen, Gerard/ACJ-5895-2022; Cima, Rilana/A-7930-2015; Vlaeyen, Johan/P-9070-2019	van+Breukelen, Gerard/0000-0003-0949-0272; Cima, Rilana/0000-0001-8465-3313; Vlaeyen, Johan/0000-0003-0437-6665; Joore, Manuela/0000-0002-5649-6768	Netherlands Organisation for Health Research and Development (ZonMW) [945-07-715]; University Hospital of Maastricht; Maastricht University, Faculty of Psychology and Neuroscience	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); University Hospital of Maastricht; Maastricht University, Faculty of Psychology and Neuroscience	Netherlands Organisation for Health Research and Development (ZonMW).; RFFC, IHM, MAJ, LJCA, and JWSV were supported by the Netherlands Organisation for Health Research and Development (ZonMW) grant number 945-07-715. We thank all professionals, support staff, and management of Adelante, Department of Audiology and Communication for enabling the randomised controlled trial; all participating patients with tinnitus; Marieke Jansen, Pauline Cox, and Martijn van Veghel (Adelante Department of Audiology and Communication, Hoensbroek, Netherlands) for randomisation, organisation of off-centre contacts, data entry, and data management; Rosanne Janssen (Maastricht University, Maastricht, Netherlands) for assisting with the online application Emium; Nele Vandebroek (University of Leuven, Leuven, Belgium), and Ken Ceulemans (Maastricht University, Maastricht, Netherlands) for their assistance in the treatment fidelity check; and the University Hospital of Maastricht and Maastricht University, Faculty of Psychology and Neuroscience, for all supporting services.	Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Cima Rilana, 2009, BMC Health Serv Res, V9, P29, DOI 10.1186/1472-6963-9-29; Cima RFF, 2011, EAR HEARING, V32, P634, DOI 10.1097/AUD.0b013e31821106dd; Cima RFF, 2011, EAR HEARING, V32, P623, DOI 10.1097/AUD.0b013e31820dd411; Devesa P. Martinez, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005233.PUB2; El Refaie A, 2004, INT J AUDIOL, V43, P410; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hiller W, 2005, BEHAV RES THER, V43, P595, DOI 10.1016/j.brat.2004.03.012; Hoare D, 2010, J EVAL CLIN PRACT, V18, P326; Hoare DJ, 2010, ANN BEHAV MED, V40, P313, DOI 10.1007/s12160-010-9213-5; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Jastreboff P. J., 2004, TINNITUS RETRAINING; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Javaheri S, 2000, LANCET, V356, P308, DOI 10.1016/S0140-6736(00)02507-1; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Kroner-Herwig B, 2003, J PSYCHOSOM RES, V54, P381, DOI 10.1016/S0022-3999(02)00400-2; Leeuw M, 2009, J CLIN EPIDEMIOL, V62, P81, DOI 10.1016/j.jclinepi.2008.03.008; Maes IHL, 2011, EAR HEARING, V32, P428, DOI 10.1097/AUD.0b013e3181fdf09f; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Meeus O, 2007, B-ENT, P11; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Phillips JS, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007330.PUB2; Rief W, 2005, PSYCHOSOM MED, V67, P833, DOI 10.1097/01.psy.0000174174.38908.c6; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Seydel C, 2010, AUDIOL NEURO-OTOL, V15, P69, DOI 10.1159/000231632; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Von Korff M, 2001, ANN INTERN MED, V134, P911, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00016; Zachriat Claudia, 2004, Cognitive Behaviour Therapy, V33, P187, DOI 10.1080/16506070410029568	35	182	186	7	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1951	1959		10.1016/S0140-6736(12)60469-3	http://dx.doi.org/10.1016/S0140-6736(12)60469-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22633033				2022-12-28	WOS:000304757700029
J	Brouwer, PW				Brouwer, Piet W.			Enter the Majorana Fermion	SCIENCE			English	Editorial Material							QUANTUM COMPUTATION; ANYONS		[Brouwer, Piet W.] Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, D-14195 Berlin, Germany; [Brouwer, Piet W.] Free Univ Berlin, Inst Theoret Phys, D-14195 Berlin, Germany	Free University of Berlin; Free University of Berlin	Brouwer, PW (corresponding author), Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, Arnimallee 14, D-14195 Berlin, Germany.	brouwer@zedat.fu-berlin.de	Brouwer, Piet/O-4828-2016					Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; Freedman MH, 1998, P NATL ACAD SCI USA, V95, P95, DOI 10.1073/pnas.95.1.95; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; JACKIW R, 1976, PHYS REV D, V13, P3398, DOI 10.1103/PhysRevD.13.3398; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Law KT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237001; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Majorana E., 1981, SORYUSIRON KENKYU, V63, P149; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Wilczek F, 2009, NAT PHYS, V5, P614, DOI 10.1038/nphys1380	15	31	33	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					989	990		10.1126/science.1223302	http://dx.doi.org/10.1126/science.1223302			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628643				2022-12-28	WOS:000304406800030
J	Kemp, C; Regier, T				Kemp, Charles; Regier, Terry			Kinship Categories Across Languages Reflect General Communicative Principles	SCIENCE			English	Article							SIBLING TERMINOLOGIES; INFORMATION-THEORY; UNIVERSALS; EVOLUTION; TYPOLOGY; TERMS; COLOR	Languages vary in their systems of kinship categories, but the scope of possible variation appears to be constrained. Previous accounts of kin classification have often emphasized constraints that are specific to the domain of kinship and are not derived from general principles. Here, we propose an account that is founded on two domain-general principles: Good systems of categories are simple, and they enable informative communication. We show computationally that kin classification systems in the world's languages achieve a near-optimal trade-off between these two competing principles. We also show that our account explains several specific constraints on kin classification proposed previously. Because the principles of simplicity and informativeness are also relevant to other semantic domains, the trade-off between them may provide a domain-general foundation for variation in category systems across languages.	[Kemp, Charles] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Regier, Terry] Univ Calif Berkeley, Dept Linguist, Cognit Sci Program, Berkeley, CA 94720 USA	Carnegie Mellon University; University of California System; University of California Berkeley	Kemp, C (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	ckemp@cmu.edu		Kemp, Charles/0000-0001-9683-8737	NSF [CDI-0835797, SBE-0541957]; Pittsburgh Life Sciences Greenhouse Opportunity Fund	NSF(National Science Foundation (NSF)); Pittsburgh Life Sciences Greenhouse Opportunity Fund	Code and data are available at www.charleskemp.com/kinship. We thank S. Gahl, A. Garrett, M. Just, A. Kemp, B. MacWhinney, Y. Xu, Y. Zhang, two anonymous reviewers, and especially P. Kay for valuable suggestions. This work was supported by the NSF under awards CDI-0835797 and SBE-0541957 and by the Pittsburgh Life Sciences Greenhouse Opportunity Fund.	ATRAN S, 1995, INVITATION COGNITIVE, V3, P131; Baddeley R, 2009, PSYCHOL SCI, V20, P1100, DOI 10.1111/j.1467-9280.2009.02412.x; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; Berlin B., 1969, BASIC COLOR TERMS TH; Brown D. E., 1991, HUMAN UNIVERSALS; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Clark H. H., 1977, PSYCHOL LANGUAGE INT; Davies M., 2020, CORPUS CONT AM ENGLI; de l'Etang M., 2005, MOTHER TONGUE, VIX, P133; EPLING PJ, 1973, AM ANTHROPOL, V75, P1596, DOI 10.1525/aa.1973.75.5.02a00250; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Godelier M, 1998, SMITHSON SER ETHNOG, P1; Goldenweiser A.A, 1913, J AM FOLKLORE, V26, P259, DOI [10.2307/534816, DOI 10.2307/534816]; Gould Sydney H., 2000, NEW SYSTEM FORMAL AN; Greenberg J. H., 1990, LANGUAGE SELECTED WR, P310, DOI DOI 10.1146/ANNUREV.AN.04.100175.000451; Greenberg JH., 1949, PHILOS SCI, V16, P58; Greenberg Joseph H., 1966, UNIVERSALS LANGUAGE; Grice P., 1989, STUDIES WAY WORDS; Griffiths TL, 2007, COGNITIVE SCI, V31, P441, DOI 10.1080/15326900701326576; Hage P, 1997, AM ETHNOL, V24, P652, DOI 10.1525/ae.1997.24.3.652; Haspelmath M, 2006, J LINGUIST, V42, P25, DOI 10.1017/S0022226705003683; Hauser MD, 2009, NATURE, V460, P190, DOI 10.1038/460190a; Hawkins J, 2003, EFFICIENCY COMPLEXIT; HEDICAN EJ, 1986, ETHNOLOGY, V25, P229, DOI 10.2307/3773711; Hume E, 2008, PHONOLOGICAL STUDIES, V11, P295; Jameson K. A., 2010, COLOR CATEGORIES THO, P295; Jones D, 2010, BEHAV BRAIN SCI, V33, P367, DOI 10.1017/S0140525X10000890; Jordan FM, 2011, HUM BIOL, V83, P297, DOI 10.3378/027.083.0209; Kay P, 1971, EXPLORATIONS MATH AN, P60; Khetarpal N., 2009, P 31 ANN C COGN SCI, P2396; Kroeber AL, 1909, J R ANTHROPOL INST G, V39, P77, DOI 10.2307/2843284; Kroeber A. L, 1917, U CALIFORNIA PUBLICA, V12; Kronenfeld D. B., 1974, AM ETHNOL, V1, P489; Kronenfeld David, 1996, PLASTIC GLASSES CHUR; Kronenfeld DB, 2006, ANTHROPOS, V101, P203; Kupietz M., 2009, WORKING PAPERS CORPU, P53; Leaf MJ, 2006, ETHNOLOGY, V45, P305, DOI 10.2307/20456604; LEHMAN FK, 2001, ANTHROPOL THEOR, V1, P212; Levinson S, 2003, LANGUAGE, V79, P485, DOI 10.1353/lan.2003.0174; MARTINET A., 1962, FUNCTIONAL VIEW LANG; Milicic B., 2010, KINSHIP LANGUAGE PRE, P212; MURDOCK GP, 1970, ETHNOLOGY, V9, P165, DOI 10.2307/3772782; Murdock GPM, 1949, SOCIAL STRUCTURE; NERLOVE S, 1967, AM ANTHROPOL, V69, P179, DOI 10.1525/aa.1967.69.2.02a00050; Pericliev V., 2011, PROFILING LANGUAGE F; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Read D. W., 1990, J QUANTITATIVE ANTHR, V2, P353; Read DW, 2007, ETHNOLOGY, V46, P329, DOI 10.2307/20456635; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Scott-Phillips TC, 2010, TRENDS COGN SCI, V14, P411, DOI 10.1016/j.tics.2010.06.006; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Valdes-Perez RE, 1999, CROSS-CULT RES, V33, P162, DOI 10.1177/106939719903300202; WALLACE AF, 1961, P NATL ACAD SCI USA, V47, P458, DOI 10.1073/pnas.47.4.458; WALLACE AFC, 1960, AM ANTHROPOL, V62, P58, DOI 10.1525/aa.1960.62.1.02a00040; Wierzbicka A., 1992, SEMANTICS CULTURE CO; WOOLFORD E, 1984, AM ETHNOL, V11, P771, DOI 10.1525/ae.1984.11.4.02a00090; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	58	118	121	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1049	1054		10.1126/science.1218811	http://dx.doi.org/10.1126/science.1218811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	947DK	22628658				2022-12-28	WOS:000304406800049
J	Sosa, BA; Rothballer, A; Kutay, U; Schwartz, TU				Sosa, Brian A.; Rothballer, Andrea; Kutay, Ulrike; Schwartz, Thomas U.			LINC Complexes Form by Binding of Three KASH Peptides to Domain Interfaces of Trimeric SUN Proteins	CELL			English	Article							NUCLEAR-MEMBRANE PROTEIN; DREIFUSS MUSCULAR-DYSTROPHY; ACTIN CYTOSKELETON; CAENORHABDITIS-ELEGANS; LAMIN-A; ENVELOPE; MIGRATION; MICE; LOCALIZATION; ANCHORAGE	Linker of nucleoskeleton and cytoskeleton (LINC) complexes span the nuclear envelope and are composed of KASH and SUN proteins residing in the outer and inner nuclear membrane, respectively. LINC formation relies on direct binding of KASH and SUN in the perinuclear space. Thereby, molecular tethers are formed that can transmit forces for chromosome movements, nuclear migration, and anchorage. We present crystal structures of the human SUN2-KASH1/2 complex, the core of the LINC complex. The SUN2 domain is rigidly attached to a trimeric coiled coil that prepositions it to bind three KASH peptides. The peptides bind in three deep and expansive grooves formed between adjacent SUN domains, effectively acting as molecular glue. In addition, a disulfide between conserved cysteines on SUN and KASH covalently links both proteins. The structure provides the basis of LINC complex formation and suggests a model for how LINC complexes might arrange into higher-order clusters to enhance force-coupling.	[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Sosa, Brian A.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rothballer, Andrea] Mol Life Sci Ph D Program, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Kutay, U (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch; tus@mit.edu	Schwartz, Thomas/ABA-1770-2021; Schwartz, Thomas/K-9029-2017	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	NIH [NS075883]; Boehringer Ingelheim PhD fellowship; SNSF [310030-313135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim PhD fellowship; SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at NE-CAT beamlines 24-ID-C/-E at the Advanced Photon Source (APS), especially K. Rajashankar for technical help with data collection. We thank C. Ashiono for excellent assistance; W. Antonin, A. Keating, and A. Helenius for discussion; and K. Knockenhauer and G. Kabachinski for critical reading of the manuscript. Imaging was performed on instruments of the ETH Light Microscopy Center. This work was supported by NIH Grant NS075883 to T.U.S., a Boehringer Ingelheim PhD fellowship to A.R., and an SNSF grant (310030-313135) to U.K.	Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mans BJ, 2004, CELL CYCLE, V3, P1612; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Worman HJ, 2006, TRENDS CELL BIOL, V16, P67, DOI 10.1016/j.tcb.2005.12.006; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhen YY, 2002, J CELL SCI, V115, P3207; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471	58	260	266	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1035	1047		10.1016/j.cell.2012.03.046	http://dx.doi.org/10.1016/j.cell.2012.03.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632968	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000304453900010
J	Thistle, R; Cameron, P; Ghorayshi, A; Dennison, L; Scott, K				Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin			Contact Chemoreceptors Mediate Male-Male Repulsion and Male-Female Attraction during Drosophila Courtship	CELL			English	Article							FRUITLESS GENE; CUTICULAR HYDROCARBONS; EXPRESSION PATTERNS; SEXUAL ORIENTATION; PHEROMONE RECEPTOR; MELANOGASTER; TASTE; BEHAVIOR; SYSTEM; FLY	The elaborate courtship ritual of Drosophila males is dictated by neural circuitry established by the transcription factor Fruitless and triggered by sexspecific sensory cues. Deciphering the role of different stimuli in driving courtship behavior has been limited by the inability to selectively target appropriate sensory classes. Here, we identify two ion channel genes belonging to the degenerin/epithelial sodium channel/pickpocket (ppk) family, ppk23 and ppk29, which are expressed in fruitless-positive neurons on the legs and are essential for courtship. Gene loss-of-function, cell-inactivation, and cell-activation experiments demonstrate that these genes and neurons are necessary and sufficient to inhibit courtship toward males and promote courtship toward females. Moreover, these cells respond to cuticular hydrocarbons, with different cells selectively responding to male or female pheromones. These studies identify a large population of pheromone-sensing neurons and demonstrate the essential role of contact chemosensation in the early courtship steps of mate selection and courtship initiation.	[Scott, Kristin] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 16 Barker Hall, Berkeley, CA 94720 USA.	kscott@berkeley.edu		Cameron, Peter/0000-0002-1443-557X	NSF; NRSA [F31DC009389]; NIDCD [1R01DC009470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009470, F31DC009389] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The Scott lab provided helpful comments and discussion. Dr. Gautam Agarwal provided MATLAB advice, and Dr. Seth Ament performed the ANOVA analysis. Dr. Charles Zuker provided UAS-GCaMP3 flies. R.T. is supported by a predoctoral NSF fellowship; P.C. was supported by a predoctoral NRSA fellowship, F31DC009389. This research was supported by a grant from the NIDCD, 1R01DC009470. K.S. is an Early Career Scientist of the Howard Hughes Medical Institute. R.T. performed most experiments, including Gal4 expression studies, calcium imaging, and behavioral assays and cowrote the paper. P.C. generated Delta ppk23 and Delta ppk29, Gal4, and UAS transgenic animals, made isogenic lines, and carried out expression studies. A.G. assisted R.T. with behavior. L.D. generated ppk28-LexA and contributed to in situ experiments. K.S. supervised the project, cowrote the manuscript, and performed expression studies.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Antony C., 1982, J INSECT PHYSL, V28, P87; Ben-Shahar Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009395; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GAILEY DA, 1984, GENETICS, V106, P613; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Villella A, 1997, GENETICS, V147, P1107; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	59	199	199	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1140	1151		10.1016/j.cell.2012.03.045	http://dx.doi.org/10.1016/j.cell.2012.03.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632976	Green Accepted, Bronze			2022-12-28	WOS:000304453900018
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Television shows and education about sexually transmitted infections: no laughing matter	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				CDC, GEN HPV INF FACT SHE; Centers for Disease Control and Prevention (CDC), GAT HLTH COMM SOC MA; Murphy ST, 2008, HLTH IS PRIME TIME A; Rabin RC, 2012, NY TIMES, pD5	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 23	2012	344								e3614	10.1136/bmj.e3614	http://dx.doi.org/10.1136/bmj.e3614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QT	22623638				2022-12-28	WOS:000304591500014
J	Loewenstein, G; Asch, DA; Friedman, JY; Melichar, LA; Volpp, KG				Loewenstein, George; Asch, David A.; Friedman, Joelle Y.; Melichar, Lori A.; Volpp, Kevin G.			Can behavioural economics make us healthier?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FINANCIAL INCENTIVES; MEDICATION ADHERENCE; COPAYMENTS; INCREASE; SMOKING; IMPACT	Behavioural economics is becoming increasingly popular as a way to improve public health. George Loewenstein and colleagues point out some of the pitfalls and warn that it cannot be used as a substitute for conventional policies to tackle fundamental problems	[Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Loewenstein, George; Asch, David A.; Friedman, Joelle Y.; Volpp, Kevin G.] Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Melichar, Lori A.] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA	Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF)	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, 208 Porter Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.	GL20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X				Bollinger B., 2010, 15648 NAT BUR EC RES; Bonell C., 2011, BRIT MED J, V342, P241; Buck Consultants, 2010, WORK WELL GLOB SURV; Camerer C, 2003, U PENN LAW REV, V151, P1211, DOI 10.2307/3312889; Chernew ME, 2008, HEALTH AFFAIR, V27, P103, DOI 10.1377/hlthaff.27.1.103; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Dolan P., 2010, MINDSPACE INFLUENCIN; Dorning M, 2010, BLOOMBERG BUSIN 0624; Doshi JA, 2009, CIRCULATION, V119, P390, DOI 10.1161/CIRCULATIONAHA.108.783944; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Hand L., 2009, HARV PUB HLTH RE WIN, P4; Heil SH, 2008, ADDICTION, V103, P1009, DOI 10.1111/j.1360-0443.2008.02237.x; HERRNSTEIN RJ, 1993, J BEHAV DECIS MAKING, V6, P149, DOI 10.1002/bdm.3960060302; House of Lords Science and Technology Select Committee, 2011, 2 HOUS LORDS SCI TEC; Lazear EP, 2000, Q J ECON, V115, P99, DOI 10.1162/003355300554683; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Loewenstein G, 2011, AM J CLIN NUTR, V93, P679, DOI 10.3945/ajcn.111.012658; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; O'Donoghue T, 2000, J BEHAV DECIS MAKING, V13, P233, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<233::AID-BDM325>3.0.CO;2-U; O'Dowd A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4548; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thaler RH, 2003, AM ECON REV, V93, P175, DOI 10.1257/000282803321947001; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V97, P31, DOI 10.1016/j.obhdp.2005.03.001; Wintour P, 2010, GUARDIAN        0910; Wisdom J, 2009, AM ECON J-APPL ECON, V99, P159	31	66	66	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e3482	10.1136/bmj.e3482	http://dx.doi.org/10.1136/bmj.e3482			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QT	22623635				2022-12-28	WOS:000304591500011
J	Shiomi, H; Nakagawa, Y; Morimoto, T; Furukawa, Y; Nakano, A; Shirai, S; Taniguchi, R; Yamaji, K; Nagao, K; Suyama, T; Mitsuoka, H; Araki, M; Takashima, H; Mizoguchi, T; Eisawa, H; Sugiyama, S; Kimura, T				Shiomi, Hiroki; Nakagawa, Yoshihisa; Morimoto, Takeshi; Furukawa, Yutaka; Nakano, Akira; Shirai, Shinichi; Taniguchi, Ryoji; Yamaji, Kyohei; Nagao, Kazuya; Suyama, Tamaki; Mitsuoka, Hirokazu; Araki, Makoto; Takashima, Hiroyuki; Mizoguchi, Tetsu; Eisawa, Hiroshi; Sugiyama, Seigo; Kimura, Takeshi		CREDO-Kyoto AMI Investigators	Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TO-BALLOON; REPERFUSION STRATEGIES; MORTALITY; ANGIOPLASTY; TRENDS; MANAGEMENT; IMPROVE	Objective To evaluate the relation of symptom onset to balloon time and door to balloon time with long term clinical outcome in patients with ST segment elevation myocardial infarction (STEMI) having primary percutaneous coronary intervention. Design Observation of large cohort of patients with acute myocardial infarction. Setting 26 tertiary hospitals in Japan. Participants 3391 patients with STEMI who had primary percutaneous coronary intervention within 24 hours of symptom onset. Main outcome measures Composite of death and congestive heart failure, compared by onset to balloon time and door to balloon time. Results Compared with an onset to balloon time greater than 3 hours, a time of less than 3 hours was associated with a lower incidence of a composite of death and congestive heart failure (13.5% (123/964) v 19.2% (429/2427), P<0.001; relative risk reduction 29.7%). After adjustment for confounders, a short onset to balloon time was independently associated with a lower risk of the composite endpoint (adjusted hazard ratio 0.70, 95% confidence interval 0.56 to 0.88; P=0.002). However, no significant difference was found in the incidence of a composite of death and congestive heart failure between the two groups of patients with short (<= 90 minutes) and long (>90 minutes) door to balloon time (16.7% (270/1671) v 18.4% (282/1720), P=0.54; relative risk reduction 9.2%). After adjustment for confounders, no significant difference was seen in the risk of the composite endpoint between the two groups of patients with short and long door to balloon time (adjusted hazard ratio: 0.98, 0.78 to 1.24: P=0.87). A door to balloon time of less than 90 minutes was associated with a lower incidence of a composite of death and congestive heart failure in patients who presented within 2 hours of symptom onset (11.9% (74/883) v 18.1% (147/655), P=0.01; relative risk reduction 34.3%) but not in patients who presented later (19.7% (196/788) v 18.7% (135/1065), P=0.44; -5.3%). Short door to balloon time was independently associated with a lower risk of a composite of death and congestive heart failure in patients with early presentation (adjusted hazard ratio 0.58, 0.38 to 0.87; P=0.009) but not in patients with delayed presentation (1.57, 1.12 to 2.18; P=0.008). A significant interaction was seen between door to balloon time and time to presentation (interaction P=0.01). Conclusions Short onset to balloon time was associated with better 3 year clinical outcome in patients with STEMI having primary percutaneous coronary intervention, whereas the benefit of short door to balloon time was limited to patients who presented early. Efforts to minimise onset to balloon time, including reduction of patient related delay, should be recommended to improve clinical outcome in STEMI patients.	[Nakagawa, Yoshihisa] Tenri Hosp, Div Cardiol, Tenri, Nara 6328552, Japan; [Shiomi, Hiroki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Morimoto, Takeshi] Kinki Univ, Sch Med, Ctr Gen Internal Med & Emergency Care, Sayama, Osaka 5898511, Japan; [Furukawa, Yutaka] Gen Hosp, Kobe City Med Ctr, Div Cardiol, Chuo Ku, Kobe, Hyogo 6500046, Japan; [Nakano, Akira] Univ Fukui Hosp, Div Cardiol, Fukui 9101193, Japan; [Shirai, Shinichi; Yamaji, Kyohei] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka 8028555, Japan; [Taniguchi, Ryoji] Hyogo Kenritsu Amagasaki Hosp, Div Cardiol, Amagasaki, Hyogo 6600828, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Div Cardiol, Tennoji Ku, Osaka 5438555, Japan; [Suyama, Tamaki] Sapporo Higashi Tokushukai Hosp, Div Cardiol, Higashi Ku, Sapporo, Hokkaido 0650033, Japan; [Mitsuoka, Hirokazu] Kishiwada City Hosp, Div Cardiol, Kishiwada, Osaka 5968501, Japan; [Araki, Makoto] Shimada Municipal Hosp, Div Cardiol, Shizuoka 4278502, Japan; [Takashima, Hiroyuki] Shiga Univ Med Sci Hosp, Dept Cardiovasc & Resp Med, Shiga 5202192, Japan; [Mizoguchi, Tetsu] Mitsubishi Kyoto Hosp, Div Cardiol, Nishigyo Ku, Kyoto 6158087, Japan; [Eisawa, Hiroshi] Nishi Kobe Med Ctr, Div Cardiol, Nishi Ku, Kobe, Hyogo 6512273, Japan; [Sugiyama, Seigo] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Tenri Hospital; Kyoto University; Kindai University (Kinki University); Kobe City Medical Center General Hospital; University of Fukui; Kokura Memorial Hospital; Osaka Red Cross Hospital; Shiga University of Medical Science; Kobe City Medical Center General Hospital; Kumamoto University	Nakagawa, Y (corresponding author), Tenri Hosp, Div Cardiol, 200 Mishimacho, Tenri, Nara 6328552, Japan.	nakagawa@tenriyorozu.jp	Shiomi, Hiroki/ADJ-9510-2022	Shiomi, Hiroki/0000-0001-7234-023X	Pharmaceuticals and Medical Devices Agency (PMDA) in Japan; Grants-in-Aid for Scientific Research [22390103] Funding Source: KAKEN	Pharmaceuticals and Medical Devices Agency (PMDA) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. The PMDA had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the reports; or in the decision to submit the article for publication.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Boden WE, 2007, J AM COLL CARDIOL, V50, P917, DOI 10.1016/j.jacc.2007.04.084; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2010, J AM COLL CARDIOL, V56, P407, DOI 10.1016/j.jacc.2010.04.020; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; GERSH BJ, 1993, CIRCULATION, V88, P296, DOI 10.1161/01.CIR.88.1.296; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hannan EL, 2010, AM J CARDIOL, V106, P143, DOI 10.1016/j.amjcard.2010.02.029; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416	19	131	137	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e3257	10.1136/bmj.e3257	http://dx.doi.org/10.1136/bmj.e3257			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QT	22623632	Green Submitted, hybrid			2022-12-28	WOS:000304591500002
J	Lerner, BH				Lerner, Barron H.			The art of medicine Drunk driving across the globe: let's learn from one another	LANCET			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.							Committee for the Study of Traffic Safety, 2011, ACH TRAFF SAF GOALS; Homel R.J., 1990, ALCOHOL HEALTH RES W, V14, P70; Lerner B. H, 2011, ONE ROAD DRUNK DRIVI; Luckin B, 2010, ADDICTION, V105, P1538, DOI 10.1111/j.1360-0443.2010.02983.x	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1870	1871		10.1016/S0140-6736(12)60798-3	http://dx.doi.org/10.1016/S0140-6736(12)60798-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	944IW	22616105				2022-12-28	WOS:000304194200015
J	Crisp, RJ; Meleady, R				Crisp, Richard J.; Meleady, Rose			ADAPTING TO A MULTICULTURAL FUTURE	SCIENCE			English	Editorial Material							REDUCE INTERGROUP BIAS; CATEGORIZATION; IDENTIFICATION; INDIVIDUALS; COGNITION	Humans have an evolved propensity to think categorically about social groups. This propensity is manifest in cognitive processes that have broad implications for public and political endorsement of multicultural policy. Drawing on these principles, we postulate a cognitive-evolutionary account of human adaptation to social diversity. This account explains broad social trends marking a resistance to multiculturalism, while providing an important reorienting call for scholars and policy-makers seeking intervention-based solutions to the problem of prejudice.	[Crisp, Richard J.; Meleady, Rose] Univ Kent, Sch Psychol, Ctr Study Grp Proc, Canterbury CT2 7NP, Kent, England	University of Kent	Crisp, RJ (corresponding author), Univ Kent, Sch Psychol, Ctr Study Grp Proc, Canterbury CT2 7NP, Kent, England.	r.crisp@kent.ac.uk	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; Meleady, Rose/0000-0002-4671-4960				Cantle T., 2001, COMMUNITY COHESION R; Caporael L R, 1997, Pers Soc Psychol Rev, V1, P276, DOI 10.1207/s15327957pspr0104_1; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; Crisp RJ, 2011, PSYCHOL BULL, V137, P242, DOI 10.1037/a0021840; Crisp RJ, 2001, PERS SOC PSYCHOL B, V27, P76, DOI 10.1177/0146167201271007; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Hall NR, 2005, PERS SOC PSYCHOL B, V31, P1435, DOI 10.1177/0146167205276084; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; Hutter RRC, 2009, GROUP PROCESS INTERG, V12, P673, DOI 10.1177/1368430209337471; Joppke C, 2004, BRIT J SOCIOL, V55, P237, DOI 10.1111/j.1468-4446.2004.00017.x; Kenrick DT, 2010, CURR DIR PSYCHOL SCI, V19, P63, DOI 10.1177/0963721409359281; Morrison KR, 2010, PERS SOC PSYCHOL B, V36, P1648, DOI 10.1177/0146167210386118; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; Plaut VC, 2010, PSYCHOL INQ, V21, P77, DOI 10.1080/10478401003676501; Rudmin FW, 2003, REV GEN PSYCHOL, V7, P3, DOI 10.1037/1089-2680.7.1.3; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Verkuyten M, 2005, J PERS SOC PSYCHOL, V88, P121, DOI 10.1037/0022-3514.88.1.121; Wolsko C, 2000, J PERS SOC PSYCHOL, V78, P635, DOI 10.1037//0022-3514.78.4.635	18	47	49	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					853	855		10.1126/science.1219009	http://dx.doi.org/10.1126/science.1219009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605761				2022-12-28	WOS:000304145600047
J	Eames, M; Kortemme, T				Eames, Matt; Kortemme, Tanja			Cost-Benefit Tradeoffs in Engineered lac Operons	SCIENCE			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; INTERDEPENDENCE; CONSEQUENCES; TRANSLATION; TRANSPORT; PRODUCTS	Cells must balance the cost and benefit of protein expression to optimize organismal fitness. The lac operon of the bacterium Escherichia coli has been a model for quantifying the physiological impact of costly protein production and for elucidating the resulting regulatory mechanisms. We report quantitative fitness measurements in 27 redesigned operons that suggested that protein production is not the primary origin of fitness costs. Instead, we discovered that the lac permease activity, which relates linearly to cost, is the major physiological burden to the cell. These findings explain control points in the lac operon that minimize the cost of lac permease activity, not protein expression. Characterizing similar relationships in other systems will be important to map the impact of cost/benefit tradeoffs on cell physiology and regulation.	[Eames, Matt; Kortemme, Tanja] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kortemme, T (corresponding author), Univ Calif San Francisco, Grad Grp Biophys, MC 2530, San Francisco, CA 94158 USA.	kortemme@cgl.ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Kortemme, Tanja/0000-0002-8494-680X	Sandler Program for Breakthrough Biomedical Research	Sandler Program for Breakthrough Biomedical Research	We thank C. Gross, A. Sali, B. Simmons, J. Tabor, R. Oberdorf, R. Ritterson, D. Stoebel, D. Dykhuizen, U. Alon, E. Dekel, A. Drummond, K. Geiler, J. Fraser, and A. Stein for discussions and comments, and McKenzie and Craig for the pGRG37 vector. This work was supported by the Sandler Program for Breakthrough Biomedical Research. Data are available in the supplementary materials.	Beckwith J. R., 1987, CELLULAR MOL BIOL, P1444; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DYKHUIZEN D, 1978, J BACTERIOL, V135, P876, DOI 10.1128/JB.135.3.876-882.1978; DYKHUIZEN D, 1980, ECOLOGY, V61, P1213, DOI 10.2307/1936839; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Green AL, 2000, J BIOL CHEM, V275, P23240, DOI 10.1074/jbc.M909202199; HUI A, 1984, EMBO J, V3, P623, DOI 10.1002/j.1460-2075.1984.tb01858.x; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OSUMI T, 1982, P NATL ACAD SCI-BIOL, V79, P1457, DOI 10.1073/pnas.79.5.1457; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; WILSON DM, 1980, FEBS LETT, V117, pK37, DOI 10.1016/0014-5793(80)80568-0; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	22	71	72	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					911	915		10.1126/science.1219083	http://dx.doi.org/10.1126/science.1219083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605776				2022-12-28	WOS:000304145600064
J	Bendavid, E; Holmes, CB; Bhattacharya, J; Miller, G				Bendavid, Eran; Holmes, Charles B.; Bhattacharya, Jay; Miller, Grant			HIV Development Assistance and Adult Mortality in Africa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESIDENTS EMERGENCY PLAN; SYSTEMATIC ANALYSIS; AIDS RELIEF; HEALTH; IMPACT	Context The effect of global health initiatives on population health is uncertain. Between 2003 and 2008, the US President's Emergency Plan for AIDS Relief (PEPFAR), the largest initiative ever devoted to a single disease, operated intensively in 12 African focus countries. The initiative's effect on all-cause adult mortality is unknown. Objective To determine whether PEPFAR was associated with relative changes in adult mortality in the countries and districts where it operated most intensively. Design, Setting, and Participants Using person-level data from the Demographic and Health Surveys, we conducted cross-country and within-country analyses of adult mortality (annual probability of death per 1000 adults between 15 and 59 years old) and PEPFAR's activities. Across countries, we compared adult mortality in 9 African focus countries (Ethiopia, Kenya, Mozambique, Namibia, Nigeria, Rwanda, Tanzania, Uganda, and Zambia) with 18 African nonfocus countries from 1998 to 2008. We performed subnational analyses using information on PEPFAR's programmatic intensity in Tanzania and Rwanda. We employed difference-in-difference analyses with fixed effects for countries and years as well as personal and time-varying area characteristics. Main Outcome Measure Adult all-cause mortality. Results We analyzed information on 1 538 612 adults, including 60 303 deaths, from 41 surveys in 27 countries, 9 of them focus countries. In 2003, age-adjusted adult mortality was 8.3 per 1000 adults in the focus countries (95% CI, 8.0-8.6) and 8.5 per 1000 adults (95% CI, 8.3-8.7) in the nonfocus countries. In 2008, mortality was 4.1 per 1000 (95% CI, 3.6-4.6) in the focus countries and 6.9 per 1000 (95% CI, 6.3-7.5) in the nonfocus countries. The adjusted odds ratio of mortality among adults living in focus countries compared with nonfocus countries between 2004 and 2008 was 0.84 (95% CI, 0.72-0.99; P=.03). Within Tanzania and Rwanda, the adjusted odds ratio of mortality for adults living in districts where PEPFAR operated more intensively was 0.83 (95% CI, 0.72-0.97; P=.02) and 0.75 (95% CI, 0.56-0.99; P=.04), respectively, compared with districts where it operated less intensively. Conclusions Between 2004 and 2008, all-cause adult mortality declined more in PEPFAR focus countries relative to nonfocus countries. It was not possible to determine whether PEPFAR was associated with mortality effects separate from reductions in HIV-specific deaths. JAMA. 2012;307(19):2060-2067	[Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Holmes, Charles B.] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20520 USA; [Miller, Grant] Natl Bur Econ Res, Cambridge, MA 02138 USA	Stanford University; Stanford University; Stanford University; National Bureau of Economic Research	Bendavid, E (corresponding author), Stanford Univ, Div Gen Med Disciplines, 251 Campus Dr, Stanford, CA 94305 USA.	ebd@stanford.edu		Miller, Grant/0000-0003-3191-2558	National Institute of Allergy and Infectious Diseases [K01-AI084582]; Dr George Rosenkranz Prize for Health Care Research in Developing Countries; National Institute of Child Health and Human Development; National Institute on Aging; Center on the Demography and Economics of Health and Aging [P30-AG17253]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dr George Rosenkranz Prize for Health Care Research in Developing Countries; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center on the Demography and Economics of Health and Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Bendavid is supported by the National Institute of Allergy and Infectious Diseases (K01-AI084582) and by the Dr George Rosenkranz Prize for Health Care Research in Developing Countries. Dr Miller receives support from the National Institute of Child Health and Human Development and the National Institute on Aging. Both received support from the Center on the Demography and Economics of Health and Aging (P30-AG17253).	Aliaga A, OPTIMAL SAMPLE SIZES; [Anonymous], IMPL GLOB HLTH IN CO; [Anonymous], DEM HLTH SURV; [Anonymous], BUDG TRACK STAT US F; Bendavid E, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6218; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Case A, 2011, DEMOGRAPHY, V48, P675, DOI 10.1007/s13524-011-0026-3; Countries, COUNTR; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Easterly W., 2002, ELUSIVE QUEST GROWTH; Easterly W, 2009, J ECON LIT, V47, P373, DOI 10.1257/jel.47.2.373; Fenner F., 1988, SMALLPOX ITS ERADICA, P1460; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Garrett L, 2007, FOREIGN AFF, V86, P14; Institute for Health Metrics and Evaluation, FIN GLOB HLTH 2010 D; Katz IT, 2008, NEW ENGL J MED, V359, P2412, DOI 10.1056/NEJMp0805791; Lewis M., 78 CTR GLOB DEV; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Over M, PEPFAR MIGHT BE SAVI; PATRIARCA PA, 1993, LANCET, V342, P1461, DOI 10.1016/0140-6736(93)92936-N; Pullum TW, 2008, ASSESSMENT QUALITY D; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Shen A, 2010, 18 INT AIDS C VIENN; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; The World Bank, WORLDW GOV IND; UNAIDS, GLOB REP UNAIDS REP; United Nations Population Division, WORLD POP PROSP 2010; USAID, US OV LOANS GRANTS G; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Wools-Kaloustian K, 2009, AIDS, V23, P195, DOI 10.1097/QAD.0b013e32831cc0e6; World Bank, WORLD DEV IND WDI	36	111	111	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2060	2067		10.1001/jama.2012.2001	http://dx.doi.org/10.1001/jama.2012.2001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942MM	22665105	Bronze, Green Accepted			2022-12-28	WOS:000304048200025
J	Ferreira, IR; Domingues, VS				Ferreira, Ivo R.; Domingues, Vital S.			Acro-osteolysis	LANCET			English	Editorial Material									[Ferreira, Ivo R.] Ctr Hosp Porto, Dept Radiol, Oporto, Portugal; [Domingues, Vital S.] Ctr Hosp Porto, Dept Internal Med, Oporto, Portugal; [Ferreira, Ivo R.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Ferreira, Ivo R.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal	Universidade do Minho		ivoferreira@ecsaude.uminho.pt							0	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					916	916		10.1016/S0140-6736(12)60275-X	http://dx.doi.org/10.1016/S0140-6736(12)60275-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22658741				2022-12-28	WOS:000308547300034
J	Herzig, S; Raemy, E; Montessuit, S; Veuthey, JL; Zamboni, N; Westermann, B; Kunji, ERS; Martinou, JC				Herzig, Sebastien; Raemy, Etienne; Montessuit, Sylvie; Veuthey, Jean-Luc; Zamboni, Nicola; Westermann, Benedikt; Kunji, Edmund R. S.; Martinou, Jean-Claude			Identification and Functional Expression of the Mitochondrial Pyruvate Carrier	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; LACTOCOCCUS-LACTIS; DEHYDROGENASE; SPECIFICITY; CATABOLISM; TRANSPORT; MEMBRANE	The transport of pyruvate, the end product of glycolysis, into mitochondria is an essential process that provides the organelle with a major oxidative fuel. Although the existence of a specific mitochondrial pyruvate carrier (MPC) has been anticipated, its molecular identity remained unknown. We report that MPC is a heterocomplex formed by two members of a family of previously uncharacterized membrane proteins that are conserved from yeast to mammals. Members of the MPC family were found in the inner mitochondrial membrane, and yeast mutants lacking MPC proteins showed severe defects in mitochondrial pyruvate uptake. Coexpression of mouse MPC1 and MPC2 in Lactococcus lactis promoted transport of pyruvate across the membrane. These observations firmly establish these proteins as essential components of the MPC.	[Herzig, Sebastien; Raemy, Etienne; Montessuit, Sylvie; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Veuthey, Jean-Luc] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Zamboni, Nicola] Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Westermann, Benedikt] Univ Bayreuth, D-95440 Bayreuth, Germany; [Kunji, Edmund R. S.] MRC, Mitochondria Biol Unit, Cambridge CB2 0XY, England	University of Geneva; University of Geneva; University of Bayreuth	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Kunji, Edmund/AAH-2362-2020; Zamboni, Nicola/K-3042-2012; Westermann, Benedikt/H-7766-2013; Herzig, Sebastien/AAA-8853-2019	Kunji, Edmund/0000-0002-0610-4500; Zamboni, Nicola/0000-0003-1271-1021; Westermann, Benedikt/0000-0002-2991-1604; Herzig, Sebastien/0000-0002-9329-2860; martinou, Jean-claude/0000-0002-9847-2051; Veuthey, Jean-Luc/0000-0002-7513-3241	Novartis Science Foundation; Swiss National Science Foundation [31003A-141068/1]; state of Geneva; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish	Novartis Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); state of Geneva; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to R. Loewith and F. Stutz for strains and technical help, L. Szweda for antibodies, A. Kastaniotis for technical help on lipoic acid determination, Y. Que for erythromycin resistance cassette, and H. Riezman, A. Jourdain, and the Martinou lab for fruitful discussions. This work was supported by Novartis Science Foundation (S. H.), the Swiss National Science Foundation (subsidy 31003A-141068/1 to J.-C.M.), and the state of Geneva.	Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; DICKINSON JR, 1992, J GEN MICROBIOL, V138, P2029, DOI 10.1099/00221287-138-10-2029; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591	17	432	457	10	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					93	96		10.1126/science.1218530	http://dx.doi.org/10.1126/science.1218530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628554				2022-12-28	WOS:000306053100051
J	Debe, MK				Debe, Mark K.			Electrocatalyst approaches and challenges for automotive fuel cells	NATURE			English	Review							OXYGEN REDUCTION REACTION; PLATINUM MONOLAYER ELECTROCATALYSTS; THIN-FILM ELECTROCATALYSTS; DEALLOYED PT-CU; SURFACE-AREA; NANOPOROUS METALS; O-2 REDUCTION; CATALYSTS; ALLOY; SHELL	Fuel cells powered by hydrogen from secure and renewable sources are the ideal solution for non-polluting vehicles, and extensive research and development on all aspects of this technology over the past fifteen years has delivered prototype cars with impressive performances. But taking the step towards successful commercialization requires oxygen reduction electrocatalysts-crucial components at the heart of fuel cells-that meet exacting performance targets. In addition, these catalyst systems will need to be highly durable, fault-tolerant and amenable to high-volume production with high yields and exceptional quality. Not all the catalyst approaches currently being pursued will meet those demands.	3M Co, Fuel Cell Components Program 3M, St Paul, MN 55144 USA	3M	Debe, MK (corresponding author), 3M Co, Fuel Cell Components Program 3M, St Paul, MN 55144 USA.	mkdebe1@mmm.com			Office of Energy Efficiency and Renewable Energy at the US Department of Energy [DE-FG36-07GO17007]	Office of Energy Efficiency and Renewable Energy at the US Department of Energy(United States Department of Energy (DOE))	I gratefully acknowledge support by the Fuel Cell Technologies Program in the Office of Energy Efficiency and Renewable Energy at the US Department of Energy, for grant DE-FG36-07GO17007.	Adzic R., 2011, 2011 DOE HYDROGEN PR; [Anonymous], 2010, GLOB CHIN LOW E GLAS; Atanasoska LL, 2011, ECS TRANSACTIONS, V41, P785, DOI 10.1149/1.3635612; Atanasoski R., 2009, ENCY ELECTROCHEMICAL, P639; Ball S, 2009, ECS TRANSACTIONS, V25, P1023, DOI 10.1149/1.3210655; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Bliznakov ST, 2011, ECS TRANSACTIONS, V41, P1055, DOI 10.1149/1.3635638; Chen S, 2010, J ELECTROCHEM SOC, V157, pA82, DOI 10.1149/1.3258275; Chen ZW, 2007, ANGEW CHEM INT EDIT, V46, P4060, DOI 10.1002/anie.200700894; Debe MK, 2011, ECS TRANSACTIONS, V41, P937, DOI 10.1149/1.3635628; Debe MK, 2011, J ELECTROCHEM SOC, V158, pB910, DOI 10.1149/1.3595748; Debe M. K., 2003, HDB FUEL CELLS FUNDA, V3; Debe M.K., 2006, ECS T, V3, P835; Debe M. K., 2006, ECS T, V1, P51; Debe M. K., 2006, P 50 ANN TECHN C SOC, P175; Debe M. K., 2011, 2009 2011 ANN MERIT; Debe MK, 2006, J POWER SOURCES, V161, P1002, DOI 10.1016/j.jpowsour.2006.05.033; Debe MK, 2012, ECS TRANSACTIONS, V45, P47, DOI 10.1149/1.3701968; Debe MK, 2012, J ELECTROCHEM SOC, V159, pB54, DOI 10.1149/2.032201jes; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Erlebacher J, 2009, ECS TRANSACTIONS, V25, P603, DOI 10.1149/1.3210611; Erlebacher J, 2009, MRS BULL, V34, P561, DOI 10.1557/mrs2009.155; Gancs L, 2008, CHEM MATER, V20, P2444, DOI 10.1021/cm702992b; Garsany Y, 2010, ANAL CHEM, V82, P6321, DOI 10.1021/ac100306c; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Gong KP, 2010, J AM CHEM SOC, V132, P14364, DOI 10.1021/ja1063873; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; Halalay IC, 2011, J ELECTROCHEM SOC, V158, pB313, DOI 10.1149/1.3530796; Haug A., 2010, 218 ECS M EL SOC; Haugen G, 2010, ACS SYM SER, V1040, P137; Imbeault R, 2010, J ELECTROCHEM SOC, V157, pB1051, DOI 10.1149/1.3428363; Ishihara A, 2010, ELECTROCHIM ACTA, V55, P8005, DOI 10.1016/j.electacta.2010.03.002; Knupp SL, 2010, ELECTROCATALYSIS, V1, P213, DOI 10.1007/s12678-010-0028-8; Koh S, 2008, J ELECTROCHEM SOC, V155, pB1281, DOI 10.1149/1.2988741; Kongkanand A, 2011, J ELECTROCHEM SOC, V158, pB1286, DOI 10.1149/2.013111jes; Korovina A., 2010, 218 ECS M EL SOC; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Lei M, 2011, J POWER SOURCES, V196, P3548, DOI 10.1016/j.jpowsour.2010.12.026; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Mani P, 2011, J POWER SOURCES, V196, P666, DOI 10.1016/j.jpowsour.2010.07.047; Markovic N., 2011, 2010 DOE HYDROGEN PR; Markovic NM, 2001, FUEL CELLS, V1, P105, DOI 10.1002/1615-6854(200107)1:2<105::AID-FUCE105>3.0.CO;2-9; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; Mayrhofer KJJ, 2008, ELECTROCHIM ACTA, V53, P3181, DOI 10.1016/j.electacta.2007.11.057; Moffat TP, 2009, J ELECTROCHEM SOC, V156, pB238, DOI 10.1149/1.3033515; Myers D., 2010, 2008 2010 DOE HYDROG; Neyerlin KC, 2009, J POWER SOURCES, V186, P261, DOI 10.1016/j.jpowsour.2008.10.062; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Oezaslan M, 2010, ECS TRANSACTIONS, V33, P333, DOI 10.1149/1.3484531; Park S, 2011, J ELECTROCHEM SOC, V158, pB297, DOI 10.1149/1.3530843; Paulus UA, 2002, ELECTROCHIM ACTA, V47, P3787, DOI 10.1016/S0013-4686(02)00349-3; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Ralph TR, 2002, PLATIN MET REV, V46, P3; Reiser CA, 2005, ELECTROCHEM SOLID ST, V8, pA273, DOI 10.1149/1.1896466; Russell AE, 2011, ECS TRANSACTIONS, V41, P55, DOI 10.1149/1.3635543; Schulenburg H, 2009, J PHYS CHEM C, V113, P4069, DOI 10.1021/jp808134j; SEPA DB, 1981, ELECTROCHIM ACTA, V26, P781, DOI 10.1016/0013-4686(81)90037-2; Shao MH, 2007, Z PHYS CHEM, V221, P1175, DOI 10.1524/zpch.2007.221.9-10.1175; Shao M, 2007, ELECTROCHEM COMMUN, V9, P2848, DOI 10.1016/j.elecom.2007.10.009; Shao M, 2011, J POWER SOURCES, V196, P2433, DOI 10.1016/j.jpowsour.2010.10.093; Snyder J, 2011, ECS TRANSACTIONS, V41, P1021, DOI 10.1149/1.3635634; Snyder J, 2010, NAT MATER, V9, P904, DOI [10.1038/NMAT2878, 10.1038/nmat2878]; Stamenkovic V, 2002, J PHYS CHEM B, V106, P11970, DOI 10.1021/jp021182h; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476; Steinbach AJ, 2011, ECS TRANSACTIONS, V41, P449, DOI 10.1149/1.3635579; Strasser P., 2006, ECS T, V3, P139; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; Thompsett D., 2003, HDB FUEL CELLS FUNDA; U.S. Department of Energy, EN EFF REN EN; van der Vliet D, 2011, ELECTROCHIM ACTA, V56, P8695, DOI 10.1016/j.electacta.2011.07.063; van derVliet D., NATURE MAT UNPUB; Vukmirovic MB, 2007, ELECTROCHIM ACTA, V52, P2257, DOI 10.1016/j.electacta.2006.05.062; Wagner F. T., 2011, 2011 DOE HYDROGEN PR; Wagner F.T., 2006, ECS T, V3, P19, DOI DOI 10.1149/1.2356119; Wagner FT, 2010, J PHYS CHEM LETT, V1, P2204, DOI 10.1021/jz100553m; Wagner Frederick T., 2008, 1 CARISMA INT C LA G; Wang C, 2011, ADV FUNCT MATER, V21, P147, DOI 10.1002/adfm.201001138; Wang C, 2010, PHYS CHEM CHEM PHYS, V12, P6933, DOI 10.1039/c000822b; Wang C, 2009, J PHYS CHEM C, V113, P19365, DOI 10.1021/jp908203p; Wang JX, 2009, J AM CHEM SOC, V131, P17298, DOI 10.1021/ja9067645; Wang SY, 2011, J AM CHEM SOC, V133, P5182, DOI 10.1021/ja1112904; Wang SY, 2010, ELECTROCHIM ACTA, V55, P7652, DOI 10.1016/j.electacta.2009.09.003; Wang X, 2005, ELECTROCHEM SOLID ST, V8, pA42, DOI 10.1149/1.1830397; Wipke K, 2011, CONTROLLED HYDROGEN; Wood TE, 2008, J POWER SOURCES, V178, P510, DOI 10.1016/j.jpowsour.2007.10.093; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Wu JB, 2010, J AM CHEM SOC, V132, P4984, DOI 10.1021/ja100571h; Xing YC, 2010, J PHYS CHEM LETT, V1, P3238, DOI 10.1021/jz101297r; Yang RZ, 2010, CHEM MATER, V22, P4712, DOI 10.1021/cm101090p; Zelenay P., 2010, 2010 DOE HYDROGEN PR; Zhang J, 2004, J PHYS CHEM B, V108, P10955, DOI 10.1021/jp0379953; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z; Zhou HJ, 2009, J PHYS CHEM C, V113, P5460, DOI 10.1021/jp811251j	96	4033	4101	168	3366	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					43	51		10.1038/nature11115	http://dx.doi.org/10.1038/nature11115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678278				2022-12-28	WOS:000304854000025
J	Ehrlich, PR; Kareiva, PM; Daily, GC				Ehrlich, Paul R.; Kareiva, Peter M.; Daily, Gretchen C.			Securing natural capital and expanding equity to rescale civilization	NATURE			English	Review							ECOSYSTEM SERVICES; HUMAN-POPULATION; SUSTAINABILITY; GROWTH; SCIENCE; ECOLOGY; CONSERVATION; BIODIVERSITY; MANAGEMENT; PAYMENTS	In biophysical terms, humanity has never been moving faster nor further from sustainability than it is now. Our increasing population size and per capita impacts are severely testing the ability of Earth to provide for peoples' most basic needs. Awareness of these circumstances has grown tremendously, as has the sophistication of efforts to address them. But the complexity of the challenge remains daunting. We explore prospects for transformative change in three critical areas of sustainable development: achieving a sustainable population size and securing vital natural capital, both in part through reducing inequity, and strengthening the societal leadership of academia.	[Ehrlich, Paul R.; Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kareiva, Peter M.] Nature Conservancy, Seattle, WA 98105 USA; [Daily, Gretchen C.] Stanford Univ, Woods Inst, Stanford, CA 94305 USA	Stanford University; Nature Conservancy; Stanford University	Ehrlich, PR (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	pre@stanford.edu			LuEsther T Mertz Charitable Trust; Moore Foundation; Winslow Foundation; Peter and Helen Bing	LuEsther T Mertz Charitable Trust; Moore Foundation(Gordon and Betty Moore Foundation); Winslow Foundation; Peter and Helen Bing	We are indebted to the following colleagues who were kind enough to give useful criticism: K. Arrow, P. Dasgupta, L. Goulder, R. Horn, D. Karp, S. Levin, C. Mendenhall, H. Mooney, P. Raven, E. Rosa, M. Ruckelshaus and H. Tallis. We are grateful for support from the LuEsther T Mertz Charitable Trust, the Moore Foundation, the Winslow Foundation, and Peter and Helen Bing.	Agarwal B, 2009, ECOL ECON, V68, P2785, DOI 10.1016/j.ecolecon.2009.04.025; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2011, 2011 WORLD POP DAT S; Ariely D, 2009, PREDICTABLY IRRATION; Aronson E., 2010, COOPERATION CLASSROO; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barrett Scott, 2003, ENV STATECRAFT STRAT; Baumol W., 1996, ENVIRON DEV ECON, V3, P221, DOI 10.1017/S1355770X98240125; Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137; Brown LE, 2009, PLAN B 4 0 MOBILIZIN; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Cialdini R.B., 2008, INFLUENCE SCI PRACTI; Clark W., 2006, GLOBAL ENV ASSESSMEN, P15; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Commoner, 1971, CLOSING CIRCLE; Cottam H., 2010, HARVARD INT REV; Daily G. C., 2002, NEW EC NATURE QUEST; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; DAILY GC, 1992, BIOSCIENCE, V42, P761, DOI 10.2307/1311995; Daily GC, 1996, ECOL APPL, V6, P991, DOI 10.2307/2269582; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dasgupta P., 2010, PLACE NATURE EC DEV, P4977; Dobbs R., 2011, RESOURCE REVOLUTION; Ehrlich P., 2010, HUMANITY TIGHTROPE T; EHRLICH PR, 1983, BIOSCIENCE, V33, P248, DOI 10.2307/1309037; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Ergas C., 2012, SOC SCI RES; Fishkin JS, 1996, ANN AM ACAD POLIT SS, V546, P132, DOI 10.1177/0002716296546001012; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Frank R.H, 2013, FALLING RISING INEQU, DOI DOI 10.1525/9780520957435; FUENTES ER, 1993, ECOL APPL, V3, P576, DOI 10.2307/1942085; Gleick P.H., 2012, WORLDS WATER, V7; Goldman-Benner RL, 2012, ORYX, V46, P55, DOI 10.1017/S0030605311001050; Hall CAS, 2009, AM SCI, V97, P230, DOI 10.1511/2009.78.230; Harff B, 2003, AM POLIT SCI REV, V97, P57, DOI 10.1017/S0003055403000522; Harte J, 2007, POPUL ENVIRON, V28, P223, DOI 10.1007/s11111-007-0048-3; Heal G.M., 2000, NATURE MARKETPLACE C; Hill A., 1995, FEMINIST EC, V1, P21, DOI DOI 10.1080/714042230; Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; HOLDREN JP, 1991, POPUL ENVIRON, V12, P231, DOI 10.1007/BF01357916; HOLDREN JP, 1974, AM SCI, V62, P282; International Energy Agency, 2021, KEY WORLD EN STAT; Johnston P, 2007, ENVIRON SCI POLLUT R, V14, P60, DOI 10.1065/espr2007.01.375; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kates RW, 2005, ENVIRONMENT, V47, P8; Kes A., 2006, GENDER TIME USE POVE, DOI [10.1596/978-0-8213-6561-8, DOI 10.1596/978-0-8213-6561-8]; Kindon SL, 2007, ROUTL STUD HUM GEOGR, V22, P1; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Klare Michael, 2012, RACE WHATS LEFT GLOB; Lakoff G., 2004, DONT THINK ELEPHANT; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; LEVIN SA, 1993, ECOL APPL, V3, P545; Li J., 2012, RURAL HOUSEHOLD LIVE; Li J, 2011, P NATL ACAD SCI USA, V108, P7721, DOI 10.1073/pnas.1101018108; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maeler KG, 2008, P NATL ACAD SCI USA, V105, P9501, DOI 10.1073/pnas.0708856105; Matson P, 2009, ISSUES SCI TECHNOL, V25, P39; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Miller C, 2001, SCI TECHNOL HUM VAL, V26, P478, DOI 10.1177/016224390102600405; National Academy of Sciences USA, 1993, POP SUMM WORLD SCI A; National Research Council (NRC), 2005, VALUING ECOSYSTEM SE; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Perrow C, 2007, NEXT CATASTROPHE: REDUCING OUR VULNERABILITIES TO NATURAL, INDUSTRIAL, AND TERRORIST DISASTERS, P1; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Potts M, 2009, PHILOS T R SOC B, V364, P3115, DOI 10.1098/rstb.2009.0181; Rees W. E., 2011, ENCY BIODIVERSITY; Robinson J. A., 2010, NATURAL EXPT HIST; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosa EA, 2004, AMBIO, V33, P509, DOI 10.1639/0044-7447(2004)033[0509:TTADOE]2.0.CO;2; Sedgh G, 2007, 37 GUTTM I; Shandra JM, 2008, POPUL ENVIRON, V30, P48, DOI 10.1007/s11111-008-0073-x; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Spence M., 2011, NEXT CONVERGENCE FUT; Study of Critical Environmental Problems, 1970, MANS IMPACT GLOBAL E; Sukhdev P, 2009, NATURE, V462, P277, DOI 10.1038/462277a; Tallis H, 2009, FRONT ECOL ENVIRON, V7, P12, DOI 10.1890/080012; Thurow L., 1975, GENERATING INEQUALTI; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; Union of Concerned Scientists, 1993, WORLD SCI WARN HUM; United Nations Department of Economic & Social Affairs, 2011, WORLD EC SOC SURV 20; Walzer M., 1984, SPHERES JUSTICE DEFE; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Westley F, 2011, AMBIO, V40, P762, DOI 10.1007/s13280-011-0186-9; Wheeler D., 2012, QUANTIFYING VULNERAB, DOI 10.2139/ssrn.1824611; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR; World Business Council for Sustainable Development, 2010, VIS 2050 NEW AG BUS; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; World Health Organization, 2011, WORLD HLTH STAT 2011	100	133	147	2	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					68	73		10.1038/nature11157	http://dx.doi.org/10.1038/nature11157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678281				2022-12-28	WOS:000304854000028
J	Smallwood, CL; Hinton, JP; Jozwiak, C; Zhang, WT; Koralek, JD; Eisaki, H; Lee, DH; Orenstein, J; Lanzara, A				Smallwood, Christopher L.; Hinton, James P.; Jozwiak, Christopher; Zhang, Wentao; Koralek, Jake D.; Eisaki, Hiroshi; Lee, Dung-Hai; Orenstein, Joseph; Lanzara, Alessandra			Tracking Cooper Pairs in a Cuprate Superconductor by Ultrafast Angle-Resolved Photoemission	SCIENCE			English	Article							QUASI-PARTICLE; LIFETIMES	In high-temperature superconductivity, the process that leads to the formation of Cooper pairs, the fundamental charge carriers in any superconductor, remains mysterious. We used a femtosecond laser pump pulse to perturb superconducting Bi2Sr2CaCu2O8+delta and studied subsequent dynamics using time-and angle-resolved photoemission and infrared reflectivity probes. Gap and quasiparticle population dynamics revealed marked dependencies on both excitation density and crystal momentum. Close to the d-wave nodes, the superconducting gap was sensitive to the pump intensity, and Cooper pairs recombined slowly. Far from the nodes, pumping affected the gap only weakly, and recombination processes were faster. These results demonstrate a new window into the dynamical processes that govern quasiparticle recombination and gap formation in cuprates.	[Smallwood, Christopher L.; Hinton, James P.; Lee, Dung-Hai; Orenstein, Joseph; Lanzara, Alessandra] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Smallwood, Christopher L.; Hinton, James P.; Zhang, Wentao; Koralek, Jake D.; Lee, Dung-Hai; Orenstein, Joseph; Lanzara, Alessandra] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Jozwiak, Christopher] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Eisaki, Hiroshi] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba 3058568, Japan	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Advanced Industrial Science & Technology (AIST)	Lanzara, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	alanzara@lbl.gov	Eisaki, Hiroshi/F-6317-2018; lanzara, alessandra/AAC-9535-2020; Orenstein, Joseph W/I-3451-2015; Smallwood, Christopher/D-4925-2011; ZHANG, Wentao/B-3626-2011	Eisaki, Hiroshi/0000-0002-8299-6416; Smallwood, Christopher/0000-0002-4103-8748; ZHANG, Wentao/0000-0001-8904-1252; Koralek, Jake/0000-0001-8289-0497; Jozwiak, Chris/0000-0002-0980-3753	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank R. A. Kaindl, D. A. Siegel, S. D. Lounis, T. Miller, and R. Johnson for useful discussions. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Beck M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.177007; Cortes R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.097002; Coslovich G, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064519; Cuk T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117003; Demsar J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.267002; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; Gedik N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117005; Gedik N, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014504; Giannetti C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224502; Graf J, 2011, NAT PHYS, V7, P805, DOI 10.1038/nphys2027; Kabanov VV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.147002; Kaindl RA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060510; KAPLAN SB, 1976, PHYS REV B, V14, P4854, DOI 10.1103/PhysRevB.14.4854; Kusar P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.227001; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; Norman MR, 1998, PHYS REV B, V57, pR11093, DOI 10.1103/PhysRevB.57.R11093; Perfetti L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.197001; Petersen JC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.177402; Rettig L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097002; Rohwer T, 2011, NATURE, V471, P490, DOI 10.1038/nature09829; ROTHWARF A, 1967, PHYS REV LETT, V19, P27, DOI 10.1103/PhysRevLett.19.27; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Schrieffer JR, 1999, THEORY SUPERCONDUCTI; Segre GP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137001; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Torchinsky DH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104518; Torchinsky DH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027005	28	154	155	1	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1137	1139		10.1126/science.1217423	http://dx.doi.org/10.1126/science.1217423			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654053	Green Submitted			2022-12-28	WOS:000304647900043
J	Shahin, J; Harrison, DA; Rowan, KM				Shahin, Jason; Harrison, David A.; Rowan, Kathryn M.			Relation between volume and outcome for patients with severe sepsis in United Kingdom: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							MIX PROGRAM DATABASE; CARE-NATIONAL-AUDIT; LENGTH-OF-STAY; INTENSIVE-CARE; MECHANICAL VENTILATION; HOSPITAL VOLUME; NORTHERN-IRELAND; HEALTH-CARE; MORTALITY; ORGANIZATION	Objective To evaluate whether a relation exists between volume and outcome for admissions with severe sepsis to adult general critical care units in the United Kingdom. Design Retrospective cohort study using data from a pooled case mix and outcome database. Setting Adult general critical care units participating in the case mix programme. Participants Consecutive admissions to participating units for the years 2008-09 meeting objective, standardised criteria for severe sepsis. Main outcome measures Mortality at ultimate discharge from acute hospital. Results The primary exposure was volume of admissions with severe sepsis per unit per year. A multivariable logistic regression analysis, using generalised estimating equations, was used to assess the association between volume, modelled using fractional polynomials, and ultimate acute hospital mortality while adjusting for potential confounders. No relation was seen between volume and outcome for admissions with severe sepsis to adult, general critical care units in the UK. Subgroup analyses tested for interactions between the effect of volume and acute severity of illness or receipt of mechanical ventilation. No significant interactions were found. Conclusions This study showed no relation between volume and outcome in admissions with severe sepsis treated in adult general critical care units in the UK.	[Shahin, Jason] McGill Univ, Dept Crit Care, Dept Med, Div Resp, Montreal, PQ H3G 1A4, Canada; [Shahin, Jason; Harrison, David A.; Rowan, Kathryn M.] ICNARC, London WC1H 9HR, England	McGill University; Intensive Care National Audit & Research Centre	Shahin, J (corresponding author), McGill Univ, Dept Crit Care, Dept Med, Div Resp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	Jason.shahin@mcgill.ca	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Rowan, Kathryn/0000-0001-8217-5602	Fonds de Recherche du Quebec-Sante	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This research received no specific funding. JS was funded through a bursary provided by the Fonds de Recherche du Quebec-Sante.	Angus DC, 2004, LANCET, V363, P1314, DOI 10.1016/S0140-6736(04)16007-8; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Christian CK, 2005, WORLD J SURG, V29, P1241, DOI 10.1007/s00268-005-7993-8; Goldfrad CK, 2000, J EPIDEMIOL COMMUNIT, V54, P779; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; Kahn JM, 2008, CRIT CARE MED, V36, P3085, DOI 10.1097/CCM.0b013e31818c37b2; Kahn JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5776; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2009, HEALTH SERV RES, V44, P862, DOI 10.1111/j.1475-6773.2009.00959.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; London Trauma Office, 2010, LOND TRAUM SYST; May Susanne, 2005, Dose-Response, V3, P474, DOI 10.2203/dose-response.003.04.004; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Needham DM, 2006, CRIT CARE MED, V34, P2349, DOI 10.1097/01.CCM.0000233858.85802.5C; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Parry G, 2003, BRIT MED J, V326, P280; Peelen L, 2007, CRIT CARE, V11, DOI 10.1186/cc5727; Ramnarayan P, 2010, LANCET, V376, P698, DOI 10.1016/S0140-6736(10)61113-0; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Royston P., 2008, MULTIVARIABLE MODEL; The Information Centre, 2010, LIST DAT; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289	26	40	40	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3394	10.1136/bmj.e3394	http://dx.doi.org/10.1136/bmj.e3394			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645208	hybrid, Green Published			2022-12-28	WOS:000304855700002
J	Reed, JC; Pellecchia, M				Reed, John C.; Pellecchia, Maurizio			Ironing Out Cell Death Mechanisms	CELL			English	Editorial Material							OXIDATIVE STRESS; CANCER-CELLS; METABOLISM	Historically, key cellular regulators of diverse physiological processes have been uncovered by studying the mechanisms by which chemical entities produce interesting biological pheno-types. In this issue, Dixon et al. interrogate compounds that selectively kill oncogene-expressing cells, providing support for the existence of an iron-requiring, regulated form of cell death, ferroptosis.	[Reed, John C.; Pellecchia, Maurizio] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	jreed@sanfordburnham.org	Pellecchia, Maurizio/Y-7072-2018		NATIONAL CANCER INSTITUTE [R01CA168517] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aracena P, 2006, BIOL RES, V39, P157, DOI 10.4067/S0716-97602006000100017; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Ramanathan RK, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e13042; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010	10	49	50	6	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					963	965		10.1016/j.cell.2012.05.009	http://dx.doi.org/10.1016/j.cell.2012.05.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632964	Bronze			2022-12-28	WOS:000304453900003
J	Lin, LY; Wong, JU				Lin, Li-Ying; Wong, Jia-Uei			Meconium-like Ileus in Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lin, Li-Ying; Wong, Jia-Uei] Cathay Gen Hosp, Taipei, Taiwan	Cathay General Hospital	Lin, LY (corresponding author), Cathay Gen Hosp, Taipei, Taiwan.	lylinbsb2000@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					2017	2017						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621629				2022-12-28	WOS:000304353000012
J	Ngaki, MN; Louie, GV; Philippe, RN; Manning, G; Pojer, F; Bowman, ME; Li, L; Larsen, E; Wurtele, ES; Noel, JP				Ngaki, Micheline N.; Louie, Gordon V.; Philippe, Ryan N.; Manning, Gerard; Pojer, Florence; Bowman, Marianne E.; Li, Ling; Larsen, Elise; Wurtele, Eve Syrkin; Noel, Joseph P.			Evolution of the chalcone-isomerase fold from fatty-acid binding to stereospecific catalysis	NATURE			English	Article							REACTION-MECHANISM; FUNCTIONAL GENOMICS; DIFFRACTION DATA; ARABIDOPSIS; GENE; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS; ALIGNMENT; PROGRAM	Specialized metabolic enzymes biosynthesize chemicals of ecological importance, often sharing a pedigree with primary metabolic enzymes(1). However, the lineage of the enzyme chalcone isomerase (CHI) remained unknown. In vascular plants, CHI-catalysed conversion of chalcones to chiral (S)-flavanones is a committed step in the production of plant flavonoids, compounds that contribute to attraction, defence(2) and development(3). CHI operates near the diffusion limit with stereospecific control(4,5). Although associated primarily with plants, the CHI fold occurs in several other eukaryotic lineages and in some bacteria. Here we report crystal structures, ligand-binding properties and in vivo functional characterization of a non-catalytic CHI-fold family from plants. Arabidopsis thaliana contains five actively transcribed genes encoding CHI-fold proteins, three of which additionally encode amino-terminal chloroplast-transit sequences. These three CHI-fold proteins localize to plastids, the site of de novo fatty-acid biosynthesis in plant cells. Furthermore, their expression profiles correlate with those of core fatty-acid biosynthetic enzymes, with maximal expression occurring in seeds and coinciding with increased fatty-acid storage in the developing embryo. In vitro, these proteins are fatty-acid-binding proteins (FAPs). FAP knockout A. thaliana plants show elevated alpha-linolenic acid levels and marked reproductive defects, including aberrant seed formation. Notably, the FAP discovery defines the adaptive evolution of a stereospecific and catalytically 'perfected' enzyme(6) from a non-enzymatic ancestor over a defined period of plant evolution.	[Ngaki, Micheline N.; Li, Ling; Wurtele, Eve Syrkin] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Louie, Gordon V.; Philippe, Ryan N.; Pojer, Florence; Bowman, Marianne E.; Larsen, Elise; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Iowa State University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Wurtele, ES (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mash@iastate.edu; noel@salk.edu	Manning, Gerard/C-8308-2009; Li, Ling/B-6598-2012; Li, Ling/AGY-7810-2022; Noel, Joseph P/A-9459-2009	Li, Ling/0000-0003-2371-6215; Li, Ling/0000-0003-2371-6215; Wurtele, Eve/0000-0003-1552-9495; Manning, Gerard/0000-0002-5087-9151	Fulbright Fellowship; National Science Foundation [MCB-0645794, EEC-0813570, MCB-0951170]; National Cancer Institute [CA14195]; Plant Sciences Institute at Iowa State University; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Fulbright Fellowship; National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Plant Sciences Institute at Iowa State University; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Perera, B. Nikolau, H. Ilarsan and J. Peng for technical training (to M.N.N.), J. Peng for the fap1-1 homozygote mutant line, D. Nettleton and H. Wang for statistical analysis of initial seed fatty-acid data, and Eric Scheeff for assistance in Bayesian phylogenetic analysis. This research was supported in part by a Fulbright Fellowship (to M.N.N.). This material is based in part upon work supported by the National Science Foundation under award number MCB-0645794 (to J.P.N.), EEC-0813570 (to E. S. W.), MCB-0951170 (to E. S. W.), and by National Cancer Institute award number CA14195 (to G. M.) and the Plant Sciences Institute at Iowa State University (to E. S. W). J.P.N. is an investigator with the Howard Hughes Medical Institute. Portions of this research were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the US Department of Energy, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences. We thank the staff at the Advanced Light Source for assistance with X-ray data collection. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davies N. A., 1998, NEW AUTOMATED MASS S; DeLano W.L, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Fatland BL, 2005, PLANT CELL, V17, P182, DOI 10.1105/tpc.104.026211; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Gensheimer M, 2004, PROTEIN SCI, V13, P540, DOI 10.1110/ps.03395404; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Invitrogen, 2003, INVITROGEN GATEWAY T; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jez JM, 2000, NAT STRUCT BIOL, V7, P786, DOI 10.1038/79025; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li L, 2007, J EXP BOT, V58, P3323, DOI 10.1093/jxb/erm180; Lohar DP, 2001, J EXP BOT, V52, P1697, DOI 10.1093/jexbot/52.361.1697; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-76; Moon S., 2009, PLANTMETABOLOMICS PL; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oursel D, 2007, RAPID COMMUN MASS SP, V21, P3229, DOI 10.1002/rcm.3177; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Perera MADN, 2003, ADVANCED RESEARCH ON PLANT LIPIDS, P225; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	56	122	135	7	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					530	U147		10.1038/nature11009	http://dx.doi.org/10.1038/nature11009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622584	Green Accepted			2022-12-28	WOS:000304344500049
J	Pyenson, ND; Goldbogen, JA; Vogl, AW; Szathmary, G; Drake, RL; Shadwick, RE				Pyenson, Nicholas D.; Goldbogen, Jeremy A.; Vogl, A. Wayne; Szathmary, Gabor; Drake, Richard L.; Shadwick, Robert E.			Discovery of a sensory organ that coordinates lunge feeding in rorqual whales	NATURE			English	Article							FIN WHALES; MYSTICETE; MECHANICS; CETACEA; BALEEN	Top ocean predators have evolved multiple solutions to the challenges of feeding in the water(1-3). At the largest scale, rorqual whales (Balaenopteridae) engulf and filter prey-laden water by lunge feeding(4), a strategy that is unique among vertebrates(1). Lunge feeding is facilitated by several morphological specializations, including bilaterally separate jaws that loosely articulate with the skull(5,6), hyper-expandable throat pleats, or ventral groove blubber(7), and a rigid y-shaped fibrocartilage structure branching from the chin into the ventral groove blubber(8). The linkages and functional coordination among these features, however, remain poorly understood. Here we report the discovery of a sensory organ embedded within the fibrous symphysis between the unfused jaws that is present in several rorqual species, at both fetal and adult stages. Vascular and nervous tissue derived from the ancestral, anterior-most tooth socket insert into this organ, which contains connective tissue and papillae suspended in a gel-like matrix. These papillae show the hallmarks of a mechanoreceptor, containing nerves and encapsulated nerve termini. Histological, anatomical and kinematic evidence indicate that this sensory organ responds to both the dynamic rotation of the jaws during mouth opening and closure, and ventral groove blubber(7) expansion through direct mechanical linkage with the y-shaped fibrocartilage structure. Along with vibrissae on the chin(9), providing tactile prey sensation, this organ provides the necessary input to the brain for coordinating the initiation, modulation and end stages of engulfment, a paradigm that is consistent with unsteady hydrodynamic models and tag data from lunge-feeding rorquals(10-13). Despite the antiquity of unfused jaws in baleen whales since the late Oligocene(14) (similar to 23-28 million years ago), this organ represents an evolutionary novelty for rorquals, based on its absence in all other lineages of extant baleen whales. This innovation has a fundamental role in one of the most extreme feeding methods in aquatic vertebrates, which facilitated the evolution of the largest vertebrates ever.	[Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA; [Goldbogen, Jeremy A.] Cascadia Res Collect, Olympia, WA 98501 USA; [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Szathmary, Gabor] FPInnovations, Vancouver, BC V6T 1W5, Canada; [Drake, Richard L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA; [Shadwick, Robert E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Smithsonian Institution; Smithsonian National Museum of Natural History; University of British Columbia; Case Western Reserve University; Cleveland Clinic Foundation; University of British Columbia	Pyenson, ND (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, POB 37012, Washington, DC 20013 USA.	pyensonn@si.edu	Goldbogen, Jeremy A./H-4287-2019	Goldbogen, Jeremy A./0000-0002-4170-7294; Pyenson, Nicholas/0000-0003-4678-5782	Natural Sciences and Engineering Research Council of Canada; Smithsonian Institution; Remington Kellogg Fund; University of British Columbia; Scripps Postdoctoral Research Fellowship; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Smithsonian Institution(Smithsonian Institution); Remington Kellogg Fund; University of British Columbia; Scripps Postdoctoral Research Fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	For logistical support, we thank K. Loftsson and the staff at Hvalur hf; D. Olafsdottir, S. D. Halldorsson and G. A. Vikingsson at the Marine Research Institute, Reykjavik; G. Bergmann and the staff at Hrefnuveioimenn ehf; S. Raverty; P. F. Brodie; and A. Trites. For additional samples and data, we also thank P.-Y. Daoust, G. Williams, the Amarok Hunters and Trappers Organization of Iqaluit, Captain S. Awa and the Inuit whaling crew from Iqaluit, J. Higgins and the Cascadia Research Collective, M. R. Buono, A. van Helden and the Museum of New Zealand Te Papa Tongarewa, and R. E. Fordyce. We also thank T. S. Hunter for assistance with laboratory samples. Comments from D. J. Bohaska, M. T. Carrano, R. B. Irmis, J. G. Mead, J. F. Parham, C. W. Potter and J. Velez-Juarbe improved this manuscript. N.D.P. was supported by a postdoctoral research fellowship from the Natural Sciences and Engineering Research Council of Canada and by funding from the Smithsonian Institution and its Remington Kellogg Fund. J. A. G. was supported by a University Graduate Fellowship for Research from the University of British Columbia, a Scripps Postdoctoral Research Fellowship and NSERC funding to R.E.S.	BEST RC, 1981, CAN J ZOOL, V59, P2386, DOI 10.1139/z81-319; Brodie Paul F., 2001, P345; BRODIE PF, 1993, CAN J ZOOL, V71, P2546, DOI 10.1139/z93-348; Canning C, 2011, ANIM BEHAV, V82, P901, DOI 10.1016/j.anbehav.2011.07.031; Catania KC, 2008, P NATL ACAD SCI USA, V105, P571, DOI 10.1073/pnas.0709534104; Currey JD, 2002, BONES STRUCTURE MECH; Czech-Damal NU, 2012, P ROY SOC B-BIOL SCI, V279, P663, DOI 10.1098/rspb.2011.1127; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; Fitzgerald EMG, 2010, ZOOL J LINN SOC-LOND, V158, P367, DOI 10.1111/j.1096-3642.2009.00572.x; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; LAMBERTSEN R, 1995, J MAMMAL, V76, P877, DOI 10.2307/1382758; LAMBERTSEN RH, 1983, J MAMMAL, V64, P76, DOI 10.2307/1380752; Ling J. K., 1977, P387; McKenna M. F., 2011, MAR MAMM SCI; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; PIVORUNAS A, 1977, J MORPHOL, V151, P299, DOI 10.1002/jmor.1051510207; Potvin J, 2010, J THEOR BIOL, V267, P437, DOI 10.1016/j.jtbi.2010.08.026; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; SANDERSON SL, 1993, SKULL, V3, P37; SCAPINO R, 1981, J MORPHOL, V167, P339, DOI 10.1002/jmor.1051670308; TERSHY BR, 1992, MAR MAMMAL SCI, V8, P315, DOI 10.1111/j.1748-7692.1992.tb00416.x; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]	30	71	71	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					498	501		10.1038/nature11135	http://dx.doi.org/10.1038/nature11135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622577				2022-12-28	WOS:000304344500042
J	Prasad, C				Prasad, Charushree			A Train of Hope, and a Chance to Train	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Prasad, C (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada.	cprasad2014@meds.uwo.ca	Prasad, Charushree/AAS-3122-2021	Prasad, Charushree/0000-0002-7214-1799					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2039	2040		10.1001/jama.2012.3580	http://dx.doi.org/10.1001/jama.2012.3580			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665102	Bronze			2022-12-28	WOS:000304048200022
J	Haines, A; Alleyne, G; Kickbusch, I; Dora, C				Haines, Andy; Alleyne, George; Kickbusch, Ilona; Dora, Carlos			From the Earth Summit to Rio+20: integration of health and sustainable development	LANCET			English	Review							CLIMATE-CHANGE; PHYSICAL-ACTIVITY; BENEFITS; STRATEGIES; MORTALITY; EXERCISE; TRAVEL	In 2012, world leaders will meet at the Rio+20 conference to advance sustainable development-20 years after the Earth Summit that resulted in agreement on important principles but insufficient action. Many of the development goals have not been achieved partly because social (including health), economic, and environmental priorities have not been addressed in an integrated manner. Adverse trends have been reported in many key environmental indicators that have worsened since the Earth Summit. Substantial economic growth has occurred in many regions but nevertheless has not benefited many populations of low income and those that have been marginalised, and has resulted in growing inequities. Variable progress in health has been made, and inequities are persistent. Improved health contributes to development and is underpinned by ecosystem stability and equitable economic progress. Implementation of policies that both improve health and promote sustainable development is urgently needed.	[Haines, Andy] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Haines, Andy] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Kickbusch, Ilona] Grad Inst, Global Hlth Programme, Geneva, Switzerland; [Dora, Carlos] WHO, Dept Publ Hlth & Environm, Intervent Hlth Environm Unit, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Pan American Health Organization; World Health Organization	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	andy.haines@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605				Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 1999, DEV FREEDOM; Apple J, 2010, INDOOR AIR, V20, P399, DOI 10.1111/j.1600-0668.2010.00664.x; Biermann F, REFORMING GLOBAL ENV; Carbon Trust, INT CARB FLOWS; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chapman R, 2009, J EPIDEMIOL COMMUN H, V63, P271, DOI 10.1136/jech.2007.070037; Chertow MR., 2000, J IND ECOL, V4, P13, DOI [DOI 10.1162/10881980052541927, 10.1162/10881980052541927]; Co-chairs of the High-level Panel on Global Sustainability, 2012, RES PEOPL RES PLAN F; Commission on the Measurement of Economic Performance and Social Progress, 2009, REP; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; Division for Sustainable Development UN Department of Economic and Social Affairs, 2011, SUST DEV 21 CENT REV; Division for Sustainable Development UN Department of Economic and Social Affairs, 2012, SUST DEV 21 CENT REV; Earth System Research Laboratory, 2012, TRENDS ATM CARB DIOX; European Environment Agency, 2011, 15 EUR ENV AG; FAO, 2006, LIV LONG SHAD; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Haines A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1018; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Institute of Grocery Distribution, 2007, EMB WAT FOOD PROD; International Energy Agency, 2010, EN POV MAK MOD EN AC; International Energy Agency, 2011, WORLD EN OUTL 2011; International Food Policy Research Institute, 2008, BIOF FOOD SEC BAL NE; Ivanova M., 2012, GLOBAL GOVERNANCE 21; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Kickbusch I, 2010, IMPLEMENTING HLTH AL; Lobelia Earth, 2021, AIR QUAL HLTH; MacKay DJC, 2010, EXP AGR, V46, P117; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; NCD Alliance, 2012, TACKL NONC DIS ENH S; Passel G, 2008, PEW RES CTR REP US P; Pruss-Ustun A., 2006, WORLD HEALTH; Raworth K., 2012, SAFE JUST SPACE HUMA, DOI DOI 10.5822/978-1-61091-458-1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Smith KR, 2005, ANNU REV ENV RESOUR, V30, P291, DOI 10.1146/annurev.energy.30.050504.144424; Steinberger JK, 2012, NAT CLIM CHANGE, V2, P81, DOI [10.1038/NCLIMATE1371, 10.1038/nclimate1371]; The Secretary General's Advisory Group on Energy and Climate, 2010, EN SUST FUT SUMM REP; Transport and Main Roads, 2011, BEN INCL ACT TRANSP; UN, 2006, JOH SUMM 2002 BAS IN; UN, POL DECL AD HIGH LEV; UN Department of Economic and Social Affairs, 2009, AG 21; UNDP, 2010, HUMAN DEV REPORT 201, DOI [10.2307/2137795, DOI 10.2307/2137795]; UNEP, 2011, KEEP TRACK OUR CHANG; UNEP, 2011, SHAP INT GOV SYST EN; UNITAID, 2012, INN FIN WORKS; United Nations Department of Economic and Social Affairs Population Division, 2010, WORLD POP PROSP 2010; van Grinsven Hans J M, 2006, Environ Health, V5, P26, DOI 10.1186/1476-069X-5-26; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; *WHO, 2002, GLOB DIET NONC DIS; WHO Executive Board, 2012, UN C RIO 20 JAN 19; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; World Health Organization, 2012, WHO FRAM CONV TOB CO; World Health Organization, 2010, WHO GLOB COD PRACT I; World Health Organization, 2012, OTT CHART HLTH PROM; World Health Organization, 2011, RIO POL DECL SOC DET; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization, 2011, GLOB REC PHYS ACT HL; World Health Organization (WHO), 2016, INT HLTH REG 2005; World Wildlife Fund, 2012, LIV PLAN REP 2012; Young O.R., 1994, INT GOVERNANCE PROTE	75	44	47	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2189	2197		10.1016/S0140-6736(12)60779-X	http://dx.doi.org/10.1016/S0140-6736(12)60779-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955BA	22682465				2022-12-28	WOS:000304990900035
J	Boehme, C; McCamey, DR				Boehme, Christoph; McCamey, Dane R.			Nuclear-Spin Quantum Memory Poised to Take the Lead	SCIENCE			English	Editorial Material							SINGLE-SHOT READOUT; ELECTRON-SPIN; SILICON		[Boehme, Christoph] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [McCamey, Dane R.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	Utah System of Higher Education; University of Utah; University of Sydney	Boehme, C (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	boehme@physics.utah.edu; dane.mccamey@sydney.edu.au	McCamey, Dane/A-1206-2011	McCamey, Dane/0000-0001-7727-6804				Becker P, 2010, PHYS STATUS SOLIDI A, V207, P49, DOI 10.1002/pssa.200925148; Bernien H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.043604; Dreher L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.027602; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; McCamey DR, 2010, SCIENCE, V330, P1652, DOI 10.1126/science.1197931; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256	15	17	17	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1239	1240		10.1126/science.1223439	http://dx.doi.org/10.1126/science.1223439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679086				2022-12-28	WOS:000304905300025
J	Hering, JG; Ingold, KM				Hering, Janet G.; Ingold, Karin M.			Water Resources Management: What Should Be Integrated?	SCIENCE			English	Editorial Material							GOVERNANCE		[Hering, Janet G.; Ingold, Karin M.] Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Hering, Janet G.] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland; [Hering, Janet G.] Swiss Fed Inst Technol, Sch Architecture Civil & Environm Engn, CH-1015 Lausanne, Switzerland; [Ingold, Karin M.] Univ Bern, Inst Polit Sci, CH-3000 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern	Hering, JG (corresponding author), Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.	janet.hering@eawag.ch	Ingold, Karin/H-5390-2012					Anderson A, 2008, WATER SA, V34, P665; [Anonymous], WAT DRAFT EX SUMM; [Anonymous], 2004, INTEGRATED WATER RES; Asano T, 2007, WATER REUSE ISSUES T; Biswas AK, 2008, INT J WATER RESOUR D, V24, P5, DOI 10.1080/07900620701871718; Blignaut J, 2009, WATER SA, V35, P415; Bolleyer N, 2010, EUR POLIT SCI REV, V2, P157, DOI 10.1017/S175577391000007X; Borchardt D., 2011, DRESD INT C INT WAT; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Brown J, 2011, GEOGR J, V177, P171, DOI 10.1111/j.1475-4959.2010.00378.x; Cash DW, 2006, ECOL SOC, V11; Engle N.L., 2011, ECOL SOC, V16; FAO, HOT ISS WAT SCARC; Gallego-Ayala J, 2011, PHYS CHEM EARTH, V36, P1103, DOI 10.1016/j.pce.2011.07.040; Gerber JD, 2009, ECOL ECON, V68, P798, DOI 10.1016/j.ecolecon.2008.06.013; Hering JG, 2012, ENVIRON SCI TECHNOL, V46, P112, DOI 10.1021/es202189s; Hooghe L, 2003, AM POLIT SCI REV, V97, P233; Ingold K, 2010, LOCAL ENVIRON, V15, P651, DOI 10.1080/13549839.2010.498811; INGRAM HM, 1984, WATER RESOUR RES, V20, P323, DOI 10.1029/WR020i003p00323; Merrey DJ, 2008, PHYS CHEM EARTH, V33, P899, DOI 10.1016/j.pce.2008.06.026; Movik S, 2011, WATER POLICY, V13, P161, DOI 10.2166/wp.2010.216; Oelkers EH, 2011, ELEMENTS, V7, P157, DOI 10.2113/gselements.7.3.157; Papadopoulos Y, 2010, WEST EUR POLIT, V33, P1030, DOI 10.1080/01402382.2010.486126; Rauschmayer F., 2009, Environmental Policy and Governance, V19, P141, DOI 10.1002/eet.504; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; Schreiner B, 2011, GLOB ISS WATER POL, V2, P271, DOI 10.1007/978-90-481-9367-7_14; UN, 2005, PLAN IMPL WORLD SUMM; Winter TC, 1999, GROUND WATER SURFACE	28	107	116	5	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1234	1235		10.1126/science.1218230	http://dx.doi.org/10.1126/science.1218230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953WV	22679083				2022-12-28	WOS:000304905300021
J	Jones, DJ; Barkun, AN; Lu, YD; Enns, R; Sinclair, P; Martel, M; Gralnek, I; Bardou, M; Kuipers, EJ; Sung, J				Jones, Derek J.; Barkun, Alan N.; Lu, Yidan; Enns, Robert; Sinclair, Paul; Martel, Myriam; Gralnek, Ian; Bardou, Marc; Kuipers, Ernst J.; Sung, Joseph		Int Consensus Upper Gastrointestin	Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							PHARMACEUTICAL-INDUSTRY; BIOMEDICAL-RESEARCH; PEPTIC-ULCER; PHYSICIANS; RECOMMENDATIONS; ASSOCIATIONS; AUTHORS; DISCLOSURE; MANAGEMENT; PROPOSAL	Background: It is unclear whether global experts with financial conflicts of interest (FCOIs) should be included in, be excluded from, or have a limited role in developing international clinical practice guidelines (CPGs). Optimal management of FCOIs to ensure independent, expert CPGs remains ethically contested. Objective: To manage FCOIs and examine whether an ethics framework with discussion recusal by experts with FCOIs affects deliberations and voting on a CPG. Design: Development of an ethics framework grounded on transparency and proportional management of COIs, including self-recusal, evaluation of the effect on COIs and CPG process by quantification of voting on recommendations, and qualitative assessment of experts' ethics dialogue. Setting: International consensus meeting to formulate a CPG in gastroenterology. Participants: 34 experts from 15 countries. Measurements: Counting the votes of experts with and without declared FCOIs and qualitative assessment of ethics discussions. Results: 62% of experts reported at least 1 FCOI. Eight out of 21 recommendations presented potential FCOIs. Experts with conflicts recused themselves from discussing 6 of the 8 recommendations, leaving a majority of nonconflicted discussants (median, 22; range, 19 to 26) for the 6 recommendations. Recusals did not affect voting outcomes but may have diluted the richness of the discussions. Ethics dialogue revealed accord on transparency but underscored challenges to proportional management of COIs beyond basic disclosure. Concerns about bias, COI definitions, expertise, and integrity express important international ethics questions. Limitation: Small participant numbers and application of the framework to only 1 meeting of 1 CPG. Conclusion: An ethics framework may help to identify and manage COIs and catalyze both ethics dialogue and innovative COI standards that seek to balance impartiality and expertise for trusted CPGs. Optimal balancing remains contested. Recommendations include frameworks, interdisciplinary analysis, and international policy initiatives to better manage COIs in the CPG process.	[Barkun, Alan N.] McGill Univ, Div Gastroenterol, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada; Canadian Assoc Gastroenterol, Oakville, ON, Canada; Technion Israel Inst Technol, Haifa, Israel; CHU Dijon, INSERM CIC P 803, Dijon, France; Univ Bourgogne, Dijon, France; Erasmus MC, Rotterdam, Netherlands; Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Technion Israel Institute of Technology; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Erasmus University Rotterdam; Erasmus MC; Chinese University of Hong Kong	Barkun, AN (corresponding author), McGill Univ, Div Gastroenterol, Ctr Hlth, Montreal Gen Hosp Site,1650 Cedar Ave,Room D7-346, Montreal, PQ H3G 1A4, Canada.	alan.barkun@muhc.mcgill.ca	Martel, Myriam/ABB-3862-2020; Moayyedi, Paul/M-6178-2014; Kuipers, Ernst J/H-3293-2019; Sung, Joseph J. Y./R-3203-2018; Calvet, Xavier/H-3288-2019	Moayyedi, Paul/0000-0002-3616-9292; Kuipers, Ernst J/0000-0002-0633-3098; Sung, Joseph J. Y./0000-0003-3125-5199; Calvet, Xavier/0000-0002-6278-9663; QUENOT, Jean-Pierre/0000-0003-2351-682X; Calvet, Xavier/0000-0002-4413-4209; Romagnuolo, Joseph/0000-0002-5630-3022	Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; Institute of Diabetes, Metabolism, and Nutrition of the Canadian Institutes of Health Research	Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; Institute of Diabetes, Metabolism, and Nutrition of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Primary Funding Source: Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; and Institute of Diabetes, Metabolism, and Nutrition of the Canadian Institutes of Health Research.; The conference was underwritten by unrestricted, pooled funds from the Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; and Canadian Institutes of Health Research Institute of Diabetes, Metabolism, and Nutrition and arms-length contributions from AstraZeneca Molndal (Sweden), Abbott Canada, and Olympus Canada. The Canadian Association of Gastroenterology also provided in-kind support and administered the meeting.	28. Food and Drug Administration, 2008, GUID PUBL FDA ADV CO; Abramson J, 2005, J AM BOARD FAM PRACT, V18, P414, DOI 10.3122/jabfm.18.5.414; Accreditation Council for Continuing Medical Education, 2004, ACCME STAND COMM SUP; Accreditation Council for Continuing Medical Education, 2007, ACCME STAND COMM SUP; Almadi MA, 2011, JAMA-J AM MED ASSOC, V306, P2367, DOI 10.1001/jama.2011.1653; American College of Gastroenterology, 2005, CONFL INT POL; American Medical Association, 2008, COD MED ETH CURR OP; American Society of Clinical Oncology, 2006, J Clin Oncol, V24, P519; American Thoracic Society, 2008, POL MAN CONFL INT OF; [Anonymous], 2005, CAN MED ASSOC J, V173, P1297; *ASS AM MED COLL, 2007, SCI BAS INFL REC S; Association of American Medical Colleges, 2008, PROT PAT PRES INT AD; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Barkun A, 2009, GASTROENTEROLOGY, P134; Barkun AN, 2010, GASTROINTEST ENDOSC, V72, P1138, DOI 10.1016/j.gie.2010.08.011; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; Bernard L, 2009, CONFLICT INTEREST ME, P189; Blumenthal D, 2004, NEW ENGL J MED, V351, P1885, DOI 10.1056/NEJMhpr042734; Boyd Elizabeth A, 2006, Health Res Policy Syst, V4, P16, DOI 10.1186/1478-4505-4-16; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Brody H, 2010, ANN FAM MED, V8, P354, DOI 10.1370/afm.1140; Buchan HA, 2010, MED J AUSTRALIA, V192, P490, DOI 10.5694/j.1326-5377.2010.tb03604.x; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Canadian Association of Gastroenterology, 2008, POL APPL IMPL CLIN P; Canadian Council on Animal Care, 2007, GUID PHYS INT IND, P5; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Chugh D., 2005, CONFLICTS INTEREST P, P74, DOI DOI 10.1017/CBO9780511610332.006; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Davis D, 2007, CANADIAN MED ASS HDB; Drazen JM, 2002, NEW ENGL J MED, V346, P1901, DOI 10.1056/NEJMe020074; Durbin CG, 2007, CRIT CARE MED, V35, P689, DOI 10.1097/01.CCM.0000257723.46818.F3; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; European Medicines Agency, 2010, EUR MED AG POL HANDL; Gale EAM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5728; Godlee F, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2947; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Haines IE, 2008, MED J AUSTRALIA, V189, P263, DOI 10.5694/j.1326-5377.2008.tb02020.x; Haute Autorite de Sante, 2010, GUID DECL INT GEST C; International Committee of Medical Journal Editors, 2007, BIOMEDICAL J UNPUB; Jones DJ, 1998, ETHICS BIOTECHNOLOGY; Lenzer J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d4007; Lo B, 2011, ARCH INTERN MED, V171, P587, DOI 10.1001/archinternmed.2011.79; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Millar JA, 2009, MED J AUSTRALIA, V190, P446, DOI 10.5694/j.1326-5377.2009.tb02496.x; Moore DA, 2006, ACAD MANAGE REV, V31, P10; Moore DA, 2010, JUDGM DECIS MAK, V5, P37; National Institute for Health and Clinical Excellence, 2009, COD PRACT DECL DEAL; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3, P344; Pharmaceutical Research and Manufacturers of America, 2008, PHARM RES MAN AM COD, P36; Rockey SJ, 2010, JAMA-J AM MED ASSOC, V303, P2400, DOI 10.1001/jama.2010.774; Rodwin M, 1993, MED MORALS MONEY PHY; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Shingina A, 2011, ALIMENT PHARM THER, V33, P1010, DOI 10.1111/j.1365-2036.2011.04618.x; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Sreedharan A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub3; Stossel TP, 2008, BRIT MED J, V336, P476, DOI 10.1136/bmj.39493.489213.AD; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; The AGREE Collaboration, 2001, OR AGREE INSTR; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Word Medical Association, 2009, WMA STAT CONFL INT; World Health Organisation (WHO), 2008, WHO HDB GUID DEV; World Health Organization, 2011, REP REV COMM FUNCT I; World Health Organization, 2010, GUID DECL INT; 2011, FED REG, V76, P53256	74	26	26	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					809	+		10.7326/0003-4819-156-11-201206050-00008	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	954ZK	22665816				2022-12-28	WOS:000304986500006
J	Walton, L				Walton, Liz			Otitis externa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sheffield, No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield	Walton, L (corresponding author), Univ Sheffield, No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England.	e.walton@sheffield.ac.uk						Hollis S, 2011, J LARYNGOL OTOL, V125, P1212, DOI 10.1017/S0022215110002550; Kaushik V, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004740.pub2; Ludman HS, 2007, ABC EAR NOSE THROAT, P2; Narayan S, 2011, BRIT J HOSP MED, V72, P554, DOI 10.12968/hmed.2011.72.10.554; van Balen FAM, 2003, BRIT MED J, V327, P1201, DOI 10.1136/bmj.327.7425.1201	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2012	344								e3623	10.1136/bmj.e3623	http://dx.doi.org/10.1136/bmj.e3623			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HA	22649116				2022-12-28	WOS:000304856400002
J	Coombes, R				Coombes, Rebecca			Safer sport, shock treatment, stroke care, and safety triumph at the BMJ Group awards	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3741	10.1136/bmj.e3741	http://dx.doi.org/10.1136/bmj.e3741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645213				2022-12-28	WOS:000304855700019
J	Hsiao, HY; Liu, CM; Lin, HW; Liu, TC; Lu, CL; Huang, YS; Chen, C; Tu, KN				Hsiao, Hsiang-Yao; Liu, Chien-Min; Lin, Han-Wen; Liu, Tao-Chi; Lu, Chia-Ling; Huang, Yi-Sa; Chen, Chih; Tu, K. N.			Unidirectional Growth of Microbumps on (111)-Oriented and Nanotwinned Copper	SCIENCE			English	Article							MAXIMUM STRENGTH; BOUNDARIES; CU	Highly oriented [111] Cu grains with densely packed nanotwins have been fabricated by direct-current electroplating with a high stirring rate. The [111]-oriented and nanotwinned Cu (nt-Cu) allow for the unidirectional growth of Cu6Sn5 intermetallics in the microbumps of three-dimensional integrated-circuit packaging; a uniform microstructure in a large number of microbumps of controlled orientation can be obtained. The high-density twin boundaries in the nt-Cu serve as vacancy sinks during the solid-state reaction between Pb-free solder and Cu and greatly reduce the formation of Kirkendall (or Frenkel) voids.	[Hsiao, Hsiang-Yao; Liu, Chien-Min; Lin, Han-Wen; Liu, Tao-Chi; Lu, Chia-Ling; Huang, Yi-Sa; Chen, Chih] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30010, Taiwan; [Tu, K. N.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA	National Yang Ming Chiao Tung University; University of California System; University of California Los Angeles	Chen, C (corresponding author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30010, Taiwan.	chih@mail.nctu.edu.tw; kntu@ucla.edu			National Science Council, Taiwan [NSC 98-2221-E-009-036-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The financial support from the National Science Council, Taiwan, under the contract NSC 98-2221-E-009-036-MY3 is acknowledged. The authors thank J.-C. Kuo at National Cheng Kung University for assistance in the EBSD analysis. A patent, "Electrodeposited nano-twins copper layer and method of fabricating the same," is under application. The processing conditions of the (111)-oriented nt-Cu have been submitted for a patent application. The rest of the data and figures in this Report have not been presented or published elsewhere.	Anderoglu O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969409; Chen C, 2010, ANNU REV MATER RES, V40, P531, DOI 10.1146/annurev.matsci.38.060407.130253; Chen KC, 2008, SCIENCE, V321, P1066, DOI 10.1126/science.1160777; Flack D. R., 2005, FUNDAMENTALS JET PRO; Labie R., 2010, 3 EL SYST INT TECHN; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Lin JC, 2010, INT EL DEVICES MEET; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463; Lu MH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936996; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Suh JO, 2007, J APPL PHYS, V102, DOI 10.1063/1.2776002; Xu L, 2008, J APPL PHYS, V104, DOI 10.1063/1.3035944; Yeoh A., 2006, EL COMP TECHN C IEEE; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Zeng KJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1839637; Zhou SJ, 1998, SCIENCE, V279, P1525, DOI 10.1126/science.279.5356.1525; Zou HF, 2008, ACTA MATER, V56, P2649, DOI 10.1016/j.actamat.2008.01.055; Zou HF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266144	21	250	257	36	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1007	1010		10.1126/science.1216511	http://dx.doi.org/10.1126/science.1216511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628648				2022-12-28	WOS:000304406800038
J	Pateman, RM; Hill, JK; Roy, DB; Fox, R; Thomas, CD				Pateman, Rachel M.; Hill, Jane K.; Roy, David B.; Fox, Richard; Thomas, Chris D.			Temperature-Dependent Alterations in Host Use Drive Rapid Range Expansion in a Butterfly	SCIENCE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; RESPONSES; DISTRIBUTIONS; MODELS; SHIFTS	Responses of species to climate change are extremely variable, perhaps because of climate-related changes to interactions among species. We show that temperature-related changes in the dependence of the butterfly Aricia agestis on different larval host plants have facilitated rapid range expansion. Historically, the butterfly was largely restricted to a single plant species, Helianthemum nummularium, but recent warmer conditions have enabled the butterfly to increasingly use the more widespread plant species Geranium molle. This has resulted in a substantial increase in available habitat and rapid range expansion by the butterfly (79 kilometers northward in Britain in 20 years). Interactions among species are often seen as constraints on species' responses to climate change, but we show that temperature-dependent changes to interspecific interactions can also facilitate change.	[Pateman, Rachel M.; Hill, Jane K.; Thomas, Chris D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pateman, Rachel M.; Roy, David B.] NERC, Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Fox, Richard] Butterfly Conservat, Manor Yard, Wareham BH20 5QP, Dorset, England	University of York - UK; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Pateman, RM (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	rmp502@york.ac.uk; jane.hill@york.ac.uk; chris.thomas@york.ac.uk	Hill, Jane K./AAJ-3374-2021; Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014; Roy, David/A-6619-2009	Hill, Jane K./0000-0003-1871-7715; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Roy, David/0000-0002-5147-0331; Fox, Richard/0000-0001-6992-3522; Pateman, Rachel/0000-0002-2260-170X	NERC Ecology and Hydrology Funding Initiative [NE/E012035]; Natural Environment Research Council [NE/E012035/1, NE/F018606/1, CEH010021] Funding Source: researchfish; NERC [NE/E012035/1, NE/F018606/1] Funding Source: UKRI	NERC Ecology and Hydrology Funding Initiative; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was funded through NERC Ecology and Hydrology Funding Initiative grant NE/E012035. Butterfly distribution data were derived from a database of records submitted by volunteers (www.butterfly-conservation.org/text/64/butterfly_distribution.html), and densities were derived from UK Butterfly Monitoring Scheme data (www.ukbms.org/obtaining.htm). Both schemes are operated by Butterfly Conservation and the Centre for Ecology & Hydrology and funded by a consortium of government agencies. Plant data were derived from a database of volunteer records managed by the Botanical Society for the British Isles (www.bsbi.org.uk/research.html). We are grateful to the volunteers who collected the original butterfly and plant data. Temperature data were derived from the Central England Temperature (CET) data set (www.metoffice.gov.uk/hadobs). Digital Elevation Models were provided by the NERC Earth Observation Data Centre (www.neodc.rl.ac.uk/browse/neodc/nextmap). Original data collected by authors is presented in the supplementary materials.	Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Asher J, 2001, MILLENNIUM ATLAS BUT; BOURN NAD, 1993, BIOL CONSERV, V63, P67, DOI 10.1016/0006-3207(93)90075-C; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Grime JP., 2014, COMP PLANT ECOLOGY F; Heath J., 1984, ATLAS BUTTERFLIES BR; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; HUTCHINS RB, 1976, SOIL SCI, V121, P234, DOI 10.1097/00010694-197604000-00008; LAKHANI KH, 1982, J APPL ECOL, V19, P621, DOI 10.2307/2403494; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; PARK T, 1954, PHYSIOL ZOOL, V27, P177, DOI 10.1086/physzool.27.3.30152164; POLLARD E, 1994, MONITORING BUTTERFLI; PROCTOR MCF, 1956, J ECOL, V44, P675, DOI 10.2307/2256855; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tolman T., 1997, COLLINS FIELD GUIDE; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	21	116	118	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1028	1030		10.1126/science.1216980	http://dx.doi.org/10.1126/science.1216980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628653				2022-12-28	WOS:000304406800043
J	Bretthauer, M; Hoff, G				Bretthauer, Michael; Hoff, Geir			Comparative effectiveness research in cancer screening programmes	BRITISH MEDICAL JOURNAL			English	Article									[Bretthauer, Michael] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, N-0317 Oslo, Norway; [Bretthauer, Michael; Hoff, Geir] Oslo Univ Hosp, Oslo, Norway; [Hoff, Geir] Canc Registry Norway, Oslo, Norway; [Hoff, Geir] Telemark Hosp, Dept Res, Skien, Norway	University of Oslo; University of Oslo; University of Oslo; Telemark Hospital Trust	Bretthauer, M (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, N-0317 Oslo, Norway.	michael.bretthauer@medisin.uio.no						Baum M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7535; Cancer Mondial, GLOB 2002 DAT; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; Fretheim A, 2010, EXPECTED IMPACT INTR; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; Sox HC, 2011, NEW ENGL J MED, V365, P455, DOI 10.1056/NEJMe1103776	7	26	26	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 24	2012	344								e2864	10.1136/bmj.e2864	http://dx.doi.org/10.1136/bmj.e2864			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QU	22628002	Bronze			2022-12-28	WOS:000304591600002
J	Chung, I; Lee, B; He, JQ; Chang, RPH; Kanatzidis, MG				Chung, In; Lee, Byunghong; He, Jiaqing; Chang, Robert P. H.; Kanatzidis, Mercouri G.			All-solid-state dye-sensitized solar cells with high efficiency	NATURE			English	Article							REDOX ELECTROLYTE; PERFORMANCE	Dye-sensitized solar cells based on titanium dioxide (TiO2) are promising low-cost alternatives to conventional solid-state photovoltaic devices based on materials such as Si, CdTe and CuIn1-xGaxSe2 (refs 1, 2). Despite offering relatively high conversion efficiencies for solar energy, typical dye-sensitized solar cells suffer from durability problems that result from their use of organic liquid electrolytes containing the iodide/tri-iodide redox couple, which causes serious problems such as electrode corrosion and electrolyte leakage(3). Replacements for iodine-based liquid electrolytes have been extensively studied, but the efficiencies of the resulting devices remain low(3-9). Here we show that the solution-processable p-type direct bandgap semiconductor CsSnI3 can be used for hole conduction in lieu of a liquid electrolyte. The resulting solid-state dye-sensitized solar cells consist of CsSnI2.95F0.05 doped with SnF2, nanoporous TiO2 and the dye N719, and show conversion efficiencies of up to 10.2 per cent (8.51 per cent with a mask). With a bandgap of 1.3 electronvolts, CsSnI3 enhances visible light absorption on the red side of the spectrum to outperform the typical dye-sensitized solar cells in this spectral region.	[Chung, In; He, Jiaqing; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	m-kanatzidis@northwestern.edu	He, Jiaqing/A-2245-2010; Chang, R.P.H/B-7505-2009; Chung, In/K-5036-2012	He, Jiaqing/0000-0003-3954-6003; Chung, In/0000-0001-6274-3369	NSF-DMR [0843962]; DOE Energy Frontier Research Center, ANSER [DE-SC0001059]; Initiative for Energy and Sustainability at Northwestern (ISEN)	NSF-DMR(National Science Foundation (NSF)); DOE Energy Frontier Research Center, ANSER; Initiative for Energy and Sustainability at Northwestern (ISEN)	The authors acknowledge support for this collaborative research: NSF-DMR 0843962 for R. P. H. C.; DOE Energy Frontier Research Center, ANSER, DE-SC0001059 for B. H. L., J.H. and M. G. K.; the Initiative for Energy and Sustainability at Northwestern (ISEN) for I.C. Device testing and measurements were done in the ANSER Facilities and materials characterization was performed in the NSFMRSEC Facilities (DMR-1121262).	Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Bandara J, 2005, SOL ENERG MAT SOL C, V85, P385, DOI 10.1016/j.solmat.2004.05.010; Bisquert J, 2011, CHEMPHYSCHEM, V12, P1633, DOI 10.1002/cphc.201100248; Cai N, 2011, NANO LETT, V11, P1452, DOI 10.1021/nl104034e; Daeneke T, 2011, NAT CHEM, V3, P211, DOI [10.1038/NCHEM.966, 10.1038/nchem.966]; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Jiang KJ, 2009, ADV FUNCT MATER, V19, P2481, DOI 10.1002/adfm.200900283; Koh JK, 2011, ADV MATER, V23, P1641, DOI 10.1002/adma.201004715; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Kroon JM, 2007, PROG PHOTOVOLTAICS, V15, P1, DOI 10.1002/pip.707; Lee B, 2011, J PHYS CHEM C, V115, P9787, DOI 10.1021/jp201555n; Lee B, 2010, J PHYS CHEM B, V114, P14582, DOI 10.1021/jp102359r; Liu XZ, 2010, ADV MATER, V22, pE150, DOI 10.1002/adma.200904168; O'Regan B, 2002, CHEM MATER, V14, P5023, DOI 10.1021/cm020572d; Shum K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3442511; Wang MK, 2010, NAT CHEM, V2, P385, DOI [10.1038/NCHEM.610, 10.1038/nchem.610]; Yanagida S, 2009, ACCOUNTS CHEM RES, V42, P1827, DOI 10.1021/ar900069p; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688	20	1390	1438	49	1618	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					486	U94		10.1038/nature11067	http://dx.doi.org/10.1038/nature11067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622574				2022-12-28	WOS:000304344500039
J	Wolkovich, EM; Cook, BI; Allen, JM; Crimmins, TM; Betancourt, JL; Travers, SE; Pau, S; Regetz, J; Davies, TJ; Kraft, NJB; Ault, TR; Bolmgren, K; Mazer, SJ; McCabe, GJ; McGill, BJ; Parmesan, C; Salamin, N; Schwartz, MD; Cleland, EE				Wolkovich, E. M.; Cook, B. I.; Allen, J. M.; Crimmins, T. M.; Betancourt, J. L.; Travers, S. E.; Pau, S.; Regetz, J.; Davies, T. J.; Kraft, N. J. B.; Ault, T. R.; Bolmgren, K.; Mazer, S. J.; McCabe, G. J.; McGill, B. J.; Parmesan, C.; Salamin, N.; Schwartz, M. D.; Cleland, E. E.			Warming experiments underpredict plant phenological responses to climate change	NATURE			English	Article							TEMPERATURE	Warming experiments are increasingly relied on to estimate plant responses to global climate change(1,2). For experiments to provide meaningful predictions of future responses, they should reflect the empirical record of responses to temperature variability and recent warming, including advances in the timing of flowering and leafing(3-5). We compared phenology (the timing of recurring life history events) in observational studies and warming experiments spanning four continents and 1,634 plant species using a common measure of temperature sensitivity (change in days per degree Celsius). We show that warming experiments underpredict advances in the timing of flowering and leafing by 8.5-fold and 4.0-fold, respectively, compared with long-term observations. For species that were common to both study types, the experimental results did not match the observational data in sign or magnitude. The observational data also showed that species that flower earliest in the spring have the highest temperature sensitivities, but this trend was not reflected in the experimental data. These significant mismatches seem to be unrelated to the study length or to the degree of manipulated warming in experiments. The discrepancy between experiments and observations, however, could arise from complex interactions among multiple drivers in the observational data, or it could arise from remediable artefacts in the experiments that result in lower irradiance and drier soils, thus dampening the phenological responses to manipulated warming. Our results introduce uncertainty into ecosystem models that are informed solely by experiments and suggest that responses to climate change that are predicted using such models should be re-evaluated.	[Wolkovich, E. M.; Cleland, E. E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Cook, B. I.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Cook, B. I.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Allen, J. M.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Crimmins, T. M.] USA Natl Phenol Network, Tucson, AZ 85721 USA; [Betancourt, J. L.] US Geol Survey, Tucson, AZ 85719 USA; [Travers, S. E.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58108 USA; [Pau, S.; Regetz, J.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Davies, T. J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Kraft, N. J. B.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Kraft, N. J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Ault, T. R.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Bolmgren, K.] Swedish Univ Agr Sci, Swedish Natl Phenol Network, Unit Field Based Forest Res, SE-36030 Lammhult, Sweden; [Bolmgren, K.] Lund Univ, SE-22362 Lund, Sweden; [Mazer, S. J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [McCabe, G. J.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [McGill, B. J.] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [McGill, B. J.] Univ Maine, Sustainabil Solut Initiat, Orono, ME 04469 USA; [Parmesan, C.] Univ Texas Austin, Austin, TX 78712 USA; [Parmesan, C.] Univ Plymouth, Inst Marine Sci, Plymouth PL4 8AA, Devon, England; [Salamin, N.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Salamin, N.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Schwartz, M. D.] Univ Wisconsin, Dept Geog, Milwaukee, WI 53201 USA	University of California System; University of California San Diego; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of Connecticut; United States Department of the Interior; United States Geological Survey; North Dakota State University Fargo; National Center for Ecological Analysis & Synthesis; McGill University; University of British Columbia; University System of Maryland; University of Maryland College Park; National Center Atmospheric Research (NCAR) - USA; Swedish University of Agricultural Sciences; Lund University; University of California System; University of California Santa Barbara; United States Department of the Interior; United States Geological Survey; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Texas System; University of Texas Austin; University of Plymouth; University of Lausanne; Swiss Institute of Bioinformatics; University of Wisconsin System; University of Wisconsin Milwaukee	Wolkovich, EM (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr 0116, La Jolla, CA 92093 USA.	wolkovich@biodiversity.ubc.ca	Crimmins, Theresa M./H-3575-2019; Cook, Benjamin I/H-2265-2012; Bolmgren, Kjell/GYR-3917-2022; Kraft, Nathan J. B./A-2817-2012; McGill, Brian J/A-3476-2008; Parmesan, Camille/GVT-5674-2022; Bolmgren, Kjell/E-1459-2016	Crimmins, Theresa M./0000-0001-9592-625X; Kraft, Nathan J. B./0000-0001-8867-7806; McGill, Brian J/0000-0002-0850-1913; Bolmgren, Kjell/0000-0001-9552-9684; Allen, Jenica/0000-0001-6741-8581; Parmesan, Camille/0000-0002-1515-274X; Salamin, Nicolas/0000-0002-3963-4954; Wolkovich, Elizabeth M/0000-0001-7653-893X	National Center for Ecological Analysis Synthesis [EF-0553768]; National Science Foundation [DBI-0905806, IOS-0639794, DEB-0922080]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [1027341] Funding Source: National Science Foundation	National Center for Ecological Analysis Synthesis; National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted as part of the Forecasting Phenology Working Group supported by the National Center for Ecological Analysis & Synthesis (EF-0553768), with additional support from National Science Foundation grants DBI-0905806, IOS-0639794, DEB-0922080 and the Natural Sciences and Engineering Research Council of Canada CREATE Training Program. Special thanks to the many data managers, including G. Aldridge, P. Huth, D. Inouye, G. Johansson, A. Miller-Rushing, J. O'Keefe, R. Primack, S. Smiley, T. Sparks and J. Thompson. We thank M. Ayres, L. Kueppers, D. Moore and M. O'Connor for comments on earlier drafts.	Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; KENNEDY AD, 1995, GLOB CHANGE BIOL, V1, P29, DOI 10.1111/j.1365-2486.1995.tb00004.x; KENNEDY AD, 1995, FUNCT ECOL, V9, P340, DOI 10.2307/2390583; Kimball BA, 2005, GLOBAL CHANGE BIOL, V11, P2041, DOI 10.1111/j.1365-2486.2005.01028.x; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molau U, 1997, GLOB CHANGE BIOL, V3, P97, DOI 10.1111/j.1365-2486.1997.gcb138.x; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	28	607	645	22	734	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					494	497		10.1038/nature11014	http://dx.doi.org/10.1038/nature11014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622576				2022-12-28	WOS:000304344500041
J	Spence, D				Spence, Des			Five years after baby Peter	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Calkin S, 2011, NURSING TIMES    NOV; McGregor K, 2011, COMMUNITY CARE   SEP; Mulholland H, 2012, GUARDIAN         FEB	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 22	2012	344								e3638	10.1136/bmj.e3638	http://dx.doi.org/10.1136/bmj.e3638			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QS	22619207				2022-12-28	WOS:000304591400028
J	Boehm, C				Boehm, Christopher			ANCESTRAL HIERARCHY AND CONFLICT	SCIENCE			English	Review							SOCIAL SELECTION; HUMAN ALTRUISM; EVOLUTION; CHIMPANZEES; BEHAVIOR; VIOLENCE; COMPETITION; RESOLUTION; MORALITY; PRIMATES	Ancestral Pan, the shared predecessor of humans, bonobos, and chimpanzees, lived in social dominance hierarchies that created conflict through individual and coalitional competition. This ancestor had male and female mediators, but individuals often reconciled independently. An evolutionary trajectory is traced from this ancestor to extant hunter-gatherers, whose coalitional behavior results in suppressed dominance and competition, except in mate competition. A territorial ancestral Pan would not have engaged in intensive warfare if we consider bonobo behavior, but modern human foragers have the potential for full-scale war. Although hunter-gatherers are able to resolve conflicts preemptively, they also use mechanisms, such as truces and peace pacts, to mitigate conflict when the costs become too high. Today, humans retain the genetic underpinnings of both conflict and conflict management; thus, we retain the potential for both war and peace.	Univ So Calif, Dept Biol Sci & Anthropol, Los Angeles, CA 90089 USA	University of Southern California	Boehm, C (corresponding author), Univ So Calif, Dept Biol Sci & Anthropol, Los Angeles, CA 90089 USA.	cboehm1@msn.com			Templeton Foundation; Goodall Research Center at University of Southern California	Templeton Foundation; Goodall Research Center at University of Southern California	Relevant research support was forthcoming from the Templeton Foundation and the Goodall Research Center at University of Southern California; comments are acknowledged from H. Gintis, M. Muller, S. Bowles, and R. Wrangham.	Boehm C, 2000, J CONSCIOUSNESS STUD, V7, P79; Boehm C, 1997, AM NAT, V150, pS100, DOI 10.1086/286052; BOEHM C, 1993, CURR ANTHROPOL, V34, P227, DOI 10.1086/204166; BOEHM C, 1982, J SOC BIOL STRUCT, V5, P413, DOI 10.1016/S0140-1750(82)92069-3; Boehm C., 1999, HIERARCHY FOREST EVO; Boehm C., 2012, MORAL ORIGINS EVOLUT; Boehm C., 1994, CHIMPANZEE CULTURES; Boehm C., 2003, EVOLUTIONARY PSYCHOL, P203; Boehm C, 2008, CROSS-CULT RES, V42, P319, DOI 10.1177/1069397108320422; Boehm C, 2011, BRIT J CRIMINOL, V51, P518, DOI 10.1093/bjc/azr020; Boehm Christopher, 2004, Journal of Bioeconomics, V6, P109, DOI 10.1023/B:JBIO.0000040455.83350.1d; Boehm Christopher, 1986, BLOOD REVENGE ENACTM; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Burch, 2005, ALLIANCE CONFLICT WO, DOI 10.2307/j.ctv6gqqgg; Chagnon N.A., 1983, YANOMAMO FIERCE PEOP; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL F, 1982, CHIMPANZEE POLITICS; DeWaal Frans B. M., 1996, GOOD NATURED ORIGINS; Flack JC, 2000, J CONSCIOUSNESS STUD, V7, P1; Fry D.P., 2000, NATURAL CONFLICT RES, P334; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; GHIGLIERI MP, 1987, J HUM EVOL, V16, P319, DOI 10.1016/0047-2484(87)90065-0; Gibbons A, 2011, SCIENCE, V332, P1370, DOI 10.1126/science.332.6036.1370; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOODALL J, 1992, TOPICS PRIMATOLOGY, V1, P131; Harris M., 1968, RISE ANTHR THEORY HI; Kano T., 1992, LAST APE PYGMY CHIMP; Keeley LH., 1996, WAR CIVILIZATION; Kelly R. C., 2000, WARLESS SOC EVOLUTIO; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Klein R. G., 1999, HUMAN CAREER HUMAN B; KNAUFT BM, 1991, CURR ANTHROPOL, V32, P391, DOI 10.1086/203975; Ladd S., 2011, CHIMP MURDER MAHALE; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; McGrew William, 2004, CULTURED CHIMPANZEE; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Nishida T., 1996, PAN AFR NEWS, V3, P4; Ord Terry J., 2010, P108; Otterbein K. F., 1974, HDB SOCIAL CULTURAL, P923; Otterbein K. F., 1965, AM ANTHROPOL, V67, P1470, DOI DOI 10.1525/AA.1965.67.6.02A00070; Parker Ian, 2007, New Yorker, P48; Pinker S., 2011, BETTER ANGELS OUR NA; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; RUVOLO M, 1991, P NATL ACAD SCI USA, V88, P1570, DOI 10.1073/pnas.88.4.1570; Service E. R., 1975, ORIGIN STATE CIVILIZ; SIMON HA, 1990, SCIENCE, V250, P1665, DOI 10.1126/science.2270480; Sober E., 1998, OTHERS EVOLUTION PSY; Sober Elliott, 1988, RECONSTRUCTING PARSI; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Stanford Craig B., 1999, HUNTING APES MEAT EA; Vescio, 2010, SOCIAL PSYCHOL POWER, P46; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Wrangham R.W., 1987, P51; Wrangham Richard, 1996, DEMONIC MALES APES O; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1; Wrangham RW, 2006, PRIMATES, V47, P14, DOI 10.1007/s10329-005-0140-1; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1	63	57	57	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					844	847		10.1126/science.1219961	http://dx.doi.org/10.1126/science.1219961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605759				2022-12-28	WOS:000304145600045
J	Sachs, JD				Sachs, Jeffrey D.			Primary Health Care in Low-Income Countries Building on Recent Achievements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Earth Inst, Low Lib 314, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, Low Lib 314, 535 W 116th St, New York, NY 10027 USA.	sachs@columbia.edu						[Anonymous], CHANG LEV TRENDS MOR; [Anonymous], DET IND; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2001, MACR HLTH INV HLTH E	6	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2031	2032		10.1001/jama.2012.4438	http://dx.doi.org/10.1001/jama.2012.4438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665098				2022-12-28	WOS:000304048200018
J	Nelson, MR; Wegmann, D; Ehm, MG; Kessner, D; Jean, PS; Verzilli, C; Shen, JD; Tang, ZZ; Bacanu, SA; Fraser, D; Warren, L; Aponte, J; Zawistowski, M; Liu, X; Zhang, H; Zhang, Y; Li, J; Li, Y; Li, L; Woollard, P; Topp, S; Hall, MD; Nangle, K; Wang, J; Abecasis, G; Cardon, LR; Zollner, S; Whittaker, JC; Chissoe, SL; Novembre, J; Mooser, V				Nelson, Matthew R.; Wegmann, Daniel; Ehm, Margaret G.; Kessner, Darren; Jean, Pamela St.; Verzilli, Claudio; Shen, Judong; Tang, Zhengzheng; Bacanu, Silviu-Alin; Fraser, Dana; Warren, Liling; Aponte, Jennifer; Zawistowski, Matthew; Liu, Xiao; Zhang, Hao; Zhang, Yong; Li, Jun; Li, Yun; Li, Li; Woollard, Peter; Topp, Simon; Hall, Matthew D.; Nangle, Keith; Wang, Jun; Abecasis, Goncalo; Cardon, Lon R.; Zoellner, Sebastian; Whittaker, John C.; Chissoe, Stephanie L.; Novembre, John; Mooser, Vincent			An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People	SCIENCE			English	Article							MISSING HERITABILITY; POPULATION-GROWTH; COMPLEX DISEASES; GENOME; ASSOCIATION; TRAITS; SPECTRUM; MUTATION; ALLELES; EUROPE	Rare genetic variants contribute to complex disease risk; however, the abundance of rare variants in human populations remains unknown. We explored this spectrum of variation by sequencing 202 genes encoding drug targets in 14,002 individuals. We find rare variants are abundant (1 every 17 bases) and geographically localized, so that even with large sample sizes, rare variant catalogs will be largely incomplete. We used the observed patterns of variation to estimate population growth parameters, the proportion of variants in a given frequency class that are putatively deleterious, and mutation rates for each gene. We conclude that because of rapid population growth and weak purifying selection, human populations harbor an abundance of rare variants, many of which are deleterious and have relevance to understanding disease risk.	[Nelson, Matthew R.; Ehm, Margaret G.; Jean, Pamela St.; Shen, Judong; Bacanu, Silviu-Alin; Fraser, Dana; Warren, Liling; Aponte, Jennifer; Li, Li; Nangle, Keith; Chissoe, Stephanie L.] GlaxoSmithKline GSK, Dept Quantitat Sci, Res Triangle Pk, NC 27709 USA; [Wegmann, Daniel; Kessner, Darren; Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Verzilli, Claudio; Woollard, Peter; Topp, Simon; Hall, Matthew D.; Whittaker, John C.] GSK, Dept Quantitat Sci, Stevenage SG1 2NY, Herts, England; [Tang, Zhengzheng; Li, Yun] Univ N Carolina, Dept Genet & Biostat, Chapel Hill, NC 27599 USA; [Zawistowski, Matthew; Abecasis, Goncalo; Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Liu, Xiao; Zhang, Hao; Zhang, Yong; Wang, Jun] BGI, Shenzhen 518083, Peoples R China; [Li, Yun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Dept Biol, DK-33939524 Copenhagen, Denmark; [Cardon, Lon R.; Mooser, Vincent] GSK, Dept Quantitat Sci, Upper Merion, PA 19406 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	GlaxoSmithKline; University of California System; University of California Los Angeles; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Beijing Genomics Institute (BGI); University of Michigan System; University of Michigan; Novo Nordisk Foundation; University of Copenhagen; GlaxoSmithKline; University of Michigan System; University of Michigan	Nelson, MR (corresponding author), GlaxoSmithKline GSK, Dept Quantitat Sci, Res Triangle Pk, NC 27709 USA.	matthew.r.nelson@gsk.com; jnovembre@ucla.edu	Wegmann, Daniel/K-2199-2012; Liu, Xiao/P-2732-2015; Tang, Zheng-Zheng/F-6642-2014; Whittaker, John C/B-8609-2012; Wang, Jun/A-7261-2013; Abecasis, Goncalo R/B-7840-2010; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wegmann, Daniel/0000-0003-2866-6739; Liu, Xiao/0000-0002-8073-0534; Tang, Zheng-Zheng/0000-0003-3802-8087; Whittaker, John C/0000-0002-3529-2379; topp, simon/0000-0002-5200-3284; Wang, Jun/0000-0002-2113-5874; Abecasis, Goncalo/0000-0003-1509-1825; Fraser, Dana/0000-0002-4542-0784; Woollard, Peter/0000-0002-7654-6902; Wang, Jun/0000-0002-8540-8931; Hall, Matthew/0000-0002-8307-8633; Bacanu, Silviu-Alin/0000-0002-4364-1583; Li, Jun/0000-0001-6727-0812	Searle Scholars Program award; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513, T32HG002536] Funding Source: NIH RePORTER	Searle Scholars Program award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank GSK colleagues who advised on the selection of genes and collections, especially W. Anderson, L. Condreay, P. Agarwal, A. Hughes, J. Rubio, C. Spraggs, and D. Waterworth; the sample preparation team, especially J. Charnecki, M. E. Volk, D. Duran, D. Briley, and K. King for data preparation; A. Slater for subject selection and preparation of genome-wide genotype data; E. Woldu for capillary sequencing; A. Nelsen, S. Buhta-Halburnt, L. Amos, and J. Forte for consent review; M. Lawson for assistance in running the association analyses; J. Brown for discussions about gene feature analyses; S. Ghosh for providing reviews of the manuscript; and G. Tian, H. Jiang, Z. Su, X. Sun, L. Yang, and X. Zhang at BGI for sequencing. We acknowledge the work of collaborating clinicians and researchers who contributed to recruiting and characterizing subjects (13). J.N. and D. W. were supported by a Searle Scholars Program award to J.N. D. K. is supported by a NIH Genome Analysis training grant. All variants described in this study have been submitted to dbSNP; accession nos. are included in database S2. Subject-level sequence data for CoLaus and LOLIPOP studies are available in dbGaP. Additional subject-level sequence data can be made available upon request from the authors under a Data Transfer Agreement for the purpose to understand, assess, or extend the conclusions of this paper.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; [Anonymous], 2012, SEATTLESNPS; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; JOBLING MA, 2003, HUMAN EVOLUTIONARY G; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Livi-Bacci M., 2007, CONCISE HIST WORLD P, p[1, 250]; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Messer PW, 2009, GENETICS, V182, P1219, DOI 10.1534/genetics.109.105692; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	28	474	484	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					100	104		10.1126/science.1217876	http://dx.doi.org/10.1126/science.1217876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22604722	Green Accepted, Green Submitted			2022-12-28	WOS:000306053100053
J	Marcantonio, ER				Marcantonio, Edward R.			Postoperative Delirium A 76-Year-Old Woman With Delirium Following Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; PATIENT-CONTROLLED ANALGESIA; TERM COGNITIVE IMPAIRMENT; CRITICALLY-ILL PATIENTS; ELDERLY-PATIENTS; HIP-FRACTURE; RISK-FACTORS; ABDOMINAL-SURGERY	Delirium (acute confusion) complicates 15% to 50% of major operations in older adults and is associated with other major postoperative complications, prolonged length of stay, poor functional recovery, institutionalization, dementia, and death. Importantly, delirium may be predictable and preventable through proactive intervention. Yet clinicians fail to recognize and address postoperative delirium in up to 80% of cases. Using the case of Ms R, a 76-year-old woman who developed delirium first after colectomy with complications and again after routine surgery, the diagnosis, prevention, and treatment of delirium in the postoperative setting is reviewed. The risk of postoperative delirium can be quantified by the sum of predisposing and precipitating factors. Successful strategies for prevention and treatment of delirium include proactive multifactorial intervention targeted to reversible risk factors, limiting use of sedating medications (especially benzodiazepines), effective management of postoperative pain, and, perhaps, judicious use of antipsychotics. JAMA. 2012;308(1):73-81	[Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Marcantonio, Edward R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Marcantonio, ER (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, CO 216,330 Brookline Ave, Boston, MA 02215 USA.	emarcant@bidmc.harvard.edu	Marcantonio, Elcio/A-4784-2008; Marcantonio, Edward R/U-3929-2017; Marcantonio Junior, Elcio/AAA-9388-2022	Marcantonio, Elcio/0000-0003-1294-2305; Marcantonio, Edward R/0000-0002-2911-4250; Marcantonio Junior, Elcio/0000-0003-1294-2305	National Institute on Aging [R01AG030618, P01AG031720, K24 AG035075]; NATIONAL INSTITUTE ON AGING [P01AG031720, R01AG030618, R03AG028189, K24AG035075] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Marcantonio receives support from grants R01AG030618, P01AG031720, and Mid-Career Investigator Award K24 AG035075, all from the National Institute on Aging.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004; Beaver KM, 1998, AM J EMERG MED, V16, P505, DOI 10.1016/S0735-6757(98)90003-1; Benoit AG, 2005, J VASC SURG, V42, P884, DOI 10.1016/j.jvs.2005.07.032; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bergmann MA, 2005, J AM GERIATR SOC, V53, P1817, DOI 10.1111/j.1532-5415.2005.53519.x; Bohner H, 2003, ANN SURG, V238, P149, DOI 10.1097/00000658-200307000-00019; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Campbell N, 2009, J GEN INTERN MED, V24, P848, DOI 10.1007/s11606-009-0996-7; Chen CCH, 2011, J AM COLL SURGEONS, V213, P245, DOI 10.1016/j.jamcollsurg.2011.05.004; Cole MG, 2009, AGE AGEING, V38, P19, DOI 10.1093/ageing/afn253; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Flaherty JH, 2003, J AM GERIATR SOC, V51, P1031, DOI 10.1046/j.1365-2389.2003.51320.x; Galanakis P, 2001, INT J GERIATR PSYCH, V16, P349, DOI 10.1002/gps.327; Gamberini M, 2009, CRIT CARE MED, V37, P1762, DOI 10.1097/CCM.0b013e31819da780; Ganai S, 2007, ARCH SURG-CHICAGO, V142, P1072, DOI 10.1001/archsurg.142.11.1072; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Grover S, 2011, J PSYCHOSOM RES, V71, P277, DOI 10.1016/j.jpsychores.2011.01.019; GUSTAFSON Y, 1988, J AM GERIATR SOC, V36, P525, DOI 10.1111/j.1532-5415.1988.tb04023.x; Hopkins RO, 2009, CLIN CHEST MED, V30, P143, DOI 10.1016/j.ccm.2008.11.001; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kalisvaart KJ, 2006, J AM GERIATR SOC, V54, P817, DOI 10.1111/j.1532-5415.2006.00704.x; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Kaneko T, 1997, SURG TODAY, V27, P107, DOI 10.1007/BF02385897; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; Kiely DK, 2004, J GERONTOL A-BIOL, V59, P344; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Larsen KA, 2010, PSYCHOSOMATICS, V51, P409, DOI 10.1176/appi.psy.51.5.409; Lemiengre J, 2006, J AM GERIATR SOC, V54, P685, DOI 10.1111/j.1532-5415.2006.00667.x; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Leung JM, 2006, NEUROLOGY, V67, P1251, DOI 10.1212/01.wnl.0000233831.87781.a9; Liptzin B, 2005, AM J GERIAT PSYCHIAT, V13, P1100, DOI 10.1176/appi.ajgp.13.12.1100; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Lundstrom M, 2007, AGING CLIN EXP RES, V19, P178; Lynch EP, 1998, ANESTH ANALG, V86, P781; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Mann C, 2000, ANESTHESIOLOGY, V92, P433, DOI 10.1097/00000542-200002000-00025; Marcantonio ER, 2011, J AM GERIATR SOC, V59, pS282, DOI 10.1111/j.1532-5415.2011.03691.x; Marcantonio ER, 2010, J AM GERIATR SOC, V58, P1019, DOI 10.1111/j.1532-5415.2010.02871.x; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 2005, J AM GERIATR SOC, V53, P963, DOI 10.1111/j.1532-5415.2005.53305.x; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; Marcantonio ER, 2011, ANN INTERN MED, V154; McNicoll L, 2005, J AM GERIATR SOC, V53, P495, DOI 10.1111/j.1532-5415.2005.53171.x; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; Milstein A, 2002, INT PSYCHOGERIATR, V14, P301, DOI 10.1017/S1041610202008499; Morimoto Y, 2009, J ANESTH, V23, P51, DOI 10.1007/s00540-008-0688-1; Morita T, 2004, PSYCHOSOMATICS, V45, P107, DOI 10.1176/appi.psy.45.2.107; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Neufeld KJ, 2011, PSYCHOSOMATICS, V52, P133, DOI 10.1016/j.psym.2010.12.018; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Paice JA, 2005, J PAIN, V6, P639, DOI 10.1016/j.jpain.2005.04.007; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Pitkala KH, 2006, J GERONTOL A-BIOL, V61, P176, DOI 10.1093/gerona/61.2.176; Ramlawi B, 2006, ANN SURG, V244, P593, DOI 10.1097/01.sla.0000239087.00826.b4; Ramlawi B, 2006, SURGERY, V140, P221, DOI 10.1016/j.surg.2006.03.007; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Rudolph JL, 2011, ANESTH ANALG, V112, P1202, DOI 10.1213/ANE.0b013e3182147f6d; Rudolph JL, 2010, J AM GERIATR SOC, V58, P643, DOI 10.1111/j.1532-5415.2010.02762.x; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Sampson EL, 2007, INT J GERIATR PSYCH, V22, P343, DOI 10.1002/gps.1679; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schug SA, 1998, ANESTH ANALG, V87, P368, DOI 10.1097/00000539-199808000-00024; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Spronk PE, 2009, INTENS CARE MED, V35, P1276, DOI 10.1007/s00134-009-1466-8; Tahir TA, 2010, J PSYCHOSOM RES, V69, P485, DOI 10.1016/j.jpsychores.2010.05.006; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; US Preventive Services Task Force, GRADE DEF; van Eijk MMJ, 2010, LANCET, V376, P1829, DOI 10.1016/S0140-6736(10)61855-7; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; WEED HG, 1995, LARYNGOSCOPE, V105, P1066, DOI 10.1288/00005537-199510000-00011; WILLIAMSRUSSO P, 1995, JAMA-J AM MED ASSOC, V274, P44, DOI 10.1001/jama.274.1.44; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182; World Health Organisation, 1993, INT STAT CLASS DIS H; Young J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3704	102	154	166	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					73	81		10.1001/jama.2012.6857	http://dx.doi.org/10.1001/jama.2012.6857			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22669559	Green Accepted			2022-12-28	WOS:000306183000026
J	Hernandez, JM; Stein, A; Behrmann, E; Riedel, D; Cypionka, A; Farsi, Z; Walla, PJ; Raunser, S; Jahn, R				Hernandez, Javier M.; Stein, Alexander; Behrmann, Elmar; Riedel, Dietmar; Cypionka, Anna; Farsi, Zohreh; Walla, Peter J.; Raunser, Stefan; Jahn, Reinhard			Membrane Fusion Intermediates via Directional and Full Assembly of the SNARE Complex	SCIENCE			English	Article							HEMIFUSION; EXOCYTOSIS; PROMOTES; VISUALIZATION; SYNAPTOTAGMIN; MECHANISMS; RESOLUTION; RELEASE; DOCKING; LIPIDS	Cellular membrane fusion is thought to proceed through intermediates including docking of apposed lipid bilayers, merging of proximal leaflets to form a hemifusion diaphragm, and fusion pore opening. A membrane-bridging four-helix complex of soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) mediates fusion. However, how assembly of the SNARE complex generates docking and other fusion intermediates is unknown. Using a cell-free reaction, we identified intermediates visually and then arrested the SNARE fusion machinery when fusion was about to begin. Partial and directional assembly of SNAREs tightly docked bilayers, but efficient fusion and an extended form of hemifusion required assembly beyond the core complex to the membrane-connecting linkers. We propose that straining of lipids at the edges of an extended docking zone initiates fusion.	[Hernandez, Javier M.; Stein, Alexander; Riedel, Dietmar; Cypionka, Anna; Farsi, Zohreh; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Cypionka, Anna; Walla, Peter J.] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Behrmann, Elmar; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Braunschweig University of Technology; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Raunser, Stefan/AHE-1573-2022; Stein, Alexander/I-4950-2012; Behrmann, Elmar/I-5808-2015	Stein, Alexander/0000-0002-2696-0611; Behrmann, Elmar/0000-0001-6794-3669; Farsi, Zohreh/0000-0001-7274-981X; Raunser, Stefan/0000-0001-9373-3016; Jahn, Reinhard/0000-0003-1542-3498	National Institutes of Health [3P01GM072694-05S1]; German Research Foundation [RA 1781/1-1, SFB 803]; Fonds der Chemischen Industrie [684052, 166660, 661218]; National Commission for Scientific and Technological Research of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); National Commission for Scientific and Technological Research of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. van den Bogaart, J. Risselada, J. Chua, R. Klemm, and T. Rapoport for critical review; G. Weber for providing the ribbon structure; and O. Hofnagel and U. Ries for valuable technical assistance. Funding was generously provided by the National Institutes of Health (3P01GM072694-05S1 to R. J.), the German Research Foundation (RA 1781/1-1 to S. R. and SFB 803 to R. J. and P. J. W.), the "Fonds der Chemischen Industrie" grant 684052 to E. B. and grants 166660 and 661218 to P. J. W., and a doctoral fellowship from the National Commission for Scientific and Technological Research of Chile to J. M. H. Additional data described in the manuscript are presented in the supplementary materials.	Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Malinin VS, 2004, BIOPHYS J, V86, P2951, DOI 10.1016/S0006-3495(04)74346-5; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nikolaus J, 2010, BIOPHYS J, V98, P1192, DOI 10.1016/j.bpj.2009.11.042; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stevens MJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.188102; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022012; Yang Y, 2010, P NATL ACAD SCI USA, V107, P22145, DOI 10.1073/pnas.1006899108; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103	30	158	159	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1581	1584		10.1126/science.1221976	http://dx.doi.org/10.1126/science.1221976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22653732	Green Accepted, Green Submitted			2022-12-28	WOS:000305507500058
J	Joy, KH; Zolensky, ME; Nagashima, K; Huss, GR; Ross, DK; McKay, DS; Kring, DA				Joy, Katherine H.; Zolensky, Michael E.; Nagashima, Kazuhide; Huss, Gary R.; Ross, D. Kent; McKay, David S.; Kring, David A.			Direct Detection of Projectile Relics from the End of the Lunar Basin-Forming Epoch	SCIENCE			English	Article							LATE HEAVY BOMBARDMENT; TERRESTRIAL PLANETS; MELT BRECCIAS; IMPACT; MOON; METEORITES; CHONDRITE; ORIGIN; PERIOD; PETROGENESIS	The lunar surface, a key proxy for the early Earth, contains relics of asteroids and comets that have pummeled terrestrial planetary surfaces. Surviving fragments of projectiles in the lunar regolith provide a direct measure of the types and thus the sources of exogenous material delivered to the Earth-Moon system. In ancient [>3.4 billion years ago (Ga)] regolith breccias from the Apollo 16 landing site, we located mineral and lithologic relics of magnesian chondrules from chondritic impactors. These ancient impactor fragments are not nearly as diverse as those found in younger (3.4 Ga to today) regolith breccias and soils from the Moon or that presently fall as meteorites to Earth. This suggests that primitive chondritic asteroids, originating from a similar source region, were common Earth-Moon-crossing impactors during the latter stages of the basin-forming epoch.	[Joy, Katherine H.; Kring, David A.] Univ Space Res Assoc, Ctr Lunar Sci & Explorat, Lunar & Planetary Inst, Houston, TX 77058 USA; [Joy, Katherine H.; Zolensky, Michael E.; McKay, David S.; Kring, David A.] NASA, Lunar Sci Inst, Houston, TX 77058 USA; [Zolensky, Michael E.; Ross, D. Kent; McKay, David S.] NASA, Johnson Space Ctr, ARES, Houston, TX 77058 USA; [Nagashima, Kazuhide; Huss, Gary R.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Ross, D. Kent] Jacobs Technol, Engn & Sci Contract Grp, Houston, TX 77058 USA	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Hawaii System; University of Hawaii Manoa	Joy, KH (corresponding author), Univ Space Res Assoc, Ctr Lunar Sci & Explorat, Lunar & Planetary Inst, 3600 Bay Area Blvd, Houston, TX 77058 USA.	joy@lpi.usra.edu		Joy, Katherine/0000-0003-4992-8750; Nagashima, Kazuhide/0000-0002-9322-3187; Zolensky, Michael/0000-0002-3181-1303; Huss, Gary/0000-0003-4281-7839	NASA Lunar Science Institute [NNA09DB33A]; NASA [NNX11AG78G, NNX08AH77G]; STFC [ST/G003068/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G003068/1] Funding Source: researchfish	NASA Lunar Science Institute; NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The data reported in this paper are tabulated in the supplementary materials. This research was funded by NASA Lunar Science Institute contract NNA09DB33A (D.A.K.), NASA Cosmochemistry grant NNX11AG78G (G.R.H.), and NASA Cosmochemistry grant NNX08AH77G (K.N.). This is Lunar and Planetary Institute contribution number 1665. We thank the three reviewers for helpful comments and D. Mittlefehldt, J. Berlin, R. Jones, and H. McSween for sharing meteorite data sets.	Artemieva NA, 2008, SOLAR SYST RES+, V42, P329, DOI 10.1134/S0038094608040059; Barringer DM, 1905, P ACAD NAT SCI PHILA, V57, P861; BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; Day JMD, 2006, GEOCHIM COSMOCHIM AC, V70, P5957, DOI 10.1016/j.gca.2006.05.001; Elardo SM, 2011, GEOCHIM COSMOCHIM AC, V75, P3024, DOI 10.1016/j.gca.2011.02.033; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hartmann WK, 2003, METEORIT PLANET SCI, V38, P579, DOI 10.1111/j.1945-5100.2003.tb00028.x; Hartmann WK, 2000, ORIGIN EARTH MOON, P805; Jolliff B L, 1993, P LUNAR PLANET SCI, V24, P729; Jorgensen UG, 2009, ICARUS, V204, P368, DOI 10.1016/j.icarus.2009.07.015; Joy KH, 2011, GEOCHIM COSMOCHIM AC, V75, P7208, DOI 10.1016/j.gca.2011.09.018; KLOCK W, 1989, NATURE, V339, P126, DOI 10.1038/339126a0; Kring D. A., 2002, J GEOPHYS RES, V107; KRING DA, 1988, THESIS HARVARD U CAM; Kyte FT, 1998, NATURE, V396, P237, DOI 10.1038/24322; Levison HF, 2001, ICARUS, V151, P286, DOI 10.1006/icar.2001.6608; Liu DY, 2012, EARTH PLANET SC LETT, V319, P277, DOI 10.1016/j.epsl.2011.12.014; Liu J. G., 2012, LUNAR PLANET SCI, VXLIII; Makide K, 2009, GEOCHIM COSMOCHIM AC, V73, P5018, DOI 10.1016/j.gca.2009.01.042; McKay D. S., 1986, P LUNAR PLANET SCI C, V16, pD277; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; Mittlefehldt DW, 2008, REV MINERAL GEOCHEM, V68, P399, DOI 10.2138/rmg.2008.68.14; MORGAN JW, 1974, P LUNAR PLANET SCI C, V5, P1703; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Norman MD, 2002, EARTH PLANET SC LETT, V202, P217, DOI 10.1016/S0012-821X(02)00780-X; Ong L, 2010, ICARUS, V207, P578, DOI 10.1016/j.icarus.2009.12.012; Papike J., 1991, LUNAR SOURCEBOOK USE, P121; Puchtel IS, 2008, GEOCHIM COSMOCHIM AC, V72, P3022, DOI 10.1016/j.gca.2008.04.006; Quaide W., 1970, P LUNAR PLANET SCI C, V1, P711; Rubin AE, 1997, METEORIT PLANET SCI, V32, P135, DOI 10.1111/j.1945-5100.1997.tb01248.x; Ryder G., 1990, EOS T AM GEOPHYS UN, VAGU71, P313, DOI [10.1029/90EO00086, DOI 10.1029/90EO00086, 10.1029/ 90EO00086]; Shearer CK, 2005, GEOCHIM COSMOCHIM AC, V69, P3445, DOI 10.1016/j.gca.2005.02.025; SHEARER CK, 1990, GEOCHIM COSMOCHIM AC, V54, P1851, DOI 10.1016/0016-7037(90)90418-K; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Swindle TD, 2009, METEORIT PLANET SCI, V44, P747, DOI 10.1111/j.1945-5100.2009.tb00766.x; Warren P. H., 1978, LUNAR PLANET SCI C, V9, P185; Wentworth S. J., 1988, P LUNAR PLANET SCI C, V18, P67; Wilhems D. E., 1987, 1348 US DEP INT US G; WOOD JA, 1970, 307 SMITHS ASTR OBS; Zappala V, 1998, ICARUS, V134, P176, DOI 10.1006/icar.1998.5946; Zolensky ME, 1997, METEORIT PLANET SCI, V32, P15, DOI 10.1111/j.1945-5100.1997.tb01235.x	41	69	72	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1426	1429		10.1126/science.1219633	http://dx.doi.org/10.1126/science.1219633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22604725				2022-12-28	WOS:000305211700041
J	Maurer, PC; Kucsko, G; Latta, C; Jiang, L; Yao, NY; Bennett, SD; Pastawski, F; Hunger, D; Chisholm, N; Markham, M; Twitchen, DJ; Cirac, JI; Lukin, MD				Maurer, P. C.; Kucsko, G.; Latta, C.; Jiang, L.; Yao, N. Y.; Bennett, S. D.; Pastawski, F.; Hunger, D.; Chisholm, N.; Markham, M.; Twitchen, D. J.; Cirac, J. I.; Lukin, M. D.			Room-Temperature Quantum Bit Memory Exceeding One Second	SCIENCE			English	Article							SINGLE-SHOT READOUT; SOLID-STATE SPIN; NUCLEAR-SPIN; ELECTRON-SPIN; TRAPPED IONS; DIAMOND; ENTANGLEMENT; SILICON	Stable quantum bits, capable both of storing quantum information for macroscopic time scales and of integration inside small portable devices, are an essential building block for an array of potential applications. We demonstrate high-fidelity control of a solid-state qubit, which preserves its polarization for several minutes and features coherence lifetimes exceeding 1 second at room temperature. The qubit consists of a single C-13 nuclear spin in the vicinity of a nitrogen-vacancy color center within an isotopically purified diamond crystal. The long qubit memory time was achieved via a technique involving dissipative decoupling of the single nuclear spin from its local environment. The versatility, robustness, and potential scalability of this system may allow for new applications in quantum information science.	[Maurer, P. C.; Kucsko, G.; Latta, C.; Yao, N. Y.; Bennett, S. D.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Jiang, L.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Pastawski, F.; Hunger, D.; Cirac, J. I.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Chisholm, N.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Markham, M.; Twitchen, D. J.] Element Six, Ascot SL5 8BP, Berks, England	Harvard University; California Institute of Technology; Max Planck Society; Harvard University; Element Six	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Jiang, Liang/GVU-8654-2022; Kucsko, Georg/I-2179-2013; Jiang, Liang/A-9847-2008; Cirac, J. Ignacio/A-9105-2017; Hunger, David/A-7673-2012; Yao, Norman/A-3929-2009	Jiang, Liang/0000-0002-0000-9342; Kucsko, Georg/0000-0002-4189-3154; Jiang, Liang/0000-0002-0000-9342; Cirac, J. Ignacio/0000-0003-3359-1743; Hunger, David/0000-0001-6156-6145; Yao, Norman/0000-0003-0194-7266; Markham, Matthew/0000-0001-8898-5884	NSF; Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUEST); Air Force Office of Scientific Research (MURI); Element 6; Packard Foundation; European Union (DIAMANT); Fulbright Science and Technology Award; Swiss National Science Foundation; Sherman Fairchild Foundation; National Basic Research Program of China (973 program) [2011CBA00300 (2011CBA00301)]; Department of Energy [FG02-97ER25308]; Defense Advanced Research Projects Agency (QUASAR)	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUEST); Air Force Office of Scientific Research (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Element 6; Packard Foundation(The David & Lucile Packard Foundation); European Union (DIAMANT); Fulbright Science and Technology Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sherman Fairchild Foundation; National Basic Research Program of China (973 program)(National Basic Research Program of China); Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency (QUASAR)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank F. Jelezko, P. Neumann, J. Wrachtrup, R. Walsworth, A. Zibrov, and P. Hemmer for stimulating discussions and experimental help. This work was supported in part by NSF, the Center for Ultracold Atoms, the Defense Advanced Research Projects Agency (QUEST and QUASAR programs), Air Force Office of Scientific Research (MURI program), Element 6, the Packard Foundation, the European Union (DIAMANT program), a Fulbright Science and Technology Award (P.C.M.), the Swiss National Science Foundation (C.L.), the Sherman Fairchild Foundation, and the National Basic Research Program of China (973 program), grant 2011CBA00300 (2011CBA00301) (L.J.), the Department of Energy (FG02-97ER25308) (Y.Y.N).	Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Balabas MV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.070801; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Burrell AH, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.040302; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Duan LM, 2010, REV MOD PHYS, V82, P1209, DOI 10.1103/RevModPhys.82.1209; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Jiang L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073001; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Khaneja N, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.032308; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Spinicelli P, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025014; Terblanche CJ, 2001, SOLID STATE NUCL MAG, V20, P1, DOI 10.1006/snmr.2001.0026; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Toyli DM, 2010, NANO LETT, V10, P3168, DOI 10.1021/nl102066q; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Waldherr G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.157601; Yao NY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1788	27	610	622	9	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1283	1286		10.1126/science.1220513	http://dx.doi.org/10.1126/science.1220513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679092	Green Accepted, Green Submitted			2022-12-28	WOS:000304905300040
J	Shetty, P				Shetty, Priya			Sarah Tabrizi: tracking Huntington's disease	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2043	2043		10.1016/S0140-6736(12)60884-8	http://dx.doi.org/10.1016/S0140-6736(12)60884-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22656876				2022-12-28	WOS:000304759100017
J	Harden, PN; Walsh, G; Bandler, N; Bradley, S; Lonsdale, D; Taylor, J; Marks, SD				Harden, P. N.; Walsh, G.; Bandler, N.; Bradley, S.; Lonsdale, D.; Taylor, J.; Marks, S. D.			Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSPLANT RECIPIENTS; HEALTH-CARE; TRANSITION; NONCOMPLIANCE; ADOLESCENTS; ADHERENCE; OUTCOMES; WORK	Problem Transition from paediatric to adult care of young adults with chronic diseases is poorly coordinated, often delayed, and usually managed through a single referral letter. About 35% of young adults lose a successfully functioning kidney transplant within 36 months of transfer from paediatric to adult services. Design Before and after study of the impact of a new integrated paediatric-adult clinical service for patients with kidney failure. Setting Adult renal centre in Oxford and two paediatric renal centres in London. Strategies for change An integrated paediatric-young adult joint transition clinic and care pathway was established in 2006, in conjunction with a young adult clinical service with regular community based clinics. Previously, young adult transplant recipients were transferred by a single referral letter to an adult renal consultant and managed in a conventional adult clinic. Key measures for improvement Rates of acute rejection and loss of kidney transplants five years before and five years after the introduction of the integrated young adult care pathway. Effects of the change Nine young adult kidney transplant recipients were transferred directly to adult care between 2000 and 2006 (group 1). From 2006 to 2010, 12 young adult transplant recipients underwent integrated transition into the new young adult service (group 2). Six transplants were lost in group 1 (67%) compared with no transplant losses in group 2. Lessons learnt Implementing an integrated transition clinic, coupled with improving young adults' healthcare experience through a young adult clinic, improved patient adherence to regular medication and engagement with healthcare providers, as judged by reduced transplant failure rates. This model may be applicable to other young adult populations with chronic disease transferring to adult healthcare.	[Harden, P. N.; Bandler, N.; Lonsdale, D.] Churchill Hosp, Oxford Kidney Unit, Oxford OX3 7LJ, England; [Harden, P. N.; Bandler, N.; Lonsdale, D.] Churchill Hosp, Transplant Ctr, Oxford OX3 7LJ, England; [Walsh, G.; Taylor, J.] Evelina Childrens Hosp, London, England; [Bradley, S.; Marks, S. D.] Great Ormond St Hosp Sick Children, London, England	University of Oxford; University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Harden, PN (corresponding author), Churchill Hosp, Oxford Kidney Unit, Oxford OX3 7LJ, England.	paul.harden@ouh.nhs.uk	Marks, Stephen/AAH-6303-2019		Oxford Kidney Unit; NHS Kidney Care as part of the Supporting Young Adults with Kidney Disease initiative in England; British Kidney Patients Association	Oxford Kidney Unit; NHS Kidney Care as part of the Supporting Young Adults with Kidney Disease initiative in England; British Kidney Patients Association	This project was mainly funded by local fund raising and voluntary donations to the Oxford Kidney Unit Discretionary Fund. In addition since August 2010 we have received a grant from NHS Kidney Care as part of the Supporting Young Adults with Kidney Disease initiative in England and a new grant from British Kidney Patients Association in 2012.	Annunziato RA, 2007, PEDIATR TRANSPLANT, V11, P608, DOI 10.1111/j.1399-3046.2007.00689.x; [Anonymous], 2010, US REN DAT SYST 2011; Anthony SJ, 2009, AM J TRANSPLANT, V9, P614, DOI 10.1111/j.1600-6143.2008.02515.x; Baltzer F, 2007, PAED CHILD HEALT-CAN, V12, P785, DOI 10.1093/pch/12.9.785; Bell L, 2007, PEDIATR NEPHROL, V22, P720, DOI 10.1007/s00467-006-0404-z; Bent N, 2002, LANCET, V360, P1280, DOI 10.1016/S0140-6736(02)11316-X; Blum RW, 2002, PEDIATRICS, V110, P1304; British Association for Pediatric Nephrology (BAPN) Renal Association, 2009, HELP AD YOUNG AD END; Cadario F, 2009, CLIN ENDOCRINOL, V71, P346, DOI 10.1111/j.1365-2265.2008.03467.x; Chaturvedi S, 2009, PEDIATR NEPHROL, V24, P1055, DOI 10.1007/s00467-009-1124-y; Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473; Department of Health, 2006, TRANS GETT RIGHT YOU; Dobbels F, 2005, PEDIATR TRANSPLANT, V9, P381, DOI 10.1111/j.1399-3046.2005.00356.x; Groothoff JW, 2002, ARCH DIS CHILD, V87, P380, DOI 10.1136/adc.87.5.380; Harden Paul N, 2006, Prog Transplant, V16, P324; Hargreaves DS, 2011, ARCH DIS CHILD; Irwin CE, 2010, J ADOLESCENT HEALTH, V46, P405, DOI 10.1016/j.jadohealth.2010.03.001; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kieckhefer G M, 2000, Pediatr Nurs, V26, P354; Lewis MA, 2009, UK RENAL REGISTRY 12; Milford DV, 2008, BR J RENAL MED, V13, P30; Miloh T, 2009, PEDIATRICS, V124, pE844, DOI 10.1542/peds.2009-0415; Pai ALH, 2011, CHILD HEALTH CARE, V40, P16, DOI 10.1080/02739615.2011.537934; Pinsky BW, 2009, AM J TRANSPLANT, V9, P2597, DOI 10.1111/j.1600-6143.2009.02798.x; Robertson LP, 2006, ANN RHEUM DIS, V65, P74, DOI 10.1136/ard.2004.032292; Steinberg L, 2010, BRAIN COGNITION, V72, P160, DOI 10.1016/j.bandc.2009.11.003; Watson AR, 2011, KIDNEY INT, V80, P704, DOI 10.1038/ki.2011.209; Watson AR, 2000, PEDIATR NEPHROL, V14, P469, DOI 10.1007/s004670050794; Watson AR, 2004, ARCH DIS CHILD, V89, P440, DOI 10.1136/adc.2002.022855	29	158	159	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2012	344								e3718	10.1136/bmj.e3718	http://dx.doi.org/10.1136/bmj.e3718			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HK	22661725				2022-12-28	WOS:000304857600005
J	van den Brand, R; Heutschi, J; Barraud, Q; DiGiovanna, J; Bartholdi, K; Huerlimann, M; Friedli, L; Vollenweider, I; Moraud, EM; Duis, S; Dominici, N; Micera, S; Musienko, P; Courtine, G				van den Brand, Rubia; Heutschi, Janine; Barraud, Quentin; DiGiovanna, Jack; Bartholdi, Kay; Huerlimann, Michele; Friedli, Lucia; Vollenweider, Isabel; Moraud, Eduardo Martin; Duis, Simone; Dominici, Nadia; Micera, Silvestro; Musienko, Pavel; Courtine, Gregoire			Restoring Voluntary Control of Locomotion after Paralyzing Spinal Cord Injury	SCIENCE			English	Article							STIMULATION; RECOVERY; REGENERATION; NEURONS; WALKING; CAT	Half of human spinal cord injuries lead to chronic paralysis. Here, we introduce an electrochemical neuroprosthesis and a robotic postural interface designed to encourage supraspinally mediated movements in rats with paralyzing lesions. Despite the interruption of direct supraspinal pathways, the cortex regained the capacity to transform contextual information into task-specific commands to execute refined locomotion. This recovery relied on the extensive remodeling of cortical projections, including the formation of brainstem and intraspinal relays that restored qualitative control over electrochemically enabled lumbosacral circuitries. Automated treadmill-restricted training, which did not engage cortical neurons, failed to promote translesional plasticity and recovery. By encouraging active participation under functional states, our training paradigm triggered a cortex-dependent recovery that may improve function after similar injuries in humans.	[van den Brand, Rubia; Heutschi, Janine; Barraud, Quentin; Bartholdi, Kay; Huerlimann, Michele; Friedli, Lucia; Vollenweider, Isabel; Duis, Simone; Dominici, Nadia; Musienko, Pavel; Courtine, Gregoire] Univ Zurich, Dept Neurol, CH-8008 Zurich, Switzerland; [DiGiovanna, Jack; Moraud, Eduardo Martin; Micera, Silvestro] Swiss Fed Inst Technol EPFL, Sch Engn, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [DiGiovanna, Jack; Moraud, Eduardo Martin; Micera, Silvestro] Swiss Fed Inst Technol, Automat Control Lab, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, CH-8008 Zurich, Switzerland.	gregoire.courtine@epfl.ch	Micera, Silvestro/AAD-6630-2021; courtine, gregoire/AAJ-1694-2020; Musienko, Pavel/L-6677-2015	courtine, gregoire/0000-0002-5744-4142; DiGiovanna, Jack/0000-0002-7757-4120; Dominici, Nadia/0000-0003-2312-915X; Musienko, Pavel/0000-0002-7324-9021; Barraud, Quentin/0000-0003-0894-1959; Martin Moraud, Eduardo/0000-0002-6148-7065	European Research Council (ERC) [261247]; International Paraplegic Foundation; Neuroscience Center Zurich; European Commission [CP-IP 258654]; Swiss National Science Foundation [310030_130850]	European Research Council (ERC)(European Research Council (ERC)European Commission); International Paraplegic Foundation; Neuroscience Center Zurich; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank U. Keller for assistance with the robotic interface. Imaging was performed using equipment maintained by the Center for Microscopy and Image Analysis, University of Zurich. Financial support was provided by a Starting Grant from the European Research Council (ERC 261247, Walk Again); an International Paraplegic Foundation Fellowship; the Neuroscience Center Zurich; European Commission's Seventh Framework Program (CP-IP 258654, NeuWALK); and funding from the Swiss National Science Foundation (subsidy 310030_130850).	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; Cai LL, 2006, J NEUROSCI, V26, P10564, DOI 10.1523/JNEUROSCI.2266-06.2006; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cowley KC, 2008, J PHYSIOL-LONDON, V586, P1623, DOI 10.1113/jphysiol.2007.148361; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; Musienko P, 2012, EXP NEUROL, V235, P100, DOI 10.1016/j.expneurol.2011.08.025; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Musienko P, 2009, IEEE T BIO-MED ENG, V56, P2707, DOI 10.1109/TBME.2009.2027226; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Wernig A, 2005, ARCH PHYS MED REHAB, V86, P2385, DOI 10.1016/j.apmr.2005.10.009; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004	28	513	532	19	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1182	1185		10.1126/science.1217416	http://dx.doi.org/10.1126/science.1217416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654062	Green Submitted, Green Published			2022-12-28	WOS:000304647900056
J	Elvis, M				Elvis, Martin			Let's mine asteroids - for science and profit	NATURE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Elvis, M (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	martinselvis2@gmail.com							0	38	38	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					549	549		10.1038/485549a	http://dx.doi.org/10.1038/485549a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22660280	Bronze			2022-12-28	WOS:000304608000013
J	Watts, G				Watts, Geoff			Down on the "pharm": do genetically modified plants hold the key to cheaper drugs?	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Chidambaram A, 2011, PROD BIOPH US PLANT; NICE, 2012, CET BEV PAN MET COL; Robinson JC, 2006, HEALTH AFFAIR, V25, P1205, DOI 10.1377/hlthaff.25.5.1205	3	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 31	2012	344								e3829	10.1136/bmj.e3829	http://dx.doi.org/10.1136/bmj.e3829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HG	22654068				2022-12-28	WOS:000304857000013
J	Saunders, K; Blundy, J; Dohmen, R; Cashman, K				Saunders, Kate; Blundy, Jon; Dohmen, Ralf; Cashman, Kathy			Linking Petrology and Seismology at an Active Volcano	SCIENCE			English	Article							MOUNT-ST-HELENS; 1980 ERUPTIONS; MAGMA CHAMBER; DIFFUSION; PHENOCRYSTS; STORAGE	Many active volcanoes exhibit changes in seismicity, ground deformation, and gas emissions, which in some instances arise from magma movement in the crust before eruption. An enduring challenge in volcano monitoring is interpreting signs of unrest in terms of the causal subterranean magmatic processes. We examined over 300 zoned orthopyroxene crystals from the 1980-1986 eruption of Mount St. Helens that record pulsatory intrusions of new magma and volatiles into an existing larger reservoir before the eruption occurred. Diffusion chronometry applied to orthopyroxene crystal rims shows that episodes of magma intrusion correlate temporally with recorded seismicity, providing evidence that some seismic events are related to magma intrusion. These time scales are commensurate with monitoring signals at restless volcanoes, thus improving our ability to forecast volcanic eruptions by using petrology.	[Saunders, Kate; Blundy, Jon; Cashman, Kathy] Univ Bristol, Dept Earth Sci, Bristol BS8 2TU, Avon, England; [Dohmen, Ralf] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, Bochum, Germany	University of Bristol; Ruhr University Bochum	Saunders, K (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 2TU, Avon, England.	Kate.Saunders@bristol.ac.uk	Dohmen, Ralf/M-2320-2017	Dohmen, Ralf/0000-0002-5216-3747	National Environment Research Council [NE/G0129X/1]; ERC; NERC [NE/G01292X/1] Funding Source: UKRI; Natural Environment Research Council [NE/G01292X/1] Funding Source: researchfish	National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Environment Research Council postdoctoral fellowship (NE/G0129X/1) to K.S. and an ERC Advanced Grant (CRITMAG) to J.B. We thank S. Kearns and B. Buse for help with analyses and are grateful to K. Berlo for access to their MSH samples. The three reviewers are thanked for their comments. The data reported in this paper are tabulated in the supplementary materials.	Berlo K, 2007, CONTRIB MINERAL PETR, V154, P291, DOI 10.1007/s00410-007-0194-8; Blundy J, 2008, USGS PROF PAP, P755; Blundy J, 2010, EARTH PLANET SC LETT, V290, P289, DOI 10.1016/j.epsl.2009.12.013; Cashman KV, 2005, B VOLCANOL, V68, P57, DOI 10.1007/s00445-005-0422-x; CASHMAN KV, 1983, SCIENCE, V221, P1385, DOI 10.1126/science.221.4618.1385; Cooper KM, 2003, EARTH PLANET SC LETT, V213, P149, DOI 10.1016/S0012-821X(03)00262-0; CRISWELL CW, 1987, J GEOPHYS RES-SOLID, V92, P10237, DOI 10.1029/JB092iB10p10237; Du Bray E. A., 2006, USGS DATA SERIES; Endo E., 1981, US GEOL SURV PROF PA, V1250, P93; Frey HM, 2011, CONTRIB MINERAL PETR, V162, P415, DOI 10.1007/s00410-010-0604-1; FRUCHTER JS, 1980, SCIENCE, V209, P1116, DOI 10.1126/science.209.4461.1116; GARDNER JE, 1995, B VOLCANOL, V57, P1, DOI 10.1007/BF00298703; HOOPER PR, 1980, SCIENCE, V209, P1125, DOI 10.1126/science.209.4461.1126; Kahl M, 2011, EARTH PLANET SC LETT, V308, P11, DOI 10.1016/j.epsl.2011.05.008; McGee K. A., 1994, 94212 US GEOL SURV; MELSON WG, 1983, SCIENCE, V221, P1387, DOI 10.1126/science.221.4618.1387; Morgan DJ, 2004, EARTH PLANET SC LETT, V222, P933, DOI 10.1016/j.epsl.2004.03.030; PALLISTER JS, 1992, B VOLCANOL, V54, P126, DOI 10.1007/BF00278003; RUTHERFORD MJ, 1988, J GEOPHYS RES-SOLID, V93, P11949, DOI 10.1029/JB093iB10p11949; RUTHERFORD MJ, 1985, J GEOPHYS RES-SOLID, V90, P2929, DOI 10.1029/JB090iB04p02929; Sarna-Wojcicki A. M., 1981, US GEOL SURV PROF PA, V1250, P667; Saunders K, 2012, AM MINERAL, V97, P532, DOI 10.2138/am.2012.3893; SAUTTER V, 1988, EARTH PLANET SC LETT, V89, P109, DOI 10.1016/0012-821X(88)90036-2; Scandone R, 2007, EARTH PLANET SC LETT, V253, P513, DOI 10.1016/j.epsl.2006.11.016; Schwandt CS, 1998, CONTRIB MINERAL PETR, V130, P390, DOI 10.1007/s004100050373; SMITH DR, 1993, J VOLCANOL GEOTH RES, V55, P271, DOI 10.1016/0377-0273(93)90042-P	26	84	86	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1023	1027		10.1126/science.1220066	http://dx.doi.org/10.1126/science.1220066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628652				2022-12-28	WOS:000304406800042
J	Baselga, J; Smith, BL; Rafferty, EA; Bombonati, A				Baselga, Jose; Smith, Barbara Lynn; Rafferty, Elizabeth A.; Bombonati, Alessandro			Case 16-2012: A 32-Year-Old Woman with HER2-Positive Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NERVOUS-SYSTEM METASTASES; MONOCLONAL-ANTIBODY; PHASE-II; PRIMARY TUMOR; 1ST-LINE TREATMENT; BRAIN METASTASES; TRASTUZUMAB; SURVIVAL; CHEMOTHERAPY; THERAPY		[Baselga, Jose] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Smith, Barbara Lynn] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Bombonati, Alessandro] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Baselga, Jose] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Smith, Barbara Lynn] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Rafferty, Elizabeth A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Bombonati, Alessandro] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Baselga, J (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.							Babiera GV, 2006, ANN SURG ONCOL, V13, P776, DOI 10.1245/ASO.2006.03.033; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Cady B, 2008, ANN SURG ONCOL, V15, P3384, DOI 10.1245/s10434-008-0085-x; Clayton AJ, 2004, BRIT J CANCER, V91, P639, DOI 10.1038/sj.bjc.6601970; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cobleigh MA, 2008, J CLIN ONCOL S, p610s; Dowsett M, 2009, J CLIN ONCOL, V27, P2962, DOI 10.1200/JCO.2008.19.7939; Fields RC, 2007, ANN SURG ONCOL, V14, P3345, DOI 10.1245/s10434-007-9527-0; Geyer CE, 2007, NEW ENGL J MED, V356, P1487; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Khan SA, 2002, SURGERY, V132, P620, DOI 10.1067/msy.2002.127544; Khan SA, 2007, ANN SURG ONCOL, V14, P3285, DOI 10.1245/s10434-007-9547-9; Lai R, 2004, CANCER-AM CANCER SOC, V101, P810, DOI 10.1002/cncr.20418; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Morrogh M, 2008, CANCER-AM CANCER SOC, V112, P1445, DOI 10.1002/cncr.23319; Niwinska A, 2010, INT J RADIAT ONCOL, V77, P1134, DOI 10.1016/j.ijrobp.2009.06.030; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Valero V, 2011, J CLIN ONCOL, V29, P149, DOI 10.1200/JCO.2010.28.6450; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolstenholme V, 2008, BREAST, V17, P661, DOI 10.1016/j.breast.2008.04.006	31	7	7	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					2018	2026		10.1056/NEJMcpc1111576	http://dx.doi.org/10.1056/NEJMcpc1111576			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621630				2022-12-28	WOS:000304353000013
J	Moreno, JA; Radford, H; Peretti, D; Steinert, JR; Verity, N; Martin, MG; Halliday, M; Morgan, J; Dinsdale, D; Ortori, CA; Barrett, DA; Tsaytler, P; Bertolotti, A; Willis, AE; Bushell, M; Mallucci, GR				Moreno, Julie A.; Radford, Helois; Peretti, Diego; Steinert, Joern R.; Verity, Nicholas; Martin, Maria Guerra; Halliday, Mark; Morgan, Jason; Dinsdale, David; Ortori, Catherine A.; Barrett, David A.; Tsaytler, Pavel; Bertolotti, Anne; Willis, Anne E.; Bushell, Martin; Mallucci, Giovanna R.			Sustained translational repression by eIF2 alpha-P mediates prion neurodegeneration	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TOXICITY IN-VIVO; ALZHEIMERS-DISEASE; GENE-EXPRESSION; ER STRESS; MICE; PRP; PROTEOSTASIS; DYSFUNCTION	The mechanisms leading to neuronal death in neurodegenerative disease are poorly understood. Many of these disorders, including Alzheimer's, Parkinson's and prion diseases, are associated with the accumulation of misfolded disease-specific proteins. The unfolded protein response is a protective cellular mechanism triggered by rising levels of misfolded proteins. One arm of this pathway results in the transient shutdown of protein translation, through phosphorylation of the alpha-subunit of eukaryotic translation initiation factor, eIF2. Activation of the unfolded protein response and/or increased eIF2 alpha-P levels are seen in patients with Alzheimer's, Parkinson's and prion diseases(1-4), but how this links to neurodegeneration is unknown. Here we show that accumulation of prion protein during prion replication causes persistent translational repression of global protein synthesis by eIF2 alpha-P, associated with synaptic failure and neuronal loss in prion-diseased mice. Further, we show that promoting translational recovery in hippocampi of prion-infected mice is neuroprotective. Overexpression of GADD34, a specific eIF2 alpha-P phosphatase, as well as reduction of levels of prion protein by lentivirally mediated RNA interference, reduced eIF2 alpha-P levels. As a result, both approaches restored vital translation rates during prion disease, rescuing synaptic deficits and neuronal loss, thereby significantly increasing survival. In contrast, salubrinal, an inhibitor of eIF2 alpha-P dephosphorylation(5), increased eIF2 alpha-P levels, exacerbating neurotoxicity and significantly reducing survival in prion-diseased mice. Given the prevalence of protein misfolding and activation of the unfolded protein response in several neurodegenerative diseases, our results suggest that manipulation of common pathways such as translational control, rather than disease-specific approaches, may lead to new therapies preventing synaptic failure and neuronal loss across the spectrum of these disorders.	[Moreno, Julie A.; Radford, Helois; Peretti, Diego; Steinert, Joern R.; Verity, Nicholas; Martin, Maria Guerra; Halliday, Mark; Morgan, Jason; Dinsdale, David; Willis, Anne E.; Bushell, Martin; Mallucci, Giovanna R.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Ortori, Catherine A.; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England; [Tsaytler, Pavel; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Leicester; University of Nottingham; MRC Laboratory Molecular Biology	Mallucci, GR (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	grm7@le.ac.uk	Steinert, Joern/ABB-4561-2020; Moreno, Julie/L-1832-2018; Martín, María/HDL-9512-2022; Steinert, Joern R/AAI-2742-2020; Barrett, David/C-9922-2011	Moreno, Julie/0000-0002-9618-2712; Steinert, Joern R/0000-0003-1640-0845; Willis, Anne/0000-0002-1470-8531; Barrett, David/0000-0001-6900-9474; Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council, UK; BBSRC [BB/F02326X/2] Funding Source: UKRI; MRC [MC_UP_A600_1024, MC_U105185860, MC_U132692719, MC_UP_A600_1023, MC_U132681855, MC_U123160654] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F02326X/2] Funding Source: researchfish; Medical Research Council [MC_U123160654, MC_UP_A600_1023, MC_UP_A600_1024, MC_U132692719, MC_U132681855, MC_U105185860] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Read for imaging analysis, J. Edwards, T. Smith, J. McWilliam, P. Glynn, C. Molloy and University of Leicester, Department of Biological Services staff for technical assistance, J. Collinge (MRC Prion Unit) for the original RML prion inoculum, and K. Liddle for reading the manuscript. This work was funded by the Medical Research Council, UK.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haustein MD, 2010, J PHYSIOL-LONDON, V588, P4683, DOI 10.1113/jphysiol.2010.199778; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	34	434	457	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					507	U119		10.1038/nature11058	http://dx.doi.org/10.1038/nature11058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622579	Green Accepted			2022-12-28	WOS:000304344500044
J	Zeigerer, A; Gilleron, J; Bogorad, RL; Marsico, G; Nonaka, H; Seifert, S; Epstein-Barash, H; Kuchimanchi, S; Peng, CG; Ruda, VM; Del Conte-Zerial, P; Hengstler, JG; Kalaidzidis, Y; Koteliansky, V; Zerial, M				Zeigerer, Anja; Gilleron, Jerome; Bogorad, Roman L.; Marsico, Giovanni; Nonaka, Hidenori; Seifert, Sarah; Epstein-Barash, Hila; Kuchimanchi, Satya; Peng, Chang Geng; Ruda, Vera M.; Del Conte-Zerial, Perla; Hengstler, Jan G.; Kalaidzidis, Yannis; Koteliansky, Victor; Zerial, Marino			Rab5 is necessary for the biogenesis of the endolysosomal system in vivo	NATURE			English	Article							POLARIZED EPITHELIAL-CELLS; LIPID-LIKE MATERIALS; RECYCLING ENDOSOMES; MEMBRANE-FUSION; PLASMA-MEMBRANE; RNAI THERAPEUTICS; ENDOCYTIC PATHWAY; TRAFFICKING; PROTEINS; TRANSPORT	An outstanding question is how cells control the number and size of membrane organelles. The small GTPase Rab5 has been proposed to be a master regulator of endosome biogenesis. Here, to test this hypothesis, we developed a mathematical model of endosome dependency on Rab5 and validated it by titrating down all three Rab5 isoforms in adult mouse liver using state-of-the-art RNA interference technology. Unexpectedly, the endocytic system was resilient to depletion of Rab5 and collapsed only when Rab5 decreased to a critical level. Loss of Rab5 below this threshold caused a marked reduction in the number of early endosomes, late endosomes and lysosomes, associated with a block of low-density lipoprotein endocytosis. Loss of endosomes caused failure to deliver apical proteins to the bile canaliculi, suggesting a requirement for polarized cargo sorting. Our results demonstrate for the first time, to our knowledge, the role of Rab5 as an endosome organizer in vivo and reveal the resilience mechanisms of the endocytic system.	[Zeigerer, Anja; Gilleron, Jerome; Marsico, Giovanni; Nonaka, Hidenori; Seifert, Sarah; Del Conte-Zerial, Perla; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Epstein-Barash, Hila; Kuchimanchi, Satya; Peng, Chang Geng; Koteliansky, Victor] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Ruda, Vera M.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ruda, Vera M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ruda, Vera M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factors, D-44139 Dortmund, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Gilleron, Jerome/GRX-8574-2022; Bogorad, Roman/G-2609-2011; Kalaidzidis, Yannis/H-3094-2016; Zeigerer, Anja/AAC-8953-2021; Hengstler, Jan G./O-1415-2013	Gilleron, Jerome/0000-0002-6389-8685; Kalaidzidis, Yannis/0000-0002-6137-1193; Hengstler, Jan/0000-0002-1427-5246; Zeigerer, Anja/0000-0003-4072-0566	Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF); Max Planck Society (MPG); DFG; Marie Curie Action, Intra-European Fellowship [fp7-people-ief-2008]; EMBO	Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society); DFG(German Research Foundation (DFG)); Marie Curie Action, Intra-European Fellowship; EMBO(European Molecular Biology Organization (EMBO))	We acknowledge K. Simons, E. Knust, C. Fetzer, T. Galvez, G. O'Sullivan and M. P. McShane for discussions and comments on the manuscript. We thank W. John and A. Muench-Wuttke from the Biomedical Services Facility for mouse care and injections. We acknowledge J. Peychl for the management of the Light Microscopy Facility and K. Manygoats as well as J.-M. Verbavatz for their support. We thank B. Bettencourt and J. Hettinger for siRNA design and serum biochemistry assays, respectively. This work was financially supported by the Virtual Liver initiative (http://www.virtual-liver.de), funded by the German Federal Ministry of Research and Education (BMBF), the Max Planck Society (MPG) and the DFG. A.Z. was supported by a grant from Marie Curie Action, Intra-European Fellowship (fp7-people-ief-2008) and J. G. from an EMBO long-term fellowship.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; KOENIG JH, 1990, CELL TISSUE RES, V262, P233, DOI 10.1007/BF00309878; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; RENAUD G, 1989, HEPATOLOGY, V9, P380, DOI 10.1002/hep.1840090307; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schroeder B. M. M., 2009, LIVER BIOL PATHOBIOL, P107; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Skjeldal F. M., 2012, J CELL SCI; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Wolfsdorf JI, 2003, REV ENDOCR METAB DIS, V4, P95, DOI 10.1023/A:1021831621210; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	49	248	254	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					465	470		10.1038/nature11133	http://dx.doi.org/10.1038/nature11133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622570				2022-12-28	WOS:000304344500035
J	Bowles, S				Bowles, Samuel			WARRIORS, LEVELERS, AND THE ROLE OF CONFLICT IN HUMAN SOCIAL EVOLUTION	SCIENCE			English	Editorial Material							PAROCHIAL ALTRUISM; COEVOLUTION; COMPETITION; BEHAVIOR	The origins of such varied features of contemporary life as the national state and the desire to uphold generous and civic social norms are to be found in a combination of conflict between groups and attenuation of both inequalities and conflicts within groups. In contrast to the adoption of a better tool or a more productive crop, which can be adopted by a single individual, a new institution works only if most people adopt it. This explains why collective action against those benefitting from the status quo at the expense of others, as well as conflict between groups governed by different norms and institutions, figures so prominently in our capacity to adapt to changing circumstances and to harness new knowledge for human benefit.	[Bowles, Samuel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bowles, Samuel] Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	samuel.bowles@gmail.com			Santa Fe Institute	Santa Fe Institute	The author declares no competing interests and would like to thank the Behavioral Sciences Program at the Santa Fe Institute for funding; R. Allen, C. Boehm, R. Boyd, J. Cohen, S. Naidu, P. Richerson, J. Roemer, J. Sabloff, N. Sambanis, and E. Wood for valuable comments; and his teacher, the late B. Moore Jr., who sparked his interest in the topic.	[Anonymous], 1983, NATIONS NATL NEW PER; BARTLETT J, 1992, FAMILIAR QUOTATIONS; Beissinger M.R., 2002, NATL MOBILIZATION CO; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; BOEHM C, 1982, J SOC BIOL STRUCT, V5, P413, DOI 10.1016/S0140-1750(82)92069-3; Boehm C., 2012, MORAL ORIGINS SOCIAL; Boehm C, 2012, SCIENCE, V336, P844, DOI 10.1126/science.1219961; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Collier RuthBerins., 1999, PATHS DEMOCRACY WORK, P110; Dafoe A, 2011, AM J POLIT SCI, V55, P247, DOI 10.1111/j.1540-5907.2010.00487.x; Darwin C., 1873, DESCENT MAN; EIBLEIBESFELDT I, 1982, Z TIERPSYCHOL, V60, P177; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Goldberg TL, 1997, ANIM BEHAV, V54, P559, DOI 10.1006/anbe.1996.0450; Hui VTB, 2005, WAR AND STATE FORMATION IN ANCIENT CHINA AND EARLY MODERN EUROPE, P1, DOI 10.1017/CBO9780511614545; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Moore Barrington, 1993, SOCIAL ORIGINS DICTA; Spencer CS, 2010, P NATL ACAD SCI USA, V107, P7119, DOI 10.1073/pnas.1002470107; Szathmary E, 1995, MAJOR TRANSITIONS EV; Therborn G., 1977, NEW LEFT REV, V103, P3; Tilly C, 1992, COERCION CAPITAL EUR; Weber Eugen., 1976, PEASANTS FRENCHMEN M; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; Wiessner P., 1982, FOOD STATUS QUEST IN; Williams G. C., 1966, P307; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wood Elisabeth J., 2000, FORGING DEMOCRACY BE	32	40	40	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					876	879		10.1126/science.1217336	http://dx.doi.org/10.1126/science.1217336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605768				2022-12-28	WOS:000304145600054
J	Bauchner, H; Frenk, J				Bauchner, Howard; Frenk, Julio			Health, Economics, and the 2012 G8 Summit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLOBAL HEALTH; DEVELOPMENT ASSISTANCE; RANDOMIZED-TRIAL; CHILDREN; SUPPLEMENTATION; MICRONUTRIENT; MORTALITY; AFRICA; EQUITY; TRENDS		[Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bauchner, H (corresponding author), 515 N State St, Chicago, IL 60654 USA.	howard.bauchner@jama-archives.org		Bauchner, Howard/0000-0002-8368-9805				[Anonymous], MILL DEV GOALS BACKG; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P2093, DOI 10.1001/jama.2012.4146; Bhutta ZA, 2012, JAMA-J AM MED ASSOC, V307, P2035, DOI 10.1001/jama.2012.4659; Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032; Casey KM., ARCH SURG, DOI 10.001/archsurg.2012.615; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Christian P, 2012, JAMA-J AM MED ASSOC, V307, P2094, DOI 10.1001/jama.2012.4436; Crabtree TG, 2012, ARCH FACIAL PLAST S, V14, P220, DOI 10.1001/archfacial.2012.397; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P2097, DOI 10.1001/jama.2012.4989; Flanagin A, 2007, JAMA-J AM MED ASSOC, V298, P1942, DOI 10.1001/jama.298.16.1942; Frick KD, 2012, ARCH OPHTHALMOL-CHIC, V130, P629, DOI 10.1001/archophthalmol.2011.2820; Gostin LO, 2012, JAMA-J AM MED ASSOC, V307, P2087, DOI 10.1001/jama.2012.4395; Holt GR, 2012, ARCH FACIAL PLAST S, V14, P219, DOI 10.1001/archfacial.2012.394; Holt GR, ARCH FACIAL PLAST S, DOI [10.1001/archfacial.2011.1643, DOI 10.1001/ARCHFACIAL.2011.1643]; Horton R, 2000, LANCET, V356, P1044, DOI 10.1016/S0140-6736(00)02721-5; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; Larrabee WF, 2012, ARCH FACIAL PLAST S, V14, P218, DOI 10.1001/archfacial.2012.400; Marmot MG, 2012, JAMA-J AM MED ASSOC, V307, P2033, DOI 10.1001/jama.2012.3534; Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Murray-Kolb LE, 2012, ARCH PEDIAT ADOL MED, V166, P404, DOI 10.1001/archpediatrics.2012.37; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Pongcharoen T, 2012, ARCH PEDIAT ADOL MED, V166, P411, DOI 10.1001/archpediatrics.2011.1413; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Sachs JD, 2012, JAMA-J AM MED ASSOC, V307, P2031, DOI 10.1001/jama.2012.4438; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; World Health Organization, GLOB HLTH OBS HLTH F	30	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2102	2104		10.1001/jama.2012.4874	http://dx.doi.org/10.1001/jama.2012.4874			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665113				2022-12-28	WOS:000304048200033
J	Rich, DQ; Kipen, HM; Huang, W; Wang, GF; Wang, YD; Zhu, P; Ohman-Strickland, P; Hu, M; Philipp, C; Diehl, SR; Lu, SE; Tong, J; Gong, JC; Thomas, D; Zhu, T; Zhang, JF				Rich, David Q.; Kipen, Howard M.; Huang, Wei; Wang, Guangfa; Wang, Yuedan; Zhu, Ping; Ohman-Strickland, Pamela; Hu, Min; Philipp, Claire; Diehl, Scott R.; Lu, Shou-En; Tong, Jian; Gong, Jicheng; Thomas, Duncan; Zhu, Tong; Zhang, Junfeng (Jim)			Association Between Changes in Air Pollution Levels During the Beijing Olympics and Biomarkers of Inflammation and Thrombosis in Healthy Young Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CASE-CROSSOVER ANALYSIS; SOLUBLE CD40 LIGAND; MYOCARDIAL-INFARCTION; AMBIENT AIR; P-SELECTIN; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; PLATELET ACTIVATION; OXIDATIVE STRESS; HEART-DISEASE	Context Air pollution is a risk factor for cardiovascular diseases (CVD), but the underlying biological mechanisms are not well understood. Objective To determine whether markers related to CVD pathophysiological pathways (biomarkers for systemic inflammation and thrombosis, heart rate, and blood pressure) are sensitive to changes in air pollution. Design, Setting, and Participants Using a quasi-experimental opportunity offered by greatly restricted air pollution emissions during the Beijing Olympics, we measured pollutants daily and the outcomes listed below in 125 healthy young adults before, during, and after the 2008 Olympics (June 2-October 30). We used linear mixed effects models to estimate the improvement in outcome levels during the Olympics and the anticipated reversal of outcome levels after pollution controls ended to determine whether changes in outcome levels were associated with changes in pollutant concentrations. Main Outcome Measures C-reactive protein (CRP), fibrinogen, von Willebrand factor, soluble CD40 ligand (sCD40L), soluble P-selectin (sCD62P) concentrations; white blood cell count (WBC); heart rate; and blood pressure. Results Concentrations of particulate and gaseous pollutants decreased substantially (-13% to -60%) from the pre-Olympic period to the during-Olympic period. Using 2-sided tests conducted at the .003 level, we observed statistically significant improvements in sCD62P levels by -34.0% (95% CI, -38.4% to -29.2%; P<.001) from a pre-Olympic mean of 6.29 ng/mL to a during-Olympic mean of 4.16 ng/mL and von Willebrand factor by -13.1% (95% CI, -18.6% to -7.5%; P<.001) from 106.4% to 92.6%. After adjustments for multiple comparisons, changes in the other outcomes were not statistically significant. In the post-Olympic period when pollutant concentrations increased, most outcomes approximated pre-Olympic levels, but only sCD62P and systolic blood pressure were significantly worsened from the during-Olympic period. The fraction of above-detection-limit values for CRP (percentage >= 0.3 mg/L) was reduced from 55% in the pre-Olympic period to 46% in the during-Olympic period and reduced further to 36% in the post-Olympic period. Interquartile range increases in pollutant concentrations were consistently associated with statistically significant increases in fibrinogen, von Willebrand factor, heart rate, sCD62P, and sCD40L concentrations. Conclusions Changes in air pollution levels during the Beijing Olympics were associated with acute changes in biomarkers of inflammation and thrombosis and measures of cardiovascular physiology in healthy young persons. These findings are of uncertain clinical significance. JAMA. 2012;307(19):2068-2078	[Gong, Jicheng; Thomas, Duncan; Zhang, Junfeng (Jim)] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Rich, David Q.] Univ Rochester, Sch Med & Dent, Dept Community & Prevent Med, Rochester, NY USA; [Kipen, Howard M.; Ohman-Strickland, Pamela; Lu, Shou-En; Zhang, Junfeng (Jim)] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Kipen, Howard M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Philipp, Claire] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Ohman-Strickland, Pamela] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Biostat, Piscataway, NJ 08854 USA; [Tong, Jian; Gong, Jicheng; Zhang, Junfeng (Jim)] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Environm Hlth, Piscataway, NJ 08854 USA; [Diehl, Scott R.] Univ Med & Dent New Jersey, Sch Dent, Ctr Pharmacogen & Complex Dis, Newark, NJ 07103 USA; [Huang, Wei; Hu, Min; Zhu, Tong] Peking Univ, Hosp 1, Coll Environm Sci & Engn, State Key Lab Environm Simulat & Pollut Control, Beijing 100871, Peoples R China; [Huang, Wei; Hu, Min; Zhu, Tong] Peking Univ, Hosp 1, Ctr Environm & Hlth, Beijing 100871, Peoples R China; [Wang, Guangfa] Peking Univ, Hosp 1, Dept Pulm Med, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Hosp 1, Dept Hematol, Beijing 100871, Peoples R China; [Wang, Yuedan] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China; [Gong, Jicheng; Thomas, Duncan; Zhang, Junfeng (Jim)] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	University of Southern California; University of Rochester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Peking University; Peking University; Peking University; Peking University; Peking University; University of Southern California	Zhang, JF (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, 2001 N Soto St,Room 225Q, Los Angeles, CA 90089 USA.	tzhu@pku.edu.cn; junfengz@usc.edu	HU, Min/D-1037-2011; Gong, Jicheng/I-5236-2016; Zhang, Junfeng/AAJ-9183-2020; ZHU, TONG/H-6501-2011; Gong, Jicheng/AAS-4862-2020	HU, Min/0000-0003-4816-9123; Gong, Jicheng/0000-0002-8943-8804; Zhang, Junfeng/0000-0003-3759-6672; ZHU, TONG/0000-0002-2752-7924; 	National Institute of Environmental Health Sciences [1R01ES015864, P30ES005022, 5P30ES007048]; Health Effects Institute [4760-RPFA05-3]; Beijing Environment Protection Bureau [OITC-G08026056]; Beijing Council of Science and Technology [HB200504-6, HB200504-2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015864, P30ES005022, P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Health Effects Institute; Beijing Environment Protection Bureau; Beijing Council of Science and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was jointly funded by grants 1R01ES015864, P30ES005022, and 5P30ES007048 from the National Institute of Environmental Health Sciences, 4760-RPFA05-3 from the Health Effects Institute, OITC-G08026056 from the Beijing Environment Protection Bureau, and HB200504-6, HB200504-2 from the Beijing Council of Science and Technology.	Anderson HR, 1998, THORAX, V53, P842, DOI 10.1136/thx.53.10.842; [Anonymous], 2004, 600P99002BF US EPA, V2; Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Brook RD, 2005, CURR HYPERTENS REP, V7, P427, DOI 10.1007/s11906-005-0037-9; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Choudhury A, 2008, CHEST, V134, P574, DOI 10.1378/chest.07-2745; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Feinstein JA, 1997, CURR OPIN CARDIOL, V12, P70, DOI 10.1097/00001573-199701000-00011; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Heeringa J, 2006, J THROMB HAEMOST, V4, P1944, DOI 10.1111/j.1538-7836.2006.02115.x; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heinrich J, 2000, AM J RESP CRIT CARE, V161, P1930, DOI 10.1164/ajrccm.161.6.9906105; Hilt B, 2002, OCCUP ENVIRON MED, V59, P9, DOI 10.1136/oem.59.1.9; Jacobs L, 2010, ENVIRON HEALTH PERSP, V118, P191, DOI 10.1289/ehp.0900942; Kappelmayer J, 2004, CLIN CHEM LAB MED, V42, P475, DOI 10.1515/CCLM.2004.082; Kipen H, 2010, ANN NY ACAD SCI, V1203, P160, DOI 10.1111/j.1749-6632.2010.05638.x; Lee JT, 2007, J AIR WASTE MANAGE, V57, P968; Lee SL, 2006, CLIN EXP ALLERGY, V36, P1138, DOI 10.1111/j.1365-2222.2006.02555.x; Liao DP, 2005, J EXPO ANAL ENV EPID, V15, P319, DOI 10.1038/sj.jea.7500408; Lin WW, 2011, ENVIRON HEALTH PERSP, V119, P1507, DOI 10.1289/ehp.1103461; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Mateen FJ, 2011, JAMA-J AM MED ASSOC, V305, P1240, DOI 10.1001/jama.2011.352; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Parker JD, 2008, EPIDEMIOLOGY, V19, P820, DOI 10.1097/EDE.0b013e3181883d5d; Peel Jennifer L, 2010, Res Rep Health Eff Inst, P3; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Rich DQ, 2010, ENVIRON HEALTH PERSP, V118, P1229, DOI 10.1289/ehp.0901624; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Riediker M, 2007, INHAL TOXICOL, V19, P99, DOI 10.1080/08958370701495238; Ruckerl Regina, 2007, Part Fibre Toxicol, V4, P1, DOI 10.1186/1743-8977-4-1; Seaton A, 1999, THORAX, V54, P1027, DOI 10.1136/thx.54.11.1027; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009; Wang T, 2010, ATMOS CHEM PHYS, V10, P7603, DOI 10.5194/acp-10-7603-2010; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550	54	299	319	6	146	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2068	2078		10.1001/jama.2012.3488	http://dx.doi.org/10.1001/jama.2012.3488			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665106	Bronze, Green Accepted			2022-12-28	WOS:000304048200026
J	Tennessen, JA; Bigham, AW; O'Connor, TD; Fu, WQ; Kenny, EE; Gravel, S; McGee, S; Do, R; Liu, XM; Jun, G; Kang, HM; Jordan, D; Leal, SM; Gabriel, S; Rieder, MJ; Abecasis, G; Altshuler, D; Nickerson, DA; Boerwinkle, E; Sunyaev, S; Bustamante, CD; Bamshad, MJ; Akey, JM				Tennessen, Jacob A.; Bigham, Abigail W.; O'Connor, Timothy D.; Fu, Wenqing; Kenny, Eimear E.; Gravel, Simon; McGee, Sean; Do, Ron; Liu, Xiaoming; Jun, Goo; Kang, Hyun Min; Jordan, Daniel; Leal, Suzanne M.; Gabriel, Stacey; Rieder, Mark J.; Abecasis, Goncalo; Altshuler, David; Nickerson, Deborah A.; Boerwinkle, Eric; Sunyaev, Shamil; Bustamante, Carlos D.; Bamshad, Michael J.; Akey, Joshua M.		Broad GO; Seattle GO; NHLBI Exome Sequencing Project	Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes	SCIENCE			English	Article							POSITIVE SELECTION; DISCOVERY; SPECTRUM	As a first step toward understanding how rare variants contribute to risk for complex diseases, we sequenced 15,585 human protein-coding genes to an average median depth of 111x in 2440 individuals of European (n = 1351) and African (n = 1088) ancestry. We identified over 500,000 single-nucleotide variants (SNVs), the majority of which were rare (86% with a minor allele frequency less than 0.5%), previously unknown (82%), and population-specific (82%). On average, 2.3% of the 13,595 SNVs each person carried were predicted to affect protein function of similar to 313 genes per genome, and similar to 95.7% of SNVs predicted to be functionally important were rare. This excess of rare functional variants is due to the combined effects of explosive, recent accelerated population growth and weak purifying selection. Furthermore, we show that large sample sizes will be required to associate rare variants with complex traits.	[Tennessen, Jacob A.; O'Connor, Timothy D.; Fu, Wenqing; McGee, Sean; Rieder, Mark J.; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bigham, Abigail W.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kenny, Eimear E.; Gravel, Simon] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Do, Ron; Gabriel, Stacey; Altshuler, David; Sunyaev, Shamil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Do, Ron] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Liu, Xiaoming; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jordan, Daniel; Sunyaev, Shamil] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine	Bamshad, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	mbamshad@u.washington.edu; akeyj@uw.edu	Jun, Goo/M-5235-2016; Abecasis, Goncalo R/B-7840-2010; Jordan, Daniel/M-6842-2019; Liu, Xiaoming/C-2743-2008; Altshuler, David M/A-4476-2009; Jun, Goo/F-1941-2017	Jun, Goo/0000-0003-0891-0204; Jordan, Daniel/0000-0002-5318-8225; Liu, Xiaoming/0000-0001-8285-5528; Altshuler, David M/0000-0002-7250-4107; Jun, Goo/0000-0003-0891-0204; Akey, Joshua/0000-0002-4411-1330; O'Connor, Timothy/0000-0002-0276-1896; Tennessen, Jacob/0000-0002-5015-4740; Bustamante, Carlos D./0000-0002-4187-7920; Abecasis, Goncalo/0000-0003-1509-1825	NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, RC2HL102925, RC2HL102926, RC2HL103010, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, U01HG006513] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the NHLBI and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research; and the Population Genetics Project Team. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (Women's Health Initiative Exome Sequencing Project, WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Filtered sets of annotated variants and their allele frequencies are available at http://evs.gs.washington.edu/EVS/ and have been deposited in dbSNP (www.ncbi.nlm.nih.gov/snp; local batch ID, ESP2500). Genotypes and phenotypes from a large subset of individuals are also available via dbGaP (www.ncbi.nlm.nih.gov/gap) using the following accession information: NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP, WHISP_Subject_Phenotypes, pht002246.v2. p2, phs000281.v2.p2; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (JHS), ESP_HeartGO_JHS_LDLandEOMI_Subject_Phenotypes, pht002539.v1.p1, phs000402.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (FHS), HeartGO_FHS_LDLandEOMI_PhenotypeDataFile, pht002476.v1.p1, phs000401.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS), HeartGO_CHS_LDL_PhenotypeDataFile, pht002536.v1.p1, phs000400.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC), ESP_ARIC_LDLandEOMI_Sample, pht002466.v1.p1, phs000398.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis), ESP_LungGO_CF_PA_Culture_Data, pht002227. v1.p1, phs000254.v1.p1; NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI), ESP_Broad_EOMI_Subject_Phenotypes, pht001437.v1.p1, phs000279.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Pulmonary Arterial Hypertension), PAH_Subject_Phenotypes_Baseline_Measures, pht002277.v1.p1, phs000290.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease), LHS_COPD_Subject_Phenotypes_Baseline_Measures, pht002272.v1.p1, phs000291. v1.p1. C. D. B. is on the scientific advisory board for Personalis, Incorporated; Mubadala Medical Holding Company; 23andme "Roots into the future" project; and Ancestry. com. M.J.R. owns stock in Illumina.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ramirez-Soriano A, 2009, GENETICS, V181, P701, DOI 10.1534/genetics.108.094060; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Tennessen JA, 2010, GENOME RES, V20, P1327, DOI 10.1101/gr.106161.110; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	28	1154	1174	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					64	69		10.1126/science.1219240	http://dx.doi.org/10.1126/science.1219240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22604720	Green Accepted			2022-12-28	WOS:000306053100043
J	Hu, B; Castillo, E; Harewood, L; Ostano, P; Reymond, A; Dummer, R; Raffoul, W; Hoetzenecker, W; Hofbauer, GFL; Dotto, GP				Hu, Bing; Castillo, Einar; Harewood, Louise; Ostano, Paola; Reymond, Alexandre; Dummer, Reinhard; Raffoul, Wassim; Hoetzenecker, Wolfram; Hofbauer, Guenther F. L.; Dotto, G. Paolo			Multifocal Epithelial Tumors and Field Cancerization from Loss of Mesenchymal CSL Signaling	CELL			English	Article							CELL FATE; NOTCH; CANCER; GENE; EXPRESSION; DIFFERENTIATION; ACTIVATION	It is currently unclear whether tissue changes surrounding multifocal epithelial tumors are a cause or consequence of cancer. Here, we provide evidence that loss of mesenchymal Notch/CSL signaling causes tissue alterations, including stromal atrophy and inflammation, which precede and are potent triggers for epithelial tumors. Mice carrying a mesenchymal-specific deletion of CSL/RBP-J(k), a key Notch effector, exhibit spontaneous multifocal keratinocyte tumors that develop after dermal atrophy and inflammation. CSL-deficient dermal fibroblasts promote increased tumor cell proliferation through upregulation of c-Jun and c-Fos expression and consequently higher levels of diffusible growth factors, inflammatory cytokines, and matrix-remodeling enzymes. In human skin samples, stromal fields adjacent to multifocal premalignant actinic keratosis lesions exhibit decreased Notch/CSL signaling and associated molecular changes. Importantly, these changes in gene expression are also induced by UVA, a known environmental cause of cutaneous field cancerization and skin cancer.	[Hu, Bing; Castillo, Einar; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Harewood, Louise; Reymond, Alexandre] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland; [Ostano, Paola] Edo & Elvo Tempia Valenta Fdn, Canc Genom Lab, I-13900 Biella, Italy; [Dummer, Reinhard; Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Raffoul, Wassim] Univ Lausanne Hosp, Dept Plast Reconstruct & Aesthet Surg, CH-1011 Lausanne, Switzerland; [Hoetzenecker, Wolfram] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Hoetzenecker, Wolfram; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	University of Lausanne; University of Lausanne; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Massachusetts General Hospital	Dotto, GP (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	paolo.dotto@unil.ch	Kutalik, Zoltan/HHZ-5697-2022; Hofbauer, Gunther/B-2671-2010; Hu, Bing/K-3541-2019; Ostano, Paola/K-1979-2018	Kutalik, Zoltan/0000-0001-8285-7523; Hofbauer, Gunther/0000-0003-0542-7989; Ostano, Paola/0000-0002-4000-2954; Reymond, Alexandre/0000-0003-1030-8327; Harewood, Louise/0000-0002-6398-6714	Swiss National Science Foundation (SNSF) [3100A0-122281/1, CRSI33-130576/1]; Oncosuisse [02361-02-2009]; European Union [LSHB-CT-2005-019067]; National Institutes of Health [AR39190, AR054856]; Gottfried und Julia Bangerter Ryner Stiftung; European Commission [037627]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039190, R01AR054856] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Oncosuisse; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gottfried und Julia Bangerter Ryner Stiftung; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. T. Honjo for RBP-J kappa<SUP>loxP/loxP</SUP> mice; P. Angel for Cre transgenics; D. Hohl for the TEWL measurement apparatus; N. Traber, I. Steiner, D. Singer, H. Janine, J.C. Stehle, and B.C. Nguyen for technical assistance; A. Balmain for advice; and C. Missero and C. Brisken for manuscript reading. This work was supported by grants from the Swiss National Science Foundation (SNSF; grant 3100A0-122281/1; CRSI33-130576/1) Oncosuisse (grant 02361-02-2009), the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067), and the National Institutes of Health (grants AR39190 and AR054856 to G.P.D.), the "Gottfried und Julia Bangerter Ryner Stiftung'' (to R.D.), and the European Commission (grant 037627) and the SNSF (to A.R.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; ROOP DR, 1983, J INVEST DERMATOL, V81, pS144, DOI 10.1111/1523-1747.ep12540939; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06	32	147	148	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1207	1220		10.1016/j.cell.2012.03.048	http://dx.doi.org/10.1016/j.cell.2012.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682244	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000305119600007
J	Hu, JZ; Sun, L; Shen, FF; Chen, YF; Hua, Y; Liu, Y; Zhang, M; Hu, YR; Wang, QS; Xu, W; Sun, F; Ji, JG; Murray, JM; Carr, AM; Kong, DC				Hu, Jiazhi; Sun, Lei; Shen, Fenfen; Chen, Yufei; Hua, Yu; Liu, Yang; Zhang, Mian; Hu, Yiren; Wang, Qingsong; Xu, Wei; Sun, Fei; Ji, Jianguo; Murray, Johanne M.; Carr, Antony M.; Kong, Daochun			The Intra-S Phase Checkpoint Targets Dna2 to Prevent Stalled Replication Forks from Reversing	CELL			English	Article							ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL REARRANGEMENTS; ENDONUCLEASE ACTIVITY; DAMAGED DNA; HOMOLOG; YEAST; KINASE; EXO1; HELICASE/NUCLEASE	When replication forks stall at damaged bases or upon nucleotide depletion, the intra-S phase checkpoint ensures they are stabilized and can restart. In intra-S checkpoint-deficient budding yeast, stalling forks collapse, and similar to 10% form pathogenic chicken foot structures, contributing to incomplete replication and cell death (Lopes et al., 2001; Sogo et al., 2002; Tercero and Diffley, 2001). Using fission yeast, we report that the Cds1(Chk2) effector kinase targets Dna2 on S220 to regulate, both in vivo and in vitro, Dna2 association with stalled replication forks in chromatin. We demonstrate that Dna2-S220 phosphorylation and the nuclease activity of Dna2 are required to prevent fork reversal. Consistent with this, Dna2 can efficiently cleave obligate precursors of fork regression-regressed leading or lagging strands-on model replication forks. We propose that Dna2 cleavage of regressed nascent strands prevents fork reversal and thus stabilizes stalled forks to maintain genome stability during replication stress.	[Hu, Jiazhi; Shen, Fenfen; Chen, Yufei; Hua, Yu; Liu, Yang; Zhang, Mian; Hu, Yiren; Wang, Qingsong; Ji, Jianguo; Kong, Daochun] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Sun, Lei; Xu, Wei; Sun, Fei] Chinese Acad Sci, Inst Biophys, Ctr Biol Electron Microscopy, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Murray, Johanne M.; Carr, Antony M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9QG, E Sussex, England	Peking University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Sussex	Kong, DC (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	kongdc@pku.edu.cn	Sun, Fei/C-4190-2015; Liu, Yang/HCH-9495-2022	Sun, Fei/0000-0002-0351-5144; Liu, Yang/0000-0002-5058-7781; Hu, Jiazhi/0000-0002-6345-0039; Carr, Antony Michael/0000-0002-2028-2389; Hu, Yiren/0000-0003-3850-0097	National Natural Science Foundation of China [30770441, 30970652]; Ministry of Science and Technology of China [2010CB912201, 2006CB910304]; 985 Program; national key laboratory of protein engineering and plant genetic engineering; MRC [G600233]; CRUK [C9601/A9484]; Medical Research Council [G0901011, G1100074] Funding Source: researchfish; MRC [G1100074, G0901011] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 985 Program; national key laboratory of protein engineering and plant genetic engineering; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all members of the laboratory for discussions and support. We thank Lilin Du for helpful comments. We also thank K. Tanaka and P. Russell for anti-Cds1 phospho-Thr-11-specific antibody, S. Forsburg for pSLF1073 plasmid, J. Sogo and M. Ding for advice of electronic microscopic examination of DNA, L. Du for the help of FACS analysis, and M. Liu for photograph of S. pombe cells. This work was supported by grants from the National Natural Science Foundation of China (no. 30770441 and no. 30970652), the Ministry of Science and Technology of China (no. 2010CB912201 and no. 2006CB910304), the "985 Program,'' and the national key laboratory of protein engineering and plant genetic engineering (to D.K). This work was also supported by the funds (MRC grant G600233 to A.M.C and CRUK grant C9601/A9484 to J.M.M).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Budd ME, 2011, CELL CYCLE, V10, P1690, DOI 10.4161/cc.10.10.15643; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Kang HY, 2000, GENETICS, V155, P1055; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Liu QQ, 2000, J BIOL CHEM, V275, P1615, DOI 10.1074/jbc.275.3.1615; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOGO JM, 1989, METHOD ENZYMOL, V170, P142; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	43	120	125	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1221	1232		10.1016/j.cell.2012.04.030	http://dx.doi.org/10.1016/j.cell.2012.04.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682245	Bronze			2022-12-28	WOS:000305119600008
J	Lenzen, M; Moran, D; Kanemoto, K; Foran, B; Lobefaro, L; Geschke, A				Lenzen, M.; Moran, D.; Kanemoto, K.; Foran, B.; Lobefaro, L.; Geschke, A.			International trade drives biodiversity threats in developing nations	NATURE			English	Article							CONSERVATION	Human activities are causing Earth's sixth major extinction event(1)-an accelerating decline of the world's stocks of biological diversity at rates 100 to 1,000 times pre-human levels(2). Historically, low-impact intrusion into species habitats arose from local demands for food, fuel and living space(3). However, in today's increasingly globalized economy, international trade chains accelerate habitat degradation far removed from the place of consumption. Although adverse effects of economic prosperity and economic inequality have been confirmed(4,5), the importance of international trade as a driver of threats to species is poorly understood. Here we show that a significant number of species are threatened as a result of international trade along complex routes, and that, in particular, consumers in developed countries cause threats to species through their demand of commodities that are ultimately produced in developing countries. We linked 25,000 Animalia species threat records from the International Union for Conservation of Nature Red List to more than 15,000 commodities produced in 187 countries and evaluated more than 5 billion supply chains in terms of their biodiversity impacts. Excluding invasive species, we found that 30% of global species threats are due to international trade. In many developed countries, the consumption of imported coffee, tea, sugar, textiles, fish and other manufactured items causes a biodiversity footprint that is larger abroad than at home. Our results emphasize the importance of examining biodiversity loss as a global systemic phenomenon, instead of looking at the degrading or polluting producers in isolation. We anticipate that our findings will facilitate better regulation, sustainable supply-chain certification and consumer product labelling.	[Lenzen, M.; Moran, D.; Kanemoto, K.; Foran, B.; Lobefaro, L.; Geschke, A.] Univ Sydney, Sch Phys A28, ISA, Sydney, NSW 2006, Australia; [Kanemoto, K.] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Foran, B.] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW 2640, Australia; [Lobefaro, L.] Univ Bari Aldo Moro, Fac Econ 1, Dept Business & Law Studies, I-70124 Bari, Italy	University of Sydney; Tohoku University; Charles Sturt University; Universita degli Studi di Bari Aldo Moro	Lenzen, M (corresponding author), Univ Sydney, Sch Phys A28, ISA, Sydney, NSW 2006, Australia.	m.lenzen@physics.usyd.edu.au	Geschke, Arne/AAM-7434-2020; Moran, Daniel/AAE-6028-2019; Lenzen, Manfred/D-3161-2013; Kanemoto, Keiichiro/O-9633-2016	Geschke, Arne/0000-0001-9193-5829; Moran, Daniel/0000-0002-2310-2275; Kanemoto, Keiichiro/0000-0003-0230-9020; Lenzen, Manfred/0000-0002-0828-5288	Australian Research Council [DP0985522, LP0669290]	Australian Research Council(Australian Research Council)	We thank C. Pollock and M. Hoffmann from the IUCN and A. Symes from BirdLife International for advice on using the Red Lists. The work described in this paper was financially supported by the Australian Research Council through its Discovery Project DP0985522 and its Linkage Project LP0669290.	BirdLife International, 2011, THREAT BIRDS WORLD; Blackman A, 2011, CONSERV BIOL, V25, P1176, DOI 10.1111/j.1523-1739.2011.01774.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Giles B. G., 2006, TOPICS BIODIVERSITY, V3, P157; Huang YA, 2009, ECON SYST RES, V21, P217, DOI 10.1080/09535310903541348; HUBER ME, 1994, MAR POLLUT BULL, V29, P69, DOI 10.1016/0025-326X(94)90428-6; International Union for Conservation of Nature, IUCN RED LIST THREAT; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Lenzen M., 2011, EORA GLOBAL MULTIREG; Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Mikkelson GM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000444; Naidoo R, 2001, CONSERV BIOL, V15, P1021, DOI 10.1046/j.1523-1739.2001.0150041021.x; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Parsons ECM, 2011, MAR POLICY, V35, P729, DOI 10.1016/j.marpol.2011.02.001; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Peters G. P., 2011, P NATL ACAD SCI US; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rotherham T, 2011, FOREST CHRON, V87, P603, DOI 10.5558/tfc2011-067; Shearman PL, 2009, BIOTROPICA, V41, P379, DOI 10.1111/j.1744-7429.2009.00495.x; Villasante S, 2012, MAR POLICY, V36, P142, DOI 10.1016/j.marpol.2011.04.007; World Trade Organization, 2012, WTO RUL ENV POL GATT	28	662	685	31	626	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					109	112		10.1038/nature11145	http://dx.doi.org/10.1038/nature11145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GD	22678290				2022-12-28	WOS:000304854000037
J	Nussbaum, JM; Schilling, S; Cynis, H; Silva, A; Swanson, E; Wangsanut, T; Tayler, K; Wiltgen, B; Hatami, A; Ronicke, R; Reymann, K; Hutter-Paier, B; Alexandru, A; Jagla, W; Graubner, S; Glabe, CG; Demuth, HU; Bloom, GS				Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.			Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta	NATURE			English	Article							TRANSGENIC MOUSE MODEL; A-BETA; ALZHEIMERS-DISEASE; IN-VITRO; PEPTIDES; PROTEIN; NEURODEGENERATION; DEGENERATION; AGGREGATION; SENSITIVITY	Extracellular plaques of amyloid-beta and intraneuronal neurofibrillary tangles made from tau are the histopathological signatures of Alzheimer's disease. Plaques comprise amyloid-beta fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease. Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-beta(1,2). Interestingly, many adverse responses to amyloid-beta, such as cytotoxicity(3), microtubule loss(4), impaired memory and learning(5), and neuritic degeneration(6), are greatly amplified by tau expression. Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-beta(7,8) are strongly associated with Alzheimer's disease, are more toxic than amyloid-beta, residues 1-42 (A beta(1-42)) and A beta(1-40), and have been proposed as initiators of Alzheimer's disease pathogenesis(9,10). Here we report a mechanism by which pE-A beta may trigger Alzheimer's disease. A beta(3(pE)-42) co-oligomerizes with excess A beta(1-42) to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from A beta(1-42) alone. Tau is required for cytotoxicity, and LNOs comprising 5% A beta(3(pE)-42) plus 95% A beta(1-42) (5% pE-A beta) seed new cytotoxic LNOs through multiple serial dilutions into A beta(1-42) monomers in the absence of additional A beta(3(pE)-42). LNOs isolated from human Alzheimer's disease brain contained A beta(3(pE)-42), and enhanced A beta(3(pE)-42) formation in mice triggered neuron loss and gliosis at 3 months, but not in a tau-null background. We conclude that A beta(3(pE)-42) confers tau-dependent neuronal death and causes template-induced misfolding of A beta(1-42) into structurally distinct LNOs that propagate by a prion-like mechanism. Our results raise the possibility that A beta(3(pE)-42) acts similarly at a primary step in Alzheimer's disease pathogenesis.	[Nussbaum, Justin M.; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Bloom, George S.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Schilling, Stephan; Cynis, Holger; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Saale, Germany; [Tayler, Kaycie; Wiltgen, Brian] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; [Hatami, Asa; Glabe, Charles G.] Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA; [Roenicke, Raik; Reymann, Klaus] Deutsch Zentrum Neurodegenerat Erkrankungen, Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Hutter-Paier, Birgit] JSW Life Sci GmbH, A-8074 Grambach, Austria; [Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Demuth, Hans-Ulrich] Ingenium Pharmaceut GmbH, D-82152 Munich, Germany; [Bloom, George S.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of Virginia; Vivoryon Therapeutics; University of Virginia; University of California System; University of California Irvine; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN); University of Virginia	Bloom, GS (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	Hans-Ulrich.Demuth@probiodrug.de; gsb4g@virginia.edu	Wiltgen, Brian/D-2947-2013; Reymann, Klaus G/J-8507-2013	Cynis, Holger/0000-0001-6655-7539	Alzheimer's Association [4079]; Owens Family Foundation; Cure Alzheimer's Fund; NIH/NIGMS [T32 GM008136]; NIH/NIA [R01 AG033069, P50 AG16573]; German Federal Department of Science and Technology [03IS2211F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573, R01AG033069] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Owens Family Foundation; Cure Alzheimer's Fund; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Federal Department of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful for support from the following sources: the Alzheimer's Association (grant 4079 to G. S. B.); the Owens Family Foundation (G. S. B.); the Cure Alzheimer's Fund (G. S. B., C. G. G.); NIH/NIGMS training grant T32 GM008136, which funded part of J.M.N.'s PhD training; NIH/NIA grant R01 AG033069 (C. G. G.); and the German Federal Department of Science and Technology grant 03IS2211F (H.-U.D.). Funding for the UCI-ADRC was provided by NIH/NIA grant P50 AG16573. We also thank H. Dawson and M. Vitek of Duke University for providing the tau-knockout mice. This work fulfilled part of the requirements for the PhD earned by J.M.N. at the University of Virginia. The technical assistance of A. Spano, H.-H. Ludwig, E. Scheel and K. Schulz is gratefully acknowledged.	Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Hartlage-Rubsamen M, 2011, ACTA NEUROPATHOL, V121, P705, DOI 10.1007/s00401-011-0806-2; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; MORI H, 1992, J BIOL CHEM, V267, P17082; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; SCUDIERO DA, 1988, CANCER RES, V48, P4827; TABATON M, 1994, BIOCHEM BIOPH RES CO, V200, P1598, DOI 10.1006/bbrc.1994.1634; Tanghe A, 2010, INT J ALZHEIMERS DIS, V2010; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WANG XM, 1993, HUM IMMUNOL, V37, P264; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	30	311	322	5	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					651	655		10.1038/nature11060	http://dx.doi.org/10.1038/nature11060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660329	Green Accepted			2022-12-28	WOS:000304608000050
J	Burke, B				Burke, Brian			It Takes KASH to Hitch to the SUN	CELL			English	Editorial Material							NUCLEAR-ENVELOPE	LINC complexes are structures embedded within the nuclear envelope that mechanically couple the nucleus and cytoskeleton. They consist of SUN domain proteins of the inner nuclear membrane associated with KASH domain proteins in the outer nuclear membrane. Atomic resolution structures of SUN-KASH pairs now provide new insight in to the mechanisms of LINC complex assembly.	Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Burke, B (corresponding author), Inst Med Biol, Singapore 138648, Singapore.	brian.burke@imb.a-star.edu.sg						Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	10	12	12	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					961	963		10.1016/j.cell.2012.05.004	http://dx.doi.org/10.1016/j.cell.2012.05.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632963	Bronze			2022-12-28	WOS:000304453900002
J	Karplus, PA; Diederichs, K				Karplus, P. Andrew; Diederichs, Kay			Linking Crystallographic Model and Data Quality	SCIENCE			English	Article							X-RAY DATA; CYSTEINE DIOXYGENASE	In macromolecular x-ray crystallography, refinement R values measure the agreement between observed and calculated data. Analogously, R-merge values reporting on the agreement between multiple measurements of a given reflection are used to assess data quality. Here, we show that despite their widespread use, R-merge values are poorly suited for determining the high-resolution limit and that current standard protocols discard much useful data. We introduce a statistic that estimates the correlation of an observed data set with the underlying ( not measurable) true signal; this quantity, CC*, provides a single statistically valid guide for deciding which data are useful. CC* also can be used to assess model and data quality on the same scale, and this reveals when data quality is limiting model improvement.	[Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	University of Konstanz; Oregon State University	Diederichs, K (corresponding author), Univ Konstanz, Dept Biol, Box 647, D-78457 Constance, Germany.	kay.diederichs@uni-konstanz.de		Karplus, Paul/0000-0001-8725-6292	Alexander von Humboldt Foundation; Konstanz Research School Chemical Biology; NIH [GM083136, DK056649]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083136] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Konstanz Research School Chemical Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Alexander von Humboldt Foundation, the Konstanz Research School Chemical Biology, and NIH grants GM083136 and DK056649. We thank R. Cooley for providing the EXP data images, V. Lunin for help with deriving Eq. 3, and A. Gittleman for help with mathematical notation. We also thank M. Junk, W. Kabsch, K. Schafer, D. Tronrud, M. Wells and W. Welte for critically reading the manuscript. The program HIRESCUT is available upon request. P. A. K. and K. D. designed and performed the research and wrote the paper. The authors declare no competing financial interests.	ARNDT UW, 1968, J PHYS E SCI INSTRUM, V1, P510, DOI 10.1088/0022-3735/1/5/303; Bobko P., 2001, CORRELATION REGRESSI; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2009, ACTA CRYSTALLOGR D, V65, P535, DOI 10.1107/S0907444909010282; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; GAUCH HG, 1993, AM SCI, V81, P468; LUZZATI V, 1953, ACTA CRYSTALLOGR, V6, P142, DOI 10.1107/S0365110X53000508; Rahman N.A., 1968, COURSE THEORETICAL S; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Wang JM, 2010, ACTA CRYSTALLOGR D, V66, P988, DOI 10.1107/S0907444910029938; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WILSON AJC, 1950, ACTA CRYSTALLOGR, V3, P397, DOI 10.1107/S0365110X50001129	20	1302	1311	5	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1030	1033		10.1126/science.1218231	http://dx.doi.org/10.1126/science.1218231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628654	Green Accepted, Green Submitted			2022-12-28	WOS:000304406800044
J	Esteban, J; Mayoral, L; Ray, D				Esteban, Joan; Mayoral, Laura; Ray, Debraj			ETHNICITY AND CONFLICT: THEORY AND FACTS	SCIENCE			English	Review							CIVIL-WAR; HORIZONTAL INEQUALITIES; NATURAL-RESOURCES; DIVERSITY; POLARIZATION	Over the second half of the 20th century, conflicts within national boundaries became increasingly dominant. One-third of all countries experienced civil conflict. Many (if not most) such conflicts involved violence along ethnic lines. On the basis of recent theoretical and empirical research, we provide evidence that preexisting ethnic divisions do influence social conflict. Our analysis also points to particular channels of influence. Specifically, we show that two different measures of ethnic division-polarization and fractionalization-jointly influence conflict, the former more so when the winners enjoy a "public" prize (such as political power or religious hegemony), the latter more so when the prize is "private" (such as looted resources, government subsidies, or infrastructures). The available data appear to strongly support existing theories of intergroup conflict. Our argument also provides indirect evidence that ethnic conflicts are likely to be instrumental, rather than driven by primordial hatreds.	[Esteban, Joan; Mayoral, Laura; Ray, Debraj] CSIC, Inst Anal Econ, ES-08193 Barcelona, Spain; [Esteban, Joan; Mayoral, Laura; Ray, Debraj] Barcelona GSE, ES-08193 Barcelona, Spain; [Ray, Debraj] NYU, New York, NY 10012 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut d'Analisi Economica (IAE); Barcelona School of Economics; New York University	Ray, D (corresponding author), CSIC, Inst Anal Econ, ES-08193 Barcelona, Spain.	debraj.ray@nyu.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; mayoral, laura/0000-0002-0674-6095	Ministerio de Economia y Competitividad [ECO2011-25293]; Recercaixa; AXA; NSF [SES-0962124]; Divn Of Social and Economic Sciences [0962124] Funding Source: National Science Foundation	Ministerio de Economia y Competitividad(Spanish Government); Recercaixa(La Caixa Foundation); AXA; NSF(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We gratefully acknowledge financial support from Ministerio de Economia y Competitividad project ECO2011-25293 and from Recercaixa. J.E. and L.M. acknowledge financial support from the AXA Research Fund. The research of D.R. was funded by NSF grant SES-0962124. We thank two referees for valuable comments and are grateful to R. Jayaraman for suggestions that improved the manuscript.	Alesina A, 1999, Q J ECON, V114, P1243, DOI 10.1162/003355399556269; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; [Anonymous], 2008, GEN DECL; Bates R. H., 1983, STATE VERSUS ETHNIC; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Brubaker R, 1998, ANNU REV SOCIOL, V24, P423, DOI 10.1146/annurev.soc.24.1.423; Caselli F., THEORY ETHNIC CONFLI; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Cederman LE, 2007, AM POLIT SCI REV, V101, P173, DOI 10.1017/S0003055407070086; Cederman LE, 2011, AM POLIT SCI REV, V105, P478, DOI 10.1017/S0003055411000207; Collier P, 1998, OXFORD ECON PAP, V50, P563, DOI 10.1093/oep/50.4.563; Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; Dahrendorf Rolf, 1959, CLASS CLASS CONFLICT; Desmet K, 2012, J DEV ECON, V97, P322, DOI 10.1016/j.jdeveco.2011.02.003; Desmet K, 2009, J EUR ECON ASSOC, V7, P1291, DOI 10.1162/JEEA.2009.7.6.1291; Duclos JY, 2004, ECONOMETRICA, V72, P1737, DOI 10.1111/j.1468-0262.2004.00552.x; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; Esteban J, 1999, J ECON THEORY, V87, P379, DOI 10.1006/jeth.1999.2549; Esteban J., 2012, AM EC REV IN PRESS, V102; ESTEBAN JM, 1994, ECONOMETRICA, V62, P819, DOI 10.2307/2951734; Esteban J, 2011, AM ECON REV, V101, P1345, DOI 10.1257/aer.101.4.1345; Esteban J, 2011, J EUR ECON ASSOC, V9, P496, DOI 10.1111/j.1542-4774.2010.01016.x; Esteban J, 2008, AM ECON REV, V98, P2185, DOI 10.1257/aer.98.5.2185; Fearon James, 2006, OXFORD HDB POLITICAL; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Garfinkel Michelle, 2012, OXFORD HDB EC PEACE; Garfinkel MR, 2007, HDB DEFENSE EC, V2; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Hegre H, 2006, J CONFLICT RESOLUT, V50, P508, DOI 10.1177/0022002706289303; Horowitz Donald., 1985, ETHNIC GROUPS CONFLI; Humphreys M, 2005, J CONFLICT RESOLUT, V49, P508, DOI 10.1177/0022002705277545; Huntington Samuel P., 1997, CLASH CIVILIZATIONS; Ignatieff M, 1993, BLOOD BELONGING; Lacina B, 2005, EUR J POPUL, V21, P145, DOI 10.1007/s10680-005-6851-6; Laitin DD, 2000, AM J POLIT SCI, V44, P142, DOI 10.2307/2669300; LICHBACH MI, 1989, WORLD POLIT, V41, P431, DOI 10.2307/2010526; Matuszeski J., 2006, PATTERNS ETHNIC GROU; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; MIDLARSKY MI, 1988, AM POLIT SCI REV, V82, P491, DOI 10.2307/1957397; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Montalvo JG, 2005, AM ECON REV, V95, P796, DOI 10.1257/0002828054201468; Ostby G, 2008, J PEACE RES, V45, P143, DOI 10.1177/0022343307087169; RABUSHKA A., 1972, POLITICS PLURAL SOC; Robinson J.A., 2001, ECON GOV, V2, P85, DOI 10.1007/PL00011021; Ross M, 2006, ANNU REV POLIT SCI, V9, P265, DOI 10.1146/annurev.polisci.9.081304.161338; Ross ML, 2004, J PEACE RES, V41, P337, DOI 10.1177/0022343304043773; Sambanis N, 2004, J CONFLICT RESOLUT, V48, P814, DOI 10.1177/0022002704269355; Sambanis N., 2005, UNDERSTANDING CIVIL, V1; Sen A., 1973, EC INEQUALITY; Stewart F, 2004, 1 CRISE; Tilly Charles, 2003, POLITICS COLLECTIVE; Varshney A., 2002, ETHNIC CONFLICT CIVI; Weidmann NB, 2010, J PEACE RES, V47, P491, DOI 10.1177/0022343310368352; Wittman, 2006, OXFORD HDB POLITICAL, P852; WOLFSON MC, 1994, AM ECON REV, V84, P353	59	73	76	6	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					858	865		10.1126/science.1222240	http://dx.doi.org/10.1126/science.1222240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605763				2022-12-28	WOS:000304145600049
J	Grangier, P				Grangier, Philippe			Room for Just One Photon	SCIENCE			English	Editorial Material							RYDBERG BLOCKADE; NEUTRAL ATOMS; ENTANGLEMENT		Inst Opt, F-91127 Palaiseau, France	UDICE-French Research Universities; Universite Paris Saclay	Grangier, P (corresponding author), Inst Opt, F-91127 Palaiseau, France.	philippe.grangier@institutoptique.fr						Bariani F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.030501; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Stanojevic J., 2012, ARXIV12036764QUANTPH; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502	12	2	2	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					812	813		10.1126/science.1222815	http://dx.doi.org/10.1126/science.1222815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605740				2022-12-28	WOS:000304145600028
J	Montpetit, B; Weis, K				Montpetit, Ben; Weis, Karsten			An Alternative Route for Nuclear mRNP Export by Membrane Budding	SCIENCE			English	Editorial Material							PORE; RECRUITMENT; TRANSPORT; DYNAMICS		[Montpetit, Ben; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Montpetit, B (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bmontpet@berkeley.edu; kweis@berkeley.edu	Weis, Karsten/F-5719-2011; Montpetit, Ben/L-6456-2019	Weis, Karsten/0000-0001-7224-925X; Montpetit, Ben/0000-0002-8317-983X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058065] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058065] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032	11	15	15	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					809	810		10.1126/science.1222243	http://dx.doi.org/10.1126/science.1222243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605737				2022-12-28	WOS:000304145600025
J	Cypel, M; Keshavjee, S				Cypel, Marcelo; Keshavjee, Shaf			Expansion of the donor lung pool: use of lungs from smokers	LANCET			English	Editorial Material							TRANSPLANTATION; IMPACT; CRITERIA; DONATION; OUTCOMES; SMOKING; DISEASE		[Cypel, Marcelo; Keshavjee, Shaf] Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON M5G 2C4, Canada	University of Toronto; University Health Network Toronto	Keshavjee, S (corresponding author), Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON M5G 2C4, Canada.	shaf.keshavjee@uhn.on.ca		Keshavjee, Shaf/0000-0003-4547-8094; Cypel, Marcelo/0000-0001-5652-1938				Aigner C, 2005, EUR J CARDIO-THORAC, V27, P757, DOI 10.1016/j.ejcts.2005.01.024; Angel LF, 2006, AM J RESP CRIT CARE, V174, P710, DOI 10.1164/rccm.200603-432OC; Berman M, 2010, ANN THORAC SURG, V90, P1786, DOI 10.1016/j.athoracsur.2010.07.073; Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Botha P, 2006, J THORAC CARDIOV SUR, V131, P1154, DOI 10.1016/j.jtcvs.2005.12.037; Castaldi PJ, 2011, THORAX, V66, P903, DOI 10.1136/thx.2010.146118; Christie JD, 2005, CHEST, V127, P161, DOI 10.1378/chest.127.1.161; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Cypel M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000266; De Meester J, 2001, J HEART LUNG TRANSPL, V20, P518, DOI 10.1016/S1053-2498(01)00241-8; de Perrot M, 2004, J HEART LUNG TRANSPL, V23, P1127, DOI 10.1016/j.healun.2003.09.010; de Perrot M, 2003, AM J RESP CELL MOL, V28, P616, DOI 10.1165/rcmb.2002-0109OC; Eberlein M, 2011, CLIN CHEST MED, V32, P213, DOI 10.1016/j.ccm.2011.02.004; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Lee JC, 2010, SEMIN RESP CRIT CARE, V31, P161, DOI 10.1055/s-0030-1249111; Schiavon M, 2012, INTERACT CARDIOV TH, V14, P183, DOI 10.1093/icvts/ivr079; Snell GI, 2009, CURR OPIN ORGAN TRAN, V14, P471, DOI 10.1097/MOT.0b013e32832fb9e1; Titman A, 2009, AM J TRANSPLANT, V9, P1640, DOI 10.1111/j.1600-6143.2009.02613.x	18	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					709	711		10.1016/S0140-6736(12)60650-3	http://dx.doi.org/10.1016/S0140-6736(12)60650-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22647757				2022-12-28	WOS:000308001300007
J	Janda, CY; Waghray, D; Levin, AM; Thomas, C; Garcia, KC				Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher			Structural Basis of Wnt Recognition by Frizzled	SCIENCE			English	Article							SIGNALING INHIBITION; CATENIN PATHWAY; PROTEINS; RECEPTORS; ACTIVATE; BINDING; FAMILY; CANCER; DOMAIN; LRP6	Wnts are lipid-modified morphogens that play critical roles in development principally through engagement of Frizzled receptors. The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites. One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD. In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD. The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.	[Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Thomas, Christoph/0000-0001-7441-1089	Howard Hughes Medical Institute; Jane Coffin Childs Fund;  [NIH-RO1-GM097015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Fund; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge advice and reagents from J. Nathans, as well as helpful discussions with F. Bazan, P. Beachy, J. Nathans, A. Brunger, and R. Nusse. We thank the staff of the Stanford Synchrotron Radiation Laboratory for support and access to beamline 11-1. This work was supported by NIH-RO1-GM097015 and the Howard Hughes Medical Institute (K. C. G.). C. J. is supported by a postdoctoral fellowship from the Jane Coffin Childs Fund. Structure factors and coordinates have been deposited in the Protein Data Bank with accession no. 4F0A. K. C. G. and A. M. L. have applied for a patent covering the discovery and use of mini-Wnt. K. C. G. is a cofounder of Eleven Biotherapeutics, which is engaged in the rational design of protein therapeutics.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hausmann G, 2006, DEV CELL, V11, P751, DOI 10.1016/j.devcel.2006.11.007; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Liepinsh E, 2006, J MOL BIOL, V357, P942, DOI 10.1016/j.jmb.2006.01.047; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	43	531	559	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					59	64		10.1126/science.1222879	http://dx.doi.org/10.1126/science.1222879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22653731	Green Accepted			2022-12-28	WOS:000306053100042
J	Tabak, AG; Herder, C; Rathmann, W; Brunner, EJ; Kivimaki, M				Tabak, Adam G.; Herder, Christian; Rathmann, Wolfgang; Brunner, Eric J.; Kivimaki, Mika			Prediabetes: a high-risk state for diabetes development	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; BETA-CELL DYSFUNCTION; FASTING PLASMA-GLUCOSE; HEART-RATE-VARIABILITY; INSULIN-RESISTANCE; KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; PREVENTION PROGRAM; AUTONOMIC FUNCTION	Prediabetes (intermediate hyperglycaemia) is a high-risk state for diabetes that is defined by glycaemic variables that are higher than normal, but lower than diabetes thresholds. 5-10% of people per year with prediabetes will progress to diabetes, with the same proportion converting back to normoglycaemia. Prevalence of prediabetes is increasing worldwide and experts have projected that more than 470 million people will have prediabetes by 2030. Prediabetes is associated with the simultaneous presence of insulin resistance and beta-cell dysfunction-abnormalities that start before glucose changes are detectable. Observational evidence shows associations between prediabetes and early forms of nephropathy, chronic kidney disease, small fibre neuropathy, diabetic retinopathy, and increased risk of macrovascular disease. Multifactorial risk scores using non-invasive measures and blood-based metabolic traits, in addition to glycaemic values, could optimise estimation of diabetes risk. For prediabetic individuals, lifestyle modification is the cornerstone of diabetes prevention, with evidence of a 40-70% relative-risk reduction. Accumulating data also show potential benefits from pharmacotherapy.	[Tabak, Adam G.; Brunner, Eric J.; Kivimaki, Mika] Univ London Univ Coll, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Internal Med 1, Budapest, Hungary; [Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany; [Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany	University of London; University College London; Semmelweis University; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Tabak, AG (corresponding author), Univ London Univ Coll, Dept Epidemiol & Publ Hlth, Torrington Pl, London WC1E 6BT, England.	a.tabak@ucl.ac.uk	Tabak, Adam/A-5007-2012; Cerviño, Alejandro/L-5853-2014; Brunner, Eric/H-2114-2011; Kivimaki, Mika/B-3607-2012	Cerviño, Alejandro/0000-0001-8014-3279; Brunner, Eric/0000-0002-0595-4474; Kivimaki, Mika/0000-0002-4699-5627; Tabak, Adam/0000-0002-6234-3936	UK Medical Research Council; US National Institutes of Health [R01HL036310, R01AG034454]; Academy of Finland; British Heart Foundation; Stroke Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G19/35, G0100222] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Stroke Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MK is supported by the UK Medical Research Council, the US National Institutes of Health (R01HL036310; R01AG034454), and the Academy of Finland. EB is supported by the British Heart Foundation and Stroke Association.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Al-Mallah M, 2010, CARDIOL J, V17, P448; ALGVERE P, 1985, BRIT J OPHTHALMOL, V69, P416, DOI 10.1136/bjo.69.6.416; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Astrup A, 2012, INT J OBESITY, V36, P843, DOI 10.1038/ijo.2011.158; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bosch J, 2006, NEW ENGL J MED, V355, P1551; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bruce SG, 2008, DIABETES CARE, V31, P1837, DOI 10.2337/dc08-0278; Brunner EJ, 2006, DIABETES CARE, V29, P26; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P2885, DOI 10.1210/jc.2007-0334; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Fujita H, 1999, DIABETES CARE, V22, P823, DOI 10.2337/diacare.22.5.823; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Gastaldelli A, 2004, DIABETOLOGIA, V47, P31, DOI 10.1007/s00125-003-1263-9; Gerritsen J, 2000, DIABETOLOGIA, V43, P561, DOI 10.1007/s001250051344; Gerstein HC, 2011, DIABETOLOGIA, V54, P487, DOI 10.1007/s00125-010-1985-4; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Grandinetti A, 2007, CLIN AUTON RES, V17, P231, DOI 10.1007/s10286-007-0426-z; Grover SA, 2006, ARCH INTERN MED, V166, P213, DOI 10.1001/archinte.166.2.213; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Heymsfield SB, 2000, ARCH INTERN MED, V160, P1321, DOI 10.1001/archinte.160.9.1321; Hoehner CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015762.92814.85; Hoffman-Snyder C, 2006, ARCH NEUROL-CHICAGO, V63, P1075, DOI 10.1001/archneur.63.8.noc50336; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Hopper I, 2011, EUR J CARDIOV PREV R, V18, P813, DOI 10.1177/1741826711421687; International Diabetes Federation, 2011, IDF DIAB ATL; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kanat M, 2012, DIABETES, V61, P447, DOI 10.2337/db11-0995; Katikireddi SV, 2011, INT J EPIDEMIOL, V40, P1542, DOI 10.1093/ije/dyr159; Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lauenborg J, 2004, DIABETES CARE, V27, P1194, DOI 10.2337/diacare.27.5.1194; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lilly M, 2009, CAN FAM PHYSICIAN, V55, P363; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; METCALF PA, 1993, DIABETES CARE, V16, P1485, DOI 10.2337/diacare.16.11.1485; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nebuchennykh M, 2008, EUR J NEUROL, V15, P810, DOI 10.1111/j.1468-1331.2008.02197.x; Nguyen TT, 2008, DIABETES, V57, P536, DOI 10.2337/db07-1376; Nguyen TT, 2007, DIABETES CARE, V30, P2708, DOI 10.2337/dc07-0732; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Pendergrass M, 2007, AM J PHYSIOL-ENDOC M, V292, pE92, DOI 10.1152/ajpendo.00617.2005; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Putz Z, 2009, DIABETES CARE, V32, P181, DOI 10.2337/dc08-1406; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Schroeder EB, 2005, DIABETES CARE, V28, P668, DOI 10.2337/diacare.28.3.668; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Singh JP, 2000, AM J CARDIOL, V86, P309, DOI 10.1016/S0002-9149(00)00920-6; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smith AG, 2006, DIABETES CARE, V29, P1294, DOI 10.2337/dc06-0224; Smith AG, 2004, ARCH INTERN MED, V164, P1021, DOI 10.1001/archinte.164.9.1021; Smith AG, 2001, NEUROLOGY, V57, P1701, DOI 10.1212/WNL.57.9.1701; Snehalatha C, 2009, DIABETES CARE, V32, P1796, DOI 10.2337/dc09-0676; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wu JS, 2007, J CLIN ENDOCR METAB, V92, P3885, DOI 10.1210/jc.2006-2175; Xu M, 2009, DIABETOLOGIA, V52, P1511, DOI 10.1007/s00125-009-1386-8; Yeboah J, 2011, J AM COLL CARDIOL, V58, P140, DOI 10.1016/j.jacc.2011.03.025; Ylitalo KR, 2011, DIABETES CARE, V34, P1642, DOI 10.2337/dc10-2150; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796; Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5	121	1419	1475	34	298	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2279	2290		10.1016/S0140-6736(12)60283-9	http://dx.doi.org/10.1016/S0140-6736(12)60283-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683128	Green Accepted			2022-12-28	WOS:000305511400035
J	LaRiviere, JP; Ravelo, AC; Crimmins, A; Dekens, PS; Ford, HL; Lyle, M; Wara, MW				LaRiviere, Jonathan P.; Ravelo, A. Christina; Crimmins, Allison; Dekens, Petra S.; Ford, Heather L.; Lyle, Mitch; Wara, Michael W.			Late Miocene decoupling of oceanic warmth and atmospheric carbon dioxide forcing	NATURE			English	Article							PANAMANIAN SEAWAY CLOSURE; PERMANENT EL-NINO; GLACIATION; MIDDLE; DEPTH; POOL; MA	Deep-time palaeoclimate studies are vitally important for developing a complete understanding of climate responses to changes in the atmospheric carbon dioxide concentration (that is, the atmospheric partial pressure of CO2, p(CO2))(1). Although past studies have explored these responses during portions of the Cenozoic era (the most recent 65.5 million years (Myr) of Earth history), comparatively little is known about the climate of the late Miocene (similar to 12-5 Myr ago), an interval with p(CO2) values of only 200-350 parts per million by volume but nearly ice-free conditions in the Northern Hemisphere(2,3) and warmer-than-modern temperatures on the continents(4). Here we present quantitative geochemical sea surface temperature estimates from the Miocene mid-latitude North Pacific Ocean, and show that oceanic warmth persisted throughout the interval of low p(CO2) similar to 12-5 Myr ago. We also present new stable isotope measurements from the western equatorial Pacific that, in conjunction with previously published data(5-10), reveal a long-term trend of thermocline shoaling in the equatorial Pacific since similar to 13 Myr ago. We propose that a relatively deep global thermocline, reductions in low-latitude gradients in sea surface temperature, and cloud and water vapour feedbacks may help to explain the warmth of the late Miocene. Additional shoaling of the thermocline after 5 Myr ago probably explains the stronger coupling between p(CO2), sea surface temperatures and climate that is characteristic of the more recent Pliocene and Pleistocene epochs(11,12).	[LaRiviere, Jonathan P.; Ravelo, A. Christina; Crimmins, Allison; Dekens, Petra S.; Ford, Heather L.; Wara, Michael W.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Lyle, Mitch] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of California System; University of California Santa Cruz; Texas A&M University System; Texas A&M University College Station	LaRiviere, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	jlarivie@ucsc.edu		Crimmins, Allison/0000-0003-1273-6069; Ravelo, Ana Christina/0000-0003-3929-677X	NSF [OCE0902047]; Division Of Ocean Sciences [0902047] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the Ravelo laboratory group for discussions. We also thank J. Zachos and P. Koch for comments on the manuscript. L. Lajoie, P. Talmage and T. M. Aung assisted in sample preparation and analysis. D. Andreasen and R. Franks provided analytical support. This research used samples and/or data provided by the Integrated Ocean Drilling Program (IODP). Funding for this research was provided by NSF grant OCE0902047.	Boccaletti G, 2004, J PHYS OCEANOGR, V34, P888, DOI 10.1175/1520-0485(2004)034<0888:TTSOTU>2.0.CO;2; Brierley CM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001809; Chaisson WP, 2000, PALEOCEANOGRAPHY, V15, P497, DOI 10.1029/1999PA000442; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Foster GL, 2010, CLIM PAST, V6, P707, DOI 10.5194/cp-6-707-2010; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Kamikuri S, 2009, PALAEOGEOGR PALAEOCL, V280, P469, DOI 10.1016/j.palaeo.2009.06.034; KELLER G, 1985, GEOL SOC AM MEM, V163, P177; KENNETT JP, 1985, GEOL SOC AM MEM, V163, P197; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Lear CH, 2003, EARTH PLANET SC LETT, V210, P425, DOI [10.1016/S0012-821X(03)00164-X, 10.1016/S0012-821X(03)-00164-X]; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Locarnini R. A., 2006, NOAA ATLAS NESDIS, V61, P182; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Lunt DJ, 2008, CLIM DYNAM, V30, P1, DOI 10.1007/s00382-007-0265-6; Lyle M, 2008, REV GEOPHYS, V46, DOI 10.1029/2005RG000190; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nathan SA, 2009, PALAEOGEOGR PALAEOCL, V274, P140, DOI 10.1016/j.palaeo.2009.01.007; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Philander SG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000837; Pound MJ, 2011, PALAEOGEOGR PALAEOCL, V300, P29, DOI 10.1016/j.palaeo.2010.11.029; Ruddiman WF, 2010, SCIENCE, V328, P838, DOI 10.1126/science.1188292; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Steph S, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001645; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang X, 2012, EARTH PLANET SC LETT, V317, P76, DOI 10.1016/j.epsl.2011.11.028	31	127	131	8	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					97	100		10.1038/nature11200	http://dx.doi.org/10.1038/nature11200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678287				2022-12-28	WOS:000304854000034
J	Breitsprecher, D; Jaiswal, R; Bombardier, JP; Gould, CJ; Gelles, J; Goode, BL				Breitsprecher, Dennis; Jaiswal, Richa; Bombardier, Jeffrey P.; Gould, Christopher J.; Gelles, Jeff; Goode, Bruce L.			Rocket Launcher Mechanism of Collaborative Actin Assembly Defined by Single-Molecule Imaging	SCIENCE			English	Article							POLYPOSIS-COLI PROTEIN; FORMIN MDIA1; APC PROTEIN; NUCLEATION; ELONGATION; MOVEMENT; SPIRE	Interacting sets of actin assembly factors work together in cells, but the underlying mechanisms have remained obscure. We used triple-color single-molecule fluorescence microscopy to image the tumor suppressor adenomatous polyposis coli (APC) and the formin mDia1 during filament assembly. Complexes consisting of APC, mDia1, and actin monomers initiated actin filament formation, overcoming inhibition by capping protein and profilin. Upon filament polymerization, the complexes separated, with mDia1 moving processively on growing barbed ends while APC remained at the site of nucleation. Thus, the two assembly factors directly interact to initiate filament assembly and then separate but retain independent associations with either end of the growing filament.	[Bombardier, Jeffrey P.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Breitsprecher, Dennis; Jaiswal, Richa; Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; goode@brandeis.edu			Deutsche Forschungsgemeinschaft [BR 4116/1-1]; NSF [DMR-MRSEC-0820492]; NIH [GM43369, GM81648, GM083137]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043369, R01GM083137, R01GM063691, R37GM043369, R01GM098143, R01GM081648, T32GM007596] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. McCartney, H. Higgs, J. Moseley, S. Reck-Petersen, and B. Smith for helpful comments on the manuscript; K. Okada and A. Deaconescu for purifying CapZ and generating the SNAP-APC-C plasmid; and B. Smith for advice on single-molecule imaging. The project was supported by grants from Deutsche Forschungsgemeinschaft (BR 4116/1-1 to D. B.), NSF (DMR-MRSEC-0820492 to J.G and B.G), and NIH (GM43369 and GM81648 to J.G., GM083137 to B.G.).	Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Graziano BR, 2011, MOL BIOL CELL, V22, P4016, DOI 10.1091/mbc.E11-05-0404; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	19	102	102	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1164	1168		10.1126/science.1218062	http://dx.doi.org/10.1126/science.1218062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654058	Green Accepted			2022-12-28	WOS:000304647900051
J	Lai, YT; Cascio, D; Yeates, TO				Lai, Yen-Ting; Cascio, Duilio; Yeates, Todd O.			Structure of a 16-nm Cage Designed by Using Protein Oligomers	SCIENCE			English	Article							INTERFACES; SYMMETRY		[Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Lai, Yen-Ting] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA; [Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu	Lai, Yen-Ting/R-2195-2017	Lai, Yen-Ting/0000-0003-3700-6417; Yeates, Todd/0000-0001-5709-9839	NSF [MCB-0843065]; Div Of Molecular and Cellular Bioscience [0843065] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank M. Sawaya and N. King for helpful advice. This work was supported by NSF grant MCB-0843065. T.O.Y. holds a patent on self-assembling proteins: US6756039. Structural data are deposited in the Protein Data Bank (codes 3vdx and 4d9j).	Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; McAllister KA, 2008, J AM CHEM SOC, V130, P11921, DOI 10.1021/ja800697g; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]	8	216	222	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1129	1129		10.1126/science.1219351	http://dx.doi.org/10.1126/science.1219351			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654051				2022-12-28	WOS:000304647900040
J	Liu, TT; Liu, ZX; Song, CJ; Hu, YF; Han, ZF; She, J; Fan, FF; Wang, JW; Jin, CW; Chang, JB; Zhou, JM; Chai, JJ				Liu, Tingting; Liu, Zixu; Song, Chuanjun; Hu, Yunfei; Han, Zhifu; She, Ji; Fan, Fangfang; Wang, Jiawei; Jin, Changwen; Chang, Junbiao; Zhou, Jian-Min; Chai, Jijie			Chitin-Induced Dimerization Activates a Plant Immune Receptor	SCIENCE			English	Article							PATTERN-RECOGNITION RECEPTORS; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; KINASE; LYSM; BINDING; DEFENSE; PERCEPTION; RESISTANCE; PROTEINS	Pattern recognition receptors confer plant resistance to pathogen infection by recognizing the conserved pathogen-associated molecular patterns. The cell surface receptor chitin elicitor receptor kinase 1 of Arabidopsis (AtCERK1) directly binds chitin through its lysine motif (LysM)-containing ectodomain (AtCERK1-ECD) to activate immune responses. The crystal structure that we solved of an AtCERK1-ECD complexed with a chitin pentamer reveals that their interaction is primarily mediated by a LysM and three chitin residues. By acting as a bivalent ligand, a chitin octamer induces AtCERK1-ECD dimerization that is inhibited by shorter chitin oligomers. A mutation attenuating chitin-induced AtCERK1-ECD dimerization or formation of nonproductive AtCERK1 dimer by overexpression of AtCERK1-ECD compromises AtCERK1-mediated signaling in plant cells. Together, our data support the notion that chitin-induced AtCERK1 dimerization is critical for its activation.	[Song, Chuanjun; Fan, Fangfang; Chang, Junbiao] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China; [Liu, Tingting] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Liu, Tingting] Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Tingting; Han, Zhifu; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Tingting; Han, Zhifu; Wang, Jiawei; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Tingting; Liu, Zixu; Zhou, Jian-Min] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Zixu] Nanjing Univ, Sch Life Sci, Nanjing 210093, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; She, Ji; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; Nanjing University; Peking University; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chang, JB (corresponding author), Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China.	changjunbiao@zzu.edu.cn; jmzhou@genetics.ac.cn; chaijj@mail.tsinghua.edu.cn	liu, ting/GZM-3326-2022; fan, fang/GQY-9173-2022; Zhou, Jian-Min/A-3140-2013; Fan, Fang/GRO-2696-2022; poinssot, benoit/B-2569-2009; Liu, Zixu/AAA-9393-2019; chang, junbiao/P-1095-2014; She, Ji/AAW-6150-2021	Zhou, Jian-Min/0000-0002-9943-2975; poinssot, benoit/0000-0001-5890-4318; chang, junbiao/0000-0001-6236-1256; Chai, Jijie/0000-0001-7591-3873; LIU, ZIXU/0000-0002-3082-6765	State Key Program of National Natural Science of China [31130063]; Chinese Ministry of Science and Technology [2010CB835300, 2011CB100700]; National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China [30825043]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank F. Yu and J. He at Shanghai Synchrotron Radiation Facility (SSRF). J. C. was funded by State Key Program of National Natural Science of China (31130063) and Chinese Ministry of Science and Technology (2010CB835300). J.M.Z. was funded by Chinese Ministry of Science and Technology (2011CB100700; 2010CB835300). J. B. C. was funded by the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China (30825043). The coordinates and structural factors for free- and chitin-bound AtCERK1-ECD have been deposited in Protein Data Bank with accession codes 4EBY and 4EBZ, respectively.	Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Parker JE, 2003, TRENDS PLANT SCI, V8, P245, DOI 10.1016/S1360-1385(03)00105-5; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Tanaka S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-288; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	32	380	422	28	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1160	1164		10.1126/science.1218867	http://dx.doi.org/10.1126/science.1218867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654057				2022-12-28	WOS:000304647900050
J	Shang, H; Xu, JJ; Han, XX; Li, JS; Arledge, KC; Zhang, LQ				Shang, Hong; Xu, Junjie; Han, Xiaoxu; Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi			Bring safe sex to China	NATURE			English	Editorial Material							BEHAVIOR; HIV; MEN		[Shang, Hong; Xu, Junjie; Han, Xiaoxu] China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang 110001, Peoples R China; [Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China	China Medical University; Tsinghua University; Tsinghua University	Shang, H (corresponding author), China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang 110001, Peoples R China.	hongshang100@hotmail.com; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022	xu, junjie/0000-0003-4303-7295				China Ministry of Health, 2010, CHIN 2010 UNGASS COU; Chinese Ministry of Health, 2012, 2010 CHIN AIDS RESP; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; UNAIDS, 2010, REP GLOB AIDS EP UNA; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	11	83	94	5	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					576	577		10.1038/485576a	http://dx.doi.org/10.1038/485576a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22660303	Bronze			2022-12-28	WOS:000304608000025
J	Nishimura, T; Honda, H; Takeichi, M				Nishimura, Tamako; Honda, Hisao; Takeichi, Masatoshi			Planar Cell Polarity Links Axes of Spatial Dynamics in Neural-Tube Closure	CELL			English	Article							CONVERGENT EXTENSION; PROTEIN DAAM1; RHO-KINASES; MORPHOGENESIS; GASTRULATION; SHAPE; NEURULATION; DROSOPHILA; CADHERIN; SHROOM	Neural-tube closure is a critical step of embryogenesis, and its failure causes serious birth defects. Coordination of two morphogenetic processes-convergent extension and neural-plate apical constriction-ensures the complete closure of the neural tube. We now provide evidence that planar cell polarity (PCP) signaling directly links these two processes. In the bending neural plates, we find that a PCP-regulating cadherin, Celsr1, is concentrated in adherens junctions (AJs) oriented toward the mediolateral axes of the plates. At these AJs, Celsr1 cooperates with Dishevelled, DAAM1, and the PDZ-RhoGEF to upregulate Rho kinase, causing their actomyosin-dependent contraction in a planar-polarized manner. This planar-polarized contraction promotes simultaneous apical constriction and midline convergence of neuroepithelial cells. Together our findings demonstrate that PCP signals confer anisotropic contractility on the AJs, producing cellular forces that promote the polarized bending of the neural plate.	[Nishimura, Tamako; Honda, Hisao; Takeichi, Masatoshi] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Honda, Hisao] Hyogo Univ, Kakogawa, Hyogo 6750195, Japan	RIKEN	Takeichi, M (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; , xi cun zhu zi/0000-0001-9015-377X	Japan Society for Promotion of Science; Grants-in-Aid for Scientific Research [20002009] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakaya for advice on chicken embryology; E. Fuchs for Celsr1 plasmids; K. Nagata for the PDZ-RhoGEF plasmid; A. Sugimoto for an EM-CCD camera; T. Nagai for computational modeling; and the RIKEN Integrated Cluster of Clusters for computation facilities. We are also grateful to T. Uemura for discussion and H. Saito, M. Nomura-Harata, H. Sylvain, Y. Inoue, S. Kobayashi, H. Abe-Ishigami, and C. Uemura-Yoshii for their technical support. This work was supported by grants from the programs Grants-in-Aid for Specially Promoted Research (to M.T.), for Scientific Research-C (to H.H.), and for Young Scientists-B (to T.N.) from the Japan Society for Promotion of Science.	ALVAREZ IS, 1992, J EXP ZOOL, V261, P340, DOI 10.1002/jez.1402610313; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Formstone CJ, 2005, DEV DYNAM, V232, P408, DOI 10.1002/dvdy.20228; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Honda H, 2008, DEV DYNAM, V237, P1826, DOI 10.1002/dvdy.21609; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Nagai T, 2001, PHILOS MAG B, V81, P699, DOI 10.1080/13642810110055328; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; SCHOENWOLF GC, 1991, DEVELOPMENT, P157; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wei L, 2001, DEVELOPMENT, V128, P2953; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	45	318	322	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1084	1097		10.1016/j.cell.2012.04.021	http://dx.doi.org/10.1016/j.cell.2012.04.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632972	Bronze			2022-12-28	WOS:000304453900014
J	Gatrad, AR; Sheikh, A				Gatrad, A. R.; Sheikh, A.			Blood stained nappy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gatrad, A. R.] Manor Hosp, Walsall WS2 9PS, W Midlands, England; [Gatrad, A. R.] Univ Kentucky, Lexington, KY 40506 USA; [Sheikh, A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland	University of Kentucky; University of Edinburgh	Gatrad, AR (corresponding author), Manor Hosp, Walsall WS2 9PS, W Midlands, England.	abdul.gatrad@walsallhospitals.nhs.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				El-Radhi AS, 2011, PAEDIAT SYMPTOM SORT, P23; National Institute for Health and Clinical Excellence, 2011, DIAGN ASS FOOD ALL C; Offit PA, 2002, RUDOLPHS PAEDIAT, P1023; Peile E, 2007, MRCPCH MASTERCOURSE, V1, P327; Rudolph M, 2006, PAEDIAT CHILD HLTH, P119	5	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 24	2012	344								e3496	10.1136/bmj.e3496	http://dx.doi.org/10.1136/bmj.e3496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QU	22628006	Green Submitted			2022-12-28	WOS:000304591600008
J	Barbe, F; Duran-Cantolla, J; Sanchez-de-la-Torre, M; Martinez-Alonso, M; Carmona, C; Barcelo, A; Chiner, E; Masa, JF; Gonzalez, M; Marin, JM; Garcia-Rio, F; de Atauri, JD; Teran, J; Mayos, M; de la Pena, M; Monasterio, C; del Campo, F; Montserrat, JM				Barbe, Ferran; Duran-Cantolla, Joaquin; Sanchez-de-la-Torre, Manuel; Martinez-Alonso, Montserrat; Carmona, Carmen; Barcelo, Antonia; Chiner, Eusebi; Masa, Juan F.; Gonzalez, Monica; Marin, Jose M.; Garcia-Rio, Francisco; Diaz de Atauri, Josefa; Teran, Joaquin; Mayos, Mercedes; de la Pena, Mnica; Monasterio, Carmen; del Campo, Felix; Montserrat, Josep M.		Spanish Sleep Breathing Network	Effect of Continuous Positive Airway Pressure on the Incidence of Hypertension and Cardiovascular Events in Nonsleepy Patients With Obstructive Sleep Apnea A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; HYPOPNEA; MORTALITY; DISEASE; IMPACT; RISK; METAANALYSIS; ASSOCIATION; OUTCOMES; THERAPY	Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with sleep-disordered breathing, regardless of daytime symptoms, is unclear. Objective To evaluate the effect of CPAP treatment on the incidence of hypertension or cardiovascular events in a cohort of nonsleepy patients with OSA. Design, Setting, and Patients Multicenter, parallel-group, randomized controlled trial in 14 teaching hospitals in Spain. Between May 2004 and May 2006, 725 consecutive patients were enrolled who had an apnea-hypopnea index of 20 h(-1) or greater and an Epworth Sleepiness Scale score of 10 or less (scores range from 0-24, with values <10 suggesting no daytime sleepiness). Exclusion criteria were previous cardiovascular event, physical or psychological incapacity, chronic disease, or drug or alcohol addiction. Follow-up ended in May 2009. Intervention Patients were allocated to receive CPAP treatment or no active intervention. All participants received dietary counseling and sleep hygiene advice. Main Outcome Measures Incidence of either systemic hypertension (taking antihypertensive medication or blood pressure greater than 140/90 mm Hg) or cardiovascular event (nonfatal myocardial infarction, nonfatal stroke, transient ischemic attack, hospitalization for unstable angina or arrhythmia, heart failure, or cardiovascular death). Results Seven hundred twenty-three patients underwent follow-up for a median of 4 (interquartile range, 2.7-4.4) years (1 patient from each group did not receive allocated treatment); 357 in the CPAP group and 366 in the control group were included in the analysis. In the CPAP group there were 68 patients with new hypertension and 28 cardiovascular events (17 unstable angina or arrhythmia, 3 nonfatal stroke, 3 heart failure, 2 nonfatal myocardial infarction, 2 transient ischemic attack, 1 cardiovascular death). In the control group there were 79 patients with new hypertension and 31 cardiovascular events (11 unstable angina or arrhythmia, 8 nonfatal myocardial infarction, 5 transient ischemic attack, 5 heart failure, 2 nonfatal stroke). The hypertension or cardiovascular event incidence density rate was 9.20 per 100 person-years (95% CI, 7.36-11.04) in the CPAP group and 11.02 per 100 person-years (95% CI, 8.96-13.08) in the control group. The incidence density ratio was 0.83 (95% CI, 0.63-1.1; P=.20). Conclusions In patients with OSA without daytime sleepiness, the prescription of CPAP compared with usual care did not result in a statistically significant reduction in the incidence of hypertension or cardiovascular events. However, the study may have had limited power to detect a significant difference.	[Barbe, Ferran] Hosp Arnau Vilanova, Resp Dept, IRB Lleida, Lleida 25198, Spain; [Duran-Cantolla, Joaquin] Hosp Univ Alava, Vitoria, Spain; [Carmona, Carmen] Hosp Virgen Rocio, Seville, Spain; [Barcelo, Antonia; de la Pena, Mnica] Hosp Univ Son Dureta, Palma de Mallorca, Spain; [Chiner, Eusebi] Hosp Sant Joan, Alacant, Spain; [Masa, Juan F.] Hosp San Pedro Alacantara Hosp, Caceres, Spain; [Gonzalez, Monica] Hosp Marques Valdecilla, Santander, Spain; [Marin, Jose M.] Hosp Miguel Servet, Zaragoza, Spain; [Garcia-Rio, Francisco] Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Diaz de Atauri, Josefa] Hosp 12 Octubre, E-28041 Madrid, Spain; [Teran, Joaquin] Hosp Gen Yague, Burgos, Spain; [Mayos, Mercedes] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Monasterio, Carmen] Hosp Bellvitge Princeps Espanya, Barcelona, Spain; [Monasterio, Carmen] Hosp Clin Barcelona, Barcelona, Spain; CIBERes, Madrid, Spain	University Hospital Arnau de Vilanova; University Hospital of Araba; Virgen del Rocio University Hospital; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Hospital Universitario Marques de Valdecilla (HUMV); Miguel Servet University Hospital; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital General Yague; Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Barbe, F (corresponding author), Hosp Arnau Vilanova, Resp Dept, IRB Lleida, Rovira Roure 80, Lleida 25198, Spain.	fbarbe@arnau.scs.es	del Campo, Felix/H-5601-2016; Chiner, Eusebi/AAM-5120-2020; de la Torre, Manuel Sanchez/B-5578-2009; Caballero Eraso, Candela/F-1455-2015; Garcia-Rio, Francisco/AAC-9981-2020; IBIS, SUEÑO/I-2520-2016; Martínez-Alonso, Montserrat/B-5582-2009; GONZALEZ, MONICA/AAM-4033-2021; Cantolla, Joaquin Duran/B-6996-2015; Mediano, Olga/AAZ-2784-2021; Carmona-Bernal, Carmen/C-9429-2015; Garin, Intza/J-4500-2012; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; del campo, Felix/G-5716-2017; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Barbé, Ferran/A-5988-2010; Capote, Francisco/E-9954-2015; Salord Oleo, Neus/AGI-6933-2022	del Campo, Felix/0000-0002-4554-2167; de la Torre, Manuel Sanchez/0000-0002-5695-348X; Martínez-Alonso, Montserrat/0000-0003-1504-8552; GONZALEZ, MONICA/0000-0003-1516-0181; Mediano, Olga/0000-0001-7824-1523; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; del campo, Felix/0000-0002-4554-2167; Barbé, Ferran/0000-0002-2340-8928; de la Pena, Monica/0000-0003-3276-776X; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Salord Oleo, Neus/0000-0002-8384-0878; Barcelo Bennasar, Antonia/0000-0002-3170-5439; Garcia-Rio, Francisco/0000-0002-7227-2238; monasterio ponsa, carmen/0000-0002-6142-0565; Marin Trigo, Jose Maria/0000-0001-9096-2294	Instituto de Salud Carlos III [PI 04/0165]; Fondo de Investigaciones Sanitarios, Ministerio de Sanidad y Consumo, Spain; Spanish Respiratory Society (SEPAR) (Barcelona); Resmed (Bella Vista, Australia); Air Products-Carburos Metalicos (Barcelona); Respironics (Murrysville, Pennsylvania); Breas Medical (Madrid, Spain)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigaciones Sanitarios, Ministerio de Sanidad y Consumo, Spain; Spanish Respiratory Society (SEPAR) (Barcelona); Resmed (Bella Vista, Australia); Air Products-Carburos Metalicos (Barcelona); Respironics (Murrysville, Pennsylvania); Breas Medical (Madrid, Spain)	This study was funded by the Instituto de Salud Carlos III (PI 04/0165) (Fondo de Investigaciones Sanitarios, Ministerio de Sanidad y Consumo, Spain), Spanish Respiratory Society (SEPAR) (Barcelona), Resmed (Bella Vista, Australia), Air Products-Carburos Metalicos (Barcelona), Respironics (Murrysville, Pennsylvania), and Breas Medical (Madrid, Spain).	Alajmi M, 2007, LUNG, V185, P67, DOI 10.1007/s00408-006-0117-x; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5991; Duran-Cantolla J, 2009, SLEEP MED REV, V13, P323, DOI 10.1016/j.smrv.2008.11.001; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub3; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Hedner J, 2001, AM J RESP CRIT CARE, V163, P5, DOI 10.1164/ajrccm.163.1.ed1400d; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; Masa JF, 2004, AM J RESP CRIT CARE, V170, P1218, DOI 10.1164/rccm.200312-1787OC; McDaid C, 2009, SLEEP MED REV, V13, P427, DOI 10.1016/j.smrv.2009.02.004; Mo Li, 2007, Zhonghua Yi Xue Za Zhi, V87, P1177; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Rutledge T, 2000, J HYPERTENS, V18, P153, DOI 10.1097/00004872-200018020-00004; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071	33	534	551	1	67	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2161	2168		10.1001/jama.2012.4366	http://dx.doi.org/10.1001/jama.2012.4366			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618923	Green Published, Bronze			2022-12-28	WOS:000304315200025
J	Parry, G; Cline, A; Goldmann, D				Parry, Gareth; Cline, Amelia; Goldmann, Don			Deciphering Harm Measurement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE EVENTS		[Parry, Gareth; Cline, Amelia; Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA 02138 USA; [Parry, Gareth; Goldmann, Don] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Institute for Healthcare Improvement; Harvard University; Harvard Medical School	Parry, G (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	gparry@ihi.org	Parry, Gareth/CAF-6975-2022					Agency for Healthcare Research and Quality, 2012, AHRQ QUAL IND TOOLK; [Anonymous], 2011, PARTN PAT BETT CAR L; [Anonymous], 2010, ADVERSE EVENTS HOSP; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Disclosure Working Group, 2008, CAN DISCL GUID; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Metersky ML, 2011, MED CARE, V49, P504, DOI 10.1097/MLR.0b013e31820fc218	8	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2155	2156		10.1001/jama.2012.3649	http://dx.doi.org/10.1001/jama.2012.3649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618920				2022-12-28	WOS:000304315200022
J	Shuster, S				Shuster, Sam			Testing athletes, and banning those who take drugs, is unjustifiable	BRITISH MEDICAL JOURNAL			English	Editorial Material									Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Shuster, S (corresponding author), Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	sam@shuster.eclipse.co.uk						[Anonymous], 2008, BR J PHARM, V154, P493; Franke WW, 1997, CLIN CHEM, V43, P1262; Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313; Meinhardt U, 2010, ANN INTERN MED, V152, P568, DOI 10.7326/0003-4819-152-9-201005040-00007; RUSHALL BS, 2006, INT J SPORTS SCI COA, V1, P1; Shuster S, 2006, PANIC NATION; World Anti-doping Agency, 2012, LIST PROH DRUGS	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 22	2012	344								e3521	10.1136/bmj.e3521	http://dx.doi.org/10.1136/bmj.e3521			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QS	22619216				2022-12-28	WOS:000304591400010
J	McNally, RJ				McNally, Richard J.			ARE WE WINNING THE WAR AGAINST POSTTRAUMATIC STRESS DISORDER?	SCIENCE			English	Editorial Material							IRAQ; RESILIENCE; DEPLOYMENT; VETERANS; TRAUMA; SYMPTOMS; COHORT	The most methodologically rigorous epidemiological study on American military personnel deployed to Iraq and Afghanistan found that 4.3% of troops developed posttraumatic stress disorder (PTSD). Among deployed combatants, 7.6% developed PTSD, whereas 1.4% of deployed noncombatants did so. The U.S. Department of Veterans Affairs has launched a program ensuring that all veterans with PTSD will receive evidence-based cognitive-behavioral therapy, and the Army has developed Battlemind postdeployment early interventions that reduce risk for the disorder.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	McNally, RJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	rjm@wjh.harvard.edu						Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Cornum R, 2011, AM PSYCHOL, V66, P4, DOI 10.1037/a0021420; Dentzer S., 2003, ONLINE NEWS HOUR; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Goldstein JS, 2012, WINNING WAR WAR DECL; Gottman JM, 2011, AM PSYCHOL, V66, P52, DOI 10.1037/a0021706; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kulka RA, 1990, TRAUMA VIETNAM WAR R; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Mulligan K, 2012, J CONSULT CLIN PSYCH; Pinker S., 2011, BETTER ANGELS OUR NA; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tedeschi RG, 2011, AM PSYCHOL, V66, P19, DOI 10.1037/a0021896; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Wright KM, 2009, PSYCHOL SERV, V6, P108, DOI 10.1037/a0012620	19	27	28	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					872	874		10.1126/science.1222069	http://dx.doi.org/10.1126/science.1222069			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605766	Green Submitted			2022-12-28	WOS:000304145600052
J	Huang, NA; Chelliah, Y; Shan, YL; Taylor, CA; Yoo, SH; Partch, C; Green, CB; Zhang, H; Takahashi, JS				Huang, Nian; Chelliah, Yogarany; Shan, Yongli; Taylor, Clinton A.; Yoo, Seung-Hee; Partch, Carrie; Green, Carla B.; Zhang, Hong; Takahashi, Joseph S.			Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex	SCIENCE			English	Article							MAMMALIAN CIRCADIAN CLOCK; DEPENDENT TRANSCRIPTION; DROSOPHILA PERIOD; B/HLH/Z DOMAIN; LIGAND-BINDING; MOUSE PERIOD2; FEEDBACK LOOP; PAS-B; PROTEIN; MECHANISM	The circadian clock in mammals is driven by an autoregulatory transcriptional feedback mechanism that takes approximately 24 hours to complete. A key component of this mechanism is a heterodimeric transcriptional activator consisting of two basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) domain protein subunits, CLOCK and BMAL1. Here, we report the crystal structure of a complex containing the mouse CLOCK: BMAL1 bHLH-PAS domains at 2.3 angstrom resolution. The structure reveals an unusual asymmetric heterodimer with the three domains in each of the two subunits-bHLH, PAS-A, and PAS-B-tightly intertwined and involved in dimerization interactions, resulting in three distinct protein interfaces. Mutations that perturb the observed heterodimer interfaces affect the stability and activity of the CLOCK:BMAL1 complex as well as the periodicity of the circadian oscillator. The structure of the CLOCK:BMAL1 complex is a starting point for understanding at an atomic level the mechanism driving the mammalian circadian clock.	[Huang, Nian; Taylor, Clinton A.; Partch, Carrie; Zhang, Hong] Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Chelliah, Yogarany; Shan, Yongli; Yoo, Seung-Hee; Partch, Carrie; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; [Chelliah, Yogarany; Partch, Carrie; Takahashi, Joseph S.] Univ Texas SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Taylor, Clinton A.] Univ Texas SW Med Ctr, Mol Biophys Grad Program, Div Basic Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, H (corresponding author), Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	zhang@chop.swmed.edu; joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Taylor IV, Clinton/0000-0002-8283-3393; Shan, Yongli/0000-0002-5870-2107	Howard Hughes Medical Institute; American Heart Association [10GRNT4310090]; NIH [R01 GM090247, R01 GM081875]; National Institute of General Medical Sciences; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090247, R01GM081875] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (J.S.T.), American Heart Association grant 10GRNT4310090 (H.Z.), NIH grant R01 GM090247 (C. B. G.), and R01 GM081875 (K. Gardner). We thank N. Grishin and K. Gardner for helpful discussions; S. Padrick for help with the fluorescence polarization assay; M. Rosen for use of his fluorometer; D. Tomchick and H. Aronovich for technical assistance; and C. Ralston, L. Steinhour, and C. Brautigam for help with data collection. The Berkeley Center for Structural Biology is supported in part by NIH, the National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. J.S.T. is an investigator, Y.C. is a research specialist 3, and C. P. was an associate in the Howard Hughes Medical Institute. J.S.T. is a cofounder of, a Scientific Advisory Board member of, and a paid consultant for Reset Therapeutics, a biotechnology company aimed at discovering small-molecule therapies that modulate circadian activity for a variety of disease indications. C. B. G. is on the Scientific Advisory Board of, is a paid consultant for, and owns stock in ReSet Therapeutics. Atomic coordinates for the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession code 4F3L.	Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King HA, 2011, J MOL BIOL, V413, P561, DOI 10.1016/j.jmb.2011.08.048; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Verger D, 2007, J MOL BIOL, V367, P102, DOI 10.1016/j.jmb.2006.12.018; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Zhao WN, 2007, NAT CELL BIOL, V9, P268, DOI 10.1038/ncb1539	43	178	196	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					189	194		10.1126/science.1222804	http://dx.doi.org/10.1126/science.1222804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22653727	Green Accepted			2022-12-28	WOS:000306323500048
J	Mees, SMD; Algra, A; Vandertop, WP; van Kooten, F; Kuijsten, HAJM; Boiten, J; van Oostenbrugge, RJ; Salman, RA; Lavados, PM; Rinkel, GJE; van den Bergh, WM				Mees, Sanne M. Dorhout; Algra, Ale; Vandertop, W. Peter; van Kooten, Fop; Kuijsten, Hans A. J. M.; Boiten, Jelis; van Oostenbrugge, Robert J.; Salman, Rustam Al-Shahi; Lavados, Pablo M.; Rinkel, Gabriel J. E.; van den Bergh, Walter M.			Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial	LANCET			English	Article							DELAYED CEREBRAL-ISCHEMIA; SULFATE; VASOSPASM; AGREEMENT; THERAPY	Background Magnesium sulphate is a neuroprotective agent that might improve outcome after aneurysmal subarachnoid haemorrhage by reducing the occurrence or improving the outcome of delayed cerebral ischaemia. We did a trial to test whether magnesium therapy improves outcome after aneurysmal subarachnoid haemorrhage. Methods We did this phase 3 randomised, placebo-controlled trial in eight centres in Europe and South America. We randomly assigned (with computer-generated random numbers, with permuted blocks of four, stratified by centre) patients aged 18 years or older with an aneurysmal pattern of subarachnoid haemorrhage on brain imaging who were admitted to hospital within 4 days of haemorrhage, to receive intravenous magnesium sulphate, 64 mmol/day, or placebo. We excluded patients with renal failure or bodyweight lower than 50 kg. Patients, treating physicians, and investigators assessing outcomes and analysing data were masked to the allocation. The primary outcome was poor outcome-defined as a score of 4-5 on the modified Rankin Scale-3 months after subarachnoid haemorrhage, or death. We analysed results by intention to treat. We also updated a previous meta-analysis of trials of magnesium treatment for aneurysmal subarachnoid haemorrhage. This study is registered with controlled-trials.com (ISRCTN 68742385) and the EU Clinical Trials Register (EudraCT 2006-003523-36). Findings 1204 patients were enrolled, one of whom had his treatment allocation lost. 606 patients were assigned to the magnesium group (two lost to follow-up), 597 to the placebo (one lost to follow-up). 158 patients (26.2%) had poor outcome in the magnesium group compared with 151 (25.3%) in the placebo group (risk ratio [RR] 1.03, 95% CI 0.85-1.25). Our updated meta-analysis of seven randomised trials involving 2047 patients shows that magnesium is not superior to placebo for reduction of poor outcome after aneurysmal subarachnoid haemorrhage (RR 0.96, 95% CI 0.84-1.10). Interpretation Intravenous magnesium sulphate does not improve clinical outcome after aneurysmal subarachnoid haemorrhage, therefore routine administration of magnesium cannot be recommended.	[Mees, Sanne M. Dorhout; Algra, Ale; Rinkel, Gabriel J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van den Bergh, Walter M.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Vandertop, W. Peter] Acad Med Ctr Amsterdam, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Vandertop, W. Peter] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Kooten, Fop] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Kuijsten, Hans A. J. M.] St Elizabeth Hosp, Dept Intens Care Med, Tilburg, Netherlands; [Boiten, Jelis] MC Haaglanden, Dept Neurol, The Hague, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Neurol, Maastricht, Netherlands; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Lavados, Pablo M.] Univ Desarrollo, Clin Alemana, Unidad Tratamiento Ataque Cewrebrovasc, Santiago, Chile	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Maastricht University; University of Edinburgh; Clinica Alemana; Universidad del Desarrollo	Mees, SMD (corresponding author), Univ Med Ctr, Dept Neurol, POB 85500, NL-3508 GA Utrecht, Netherlands.	s.m.dorhoutmees@umcutrecht.nl	Vandertop, William P./K-9288-2018; Mali, Willem PThM/I-1123-2014; Lavados, Pablo M/E-9918-2016; van der Bom, Johanna G./G-1965-2018	Mali, Willem PThM/0000-0003-4391-0904; Lavados, Pablo M/0000-0002-9118-9093; Vandertop, William/0000-0001-5417-0265; van der Bom, Johanna G./0000-0001-9095-2475; Al-Shahi Salman, Rustam/0000-0002-2108-9222	Netherlands Heart Foundation; UK Medical Research Council; Netherlands Heart Foundation [2005BO16]; UK Medical Research Council [G108/613]; van Leersumfonds; UK Stroke Research Network; MRC [G108/613, G1002605] Funding Source: UKRI; Medical Research Council [G1002605, G108/613] Funding Source: researchfish	Netherlands Heart Foundation(Netherlands Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Heart Foundation(Netherlands Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); van Leersumfonds; UK Stroke Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Netherlands Heart Foundation, UK Medical Research Council.; This trial was funded by the Netherlands Heart Foundation (grant number 2005BO16) and UK Medical Research Council (clinician scientist fellowship G108/613). The van Leersumfonds financially supported part of the production of the study medication. This trial was done with the support of the research nurses at the Edinburgh Wellcome Trust Clinical Research Facility and was supported by the UK Stroke Research Network. We thank Bridget Colam for trial management and Hazel Milligan for handling study drug supplies in Scotland. We also thank Jacoba Greving for preparation of interim analysis reports.	Akdemir H, 2009, NEUROSURG QUART, V19, P35, DOI 10.1097/WNQ.0b013e31818d0ecf; Belfort MA, 2003, NEW ENGL J MED, V348, P304, DOI 10.1056/NEJMoa021180; Brilstra EH, 2000, NEUROLOGY, V55, P1656, DOI 10.1212/WNL.55.11.1656; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000277.pub3; DRAKE CG, 1988, J NEUROSURG, V68, P985; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Hop JW, 1999, STROKE, V30, P2268, DOI 10.1161/01.STR.30.11.2268; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; MCLEAN RM, 1994, AM J MED, V96, P63, DOI 10.1016/0002-9343(94)90117-1; Mees SMD, 2008, INT J STROKE, V3, P63, DOI 10.1111/j.1747-4949.2008.00168.x; Mori K, 2009, NEUROL MED-CHIR, V49, P139, DOI 10.2176/nmc.49.139; Muroi C, 2008, SURG NEUROL, V69, P33, DOI 10.1016/j.surneu.2007.07.015; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Shinohara Y, 2006, CEREBROVASC DIS, V21, P271, DOI 10.1159/000091226; STREINER DL, 1995, HLTH MEASUREMENTS SC; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2004, MAGNESIUM RES, V17, P301; van den Bergh WM, 2003, ACTA NEUROCHIR, V145, P195, DOI 10.1007/s00701-002-1064-9; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; van Norden AGW, 2005, J CLIN PHARM THER, V30, P439, DOI 10.1111/j.1365-2710.2005.00642.x; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Wong GKC, 2011, CRIT CARE, V15, DOI 10.1186/cc10017; Wong GKC, 2009, MAGNESIUM RES, V22, P60, DOI 10.1684/mrh.2009.0167; Wong GKC, 2010, STROKE, V41, P921, DOI 10.1161/STROKEAHA.109.571125	29	168	173	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					44	49		10.1016/S0140-6736(12)60724-7	http://dx.doi.org/10.1016/S0140-6736(12)60724-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	970GK	22633825	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000306115900032
J	Faini, M; Prinz, S; Beck, R; Schorb, M; Riches, JD; Bacia, K; Brugger, B; Wieland, FT; Briggs, JAG				Faini, Marco; Prinz, Simone; Beck, Rainer; Schorb, Martin; Riches, James D.; Bacia, Kirsten; Brugger, Britta; Wieland, Felix T.; Briggs, John A. G.			The Structures of COPI-Coated Vesicles Reveal Alternate Coatomer Conformations and Interactions	SCIENCE			English	Article							CRYOELECTRON TOMOGRAPHY; CLATHRIN; TRANSPORT; COMPLEXES; MECHANISM; CAGE	Transport between compartments of eukaryotic cells is mediated by coated vesicles. The archetypal protein coats COPI, COPII, and clathrin are conserved from yeast to human. Structural studies of COPII and clathrin coats assembled in vitro without membranes suggest that coat components assemble regular cages with the same set of interactions between components. Detailed three-dimensional structures of coated membrane vesicles have not been obtained. Here, we solved the structures of individual COPI-coated membrane vesicles by cryoelectron tomography and subtomogram averaging of in vitro reconstituted budding reactions. The coat protein complex, coatomer, was observed to adopt alternative conformations to change the number of other coatomers with which it interacts and to form vesicles with variable sizes and shapes. This represents a fundamentally different basis for vesicle coat assembly.	[Faini, Marco; Prinz, Simone; Schorb, Martin; Riches, James D.; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstrasse 1, D-69117 Heidelberg, Germany; [Beck, Rainer; Brugger, Britta; Wieland, Felix T.] Heidelberg Univ Biochem Ctr, Univ Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [Bacia, Kirsten] Univ Halle, HALOmem, Kurt Mothes Strasse 3, D-06120 Halle, Germany; [Briggs, John A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstrasse 1, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL)	Riches, JD (corresponding author), Queensland Univ Technol, Analyt Elect Microscopy Facil, Brisbane, Qld, Australia.		Riches, James/M-3873-2013; Briggs, John/J-3096-2012	Riches, James/0000-0001-8494-4743; Beck, Rainer/0000-0001-9304-2733; Faini, Marco/0000-0001-8131-7648; Schorb, Martin/0000-0003-4910-1868; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SFB638 (A16)]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank M. Beck, J. Ellenberg, M. Kaksonen, and S. Welsch for critically reading the manuscript and F. Thommen, T. Bharat, and A. de Marco for technical assistance. This work was funded by the Deutsche Forschungsgemeinschaft within SFB638 (A16) to J.A.G.B. and F.T.W., by Bundesministerium fur Bildung und Forschung to K.B., and was technically supported by use of the European Molecular Biology Laboratory EM Core Facility and Information Technology Services. EM maps are deposited in the Electron Microscopy Data Bank (EMDB) (accession codes from EMD-2084 to EMD-2088). J.A.G.B. and F.T.W. conceived and administered the study. S.P., M.F., and R.B. reconstituted budding reactions, supported by K.B. and B.B. S.P., R.B., and K. B. prepared reagents. M.F., S.P., and J.D.R. collected data. M.F., M.S., and J.A.G.B. developed image processing routines. M.F. and J.A.G.B. analyzed data. M.F., F.T.W. and J.A.G.B. interpreted data. M.F. and J.A.G.B. wrote the paper, supported by all authors.	Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Sahlmuller MC, 2011, TRAFFIC, V12, P682, DOI 10.1111/j.1600-0854.2011.01177.x; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Yip CK, 2011, J MOL BIOL, V408, P825, DOI 10.1016/j.jmb.2011.03.029; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	22	60	61	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1451	+		10.1126/science.1221443	http://dx.doi.org/10.1126/science.1221443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22628556				2022-12-28	WOS:000305211700049
J	Sachs, JD				Sachs, Jeffrey D.			From Millennium Development Goals to Sustainable Development Goals	LANCET			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	sachs@columbia.edu						Sachs Jeffrey D., 2008, COMMON WEALTH EC CRO; UN Millennium Project, 2005, INV DEV PRACT PLAN A	2	807	823	5	224	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2206	2211		10.1016/S0140-6736(12)60685-0	http://dx.doi.org/10.1016/S0140-6736(12)60685-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682467				2022-12-28	WOS:000304990900037
J	Gordon, JI				Gordon, Jeffrey I.			Honor Thy Gut Symbionts Redux	SCIENCE			English	Editorial Material							HUMAN MICROBIOME; GASTROINTESTINAL TRACT; BACTERIAL FLORA; MICE	Exploring our gut microbial communities with new tools is allowing us to revisit old questions; to develop new concepts about our evolution, postnatal development, systems physiology, individuality, and definitions of health; and to further delineate the impact of our changing life-styles. It is also allowing us to envision exciting new ways for addressing global health problems. This area is inherently interdisciplinary, offering a wealth of opportunities to create new fields, partnerships, and educational initiatives. It is captivating to the public and carries substantial expectations. As such, participating scientists need to sponsor proactive, solution-focused discussions of its societal implications.	Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu						Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Benezra A, 2012, P NATL ACAD SCI USA, V109, P6378, DOI 10.1073/pnas.1200515109; BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; BERG P, 1995, P NATL ACAD SCI USA, V92, P9011, DOI 10.1073/pnas.92.20.9011; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; de Kruif P, 1926, MICROBE HUNTERS; DUBOS R, 1965, J EXP MED, V122, P67, DOI 10.1084/jem.122.1.67; FRETER R, 1983, HUMAN INTESTINAL MIC, P33; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hawkins AK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-72; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kendall AI, 1915, SCIENCE, V42, P209, DOI 10.1126/science.42.1076.209; Kendall AI, 1909, J BIOL CHEM, V6, P499; LEE A, 1971, J EXP MED, V133, P339, DOI 10.1084/jem.133.2.339; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; McClellan HL, 2008, NUTR RES REV, V21, P97, DOI 10.1017/S0954422408100749; McGuire AL, 2008, GENOME RES, V18, P1861, DOI 10.1101/gr.081653.108; Metchnikoff E., 1908, PROLONGATION LIFE OP, P169; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; SAVAGE DC, 1968, J EXP MED, V127, P67, DOI 10.1084/jem.127.1.67; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Sharp RR, 2009, AM J GASTROENTEROL, V104, P809, DOI 10.1038/ajg.2008.68; Torrey JC, 1919, J MED RES, V39, P415; Yatsunenko T, 2012, NATURE; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	33	120	131	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1251	1253		10.1126/science.1224686	http://dx.doi.org/10.1126/science.1224686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674326				2022-12-28	WOS:000304905300032
J	Steger, M; Saeedi, K; Thewalt, MLW; Morton, JJL; Riemann, H; Abrosimov, NV; Becker, P; Pohl, HJ				Steger, M.; Saeedi, K.; Thewalt, M. L. W.; Morton, J. J. L.; Riemann, H.; Abrosimov, N. V.; Becker, P.; Pohl, H. -J.			Quantum Information Storage for over 180 s Using Donor Spins in a Si-28 "Semiconductor Vacuum"	SCIENCE			English	Article							NUCLEAR-SPIN; ELECTRON-SPIN; SILICON; COMPUTER; MEMORY	A quantum computer requires systems that are isolated from their environment, but can be integrated into devices, and whose states can be measured with high accuracy. Nuclear spins in solids promise long coherence lifetimes, but they are difficult to initialize into known states and to detect with high sensitivity. We show how the distinctive optical properties of enriched Si-28 enable the use of hyperfine-resolved optical transitions, as previously applied to great effect for isolated atoms and ions in vacuum. Together with efficient Auger photoionization, these resolved hyperfine transitions permit rapid nuclear hyperpolarization and electrical spin-readout. We combine these techniques to detect nuclear magnetic resonance from dilute P-31 in the purest available sample of Si-28, at concentrations inaccessible to conventional measurements, measuring a solid-state coherence time of over 180 seconds.	[Steger, M.; Saeedi, K.; Thewalt, M. L. W.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Morton, J. J. L.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Riemann, H.; Abrosimov, N. V.] Leibniz Inst Kristallzuchtung, D-12489 Berlin, Germany; [Becker, P.] PTB Phys Tech Bundesanstalt Braunschweig, D-38116 Braunschweig, Germany; [Pohl, H. -J.] Vitcon Projectconsult GmbH, D-07745 Jena, Germany	Simon Fraser University; University of Oxford; Leibniz Institut fur Kristallzuchtung (IKZ); Physikalisch-Technische Bundesanstalt (PTB)	Thewalt, MLW (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	thewalt@sfu.ca	Morton, John/I-3515-2013	Saeedi, Kamyar/0000-0003-3653-3135	Natural Sciences and Engineering Research Council of Canada (NSERC); Royal Society (UK); St. John's College, Oxford; Engineering and Physical Sciences Research Council [EP/I035536/1]; European Research Council; EPSRC [EP/I035536/2, EP/H025952/2, EP/I035536/1, EP/H025952/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H025952/1, EP/H025952/2, EP/I035536/2] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Society (UK)(Royal Society of London); St. John's College, Oxford; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). J.J.L.M. acknowledges support from the Royal Society (UK), St. John's College, Oxford, the Engineering and Physical Sciences Research Council (EP/I035536/1), and a European Research Council Starter Grant.	Becker P, 2010, PHYS STATUS SOLIDI A, V207, P49, DOI 10.1002/pssa.200925148; Cardona M, 2005, REV MOD PHYS, V77, P1173, DOI 10.1103/RevModPhys.77.1173; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Dreher L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.027602; FEHER G, 1959, PHYS REV, V114, P1245, DOI 10.1103/PhysRev.114.1245; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; McCamey DR, 2010, SCIENCE, V330, P1652, DOI 10.1126/science.1197931; McCamey DR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.027601; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morishita H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205206; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; SCHMID W, 1977, PHYS STATUS SOLIDI B, V84, P529, DOI 10.1002/pssb.2220840216; Schofield SR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.136104; Sekiguchi T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137402; Simmons S, 2011, NATURE, V470, P69, DOI 10.1038/nature09696; Sleiter D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093028; Steger M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3577614; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Viola L, 1998, PHYS REV A, V58, P2733, DOI 10.1103/PhysRevA.58.2733; Witzel WM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187602; Yang A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.227401; Yang A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238268; Yang A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257401	29	231	234	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1280	1283		10.1126/science.1217635	http://dx.doi.org/10.1126/science.1217635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679091				2022-12-28	WOS:000304905300039
J	Cassidy, JD; Bronfort, G; Hartvigsen, J				Cassidy, J. David; Bronfort, Gert; Hartvigsen, Jan			Should we abandon cervical spine manipulation for mechanical neck pain? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							2000-2010 TASK-FORCE; ARTERY DISSECTION; CASE-CROSSOVER; DISORDERS; STROKE; RISK; BONE; INTERVENTIONS		[Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Bronfort, Gert] NW Hlth Sci Univ, Dept Res, Bloomington, MN USA; [Hartvigsen, Jan] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	University of Toronto; University of Southern Denmark	Cassidy, JD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	dcassidy@uhnresearch.ca		Hartvigsen, Jan/0000-0002-5876-7410				Bronfort G, 2012, ANN INTERN MED, V156, P1, DOI 10.7326/0003-4819-156-1-201201030-00002; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; Guzman J, 2008, SPINE, V33, pS199, DOI 10.1097/BRS.0b013e3181644641; Haldeman S, 2010, J OCCUP ENVIRON MED, V52, P424, DOI 10.1097/JOM.0b013e3181d44f3b; Hurwitz EL, 2012, J ELECTROMYOGR  0128; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Leaver AM, 2010, J PHYSIOTHER, V56, P73, DOI 10.1016/S1836-9553(10)70037-0; Lee VH, 2006, NEUROLOGY, V67, P1809, DOI 10.1212/01.wnl.0000244486.30455.71; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Rothwell DM, 2001, STROKE, V32, P1054, DOI 10.1161/01.STR.32.5.1054; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; Smith WS, 2003, NEUROLOGY, V60, P1424, DOI 10.1212/01.WNL.0000063305.61050.E6; van der Velde G, 2008, SPINE, V33, pS184, DOI 10.1097/BRS.0b013e31816454f8	15	25	27	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2012	344								e3680	10.1136/bmj.e3680	http://dx.doi.org/10.1136/bmj.e3680			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957TG	22677797				2022-12-28	WOS:000305185200011
J	Uttenthal, BJ; Layton, DM; Vyse, TJ; Schreiber, BE				Uttenthal, Benjamin J.; Layton, D. Mark; Vyse, Timothy J.; Schreiber, Benjamin E.			The Wolf at the Door	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REACTIVE HEMOPHAGOCYTIC SYNDROME; MACROPHAGE ACTIVATION SYNDROME; PERFORIN GENE-MUTATIONS; CLINICAL-FEATURES; DISEASE; LYMPHOHISTIOCYTOSIS	A 29-year-old man presented to a local hospital with a 1-week history of intermittent fever, drenching night sweats, reduced appetite, and left upper abdominal pain exacerbated by inspiration. He reported no weight loss, cough, dyspnea, nausea, diarrhea, rash, mouth ulcers, arthralgias, or ocular or urinary symptoms.	[Uttenthal, Benjamin J.] Royal Free Hosp, Dept Haematol, Royal Free & Univ Coll Med Sch, London NW3 2QG, England; [Layton, D. Mark] Imperial Coll Healthcare Natl Hlth Serv NHS Trust, Dept Haematol, London, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London, England; [Schreiber, Benjamin E.] Royal Free Hampstead NHS Trust, Dept Rheumatol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; King's College London; University of London; University College London	Uttenthal, BJ (corresponding author), Royal Free Hosp, Dept Haematol, Royal Free & Univ Coll Med Sch, 1st Fl,Pond St, London NW3 2QG, England.	b.uttenthal@ucl.ac.uk						Deane S, 2010, INT ARCH ALLERGY IMM, V153, P109, DOI 10.1159/000312628; Dhote R, 2003, ARTHRIT RHEUM-ARTHR, V49, P633, DOI 10.1002/art.11368; Fardet L, 2010, AIDS, V24, P1299, DOI 10.1097/QAD.0b013e328339e55b; Freeman HR, 2011, ARCH DIS CHILD, V96, P688, DOI 10.1136/adc.2009.176610; Fukaya S, 2008, RHEUMATOLOGY, V47, P1686, DOI 10.1093/rheumatology/ken342; Hot A, 2010, MEDICINE, V89, P37, DOI 10.1097/MD.0b013e3181caf100; Lambotte O, 2006, MEDICINE, V85, P169, DOI 10.1097/01.md.0000224708.62510.d1; Maakaroun NR, 2010, REV MED VIROL, V20, P93, DOI 10.1002/rmv.638; Nagafuji K, 2007, HAEMATOLOGICA, V92, P978, DOI 10.3324/haematol.11233; Shabbir M, 2011, HEMATOL ONCOL, V29, P100, DOI 10.1002/hon.960; Ueda I, 2007, AM J HEMATOL, V82, P427, DOI 10.1002/ajh.20878; Vastert SJ, 2010, RHEUMATOLOGY, V49, P441, DOI 10.1093/rheumatology/kep418; Wang Zhao, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P1064	13	11	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2216	2221						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670907				2022-12-28	WOS:000304863400013
J	Walker, CLF; Black, RE				Walker, Christa L. Fischer; Black, Robert E.			Zinc treatment for serious infections in young infants	LANCET			English	Editorial Material							SUPPLEMENTATION; CHILDREN; PNEUMONIA; MORTALITY; DIARRHEA; MORBIDITY		[Walker, Christa L. Fischer; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	rblack@jhsph.edu		Black, Robert/0000-0001-9926-7984				Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Haider BA, 2009, FOOD NUTR BULL, V30, pS41, DOI 10.1177/15648265090301S104; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Knoell DL, 2011, BIOMED HEALTH RES, V76, P254, DOI 10.3233/978-1-60750-816-8-254; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Roth DE, 2010, INT J EPIDEMIOL, V39, P795, DOI 10.1093/ije/dyp391; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; WHO and UNICEF, 2004, JOINT STAT CLIN MAN; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23	15	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2031	2033		10.1016/S0140-6736(12)60695-3	http://dx.doi.org/10.1016/S0140-6736(12)60695-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22656334				2022-12-28	WOS:000304759100011
J	King, NP; Sheffler, W; Sawaya, MR; Vollmar, BS; Sumida, JP; Andre, I; Gonen, T; Yeates, TO; Baker, D				King, Neil P.; Sheffler, William; Sawaya, Michael R.; Vollmar, Breanna S.; Sumida, John P.; Andre, Ingemar; Gonen, Tamir; Yeates, Todd O.; Baker, David			Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy	SCIENCE			English	Article							DNA; PEPTIDE; SYMMETRY; CRYSTAL; BUNDLE	We describe a general computational method for designing proteins that self-assemble to a desired symmetric architecture. Protein building blocks are docked together symmetrically to identify complementary packing arrangements, and low-energy protein-protein interfaces are then designed between the building blocks in order to drive self-assembly. We used trimeric protein building blocks to design a 24-subunit, 13-nm diameter complex with octahedral symmetry and a 12-subunit, 11-nm diameter complex with tetrahedral symmetry. The designed proteins assembled to the desired oligomeric states in solution, and the crystal structures of the complexes revealed that the resulting materials closely match the design models. The method can be used to design a wide variety of self-assembling protein nanomaterials.	[King, Neil P.; Sheffler, William; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, US DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Vollmar, Breanna S.; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Sumida, John P.] Univ Washington, Dept Med Chem, Seattle, WA 98177 USA; [Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Lund University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	André, Ingemar/O-4777-2014; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Baker, David/0000-0001-7896-6217; Yeates, Todd/0000-0001-5709-9839	DOE Biological and Environmental Research (DOE-BER) [DE-FC03-02ER63421]; National Center for Research Resources, NIH [RR-15301]; DOE [DE-AC02-06CH11357]; Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; Howard Hughes Medical Institute (HHMI); International Aids Vaccine Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	DOE Biological and Environmental Research (DOE-BER); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); International Aids Vaccine Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Navarro for assistance with protein crystallization at the UCLA crystallization core facility, which is supported by DOE Biological and Environmental Research (DOE-BER) grant DE-FC03-02ER63421, and D. Cascio and the 24-ID-C beamline staff for their assistance in data collection. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources, NIH. Use of the Advanced Photon Source, operated for the Office of Science, DOE, by Argonne National Laboratory, was supported by the DOE under contract no. DE-AC02-06CH11357. Analytical ultracentrifugation was performed in the Bioanalytical Pharmacy Core at the University of Washington, which is supported by the Washington State Life Sciences Discovery Fund and the Center for the Intracellular Delivery of Biologics. We also thank M. Iadanza for EM analysis of T3-10; Y. Cheng and X. Li (UCSF) for giving us access to their electron cryomicroscope for data collection, for helpful discussions, and for sharing scripts with us; and N. Grigorieff (Brandeis) for helpful discussions. The Gonen laboratory is supported by Howard Hughes Medical Institute (HHMI). Work by N. P. K., W. S., and D. B. was supported by DOE, HHMI, and the International Aids Vaccine Initiative. Coordinates and structure factors were deposited in the Protein Data Bank with the accession codes 3VCD (O3-33, R32 crystal form), 4DDF (O3-33, P4 crystal form), 4DCL (T3-08), and 4EGG (T3-10). N. P. K., W. S., T.O.Y., and D. B. have filed a provisional patent application, U. S. 61/622,889, on the described method for designing self-assembling protein materials.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fleishman SJ, 2011, J MOL BIOL, V413, P1047, DOI 10.1016/j.jmb.2011.09.001; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LOVEJOY B, 1993, SCIENCE, V259, P1288, DOI 10.1126/science.8446897; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	32	440	459	8	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1171	1174		10.1126/science.1219364	http://dx.doi.org/10.1126/science.1219364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654060	Green Accepted			2022-12-28	WOS:000304647900053
J	Koschorreck, M; Pertot, D; Vogt, E; Frohlich, B; Feld, M; Kohl, M				Koschorreck, Marco; Pertot, Daniel; Vogt, Enrico; Froehlich, Bernd; Feld, Michael; Koehl, Michael			Attractive and repulsive Fermi polarons in two dimensions	NATURE			English	Article							SPECTROSCOPY	The dynamics of a single impurity in an environment is a fundamental problem in many-body physics. In the solid state, a well known case is an impurity coupled to a bosonic bath (such as lattice vibrations); the impurity and its accompanying lattice distortion form a new entity, a polaron. This quasiparticle plays an important role in the spectral function of high-transition-temperature superconductors, as well as in colossal magnetoresistance in manganites(1). For impurities in a fermionic bath, studies have considered heavy or immobile impurities which exhibit Anderson's orthogonality catastrophe(2) and the Kondo effect(3). More recently, mobile impurities have moved into the focus of research, and they have been found to form new quasiparticles known as Fermi polarons(4-7). The Fermi polaron problem constitutes the extreme, but conceptually simple, limit of two important quantum many-body problems: the crossover between a molecular Bose-Einstein condensate and a superfluid with BCS (Bardeen-Cooper-Schrieffer) pairing with spin-imbalance(8) for attractive interactions, and Stoner's itinerant ferromagnetism(9) for repulsive interactions. It has been proposed that such quantum phases (and other elusive exotic states) might become realizable in Fermi gases confined to two dimensions(10,11). Their stability and observability are intimately related to the theoretically debated(12-16) properties of the Fermi polaron in a two-dimensional Fermi gas. Here we create and investigate Fermi polarons in a two-dimensional, spin-imbalanced Fermi gas, measuring their spectral function using momentum-resolved photoemission spectroscopy(17-19). For attractive interactions, we find evidence for a disputed pairing transition between polarons and tightly bound dimers, which provides insight into the elementary pairing mechanism of imbalanced, strongly coupled two-dimensional Fermi gases. Additionally, for repulsive interactions, we study novel quasiparticles-repulsive polarons-the lifetime of which determines the possibility of stabilizing repulsively interacting Fermi systems.	[Koschorreck, Marco; Pertot, Daniel; Vogt, Enrico; Froehlich, Bernd; Feld, Michael; Koehl, Michael] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Kohl, M (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	mk540@cam.ac.uk	Koschorreck, Marco/D-1536-2009; Kohl, Michael/C-6114-2009	Koschorreck, Marco/0000-0003-0974-7007; Kohl, Michael/0000-0003-4055-713X	EPSRC [EP/G029547/1]; Daimler-Benz Foundation; Studienstiftung; DAAD; Engineering and Physical Sciences Research Council [EP/G029547/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Daimler-Benz Foundation; Studienstiftung; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Baur, N. Cooper, E. Demler, T. Enss, C. Kollath, J. Levinsen, M. Parish, R. Schmidt and W. Zwerger for discussions, and J. Bohn for communicating unpublished details of the vertical bar-5/2 >/vertical bar-3/2 > Feshbach resonance in <SUP>40</SUP>K. The work was supported by EPSRC (EP/G029547/1), Daimler-Benz Foundation (B.F.), Studienstiftung and DAAD (M.F.).	ANDERSON PW, 1967, PHYS REV LETT, V18, P1049, DOI 10.1103/PhysRevLett.18.1049; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Chevy F, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/112401; Conduit GJ, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.053617; Cui XL, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.041602; Dao TL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.240402; Devreese JT, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/6/066501; Feld M, 2011, NATURE, V480, P75, DOI 10.1038/nature10627; Frohlich B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105301; Klawunn M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033607; Kohstall C., 2011, METASTABILITY COHERE; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Levinsen J., 2012, GROUND STATE IMPURIT; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; MCGUIRE JB, 1966, J MATH PHYS, V7, P123, DOI 10.1063/1.1704798; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; Ngampruetikorn V., 2011, REPULSIVE POLARONS 2; Parish MM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.051603; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Pietila V, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.023621; Pilati S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.030405; Prokof'ev N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020408; Punk M, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.053605; Sanner C., 2011, CORRELATIONS PAIR FO; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Schmidt R, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.021602; Schmidt R, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063620; Sommer AT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045302; Stewart JT, 2008, NATURE, V454, P744, DOI 10.1038/nature07172; Zollner S, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.021603	32	311	312	7	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					619	+		10.1038/nature11151	http://dx.doi.org/10.1038/nature11151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660322	Green Submitted			2022-12-28	WOS:000304608000043
J	Nuttall, WJ; Clarke, RH; Glowacki, BA				Nuttall, William J.; Clarke, Richard H.; Glowacki, Bartek A.			Stop squandering helium	NATURE			English	Editorial Material									[Nuttall, William J.] Univ Cambridge, Judge Business Sch, Cambridge CB2 1AG, England; [Clarke, Richard H.] Culham Ctr Fus Energy, Abingdon OX14 3DB, Oxon, England; [Glowacki, Bartek A.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge; University of Cambridge	Nuttall, WJ (corresponding author), Univ Cambridge, Judge Business Sch, Cambridge CB2 1AG, England.	wjn21@cam.ac.uk		Glowacki, Bartlomiej/0000-0003-2165-6378	EPSRC [EP/I501045/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I501045/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Andrieu F., 2006, RAS LAFFAN HELIUM PU; [Anonymous], 2010, RASGAS MAGAZINE, V30, P10; Cai ZM, 2010, RESOUR POLICY, V35, P77, DOI 10.1016/j.resourpol.2009.10.002; McKie R., 2012, OBSERVER        0318; *NAT RES COUNC, 2010, SELL NAT HEL RES; Peterson JB, 2012, ROUTL EXPLOR ENVIRON, V35, P48; Rascoe A., 2012, REUTERS         0216; Sears B, 2012, ROUTL EXPLOR ENVIRON, V35, P15	8	69	71	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					573	575		10.1038/485573a	http://dx.doi.org/10.1038/485573a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22660302	Bronze			2022-12-28	WOS:000304608000024
J	Rice, J				Rice, Jocelyn			METASTASIS The rude awakening	NATURE			English	Editorial Material							CANCER											Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Suzuki M, 2006, AM J PATHOL, V169, P673, DOI 10.2353/ajpath.2006.060053	7	27	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S55	S57		10.1038/485S55a	http://dx.doi.org/10.1038/485S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648500				2022-12-28	WOS:000304608000004
J	Seshadri, S; Oakeshott, P; Nelson-Piercy, C; Chappell, LC				Seshadri, Srividya; Oakeshott, Pippa; Nelson-Piercy, Catherine; Chappell, Lucy C.			Prepregnancy care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREGNANCY OUTCOMES; WOMEN		[Chappell, Lucy C.] Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England; [Seshadri, Srividya; Nelson-Piercy, Catherine] Guys & St Thomas NHS Fdn Trust, London, England; [Oakeshott, Pippa] Univ London, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk		Seshadri, Srividya/0000-0003-1967-6089; Oakeshott, Pippa/0000-0003-2568-8211				[Anonymous], 2011, Obstet Gynecol, V117, P1028, DOI 10.1097/AOG.0b013e31821922c2; [Anonymous], 2004, FERT ASS TREATM PEOP; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Beaulieu DB, 2011, GASTROENTEROL CLIN N, V40, P399, DOI 10.1016/j.gtc.2011.03.006; British Association for Sexual Health and HIV, 2008, UK NAT GUID HIV TEST; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Deshpande NA, 2011, AM J TRANSPLANT, V11, P2388, DOI 10.1111/j.1600-6143.2011.03656.x; Deshpande NA, 2012, LIVER TRANSPL; Hardy JR, 2006, PHARMACOEPIDEM DR S, V15, P555, DOI 10.1002/pds.1269; Hezelgrave NL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2506; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Lazarus JH, 2011, BRIT MED BULL, V97, P137, DOI 10.1093/bmb/ldq039; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; NHS UK screening portal, POL DAT; Simmons D, 2010, BEST PRACT RES CL EN, V24, P625, DOI 10.1016/j.beem.2010.05.002; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; te Velde ER, 2000, LANCET, V355, P1928, DOI 10.1016/S0140-6736(00)02320-5; UK National Screening Committee, 2011, UK NSC POL RUB SUSC; UK National Screening Committee, 2007, SICKL CELL THAL POL; Wahabi HA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-63; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2	23	25	25	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3467	10.1136/bmj.e3467	http://dx.doi.org/10.1136/bmj.e3467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22654073				2022-12-28	WOS:000304857000002
J	Karthikeyan, K; Venkatesh, C; Soundararajan, P				Karthikeyan, Kadirvel; Venkatesh, Chandrasekaran; Soundararajan, Palanisamy			Congenital rubella syndrome: a continuing conundrum	LANCET			English	Editorial Material									[Karthikeyan, Kadirvel; Venkatesh, Chandrasekaran; Soundararajan, Palanisamy] Mahatma Gandhi Med Coll & Res Inst, Dept Pediat, Pondicherry 607402, India	Mahatma Gandhi Medical College & Research Institute	Karthikeyan, K (corresponding author), Mahatma Gandhi Med Coll & Res Inst, Dept Pediat, Pondicherry 607402, India.	drkk31@yahoo.co.in	Chandrasekaran, Venkatesh/AAU-4872-2020	Chandrasekaran, Venkatesh/0000-0003-4409-6860				[Anonymous], 2001, MMWR Recomm Rep, V50, P1; Lambert SR, 2007, BRIT J OPHTHALMOL, V91, P1418, DOI 10.1136/bjo.2007.117960; Ramamurty N, 2006, INDIAN J MED RES, V123, P51; Thant K-Z, 2007, TROP MED HLTH, V35, P271	5	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					2022	2022		10.1016/S0140-6736(12)60351-1	http://dx.doi.org/10.1016/S0140-6736(12)60351-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22633034				2022-12-28	WOS:000304757700038
J	Liu, Q; Dahmane, T; Zhang, Z; Assur, Z; Brasch, J; Shapiro, L; Mancia, F; Hendrickson, WA				Liu, Qun; Dahmane, Tassadite; Zhang, Zhen; Assur, Zahra; Brasch, Julia; Shapiro, Lawrence; Mancia, Filippo; Hendrickson, Wayne A.			Structures from Anomalous Diffraction of Native Biological Macromolecules	SCIENCE			English	Article							SOFT X-RAYS; CRYSTAL-STRUCTURE; RADIATION-DAMAGE; SULFUR; SIGNAL; RESOLUTION; CRYSTALLOGRAPHY; REDUNDANCY; MAD	Crystal structure analyses for biological macromolecules without known structural relatives entail solving the crystallographic phase problem. Typical de novo phase evaluations depend on incorporating heavier atoms than those found natively; most commonly, multi- or single-wavelength anomalous diffraction (MAD or SAD) experiments exploit selenomethionyl proteins. Here, we realize routine structure determination using intrinsic anomalous scattering from native macromolecules. We devised robust procedures for enhancing the signal-to-noise ratio in the slight anomalous scattering from generic native structures by combining data measured from multiple crystals at lower-than-usual x-ray energy. Using this multicrystal SAD method (5 to 13 equivalent crystals), we determined structures at modest resolution (2.8 to 2.3 angstroms) for native proteins varying in size (127 to 1148 unique residues) and number of sulfur sites (3 to 28). With no requirement for heavy-atom incorporation, such experiments provide an attractive alternative to selenomethionyl SAD experiments.	[Liu, Qun; Hendrickson, Wayne A.] Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Dahmane, Tassadite; Zhang, Zhen; Assur, Zahra; Brasch, Julia; Shapiro, Lawrence; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Mancia, Filippo; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Bldg 725, Upton, NY 11973 USA.	wayne@convex.hhmi.columbia.edu	Liu, Qun/A-8757-2011; Shapiro, Lawrence/AAE-7172-2019	Liu, Qun/0000-0002-1179-290X; Mancia, Filippo/0000-0003-3293-2200	Protein Structure Initiative (CysZ) [GM095315]; NIH [GM034102, GM062270]; New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM062270, R01GM034102, R37GM034102] Funding Source: NIH RePORTER	Protein Structure Initiative (CysZ); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for help with synchrotron data collection. This work was supported in part by cooperative agreement GM095315 from the Protein Structure Initiative (CysZ), and by NIH grants GM034102 (HK9<INF>s</INF> and TorT/TorS<INF>s</INF>) and GM062270 (netrin G2). Beamline X4A of the NSLS at Brookhaven National Laboratory, a U.S. Department of Energy facility, is supported by the New York Structural Biology Center. Accession codes for PDB deposits are listed in Table 1. DNA constructs and cell lines may require a material transfer agreement with Columbia University.	Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Cianci M, 2008, ACTA CRYSTALLOGR D, V64, P1196, DOI 10.1107/S0907444908030503; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dauter Z, 2001, ACTA CRYSTALLOGR D, V57, P990, DOI 10.1107/S0907444901006382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garman E, 1999, ACTA CRYSTALLOGR D, V55, P1641, DOI 10.1107/S0907444999008653; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Hendrickson WA, 1999, J SYNCHROTRON RADIAT, V6, P845, DOI 10.1107/S0909049599007591; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Liu ZJ, 2000, PROTEIN SCI, V9, P2085, DOI 10.1110/ps.9.11.2085; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; Mueller-Dieckmann C, 2005, ACTA CRYSTALLOGR D, V61, P1263, DOI 10.1107/S0907444905021475; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2005, J SYNCHROTRON RADIAT, V12, P304, DOI 10.1107/S0909049505003328; Weiss MS, 2001, STRUCTURE, V9, P771, DOI 10.1016/S0969-2126(01)00647-5; Yang C, 2003, ACTA CRYSTALLOGR D, V59, P1943, DOI 10.1107/S0907444903018547	23	139	140	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1033	1037		10.1126/science.1218753	http://dx.doi.org/10.1126/science.1218753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628655	Green Accepted			2022-12-28	WOS:000304406800045
J	Denardo, SJ; Carpinone, PL; Vock, DM; Batich, CD; Pepine, CJ				Denardo, Scott J.; Carpinone, Paul L.; Vock, David M.; Batich, Christopher D.; Pepine, Carl J.			Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Denardo, Scott J.; Carpinone, Paul L.; Vock, David M.; Batich, Christopher D.; Pepine, Carl J.] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA	Duke University	Denardo, SJ (corresponding author), Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA.	scott.denardo@duke.edu	Batich, Chris/H-3966-2017	Vock, David M/0000-0002-5459-9579	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR029890] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Basalus MWZ, 2009, EUROINTERVENTION, V5, P157, DOI 10.4244/EIJV5I1A24; Boden M, 2009, J MATER SCI-MATER M, V20, P1553, DOI 10.1007/s10856-009-3705-5; Malenka DJ, 2008, JAMA-J AM MED ASSOC, V299, P2868, DOI 10.1001/jama.299.24.2868; Mehta RI, 2010, MODERN PATHOL, V23, P921, DOI 10.1038/modpathol.2010.74; Otsuka Yoritaka, 2007, J Invasive Cardiol, V19, P71; van den Heuvel M, 2009, Minerva Cardioangiol, V57, P629	6	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2148	2150		10.1001/jama.2012.4111	http://dx.doi.org/10.1001/jama.2012.4111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618916	Green Accepted, Bronze			2022-12-28	WOS:000304315200018
J	Patrick, K				Patrick, Kirsten			Passport to clean competition	BRITISH MEDICAL JOURNAL			English	Editorial Material												kpatrick@bmj.com		Patrick, Kirsten/0000-0003-4525-8323				[Anonymous], 2012, CYCLING NEWS    0206; Cossins P, 2011, CYCLING NEWS    0420; The World Anti-Doping Agency, ATHL BIOL PASSP OP G; World Anti-Doping Agency, 2011, THER US EX; Zorzoli M, 2010, DRUG TEST ANAL, V2, P542, DOI 10.1002/dta.173	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 22	2012	344								e2077	10.1136/bmj.e2077	http://dx.doi.org/10.1136/bmj.e2077			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QS	22619215				2022-12-28	WOS:000304591400001
J	Gabow, P; Halvorson, G; Kaplan, G				Gabow, Patricia; Halvorson, George; Kaplan, Gary			Marshaling Leadership for High-Value Health Care An Institute of Medicine Discussion Paper	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GROWTH		[Gabow, Patricia] Denver Hlth Fdn, Denver, CO USA; [Halvorson, George] Kaiser Permanente, Oakland, CA USA; [Kaplan, Gary] Virginia Mason Hlth Syst, Seattle, WA USA	Denver Health Medical Center; Kaiser Permanente; Virginia Mason Medical Center	Gabow, P (corresponding author), Denver Hlth, 660 Bannock St, Denver, CO 80204 USA.	pgabow@dhha.org						Auerbach DI, 2011, HEALTH AFFAIR, V30, P1630, DOI 10.1377/hlthaff.2011.0585; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Cosgrove D, 2012, CEO CHECKLIST HIGH V; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kaiser Family Foundation and Health Research & Educational Trust, EMPL HLTH BEN 2011 S; Keehan SP, 2011, HEALTH AFFAIR, V30, P1594, DOI 10.1377/hlthaff.2011.0662; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; National Association of State Budget Officers, STAT EXP REP 2010 FI; Office of the Inspector General, 2010, ADVERSE EVENTS HOSP	9	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2012	308	3					239	240		10.1001/jama.2012.7081	http://dx.doi.org/10.1001/jama.2012.7081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975AC	22669121				2022-12-28	WOS:000306477900021
J	Sandercock, P; Wardlaw, JM; Lindley, RI; Dennis, M; Cohen, G; Murray, G; Innes, K; Venables, G; Czlonkowska, A; Kobayashi, A; Ricci, S; Murray, V; Berge, E; Slot, KB; Hankey, GJ; Correia, M; Peeters, A; Matz, K; Lyrer, P; Gubitz, G; Phillips, SJ; Arauz, A; Baigent, C; Chadwick, D; Tyrrell, P; Lowe, G; Farrall, A; von Kummer, R; Cala, L; von Heijne, A; Morris, Z; Adami, A; Potter, G; Brady, N; Collins, R; Bath, P; van Gijn, J; Gray, R; Hart, R; Yusuf, S; Muir, K; Brainin, M; Engelter, S; Terent, A; Norrving, B; Wester, P; Clark, A; Perry, D; Soosay, V; Buchanan, D; Grant, S; Sakka, E; Drever, J; Walker, P; Herath, I; Brown, AL; Chmielnik, P; Armit, C; Walton, A; Hautvast, M; Lewis, S; Heron, G; Odusanya, S; Linksted, P; Kane, I; Whiteley, W; Sellar, R; White, P; Keston, P; Farrell, A; Morris, Z; Miranda, H; Blackwell, L; Celani, MG; Righetti, E; Cenciarelli, S; Mazzoli, T; Cantisani, TA; Bembenek, J; Isaakson, E; Freys, G				Sandercock, Peter; Wardlaw, Joanna M.; Lindley, Richard I.; Dennis, Martin; Cohen, Geoff; Murray, Gordon; Innes, Karen; Venables, Graham; Czlonkowska, Anna; Kobayashi, Adam; Ricci, Stefano; Murray, Veronica; Berge, Eivind; Slot, Karsten Bruins; Hankey, Graeme J.; Correia, Manuel; Peeters, Andre; Matz, Karl; Lyrer, Phillippe; Gubitz, Gord; Phillips, Stephen J.; Arauz, Antonio; Baigent, Colin; Chadwick, David; Tyrrell, Pippa; Lowe, Gordon; Farrall, Andrew; von Kummer, Rudiger; Cala, Lesley; von Heijne, Anders; Morris, Zoe; Adami, Alessandro; Potter, Gillian; Brady, Nick; Collins, Rory; Bath, Philip; van Gijn, Jan; Gray, Richard; Hart, Robert; Yusuf, Salim; Muir, Keith; Brainin, Michael; Engelter, Stefan; Terent, Andreas; Norrving, Bo; Wester, Per; Clark, Alison; Perry, David; Soosay, Vera; Buchanan, David; Grant, Sheila; Sakka, Eleni; Drever, Jonathan; Walker, Pauli; Herath, Indee; Brown, Ann Leigh; Chmielnik, Paul; Armit, Christopher; Walton, Andrea; Hautvast, Mischa; Lewis, Steff; Heron, Graeme; Odusanya, Sylvia; Linksted, Pam; Kane, Ingrid; Whiteley, Will; Sellar, Robin; White, Philip; Keston, Peter; Farrell, Andrew; Morris, Zoe; Miranda, Hector; Blackwell, Lisa; Celani, Maria Grazia; Righetti, Enrico; Cenciarelli, Silvia; Mazzoli, Tatiana; Cantisani, Teresa Anna; Bembenek, Jan; Isaakson, Eva; Freys, Genevieve		IST 3 Collaborative Grp	The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial	LANCET			English	Article							CASE-FATALITY; STATISTICAL-ANALYSIS; RISK-FACTORS; CT; OXFORDSHIRE; MORTALITY; ALTEPLASE; DISEASE; IMPACT; BRAIN	Background Thrombolysis is of net benefit in patients with acute ischaemic stroke, who are younger than 80 years of age and are treated within 4.5 h of onset. The third International Stroke Trial (IST-3) sought to determine whether a wider range of patients might benefit up to 6 h from stroke onset. Methods In this international, multicentre, randomised, open-treatment trial, patients were allocated to 0.9 mg/kg intravenous recombinant tissue plasminogen activator (rt-PA) or to control. The primary analysis was of the proportion of patients alive and independent, as defined by an Oxford Handicap Score (OHS) of 0-2 at 6 months. The study is registered, ISRCTN25765518. Findings 3035 patients were enrolled by 156 hospitals in 12 countries. All of these patients were included in the analyses (1515 in the rt-PA group vs 1520 in the control group), of whom 1617 (53%) were older than 80 years of age. At 6 months, 554 (37%) patients in the rt-PA group versus 534 (35%) in the control group were alive and independent (OHS 0-2; adjusted odds ratio [OR] 1.13, 95% CI 0.95-1.35, p=0.181; a non-significant absolute increase of 14/1000, 95% CI -20 to 48). An ordinal analysis showed a significant shift in OHS scores; common OR 1.27 (95% CI 1.10-1.47, p=0.001). Fatal or non-fatal symptomatic intracranial haemorrhage within 7 days occurred in 104 (7%) patients in the rt-PA group versus 16 (1%) in the control group (adjusted OR 6.94, 95% CI 4.07-11.8; absolute excess 58/1000, 95% CI 44-72). More deaths occurred within 7 days in the rt-PA group (163 [11%]) than in the control group (107 [7%], adjusted OR 1.60, 95% CI 1.22-2.08, p=0.001; absolute increase 37/1000, 95% CI 17-57), but between 7 days and 6 months there were fewer deaths in the rt-PA group than in the control group, so that by 6 months, similar numbers, in total, had died (408 [27%] in the rt-PA group vs 407 [27%] in the control group). Interpretation For the types of patient recruited in IST-3, despite the early hazards, thrombolysis within 6 h improved functional outcome. Benefit did not seem to be diminished in elderly patients.	[Sandercock, Peter] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Lindley, Richard I.] Univ Sydney, Westmead Hosp, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Venables, Graham] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Czlonkowska, Anna] Med Univ Warsaw, Warsaw, Poland; [Ricci, Stefano] Osped Citta Castello, Dept Neurol ASL1, Citta Di Castello, Italy; [Murray, Veronica] Karolinska Inst, Stockholm, Sweden; [Berge, Eivind; Slot, Karsten Bruins] Oslo Univ Hosp, Oslo, Norway; [Hankey, Graeme J.] Royal Perth Hosp, Perth, WA, Australia; [Correia, Manuel] Hosp Geral Santo Antonio, Oporto, Portugal; [Peeters, Andre] Clin Univ St Luc, B-1200 Brussels, Belgium; [Matz, Karl] Landesklinikum Donaureg Tulln, Tulln, Austria; [Lyrer, Phillippe] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Gubitz, Gord; Phillips, Stephen J.] Dalhousie Univ, Halifax, NS, Canada; [Gubitz, Gord; Phillips, Stephen J.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Arauz, Antonio] Inst Nacl Neurol, Mexico City, DF, Mexico; [Baigent, Colin; Collins, Rory; Gray, Richard] Univ Oxford, Oxford, England; [Chadwick, David] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Tyrrell, Pippa] Univ Manchester, Manchester, Lancs, England; [Muir, Keith] Univ Glasgow, Inst Neurol Sci, Glasgow, Lanark, Scotland; [Bath, Philip] Univ Nottingham, Nottingham NG7 2RD, England; [van Gijn, Jan] Univ Utrecht, Utrecht, Netherlands; [Hart, Robert; Yusuf, Salim] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Blackwell, Lisa] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England	University of Edinburgh; University of Sydney; George Institute for Global Health; University of Sydney; University of Sheffield; Medical University of Warsaw; Karolinska Institutet; University of Oslo; Royal Perth Hospital; University of Western Australia; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Basel; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Oxford; University of Liverpool; University of Manchester; University of Glasgow; University of Nottingham; Utrecht University; McMaster University; Radcliffe Infirmary; University of Oxford	Sandercock, P (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	peter.sandercock@ed.ac.uk	Werring, David/Q-8435-2019; Kobayashi, Adam/AAL-7232-2020; Armit, Chris/AAZ-5613-2020; Parsons, Mark W./G-3750-2014; bladin, chris/B-9136-2013; Spratt, Neil J/K-4208-2012; Collins, Rory/ABA-8487-2020; Gojska-Grymajlo, Anna/F-3147-2012; von Kummer, Rüdiger/AAA-4478-2019; Macleod, Malcolm Robert/B-2052-2010; Lindley, Richard/B-8148-2013; Adami, Alessandro/P-1831-2018; Badve, Monica/W-2187-2017; Ginsberg, Lionel/C-8704-2009; Hill, Michael D/C-9073-2012; Wardlaw, Joanna M/Y-3456-2019; Leńska-Mieciek, Marta/ABH-8893-2020; Hankey, Graeme J/H-4968-2014; Bonati, Leo/G-4058-2012; Brola, Waldemar/D-8813-2014; Lueck, Christian Joseph/O-4031-2016; Benedetti, Luana/J-8450-2018; Zini, Andrea/K-1136-2014; celani, maria grazia/AAF-4143-2020; Hernandez, María/GYU-3543-2022; Barilaro, Alessandro/AAB-8373-2020; Demchuk, Andrew M/E-1103-2012; Calleja, Juan/AAX-3777-2020; Buchan, Alastair M/B-9095-2009; Aaseth, Jan/J-6764-2017; Balestrino, Maurizio/A-2305-2008; Bath, Philip/F-9020-2011	Werring, David/0000-0003-2074-1861; Armit, Chris/0000-0002-9952-8141; Spratt, Neil J/0000-0002-9023-6177; Gojska-Grymajlo, Anna/0000-0002-6065-3754; von Kummer, Rüdiger/0000-0003-0119-4604; Macleod, Malcolm Robert/0000-0001-9187-9839; Lindley, Richard/0000-0002-0104-5679; Adami, Alessandro/0000-0002-9163-4900; Badve, Monica/0000-0002-1115-6719; Hill, Michael D/0000-0002-6269-1543; Wardlaw, Joanna M/0000-0002-9812-6642; Hankey, Graeme J/0000-0002-6044-7328; Bonati, Leo/0000-0003-1163-8133; Brola, Waldemar/0000-0002-7955-3454; Lueck, Christian Joseph/0000-0003-1537-7612; Benedetti, Luana/0000-0002-9540-9727; Zini, Andrea/0000-0003-1486-4507; Demchuk, Andrew M/0000-0002-4930-7789; Calleja, Juan/0000-0002-0423-9719; Buchan, Alastair M/0000-0002-2918-5200; Aaseth, Jan/0000-0002-7518-5703; Balestrino, Maurizio/0000-0002-5971-2200; Tyrrell, Pippa/0000-0001-9609-1231; Sudlow, Cathie/0000-0002-7725-7520; Lewis, Steff/0000-0003-1210-2314; Emsley, Hedley/0000-0003-0129-4488; Doig, David/0000-0002-7492-6610; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Felgueiras, Rui/0000-0001-9372-8743; Yusuf, Salim/0000-0003-4776-5601; Bath, Philip/0000-0003-2734-5132; Wardle, Mark/0000-0002-4543-7068; Strain, William/0000-0002-6826-418X; Cloud, Geoffrey/0000-0002-8365-6907; Czlonkowska, Anna/0000-0002-1956-1866; Bilik, Marta/0000-0001-7049-3988; White, Philip/0000-0001-6007-6013; Whiteley, William/0000-0002-4816-8991; Damasio, Joana/0000-0002-6539-6398; corea, francesco/0000-0002-5864-9991; Karaszewski, Bartosz/0000-0003-2726-0016; Lundstrom, Erik/0000-0002-5313-9052; Gray, Richard/0000-0003-4440-574X; Fiszer, Urszula/0000-0002-9286-2454; Randall, Marc/0000-0002-3196-182X; Matz, Karl/0000-0002-2851-9897; Kwan, Joseph/0000-0003-4635-3322; Sandercock, Peter/0000-0001-8484-0135; Tamburin, Stefano/0000-0002-1561-2187; Murray, Gordon/0000-0001-9866-4734; Vucic, Steve/0000-0002-8323-873X; Engelter, Stefan/0000-0003-3855-6234; Lenska-Mieciek, Marta/0000-0001-7245-7817	UK Medical Research Council; Health Foundation UK; Stroke Association UK; Research Council of Norway; Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden; Swedish Heart Lung Fund; Foundation of Marianne and Marcus Wallenberg; Polish Ministry of Science and Education; Australian Heart Foundation; Australian National Health and Medical Research Council (NHMRC); Swiss National Research Foundation; Swiss Heart Foundation; Assessorato alla Sanita; Regione dell'Umbria, Italy; Danube University; Boehringer Ingelheim; Sanofi Synthlabo Aventis; Hoffman La Roche; Novo Nordisk; UK Research Councils Joint Research Equipment Initiative; UK MRC [G0400069, EME 09-800-15]; AFA Insurances (Sweden); Stockholm County Council; Karolinska Institute (Sweden); Government of Poland [2PO5B10928]; Australian Heart Foundation [G 04S 1638]; Australian NHMRC [457343]; Foundation for health and cardio-/neurovascular research, Basel, Switzerland; Danube University, Krems, Austria; NIHR Stroke Research Network; NHS Research Scotland, through the Scottish Stroke Research Network; National Institute for Social Care and Health Research Clinical Research Centre; Scottish Funding Council; Chief Scientist Office of the Scottish Executive; Chest Heart and Stroke Scotland; DesAcc; University of Edinburgh; Danderyd Hospital RD Department; Oslo University Hospital; Dalhousie University; NIHR through the UK Stroke Research Network; MRC [MC_G1002455, G0400069, G0800803, G0902303] Funding Source: UKRI; Medical Research Council [MC_G1002455, G0400069, G0800803, G0700704B, G0902303] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Foundation UK; Stroke Association UK; Research Council of Norway(Research Council of Norway); Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden; Swedish Heart Lung Fund(Swedish Heart-Lung Foundation); Foundation of Marianne and Marcus Wallenberg; Polish Ministry of Science and Education(Ministry of Science and Higher Education, Poland); Australian Heart Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss Heart Foundation; Assessorato alla Sanita; Regione dell'Umbria, Italy; Danube University; Boehringer Ingelheim(Boehringer Ingelheim); Sanofi Synthlabo Aventis; Hoffman La Roche; Novo Nordisk(Novo Nordisk); UK Research Councils Joint Research Equipment Initiative; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AFA Insurances (Sweden); Stockholm County Council(Stockholm County Council); Karolinska Institute (Sweden)(Karolinska Institutet); Government of Poland; Australian Heart Foundation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Foundation for health and cardio-/neurovascular research, Basel, Switzerland; Danube University, Krems, Austria; NIHR Stroke Research Network; NHS Research Scotland, through the Scottish Stroke Research Network; National Institute for Social Care and Health Research Clinical Research Centre; Scottish Funding Council; Chief Scientist Office of the Scottish Executive; Chest Heart and Stroke Scotland; DesAcc; University of Edinburgh; Danderyd Hospital RD Department; Oslo University Hospital; Dalhousie University; NIHR through the UK Stroke Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, Health Foundation UK, Stroke Association UK, Research Council of Norway, Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden, Swedish Heart Lung Fund, The Foundation of Marianne and Marcus Wallenberg, Polish Ministry of Science and Education, the Australian Heart Foundation, Australian National Health and Medical Research Council (NHMRC), Swiss National Research Foundation, Swiss Heart Foundation, Assessorato alla Sanita, Regione dell'Umbria, Italy, and Danube University.r EB has received honoraria for lectures at meetings arranged by Boehringer Ingelheim, and reimbursement for costs for attending these meetings. AC has received lecture fees and conference travel costs from Boehringer Ingelheim. GB has received honoraria and speaker fees from Boehringer Ingelheim, Sanofi Synthlabo Aventis, Hoffman La Roche, and Novo Nordisk. AK has received lecture fees and conference travel costs from Boehringer Ingelheim. RIL has received payment in his role as conference scientific committee member and for occasional lectures from Boehringer Ingelheim; has attended national stroke meetings organised and funded by Boehringer Ingelheim; and is not a member of any industry advisory boards. PS has received lecture fees (paid to the Division of Clinical Neurosciences, University of Edinburgh) and travel expenses from Boehringer Ingelheim for occasional lectures given at international conferences; and was a member of the Independent Data and Safety Monitoring Board (DSMB) of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial funded by Boehringer Ingelheim and received attendance fees and travel expenses for attending DSMB meetings (paid to the Division of Clinical Neurosciences, University of Edinburgh). KBS has received an honorarium for a lecture from Boehringer Ingelheim and had costs for participating in scientific meetings reimbursed; is a member of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) and the Cardiovascular Working Party. The views expressed in this article are the personal views of KBS and should not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency or one of its committees or working parties. VM has received an unrestricted educational grant for a meeting on thrombolysis in stroke at which IST-3 was discussed. JMW received reimbursement for reading CT scans for European Cooperative Acute Stroke Study III (ECASS III) from Boehringer Ingelheim in the form of funding to her department, the Division of Clinical Neurosciences, University of Edinburgh; is the contact reviewer for the Cochrane systematic reviews of thrombolytic treatment for acute stroke; has attended meetings held by Boehringer Ingelheim as an unpaid independent external adviser during the licensing of rt-PA, but was refunded her travel expenses and the time away from work; has attended and spoken at national and international stroke meetings organised and funded by Boehringer Ingelheim for which she received honoraria and travel expenses; and is director of the Brain Research Imaging Centre for Scotland, which is located within the Department of Clinical Neurosciences at the University of Edinburgh, Edinburgh, Scotland and houses a research MRI scanner, which was funded by the UK Research Councils Joint Research Equipment Initiative, supplemented by grants and donations from various other sources including Novartis, Schering, General Electric, and Boehringer Ingelheim.; These commercial sources contributed to the purchase of the scanner, but not the running costs or any individual studies. All other members of the writing committee declare that they have no conflicts of interest.r The IST-3 collaborative group thanks all the patients who participated in the study, and the many individuals not specifically mentioned in the paper who have supported the study. IST-3 is an investigator led trial. The University of Edinburgh and the Lothian Health Board are cosponsors. The start-up phase was supported by a grant from the Stroke Association, UK. The expansion phase was funded by The Health Foundation UK. The main phase of the trial is funded by the following organisations: UK MRC (grant numbers G0400069 and EME 09-800-15) and managed by NIHR on behalf of the MRC-NIHR partnership; The Research Council of Norway; AFA Insurances (Sweden); the Swedish Heart Lung Fund; The Foundation of Marianne and Marcus Wallenberg; Stockholm County Council and Karolinska Institute Joint ALF-project grants (Sweden); the Government of Poland (grant number 2PO5B10928); the Australian Heart Foundation (grant number G 04S 1638); Australian NHMRC (grant number 457343); the Swiss National Research Foundation; the Swiss Heart Foundation; Foundation for health and cardio-/neurovascular research, Basel, Switzerland; the Assessorato alla Sanita, Regione dell'Umbria; Danube University, Krems, Austria. Drug and placebo for the 300 patients in the double-blind component of the start-up phase were supplied by Boehringer Ingelheim. We thank the NIHR Stroke Research Network, NHS Research Scotland, through the Scottish Stroke Research Network, and the National Institute for Social Care and Health Research Clinical Research Centre for their support. The imaging work was undertaken at the Brain Imaging Research Centre, a member of the SINAPSE collaboration, at the Division of Clinical Neurosciences, University of Edinburgh. SINAPSE is funded by the Scottish Funding Council and the Chief Scientist Office of the Scottish Executive. Additional support was received from Chest Heart and Stroke Scotland, DesAcc, University of Edinburgh, Danderyd Hospital R&D Department, Karolinska Institutet, Oslo University Hospital, and the Dalhousie University Internal Medicine Research Fund. This report presents independent research supported by the NIHR through the UK Stroke Research Network. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bembenek J, 2010, INT J STROKE, V5, P430, DOI 10.1111/j.1747-4949.2010.00479.x; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lyden PD, 2012, STROKE, V43, P1691, DOI 10.1161/STROKEAHA.112.656876; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sandercock P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-252; Sandercock P, 2012, INT J STROKE, V7, P186, DOI 10.1111/j.1747-4949.2012.00782.x; Sandercock P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-37; Sanossian N, 2009, LANCET NEUROL, V8, P1031, DOI 10.1016/S1474-4422(09)70259-5; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; VANSWIETEN JC, 1990, J NEUROL NEUROSUR PS, V53, P1080, DOI 10.1136/jnnp.53.12.1080; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; WARDLAW JM, 1994, AM J NEURORADIOL, V15, P1933; Wardlaw JM, 2007, STROKE, V38, P1250, DOI 10.1161/01.STR.0000259715.53166.25; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Whiteley W, 2006, INT J STROKE, V1, P172, DOI 10.1111/j.1747-4949.2006.00043.x	35	839	871	4	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2352	2363		10.1016/S0140-6736(12)60768-5	http://dx.doi.org/10.1016/S0140-6736(12)60768-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961ZV	22632908	Green Published			2022-12-28	WOS:000305509600030
J	Meyer, KD; Saletore, Y; Zumbo, P; Elemento, O; Mason, CE; Jaffrey, SR				Meyer, Kate D.; Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.; Jaffrey, Samie R.			Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3 ' UTRs and near Stop Codons	CELL			English	Article							N-6-METHYLADENOSINE RESIDUES; SEQUENCE SPECIFICITY; N6-METHYLADENOSINE; IDENTIFICATION; LOCALIZATION; SYSTEM; GENES; MOUSE; ACID; DNA	Methylation of the N-6 position of adenosine (m(6)A) is a posttranscriptional modification of RNA with poorly understood prevalence and physiological relevance. The recent discovery that FTO, an obesity risk gene, encodes an m(6)A demethylase implicates m(6)A as an important regulator of physiological processes. Here, we present a method for transcriptome-wide m(6)A localization, which combines m(6)A-specific methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-Seq). We use this method to identify mRNAs of 7,676 mammalian genes that contain m(6)A, indicating that m(6)A is a common base modification of mRNA. The m(6)A modification exhibits tissue-specific regulation and is markedly increased throughout brain development. We find that m(6)A sites are enriched near stop codons and in 3' UTRs, and we uncover an association between m 6 A residues and microRNA-binding sites within 3' UTRs. These findings provide a resource for identifying transcripts that are substrates for adenosine methylation and reveal insights into the epigenetic regulation of the mammalian transcriptome.	[Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Meyer, Kate D.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Mason, CE (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	chm2042@med.cornell.edu; srj2003@med.cornell.edu	Mason, Christopher/HCH-3977-2022	Jaffrey, Samie/0000-0003-3615-6958; Meyer, Kate/0000-0001-7197-4054	NIH [T32CA062948, 1F32MH095353-01, 1R01NS076465-01, MH080420]; NSF [1054964]; Starr Cancer Consortium [I4-A411]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH095353, R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Richard Roberts and New England Biolabs for generously providing the m<SUP>6</SUP>A (NEB) antibody. We also thank members of the Jaffrey and Mason laboratories for helpful comments and suggestions. This work was supported by NIH grants T32CA062948 (K. D. M.), 1F32MH095353-01 (K. D. M.), 1R01NS076465-01 (C. E. M.), and MH080420 (S.R.J.); NSF CAREER grant 1054964 (O.E.); and the Starr Cancer Consortium (I4-A411; C.E.M.).	BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Brockman JM, 2005, BIOINFORMATICS, V21, P3691, DOI 10.1093/bioinformatics/bti589; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KLAGSBRUN M, 1973, Journal of Biological Chemistry, V248, P2612; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; MUNNS TW, 1977, BIOCHEMISTRY-US, V16, P2163, DOI 10.1021/bi00629a019; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024	41	2120	2236	26	297	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1635	1646		10.1016/j.cell.2012.05.003	http://dx.doi.org/10.1016/j.cell.2012.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22608085	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000305753800026
J	Weaver, JC; Milliron, GW; Miserez, A; Evans-Lutterodt, K; Herrera, S; Gallana, I; Mershon, WJ; Swanson, B; Zavattieri, P; DiMasi, E; Kisailus, D				Weaver, James C.; Milliron, Garrett W.; Miserez, Ali; Evans-Lutterodt, Kenneth; Herrera, Steven; Gallana, Isaias; Mershon, William J.; Swanson, Brook; Zavattieri, Pablo; DiMasi, Elaine; Kisailus, David			The Stomatopod Dactyl Club: A Formidable Damage-Tolerant Biological Hammer	SCIENCE			English	Article							X-RAY MICRODIFFRACTION; MANTIS SHRIMP; COMPOSITES; TEETH; BONE; CRUSTACEANS; STRATEGIES; BEHAVIOR; FRACTURE; STORAGE	Nature has evolved efficient strategies to synthesize complex mineralized structures that exhibit exceptional damage tolerance. One such example is found in the hypermineralized hammer-like dactyl clubs of the stomatopods, a group of highly aggressive marine crustaceans. The dactyl clubs from one species, Odontodactylus scyllarus, exhibit an impressive set of characteristics adapted for surviving high-velocity impacts on the heavily mineralized prey on which they feed. Consisting of a multiphase composite of oriented crystalline hydroxyapatite and amorphous calcium phosphate and carbonate, in conjunction with a highly expanded helicoidal organization of the fibrillar chitinous organic matrix, these structures display several effective lines of defense against catastrophic failure during repetitive high-energy loading events.	[Milliron, Garrett W.; Herrera, Steven; Kisailus, David] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Weaver, James C.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 01238 USA; [Miserez, Ali] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Miserez, Ali] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Evans-Lutterodt, Kenneth; DiMasi, Elaine] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Gallana, Isaias; Zavattieri, Pablo] Purdue Univ, Coll Engn, W Lafayette, IN 47907 USA; [Mershon, William J.] Tescan USA, Cranberry Township, PA 16066 USA; [Swanson, Brook] Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA	University of California System; University of California Riverside; Harvard University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Gonzaga University	Kisailus, D (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	david@engr.ucr.edu	Miserez, Ali/D-1074-2010; Kisailus, David/AAW-9736-2021; Miserez, Ali/CAF-2662-2022; Weaver, James C./AAE-7870-2019	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170; Zavattieri, Pablo/0000-0003-4953-150X	National Science Foundation [DMR-0906770]; Singapore National Research Foundation (NRF); Air Force Office of Scientific Research [AFOSR-FA9550-10-1-0322, AFOSR-FA9550-10-1-0209]; U.S. Department of Energy [DE-AC02-98CH10886]	National Science Foundation(National Science Foundation (NSF)); Singapore National Research Foundation (NRF)(National Research Foundation, Singapore); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy(United States Department of Energy (DOE))	We thank J. Vieregge, R. Nay, J. Rawlins, and S. Amini for technical assistance and S. Baron, P. Allen, and D. McLaren for specimen photography and graphic design. This research was supported by grants from the National Science Foundation, DMR-0906770 (D.K.), the Singapore National Research Foundation (NRF) through a NRF Fellowship (A.M.), and Air Force Office of Scientific Research (AFOSR-FA9550-10-1-0322 and AFOSR-FA9550-10-1-0209). Brookhaven National Laboratory is supported under U.S. Department of Energy Contract DE-AC02-98CH10886.	Ahyong ST, 2000, AUST J ZOOL, V48, P607, DOI 10.1071/ZO00042; Al-Sawalmih A, 2008, ADV FUNCT MATER, V18, P3307, DOI 10.1002/adfm.200800520; Apichattrabrut T, 2006, MECH ADV MATER STRUC, V13, P61, DOI 10.1080/15376490500343808; Brooks W. K., 1886, REPORT SCI RESULTS E, V45; Bruet BJF, 2008, NAT MATER, V7, P748, DOI 10.1038/nmat2231; CALDWELL RL, 1975, NATURWISSENSCHAFTEN, V62, P214, DOI 10.1007/BF00603166; CHAN KS, 1993, MAT SCI ENG A-STRUCT, V167, P57, DOI 10.1016/0921-5093(93)90337-E; Cheng L, 2008, J MATER RES, V23, P2854, DOI 10.1557/JMR.2008.0375; Claverie T, 2011, EVOLUTION, V65, P443, DOI 10.1111/j.1558-5646.2010.01133.x; CRONIN TW, 1989, NATURE, V339, P137, DOI 10.1038/339137a0; CURREY JD, 1982, J MATER SCI, V17, P1939, DOI 10.1007/BF00540410; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Dowling N. E., 2006, MECH BEHAV MATERERIA; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Fratzl P, 2007, ADV MATER, V19, P2657, DOI 10.1002/adma.200602394; Habelitz S, 2002, J BIOMECH, V35, P995, DOI 10.1016/S0021-9290(02)00039-8; HE MY, 1989, INT J SOLIDS STRUCT, V25, P1053, DOI 10.1016/0020-7683(89)90021-8; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Lichtenegger H, 1999, J APPL CRYSTALLOGR, V32, P1127, DOI 10.1107/S0021889899010961; Loste E, 2003, J CRYST GROWTH, V254, P206, DOI 10.1016/S0022-0248(03)01153-9; LUKIS FC, 1835, MAGAZINE NATURAL HIS, V8, P459; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001; Paris O, 2003, NUCL INSTRUM METH B, V200, P390, DOI 10.1016/S0168-583X(02)01728-7; Patek SN, 2005, J EXP BIOL, V208, P3655, DOI 10.1242/jeb.01831; Politi Y., 2010, J MAT, V22, P161; REAKA ML, 1975, J MORPHOL, V146, P55, DOI 10.1002/jmor.1051460104; ROER R, 1984, AM ZOOL, V24, P893; Schram FR, 2007, J PALEONTOL, V81, P895, DOI 10.1666/pleo05-075.1; SHIH CF, 1981, J MECH PHYS SOLIDS, V29, P305, DOI 10.1016/0022-5096(81)90003-X; Taylor JRA, 2010, J EXP BIOL, V213, P3496, DOI 10.1242/jeb.047233; Viswanath B, 2007, SCRIPTA MATER, V57, P361, DOI 10.1016/j.scriptamat.2007.04.027; Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; Weiner S, 1997, BONE, V20, P509, DOI 10.1016/S8756-3282(97)00053-7	37	487	499	37	577	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1275	1280		10.1126/science.1218764	http://dx.doi.org/10.1126/science.1218764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679090				2022-12-28	WOS:000304905300038
J	Keppler, F; Vigano, I; McLeod, A; Ott, U; Fruchtl, M; Rockmann, T				Keppler, Frank; Vigano, Ivan; McLeod, Andy; Ott, Ulrich; Fruchtl, Marion; Rockmann, Thomas			Ultraviolet-radiation-induced methane emissions from meteorites and the Martian atmosphere	NATURE			English	Article							ORGANIC-COMPOUNDS; MARS; CHEMISTRY; NITROGEN; CARBON; SOIL	Almost a decade after methane was first reported in the atmosphere of Mars(1,2) there is an intensive discussion about both the reliability of the observations(3,4)-particularly the suggested seasonal and latitudinal variations(5,6)-and the sources of methane on Mars. Given that the lifetime of methane in the Martian atmosphere is limited(1,6), a process on or below the planet's surface would need to be continuously producing methane. A biological source would provide support for the potential existence of life on Mars, whereas a chemical origin would imply that there are unexpected geological processes(7). Methane release from carbonaceous meteorites associated with ablation during atmospheric entry is considered negligible(8). Here we show that methane is produced in much larger quantities from the Murchison meteorite (a type CM2 carbonaceous chondrite) when exposed to ultraviolet radiation under conditions similar to those expected at the Martian surface. Meteorites containing several per cent of intact organic matter reach the Martian surface at high rates(9), and our experiments suggest that a significant fraction of the organic matter accessible to ultraviolet radiation is converted to methane. Ultraviolet-radiation-induced methane formation from meteorites could explain a substantial fraction of the most recently estimated atmospheric methane mixing ratios(3,4). Stable hydrogen isotope analysis unambiguously confirms that the methane released from Murchison is of extraterrestrial origin. The stable carbon isotope composition, in contrast, is similar to that of terrestrial microbial origin; hence, measurements of this signature in future Mars missions may not enable an unambiguous identification of biogenic methane.	[Keppler, Frank; Vigano, Ivan; Ott, Ulrich] Max Planck Inst Chem, Dept Atmospher Chem, D-55128 Mainz, Germany; [Vigano, Ivan; Fruchtl, Marion; Rockmann, Thomas] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [McLeod, Andy] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; [Ott, Ulrich] Univ W Hungary, H-9700 Szombathely, Hungary	Max Planck Society; Utrecht University; University of Edinburgh; University of West Hungary	Keppler, F (corresponding author), Max Planck Inst Chem, Dept Atmospher Chem, Hahn Meitner Weg 1, D-55128 Mainz, Germany.	frank.keppler@mpic.de	Röckmann, Thomas/F-4479-2015; Keppler, Frank/F-4401-2012; Ott, Ulrich/ABH-2337-2020	Röckmann, Thomas/0000-0002-6688-8968; Keppler, Frank/0000-0003-2766-8812; Ulrich, Ott/0000-0003-3574-9591	ESF; DFG [KE 884/2-1]; Dutch NWO [865.07.001]; NERC [NE/F020422/1]; Royal Society Leverhulme Trust; Natural Environment Research Council [NE/F020422/1] Funding Source: researchfish	ESF(European Commission); DFG(German Research Foundation (DFG)); Dutch NWO(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Leverhulme Trust(Royal Society of LondonLeverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	F.K. was supported by the ESF (EURYI award to F. K.) and DFG (KE 884/2-1). Measurements at Utrecht University were funded by the Dutch NWO (grant number 865.07.001). A. M. was supported by the NERC (NE/F020422/1) and a Royal Society Leverhulme Trust senior research fellowship. We thank M. Greule, F. Althoff, A. Jugold, C. Tubbesing and H. F. Scholer for technical support; H. van Weelden from the Utrecht Medical Center for measuring the spectral distribution of the Xe lamp and calibrating the Waldmann ultraviolet meter; C. Brenninkmeijer, J. Lelieveld and C. Cockell for advice; and C. Jager for providing data on ultraviolet absorption by minerals.	ALLEN CC, 1981, ICARUS, V45, P347, DOI 10.1016/0019-1035(81)90040-3; Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Bartoszek M, 2011, PLANET SPACE SCI, V59, P259, DOI 10.1016/j.pss.2010.09.008; Butterworth AL, 2004, MON NOT R ASTRON SOC, V347, P807, DOI 10.1111/j.1365-2966.2004.07251.x; CHUN SFS, 1978, NATURE, V274, P875, DOI 10.1038/274875a0; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Cockell CS, 2000, ICARUS, V146, P343, DOI 10.1006/icar.2000.6393; Court RW, 2009, EARTH PLANET SC LETT, V288, P382, DOI 10.1016/j.epsl.2009.09.041; Etiope G, 2011, PLANET SPACE SCI, V59, P182, DOI 10.1016/j.pss.2010.06.003; Flynn GJ, 1996, EARTH MOON PLANETS, V72, P469, DOI 10.1007/BF00117551; FLYNN GJ, 1990, J GEOPHYS RES-SOLID, V95, P14497, DOI 10.1029/JB095iB09p14497; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; McLeod AR, 2008, NEW PHYTOL, V180, P124, DOI 10.1111/j.1469-8137.2008.02571.x; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Navarro-Gonzalez R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003599; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Schuerger AC, 2011, ICARUS, V213, P393, DOI 10.1016/j.icarus.2011.02.017; Sephton MA, 2003, GEOCHIM COSMOCHIM AC, V67, P2093, DOI 10.1016/S0016-7037(02)01320-0; Sephton MA, 2002, NAT PROD REP, V19, P292, DOI 10.1039/b103775g; Shkrob IA, 2010, ASTROBIOLOGY, V10, P425, DOI 10.1089/ast.2009.0433; Stoker CR, 1997, J GEOPHYS RES-PLANET, V102, P10881, DOI 10.1029/97JE00667; ten Kate IL, 2005, METEORIT PLANET SCI, V40, P1185, DOI 10.1111/j.1945-5100.2005.tb00183.x; ten Kate IL, 2010, ASTROBIOLOGY, V10, P589, DOI 10.1089/ast.2010.0498; Vigano I, 2008, BIOGEOSCIENCES, V5, P937, DOI 10.5194/bg-5-937-2008; Vigano I, 2009, ATMOS ENVIRON, V43, P5637, DOI 10.1016/j.atmosenv.2009.07.046; Wong N., 2010, P 12 ASCE AER DIV IN, P29; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027	33	54	54	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					93	96		10.1038/nature11203	http://dx.doi.org/10.1038/nature11203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678286				2022-12-28	WOS:000304854000033
J	Ren, AM; Rajashankar, KR; Patel, DJ				Ren, Aiming; Rajashankar, Kanagalaghatta R.; Patel, Dinshaw J.			Fluoride ion encapsulation by Mg2+ ions and phosphates in a fluoride riboswitch	NATURE			English	Article							THIAMINE PYROPHOSPHATE RIBOSWITCH; BACTERIAL GENE-EXPRESSION; STRUCTURAL BASIS; GLYCINE RIBOSWITCH; MESSENGER-RNAS; LIGAND; RECOGNITION; DOMAIN; MOLECULES; MECHANISM	Significant advances in our understanding of RNA architecture, folding and recognition have emerged from structure-function studies on riboswitches, non-coding RNAs whose sensing domains bind small ligands and whose adjacent expression platforms contain RNA elements involved in the control of gene regulation. We now report on the ligand-bound structure of the Thermotoga petrophila fluoride riboswitch, which adopts a higher-order RNA architecture stabilized by pseudoknot and long-range reversed Watson-Crick and Hoogsteen A.U pair formation. The bound fluoride ion is encapsulated within the junctional architecture, anchored in place through direct coordination to three Mg2+ ions, which in turn are octahedrally coordinated to water molecules and five inwardly pointing backbone phosphates. Our structure of the fluoride riboswitch in the bound state shows how RNA can form a binding pocket selective for fluoride, while discriminating against larger halide ions. The T. petrophila fluoride riboswitch probably functions in gene regulation through a transcription termination mechanism.	[Ren, Aiming; Patel, Dinshaw J.] Mem Sloan Kettering Ctr, Struct Biol Program, New York, NY 10065 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Adv Photon Source, NE CAT, Chicago, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University	Patel, DJ (corresponding author), Mem Sloan Kettering Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org			NIH [GM34504]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034504] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldberg and C. Lima for discussion and insights, Y. Liu for recording imino proton NMR spectra, and the personnel of the synchrotron beamlines 24-ID-C/E at the Advanced Photon Source, Argonne National Laboratory for their assistance. This research was funded by NIH grant GM34504 to D.J.P.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anthony PC, 2012, P NATL ACAD SCI USA, V109, P1485, DOI 10.1073/pnas.1115045109; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig A. L., 1999, RNA WORLD, P287; Hanna R, 2000, CURR OPIN CHEM BIOL, V4, P166, DOI 10.1016/S1367-5931(99)00071-X; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Lang K, 2007, NUCLEIC ACIDS RES, V35, P5370, DOI 10.1093/nar/gkm580; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pikovskaya Olga, 2009, V540, P115, DOI 10.1007/978-1-59745-558-9_9; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	31	107	112	8	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					85	U1501		10.1038/nature11152	http://dx.doi.org/10.1038/nature11152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678284	Green Accepted			2022-12-28	WOS:000304854000031
J	Scarano, F; Guimaraes, A; da Silva, JM				Scarano, Fabio; Guimaraes, Andre; da Silva, Jose Maria			Lead by example	NATURE			English	Editorial Material									[Scarano, Fabio] Conservat Int, Rio De Janeiro, Brazil; Conservat Int, Arlington, VA USA	Conservation International	Scarano, F (corresponding author), Conservat Int, Rio De Janeiro, Brazil.	f.scarano@conservacao.org	da Silva, José Maria Cardoso/K-3479-2016; Scarano, Fabio Rubio/F-6620-2012	da Silva, José Maria Cardoso/0000-0002-7229-6694; Scarano, Fabio Rubio/0000-0003-3355-9882				Franco C.A., 2008, 46 C SOC BRAS EC ADM; Greenpeace, 2010, GREENPEACE MAR PETRO; Instituto de Pesquisas Economicas Aplicadas, 2011, COD FLOR IMPL PL 187; Martinelli LA, 2010, BIOTA NEOTROP, V10, P323, DOI 10.1590/S1676-06032010000400036; Mittermeier R, 2010, NAT CONSERVACAO, V8, P197, DOI 10.4322/natcon.00802017; Rocha C. O. D., 2010, S MAN FLOR AM BRAS; Viana Virgilio M., 2008, Estud. av., V22, P143, DOI 10.1590/S0103-40142008000300009	7	25	27	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					25	26		10.1038/486025a	http://dx.doi.org/10.1038/486025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GD	22678263				2022-12-28	WOS:000304854000010
J	Wand, BM; Heine, PJ; O'Connell, NE				Wand, Benedict M.; Heine, Peter J.; O'Connell, Neil E.			Should we abandon cervical spine manipulation for mechanical neck pain? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOME EXERCISE; STROKE; RISK		[O'Connell, Neil E.] Brunel Univ, Rehabil Res Ctr, Uxbridge UB8 3PH, Middx, England; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA 6959, Australia; [Heine, Peter J.] Univ Warwick, Div Hlth Sci, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England	Brunel University; University of Notre Dame Australia; University of Warwick	O'Connell, NE (corresponding author), Brunel Univ, Rehabil Res Ctr, Uxbridge UB8 3PH, Middx, England.	neil.oconnell@brunel.ac.uk	Wand, Benedict/C-3341-2011; O'CONNELL, NEIL/A-6907-2014	O'CONNELL, NEIL/0000-0003-1989-4537; Wand, Benedict/0000-0002-0297-0292				Boyle E, 2009, J MANIP PHYSIOL THER, V32, pS194, DOI 10.1016/j.jmpt.2008.11.019; Bronfort G, 2012, ANN INTERN MED, V156, P1, DOI 10.7326/0003-4819-156-1-201201030-00002; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Ernst E, 2007, J ROY SOC MED, V100, P330, DOI 10.1258/jrsm.100.7.330; Ernst E, 2010, INT J CLIN PRACT, V64, P673, DOI 10.1111/j.1742-1241.2009.02237.x; Evans R, 2012, SPINE, V37, P903, DOI 10.1097/BRS.0b013e31823b3bdf; Gross A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub3; Kawchuk GN, 2008, J NEUROL, V255, P371, DOI 10.1007/s00415-008-0667-3; Leaver AM, 2010, ARCH PHYS MED REHAB, V91, P1313, DOI 10.1016/j.apmr.2010.06.006; Rothwell DM, 2001, STROKE, V32, P1054, DOI 10.1161/01.STR.32.5.1054; Smith WS, 2003, NEUROLOGY, V60, P1424, DOI 10.1212/01.WNL.0000063305.61050.E6; Thomas LC, 2011, MANUAL THER, V16, P351, DOI 10.1016/j.math.2010.12.008	13	29	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2012	344								e3679	10.1136/bmj.e3679	http://dx.doi.org/10.1136/bmj.e3679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957TG	22677796	Green Published, Green Submitted			2022-12-28	WOS:000305185200010
J	Sabah, M; Mulcahy, J; Zeman, A				Sabah, Mazen; Mulcahy, James; Zeman, Adam			Herpes simplex encephalitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sabah, Mazen] Southampton Gen Hosp, Dept Neurol, Southampton SO16 6YD, Hants, England; [Mulcahy, James] Royal Devon & Exeter Hosp, Acute Med Dept, Exeter EX2 5DW, Devon, England; [Zeman, Adam] Univ Exeter, Peninsula Med Sch, Exeter, Devon, England	University of Southampton; University of Exeter; University of Exeter	Sabah, M (corresponding author), Southampton Gen Hosp, Dept Neurol, Southampton SO16 6YD, Hants, England.	m3sab3@gmail.com		Zeman, Adam/0000-0003-4875-658X				Anderson WE, 2011, HERPES SIMPLEX ENCEP; Banatvala JE, 2011, LANCET INFECT DIS, V11, P80, DOI 10.1016/S1473-3099(11)70012-3; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Solomon T, 2011, J INFECT        1118; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Tuzun E, 2007, NEUROLOGIST, V13, P261, DOI 10.1097/NRL.0b013e31813e34a5; Wearing D, 2006, FOREVER TODAY TRUE S; WHITLEY RJ, 1982, JAMA-J AM MED ASSOC, V247, P317, DOI 10.1001/jama.247.3.317; Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X	9	22	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2012	344								e3166	10.1136/bmj.e3166	http://dx.doi.org/10.1136/bmj.e3166			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957TC	22674925				2022-12-28	WOS:000305184700004
J	Ivers, LC; Farmer, PE; Pape, WJ				Ivers, Louise C.; Farmer, Paul E.; Pape, William J.			Oral cholera vaccine and integrated cholera control in Haiti	LANCET			English	Editorial Material									[Ivers, Louise C.; Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Ivers, Louise C.; Farmer, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ivers, Louise C.; Farmer, Paul E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pape, William J.] GHESKIO, Port Au Prince, Haiti; [Pape, William J.] Weill Cornell Med Coll, New York, NY USA	Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cornell University	Ivers, LC (corresponding author), Partners Hlth, Boston, MA USA.	livers@pih.org	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				Center for Economic and Policy Research, 2011, CHOL CAS AR MIST BEI; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Harmon K, 2012, SCI AM          0112; Hinman A, 2011, HARVARD INT REV, V33, P51; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Knox R, 2010, NPR             1028; Krishna A, 2006, WORLD DEV, V34, P271, DOI 10.1016/j.worlddev.2005.08.003; Ministere de la Sante et de la Population, RAPP 23 AVR 2012; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Trenton D, 2011, US TODAY NEWS   1109; US Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P309; World Health Organization, NUMB REP CHOL CAS GL	12	18	18	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2026	2028		10.1016/S0140-6736(12)60832-0	http://dx.doi.org/10.1016/S0140-6736(12)60832-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22656874				2022-12-28	WOS:000304759100008
J	Jordan, SP; Lee, KSM; Preskill, J				Jordan, Stephen P.; Lee, Keith S. M.; Preskill, John			Quantum Algorithms for Quantum Field Theories	SCIENCE			English	Article							MATRIX MULTIPLICATION; SCATTERING MATRIX; OPTICAL LATTICES; TRAPPED IONS; MODELS; SIMULATIONS; COMPUTER; SYSTEMS; PHYSICS; MASS	Quantum field theory reconciles quantum mechanics and special relativity, and plays a central role in many areas of physics. We developed a quantum algorithm to compute relativistic scattering probabilities in a massive quantum field theory with quartic self-interactions (phi(4) theory) in spacetime of four and fewer dimensions. Its run time is polynomial in the number of particles, their energy, and the desired precision, and applies at both weak and strong coupling. In the strong-coupling and high-precision regimes, our quantum algorithm achieves exponential speedup over the fastest known classical algorithm.	[Jordan, Stephen P.] NIST, Appl & Computat Math Div, Gaithersburg, MD 20899 USA; [Lee, Keith S. M.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh Particle Phys Astrophys & Cosmol Ctr, Pittsburgh, PA 15260 USA; [Preskill, John] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA	National Institute of Standards & Technology (NIST) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Institute of Technology	Jordan, SP (corresponding author), NIST, Appl & Computat Math Div, Gaithersburg, MD 20899 USA.	stephen.jordan@nist.gov	Puzyrev, Valery P/A-7925-2014; Puzyrev, Valery P/S-3144-2016; Stepanov, Vadim/G-4320-2013; Stepanov, Vadim A./N-7657-2014	Puzyrev, Valery P/0000-0002-2113-4556; Stepanov, Vadim/0000-0002-5166-331X; Jordan, Stephen/0000-0003-1035-1827	NSF [PHY-0803371, PHY-0854782]; U.S. Department of Energy [DE-FG03-92-ER40701]; NSA/Army Research Office [W911NF-09-1-0442]; Sherman Fairchild Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NSA/Army Research Office; Sherman Fairchild Foundation	We thank A. Gorshkov for helpful discussions. Supported by NSF grant PHY-0803371, U.S. Department of Energy grant DE-FG03-92-ER40701, and NSA/Army Research Office grant W911NF-09-1-0442. Much of this work was done while S.P.J. was at the Institute for Quantum Information (IQI), Caltech, supported by the Sherman Fairchild Foundation. K. S. M. L. was supported in part by NSF grant PHY-0854782. He is grateful for the hospitality of the IQI, Caltech, during parts of this work.	Abrams DS, 1997, PHYS REV LETT, V79, P2586, DOI 10.1103/PhysRevLett.79.2586; ARZT C, 1995, PHYS LETT B, V342, P189, DOI 10.1016/0370-2693(94)01419-D; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Bermudez A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190404; Berry DW, 2007, COMMUN MATH PHYS, V270, P359, DOI 10.1007/s00220-006-0150-x; Boada O, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/035002; Buchler HP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040402; BUNCH JR, 1974, MATH COMPUT, V28, P231, DOI 10.1090/S0025-5718-1974-0331751-8; Casanova J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.260501; Cirac JI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190403; CONSTANTINESCU F, 1977, ANN PHYS-NEW YORK, V108, P37, DOI 10.1016/0003-4916(77)90349-9; COPPERSMITH D, 1990, J SYMB COMPUT, V9, P251, DOI 10.1016/S0747-7171(08)80013-2; Doucot B, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214501; ECKMANN JP, 1976, ANN I H POINCARE A, V25, P1; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; GEORGI H, 1991, NUCL PHYS B, V361, P339, DOI 10.1016/0550-3213(91)90244-R; GLIMM J, 1974, PHYS REV D, V10, P536, DOI 10.1103/PhysRevD.10.536; GUERRA F, 1975, COMMUN MATH PHYS, V41, P19, DOI 10.1007/BF01608544; Johanning M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154009; Kapit E, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033625; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Lepori L, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/50003; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Maeda K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.085301; Maraner P, 2009, PHYS LETT A, V373, P2542, DOI 10.1016/j.physleta.2009.05.029; Mazza L, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/015007; MCBRYAN OA, 1976, COMMUN MATH PHYS, V51, P97, DOI 10.1007/BF01609341; Muller M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/085007; OSTERWALDER K, 1976, HELV PHYS ACTA, V49, P525; Peskin M., 1995, INTRO QUANTUM FIELD; Rapp A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160405; SUZUKI M, 1990, PHYS LETT A, V146, P319, DOI 10.1016/0375-9601(90)90962-N; Szirmai G, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.011611; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Zalka C, 1998, P ROY SOC A-MATH PHY, V454, P313, DOI 10.1098/rspa.1998.0162	38	231	232	8	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1130	1133		10.1126/science.1217069	http://dx.doi.org/10.1126/science.1217069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654052	Green Submitted, Green Accepted			2022-12-28	WOS:000304647900041
J	Hugall, AF; Stuart-Fox, D				Hugall, Andrew F.; Stuart-Fox, Devi			Accelerated speciation in colour-polymorphic birds	NATURE			English	Article							FREQUENCY-DEPENDENT SELECTION; SYMPATRIC SPECIATION; EXTINCTION RATES; SEXUAL SELECTION; EVOLUTION; CONSEQUENCES; MAINTENANCE; MECHANISMS; FISH	Colour polymorphism exemplifies extreme morphological diversity within populations(1,2). It is taxonomically widespread but generally rare. Theory suggests that where colour polymorphism does occur, processes generating and maintaining it can promote speciation but the generality of this claim is unclear(1). Here we confirm, using species-level molecular phylogenies for five families of non-passerine birds, that colour polymorphism is associated with accelerated speciation rates in the three groups in which polymorphism is most prevalent. In all five groups, colour polymorphism is lost at a significantly greater rate than it is gained. Thus, the general rarity and phylogenetic dispersion of colour polymorphism is accounted for by a combination of higher speciation rate and higher transition rate from polymorphism to monomorphism, consistent with theoretical models where speciation is driven by fixation of one or more morphs(3). This is corroborated by evidence from a species-level molecular phylogeny of passerines, incorporating 4,128 (66.5%) extant species, that polymorphic species tend to be younger than monomorphic species. Our results provide empirical support for the general proposition, dating from classical evolutionary theory(2,4-6), that colour polymorphism can increase speciation rates.	[Hugall, Andrew F.; Stuart-Fox, Devi] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia	University of Melbourne	Stuart-Fox, D (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	ahugall@museum.vic.gov.au; devis@unimelb.edu.au		Stuart-Fox, Devi/0000-0003-3362-1412	Australian Research Council [DP1092908]	Australian Research Council(Australian Research Council)	We thank M. Elgar, J. Endler, L. Joseph, A. Moussalli, A. Phillimore, S. Pryke and D. Rabosky for critical comments. This work was supported by the Australian Research Council (DP1092908).	CAIN AJ, 1954, GENETICS, V39, P89; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Coyne J.A., 2004, SPECIATION; Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Endler J.A., 1977, Monographs in Population Biology, pi; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; FORD E, 1964, ECOLOGICAL GENETICS; FORD EB, 1945, BIOL REV, V20, P73, DOI 10.1111/j.1469-185X.1945.tb00315.x; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Galeotti P, 2004, BIOL J LINN SOC, V82, P237, DOI 10.1111/j.1095-8312.2004.00355.x; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Huxley J., 1955, Int Orn Congr, V11, P309; Huxley J., 1963, EVOLUTION MODERN SYN, V2nd; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Otto SP, 2008, GENETICS, V179, P2091, DOI 10.1534/genetics.107.084418; Price T, 2008, SPECIATION BIRDS; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Seehausen O, 1999, ECOL LETT, V2, P367; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Sinervo B, 2006, ANNU REV ECOL EVOL S, V37, P581, DOI 10.1146/annurev.ecolsys.37.091305.110128; Van Gossum H, 2008, ANIM BIOL, V58, P257, DOI 10.1163/157075608X328099; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388	35	136	141	1	166	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					631	+		10.1038/nature11050	http://dx.doi.org/10.1038/nature11050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660325				2022-12-28	WOS:000304608000046
J	Song, KH; Nam, YJ; Luo, X; Qi, XX; Tan, W; Huang, GN; Acharya, A; Smith, CL; Tallquist, MD; Neilson, EG; Hill, JA; Bassel-Duby, R; Olson, EN				Song, Kunhua; Nam, Young-Jae; Luo, Xiang; Qi, Xiaoxia; Tan, Wei; Huang, Guo N.; Acharya, Asha; Smith, Christopher L.; Tallquist, Michelle D.; Neilson, Eric G.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			Heart repair by reprogramming non-myocytes with cardiac transcription factors	NATURE			English	Article							FIBROBLASTS; EXPRESSION; DISEASE; ADULT; CELLS; CARDIOMYOCYTES; GENERATION; REGULATOR; THERAPY; NEURONS	The adult mammalian heart possesses little regenerative potential following injury. Fibrosis due to activation of cardiac fibroblasts impedes cardiac regeneration and contributes to loss of contractile function, pathological remodelling and susceptibility to arrhythmias. Cardiac fibroblasts account for a majority of cells in the heart and represent a potential cellular source for restoration of cardiac function following injury through phenotypic reprogramming to a myocardial cell fate. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro. Forced expression of these factors in dividing non-cardiomyocytes in mice reprograms these cells into functional cardiac-like myocytes, improves cardiac function and reduces adverse ventricular remodelling following myocardial infarction. Our results suggest a strategy for cardiac repair through reprogramming fibroblasts resident in the heart with cardiogenic transcription factors or other molecules.	[Song, Kunhua; Nam, Young-Jae; Qi, Xiaoxia; Huang, Guo N.; Acharya, Asha; Smith, Christopher L.; Tallquist, Michelle D.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nam, Young-Jae; Luo, Xiang; Tan, Wei; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Tallquist, Michelle/AAU-5277-2021	Tallquist, Michelle/0000-0002-1383-144X; Huang, Guo/0000-0002-4335-9123	NIH; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation [I-0025]; Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research; American Heart Association-Jon Holden DeHaan Foundation; Cancer Prevention & Research Institute of Texas (CPRIT); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114738, R01HL053351, R01HL111665, R01HL061544, R01HL074257, R01HL083371, K08HL111420, P50HL061033, R37HL053351, R01HL077439, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research; American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); Cancer Prevention & Research Institute of Texas (CPRIT); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Cabrera for graphics. We are grateful to members of the Olson lab for critical reading of the manuscript. We thank D. Sosic, W. Tang, J. O'Rourke, N. Liu, M. Xin, A. Johnson and J. McAnally for discussions; J. Shelton and J. A. Richardson for histology. We are grateful to I. Bezprozvanny for the PTI Ca<SUP>2+</SUP> Imaging System, and D. Srivastava for lentiviral plasmids. We thank the microarray core at University of Texas Southwestern Medical Center for collecting gene expression data. E.N.O. is supported by grants from NIH, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Robert A. Welch Foundation (grant I-0025), the Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research Program, the American Heart Association-Jon Holden DeHaan Foundation and the Cancer Prevention & Research Institute of Texas (CPRIT).	Acharya A, 2011, GENESIS, V49, P870, DOI 10.1002/dvg.20750; Beyer E C, 1993, Int Rev Cytol, V137C, P1; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Byun JH, 2000, J GENE MED, V2, P2; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy Matthew E. L., 2009, Journal of Pharmacological and Toxicological Methods, V60, P94, DOI 10.1016/j.vascn.2009.03.005; Hoover-Plow J, 2012, VASC HEALTH RISK MAN, V8, P99, DOI 10.2147/VHRM.S25665; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perin E. C., 2012, J AM MED ASS; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yacoub Magdi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS133, DOI 10.1038/ncpcardio0401; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zang MX, 2004, J BIOL CHEM, V279, P54258, DOI 10.1074/jbc.M408502200; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	798	844	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					599	+		10.1038/nature11139	http://dx.doi.org/10.1038/nature11139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660318	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000304608000039
J	van Hagen, P; Hulshof, MCCM; van Lanschot, JJB; Steyerberg, EW; Henegouwen, MIV; Wijnhoven, BPL; Richel, DJ; Nieuwenhuijzen, GAP; Hospers, GAP; Bonenkamp, JJ; Cuesta, MA; Blaisse, RJB; Busch, ORC; ten Kate, FJW; Creemers, GJ; Punt, CJA; Plukker, JTM; Verheul, HMW; Bilgen, EJS; van Dekken, H; van der Sangen, MJC; Rozema, T; Biermann, K; Beukema, JC; Piet, AHM; van Rij, CM; Reinders, JG; Tilanus, HW; van der Gaast, A				van Hagen, P.; Hulshof, M. C. C. M.; van Lanschot, J. J. B.; Steyerberg, E. W.; Henegouwen, M. I. van Berge; Wijnhoven, B. P. L.; Richel, D. J.; Nieuwenhuijzen, G. A. P.; Hospers, G. A. P.; Bonenkamp, J. J.; Cuesta, M. A.; Blaisse, R. J. B.; Busch, O. R. C.; ten Kate, F. J. W.; Creemers, G. -J.; Punt, C. J. A.; Plukker, J. T. M.; Verheul, H. M. W.; Bilgen, E. J. Spillenaar; van Dekken, H.; van der Sangen, M. J. C.; Rozema, T.; Biermann, K.; Beukema, J. C.; Piet, A. H. M.; van Rij, C. M.; Reinders, J. G.; Tilanus, H. W.; van der Gaast, A.		Cross Grp	Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; PERIOPERATIVE CHEMOTHERAPY; WEEKLY PACLITAXEL; SURGERY; CARCINOMA; CHEMORADIATION; ADENOCARCINOMA; RADIOTHERAPY; CISPLATIN; SURVIVAL	BACKGROUND The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population. METHODS We randomly assigned patients with resectable tumors to receive surgery alone or weekly administration of carboplatin (doses titrated to achieve an area under the curve of 2 mg per milliliter per minute) and paclitaxel (50 mg per square meter of body-surface area) for 5 weeks and concurrent radiotherapy (41.4 Gy in 23 fractions, 5 days per week), followed by surgery. RESULTS From March 2004 through December 2008, we enrolled 368 patients, 366 of whom were included in the analysis: 275 (75%) had adenocarcinoma, 84 (23%) had squamous-cell carcinoma, and 7 (2%) had large-cell undifferentiated carcinoma. Of the 366 patients, 178 were randomly assigned to chemoradiotherapy followed by surgery, and 188 to surgery alone. The most common major hematologic toxic effects in the chemoradiotherapy-surgery group were leukopenia (6%) and neutropenia (2%); the most common major nonhematologic toxic effects were anorexia (5%) and fatigue (3%). Complete resection with no tumor within 1 mm of the resection margins (R0) was achieved in 92% of patients in the chemoradiotherapy-surgery group versus 69% in the surgery group (P<0.001). A pathological complete response was achieved in 47 of 161 patients (29%) who underwent resection after chemoradiotherapy. Postoperative complications were similar in the two treatment groups, and in-hospital mortality was 4% in both. Median overall survival was 49.4 months in the chemoradiotherapy-surgery group versus 24.0 months in the surgery group. Overall survival was significantly better in the chemoradiotherapy-surgery group (hazard ratio, 0.657; 95% confidence interval, 0.495 to 0.871; P = 0.003). CONCLUSIONS Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation [KWF Kankerbestrijding]; Netherlands Trial Register number, NTR487.)	[van der Gaast, A.] Erasmus Univ, Med Ctr, Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [van Hagen, P.; van Lanschot, J. J. B.; Wijnhoven, B. P. L.; Tilanus, H. W.] Erasmus Univ, Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands; [Steyerberg, E. W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [ten Kate, F. J. W.; van Dekken, H.; Biermann, K.] Erasmus Univ, Med Ctr, Dept Pathol, NL-3000 CA Rotterdam, Netherlands; [van Rij, C. M.] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands; [Hulshof, M. C. C. M.] Univ Amsterdam, Acad Med Ctr, Dept Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Lanschot, J. J. B.; Henegouwen, M. I. van Berge; Busch, O. R. C.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Richel, D. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [ten Kate, F. J. W.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Cuesta, M. A.] VU Med Ctr Amsterdam, Dept Surg, Amsterdam, Netherlands; [Verheul, H. M. W.] VU Med Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands; [Piet, A. H. M.] VU Med Ctr Amsterdam, Dept Radiat Oncol, Amsterdam, Netherlands; [van Dekken, H.] St Lucas Andreas Hosp Amsterdam, Dept Pathol, Amsterdam, Netherlands; [Nieuwenhuijzen, G. A. P.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Creemers, G. -J.] Catharina Hosp, Dept Med Oncol, Eindhoven, Netherlands; [van der Sangen, M. J. C.] Catharina Hosp, Dept Radiat Oncol, Eindhoven, Netherlands; [Hospers, G. A. P.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, NL-9713 AV Groningen, Netherlands; [Plukker, J. T. M.] Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [Beukema, J. C.] Univ Med Ctr Groningen, Dept Radiat Oncol, NL-9713 AV Groningen, Netherlands; [Bonenkamp, J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Punt, C. J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [Rozema, T.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands; [Blaisse, R. J. B.] Rijnstate Hosp Arnhem, Dept Med Oncol, Arnhem, Netherlands; [Bilgen, E. J. Spillenaar] Rijnstate Hosp Arnhem, Dept Surg, Arnhem, Netherlands; [Reinders, J. G.] Arnhem Radiotherapeut Inst, Arnhem, Netherlands; [Rozema, T.] Verbeeten Inst Tilburg, Tilburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sint Lucas Andreas Hospital; Catharina Hospital; Catharina Hospital; Catharina Hospital; University of Groningen; University of Groningen; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rijnstate Hospital; Rijnstate Hospital; Instituut Verbeeten	van der Gaast, A (corresponding author), Erasmus Univ, Med Ctr, Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, POB 2040f, NL-3000 CA Rotterdam, Netherlands.	a.vandergaast@erasmusmc.nl	koning, caro/A-5339-2008; Verheul, Henk/V-6462-2019; van Krieken, Joannes H J M/D-4138-2009; Busch, Olivier/AAC-3650-2020; Bonenkamp, J.J./L-4213-2015; Bergman, Jacques/AAS-2500-2021; Wijnhoven, Bas/AAF-4838-2020; Verheul, Henk M.W./J-9775-2013; Steyerberg, Ewout/C-1509-2018	Verheul, Henk/0000-0001-5981-922X; van Krieken, Joannes H J M/0000-0001-6544-1040; Steyerberg, Ewout/0000-0002-7787-0122; Hospers, Geke/0000-0002-3047-7892; beukema, jannet/0000-0002-1648-6813; van der Sangen, Maurice/0000-0003-1866-7367; Hulshof, Maarten CCM/0000-0001-5240-3467; Nieuwenhuijzen, Grard/0000-0002-5837-5513; van Berge Henegouwen, Mark/0000-0001-8689-3134	Dutch Cancer Foundation (KWF Kankerbestrijding)	Dutch Cancer Foundation (KWF Kankerbestrijding)	Supported by the Dutch Cancer Foundation (KWF Kankerbestrijding).	Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Chirieac LR, 2005, CANCER-AM CANCER SOC, V103, P1347, DOI 10.1002/cncr.20916; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; Gannett David E, 2007, Gastrointest Cancer Res, V1, P132; International Union Against Cancer, 2002, TNM CLASS MAL TUM; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Lee JL, 2004, ANN ONCOL, V15, P947, DOI 10.1093/annonc/mdh219; Lin CC, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdl339; MALTHANER R, 2001, COCHRANE DB SYST REV, V1; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Urba SG, 2001, J CLIN ONCOL, V19, P305, DOI 10.1200/JCO.2001.19.2.305; van Heijl M, 2008, BMC Surg, V8, P21, DOI 10.1186/1471-2482-8-21; van Meerten E, 2006, BRIT J CANCER, V94, P1389, DOI 10.1038/sj.bjc.6603134; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Walsh TN, 1999, NEW ENGL J MED, V341, P384; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	25	3321	3338	6	168	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2074	2084		10.1056/NEJMoa1112088	http://dx.doi.org/10.1056/NEJMoa1112088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646630	Green Published			2022-12-28	WOS:000304613400007
J	Vize, R				Vize, Richard			Integrated care: a story of hard won success	BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	14	14	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 31	2012	344								e3529	10.1136/bmj.e3529	http://dx.doi.org/10.1136/bmj.e3529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HG	22654064				2022-12-28	WOS:000304857000005
J	Moore, W				Moore, Wendy			A doctor's lifelong campaign to revive the Olympic games	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Cromarty HC, 1809, OXFORD DICT NATL BIO; Furbank M, 2007, WP BROOKES OLYMPIC C	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3691	10.1136/bmj.e3691	http://dx.doi.org/10.1136/bmj.e3691			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645211				2022-12-28	WOS:000304855700016
J	Bowerman, B; O'Rourke, SM				Bowerman, Bruce; O'Rourke, Sean M.			Pushing Your Back into Place	SCIENCE			English	Editorial Material							DROSOPHILA OOCYTE; POLARITY; PATTERN; DYNEIN		[Bowerman, Bruce; O'Rourke, Sean M.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Bowerman, B (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bbowerman@molbio.uoregon.edu			NIGMS NIH HHS [R01 GM049869] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Roth S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001891; Steinhauer J, 2006, DEV DYNAM, V235, P1455, DOI 10.1002/dvdy.20770; STJOHNSTON D, 1992, CELL, V68, P201; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147	9	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					984	985		10.1126/science.1223141	http://dx.doi.org/10.1126/science.1223141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628639	Green Accepted			2022-12-28	WOS:000304406800026
J	Wheeler, DG; Groth, RD; Ma, H; Barrett, CF; Owen, SF; Safa, P; Tsien, RW				Wheeler, Damian G.; Groth, Rachel D.; Ma, Huan; Barrett, Curtis F.; Owen, Scott F.; Safa, Parsa; Tsien, Richard W.			Ca(v)1 and Ca(v)2 Channels Engage Distinct Modes of Ca2+ Signaling to Control CREB-Dependent Gene Expression	CELL			English	Article							BULLFROG SYMPATHETIC NEURONS; SENSITIVE CALCIUM-CHANNELS; PROTEIN-KINASE-II; NUCLEAR; DEPOLARIZATION; PHOSPHORYLATION; TRANSCRIPTION; MITOCHONDRIA; STIMULATION; MODULATION	Activity-dependent gene expression triggered by Ca2+ entry into neurons is critical for learning and memory, but whether specific sources of Ca2+ act distinctly or merely supply Ca2+ to a common pool remains uncertain. Here, we report that both signaling modes coexist and pertain to Ca(v)1 and Ca(v)2 channels, respectively, coupling membrane depolarization to CREB phosphorylation and gene expression. Ca(v)1 channels are advantaged in their voltage-dependent gating and use nanodomain Ca2+ to drive local CaMKII aggregation and trigger communication with the nucleus. In contrast, Ca(v)2 channels must elevate [Ca2+](i) microns away and promote CaMKII aggregation at Ca(v)1 channels. Consequently, Ca(v)2 channels are similar to 10-fold less effective in signaling to the nucleus than are Ca(v)1 channels for the same bulk [Ca2+](i) increase. Further-more, Ca(v)2-mediated Ca2+ rises are preferentially curbed by uptake into the endoplasmic reticulum and mitochondria. This source-biased buffering limits the spatial spread of Ca2+, further attenuating Ca(v)2-mediated gene expression.	[Wheeler, Damian G.; Groth, Rachel D.; Ma, Huan; Barrett, Curtis F.; Owen, Scott F.; Safa, Parsa; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ma, Huan; Tsien, Richard W.] NYU Langone Med Ctr, NYU Neurosci Inst, New York, NY 10016 USA	Stanford University; NYU Langone Medical Center	Ma, H (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	huan.ma@nyumc.org; richard.tsien@nyumc.org	Ma, Huan/A-1379-2012	Owen, Scott/0000-0001-6294-7513	NIGMS; NINDS; Mathers Foundation; Burnett Family Foundation; NIMH [F31MH084430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH084430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mathers Foundation; Burnett Family Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rich Lewis, David Friel, Michael Tadross, Damon Poburko, Yulong Li, Hyokeun Park, Haruhiko Bito, S. Brian Andrews, Paul De Koninck, and George Miljanich for helpful discussions and Atsushi Miyawaki for PericamMT. This work was supported by research grants to R.W.T. from NIGMS, NINDS, and the Mathers Foundation. S.F.O. is supported by the Burnett Family Foundation and an NRSA from the NIMH (F31MH084430).	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; Alonso MT, 2009, ACTA PHYSIOL, V195, P37, DOI 10.1111/j.1748-1716.2008.01920.x; Babcock DF, 1998, CURR OPIN NEUROBIOL, V8, P398, DOI 10.1016/S0959-4388(98)80067-6; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colegrove SL, 2000, J GEN PHYSIOL, V115, P371, DOI 10.1085/jgp.115.3.371; Colegrove SL, 2000, J GEN PHYSIOL, V115, P351, DOI 10.1085/jgp.115.3.351; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Friel DD, 2000, CELL CALCIUM, V28, P307, DOI 10.1054/ceca.2000.0172; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Liu Z, 2003, J PHYSIOL-LONDON, V553, P473, DOI 10.1113/jphysiol.2003.051110; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McDonough SI, 2000, J NEUROSCI, V20, P9059; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Twede VD, 2009, IDRUGS, V12, P231; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Weick JP, 2003, J NEUROSCI, V23, P3446; Wheeler DG, 2006, NEUROPHARMACOLOGY, V51, P27, DOI 10.1016/j.neuropharm.2006.02.010; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; Yenari MA, 1996, BRAIN RES, V739, P36, DOI 10.1016/S0006-8993(96)00808-6	66	188	192	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1112	1124		10.1016/j.cell.2012.03.041	http://dx.doi.org/10.1016/j.cell.2012.03.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632974	Green Accepted, Bronze			2022-12-28	WOS:000304453900016
J	Winklhofer, M				Winklhofer, Michael			An Avian Magnetometer	SCIENCE			English	Editorial Material							TRIGEMINAL MEDIATION; MIGRATORY BIRD; MAGNETORECEPTION; INFORMATION		Univ Munich, Dept Earth & Environm Sci, Munich, Germany	University of Munich	Winklhofer, M (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	michael@geophysik.uni-muenchen.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723				Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Gagliardo A, 2009, J EXP BIOL, V212, P3119, DOI 10.1242/jeb.031864; Harada Y, 2008, ACTA OTO-LARYNGOL, V128, P432, DOI 10.1080/00016480701724920; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wiltschko R., 1995, TIEROSYCHOL; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	15	11	11	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					991	992		10.1126/science.1223786	http://dx.doi.org/10.1126/science.1223786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628645				2022-12-28	WOS:000304406800032
J	Blumberg, JM				Blumberg, Jeremy M.			Considering Life Before Lifestyle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Kidney Transplant Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blumberg, JM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Kidney Transplant Program, Los Angeles, CA 90095 USA.	jblumberg@mednet.ucla.edu						[Anonymous], 2012, WAG STAT 2010 SOC SE; Medical student debt. American Medical Association, 2011, MED STUD DEBT	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2159	2160		10.1001/jama.2012.4522	http://dx.doi.org/10.1001/jama.2012.4522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618922				2022-12-28	WOS:000304315200024
J	Jenq, G; Tinetti, ME				Jenq, Grace; Tinetti, Mary E.			The Journey Across the Health Care (Dis)Continuum for Vulnerable Patients Policies, Pitfalls, and Possibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jenq, Grace; Tinetti, Mary E.] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA	Yale University	Tinetti, ME (corresponding author), Yale Univ, Dept Internal Med, Sch Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu						Berkowitz RE, 2011, J AM GERIATR SOC, V59, P1130, DOI 10.1111/j.1532-5415.2011.03417.x; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Centers for Medicare & Medicaid Services, HOSP QUAL IN; Goodman DC, HOSPITALIZATION DART; Hartocollis A, 2012, NY TIMES, pA1; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; (MedPAC) MPAC, 2012, REP C MED PAYM POL M; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015	8	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2157	2158		10.1001/jama.2012.5566	http://dx.doi.org/10.1001/jama.2012.5566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945YX	22618921				2022-12-28	WOS:000304315200023
J	Marin, JM; Agusti, A; Villar, I; Forner, M; Nieto, D; Carrizo, SJ; Barbe, F; Vicente, E; Wei, Y; Nieto, FJ; Jelic, S				Marin, Jose M.; Agusti, Alvar; Villar, Isabel; Forner, Marta; Nieto, David; Carrizo, Santiago J.; Barbe, Ferran; Vicente, Eugenio; Wei, Ying; Nieto, F. Javier; Jelic, Sanja			Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; MULTIPLE IMPUTATION; ADHERENCE; REGRESSION; COMMITTEE; THERAPY; STROKE; MEN	Context Systemic hypertension is prevalent among patients with obstructive sleep apnea (OSA). Short-term studies indicate that continuous positive airway pressure (CPAP) therapy reduces blood pressure in patients with hypertension and OSA. Objective To determine whether CPAP therapy is associated with a lower risk of incident hypertension. Design, Setting, and Participants A prospective cohort study of 1889 participants without hypertension who were referred to a sleep center in Zaragoza, Spain, for nocturnal polysomnography between January 1, 1994, and December 31, 2000. Incident hypertension was documented at annual follow-up visits up to January 1, 2011. Multivariable models adjusted for confounding factors, including change in body mass index from baseline to censored time, were used to calculate hazard ratios (HRs) of incident hypertension in participants without OSA (controls), with untreated OSA, and in those treated with CPAP therapy according to national guidelines. Main Outcome Measure Incidence of new-onset hypertension. Results During 21 003 person-years of follow-up (median, 12.2 years), 705 cases (37.3%) of incident hypertension were observed. The crude incidence of hypertension per 100 person-years was 2.19 (95% CI, 1.71-2.67) in controls, 3.34 (95% CI, 2.85-3.82) in patients with OSA ineligible for CPAP therapy, 5.84 (95% CI, 4.82-6.86) in patients with OSA who declined CPAP therapy, 5.12 (95% CI, 3.76-6.47) in patients with OSA nonadherent to CPAP therapy, and 3.06 (95% CI, 2.70-3.41) in patients with OSA and treated with CPAP therapy. Compared with controls, the adjusted HRs for incident hypertension were greater among patients with OSA ineligible for CPAP therapy (1.33; 95% CI, 1.01-1.75), among those who declined CPAP therapy (1.96; 95% CI, 1.44-2.66), and among those nonadherent to CPAP therapy (1.78; 95% CI, 1.23-2.58), whereas the HR was lower in patients with OSA who were treated with CPAP therapy (0.71; 95% CI, 0.53-0.94). Conclusion Compared with participants without OSA, the presence of OSA was associated with increased adjusted risk of incident hypertension; however, treatment with CPAP therapy was associated with a lower risk of hypertension. JAMA. 2012;307(20):2169-2176	[Marin, Jose M.; Nieto, David; Carrizo, Santiago J.; Vicente, Eugenio] Hosp Univ Miguel Servet, Resp Dept, Zaragoza 50006, Spain; [Marin, Jose M.; Villar, Isabel; Forner, Marta] Aragon Inst Hlth Sci, Zaragoza, Spain; [Agusti, Alvar] Hosp Clin Barcelona, Inst Invest Biomed Pi Sunyer, Thorax Inst, Barcelona, Spain; [Wei, Ying; Jelic, Sanja] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Barbe, Ferran] Hosp Arnau Vilanova, Lleida, Spain; [Marin, Jose M.; Agusti, Alvar; Barbe, Ferran] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Nieto, F. Javier] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Miguel Servet University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Columbia University; University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Wisconsin System; University of Wisconsin Madison	Marin, JM (corresponding author), Hosp Univ Miguel Servet, Resp Dept, Avda Isabel Catolica,1-3, Zaragoza 50006, Spain.	jmmarint@unizar.es	CARRIZO SIERRA, SANTIAGO/AAO-1780-2021; Barbé, Ferran/A-5988-2010; Garcia-Navarro, Alvar Agusti/F-4474-2015; Lavu, Madhav/A-9409-2013	Barbé, Ferran/0000-0002-2340-8928; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Marin Trigo, Jose Maria/0000-0001-9096-2294	National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL106041-01A1]; Instituto Carlos III, Ministry of Health, Madrid, Spain [FISS PI04/1684, FISS PS09/02449]; Spanish Society of Respiratory Medicine [SEPAR/2007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106041] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Instituto Carlos III, Ministry of Health, Madrid, Spain; Spanish Society of Respiratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jelic reported receiving grants/pending grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (1R01HL106041-01A1). No other authors reported any financial disclosures.; This work was supported by grants FISS PI04/1684 and FISS PS09/02449 from the Instituto Carlos III, Ministry of Health, Madrid, Spain, and SEPAR/2007 from the Spanish Society of Respiratory Medicine.	Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; HLA KM, 1994, ANN INTERN MED, V120, P382, DOI 10.7326/0003-4819-120-5-199403010-00005; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; Jelic S, 2010, CIRCULATION, V121, P1014, DOI 10.1161/CIRCULATIONAHA.109.900357; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kales A, 1968, MANUAL STANDARDIZED; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; LaFleur J, 2011, HEART, V97, P1862, DOI 10.1136/hrt.2011.223289; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Montserrat J M, 1998, Arch Bronconeumol, V34, P204; Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Pan W, 2000, BIOMETRICS, V56, P199, DOI 10.1111/j.0006-341X.2000.00199.x; Markus MRP, 2010, J AM COLL CARDIOL, V56, P65, DOI 10.1016/j.jacc.2010.01.056; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Platt AB, 2010, CHEST, V137, P102, DOI 10.1378/chest.09-0842; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; SCHOENFELD D, 1981, BIOMETRIKA, V68, P316, DOI 10.1093/biomet/68.1.316; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Villar I, 2009, SLEEP, V32, P623, DOI 10.1093/sleep/32.5.623; WEI GCG, 1991, BIOMETRICS, V47, P1297, DOI 10.2307/2532387; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young T, 2008, SLEEP, V31, P1071	32	478	499	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2169	2176		10.1001/jama.2012.3418	http://dx.doi.org/10.1001/jama.2012.3418			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618924	Bronze, Green Accepted			2022-12-28	WOS:000304315200026
J	Bhutta, ZA; Reddy, KS				Bhutta, Zulfiqar A.; Reddy, K. Srinath			Achieving Equity in Global Health So Near and Yet So Far	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COUNTDOWN; NEWBORN		[Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	Aga Khan University; Public Health Foundation of India	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Stadium Rd, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; De Ferranti D, UNIVERSAL HLTH COVER; Food and Agriculture Organization of the United Nations, STAT FOOD INS WORLD; Global Alliance for Vaccines Initiative (GAVI), GAVI FACTS FIG; Marrero SL, 2012, JAMA-J AM MED ASSOC, V307, P2037, DOI 10.1001/jama.2012.3546; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; The Global Fund to fights AIDS TB and Malaria, 10 YEARS IMP	9	17	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2035	2036		10.1001/jama.2012.4659	http://dx.doi.org/10.1001/jama.2012.4659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665100				2022-12-28	WOS:000304048200020
J	Leys, D; Cordonnier, C				Leys, Didier; Cordonnier, Charlotte			rt-PA for ischaemic stroke: what will the next question be?	LANCET			English	Editorial Material							POOLED ANALYSIS; THROMBOLYSIS; RISK; ALTEPLASE; AGE		[Leys, Didier; Cordonnier, Charlotte] Roger Salengro Hosp, Stroke Unit, Dept Neurol, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Leys, D (corresponding author), Roger Salengro Hosp, Stroke Unit, Dept Neurol, F-59037 Lille, France.	didier.leys@chru-lille.fr	LEYS, Didier/G-2955-2016; Cordonnier, Charlotte/O-3258-2017	LEYS, Didier/0000-0003-4408-4392; Cordonnier, Charlotte/0000-0002-5697-6892				Alshekhlee A, 2011, NEUROLOGY, V76, P1575, DOI 10.1212/WNL.0b013e3182190d37; Busl KM, 2013, J STROKE CEREBROVASC, V22, P718, DOI 10.1016/j.jstrokecerebrovasdis.2011.11.005; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Fiehler J, 2007, STROKE, V38, P2738, DOI 10.1161/STROKEAHA.106.480848; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2010, STROKE, V41, P1450, DOI 10.1161/STROKEAHA.109.576140; Mishra NK, 2010, STROKE, V41, P2840, DOI 10.1161/STROKEAHA.110.586206; Neumann-Haefelin T, 2006, STROKE, V37, P2463, DOI 10.1161/01.STR.0000239321.53203.ea; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Teter B, 2002, J NEUROSCI RES, V70, P402, DOI 10.1002/jnr.10441; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7	17	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2320	2321		10.1016/S0140-6736(12)60822-8	http://dx.doi.org/10.1016/S0140-6736(12)60822-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961ZV	22632906				2022-12-28	WOS:000305509600007
J	Arrigo, KR; Perovich, DK; Pickart, RS; Brown, ZW; van Dijken, GL; Lowry, KE; Mills, MM; Palmer, MA; Balch, WM; Bahr, F; Bates, NR; Benitez-Nelson, C; Bowler, B; Brownlee, E; Ehn, JK; Frey, KE; Garley, R; Laney, SR; Lubelczyk, L; Mathis, J; Matsuoka, A; Mitchell, BG; Moore, GWK; Ortega-Retuerta, E; Pal, S; Polashenski, CM; Reynolds, RA; Schieber, B; Sosik, HM; Stephens, M; Swift, JH				Arrigo, Kevin R.; Perovich, Donald K.; Pickart, Robert S.; Brown, Zachary W.; van Dijken, Gert L.; Lowry, Kate E.; Mills, Matthew M.; Palmer, Molly A.; Balch, William M.; Bahr, Frank; Bates, Nicholas R.; Benitez-Nelson, Claudia; Bowler, Bruce; Brownlee, Emily; Ehn, Jens K.; Frey, Karen E.; Garley, Rebecca; Laney, Samuel R.; Lubelczyk, Laura; Mathis, Jeremy; Matsuoka, Atsushi; Mitchell, B. Greg; Moore, G. W. K.; Ortega-Retuerta, Eva; Pal, Sharmila; Polashenski, Chris M.; Reynolds, Rick A.; Schieber, Brian; Sosik, Heidi M.; Stephens, Michael; Swift, James H.			Massive Phytoplankton Blooms Under Arctic Sea Ice	SCIENCE			English	Article									[Arrigo, Kevin R.; Brown, Zachary W.; van Dijken, Gert L.; Lowry, Kate E.; Mills, Matthew M.; Palmer, Molly A.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Perovich, Donald K.; Polashenski, Chris M.] Engn Res & Dev Ctr, Cold Regions Res & Engn Lab, Hanover, NH 03755 USA; [Perovich, Donald K.] Thayer Sch Engn, Dartmouth Coll, Hanover, NH 03755 USA; [Pickart, Robert S.; Bahr, Frank] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA; [Balch, William M.; Bowler, Bruce; Lubelczyk, Laura] Bigelow Lab Ocean Sci, West Boothbay Harbor, ME 04575 USA; [Bates, Nicholas R.; Garley, Rebecca] Bermuda Inst Ocean Sci, Ferry Reach, Bermuda; [Benitez-Nelson, Claudia; Pal, Sharmila] Univ South Carolina, Marine Sci Program, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Brownlee, Emily; Laney, Samuel R.; Sosik, Heidi M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Ehn, Jens K.; Mitchell, B. Greg; Reynolds, Rick A.; Schieber, Brian; Swift, James H.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Frey, Karen E.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Mathis, Jeremy] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Matsuoka, Atsushi] Univ Paris 06, Lab Oceanograph Villefranche, F-06238 Villefranche sur Mer, France; [Moore, G. W. K.] Univ Toronto, Dept Phys, Toronto, ON M5S IA7, Canada; [Ortega-Retuerta, Eva] Univ Paris 06, Lab Oceanog Microbienne, Observ Oceanol, CNRS, F-66650 Banyuls Sur Mer, France; [Stephens, Michael] Colby Coll, Waterville, ME 04901 USA	Stanford University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); Dartmouth College; Woods Hole Oceanographic Institution; Bigelow Laboratory for Ocean Sciences; Bermuda Institute of Ocean Sciences; University of South Carolina System; University of South Carolina Columbia; Woods Hole Oceanographic Institution; University of California System; University of California San Diego; Scripps Institution of Oceanography; Clark University; University of Alaska System; University of Alaska Fairbanks; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Colby College	Arrigo, KR (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	arrigo@stanford.edu	Van Dijken, Gert/C-5276-2011; Moore, Kent/D-8518-2011; Lowry, Kate E/J-9449-2019; Reynolds, Rick A/C-7470-2014; Ortega-Retuerta, Eva/I-2432-2015	Moore, Kent/0000-0002-3986-5605; Lowry, Kate E/0000-0002-1604-5428; Reynolds, Rick A/0000-0002-1579-3600; Ortega-Retuerta, Eva/0000-0003-0780-8347; Arrigo, Kevin/0000-0002-7364-876X; Mitchell, B. Greg/0000-0002-8550-4333; Sosik, Heidi/0000-0002-4591-2842; Benitez-Nelson, Claudia/0000-0002-1004-5048	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank the crew of the U.S. Coast Guard Cutter Healy for their dedication. This research was supported by the Ocean Biology and Biogeochemistry and the Cryospheric Sciences programs of NASA. Data deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.4dn793t6. R. J. Olson and H.M.S. have U.S. Patent Application 20090109432.	Arrigo KR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007151; Fortier M, 2002, MAR ECOL PROG SER, V225, P1, DOI 10.3354/meps225001; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Strass VH, 1996, POLAR BIOL, V16, P409; Zhang JL, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005387	5	499	523	6	365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1408	1408		10.1126/science.1215065	http://dx.doi.org/10.1126/science.1215065			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22678359				2022-12-28	WOS:000305211700035
J	Sekulic, A; Migden, MR; Oro, AE; Dirix, L; Lewis, KD; Hainsworth, JD; Solomon, JA; Yoo, S; Arron, ST; Friedlander, PA; Marmur, E; Rudin, CM; Chang, ALS; Low, JA; Mackey, HM; Yauch, RL; Graham, RA; Reddy, JC; Hauschild, A				Sekulic, Aleksandar; Migden, Michael R.; Oro, Anthony E.; Dirix, Luc; Lewis, Karl D.; Hainsworth, John D.; Solomon, James A.; Yoo, Simon; Arron, Sarah T.; Friedlander, Philip A.; Marmur, Ellen; Rudin, Charles M.; Chang, Anne Lynn S.; Low, Jennifer A.; Mackey, Howard M.; Yauch, Robert L.; Graham, Richard A.; Reddy, Josina C.; Hauschild, Axel			Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SONIC-HEDGEHOG	BACKGROUND Alterations in hedgehog signaling are implicated in the pathogenesis of basal-cell carcinoma. Although most basal-cell carcinomas are treated surgically, no effective therapy exists for locally advanced or metastatic basal-cell carcinoma. A phase 1 study of vismodegib (GDC-0449), a first-in-class, small-molecule inhibitor of the hedgehog pathway, showed a 58% response rate among patients with advanced basal-cell carcinoma. METHODS In this multicenter, international, two-cohort, nonrandomized study, we enrolled patients with metastatic basal-cell carcinoma and those with locally advanced basal-cell carcinoma who had inoperable disease or for whom surgery was inappropriate (because of multiple recurrences and a low likelihood of surgical cure, or substantial anticipated disfigurement). All patients received 150 mg of oral vismodegib daily. The primary end point was the independently assessed objective response rate; the primary hypotheses were that the response rate would be greater than 20% for patients with locally advanced basal-cell carcinoma and greater than 10% for those with metastatic basal-cell carcinoma. RESULTS In 33 patients with metastatic basal-cell carcinoma, the independently assessed response rate was 30% (95% confidence interval [CI], 16 to 48; P=0.001). In 63 patients with locally advanced basal-cell carcinoma, the independently assessed response rate was 43% (95% CI, 31 to 56; P<0.001), with complete responses in 13 patients (21%). The median duration of response was 7.6 months in both cohorts. Adverse events occurring in more than 30% of patients were muscle spasms, alopecia, dysgeusia (taste disturbance), weight loss, and fatigue. Serious adverse events were reported in 25% of patients; seven deaths due to adverse events were noted. CONCLUSIONS Vismodegib is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma. (Funded by Genentech; Erivance BCC ClinicalTrials.gov number, NCT00833417.)	[Sekulic, Aleksandar] Mayo Clin, Scottsdale, AZ 85259 USA; [Migden, Michael R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Oro, Anthony E.; Chang, Anne Lynn S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Dirix, Luc] Sint Augustinus Hosp, Antwerp, Belgium; [Lewis, Karl D.] Univ Colorado, Ctr Canc, Denver, CO 80262 USA; [Hainsworth, John D.] Sarah Cannon Res Inst, Nashville, TN USA; [Solomon, James A.] Ameriderm Res, Ormond Beach, FL USA; [Yoo, Simon] Northwestern Univ, Chicago, IL 60611 USA; [Arron, Sarah T.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Friedlander, Philip A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Friedlander, Philip A.; Marmur, Ellen] Mt Sinai Med Ctr, New York, NY 10029 USA; [Rudin, Charles M.] Johns Hopkins Univ, Baltimore, MD USA; [Low, Jennifer A.; Mackey, Howard M.; Yauch, Robert L.; Graham, Richard A.; Reddy, Josina C.] Genentech Inc, San Francisco, CA 94080 USA; [Hauschild, Axel] Univ Klinikum Schleswig Holstein, Kiel, Germany	Mayo Clinic; Mayo Clinic Phoenix; University of Texas System; UTMD Anderson Cancer Center; Stanford University; University of Colorado System; University of Colorado Denver; Sarah Cannon Research Institute; Northwestern University; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Roche Holding; Genentech; University of Kiel; Schleswig Holstein University Hospital	Sekulic, A (corresponding author), Mayo Clin, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	sekulic.aleksandar@mayo.edu	Solomon, James/N-2560-2019; Rudin, Charles/R-2530-2019; Dirix, Luc/AAI-8880-2020	Rudin, Charles/0000-0001-5204-3465; Arron, Sarah/0000-0001-5669-0627; Oro, Anthony/0000-0002-6261-138X	Genentech; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Genentech.	Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Bonifas JM, 2001, J INVEST DERMATOL, V116, P739, DOI 10.1046/j.1523-1747.2001.01315.x; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Graham RA, 2011, CLIN CANCER RES, V17, P2512, DOI 10.1158/1078-0432.CCR-10-2736; Hall JMH, 2003, DEV BIOL, V255, P263, DOI 10.1016/S0012-1606(02)00048-9; Liu HX, 2004, DEV BIOL, V276, P280, DOI 10.1016/j.ydbio.2004.07.042; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360	14	902	936	2	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2171	2179						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670903	Green Accepted, Bronze			2022-12-28	WOS:000304863400006
J	Uniacke, J; Holterman, CE; Lachance, G; Franovic, A; Jacob, MD; Fabian, MR; Payette, J; Holcik, M; Pause, A; Lee, S				Uniacke, James; Holterman, Chet E.; Lachance, Gabriel; Franovic, Aleksandra; Jacob, Mathieu D.; Fabian, Marc R.; Payette, Josianne; Holcik, Martin; Pause, Arnim; Lee, Stephen			An oxygen-regulated switch in the protein synthesis machinery	NATURE			English	Article							MESSENGER-RNA TRANSLATION; BINDING PROTEIN; HIF-ALPHA; HYPOXIA; CANCER; MECHANISMS; STRESS; GROWTH; HYDROXYLATION; EXPRESSION	Protein synthesis involves the translation of ribonucleic acid information into proteins, the building blocks of life. The initial step of protein synthesis is the binding of the eukaryotic translation initiation factor 4E (eIF4E) to the 7-methylguanosine (m(7)-GpppG) 5' cap of messenger RNAs1,2. Low oxygen tension (hypoxia) represses cap-mediated translation by sequestering eIF4E through mammalian target of rapamycin (mTOR)dependent mechanisms(3-6). Although the internal ribosome entry site is an alternative translation initiation mechanism, this pathway alone cannot account for the translational capacity of hypoxic cells(7,8). This raises a fundamental question in biology as to how proteins are synthesized in periods of oxygen scarcity and eIF4E inhibition(9). Here we describe an oxygen-regulated translation initiation complex that mediates selective cap-dependent protein synthesis. We show that hypoxia stimulates the formation of a complex that includes the oxygen-regulated hypoxia-inducible factor 2 alpha (HIF-2 alpha), the RNA-binding protein RBM4 and the cap-binding eIF4E2, an eIF4E homologue. Photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP)(10) analysis identified an RNA hypoxia response element (rHRE) that recruits this complex to a wide array of mRNAs, including that encoding the epidermal growth factor receptor. Once assembled at the rHRE, the HIF-2 alpha-RBM4-eIF4E2 complex captures the 5' cap and targets mRNAs to polysomes for active translation, thereby evading hypoxia-induced repression of protein synthesis. These findings demonstrate that cells have evolved a program by which oxygen tension switches the basic translation initiation machinery.	[Uniacke, James; Holterman, Chet E.; Lachance, Gabriel; Franovic, Aleksandra; Jacob, Mathieu D.; Payette, Josianne; Lee, Stephen] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Fabian, Marc R.; Pause, Arnim] McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Holcik, Martin] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada	University of Ottawa; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario	Lee, S (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.	slee@uottawa.ca	Holcik, Martin/AAC-6660-2019; Holcik, Martin/E-5372-2011	Holcik, Martin/0000-0002-1922-5299; Holterman, Chet/0000-0002-9002-6073	Canadian Institutes of Health Research; Terry Fox Foundation (Canadian Cancer Society) [700014]; Terry Fox Foundation; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation (Canadian Cancer Society); Terry Fox Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS))	We thank J. Cote, W. Kaelin, C. Kennedy and T. Tuschl for reagents and technical advice. This work was funded by the Canadian Institutes of Health Research (S. L. and M. H.). J. U. is a Research Fellow of the Terry Fox Foundation (Canadian Cancer Society Award no. 700014). A. F. was supported by a Terry Fox Foundation Studentship from the Canadian Cancer Society.	Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P925, DOI 10.1001/jama.2010.236; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin JC, 2009, J BIOL CHEM, V284, P34658, DOI 10.1074/jbc.M109.032946; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tee AR, 2004, FEBS LETT, V564, P58, DOI 10.1016/S0014-5793(04)00313-8; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200	32	209	209	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					126	U154		10.1038/nature11055	http://dx.doi.org/10.1038/nature11055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678294	Green Accepted			2022-12-28	WOS:000304854000041
J	Al-Hadithy, N; Panagiotidou, A; Hamilton, S				Al-Hadithy, Nada; Panagiotidou, Anna; Hamilton, Stuart			A painful swollen finger	BRITISH MEDICAL JOURNAL			English	Editorial Material							PYOGENIC FLEXOR TENOSYNOVITIS; HAND INFECTIONS; CATHETER IRRIGATION; TENDON SHEATHS		[Al-Hadithy, Nada] St Johns Hosp, Dept Plast Surg, Livingston EH54 6PP, Scotland; [Panagiotidou, Anna] Royal Natl Orthopaed Hosp, London W1N 6AD, England; [Hamilton, Stuart] St Johns Hosp, Plast & Reconstruct Surg Dept, Livingston, Scotland	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Al-Hadithy, N (corresponding author), St Johns Hosp, Dept Plast Surg, Livingston EH54 6PP, Scotland.	nadaucl@yahoo.com						Al-Hadithy N, 2010, CLIN RESPIR J, V4, P61, DOI 10.1111/j.1752-699X.2009.00150.x; [Anonymous], IMM INF DIS; Boles SD, 1998, HAND CLIN, V14, P567; BROWN DM, 1993, SOUTH MED J, V86, P56, DOI 10.1097/00007611-199301000-00013; Cardinal E, 2001, RADIOL CLIN N AM, V39, P191, DOI 10.1016/S0033-8389(05)70272-4; Clark DC, 2003, AM FAM PHYSICIAN, V68, P2167; Dailiana ZH, 2008, J HAND SURG-EUR VOL, V33E, P280, DOI 10.1177/1753193408087071; De Smet L, 2008, ACTA CHIR BELG, V108, P779, DOI 10.1080/00015458.2008.11680340; DELLINGER EP, 1988, ARCH SURG-CHICAGO, V123, P745; Fussey JM, 2009, J HAND SURG-EUR VOL, V34E, P762, DOI 10.1177/1753193409344529; Gaston R Glenn, 2009, Tech Hand Up Extrem Surg, V13, P182, DOI 10.1097/BTH.0b013e3181bef5a3; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; Gunther SF, 1998, HAND CLIN, V14, P647; Gutowski KA, 2002, ANN PLAS SURG, V49, P350, DOI 10.1097/00000637-200210000-00003; Harris PA, 1999, J HAND SURG-BRIT EUR, V24B, P328, DOI 10.1054/jhsb.1998.0009; HAUSMAN MR, 1992, ORTHOP CLIN N AM, V23, P171; Kanavel A.B., 1939, INFECT HAND GUIDE SU; Krieger LE, 1997, ORTHOPEDICS, V20, P649; Lille S, 2000, J HAND SURG-BRIT EUR, V25B, P304, DOI 10.1054/jhsb.2000.0400; Nathan R, 1995, REHABILATION HAND SU, P251; Neviaser R J, 1978, J Hand Surg Am, V3, P462; NEVIASER RJ, 1989, HAND CLIN, V5, P525; Pang HN, 2007, J BONE JOINT SURG AM, V89A, P1742, DOI 10.2106/JBJS.F.01356; POLLEN AG, 1974, HAND, V6, P21, DOI 10.1016/0072-968X(74)90005-9; Ramsey K, 2010, J HAND SURG-EUR VOL, V35E, P151, DOI 10.1177/1753193409344504; Schnall SB, 1996, J BONE JOINT SURG BR, V78B, P793, DOI 10.1302/0301-620X.78B5.0780793; STEVENSON J, 1993, J HAND SURG-BRIT EUR, V18B, P115, DOI 10.1016/0266-7681(93)90208-W; ZOOK EG, 1977, ILLINOIS MED J, V152, P36	28	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 6	2012	344								e3441	10.1136/bmj.e3441	http://dx.doi.org/10.1136/bmj.e3441			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957TC	22674926				2022-12-28	WOS:000305184700005
J	Bannard, OM; Cyster, JG				Bannard, Oliver M.; Cyster, Jason G.			When Less Signaling Is More	SCIENCE			English	Editorial Material							GERMINAL-CENTERS; B-CELLS; DYNAMICS; RECEPTOR; MICROSCOPY		[Bannard, Oliver M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bannard, OM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI045073] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Draghi NA, 2010, P NATL ACAD SCI USA, V107, P16607, DOI 10.1073/pnas.1004664107; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012; Yang ZY, 2012, IMMUNITY, V36, P857, DOI 10.1016/j.immuni.2012.02.009	13	2	2	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1120	1121		10.1126/science.1223811	http://dx.doi.org/10.1126/science.1223811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654048				2022-12-28	WOS:000304647900036
J	Eisenstein, M				Eisenstein, Michael			PREGNANCY Delivery from breast cancer	NATURE			English	Editorial Material																		Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Azim HA, 2012, ACTA ONCOL, V51, P653, DOI 10.3109/0284186X.2011.636069; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110	3	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S54	S54		10.1038/485S54a	http://dx.doi.org/10.1038/485S54a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648499	Bronze			2022-12-28	WOS:000304608000003
J	Langguth, B				Langguth, Berthold			Tinnitus: the end of therapeutic nihilism	LANCET			English	Editorial Material							COMPLEXITY; PREDICTORS; MANAGEMENT		Univ Regensburg, Dept Psychiat & Psychotherapy, Tinnitus Ctr, D-93049 Regensburg, Germany	University of Regensburg	Langguth, B (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Tinnitus Ctr, D-93049 Regensburg, Germany.	berthold.langguth@medbo.de	Langguth, Berthold/AAP-2638-2021					AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Elgoyhen AB, 2010, DRUG DISCOV TODAY, V15, P300, DOI 10.1016/j.drudis.2009.11.003; Friberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029966; Hall DA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-302; Hoare DJ, 2011, EVAL HEALTH PROF, V34, P413, DOI 10.1177/0163278710390355; Hoare DJ, 2011, LARYNGOSCOPE, V121, P1555, DOI 10.1002/lary.21825; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2011, EVAL HEALTH PROF, V34, P429, DOI 10.1177/0163278710394337; Langguth B, 2011, TEXTBOOK OF TINNITUS, P381, DOI 10.1007/978-1-60761-145-5_46; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; Mazurek B, 2006, AUDIOL NEURO-OTOL, V11, P276, DOI 10.1159/000093526	14	17	17	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1926	1928		10.1016/S0140-6736(12)60561-3	http://dx.doi.org/10.1016/S0140-6736(12)60561-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22633023				2022-12-28	WOS:000304757700007
J	Galiano, MR; Jha, S; Ho, TSY; Zhang, CS; Ogawa, Y; Chang, KJ; Stankewich, MC; Mohler, PJ; Rasband, MN				Galiano, Mauricio R.; Jha, Smita; Ho, Tammy Szu-Yu; Zhang, Chuansheng; Ogawa, Yasuhiro; Chang, Kae-Jiun; Stankewich, Michael C.; Mohler, Peter J.; Rasband, Matthew N.			A Distal Axonal Cytoskeleton Forms an Intra-Axonal Boundary that Controls Axon Initial Segment Assembly	CELL			English	Article							BETA-IV-SPECTRIN; ANKYRIN-G; MEMBRANE; NEUROFASCIN; NODES; ESTABLISHMENT; MAINTENANCE; DIFFUSION; CHANNELS; DOMAINS	AnkyrinG (ankG) is highly enriched in neurons at axon initial segments (AISs) where it clusters Na+ and K+ channels and maintains neuronal polarity. How ankG becomes concentrated at the AIS is unknown. Here, we show that as neurons break symmetry, they assemble a distal axonal submembranous cytoskeleton, comprised of ankyrinB (ankB), alpha II-spectrin, and beta II-spectrin, that defines a boundary limiting ankG to the proximal axon. Experimentally moving this boundary altered the length of ankG staining in the proximal axon, whereas disruption of the boundary through silencing of ankB, alpha II-spectrin, or beta II-spectrin expression blocked AIS assembly and permitted ankG to redistribute throughout the distal axon. In support of an essential role for the distal cytoskeleton in ankG clustering, we also found that alpha II and beta II-spectrin-deficient mice had disrupted AIS. Thus, the distal axonal cytoskeleton functions as an intra-axonal boundary restricting ankG to the AIS.	[Galiano, Mauricio R.; Jha, Smita; Zhang, Chuansheng; Ogawa, Yasuhiro; Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ho, Tammy Szu-Yu; Chang, Kae-Jiun; Rasband, Matthew N.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Stankewich, Michael C.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA	Baylor College of Medicine; Baylor College of Medicine; Yale University; University System of Ohio; Ohio State University	Rasband, MN (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	rasband@bcm.edu		Galiano, Mauricio/0000-0002-8245-1715; Chang, Kae-Jiun/0000-0002-3656-7725; Rasband, Matthew/0000-0001-8184-2477	NIH [NS044916, NS069688, HL083422, HL084583]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development, Baylor College of Medicine IDDRC [5P30HD024064-23]; Mission Connect; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL084583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS044916, R01NS069688, R01NS044916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development, Baylor College of Medicine IDDRC; Mission Connect; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Ed Cooper and the Rasband lab for discussions and critical reading of the manuscript. This research was supported by NIH grants NS044916 (M.N.R.), NS069688 (M.N.R.), HL083422 (P.J.M.), and HL084583 (P.J.M.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and Mission Connect. The generation of the SPNB2<SUP>fl/fl</SUP> mice was supported in part by Baylor College of Medicine IDDRC Grant Number 5P30HD024064-23 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Stankewich MC, 2011, J CELL SCI, V124, P3956, DOI 10.1242/jcs.080374; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	42	174	174	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1125	1139		10.1016/j.cell.2012.03.039	http://dx.doi.org/10.1016/j.cell.2012.03.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632975	Bronze, Green Accepted			2022-12-28	WOS:000304453900017
J	Kaya, E; Doudna, JA				Kaya, Emine; Doudna, Jennifer A.			Guided Tour to the Heart of RISC	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; ARGONAUTE; RNA; GW182; DNA		[Kaya, Emine; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kaya, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Nakanishi K., 2012, NATURE; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	11	8	8	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					985	986		10.1126/science.1223549	http://dx.doi.org/10.1126/science.1223549			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628640				2022-12-28	WOS:000304406800027
J	Becattini, C; Agnelli, G; Schenone, A; Eichinger, S; Bucherini, E; Silingardi, M; Bianchi, M; Moia, M; Ageno, W; Vandelli, MR; Grandone, E; Prandoni, P				Becattini, Cecilia; Agnelli, Giancarlo; Schenone, Alessandro; Eichinger, Sabine; Bucherini, Eugenio; Silingardi, Mauro; Bianchi, Marina; Moia, Marco; Ageno, Walter; Vandelli, Maria Rita; Grandone, Elvira; Prandoni, Paolo		Warfasa Investigators	Aspirin for Preventing the Recurrence of Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; LOW-DOSE ASPIRIN; INTENSITY WARFARIN THERAPY; PULMONARY-EMBOLISM; LONG-TERM; CARDIOVASCULAR EVENTS; RISK; DISEASE; TRIAL	Background About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. Methods In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. Results Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. Conclusions Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding.	[Becattini, Cecilia; Agnelli, Giancarlo] Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, I-06129 Perugia, Italy; [Becattini, Cecilia; Agnelli, Giancarlo] Univ Perugia, Dept Internal Med, Stroke Unit, I-06100 Perugia, Italy; [Schenone, Alessandro] Galliera Hosp, Genoa, Italy; [Bucherini, Eugenio] Faenza Hosp, Faenza, Italy; [Silingardi, Mauro] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Bianchi, Marina] Valduce Hosp, Como, Italy; [Moia, Marco] Osped Maggiore Policlin, Fdn IRCCS Casa Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Ageno, Walter] Univ Insubria, Varese, Italy; [Vandelli, Maria Rita] Baggiovara Hosp, Modena, Italy; [Grandone, Elvira] Casa Sollievo Sofferenza, Foggia, Italy; [Prandoni, Paolo] Univ Padua, Dept Cardiothorac & Vasc Sci, Padua, Italy; [Eichinger, Sabine] Med Univ Vienna, Vienna, Austria	University of Perugia; University of Perugia; Ente Ospedaliero Ospedali Galliera; IRCCS Arcispedale S. Maria Nuova; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Insubria; IRCCS Casa Sollievo Della Sofferenza; University of Padua; Medical University of Vienna	Becattini, C (corresponding author), Univ Perugia, Dept Internal Med, Div Internal & Cardiovasc Med, Piazzale Menghini 1, I-06129 Perugia, Italy.	cecilia.becattini@unipg.it	Pasca, Samantha/AAM-5310-2020; Lodigiani, Corrado/AAW-1964-2020; Grandone, Elvira/M-1127-2019; Tufano, Antonella/AHD-0570-2022; Moia, Marco/J-2888-2015; Tiscia, Giovanni/AAC-8788-2019; Becattini, Cecilia/L-1739-2018; schenone, angelo/I-3194-2012; COLAIZZO, DONATELLA/K-5654-2016; Zanatta, Nilo/P-7137-2017	Pasca, Samantha/0000-0002-0954-013X; Lodigiani, Corrado/0000-0002-9152-9385; Grandone, Elvira/0000-0002-8980-9783; Tufano, Antonella/0000-0003-2398-6135; Moia, Marco/0000-0002-7041-7755; Tiscia, Giovanni/0000-0001-5896-2024; schenone, angelo/0000-0002-2604-7830; COLAIZZO, DONATELLA/0000-0001-6927-7428; Zanatta, Nilo/0000-0002-0959-9043; ageno, walter/0000-0002-1922-8879; Silingardi, Mauro/0000-0002-9518-8725; BECATTINI, Cecilia/0000-0002-8343-4888; Alatri, Adriano/0000-0001-7116-1846	University of Perugia; Bayer HealthCare; International Society of Thrombosis and Haemostasis; Boehringer Ingelheim; Daiichi Sankyo; Bristol-Myers Squibb; Sanofi-Aventis; Pfizer; Bayer Schering Pharma; GlaxoSmithKline	University of Perugia; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); International Society of Thrombosis and Haemostasis; Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Bayer Schering Pharma(Bayer AG); GlaxoSmithKline(GlaxoSmithKline)	Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.; Supported by the University of Perugia, a grant-in-aid from Bayer HealthCare, and an Aventis Fellowship for Clinical Research from the International Society of Thrombosis and Haemostasis (to Dr. Becattini).; Dr. Agnelli reports receiving consulting fees from Bayer HealthCare, Boehringer Ingelheim, and Daiichi Sankyo and lecture fees from Bayer HealthCare, Bristol-Myers Squibb, and Sanofi-Aventis; Dr. Eichinger, board memberships from Bayer and Boehringer Ingelheim and lecture fees from Bayer, Boehringer Ingelheim, Pfizer, and Sanofi-Aventis; and Dr. Ageno, board memberships from Bristol-Myers Squibb, Pfizer, and Bayer Schering Pharma and lecture fees from GlaxoSmithKline, Sanofi-Aventis, Bayer Schering Pharma, Bristol-Myers Squibb, Pfizer, and Boehringer Ingelheim. No other relevant conflict of interest relevant to this article was reported.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; [Anonymous], 1994, BMJ, V308, P235; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2005, EUR HEART J, V26, P77, DOI 10.1093/eurheartj/ehi018; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; Chirinos JA, 2005, J AM COLL CARDIOL, V45, P1467, DOI 10.1016/j.jacc.2004.12.075; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Douketis JD, 2007, ANN INTERN MED, V147, P766, DOI 10.7326/0003-4819-147-11-200712040-00007; European Stroke Prevention Study 2 Group, 1997, J NEUROL SCI S, V151, pS27; Glynn RJ, 2007, ANN INTERN MED, V147, P525, DOI 10.7326/0003-4819-147-8-200710160-00004; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2008, CHEST, V134, P892, DOI DOI 10.1378/CHEST.08-0658; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; KLOTZ TA, 1984, CHEST, V85, P329, DOI 10.1378/chest.85.3.329; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; O'Brien J, 2000, LANCET, V355, P1295; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Prandoni P, 2006, J THROMB HAEMOST, V4, P1891, DOI 10.1111/j.1538-7836.2006.02058.x; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prandoni P, 2002, THROMB HAEMOSTASIS, V88, P402; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schafer AI, 1999, NEW ENGL J MED, V340, P955, DOI 10.1056/NEJM199903253401209; Schulman S, 2011, J THROMB HAEMOST, V9, P731; Schulman S, 2011, J THROMB HAEMOST, V9, P22; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; SEVITT S, 1974, J CLIN PATHOL, V27, P517, DOI 10.1136/jcp.27.7.517; Sorensen HT, 2009, J THROMB HAEMOST, V7, P521, DOI 10.1111/j.1538-7836.2009.03279.x; STEELE P, 1980, LANCET, V2, P1328; VESTERQVIST O, 1987, THROMB RES, V45, P393, DOI 10.1016/0049-3848(87)90228-3; Wang XK, 2007, THROMB RES, V119, P593, DOI 10.1016/j.thromres.2006.04.011	34	462	482	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1959	1967		10.1056/NEJMoa1114238	http://dx.doi.org/10.1056/NEJMoa1114238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621626	Green Published			2022-12-28	WOS:000304353000006
J	Raghu, G; Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ				Raghu, Ganesh; Anstrom, Kevin J.; King, Talmadge E., Jr.; Lasky, Joseph A.; Martinez, Fernando J.		Idiopathic Pulm Fibrosis Clinical	Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED-TRIAL; SAMPLE-SIZE; DIAGNOSIS; BOSENTAN; THERAPY	Background A combination of prednisone, azathioprine, and N-acetylcysteine (NAC) has been widely used as a treatment for idiopathic pulmonary fibrosis. The safety and efficacy of this three-drug regimen is unknown. Methods In this randomized, double-blind, placebo-controlled trial, we assigned patients with idiopathic pulmonary fibrosis who had mild-to-moderate lung-function impairment to one of three groups - receiving a combination of prednisone, azathioprine, and NAC (combination therapy), NAC alone, or placebo - in a 1:1:1 ratio. The primary outcome was the change in longitudinal measurements of forced vital capacity during a 60-week treatment period. Results When approximately 50% of data had been collected (with 77 patients in the combination-therapy group and 78 in the placebo group), a planned interim analysis revealed that patients in the combination-therapy group, as compared with the placebo group, had an increased rate of death (8 vs. 1, P = 0.01) and hospitalization (23 vs. 7, P<0.001). These observations, coupled with no evidence of physiological or clinical benefit for combination therapy, prompted the independent data and safety monitoring board to recommend termination of the combination-therapy group at a mean follow-up of 32 weeks. Data from the ongoing comparison of the NAC-only group and the placebo group are not reported here. Conclusions Increased risks of death and hospitalization were observed in patients with idiopathic pulmonary fibrosis who were treated with a combination of prednisone, azathioprine, and NAC, as compared with placebo. These findings provide evidence against the use of this combination in such patients. (Funded by the National Heart, Lung, and Blood Institute and the Cowlin Family Fund; ClinicalTrials.gov number, NCT00650091.)	[Martinez, Fernando J.] Univ Michigan Hlth Syst, Ann Arbor, MI 48103 USA; [Raghu, Ganesh] Univ Washington, Seattle, WA 98195 USA; [Anstrom, Kevin J.] Duke Clin Res Inst, Durham, NC USA; [King, Talmadge E., Jr.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lasky, Joseph A.] Tulane Univ, New Orleans, LA 70118 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Duke University; University of California System; University of California San Francisco; Tulane University	Martinez, FJ (corresponding author), Univ Michigan Hlth Syst, TC 3916,1500 E Med Ctr Dr, Ann Arbor, MI 48103 USA.	fmartine@umich.edu		Ryu, Jay/0000-0002-9576-2272; Moore, Bethany/0000-0003-3051-745X	National Heart, Lung, and Blood Institute [U10HL080413, U10HL080274, U10HL080370, U10HL080371, U10HL080383, U10HL080411, U10HL080509, U10HL080510, U10HL080513,, U10HL080543, U10HL080571, U10HL080685]; Cowlin Family Fund; Cowlin Family Fund at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL080509, U10HL080413, U10HL080411, U10HL080513, U10HL080383, U10HL080571, U10HL080274, R01HL105479, U10HL080685, K24HL111316, U10HL080371, U10HL080370, U10HL080543, U10HL080510] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cowlin Family Fund; Cowlin Family Fund at the Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and the Cowlin Family Fund; ClinicalTrials. gov number, NCT00650091.; Supported by grants (U10HL080413 [to the data coordinating center], U10HL080274, U10HL080370, U10HL080371, U10HL080383, U10HL080411, U10HL080509, U10HL080510, U10HL080513, U10HL080543, U10HL080571, and U10HL080685 [to the clinical centers]) from the NHLBI; and the Cowlin Family Fund at the Chicago Community Trust. NAC and matching placebo were donated by Zambon.	Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bradley B, 2008, THORAX, V63, P1029; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Hunninghake GW, 2005, NEW ENGL J MED, V353, P2285, DOI 10.1056/NEJMe058210; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Mallinckrodt Craig H, 2004, Clin Trials, V1, P477, DOI 10.1191/1740774504cn049oa; Peikert T, 2008, RESP MED, V102, P1342, DOI 10.1016/j.rmed.2008.03.018; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rochon J, 1998, STAT MED, V17, P1643, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1643::AID-SIM869>3.0.CO;2-3; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053	18	1026	1060	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1968	1977		10.1056/NEJMoa1113354	http://dx.doi.org/10.1056/NEJMoa1113354			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22607134	Green Accepted			2022-12-28	WOS:000304353000007
J	Poole, KE; Compston, JE				Poole, Kenneth E.; Compston, Juliet E.			Bisphosphonates in the treatment of osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTMENOPAUSAL OSTEOPOROSIS; NONVERTEBRAL FRACTURES; VERTEBRAL FRACTURES; FEMORAL FRACTURES; AMERICAN-SOCIETY; RANDOMIZED-TRIAL; MINERAL-RESEARCH; TASK-FORCE; WOMEN; RISEDRONATE		[Compston, Juliet E.] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Poole, Kenneth E.] Cambridge Univ Hosp NHS Fdn Trust, Dept Med, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Compston, JE (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Box 157, Cambridge CB2 2QQ, England.	jec1001@cam.ac.uk						Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Compston J, 2011, OSTEOPOROSIS INT, V22, P2951, DOI 10.1007/s00198-011-1804-x; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Compston JE, 2012, J BONE MINER RES, V27, P240, DOI 10.1002/jbmr.1542; Cranney A, 2009, OSTEOPOROSIS INT, V20, P291, DOI 10.1007/s00198-008-0653-8; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Delmas PD, 2004, OSTEOPOROSIS INT, V15, P792, DOI 10.1007/s00198-004-1602-9; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Kanis JA, 2008, BONE, V42, P4, DOI 10.1016/j.bone.2007.10.019; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; National Institute for Health and Clinical Excellence, 2011, OST SEC PREV INCL ST; National Institute for Health and Clinical Excellence, 2011, OST PRIM PREV AL ET; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253	20	22	22	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 22	2012	344								e3211	10.1136/bmj.e3211	http://dx.doi.org/10.1136/bmj.e3211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QS	22619192				2022-12-28	WOS:000304591400005
J	Ebrahim, S; Casas, JP				Ebrahim, Shah; Casas, Juan P.			Statins for all by the age of 50 years?	LANCET			English	Editorial Material							CHOLESTEROL; DISEASE		[Ebrahim, Shah; Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Ebrahim, Shah; Casas, Juan P.] Cochrane Collaborat, Cochrane Heart Grp, London WC1E 7HT, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Ebrahim, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	shah.ebrahim@lshtm.ac.uk			British Heart Foundation [PG/09/022/26739] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Anekwe L, 2010, PULSE           0113; Boggon R, 2012, BR J CARDIOL, V19, P24, DOI [10.5837/bjc, DOI 10.5837/BJC.2012.003]; de Lusignan S, 2006, J PUBLIC HEALTH-UK, V28, P361, DOI 10.1093/pubmed/fdl052; *DEP HLTH, HLTH SURV ENGL 2003; DOWSE GK, 1995, BRIT MED J, V311, P1255, DOI 10.1136/bmj.311.7015.1255; Hingorani AD, EUR HEART J IN PRESS; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID 67 LI; *NHS INF CTR, PRESCR; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wright JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001841.pub2; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	15	38	38	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					545	547		10.1016/S0140-6736(12)60694-1	http://dx.doi.org/10.1016/S0140-6736(12)60694-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988SQ	22607823				2022-12-28	WOS:000307511400007
J	Brahmer, JR; Tykodi, SS; Chow, LQM; Hwu, WJ; Topalian, SL; Hwu, P; Drake, CG; Camacho, LH; Kauh, J; Odunsi, K; Pitot, HC; Hamid, O; Bhatia, S; Martins, R; Eaton, K; Chen, SM; Salay, TM; Alaparthy, S; Grosso, JF; Korman, AJ; Parker, SM; Agrawal, S; Goldberg, SM; Pardoll, DM; Gupta, A; Wigginton, JM				Brahmer, Julie R.; Tykodi, Scott S.; Chow, Laura Q. M.; Hwu, Wen-Jen; Topalian, Suzanne L.; Hwu, Patrick; Drake, Charles G.; Camacho, Luis H.; Kauh, John; Odunsi, Kunle; Pitot, Henry C.; Hamid, Omid; Bhatia, Shailender; Martins, Renato; Eaton, Keith; Chen, Shuming; Salay, Theresa M.; Alaparthy, Suresh; Grosso, Joseph F.; Korman, Alan J.; Parker, Susan M.; Agrawal, Shruti; Goldberg, Stacie M.; Pardoll, Drew M.; Gupta, Ashok; Wigginton, Jon M.			Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL ACTIVITY; B7 FAMILY; PHASE-I; IMMUNOTHERAPY; BLOCKADE; LIGAND; B7-H1; PD-1; CTLA-4; GUIDELINES	BACKGROUND Programmed death 1 (PD-1) protein, a T-cell coinhibitory receptor, and one of its ligands, PD-L1, play a pivotal role in the ability of tumor cells to evade the host's immune system. Blockade of interactions between PD-1 and PD-L1 enhances immune function in vitro and mediates antitumor activity in preclinical models. METHODS In this multicenter phase 1 trial, we administered intravenous anti-PD-L1 antibody (at escalating doses ranging from 0.3 to 10 mg per kilogram of body weight) to patients with selected advanced cancers. Anti-PD-L1 antibody was administered every 14 days in 6-week cycles for up to 16 cycles or until the patient had a complete response or confirmed disease progression. RESULTS As of February 24, 2012, a total of 207 patients - 75 with non-small-cell lung cancer, 55 with melanoma, 18 with colorectal cancer, 17 with renal-cell cancer, 17 with ovarian cancer, 14 with pancreatic cancer, 7 with gastric cancer, and 4 with breast cancer - had received anti-PD-L1 antibody. The median duration of therapy was 12 weeks (range, 2 to 111). Grade 3 or 4 toxic effects that investigators considered to be related to treatment occurred in 9% of patients. Among patients with a response that could be evaluated, an objective response (a complete or partial response) was observed in 9 of 52 patients with melanoma, 2 of 17 with renal-cell cancer, 5 of 49 with non-small-cell lung cancer, and 1 of 17 with ovarian cancer. Responses lasted for 1 year or more in 8 of 16 patients with at least 1 year of follow-up. CONCLUSIONS Antibody-mediated blockade of PD-L1 induced durable tumor regression (objective response rate of 6 to 17%) and prolonged stabilization of disease (rates of 12 to 41% at 24 weeks) in patients with advanced cancers, including non-small-cell lung cancer, melanoma, and renal-cell cancer. (Funded by Bristol-Myers Squibb and others; ClinicalTrials.gov number, NCT00729664.)	[Brahmer, Julie R.; Topalian, Suzanne L.; Drake, Charles G.; Chen, Shuming; Salay, Theresa M.; Pardoll, Drew M.] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Tykodi, Scott S.; Chow, Laura Q. M.; Bhatia, Shailender; Martins, Renato; Eaton, Keith] Univ Washington, Seattle, WA 98195 USA; [Tykodi, Scott S.; Chow, Laura Q. M.; Bhatia, Shailender; Martins, Renato; Eaton, Keith] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Hwu, Wen-Jen; Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Camacho, Luis H.] St Lukes Episcopal Hosp, Ctr Canc, Houston, TX 77030 USA; [Kauh, John] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Pitot, Henry C.] Mayo Clin, Coll Med, Rochester, MN USA; [Hamid, Omid] Angeles Clin, Santa Monica, CA USA; [Korman, Alan J.] Bristol Myers Squibb Co, Milpitas, CA USA; [Alaparthy, Suresh; Grosso, Joseph F.; Parker, Susan M.; Agrawal, Shruti; Goldberg, Stacie M.; Gupta, Ashok; Wigginton, Jon M.] Bristol Myers Squibb Co, Princeton, NJ USA	Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Emory University; Roswell Park Cancer Institute; Mayo Clinic; Angeles Clinic & Research Institute; Bristol-Myers Squibb; Bristol-Myers Squibb	Brahmer, JR (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Bunting Blaustein CRB G94,1650 Orleans St, Baltimore, MD 21231 USA.			Eaton, Keith/0000-0001-5025-2001; Camacho, Luis H./0000-0003-1856-8641	Bristol-Myers Squibb; National Institutes of Health [5R01 CA142779]; Melanoma Research Alliance; NATIONAL CANCER INSTITUTE [P30CA006973, P30CA015704, R01CA142779] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by Bristol-Myers Squibb and by grants (5R01 CA142779, to Drs. Topalian, Chen, and Pardoll) from the National Institutes of Health, and from the Melanoma Research Alliance (to Drs. Topalian and Pardoll and Ms. Salay).	Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holt Gregory E, 2011, Therapy, V8, P43, DOI 10.2217/thy.10.84; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	39	5519	5894	39	1151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2455	2465		10.1056/NEJMoa1200694	http://dx.doi.org/10.1056/NEJMoa1200694			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22658128	Green Accepted, Bronze			2022-12-28	WOS:000305747000005
J	Kurita, N				Kurita, Naoyuki			Dancing to the Tune of the Glacial Cycles	SCIENCE			English	Editorial Material							WEST PACIFIC; ISOTOPES		Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kurita, N (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan.	nkurita@jamstec.go.jp	Kurita, Naoyuki/C-6120-2014					Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; DANSGAARD W, 1964, TELLUS, V16, P436; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Kurita N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015209; Lawrence JR, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004046; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Meckler AN, 2012, SCIENCE, V336, P1301, DOI 10.1126/science.1218340; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Risi C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009943; Tzedakis PC, 2009, NAT GEOSCI, V2, P751, DOI 10.1038/NGEO660; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918	12	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1242	1243		10.1126/science.1223527	http://dx.doi.org/10.1126/science.1223527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953WV	22679088				2022-12-28	WOS:000304905300027
J	Popmintchev, T; Chen, MC; Popmintchev, D; Arpin, P; Brown, S; Alisauskas, S; Andriukaitis, G; Balciunas, T; Mucke, OD; Pugzlys, A; Baltuska, A; Shim, B; Schrauth, SE; Gaeta, A; Hernandez-Garcia, C; Plaja, L; Becker, A; Jaron-Becker, A; Murnane, MM; Kapteyn, HC				Popmintchev, Tenio; Chen, Ming-Chang; Popmintchev, Dimitar; Arpin, Paul; Brown, Susannah; Alisauskas, Skirmantas; Andriukaitis, Giedrius; Balciunas, Tadas; Muecke, Oliver D.; Pugzlys, Audrius; Baltuska, Andrius; Shim, Bonggu; Schrauth, Samuel E.; Gaeta, Alexander; Hernandez-Garcia, Carlos; Plaja, Luis; Becker, Andreas; Jaron-Becker, Agnieszka; Murnane, Margaret M.; Kapteyn, Henry C.			Bright Coherent Ultrahigh Harmonics in the keV X-ray Regime from Mid-Infrared Femtosecond Lasers	SCIENCE			English	Article							ATTOSECOND PULSES; WAVE-GUIDES; GENERATION; SOFT; LIGHT	High-harmonic generation (HHG) traditionally combines similar to 100 near-infrared laser photons to generate bright, phase-matched, extreme ultraviolet beams when the emission from many atoms adds constructively. Here, we show that by guiding a mid-infrared femtosecond laser in a high-pressure gas, ultrahigh harmonics can be generated, up to orders greater than 5000, that emerge as a bright supercontinuum that spans the entire electromagnetic spectrum from the ultraviolet to more than 1.6 kilo-electron volts, allowing, in principle, the generation of pulses as short as 2.5 attoseconds. The multiatmosphere gas pressures required for bright, phase-matched emission also support laser beam self-confinement, further enhancing the x-ray yield. Finally, the x-ray beam exhibits high spatial coherence, even though at high gas density the recolliding electrons responsible for HHG encounter other atoms during the emission process.	[Popmintchev, Tenio; Chen, Ming-Chang; Popmintchev, Dimitar; Arpin, Paul; Brown, Susannah; Becker, Andreas; Jaron-Becker, Agnieszka; Murnane, Margaret M.; Kapteyn, Henry C.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Alisauskas, Skirmantas; Andriukaitis, Giedrius; Balciunas, Tadas; Muecke, Oliver D.; Pugzlys, Audrius; Baltuska, Andrius] Vienna Univ Technol, Photon Inst, A-1040 Vienna, Austria; [Shim, Bonggu; Schrauth, Samuel E.; Gaeta, Alexander] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Hernandez-Garcia, Carlos; Plaja, Luis] Univ Salamanca, Grp Invest Opt Extrema, E-37008 Salamanca, Spain	University of Colorado System; University of Colorado Boulder; Technische Universitat Wien; Cornell University; University of Salamanca	Popmintchev, T (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	popmintchev@jila.colorado.edu	Popmintchev, Dimitar/GLU-8991-2022; Popmintchev, Dimitar/A-2164-2011; Gaeta, Alexander/AAE-2095-2019; Jaron-Becker, Agnieszka A./C-1227-2014; Becker, Andreas/K-4402-2013; Pugzlys, Audrius/S-6299-2016; Baltuska, ANDRIUS/ABE-2033-2020; Popmintchev, Dimitar/AAH-1084-2019; Kapteyn, Henry C/H-6559-2011; Plaja, Luis/K-8701-2014; Balciunas, Tadas/W-2795-2019; Popmintchev, Tenio/B-6715-2008; Hernández-García, Carlos/G-3681-2011; Popmintchev, Dimitar/R-8291-2016; brown, stephen/E-2085-2012	Popmintchev, Dimitar/0000-0001-8203-4703; Popmintchev, Dimitar/0000-0001-8203-4703; Jaron-Becker, Agnieszka A./0000-0003-2339-8544; Pugzlys, Audrius/0000-0002-4523-2708; Popmintchev, Dimitar/0000-0003-4330-8235; Kapteyn, Henry C/0000-0001-8386-6317; Plaja, Luis/0000-0001-8709-7295; Balciunas, Tadas/0000-0001-7713-3344; Popmintchev, Tenio/0000-0002-2023-2226; Hernández-García, Carlos/0000-0002-6153-2647; Popmintchev, Dimitar/0000-0001-8203-4703; Baltuska, Andrius/0000-0002-5267-0626	National Security Science and Engineering Faculty Fellowship; NSF Center for EUV Science and Technology; U.S. Air Force Office of Scientific Research [FA9550-10-1-0561]; Austrian Science Fund (FWF) [U33-16]; Austrian Research Promotion Agency (FFG) [820831 UPLIT]; Junta de Castilla y Leon, Spanish MINECO [CSD2007-00013, FIS2009-09522]; Centro de Laseres Pulsados, CLPU	National Security Science and Engineering Faculty Fellowship; NSF Center for EUV Science and Technology; U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG); Junta de Castilla y Leon, Spanish MINECO; Centro de Laseres Pulsados, CLPU	The experimental work was funded by a National Security Science and Engineering Faculty Fellowship, and the NSF Center for EUV Science and Technology. A.G., A.J.-B., M.M.M., H.C.K. and A. Becker acknowledge support for theory from the U.S. Air Force Office of Scientific Research (grant no. FA9550-10-1-0561); A. Baltuska acknowledges support from Austrian Science Fund (FWF, grant no. U33-16) and the Austrian Research Promotion Agency (FFG, Project 820831 UPLIT); and C.H.-G. and L.P. acknowledge support from Junta de Castilla y Leon, Spanish MINECO (CSD2007-00013 and FIS2009-09522), and from Centro de Laseres Pulsados, CLPU. T.P., M.-C.C., A. Bahabad, M.M.M. and H.C.K. have filed for a patent on "Method for phase-matched generation of coherent soft and hard X-rays using IR lasers," U.S. patent application 61171783 (2008).	Ammosov M. V., 1986, Soviet Physics - JETP, V64, P1191; Andriukaitis G, 2011, OPT LETT, V36, P2755, DOI 10.1364/OL.36.002755; ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Aseyev SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.223902; Bartels RA, 2002, SCIENCE, V297, P376, DOI 10.1126/science.1071718; Bauer M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.025501; Chen MC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.173901; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Constant E, 1999, PHYS REV LETT, V82, P1668, DOI 10.1103/PhysRevLett.82.1668; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; Durfee CG, 1999, PHYS REV LETT, V83, P2187, DOI 10.1103/PhysRevLett.83.2187; Frolov MV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173001; Haight R., 1995, SURF SCI REP, V21, P275; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Hernandez-Garcia C, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.033432; KULANDER KC, 1993, NATO ADV SCI INST SE, V316, P95, DOI 10.1007/978-1-4615-7963-2_10; La-O-Vorakiat C, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.011005; La-O-Vorakiat C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257402; Lee DG, 2003, OPT LETT, V28, P480, DOI 10.1364/OL.28.000480; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Li W, 2010, P NATL ACAD SCI USA, V107, P20219, DOI 10.1073/pnas.1014723107; Mathias S, 2012, P NATL ACAD SCI USA, V109, P4792, DOI 10.1073/pnas.1201371109; Miaja-Avila L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.046101; Mlejnek M, 1998, PHYS REV E, V58, P4903, DOI 10.1103/PhysRevE.58.4903; Perez-Hernandez JA, 2009, OPT EXPRESS, V17, P9891, DOI 10.1364/OE.17.009891; Popmintchev T, 2010, NAT PHOTONICS, V4, P822, DOI 10.1038/nphoton.2010.256; Popmintchev T, 2009, P NATL ACAD SCI USA, V106, P10516, DOI 10.1073/pnas.0903748106; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Schroer CG, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090801; Schweigert IV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163001; Seaberg MD, 2011, OPT EXPRESS, V19, P22470, DOI 10.1364/OE.19.022470; Seres E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364126; Shan B, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.011804; Shim B, 2011, OPT EXPRESS, V19, P9118, DOI 10.1364/OE.19.009118; Tate J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.013901; Thomann I, 2009, OPT EXPRESS, V17, P4611, DOI 10.1364/OE.17.004611; Vozzi C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.153902	37	1205	1235	28	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1287	1291		10.1126/science.1218497	http://dx.doi.org/10.1126/science.1218497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679093	Green Published			2022-12-28	WOS:000304905300041
J	Redfield, S				Redfield, Seth			Gathering Interstellar Gas	SCIENCE			English	Editorial Material							ENVIRONMENTS; SUN		Wesleyan Univ, Dept Astron, Van Vleck Observ, Middletown, CT 06459 USA	Wesleyan University	Redfield, S (corresponding author), Wesleyan Univ, Dept Astron, Van Vleck Observ, Middletown, CT 06459 USA.	sredfield@wesleyan.edu		Redfield, Seth/0000-0003-3786-3486				Frisch PC, 2011, ANNU REV ASTRON ASTR, V49, P237, DOI 10.1146/annurev-astro-081710-102613; McComas DJ, 2012, SCIENCE, V336, P1291, DOI 10.1126/science.1221054; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; Muller HR, 2006, ASTROPHYS J, V647, P1491, DOI 10.1086/505588; Redfield S, 2000, ASTROPHYS J, V534, P825, DOI 10.1086/308769; Scherer K, 2006, SPACE SCI REV, V127, P327, DOI 10.1007/s11214-006-9126-6; Welsh BY, 2009, ASTROPHYS SPACE SCI, V323, P1, DOI 10.1007/s10509-009-0053-3; Wood B. E., 2004, SOL PHYS, V1, P2; Zank GP, 1999, ASTROPHYS J, V518, P965, DOI 10.1086/307320	9	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1243	1244		10.1126/science.1223677	http://dx.doi.org/10.1126/science.1223677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679089				2022-12-28	WOS:000304905300028
J	Payandeh, J; El-Din, TMG; Scheuer, T; Zheng, N; Catterall, WA				Payandeh, Jian; El-Din, Tamer M. Gamal; Scheuer, Todd; Zheng, Ning; Catterall, William A.			Crystal structure of a voltage-gated sodium channel in two potentially inactivated states	NATURE			English	Article							AMINO-ACID-RESIDUES; C-TYPE INACTIVATION; SLOW INACTIVATION; NA+ CHANNELS; MOLECULAR DETERMINANTS; LOCAL-ANESTHETICS; PROTEIN-STRUCTURE; BLOCK; CONDUCTANCE; REFINEMENT	In excitable cells, voltage-gated sodium (Na-V) channels activate to initiate action potentials and then undergo fast and slow inactivation processes that terminate their ionic conductance(1,2). Inactivation is a hallmark of Na-V channel function and is critical for control of membrane excitability(3), but the structural basis for this process has remained elusive. Here we report crystallographic snapshots of the wild-type Na(V)Ab channel from Arcobacter butzleri captured in two potentially inactivated states at 3.2 angstrom resolution. Compared to previous structures of Na(V)Ab channels with cysteine mutations in the pore-lining S6 helices (ref. 4), the S6 helices and the intracellular activation gate have undergone significant rearrangements: one pair of S6 helices has collapsed towards the central pore axis and the other S6 pair has moved outward to produce a striking dimer-of-dimers configuration. An increase in global structural asymmetry is observed throughout our wild-type Na(V)Ab models, reshaping the ion selectivity filter at the extracellular end of the pore, the central cavity and its residues that are analogous to the mammalian drug receptor site, and the lateral pore fenestrations. The voltage-sensing domains have also shifted around the perimeter of the pore module in wild-type Na(V)Ab, compared to the mutant channel, and local structural changes identify a conserved interaction network that connects distant molecular determinants involved in Na-V channel gating and inactivation. These potential inactivated-state structures provide new insights into Na-V channel gating and novel avenues to drug development and therapy for a range of debilitating Na-V channelopathies.	[Payandeh, Jian; El-Din, Tamer M. Gamal; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nzheng@uw.edu; wcatt@uw.edu		Gamal El-Din, Tamer/0000-0002-7406-7393	Canadian Institutes of Health Research; National Institutes of Health [R01 NS15751, U01 NS058039]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751, U01NS058039] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Hille for comments on a draft of the manuscript and members of the Zheng and Catterall groups for their insight and support throughout this project. We are grateful to the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. J.P. acknowledges support from a Canadian Institutes of Health Research fellowship and the support of N. and E. Payandeh. This work was supported by grants from the National Institutes of Health (R01 NS15751 and U01 NS058039 to W. A. C.) and by the Howard Hughes Medical Institute (N.Z.). We dedicate this work to the memory of our colleague Laura Sheard.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kauffmann B, 2006, STRUCTURE, V14, P1099, DOI 10.1016/j.str.2006.05.015; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koth CMM, 2009, ADV PROTEIN CHEM STR, V76, P43, DOI 10.1016/S1876-1623(08)76002-4; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Nesterenko VV, 2011, AM J PHYSIOL-HEART C, V301, pH1615, DOI 10.1152/ajpheart.00243.2011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zarrabi T, 2010, J BIOL CHEM, V285, P39458, DOI 10.1074/jbc.M110.132886; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	46	365	377	1	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					135	U166		10.1038/nature11077	http://dx.doi.org/10.1038/nature11077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678296	Green Accepted			2022-12-28	WOS:000304854000043
J	Sukhdev, P				Sukhdev, Pavan			The corporate climate overhaul	NATURE			English	Editorial Material												pavan@corp2020.com						[Anonymous], 2010, UN OWN WHY ENV EXT M; Geanakoplos J, 2009, NATURE, V457, P963, DOI 10.1038/457963a; Rockstrom J, 2009, ECOL SOC, V14; Sukhdev P., CORPORATION IN PRESS; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; WWF, 2012, LIV PLAN REP 2012	6	19	19	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					27	28		10.1038/486027a	http://dx.doi.org/10.1038/486027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GD	22678264	Bronze			2022-12-28	WOS:000304854000011
J	Yu, YC; He, SJ; Chen, S; Fu, YH; Brown, KN; Yao, XH; Ma, J; Gao, KP; Sosinsky, GE; Huang, K; Shi, SH				Yu, Yong-Chun; He, Shuijin; Chen, She; Fu, Yinghui; Brown, Keith N.; Yao, Xing-Hua; Ma, Jian; Gao, Kate P.; Sosinsky, Gina E.; Huang, Kun; Shi, Song-Hai			Preferential electrical coupling regulates neocortical lineage-dependent microcircuit assembly	NATURE			English	Article							INHIBITORY NEURONS; CIRCUIT FORMATION; MAMMALIAN BRAIN; SYNAPSES; JUNCTION; CELLS; CONNEXIN; MOUSE; MECHANISMS; NETWORKS	Radial glial cells are the primary neural progenitor cells in the developing neocortex(1). Consecutive asymmetric divisions of individual radial glial progenitor cells produce a number of sister excitatory neurons that migrate along the elongated radial glial fibre, resulting in the formation of ontogenetic columns(2-4). Moreover, sister excitatory neurons in ontogenetic columns preferentially develop specific chemical synapses with each other rather than with nearby non-siblings(5). Although these findings provide crucial insight into the emergence of functional columns in the neocortex, little is known about the basis of this lineage-dependent assembly of excitatory neuron microcircuits at single-cell resolution. Here we show that transient electrical coupling between radially aligned sister excitatory neurons regulates the subsequent formation of specific chemical synapses in the neocortex. Multiple-electrode whole-cell recordings showed that sister excitatory neurons preferentially form strong electrical coupling with each other rather than with adjacent non-sister excitatory neurons during early postnatal stages. This preferential coupling allows selective electrical communication between sister excitatory neurons, promoting their action potential generation and synchronous firing. Interestingly, although this electrical communication largely disappears before the appearance of chemical synapses, blockade of the electrical communication impairs the subsequent formation of specific chemical synapses between sister excitatory neurons in ontogenetic columns. These results suggest a strong link between lineage-dependent transient electrical coupling and the assembly of precise excitatory neuron microcircuits in the neocortex.	[Yu, Yong-Chun; Fu, Yinghui; Yao, Xing-Hua; Ma, Jian] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China; [Yu, Yong-Chun; Fu, Yinghui; Yao, Xing-Hua; Ma, Jian] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [He, Shuijin; Chen, She; Brown, Keith N.; Gao, Kate P.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Brown, Keith N.; Gao, Kate P.; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Huang, Kun] Ohio State Univ, Comprehens Canc Ctr Biomed Informat Shared Resour, Dept Biomed Informat, Columbus, OH 43210 USA	Fudan University; Fudan University; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; Ohio State University	Yu, YC (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	ycyu@fudan.edu.cn; hes@mskcc.org; shis@mskcc.org	Huang, Kun/E-3272-2011		Ministry of Science and Technology of China [2012CB966300]; Natural Science Foundation of China [31121061, 31070947]; Shanghai Science and Technology Committee [10PJ1400700]; Foundation of the Ministry of Education of China [20100071120061]; National Institutes of Health [R01DA024681, R21NS072483, R21MH083624, R01GM065947]; McKnight Foundation; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937, R01GM072881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Foundation of the Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the following: C. I. Bargmann, Y. Dan, A. L. Joyner, K. M. Hively and Y. Chin for comments on the manuscript; F. H. Gage for the 293gp NIT-GFP package cell line; E. C. Holland for nestin-TVA transgenic mice; and members of the Shi and Yu laboratories for their input. This work was supported by grants from the Ministry of Science and Technology of China (2012CB966300), the Natural Science Foundation of China (31121061 and 31070947), the Pujiang Talent Project of the Shanghai Science and Technology Committee (10PJ1400700), the Foundation of the Ministry of Education of China (20100071120061) (Y.-C.Y.), the National Institutes of Health (R01DA024681 and R21NS072483 (S.-H. S.), R21MH083624 (S.-H. S. and K. H.) and R01GM065947 (G. E. S.)), the McKnight Foundation and the March of Dimes Foundation (S.-H.S.).	Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; Curtin KD, 2002, J NEUROSCI, V22, P7088; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hebb Donald O., 1949, ORG BEHAV; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Kandler K, 1998, J NEUROSCI, V18, P1419; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Nadarajah B, 1997, J NEUROSCI, V17, P3096; NEYTON J, 1985, NATURE, V317, P331, DOI 10.1038/317331a0; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Pangratz-Fuehrer S, 2011, J NEUROSCI, V31, P10767, DOI 10.1523/JNEUROSCI.6655-10.2011; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rouan F, 2001, J CELL SCI, V114, P2105; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Vos BP, 1999, J NEUROSCI, V19; Wang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010253; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	33	166	168	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					113	U139		10.1038/nature10958	http://dx.doi.org/10.1038/nature10958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678291	Green Accepted			2022-12-28	WOS:000304854000038
J	Zhang, X; Ren, WL; DeCaen, P; Yan, CY; Tao, X; Tang, L; Wang, JJ; Hasegawa, K; Kumasaka, T; He, JH; Wang, JW; Clapham, DE; Yan, N				Zhang, Xu; Ren, Wenlin; DeCaen, Paul; Yan, Chuangye; Tao, Xiao; Tang, Lin; Wang, Jingjing; Hasegawa, Kazuya; Kumasaka, Takashi; He, Jianhua; Wang, Jiawei; Clapham, David E.; Yan, Nieng			Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel	NATURE			English	Article							SWISS-MODEL; GATING CHARGE; K+ CHANNEL; INACTIVATION; CRYSTALLOGRAPHY; ENVIRONMENT; ACTIVATION; MOVEMENT; SOFTWARE; MOTIONS	Voltage-gated sodium (Na-v) channels are essential for the rapid depolarization of nerve and muscle(1), and are important drug targets(2). Determination of the structures of Na-v channels will shed light on ion channel mechanisms and facilitate potential clinical applications. A family of bacterial Na-v channels, exemplified by the Na+-selective channel of bacteria (NaChBac)(3), provides a useful model system for structure-function analysis. Here we report the crystal structure of NavRh, a NaChBac orthologue from the marine alphaproteobacterium HIMB114 (Rickettsiales sp. HIMB114; denoted Rh), at 3.05 angstrom resolution. The channel comprises an asymmetric tetramer. The carbonyl oxygen atoms of Thr 178 and Leu 179 constitute an inner site within the selectivity filter where a hydrated Ca2+ resides in the crystal structure. The outer mouth of the Na+ selectivity filter, defined by Ser 181 and Glu 183, is closed, as is the activation gate at the intracellular side of the pore. The voltage sensors adopt a depolarized conformation in which all the gating charges are exposed to the extracellular environment. We propose that NavRh is in an 'inactivated' conformation. Comparison of NavRh with Na(v)Ab(4) reveals considerable conformational rearrangements that may underlie the electromechanical coupling mechanism of voltage-gated channels.	[Zhang, Xu; Ren, Wenlin; Yan, Chuangye; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Zhang, Xu; Ren, Wenlin; Yan, Chuangye; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zhang, Xu; Ren, Wenlin; Yan, Chuangye; Yan, Nieng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [DeCaen, Paul; Clapham, David E.] Childrens Hosp Boston, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [DeCaen, Paul; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Tao, Xiao] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Tang, Lin; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China; [Wang, Jingjing] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Hasegawa, Kazuya; Kumasaka, Takashi] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Tsinghua University; Tsinghua University; Tsinghua University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Japan Synchrotron Radiation Research Institute	Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Kumasaka, Takashi/D-7428-2018; Clapham, David/S-1123-2019; Yan, Chuangye/AAJ-5832-2021; Clapham, David/R-5974-2019; Wang, Jiawei/D-1144-2010	Kumasaka, Takashi/0000-0001-9289-1557; Clapham, David/0000-0002-4459-9428; Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2009CB918802, 2011CB910501, 2011CB911102]; National Natural Science Foundation of China [31125009, 91017011]; Tsinghua University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072040] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. MacKinnon at Rockefeller University for discussions and reading the manuscript. We thank L. Feng at Rockefeller University for help. We thank S. Huang and F. Yu at Shanghai Synchrotron Radiation Facility beamline BL17U. K. H. acknowledges SPring-8 beamline BL41XU for proposal 2011A2039. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802, 2011CB910501 and 2011CB911102), projects 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua University.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; CATTERALL WA, 1984, SCIENCE, V223, P653, DOI 10.1126/science.6320365; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeLano W.L, PYMOL MOL GRAPHICS S; Durell SR, 2001, BIOCHEM BIOPH RES CO, V281, P741, DOI 10.1006/bbrc.2001.4408; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; HILLE B, 1971, P NATL ACAD SCI USA, V68, P280, DOI 10.1073/pnas.68.2.280; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	47	368	380	15	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					130	U160		10.1038/nature11054	http://dx.doi.org/10.1038/nature11054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678295	Green Accepted			2022-12-28	WOS:000304854000042
J	Rosenfeld, M; Ratjen, F; Brumback, L; Daniel, S; Rowbotham, R; McNamara, S; Johnson, R; Kronmal, R; Davis, SD				Rosenfeld, Margaret; Ratjen, Felix; Brumback, Lyndia; Daniel, Stephen; Rowbotham, Ron; McNamara, Sharon; Johnson, Robin; Kronmal, Richard; Davis, Stephanie D.		ISIS Study Grp	Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis The ISIS Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSEUDOMONAS-AERUGINOSA; PULMONARY-FUNCTION; FUNCTION TESTS; LUNG-FUNCTION; SAFETY; TOLERABILITY; INFECTION; EFFICACY	Context Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with cystic fibrosis (CF), but its efficacy has never been evaluated in patients younger than 6 years with CF. Objective To determine if hypertonic saline reduces the rate of protocol-defined pulmonary exacerbations in patients younger than 6 years with CF. Design, Setting, and Participants The Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS), a multicenter, randomized, double-blind, placebo-controlled trial conducted from April 2009 to October 2011 at 30 CF care centers in the United States and Canada. Participants were aged 4 to 60 months and had an established diagnosis of CF. A total of 344 patients were assessed for eligibility; 321 participants were randomized; 29 (9%) withdrew prematurely. Intervention The active treatment group (n=158) received 7% hypertonic saline and the control group (n=163) received 0.9% isotonic saline, nebulized twice daily for 48 weeks. Both groups received albuterol or levalbuterol prior to each study drug dose. Main Outcome Measures Rate during the 48-week treatment period of protocol-defined pulmonary exacerbations treated with oral, inhaled, or intravenous antibiotics. Results The mean pulmonary exacerbation rate (events per person-year) was 2.3 (95% CI, 2.0-2.5) in the active treatment group and 2.3 (95% CI, 2.1-2.6) in the control group; the adjusted rate ratio was 0.98 (95% CI, 0.84-1.15). Among participants with pulmonary exacerbations, the mean number of total antibiotic treatment days for a pulmonary exacerbation was 60 (95% CI, 49-70) in the active treatment group and 52 (95% CI, 43-61) in the control group. There was no significant difference in secondary end points including height, weight, respiratory rate, oxygen saturation, cough, or respiratory symptom scores. Infant pulmonary function testing performed as an exploratory outcome in a subgroup (n=73, with acceptable measurements at 2 visits in 45 participants) did not demonstrate significant differences between groups except for the mean change in forced expiratory volume in 0.5 seconds, which was 38 mL (95% CI, 1-76) greater in the active treatment group. Adherence determined by returned study drug ampoules was at least 75% in each group. Adverse event profiles were also similar, with the most common adverse event of moderate or severe severity in each group being cough (39% of active treatment group, 38% of control group). Conclusion Among infants and children younger than 6 years with cystic fibrosis, the use of inhaled hypertonic saline compared with isotonic saline did not reduce the rate of pulmonary exacerbations over the course of 48 weeks of treatment.	[Rosenfeld, Margaret; McNamara, Sharon] Seattle Childrens Hosp, Div Pulm Med, Seattle, WA 98105 USA; [Rowbotham, Ron] Seattle Childrens Hosp, Cyst Fibrosis Fdn Therapeut Dev Network Coordinat, Seattle, WA USA; [Rosenfeld, Margaret] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Brumback, Lyndia; Daniel, Stephen; Kronmal, Richard] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA; [Ratjen, Felix] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Johnson, Robin; Davis, Stephanie D.] Univ N Carolina, Dept Pediat, Div Pediat Pulmonol, Chapel Hill, NC 27515 USA	Seattle Children's Hospital; Cystic Fibrosis Foundation; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of North Carolina; University of North Carolina Chapel Hill	Rosenfeld, M (corresponding author), Seattle Childrens Hosp, Div Pulm Med, A5937,4800 Sandpoint Way NE, Seattle, WA 98105 USA.	margaret.rosenfeld@seattlechildrens.org		McIlwaine, Maggie/0000-0002-4646-3209; Weiner, Daniel/0000-0001-8245-1961; Jensen, Renee/0000-0002-0877-9579; Ratjen, Felix/0000-0003-4057-6592; Rosenfeld, Margaret/0000-0002-8105-614X; Milla, Carlos/0000-0001-5515-3053	CF Foundation Therapeutics Inc [ISIS07K1]; National Institutes of Health (NIH) [U01 HL 092931, U01 HL092932, UL1RR025014]; Genentech; CF Canada; Canadian Institute for Child Health; Inspire Inc; National Heart, Lung, and Blood Institute; subsidiary of the not-for-profit Cystic Fibrosis Foundation; Natinal Center for Research Resources; National Center for Advancing Translational Sciences, NIH [UL1RR025014]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL092931, U01HL092932] Funding Source: NIH RePORTER	CF Foundation Therapeutics Inc; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech(Roche HoldingGenentech); CF Canada; Canadian Institute for Child Health; Inspire Inc; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); subsidiary of the not-for-profit Cystic Fibrosis Foundation; Natinal Center for Research Resources; National Center for Advancing Translational Sciences, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rosenfeld reported receiving funding (institutional) from CF Foundation Therapeutics Inc and the National Institutes of Health (NIH) and serving as a consultant for Vertex Pharmaceuticals and for the North American Scientific Advisory Group of the Epidemiologic Study of CF sponsored by Genentech. Dr Ratjen reported receiving funding (institutional) from CF Foundation Therapeutics Inc, the NIH, CF Canada, the Canadian Institute for Child Health, and Inspire Inc; serving as a consultant for Inspire Inc, Vertex Pharmaceuticals, Novartis, Bayer, Talecris, CSL Behring, Roche, and Gilead; serving on a speakers board for Genentech; and receiving meeting expenses from Pari Respiratory Equipment. Ms Johnson reported serving as a consultant for nSpire Health. Dr Brumback, Dr Daniel, and Dr Kronmal reported receiving funding (institutional) from the National Heart, Lung, and Blood Institute and CF Foundation Therapeutics Inc. Dr Davis reported receiving funding (institutional) from CF Foundation Therapeutics Inc and the NIH and serving as a consultant or on the advisory board for Vertex Pharmaceuticals, Novartis and Inspire Inc. No other authors reported disclosures.; This study was jointly funded by the NIH (U01 HL 092931, U01 HL092932, UL1RR025014) and CF Foundation Therapeutics Inc (ISIS07K1), the subsidiary of the not-for-profit Cystic Fibrosis Foundation that sponsors research grants and contracts. The University of Washington site was also supported by the Natinal Center for Research Resources and the National Center for Advancing Translational Sciences, NIH (UL1RR025014). Study drug and placebo were supplied by Pari Respiratory Equipment and Catalent, respectively, which were not otherwise involved in any aspect of the study.	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Castile R, 2000, PEDIATR PULM, V30, P215, DOI 10.1002/1099-0496(200009)30:3<215::AID-PPUL6>3.0.CO;2-V; Cystic Fibrosis Foundation, 2011, NAT PAT REG 2010 ANN; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; Davis SD, 2010, AM J RESP CRIT CARE, V182, P1387, DOI 10.1164/rccm.200908-1236OC; Dellon EP, 2008, PEDIATR PULM, V43, P1100, DOI 10.1002/ppul.20909; Dmello D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000019; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Eng PA, 1996, PEDIATR PULM, V21, P77, DOI 10.1002/(SICI)1099-0496(199602)21:2<77::AID-PPUL3>3.0.CO;2-M; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Livraghi A, 2007, TOXICOL PATHOL, V35, P116, DOI 10.1080/01926230601060025; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; Mayer-Hamblett Nicole, 2007, Proc Am Thorac Soc, V4, P370, DOI 10.1513/pats.200703-040BR; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403; Ranganathan SC, 2004, AM J RESP CRIT CARE, V169, P928, DOI 10.1164/rccm.200309-1344OC; Rosenfeld M, 2011, PEDIATR PULM, V46, P666, DOI 10.1002/ppul.21425; Rosenfeld M, 2010, PEDIATR PULM, V45, P934, DOI 10.1002/ppul.21279; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Saiman L, 2010, JAMA-J AM MED ASSOC, V303, P1707, DOI 10.1001/jama.2010.563; Stocks J, 2001, EUR RESPIR J, V17, P302, DOI 10.1183/09031936.01.17203020; Subbarao P, 2007, PEDIATR PULM, V42, P471, DOI 10.1002/ppul.20603; Treggiari MM, 2011, ARCH PEDIAT ADOL MED, V165, P847, DOI 10.1001/archpediatrics.2011.136; van Ewijk Bart E, 2005, J Cyst Fibros, V4 Suppl 2, P31, DOI 10.1016/j.jcf.2005.05.011; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3; West SEH, 2002, JAMA-J AM MED ASSOC, V287, P2958, DOI 10.1001/jama.287.22.2958; Zhang LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006286.pub2	30	149	151	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2269	2277		10.1001/jama.2012.5214	http://dx.doi.org/10.1001/jama.2012.5214			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22610452	Green Accepted, Bronze			2022-12-28	WOS:000304801700021
J	Gaffga, NH; Behravesh, CB; Ettestad, PJ; Smelser, CB; Rhorer, AR; Cronquist, AB; Comstock, NA; Bidol, SA; Patel, NJ; Gerner-Smidt, P; Keene, WE; Gomez, TM; Hopkins, BA; Sotir, MJ; Angulo, FJ				Gaffga, Nicholas H.; Behravesh, Casey Barton; Ettestad, Paul J.; Smelser, Chad B.; Rhorer, Andrew R.; Cronquist, Alicia B.; Comstock, Nicole A.; Bidol, Sally A.; Patel, Nehal J.; Gerner-Smidt, Peter; Keene, William E.; Gomez, Thomas M.; Hopkins, Brett A.; Sotir, Mark J.; Angulo, Frederick J.			Outbreak of Salmonellosis Linked to Live Poultry from a Mail-Order Hatchery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES	BACKGROUND Outbreaks of human salmonella infections are increasingly associated with contact with live poultry, but effective control measures are elusive. In 2005, a cluster of human salmonella Montevideo infections with a rare pattern on pulsed-field gel electrophoresis (the outbreak strain) was identified by PulseNet, a national subtyping network. METHODS In cooperation with public health and animal health agencies, we conducted multistate investigations involving patient interviews, trace-back investigations, and environmental testing at a mail-order hatchery linked to the outbreak in order to identify the source of infections and prevent additional illnesses. A case was defined as an infection with the outbreak strain between 2004 and 2011. RESULTS From 2004 through 2011, we identified 316 cases in 43 states. The median age of the patient was 4 years. Interviews were completed with 156 patients (or their caretakers) (49%), and 36 of these patients (23%) were hospitalized. Among the 145 patients for whom information was available, 80 (55%) had bloody diarrhea. Information on contact with live young poultry was available for 159 patients, and 122 of these patients (77%) reported having such contact. A mail-order hatchery in the western United States was identified in 81% of the trace-back investigations, and the outbreak strain was isolated from samples collected at the hatchery. After interventions at the hatchery, the number of human infections declined, but transmission continued. CONCLUSIONS We identified a prolonged multistate outbreak of salmonellosis, predominantly affecting young children and associated with contact with live young poultry from a mail-order hatchery. Interventions performed at the hatchery reduced, but did not eliminate, associated human infections, demonstrating the difficulty of eliminating salmonella transmission from live poultry.	[Gaffga, Nicholas H.; Behravesh, Casey Barton; Patel, Nehal J.; Gerner-Smidt, Peter; Sotir, Mark J.; Angulo, Frederick J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Water Borne & Environm Dis, Atlanta, GA 30333 USA; [Ettestad, Paul J.; Smelser, Chad B.] New Mexico Dept Hlth, Santa Fe, NM USA; [Rhorer, Andrew R.] Natl Poultry Improvement Plan, Anim & Plant Hlth Inspect Serv, Washington, DC USA; [Gomez, Thomas M.] Vet Serv, Washington, DC USA; [Gomez, Thomas M.] Dept Agr, Washington, DC USA; [Cronquist, Alicia B.; Comstock, Nicole A.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Bidol, Sally A.] Michigan Dept Community Hlth, Lansing, MI USA; [Keene, William E.] Oregon Publ Hlth Div, Portland, OR USA; [Hopkins, Brett A.] Pfizer Anim Hlth, Overland Pk, KS USA	Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Colorado Department of Public Health & Environment; MDHHS - Michigan Department of Health & Human Services; Pfizer	Gaffga, NH (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Water Borne & Environm Dis, 1600 Clifton Rd,NE MS E 02, Atlanta, GA 30333 USA.	ngaffga@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022	BARTON BEHRAVESH, Casey/0000-0003-2270-5573				ANDERSON AS, 1955, JAMA-J AM MED ASSOC, V158, P1153, DOI 10.1001/jama.1955.02960130007003; [Anonymous], RISK HUM SALM INF LI; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P185; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P25; [Anonymous], 2011, 2011 COMP HANDW MAT; [Anonymous], 2009, HUM IS FIN REP 2007; [Anonymous], 2006, NAT POULTR IMPR PLAN; [Anonymous], 1997, MMWR MORB MORTAL WKL, V46, P237; [Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P273; Neuman W, 2009, NY TIMES        0814; Roy P, 2001, AVIAN DIS, V45, P922, DOI 10.2307/1592871; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Wilkins MJ, 2002, EPIDEMIOL INFECT, V129, P19, DOI 10.1017/S0950268802007112; 2000, MMWR MORB MORTAL WKL, V49, P297	15	41	43	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2065	2073						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646629	Bronze			2022-12-28	WOS:000304613400006
J	Nedeva, M; Stampfer, M				Nedeva, Maria; Stampfer, Michael			From "Science in Europe" to "European Science"	SCIENCE			English	Editorial Material									[Nedeva, Maria] Univ Manchester, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England; [Nedeva, Maria] Lund Univ, Res Policy Inst, SE-22100 Lund, Sweden; [Stampfer, Michael] Vienna Sci & Technol Fund, A-1090 Vienna, Austria	University of Manchester; Lund University; Technische Universitat Wien	Nedeva, M (corresponding author), Univ Manchester, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England.	maria.nedeva@mbs.ac.uk		Nedeva, Maria/0000-0003-0412-8063				Arnold E., 2008, IMPACTS FRAMEWORK PR; CERN, 1953, CONV EST EUR ORG NUC; Dosi G, 2006, RES POLICY, V35, P1450, DOI 10.1016/j.respol.2006.09.012; EC, 2004, COM20049 EC; *EC, 2000, COM20006 EC; EC, 2011, COM2011808 EC; EC, 2007, DG INF SOC MED SELF; Edler J., 2012, IMPACT ERC U PUBLIC; ERC Expert Group, 2003, EUR RES COUNC CORN E; ESF, CALL PROP 2012 RES C; EURECIA is an international research project funded by the ERC, 229286 EURECIA ERC; Georghiou L, 1998, RES POLICY, V27, P611, DOI 10.1016/S0048-7333(98)00054-7; Gronbaek D. J v H., 2003, SCI PUBL POLICY, V30, P391, DOI DOI 10.3152/147154303781780263; Guy K., 2005, FP5 IMPACT ASSESSMEN; High-Level Expert Group, 2005, FRONT RES EUR CHALL; Krull W, 2004, SCIENCE, V306, P941, DOI 10.1126/science.1106368; Laudel G., 2012, ERCS IMPACT GRANTEES; Luukkonen T, 2002, RES POLICY, V31, P437, DOI 10.1016/S0048-7333(01)00118-4; Luukkonen T., 2012, IMPACT ERC NATL FUND; Luukkonen T., 2012, ERC EUROPEAN RES FUN; Luukkonen T, 2010, RES POLICY, V39, P674, DOI 10.1016/j.respol.2010.02.008; Pavitt K., 2000, SCI PUBL POLICY, V27, P455, DOI DOI 10.3152/147154300781781779; Polt Wolfgang, 2006, IST EVALUATION MONIT; Rosenberg N., 2002, KNOWLEDGE INCLUSIVE; Sharp M., 1997, SCI TOMORROWS EUROPE, P201; Stampfer M., 2008, EUROPEAN ADDED VALUE; Thomas D., 2011, SURVEY STARTING INDE	27	22	22	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					982	983		10.1126/science.1216878	http://dx.doi.org/10.1126/science.1216878			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628638				2022-12-28	WOS:000304406800025
J	Albrecht-Schmitt, TE				Albrecht-Schmitt, Thomas E.			NMR Tools for Determining the Structure of Plutonium Materials	SCIENCE			English	Editorial Material									[Albrecht-Schmitt, Thomas E.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA; [Albrecht-Schmitt, Thomas E.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Albrecht-Schmitt, TE (corresponding author), Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA.	talbrec1@nd.edu						Ikushima K, 1998, J PHYS SOC JPN, V67, P65, DOI 10.1143/JPSJ.67.65; Yasuoka H, 2012, SCIENCE, V336, P901, DOI 10.1126/science.1220801	2	5	5	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					811	812		10.1126/science.1222927	http://dx.doi.org/10.1126/science.1222927			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605739				2022-12-28	WOS:000304145600027
J	Futuyma, DJ				Futuyma, Douglas J.			RETROSPECTIVE Robert R. Sokal (1926-2012)	SCIENCE			English	Biographical-Item									SUNY Stony Brook, Dept Ecol & Evolut, Life Sci Labs, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Futuyma, DJ (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Life Sci Labs, Stony Brook, NY 11794 USA.	futuyma@life.bio.sunysb.edu						SOKAL RR, PUBLICATION LIST	1	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					816	816		10.1126/science.1224101	http://dx.doi.org/10.1126/science.1224101			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605743				2022-12-28	WOS:000304145600031
J	Stanford, SC				Stanford, S. Clare			PERSONAL VIEW The NHS is right to fund homoeopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Stanford, SC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England.	c.stanford@ucl.ac.uk		Stanford, Susan/0000-0002-5623-1751					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2011	342								d2642	10.1136/bmj.d2642	http://dx.doi.org/10.1136/bmj.d2642			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MB	22677223				2022-12-28	WOS:000290481700005
J	Einstein, AJ				Einstein, Andrew J.			Beyond the bombs: cancer risks of low-dose medical radiation	LANCET			English	Editorial Material							EXPOSURE; CT		[Einstein, Andrew J.] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10032 USA; [Einstein, Andrew J.] Columbia Univ, Dept Radiol, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Einstein, AJ (corresponding author), Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10032 USA.	andrew.einstein@columbia.edu			NHLBI NIH HHS [R01 HL109711] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109711] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Association of Physicists in Medicine, AAPM POS STAT RAD RI; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2012, J AM COLL CARDIOL, V59, P553, DOI 10.1016/j.jacc.2011.08.079; International Agency for Research on Cancer, EPI CT INT PED CT SC; Malone J, 2012, BRIT J RADIOL, V85, P523, DOI 10.1259/bjr/42893576; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091	11	35	38	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					455	457		10.1016/S0140-6736(12)60897-6	http://dx.doi.org/10.1016/S0140-6736(12)60897-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	983GY	22681861	Green Accepted			2022-12-28	WOS:000307109000008
J	Hall, KS; Hendrie, HC				Hall, Kathleen S.; Hendrie, Hugh C.			Early childhood environment and dementia	LANCET			English	Editorial Material							EDUCATION; DISEASE; RISK; MORTALITY; YORUBA		[Hall, Kathleen S.; Hendrie, Hugh C.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Hendrie, Hugh C.] Indiana Univ, Sch Med, Regenstrief Inst, Indianapolis, IN 46202 USA; [Hendrie, Hugh C.] Indiana Univ, Sch Med, Ctr Aging Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis	Hall, KS (corresponding author), Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA.	khall@iupui.edu						Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Fleischer NL, 2008, J URBAN HEALTH, V85, P923, DOI 10.1007/s11524-008-9319-2; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.023; Hall KS, 2000, NEUROLOGY, V54, P95, DOI 10.1212/WNL.54.1.95; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Higgins C, 2008, HLTH IMPACTS ED REV; Marks Carole, 1989, FAREWELL WERE GOOD G; Miech R, 2011, AM SOCIOL REV, V76, P913, DOI 10.1177/0003122411411276; Perkins AJ, 2002, INT J GERIATR PSYCH, V17, P566, DOI 10.1002/gps.643; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012	12	7	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					11	12		10.1016/S0140-6736(12)60767-3	http://dx.doi.org/10.1016/S0140-6736(12)60767-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22626852				2022-12-28	WOS:000306115900009
J	Schoen, RE; Pinsky, PF; Weissfeld, JL; Yokochi, LA; Church, T; Laiyemo, AO; Bresalier, R; Andriole, GL; Buys, SS; Crawford, ED; Fouad, MN; Isaacs, C; Johnson, CC; Reding, DJ; O'Brien, B; Carrick, DM; Wright, P; Riley, TL; Purdue, MP; Izmirlian, G; Kramer, BS; Miller, AB; Gohagan, JK; Prorok, PC; Berg, CD				Schoen, Robert E.; Pinsky, Paul F.; Weissfeld, Joel L.; Yokochi, Lance A.; Church, Timothy; Laiyemo, Adeyinka O.; Bresalier, Robert; Andriole, Gerald L.; Buys, Saundra S.; Crawford, E. David; Fouad, Mona N.; Isaacs, Claudine; Johnson, Christine C.; Reding, Douglas J.; O'Brien, Barbara; Carrick, Danielle M.; Wright, Patrick; Riley, Thomas L.; Purdue, Mark P.; Izmirlian, Grant; Kramer, Barnett S.; Miller, Anthony B.; Gohagan, John K.; Prorok, Philip C.; Berg, Christine D.		PLCO Project Team	Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OCCULT BLOOD-TEST; SURVEILLANCE COLONOSCOPY; NEGATIVE COLONOSCOPY; PROSTATE; LUNG; ASSOCIATION; DEATH; YIELD; RISK	BACKGROUND The benefits of endoscopic testing for colorectal-cancer screening are uncertain. We evaluated the effect of screening with flexible sigmoidoscopy on colorectal-cancer incidence and mortality. METHODS From 1993 through 2001, we randomly assigned 154,900 men and women 55 to 74 years of age either to screening with flexible sigmoidoscopy, with a repeat screening at 3 or 5 years, or to usual care. Cases of colorectal cancer and deaths from the disease were ascertained. RESULTS Of the 77,445 participants randomly assigned to screening (intervention group), 83.5% underwent baseline flexible sigmoidoscopy and 54.0% were screened at 3 or 5 years. The incidence of colorectal cancer after a median follow-up of 11.9 years was 11.9 cases per 10,000 person-years in the intervention group (1012 cases), as compared with 15.2 cases per 10,000 person-years in the usual-care group (1287 cases), which represents a 21% reduction (relative risk, 0.79; 95% confidence interval [CI], 0.72 to 0.85; P < 0.001). Significant reductions were observed in the incidence of both distal colorectal cancer (479 cases in the intervention group vs. 669 cases in the usual-care group; relative risk, 0.71; 95% CI, 0.64 to 0.80; P < 0.001) and proximal colorectal cancer (512 cases vs. 595 cases; relative risk, 0.86; 95% CI, 0.76 to 0.97; P = 0.01). There were 2.9 deaths from colorectal cancer per 10,000 person-years in the intervention group (252 deaths), as compared with 3.9 per 10,000 person-years in the usual-care group (341 deaths), which represents a 26% reduction (relative risk, 0.74; 95% CI, 0.63 to 0.87; P < 0.001). Mortality from distal colorectal cancer was reduced by 50% (87 deaths in the intervention group vs. 175 in the usual-care group; relative risk, 0.50; 95% CI, 0.38 to 0.64; P < 0.001); mortality from proximal colorectal cancer was unaffected (143 and 147 deaths, respectively; relative risk, 0.97; 95% CI, 0.77 to 1.22; P = 0.81). CONCLUSIONS Screening with flexible sigmoidoscopy was associated with a significant decrease in colorectal-cancer incidence (in both the distal and proximal colon) and mortality (distal colon only). (Funded by the National Cancer Institute; PLCO ClinicalTrials.gov number, NCT00002540.)	[Schoen, Robert E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Schoen, Robert E.; Weissfeld, Joel L.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Schoen, Robert E.; Weissfeld, Joel L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Pinsky, Paul F.; Izmirlian, Grant; Kramer, Barnett S.; Prorok, Philip C.; Berg, Christine D.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Purdue, Mark P.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gohagan, John K.] NIH, Off Dis Prevent, Bethesda, MD 20892 USA; [O'Brien, Barbara; Carrick, Danielle M.] Westat Corp, Rockville, MD USA; [Wright, Patrick; Riley, Thomas L.] Informat Management Serv Inc, Rockville, MD USA; [Yokochi, Lance A.] Pacific Hlth Res & Educ Inst, Rockville, MD USA; [Church, Timothy] Univ Minnesota, Dept Hlth Studies & Environm Hlth Sci, Minneapolis, MN USA; [Laiyemo, Adeyinka O.] Howard Univ, Dept Med, Washington, DC 20059 USA; [Isaacs, Claudine] Georgetown Univ, Washington, DC USA; [Bresalier, Robert] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Andriole, Gerald L.] Washington Univ, St Louis, MO 63130 USA; [Buys, Saundra S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Crawford, E. David] Univ Colorado, Anschutz Canc Pavil, Denver, CO 80202 USA; [Fouad, Mona N.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Johnson, Christine C.] Henry Ford Hlth Syst, Detroit, MI USA; [Reding, Douglas J.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Miller, Anthony B.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Westat; Information Management Services, Inc.; University of Minnesota System; University of Minnesota Twin Cities; Howard University; Georgetown University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Washington University (WUSTL); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham; Henry Ford Health System; Henry Ford Hospital; University of Toronto	Schoen, RE (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.		Purdue, Mark P/C-9228-2016; Berg, Christine/K-1047-2014; Church, Timothy/AAH-7017-2020	Purdue, Mark P/0000-0003-1177-3108; Church, Timothy/0000-0003-3292-5035; Johnson, Christine Cole/0000-0002-6864-6604; Bresalier, Robert/0000-0002-9740-281X	Division of Cancer Prevention, National Cancer Institute [N01-CN-25476, N01-CN-25511, N01-CN-25512, N01-CN-25513, N01-CN-25514, N01-CN-25515, N01-CN-25516, N01-CN-25518, N01-CN-25522, N01-CN-25524, N01-CN-75022]; Amgen; Augmenix; Bayer; Bristol-Myers Squibb; Cambridge Endo; Caris; GlaxoSmithKline; Janssen Biotech; Myriad Genetics; Steba Biotech; Ortho Clinical Diagnostics; UpToDate; Year Book of Urology; Johnson Johnson; Medivation; Wilex; Viking Medical; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025522, N01CN025476, N01CN025518, N01CN025514, N01CN025512, N01CN075022, N01CN025524, N01CN025511, N01CN025515, N01CN025516, N01CN025513] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA025515, N01CA025522, N01CA025516, N01CA075022, N01CA025524, N01CA025511, N01CA025514, N01CA025512, N01CA025518, N01CA025513] Funding Source: NIH RePORTER	Division of Cancer Prevention, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen(Amgen); Augmenix; Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Cambridge Endo; Caris; GlaxoSmithKline(GlaxoSmithKline); Janssen Biotech(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Myriad Genetics; Steba Biotech; Ortho Clinical Diagnostics; UpToDate; Year Book of Urology; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Medivation; Wilex; Viking Medical; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by contracts from the Division of Cancer Prevention, National Cancer Institute, to the 10 screening centers and to the coordinating center (N01-CN-25476, to Westat; N01-CN-25511, to the University of Pittsburgh Cancer Institute; N01-CN-25512, to Henry Ford Health System; N01-CN-25513, to the University of Minnesota School of Public Health; N01-CN-25514, to the University of Colorado; N01-CN-25515, to Pacific Health Research and Education Institute; N01-CN-25516, to Washington University; N01-CN-25518, to Marshfield Clinic Research Foundation; N01-CN-25522, to Georgetown University Medical Center; N01-CN-25524, to the University of Utah; and N01-CN-75022, to the University of Alabama at Birmingham).; Dr. Andriole reports receiving consulting fees, payment for the development of presentations, and payment for travel, accommodation, and meeting expenses from Amgen; consulting fees, stock options, and payment for travel, accommodation, and meeting expenses from Augmenix; consulting fees and payment for travel, accommodation, and meeting expenses from Bayer; consulting fees and payment for travel, accommodation, and meeting expenses from Bristol-Myers Squibb; consulting fees, stock options, and payment for travel, accommodation, and meeting expenses from Cambridge Endo; consulting fees and payment for travel, accommodation, and meeting expenses from Caris; consulting fees and payment for travel, accommodation, and meeting expenses from GlaxoSmithKline; consulting fees and payment for travel, accommodation, and meeting expenses from Janssen Biotech; consulting fees and payment for travel, accommodation, and meeting expenses from Myriad Genetics; consulting fees and payment for travel, accommodation, and meeting expenses from Steba Biotech; consulting fees and payment for travel, accommodation, and meeting expenses from Ortho Clinical Diagnostics; consulting fees and stock options from Viking Medical; royalties from UpToDate and Year Book of Urology; stock options from Envisioneering Medical; and grant support to his institution from Johnson & Johnson, Medivation, and Wilex; and being a member of an independent data monitoring committee for Amarex. Dr. Schoen reports receiving stock options from Onconome. No other potential conflict of interest relevant to this article was reported.	Ahlbom A, 1993, BIOSTATISTICS EPIDEM; [Anonymous], 1997, AJCC CANC STAGING MA; [Anonymous], 2010, SAS STAT VERS 9; [Anonymous], 2010, R LANG ENV STAT COMP; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2011, GASTROENTEROLOGY, V140, pS74; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; DeMets D L, 1995, Cancer Treat Res, V75, P1; Deng G, 2008, EUR J CANCER, V44, P1290, DOI 10.1016/j.ejca.2008.03.014; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Izmirlian G, 2011, ESTIMATION RELATIVE; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lin DY, 1999, J AM STAT ASSOC, V94, P510, DOI 10.2307/2670171; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; Miller AB, 2000, CONTROL CLIN TRIALS, V21, p400S, DOI 10.1016/S0197-2456(00)00095-7; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Richardson Lisa C., 2011, Morbidity and Mortality Weekly Report, V60, P884; Schoen RE, 2012, GASTROINTEST ENDOSC, V75, P612, DOI 10.1016/j.gie.2011.10.024; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Segnan N, 2007, GASTROENTEROLOGY, V132, P2304, DOI 10.1053/j.gastro.2007.03.030; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simpson NK, 2000, CONTROL CLIN TRIALS, V21, p356S, DOI 10.1016/S0197-2456(00)00102-1; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Singh H, 2010, AM J GASTROENTEROL, V105, P663, DOI 10.1038/ajg.2009.650; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; Weissfeld JL, 2012, JNCI-J NATL CANCER I, V104, P280, DOI 10.1093/jnci/djr549	42	688	708	0	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2345	2357		10.1056/NEJMoa1114635	http://dx.doi.org/10.1056/NEJMoa1114635			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22612596	Green Accepted			2022-12-28	WOS:000305451700004
J	Jarrett, J; Woodcock, J; Griffiths, UK; Chalabi, Z; Edwards, P; Roberts, I; Haines, A				Jarrett, James; Woodcock, James; Griffiths, Ulla K.; Chalabi, Zaid; Edwards, Phil; Roberts, Ian; Haines, Andy			Effect of increasing active travel in urban England and Wales on costs to the National Health Service	LANCET			English	Review							PHYSICAL-ACTIVITY; CARE COSTS; CANCER; RISK; TRENDS	Increased walking and cycling in urban areas and reduced use of private cars could have positive effects on many health outcomes. We estimated the potential effect of increased walking and cycling in urban England and Wales on costs to the National Health Service (NHS) for seven diseases-namely, type 2 diabetes, dementia, cerebrovascular disease, breast cancer, colorectal cancer, depression, and ischaemic heart disease-that are associated with physical inactivity. Within 20 years, reductions in the prevalences of type 2 diabetes, dementia, ischaemic heart disease, cerebrovascular disease, and cancer because of increased physical activity would lead to savings of roughly UK 17 pound billion (in 2010 prices) for the NHS, after adjustment for an increased risk of road traffic injuries. Further costs would be averted after 20 years. Sensitivity analyses show that results are invariably positive but sensitive to assumptions about time lag between the increase in active travel and changes in health outcomes. Increasing the amount of walking and cycling in urban settings could reduce costs to the NHS, permitting decreased government expenditure on health or releasing resources to fund additional health care.	[Jarrett, James] Univ E Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England; [Jarrett, James; Woodcock, James] Univ Cambridge, Inst Publ Hlth, Clin Res Collaborat Ctr Diet & Act Res, Cambridge, England; [Griffiths, Ulla K.; Chalabi, Zaid; Haines, Andy] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Edwards, Phil; Roberts, Ian; Haines, Andy] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of East Anglia; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Jarrett, J (corresponding author), Univ E Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England.	j.jarrett@uea.ac.uk	Woodcock, James/AAH-6753-2021	Edwards, Phil/0000-0003-4431-8822; Woodcock, James/0000-0003-4769-5375; Haines, Andy/0000-0002-8053-4605	UK Department of Health; ESRC [ES/G007462/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish	UK Department of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This is an independent report commissioned and funded by the Policy Research Programme in the UK Department of Health. The views expressed are the authors' and not necessarily those of the Department. We thank the following colleagues who attended meetings where the emerging findings were discussed for their constructive comments: Alan Dangour, Michael Davies, Tara Garnett, Moshe Givoni, Ian Hamilton, Marcus Keogh-Brown, Henning Tarp Jensen, and Paul Wilkinson.	Baker PRA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub2; Bauman A., 2008, CYCLING GETTING AUST; Cancer Research UK, CANC STAT UK; Clarke P, 2003, DIABETIC MED, V20, P442, DOI 10.1046/j.1464-5491.2003.00972.x; Commission of the European Communities, 2006, ANN COMM COMM COUNC; Committee on Climate Change, 2008, BUILD LOW CARB EC UK; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta.14320, 10.3310/hta14320]; CTC (National Cyclists' Organisation), SAF NUMB ENGL; Curtis LA, 2010, UN COSTS HLTH SOC CA; Danish Ministry of Transport, 2011, DAN NAT TRAV SURV; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Department of Health, ENGL LEV PROGR BUDG; Department of Transport, TABL NTS9904 AV DIST; Edwards P., 2006, PROMOTING PHYS ACTIV; European Cyclists' Federation, CYCL MOR OFT 2 COOL; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; HICKMAN R, 2009, VISIONING BACKCASTIN; HM Treasury, 2010, SPEND REV 2010; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Kahlmeier S, 2011, HLTH EC ASSESSMENT T; Karnon J, 2007, BRIT J CANCER, V97, P479, DOI 10.1038/sj.bjc.6603887; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Luengo-Fernandez R., 2010, DEMENTIA 2010 EC BUR; Luengo-Fernandez R, 2006, STROKE, V37, P2579, DOI 10.1161/01.STR.0000240508.28625.2c; MassoGonzalez E. L., 2009, Journal of Epidemiology & Community Health, V63, P332, DOI 10.1136/jech.2008.080382; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; McCrone PR., 2008, PAYING PRICE COST ME; Metz D, 2008, TRANSPORT REV, V28, P321, DOI 10.1080/01441640701642348; Morgan AS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-699; National Institute for Health and Clinical Excellence, 2007, HEAD INJ COST TEMPL; *OFF NAT STAT, 2000, PSYCH MORB AD LIV PR; Office of National Statistics, DET CPI RPI REF TABL; Organisation for Economic Cooperation and Development, 2002, STRAT RED GREENH GAS; Scarborough P, 2010, UK CORONARY HEART DI; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; *STATS19, STATS 19 HELP FIL; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; *TRANSP LOND, 2001, LOND AR TRANSP SURV; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Vercambre MN, 2011, ARCH INTERN MED, V171, P1244, DOI 10.1001/archinternmed.2011.282; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WHO Europe, HLTH EC ASS TOOL HEA; Williams R, 2001, PRACT DIABETES INT, V18, P235; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	48	128	129	2	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2198	2205		10.1016/S0140-6736(12)60766-1	http://dx.doi.org/10.1016/S0140-6736(12)60766-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682466				2022-12-28	WOS:000304990900036
J	Lynch, JM; Maillet, M; Vanhoutte, D; Schloemer, A; Sargent, MA; Blair, NS; Lynch, KA; Okada, T; Aronow, BJ; Osinska, H; Prywes, R; Lorenz, JN; Mori, K; Lawler, J; Robbins, J; Molkentin, JD				Lynch, Jeffrey M.; Maillet, Marjorie; Vanhoutte, Davy; Schloemer, Aryn; Sargent, Michelle A.; Blair, N. Scott; Lynch, Kaari A.; Okada, Tetsuya; Aronow, Bruce J.; Osinska, Hanna; Prywes, Ron; Lorenz, John N.; Mori, Kazutoshi; Lawler, Jack; Robbins, Jeffrey; Molkentin, Jeffery D.			A Thrombospondin-Dependent Pathway for a Protective ER Stress Response	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; OLIGOMERIC MATRIX PROTEIN; QUALITY-CONTROL; TRANSGENIC MICE; GENE; PSEUDOACHONDROPLASIA; EXPRESSION; ATF6; COMP; CARDIOMYOPATHY	Thrombospondin (Thbs) proteins are induced in sites of tissue damage or active remodeling. The endoplasmic reticulum (ER) stress response is also prominently induced with disease where it regulates protein production and resolution of misfolded proteins. Here we describe a function for Thbs as ER-resident effectors of an adaptive ER stress response. Thbs4 cardiac-specific transgenic mice were protected from myocardial injury, whereas Thbs4(-/-) mice were sensitized to cardiac maladaptation. Thbs induction produced a unique profile of adaptive ER stress response factors and expansion of the ER and downstream vesicles. Thbs bind the ER lumenal domain of activating transcription factor 6 alpha (Atf6 alpha) to promote its nuclear shuttling. Thbs4(-/-) mice showed blunted activation of Atf6 alpha and other ER stress-response factors with injury, and Thbs4-mediated protection was lost upon Atf6 alpha deletion. Hence, Thbs can function inside the cell during disease remodeling to augment ER function and protect through a mechanism involving regulation of Atf6 alpha.	[Lynch, Jeffrey M.; Maillet, Marjorie; Vanhoutte, Davy; Schloemer, Aryn; Sargent, Michelle A.; Blair, N. Scott; Aronow, Bruce J.; Osinska, Hanna; Robbins, Jeffrey; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH 45247 USA; [Sargent, Michelle A.; Molkentin, Jeffery D.] Univ Cincinnati, Howard Hughes Med Inst, Cincinnati, OH 45267 USA; [Lynch, Kaari A.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Okada, Tetsuya; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lorenz, John N.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Lawler, Jack] Harvard Univ, Sch Med, Boston, MA 02215 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Kyoto University; Columbia University; University System of Ohio; University of Cincinnati; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH 45247 USA.	jeff.molkentin@cchmc.org	Mori, Kazutoshi/K-6106-2015; Mori, Kazutoshi/AAW-5449-2020; Aronow, Bruce J/F-8438-2012; Vanhoutte, Davy/F-8071-2017; Lawler, Jack/AAJ-1379-2020	Vanhoutte, Davy/0000-0002-8147-6953; Okada, Tetsuya/0000-0002-2513-1301; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [HL049081]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081, R01HL105924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (J.D.M., J.R., M.M., J.La. [HL049081], J.N.L., R.P.) and the Howard Hughes Medical Institute (to J.D.M.). We would like to thank Allen York, Mark Duquette, and Zeenat Jamal for excellent technical assistance in conducting this study.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Cool AR, 2009, J MOL CELL CARDIOL, V46, P225, DOI 10.1016/j.yjmcc.2008.10.013; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; Gabrielsen A, 2007, J MOL CELL CARDIOL, V42, P870, DOI 10.1016/j.yjmcc.2006.12.016; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Greco SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-494; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; HAUSER N, 1995, FEBS LETT, V368, P307, DOI 10.1016/0014-5793(95)00675-Y; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mustonen E, 2008, BIOCHEM BIOPH RES CO, V373, P186, DOI 10.1016/j.bbrc.2008.05.164; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Prabakaran D, 1996, EUR J CELL BIOL, V70, P134; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Schellings MWM, 2009, J CELL COMMUN SIGNAL, V3, P201, DOI 10.1007/s12079-009-0070-6; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Sodersten F, 2007, CONNECT TISSUE RES, V48, P254, DOI 10.1080/03008200701587505; Stenina OI, 2007, ARTERIOSCL THROM VAS, V27, P1886, DOI 10.1161/ATVBAHA.107.141713; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Veliceasa D, 2007, FEBS J, V274, P6365, DOI 10.1111/j.1742-4658.2007.06159.x; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	43	147	161	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1257	1268		10.1016/j.cell.2012.03.050	http://dx.doi.org/10.1016/j.cell.2012.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682248	Bronze, Green Accepted			2022-12-28	WOS:000305119600011
J	Baker, M				Baker, Monya			BUILDING BETTER BIOBANKS	NATURE			English	Editorial Material																		Eiseman E., 1999, HDB HUMAN TISSUE SOU; Hubel A, 2011, BIOPRESERV BIOBANK, V9, P237, DOI 10.1089/bio.2010.0034; Kisand K, 2011, CLIN CHEM LAB MED, V49, P229, DOI 10.1515/CCLM.2011.049; Kugler Karl G, 2011, J Clin Bioinforma, V1, DOI 10.1186/2043-9113-1-9; Massett Holly A., 2011, Journal of the National Cancer Institute Monographs, P8, DOI 10.1093/jncimonographs/lgr007; Scott CT, 2012, NAT BIOTECHNOL, V30, P141, DOI 10.1038/nbt.2116; Simeon-Dubach D, 2011, NATURE, V475, P454, DOI 10.1038/475454d; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P24, DOI 10.1093/jncimonographs/lgr009	8	90	94	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2012	486	7401					141	146		10.1038/486141a	http://dx.doi.org/10.1038/486141a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	953GD	22678297	Bronze			2022-12-28	WOS:000304854000044
J	Li, Y; Lu, H; Cheng, PL; Ge, SY; Xu, HT; Shi, SH; Dan, Y				Li, Ye; Lu, Hui; Cheng, Pei-lin; Ge, Shaoyu; Xu, Huatai; Shi, Song-Hai; Dan, Yang			Clonally related visual cortical neurons show similar stimulus feature selectivity	NATURE			English	Article							CIRCUIT FORMATION; RECEPTIVE-FIELDS; IN-VIVO; CORTEX; NEOCORTEX; NETWORKS; SPECIFICATION; NEUROGENESIS; PATTERNS; CONNEXIN	A fundamental feature of the mammalian neocortex is its columnar organization(1). In the visual cortex, functional columns consisting of neurons with similar orientation preferences have been characterized extensively(2-4), but how these columns are constructed during development remains unclear(5). The radial unit hypothesis(6) posits that the ontogenetic columns formed by clonally related neurons migrating along the same radial glial fibre during corticogenesis(7) provide the basis for functional columns in adult neocortex(1). However, a direct correspondence between the ontogenetic and functional columns has not been demonstrated(8). Here we show that, despite the lack of a discernible orientation map in mouse visual cortex(4,9,10), sister neurons in the same radial clone exhibit similar orientation preferences. Using a retroviral vector encoding green fluorescent protein to label radial clones of excitatory neurons, and in vivo two-photon calcium imaging to measure neuronal response properties, we found that sister neurons preferred similar orientations whereas nearby non-sister neurons showed no such relationship. Interestingly, disruption of gap junction coupling by viral expression of a dominant-negative mutant of Cx26 (also known as Gjb2) or by daily administration of a gap junction blocker, carbenoxolone, during the first postnatal week greatly diminished the functional similarity between sister neurons, suggesting that the maturation of ontogenetic into functional columns requires intercellular communication through gap junctions. Together with the recent finding of preferential excitatory connections among sister neurons(11), our results support the radial unit hypothesis and unify the ontogenetic and functional columns in the visual cortex.	[Li, Ye; Lu, Hui; Cheng, Pei-lin; Dan, Yang] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; [Li, Ye; Lu, Hui; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Xu, Huatai; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center	Dan, Y (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Lu, Hui/K-2322-2013; Cheng, Pei-Lin/ABB-2255-2021	Cheng, Pei-Lin/0000-0002-0090-8153; Dan, Yang/0000-0002-3818-877X	National Institutes of Health (NIH) [R01 EY018861, R01 DA024681, R21NS072483]; NSF [22250400-42533]; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065915, R21NS072483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grant R01 EY018861 and NSF grant 22250400-42533 (to Y.D.), and NIH grants R01 DA024681 and R21NS072483 (to S.-H. S.). We thank L. E. White and S. D. Van Hooser for comments on the manuscript, A. Kwan and S. D. Van Hooser for help with two-photon imaging techniques and analysis and Y. Gu for help in making retrovirus.	Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; CEPKO CL, 1990, COLD SH Q B, V55, P265; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kandler K, 1998, J NEUROSCI, V18, P1419; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Polleux F, 1997, J COMP NEUROL, V385, P95; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rouan F, 2001, J CELL SCI, V114, P2105; Schuett S, 2002, J NEUROSCI, V22, P6549; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	33	165	167	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					118	U144		10.1038/nature11110	http://dx.doi.org/10.1038/nature11110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678292	Green Accepted, Green Submitted			2022-12-28	WOS:000304854000039
J	Yoshida, N; Kanda, J				Yoshida, Naohiro; Kanda, Jota			Tracking the Fukushima Radionuclides	SCIENCE			English	Editorial Material							PLANT; CONTAMINATION; DISPERSION; CESIUM-137; SOILS; I-131; OCEAN		[Yoshida, Naohiro] Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Kanda, Jota] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan	Tokyo Institute of Technology; Tokyo University of Marine Science & Technology	Yoshida, N (corresponding author), Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan.	yoshida.n.aa@m.titech.ac.jp; jkanda@kaiyodai.ac.jp	Kanda, Jota/O-1881-2014; Yoshida, Naohiro/A-8335-2010; Ley, Sarah/Y-9216-2019	Kanda, Jota/0000-0002-5099-6278; Yoshida, Naohiro/0000-0003-0454-3849; 				Aoyama M., 2012, OC SCI M 21 FEBR SAL; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Burns PC, 2012, SCIENCE, V335, P1184, DOI 10.1126/science.1211285; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Honda MC, 2012, GEOCHEM J, V46, pE1; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Stohl A., 2011, ATMOS CHEM PHYS DISC, V11, P28319, DOI DOI 10.5194/ACPD-11-28319-2011; Tanaka K, 2012, GEOCHEM J, V46, P73, DOI 10.2343/geochemj.1.0137; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Weiss R, 2012, SCIENCE, V336, P1117, DOI 10.1126/science.1221452; Yamamoto M., 2011, MINERAL MAG, V75, P2296; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	17	212	229	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1115	1116		10.1126/science.1219493	http://dx.doi.org/10.1126/science.1219493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654046				2022-12-28	WOS:000304647900033
J	Ranieri, VM; Thompson, BT; Barie, PS; Dhainaut, JF; Douglas, IS; Finfer, S; Gardlund, B; Marshall, JC; Rhodes, A; Artigas, A; Payen, D; Tenhunen, J; Al-Khalidi, HR; Thompson, V; Janes, J; Macias, WL; Vangerow, B; Williams, MD				Ranieri, V. Marco; Thompson, B. Taylor; Barie, Philip S.; Dhainaut, Jean-Francois; Douglas, Ivor S.; Finfer, Simon; Gardlund, Bengt; Marshall, John C.; Rhodes, Andrew; Artigas, Antonio; Payen, Didier; Tenhunen, Jyrki; Al-Khalidi, Hussein R.; Thompson, Vivian; Janes, Jonathan; Macias, William L.; Vangerow, Burkhard; Williams, Mark D.		PROWESS-SHOCK Study Grp	Drotrecogin Alfa (Activated) in Adults with Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-ORGAN DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; SEVERE SEPSIS; PROTEIN-C; APACHE-II; SURGICAL-PATIENTS; UNITED-STATES; NOREPINEPHRINE; EPIDEMIOLOGY; SURVIVAL	BACKGROUND There have been conflicting reports on the efficacy of recombinant human activated protein C, or drotrecogin alfa (activated) (DrotAA), for the treatment of patients with septic shock. METHODS In this randomized, double-blind, placebo-controlled, multicenter trial, we assigned 1697 patients with infection, systemic inflammation, and shock who were receiving fluids and vasopressors above a threshold dose for 4 hours to receive either DrotAA (at a dose of 24 mu g per kilogram of body weight per hour) or placebo for 96 hours. The primary outcome was death from any cause 28 days after randomization. RESULTS At 28 days, 223 of 846 patients (26.4%) in the DrotAA group and 202 of 834 (24.2%) in the placebo group had died (relative risk in the DrotAA group, 1.09; 95% confidence interval [CI], 0.92 to 1.28; P = 0.31). At 90 days, 287 of 842 patients (34.1%) in the DrotAA group and 269 of 822 (32.7%) in the placebo group had died (relative risk, 1.04; 95% CI, 0.90 to 1.19; P = 0.56). Among patients with severe protein C deficiency at baseline, 98 of 342 (28.7%) in the DrotAA group had died at 28 days, as compared with 102 of 331 (30.8%) in the placebo group (risk ratio, 0.93; 95% CI, 0.74 to 1.17; P = 0.54). Similarly, rates of death at 28 and 90 days were not significantly different in other predefined subgroups, including patients at increased risk for death. Serious bleeding during the treatment period occurred in 10 patients in the DrotAA group and 8 in the placebo group (P = 0.81). CONCLUSIONS DrotAA did not significantly reduce mortality at 28 or 90 days, as compared with placebo, in patients with septic shock. (Funded by Eli Lilly; PROWESS-SHOCK ClinicalTrials.gov number, NCT00604214.)	[Ranieri, V. Marco] Univ Turin, Osped S Giovanni Battista Molinette, Turin, Italy; [Thompson, B. Taylor] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Barie, Philip S.] Weill Cornell Med Coll, Dept Surg, New York, NY USA; [Barie, Philip S.] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Dhainaut, Jean-Francois] Paris Descartes Univ, Royal Hosp, Paris, France; [Payen, Didier] Univ Paris Diderot, Paris, France; [Payen, Didier] Hop Lariboisiere, AP HP, Dept Anesthesie Reanimat SMUR, F-75475 Paris, France; [Douglas, Ivor S.] Univ Colorado, Sch Med, Denver, CO USA; [Finfer, Simon] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia; [Finfer, Simon] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Gardlund, Bengt] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Inst, Dept Surg, Toronto, ON M5B 1W8, Canada; [Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Inst, Dept Crit Care Med, Toronto, ON M5B 1W8, Canada; [Rhodes, Andrew] St Georges Healthcare NHS Trust, London, England; [Artigas, Antonio] St Georges Univ, London, England; [Artigas, Antonio] Univ Autonoma Barcelona, Univ Parc Tauli, CIBER Enfermedades Resp, Crit Care Ctr,Hosp Sabadell, Sabadell, Spain; [Tenhunen, Jyrki] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, Uppsala, Sweden; [Al-Khalidi, Hussein R.; Thompson, Vivian] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Janes, Jonathan; Macias, William L.; Vangerow, Burkhard; Williams, Mark D.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Harvard University; Massachusetts General Hospital; Cornell University; Cornell University; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Royal North Shore Hospital; University of Sydney; George Institute for Global Health; University of Sydney; Karolinska Institutet; Karolinska University Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; St Georges University London; St Georges University London; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Uppsala University; Duke University; Eli Lilly			Asfar, Pierre/K-1402-2015; François, Bruno/O-8404-2016; Rello, Jordi/P-2402-2019; Whitehouse, Tony/AAC-1215-2020; Van Haren, Frank/G-1335-2015; van Zanten, Arthur R.H./ABB-1169-2021; Barie, Philip/AAN-8811-2020; Sevcik, Pavel/G-6052-2017; Frendl, Gyorgy/AAE-5345-2020; Malbrain, Manu LNG/B-3680-2017; Sramek, Vladimir/M-2152-2016; Pickkers, P./H-8080-2014; Ferguson, Niall/D-7619-2019; Douglas, Ivor S/AAC-6245-2021; Rhodes, Andrew/G-4265-2011; Leditschke, Isabel A/M-1186-2015; de Carvalho, Frederico Bruzzi/ABB-3911-2020; Ruiz-Rodriguez, Juan Carlos/H-7703-2012; Ranieri, Marco/AFX-8152-2022; Betbesé, Antoni/H-3419-2013	François, Bruno/0000-0002-2531-1652; Rello, Jordi/0000-0003-0676-6210; Whitehouse, Tony/0000-0002-4387-3421; Van Haren, Frank/0000-0001-8037-4229; van Zanten, Arthur R.H./0000-0001-6276-7192; Sevcik, Pavel/0000-0003-1635-7832; Frendl, Gyorgy/0000-0001-8918-8553; Malbrain, Manu LNG/0000-0002-1816-5255; Pickkers, P./0000-0002-1104-4303; Ferguson, Niall/0000-0002-6213-5264; Douglas, Ivor S/0000-0002-4541-1431; Rhodes, Andrew/0000-0002-8737-574X; Leditschke, Isabel A/0000-0003-2212-2140; de Carvalho, Frederico Bruzzi/0000-0002-9752-5625; Ruiz-Rodriguez, Juan Carlos/0000-0001-7392-8617; Betbesé, Antoni/0000-0002-9059-4046; Della Corte, Francesco/0000-0003-1736-2318; QUENOT, Jean-Pierre/0000-0003-2351-682X; /0000-0002-4157-5148; Malledant, yannick/0000-0001-6680-5184; Neiser, Jan/0000-0002-0196-6566; Maggiorini, Marco/0000-0001-8180-2117; Finfer, Simon/0000-0002-2785-5864; Paiva, Jose-Artur/0000-0003-4323-0220; antonio, artigas/0000-0002-8029-1017; LEPAPE, Alain/0000-0001-5950-7533	Eli Lilly; Abbott; Sanofi-Aventis; Immunetrics; US Biotest; Sirius Genomics; Eisai; Agennix; Idaho Technology; Roche Diagnostics; Bayer; Vertex Technologies; Pfizer; Daiichi Sankyo; Hoffmann-La Roche; BioMerieux; Edwards; LiDCO; Covidien; Brahms; Naturalia et Biologia	Eli Lilly(Eli Lilly); Abbott(Abbott Laboratories); Sanofi-Aventis(Sanofi-Aventis); Immunetrics; US Biotest; Sirius Genomics; Eisai(Eisai Co Ltd); Agennix; Idaho Technology; Roche Diagnostics; Bayer(Bayer AG); Vertex Technologies(Vertex Pharmaceuticals); Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Hoffmann-La Roche(Hoffmann-La Roche); BioMerieux; Edwards; LiDCO; Covidien; Brahms; Naturalia et Biologia	Dr. Ranieri reports serving as a member of a data and safety monitoring board for Biotest and an advisory board member for Hemodec and Maquet; Dr. Thompson, serving as the chair of a data and safety monitoring board for AstraZeneca and as an advisory board member for Hemodec, receiving consulting fees from Abbott, Sanofi-Aventis, Immunetrics, US Biotest, Sirius Genomics, and Eli Lilly; Dr. Barie, receiving consulting fees from Eisai and lecture fees from Eli Lilly; Dr. Douglas, receiving grant support from Eli Lilly, Eisai, and Agennix and serving as cochair for the International Guidelines Committee for the 2012 Surviving Sepsis Campaign; Dr. Finfer, receiving consulting fees from Eisai, being a member of the International Sepsis Forum (ISF), and receiving travel support from ISF corporate sponsors; Dr. Marshall, receiving consulting fees from Eisai, Idaho Technology, Roche Diagnostics, Bayer, Vertex Technologies, Pfizer, Daiichi Sankyo, and Hoffmann-La Roche, receiving grant support and travel expenses from BioMerieux, serving as a member of the ISF and receiving travel support from ISF corporate sponsors, serving as a member of the Center for Sepsis Control and Care at the University of Jena and as a member of the data and safety monitoring board for Artisan Pharma, Leo Pharma, Celgene Therapeutics, and Therapeutic Monitoring Systems, and serving as a steering committee member for Spectral Diagnostics and Eisai; Dr. Rhodes, serving on advisory boards for LiDCO and BioMerieux and receiving lecture fees from Edwards, LiDCO, and Covidien; all the preceding authors, or their institutions, received financial support from Eli Lilly for time spent performing committee activities and for travel; Dr. Artigas, receiving travel support and lecture fees and grant support and support for patient recruitment (through his institution) from Eli Lilly, serving on advisory boards for Gambro and Hemodec, and receiving consulting fees from Brahms; Dr. Payen, serving on an advisory board for Homeostasie Consulting and receiving consulting and lecture fees from Homeostasie Consulting and institutional grant support from Naturalia et Biologia; Dr. Tenhunen, receiving institutional grant support for lectures, travel expenses, and data analysis from Eli Lilly; Dr. Al-Khalidi and Ms. Thompson, being employees of the Duke Clinical Research Institute, which received financial support for statistical analysis, preparation of study reports, manuscript review and writing, and travel from Eli Lilly; and Drs. Janes, Macias, Vangerow, and Williams, being current or former employees of and having an equity interest in Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; [Anonymous], 2007, 4 ANN REASSESSMENT X; ARISE, 2007, Crit Care Resusc, V9, P8; Barie PS, 2011, SURG INFECT, V12, P443, DOI 10.1089/sur.2011.133; Bernard GR, 2003, CRIT CARE, V7, P155, DOI 10.1186/cc2167; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Dhainaut JF, 2003, INTENS CARE MED, V29, P894, DOI 10.1007/s00134-003-1731-1; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; European Medicines Agency, 2002, MARK AUTH DROTR ALF; Finfer S, 2008, INTENS CARE MED, V34, P1935, DOI 10.1007/s00134-008-1266-6; Finfer S, 2011, INTENS CARE MED, V37, P372, DOI 10.1007/s00134-010-2081-4; Food and Drug Administration, 2011, VOL MARK WITHDR XIGR; Fry Donald E, 2004, Surg Infect (Larchmt), V5, P253, DOI 10.1089/sur.2004.5.253; Gardlund B, 2006, ACTA ANAESTH SCAND, V50, P907, DOI 10.1111/j.1399-6576.2006.01086.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koperna T, 2001, ARCH SURG-CHICAGO, V136, P55, DOI 10.1001/archsurg.136.1.55; Levi M, 2007, AM J RESP CRIT CARE, V176, P483, DOI 10.1164/rccm.200612-1803OC; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Macias WL, 2004, CRIT CARE MED, V32, pS223, DOI 10.1097/01.CCM.0000126120.49367.AC; Maharaj R, 2011, CONTEMP CLIN TRIALS, V32, P924, DOI 10.1016/j.cct.2011.07.010; Marti-Carvajal AJ, 2011, COCHRANE DB SYST REV, V4; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Opal S, 2010, CRIT CARE MED, V38, pU119; Ranieri VM, 2011, INTENS CARE MED, V37, P1384, DOI 10.1007/s00134-011-2272-7; Rao SR, 2007, CIRCULATION, V115, P109, DOI 10.1161/CIRCULATIONAHA.106.614859; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4946; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Thompson BT, 2010, INTENS CARE MED, V36, P1972, DOI 10.1007/s00134-010-1977-3; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2003, CRIT CARE MED, V31, P834, DOI 10.1097/01.CCM.0000051515.56179.E1	39	852	906	1	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2055	2064		10.1056/NEJMoa1202290	http://dx.doi.org/10.1056/NEJMoa1202290			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22616830	Green Published			2022-12-28	WOS:000304613400005
J	Singh, M; Comfere, N				Singh, Meena; Comfere, Nneka			Palisaded Neutrophilic and Granulomatous Dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Singh, Meena; Comfere, Nneka] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Singh, M (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	comfere.nneka@mayo.edu							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					E33	E33						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646653				2022-12-28	WOS:000304613400012
J	Chan, CH; Li, CF; Yang, WL; Gao, Y; Lee, SW; Feng, ZZ; Huang, HY; Tsai, KKC; Flores, LG; Shao, YP; Hazle, JD; Yu, DH; Wei, WY; Sarbassov, D; Hung, MC; Nakayama, KI; Lin, HK				Chan, Chia-Hsin; Li, Chien-Feng; Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Feng, Zizhen; Huang, Hsuan-Ying; Tsai, Kelvin K. C.; Flores, Leo G.; Shao, Yiping; Hazle, John D.; Yu, Dihua; Wei, Wenyi; Sarbassov, Dos; Hung, Mien-Chie; Nakayama, Keiichi I.; Lin, Hui-Kuan			The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis	CELL			English	Article							UNANCHORED POLYUBIQUITIN CHAINS; GENE-EXPRESSION; BREAST-CANCER; KINASE; GROWTH; METABOLISM; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; LOCALIZATION	Akt kinase plays a central role in cell growth, metabolism, and tumorigenesis. The TRAF6 E3 ligase orchestrates IGF-1-mediated Akt ubiquitination and activation. Here, we show that Akt ubiquitination is also induced by activation of ErbB receptors; unexpectedly, and in contrast to IGF-1 induced activation, the Skp2 SCF complex, not TRAF6, is a critical E3 ligase for ErbB-receptor-mediated Akt ubiquitination and membrane recruitment in response to EGF. Skp2 deficiency impairs Akt activation, Glut1 expression, glucose uptake and glycolysis, and breast cancer progression in various tumor models. Moreover, Skp2 overexpression correlates with Akt activation and breast cancer metastasis and serves as a marker for poor prognosis in Her2-positive patients. Finally, Skp2 silencing sensitizes Her2-overexpressing tumors to Herceptin treatment. Our study suggests that distinct E3 ligases are utilized by diverse growth factors for Akt activation and that targeting glycolysis sensitizes Her2-positive tumors to Herceptin treatment.	[Chan, Chia-Hsin; Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Feng, Zizhen; Yu, Dihua; Sarbassov, Dos; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Flores, Leo G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Shao, Yiping; Hazle, John D.] Univ Texas MD Anderson Canc Ctr, Dept Image Phys, Houston, TX 77030 USA; [Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Yu, Dihua; Sarbassov, Dos; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Li, Chien-Feng] Chi Mei Fdn Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Li, Chien-Feng; Tsai, Kelvin K. C.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Huang, Hsuan-Ying] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung 833, Kaohsiung Count, Taiwan; [Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Li, Chien-Feng] So Taiwan Univ, Dept Biotechnol, Tainan 710, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Chi Mei Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Southern Taiwan University of Science & Technology	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Yang, Wei-Lei/E-2598-2012; Sarbassov, Dos/AAS-4950-2020; Tsai, Kun-Chih/C-1371-2010; Chan, Chia-Hsin/AAT-7782-2020; 高, 雨莉/HGU-8187-2022; Hung, Mien-Chie/ABD-5911-2021; Feng, Zizhen/G-2322-2014	Hung, Mien-Chie/0000-0003-4317-4740; Feng, Zizhen/0000-0002-7763-1869; Yu, Dihua/0000-0001-6231-9381; Tsai, Kelvin/0000-0002-1612-2868; Chan, Chia-Hsin/0000-0001-8506-7500; Sarbassov, Dos/0000-0002-6848-1133	MD Anderson Cancer Center Trust; Prostate SPORE Career Development Award [P50 CA140388 SPORE]; NIH; CPRIT; DOD; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation; Department of Health in Taiwan; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA149321, R01CA136787] Funding Source: NIH RePORTER	MD Anderson Cancer Center Trust; Prostate SPORE Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; DOD(United States Department of Defense); MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Health in Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Mrs. J. Delacerda and C.V. Kingsley at small animal imaging facility of MD Anderson Cancer Center for their assistance in CT/PET imaging. We also thank the members from Lin's laboratory for their valuable comments and suggestions. We thank Drs. W. Tansey and M. H. Lee for reagents. This work was supported by the MD Anderson Cancer Center Trust Scholar Award, Prostate SPORE Career Development Award (P50 CA140388 SPORE), NIH grants, CPRIT grant, DOD prostate cancer New Investigator Award (H.K.L.), the MD Anderson Cancer Center Breast SPORE Career Development Award (C.H.C.), the Susan G. Komen Breast Cancer Foundation postdoctoral fellowship (C.H.C.), and a grant from the Department of Health in Taiwan (C.F.L.).	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Birnbaum MJ, 2004, DEV CELL, V7, P781, DOI 10.1016/j.devcel.2004.11.016; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chan CH, 2011, J MOL MED, V89, P857, DOI 10.1007/s00109-011-0766-y; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; DATTA K, 1995, MOL CELL BIOL, V15, P2304; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HY, 2006, CLIN CANCER RES, V12, P487, DOI 10.1158/1078-0432.CCR-05-1497; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; Osthus R.C., 2000, ONCOGENE, V275, P21797; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012	45	265	280	6	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1098	1111		10.1016/j.cell.2012.02.065	http://dx.doi.org/10.1016/j.cell.2012.02.065			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632973	Green Accepted, Bronze			2022-12-28	WOS:000304453900015
J	D'Angiolella, V; Donato, V; Forrester, FM; Jeong, YT; Pellacani, C; Kudo, Y; Saraf, A; Florens, L; Washburn, MP; Pagano, M				D'Angiolella, Vincenzo; Donato, Valerio; Forrester, Frances M.; Jeong, Yeon-Tae; Pellacani, Claudia; Kudo, Yasusei; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Pagano, Michele			Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair	CELL			English	Article							NORMAL-CELL CYCLE; SEQUENCE-ANALYSIS; R2 PROTEIN; DTTP POOL; DAMAGE; REPLICATION; SUBUNIT; CHECKPOINT; MUTATIONS; KINASE	F-box proteins are the substrate binding subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes. Using affinity purifications and mass spectrometry, we identified RRM2 (the ribonucleotide reductase family member 2) as an interactor of the F-box protein cyclin F. Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to deoxyribonucleotides (dNTPs), which are necessary for both replicative and repair DNA synthesis. We found that, during G2, following CDK-mediated phosphorylation of Thr33, RRM2 is degraded via SCFcyclin (F) to maintain balanced dNTP pools and genome stability. After DNA damage, cyclin F is downregulated in an ATR-dependent manner to allow accumulation of RRM2. Defective elimination of cyclin F delays DNA repair and sensitizes cells to DNA damage, a phenotype that is reverted by expressing a nondegradable RRM2 mutant. In summary, we have identified a biochemical pathway that controls the abundance of dNTPs and ensures efficient DNA repair in response to genotoxic stress.	[D'Angiolella, Vincenzo; Donato, Valerio; Forrester, Frances M.; Jeong, Yeon-Tae; Pellacani, Claudia; Kudo, Yasusei; Pagano, Michele] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA; [Kudo, Yasusei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708501, Japan; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, Bethesda, MD USA	New York University; Tokushima University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		Washburn, Michael/0000-0001-7568-2585; Kudo, Yasusei/0000-0002-0392-7720; pagano, michele/0000-0003-3210-2442; Florens, Laurence/0000-0002-9310-6650; Pellacani, Claudia/0000-0002-6818-1229	American Italian Cancer Foundation; National Institutes of Health [R01-GM057587, R37-CA076584, R21-CA161108]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	American Italian Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Elledge, L. Gardner and N. Zheng for reagents, V. Bianchi for suggestions, and J.R. Skaar for reading the manuscript. M. P. is grateful to T.M. Thor for continuous support. V.D'A. was a Leukemia and Lymphoma Society Scholar. V.D'A. and V.D. received support from the American Italian Cancer Foundation. This work was supported by grants from the National Institutes of Health to M.P. (R01-GM057587, R37-CA076584, and R21-CA161108). A.S., L.F., and M.P.W. are supported by the Stowers Institute for Medical Research. M.P. is an Investigator with the Howard Hughes Medical Institute.	ANDERSSON B, 1992, ENVIRON MOL MUTAGEN, V20, P89, DOI 10.1002/em.2850200204; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chan AK, 1999, BBA-MOL CELL RES, V1448, P363, DOI 10.1016/S0167-4889(98)00115-3; CHAN AK, 1993, BIOCHEMISTRY-US, V32, P12835, DOI 10.1021/bi00210a036; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; DARE E, 1995, J MOL BIOL, V252, P514, DOI 10.1006/jmbi.1995.0516; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Ferrandina G, 2010, CANCER CHEMOTH PHARM, V65, P679, DOI 10.1007/s00280-009-1073-y; Florens Laurence, 2006, V328, P159; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jones RJ, 2011, BLOOD, V118, P4140, DOI 10.1182/blood-2011-03-340323; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Kunz BA, 1998, GENETICS, V148, P1491; KUNZ BA, 1988, MUTAT RES, V200, P133, DOI 10.1016/0027-5107(88)90076-0; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Martin L., 2011, ONCOGENE, V2011, P19; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PHEAR G, 1989, MUTAT RES, V214, P201, DOI 10.1016/0027-5107(89)90164-4; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Wang XC, 2011, BIOCHEM BIOPH RES CO, V410, P102, DOI 10.1016/j.bbrc.2011.05.114; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Xue LJ, 2003, CANCER RES, V63, P980; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	63	244	245	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1023	1034		10.1016/j.cell.2012.03.043	http://dx.doi.org/10.1016/j.cell.2012.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632967	Green Accepted, Bronze			2022-12-28	WOS:000304453900009
J	Bell, RD; Winkler, EA; Singh, I; Sagare, AP; Deane, R; Wu, ZH; Holtzman, DM; Betsholtz, C; Armulik, A; Sallstrom, J; Berk, BC; Zlokovic, BV				Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Holtzman, David M.; Betsholtz, Christer; Armulik, Annika; Sallstrom, Jan; Berk, Bradford C.; Zlokovic, Berislav V.			Apolipoprotein E controls cerebrovascular integrity via cyclophilin A	NATURE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; APOE; DEMENTIA; PROTEIN; MICE; NEURODEGENERATION; EXPRESSION	Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4(1). APOE4 is a major genetic risk factor for Alzheimer's disease(2,3) and is associated with Down's syndrome dementia and poor neurological outcome after traumatic brain injury and haemorrhage(3). Neurovascular dysfunction is present in normal APOE4 carriers(4-6) and individuals with APOE4-associated disorders(3,7-10). In mice, lack of Apoe leads to blood-brain barrier (BBB) breakdown(11,12), whereas APOE4 increases BBB susceptibility to injury(13). How APOE genotype affects brain microcirculation remains elusive. Using different APOE transgenic mice, including mice with ablation and/or inhibition of cyclophilin A (CypA), here we show that expression of APOE4 and lack of murine Apoe, but not APOE2 and APOE3, leads to BBB breakdown by activating a proinflammatory CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes. This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic proteins, and microvascular and cerebral blood flow reductions. We show that the vascular defects in Apoe-deficient and APOE4-expressing mice precede neuronal dysfunction and can initiate neurodegenerative changes. Astrocyte-secreted APOE3, but not APOE4, suppressed the CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes through a lipoprotein receptor. Our data suggest that CypA is a key target for treating APOE4-mediated neurovascular injury and the resulting neuronal dysfunction and degeneration.	[Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Sallstrom, Jan; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Bell, Robert D.; Berk, Bradford C.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, St Louis, MO 63110 USA; [Betsholtz, Christer; Armulik, Annika] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Armulik, Annika] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Ctr Neurodegenerat & Regenerat, Los Angeles, CA 90089 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Rochester; University of Rochester; Washington University (WUSTL); Karolinska Institutet; University of Zurich; University Zurich Hospital; University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	zlokovic@usc.edu	Sagare, Abhay/Y-3273-2019	Sagare, Abhay/0000-0002-8178-3785; Berk, Bradford/0000-0002-2767-4115; Keller, Annika/0000-0003-1466-3633	National Institute of Health [R37NS34467, R37AG23084, RO1AG039452, R37AG13956]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039452, RF1AG039452, R37AG013956, R37AG023084] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank the National Institute of Health for grants R37NS34467 (B.V.Z.); R37AG23084 (B.V.Z.); RO1AG039452 (B.V.Z.); and R37AG13956 (D. M. H.) used to support this study.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Garcia-Alloza M, 2009, J NEUROCHEM, V109, P1636, DOI 10.1111/j.1471-4159.2009.06096.x; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	30	808	835	12	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					512	516		10.1038/nature11087	http://dx.doi.org/10.1038/nature11087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622580	Green Accepted			2022-12-28	WOS:000304344500045
J	Pearce, MS; Salotti, JA; Little, MP; McHugh, K; Lee, C; Kim, KP; Howe, NL; Ronckers, CM; Rajaraman, P; Craft, AW; Parker, L; de Gonzalez, AB				Pearce, Mark S.; Salotti, Jane A.; Little, Mark P.; McHugh, Kieran; Lee, Choonsik; Kim, Kwang Pyo; Howe, Nicola L.; Ronckers, Cecile M.; Rajaraman, Preetha; Craft, Alan W.; Parker, Louise; de Gonzalez, Amy Berrington			Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study	LANCET			English	Article							COMPUTED-TOMOGRAPHY; IONIZING-RADIATION; PEDIATRIC-PATIENTS; CANCER INCIDENCE; CHILDREN; BODY	Background Although CT scans are very useful clinically, potential cancer risks exist from associated ionising radiation, in particular for children who are more radiosensitive than adults. We aimed to assess the excess risk of leukaemia and brain tumours after CT scans in a cohort of children and young adults. Methods In our retrospective cohort study, we included patients without previous cancer diagnoses who were first examined with CT in National Health Service (NHS) centres in England, Wales, or Scotland (Great Britain) between 1985 and 2002, when they were younger than 22 years of age. We obtained data for cancer incidence, mortality, and loss to follow-up from the NHS Central Registry from Jan 1, 1985, to Dec 31, 2008. We estimated absorbed brain and red bone marrow doses per CT scan in mGy and assessed excess incidence of leukaemia and brain tumours cancer with Poisson relative risk models. To avoid inclusion of CT scans related to cancer diagnosis, follow-up for leukaemia began 2 years after the first CT and for brain tumours 5 years after the first CT. Findings During follow-up, 74 of 178 604 patients were diagnosed with leukaemia and 135 of 176 587 patients were diagnosed with brain tumours. We noted a positive association between radiation dose from CT scans and leukaemia (excess relative risk [ERR] per mGy 0.036, 95% CI 0.005-0.120; p=0.0097) and brain tumours (0.023, 0.010-0.049; p<0.0001). Compared with patients who received a dose of less than 5 mGy, the relative risk of leukaemia for patients who received a cumulative dose of at least 30 mGy (mean dose 51.13 mGy) was 3.18 (95% CI 1.46-6.94) and the relative risk of brain cancer for patients who received a cumulative dose of 50-74 mGy (mean dose 60.42 mGy) was 2.82 (1.33-6.03). Interpretation Use of CT scans in children to deliver cumulative doses of about 50 mGy might almost triple the risk of leukaemia and doses of about 60 mGy might triple the risk of brain cancer. Because these cancers are relatively rare, the cumulative absolute risks are small: in the 10 years after the first scan for patients younger than 10 years, one excess case of leukaemia and one excess case of brain tumour per 10 000 head CT scans is estimated to occur. Nevertheless, although clinical benefits should outweigh the small absolute risks, radiation doses from CT scans ought to be kept as low as possible and alternative procedures, which do not involve ionising radiation, should be considered if appropriate.	[Pearce, Mark S.; Salotti, Jane A.; Howe, Nicola L.] Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Craft, Alan W.] Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, No Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Little, Mark P.; Lee, Choonsik; Ronckers, Cecile M.; Rajaraman, Preetha; de Gonzalez, Amy Berrington] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [McHugh, Kieran] Children NHS Trust, Great Ormond St Hosp, London, England; [Kim, Kwang Pyo] Kyung Hee Univ, Dept Nucl Engn, Gyeongi Do, South Korea; [Ronckers, Cecile M.] Dutch Childhood Oncol Grp Longterm Effects Childh, The Hague, Netherlands; [Parker, Louise] Dalhousie Univ, Populat Canc Res Program, Dept Med, Halifax, NS, Canada; [Parker, Louise] Dalhousie Univ, Populat Canc Res Program, Dept Paediat, Halifax, NS, Canada	Newcastle University - UK; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Kyung Hee University; Dutch Childhood Oncology Group; Dalhousie University; Dalhousie University	Pearce, MS (corresponding author), Newcastle Univ, Royal Victoria Infirm, Sir James Spence Inst, Inst Hlth & Soc, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	mark.pearce@ncl.ac.uk	Ronckers, Cecile/GWN-0737-2022; Lee, Choonsik/C-9023-2015; Berrington, Amy/L-7017-2017	Lee, Choonsik/0000-0003-4289-9870; Little, Mark/0000-0003-0980-7567; PARKER, LOUISE/0000-0002-5188-8113; Berrington, Amy/0000-0002-7332-8387; Ronckers, Cecile M./0000-0003-3524-4657; Pearce, Mark/0000-0002-0583-3779	US National Cancer Institute [NO2-CP-75501]; UK Department of Health [RRX119]; North of England Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [ZIACP010222] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UK Department of Health; North of England Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by contract NO2-CP-75501 from the US National Cancer Institute and by the Radiation Research Programme of the UK Department of Health (RRX119). We thank the North of England Children's Cancer Research Fund for their continued support of paediatric cancer epidemiology studies at Newcastle University (Newcastle upon Tyne, UK); the staff in radiology departments across Great Britain who contributed data; Richard Hardy, Katharine Kirton, and Wenhua Metcalf from Newcastle University; Jeremy Miller (Information Management Services, Rockville, MD, USA); and Martha Linet and Lindsay Morton from the National Cancer Institute (Bethesda, MD, USA) for their assistance. Elaine Ron, who was one of the original investigators for this study, died of cancer on Nov 20, 2010. We greatly appreciate her contributions, support, and devotion to this study and to the field of radiation epidemiology.	Ahmed BA, 2010, PEDIATRICS, V126, pE851, DOI 10.1542/peds.2009-2675; [Anonymous], 2011, SUMM QUAL REP CANC R; Blettner M, 2007, EUR J CANCER, V43, P1990, DOI 10.1016/j.ejca.2007.06.020; BOICE JD, 1991, RADIAT RES, V125, P214, DOI 10.2307/3577890; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Budoff M, 2011, J CARDIOVASC COMPUT, V5, P275, DOI 10.1016/j.jcct.2011.05.004; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Carroll RJ, 2006, MODERN PERSPECTIVE, P1; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Davis F, 2011, RADIAT RES, V175, P790, DOI 10.1667/RR2186.1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Einstein AJ, 2012, J AM COLL CARDIOL, V59, P553, DOI 10.1016/j.jacc.2011.08.079; Kim KP, 2012, RADIAT PROT DOSIM, V150, P415, DOI 10.1093/rpd/ncr429; Lee C, 2011, MED PHYS, V38, P1196, DOI 10.1118/1.3544658; Lee C, 2010, PHYS MED BIOL, V55, P339, DOI 10.1088/0031-9155/55/2/002; Little MP, ENV HLTH PE IN PRESS; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, p[1, 1], DOI DOI 10.1007/978-1-4899-3242-6; National Radiological Protection Board, 1991, SURV CT PRACT UK; Parker L, 2001, PEDIATR HEMAT ONCOL, V18, P307, DOI 10.1080/088800101300312564; Paterson A, 2001, AM J ROENTGENOL, V176, P297, DOI 10.2214/ajr.176.2.1760297; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; PRESTON D. L., 1993, EPICURE USERS GUIDE; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; Rehani MM, 2000, BRIT MED J, V320, P593, DOI 10.1136/bmj.320.7235.593; Shrimpton PC., 2005, DOSES COMPUTED TOMOG; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN	31	2321	2419	4	195	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					499	505		10.1016/S0140-6736(12)60815-0	http://dx.doi.org/10.1016/S0140-6736(12)60815-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983GY	22681860	hybrid, Green Published			2022-12-28	WOS:000307109000031
J	Chan, M; Lake, A				Chan, Margaret; Lake, Anthony			Towards ending preventable child deaths	LANCET			English	Editorial Material							MORTALITY		[Lake, Anthony] UNICEF, New York, NY 10017 USA; [Chan, Margaret] WHO, CH-1211 Geneva, Switzerland	UNICEF; World Health Organization	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						[Anonymous], 2011, AN COMM ADV GLOB STR; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; UN Department of Economic and Social Affairs, 2009, MILL DEV GOALS REP 2; UNICEF, 2011, INT GROUP CHILD MORT; UNICEF (United Nations International Children's Emergency Fund), 2010, NARR GAPS MEET GOALS; United Nations Secretary-General Ban Ki-moon, 2010, GLOB STRAT WOM CHILD; You D, 2012, MODELING REQUIRED AC; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	9	19	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2119	2120		10.1016/S0140-6736(12)60908-8	http://dx.doi.org/10.1016/S0140-6736(12)60908-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682447				2022-12-28	WOS:000304990900004
J	Deng, WL; Lee, J; Wang, HX; Miller, J; Reik, A; Gregory, PD; Dean, A; Blobel, GA				Deng, Wulan; Lee, Jongjoo; Wang, Hongxin; Miller, Jeff; Reik, Andreas; Gregory, Philip D.; Dean, Ann; Blobel, Gerd A.			Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor	CELL			English	Article							BETA-GLOBIN LOCUS; TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; GENE-EXPRESSION; CONTROL REGION; CHROMOSOMAL INTERACTIONS; FUNCTIONAL-ANALYSIS; BINDING PROTEIN; POSITIVE ROLE; IN-VIVO	Chromatin loops juxtapose distal enhancers with active promoters, but their molecular architecture and relationship with transcription remain unclear. In erythroid cells, the locus control region (LCR) and beta-globin promoter form a chromatin loop that requires transcription factor GATA1 and the associated molecule Ldb1. We employed artificial zinc fingers (ZF) to tether Ldb1 to the b-globin promoter in GATA1 null erythroblasts, in which the b-globin locus is relaxed and inactive. Remarkably, targeting Ldb1 or only its self-association domain to the b-globin promoter substantially activated b-globin transcription in the absence of GATA1. Promotertethered Ldb1 interacted with endogenous Ldb1 complexes at the LCR to form a chromatin loop, causing recruitment and phosphorylation of RNA polymerase II. ZF-Ldb1 proteins were inactive at alleles lacking the LCR, demonstrating that their activities depend on long-range interactions. Our findings establish Ldb1 as a critical effector of GATA1-mediated loop formation and indicate that chromatin looping causally underlies gene regulation.	[Deng, Wulan; Wang, Hongxin; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Deng, Wulan] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, Jongjoo; Dean, Ann] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Miller, Jeff; Reik, Andreas; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA 94804 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Sangamo Therapeutics, Inc.	Blobel, GA (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	Deng, Wulan/ABX-6870-2022	Gregory, Philip/0000-0001-9249-2468	NIH [5R37DK058044, 2RO1DK054937]; NIDDK; Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075033, R01DK054937, R37DK058044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mark Groudine for the Delta LCR mice and Stephen Brandt for the Ldb1 construct. We are grateful to Liping Han for technical assistance, to Anna Vincent for performing ELISA assays on the ZF proteins, and to members of the laboratory for valuable discussions. We thank Mitch Weiss and Chris Vakoc for helpful comments on the manuscript. This work was supported by NIH grants 5R37DK058044 and 2RO1DK054937 to G.A.B. Work in the lab of A.D. is supported by the Intramural Program, NIDDK, and NIH. J.M., P.D.G., and A.R. were employees of Sangamo Biosciences when involved in this work. W.D., J.L., H.W., A.R., J.M., and P.G. performed experiments; W.D. and G.A.B. conceived the study; and W.D., A.R., P.G, A.D., and G.A.B. wrote the manuscript.	Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bottardi S, 2011, NUCLEIC ACIDS RES, V39, P3505, DOI 10.1093/nar/gkq1271; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Dean A, 2011, BRIEF FUNCT GENOMICS, V10, P3, DOI 10.1093/bfgp/elq033; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Mahmoudi T, 2002, EMBO J, V21, P1775, DOI 10.1093/emboj/21.7.1775; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Petrascheck M, 2005, NUCLEIC ACIDS RES, V33, P3743, DOI 10.1093/nar/gki689; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	49	436	451	1	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1233	1244		10.1016/j.cell.2012.03.051	http://dx.doi.org/10.1016/j.cell.2012.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682246	Green Accepted, Bronze			2022-12-28	WOS:000305119600009
J	Ren, HX; Orozco, IJ; Su, Y; Suyama, S; Gutierrez-Juarez, R; Horvath, TL; Wardlaw, SL; Plum, L; Arancio, O; Accili, D				Ren, Hongxia; Orozco, Ian J.; Su, Ya; Suyama, Shigetomo; Gutierrez-Juarez, Roger; Horvath, Tamas L.; Wardlaw, Sharon L.; Plum, Leona; Arancio, Ottavio; Accili, Domenico			FoxO1 Target Gpr17 Activates AgRP Neurons to Regulate Food Intake	CELL			English	Article							AGOUTI-RELATED PROTEIN; TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; PROOPIOMELANOCORTIN NEURONS; ENERGY HOMEOSTASIS; NEUROPEPTIDE-Y; FEEDING CIRCUITS; RECEPTOR GPR17; INSULIN ACTION; IN-VIVO	Hypothalamic neurons expressing Agouti-related peptide (AgRP) are critical for initiating food intake, but druggable biochemical pathways that control this response remain elusive. Thus, genetic ablation of insulin or leptin signaling in AgRP neurons is predicted to reduce satiety but fails to do so. FoxO1 is a shared mediator of both pathways, and its inhibition is required to induce satiety. Accordingly, FoxO1 ablation in AgRP neurons of mice results in reduced food intake, leanness, improved glucose homeostasis, and increased sensitivity to insulin and leptin. Expression profiling of flow-sorted FoxO1-deficient AgRP neurons identifies G-protein-coupled receptor Gpr17 as a FoxO1 target whose expression is regulated by nutritional status. Intracerebroventricular injection of Gpr17 agonists induces food intake, whereas Gpr17 antagonist cangrelor curtails it. These effects are absent in Agrp-Foxo1 knockouts, suggesting that pharmacological modulation of this pathway has therapeutic potential to treat obesity.	[Ren, Hongxia; Wardlaw, Sharon L.; Plum, Leona; Accili, Domenico] Columbia Univ, Berrie Diabet Ctr, New York, NY 10032 USA; [Ren, Hongxia; Wardlaw, Sharon L.; Plum, Leona; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Orozco, Ian J.; Arancio, Ottavio] Columbia Univ, Taub Inst, New York, NY 10032 USA; [Orozco, Ian J.; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Su, Ya; Gutierrez-Juarez, Roger] Albert Einstein Coll Med, Diabet Res & Training Ctr, Bronx, NY 10461 USA; [Suyama, Shigetomo; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06519 USA	Columbia University; Columbia University; Columbia University; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Yale University	Accili, D (corresponding author), Columbia Univ, Berrie Diabet Ctr, New York, NY 10032 USA.	da230@columbia.edu	arancio, ottavio/AAB-7959-2019; Plum-Mörschel, Leona/W-9413-2019	Plum-Mörschel, Leona/0000-0002-1907-761X; arancio, ottavio/0000-0001-6335-164X	American Diabetes Association; NIH [DK58282, DK57539, DK80003, DK45024, NS49442, DK080000, OD006850]; Columbia University Diabetes Research Center [DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R01DK058282, R01DK080003, R29DK045024, R01DK080000, P30DK063608, R37DK058282, R01DK045024, R01DK064819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.R. is the recipient of a mentor-based postdoctoral fellowship from the American Diabetes Association. This work was supported by NIH grants DK58282 and DK57539 (D.A.), DK80003 (S.L.W.), DK45024 (R.G.-J.), NS49442 (O.A.), DK080000 and OD006850 (T.L.H.), and DK63608 (Columbia University Diabetes Research Center). We thank Ms. Taylor Y. Lu and Kana Meece for excellent technical support, and we thank members of the Accili laboratory for critical discussion of the data.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Breen TL, 2005, BRAIN RES, V1032, P141, DOI 10.1016/j.brainres.2004.11.008; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daniele S, 2011, J PHARMACOL EXP THER, V338, P559, DOI 10.1124/jpet.110.178715; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Erlinge D, 2011, ADV PHARMACOL, V61, P417, DOI 10.1016/B978-0-12-385526-8.00013-8; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Kastrati A, 2009, NEW ENGL J MED, V361, P2382, DOI 10.1056/NEJMe0910677; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Levine AS, 2004, PEPTIDES, V25, P505, DOI 10.1016/j.peptides.2004.01.005; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Shi HF, 2008, AM J PHYSIOL-ENDOC M, V294, pE630, DOI 10.1152/ajpendo.00704.2007; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	51	124	128	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1314	1326		10.1016/j.cell.2012.04.032	http://dx.doi.org/10.1016/j.cell.2012.04.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682251	Green Accepted, Bronze			2022-12-28	WOS:000305119600015
J	Foster, C				Foster, Charles			The art of medicine Putting dignity to work	LANCET			English	Editorial Material									Univ Oxford, Green Templeton Coll, Oxford OX2 6HG, England	University of Oxford	Foster, C (corresponding author), Univ Oxford, Green Templeton Coll, Oxford OX2 6HG, England.	charles.foster@gtc.ox.ac.uk						Bagaric M., 2006, J HUMAN RIGHTS, V5, P257, DOI 10.1080/14754830600653603; Foster C., 2011, HUMAN DIGNITY BIOETH; Harris J, 1998, CAMB Q HEALTHC ETHIC, V7, P163, DOI 10.1017/S0963180198702087; Macklin R, 2003, BRIT MED J, V327, P1419, DOI 10.1136/bmj.327.7429.1419; McCrudden C, 2008, EUR J INT LAW, V19, P655, DOI 10.1093/ejil/chn043; Pellegrino E., 2009, HUMAN DIGNITY BIOETH; Pleschberger S, 2007, AGE AGEING, V36, P197, DOI 10.1093/ageing/afl152	7	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2044	2045		10.1016/S0140-6736(12)60885-X	http://dx.doi.org/10.1016/S0140-6736(12)60885-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22666882				2022-12-28	WOS:000304759100018
J	Hawkey, PM; Livermore, DM				Hawkey, Peter M.; Livermore, David M.			Carbapenem antibiotics for serious infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PENICILLIN ALLERGY; BETA-LACTAMASE; MEROPENEM; IMIPENEM; RESISTANCE; DORIPENEM; SAFETY; EPIDEMIOLOGY; PNEUMONIA; MECHANISM		[Hawkey, Peter M.] Heart England NHS Fdn Trust, W Midlands Publ Hlth Lab, Birmingham B9 5SS, W Midlands, England; [Hawkey, Peter M.] Univ Birmingham, Sch Med, Sch Immun & Infect, Edgbaston B15 2TT, England; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Livermore, David M.] Hlth Protect Agency Colindale, Antibiot Resistance Monitoring & Reference Lab, London NW9 5EQ, England	Heart of England NHS Foundation Trust; University of Birmingham; University of East Anglia; Health Protection Agency	Hawkey, PM (corresponding author), Heart England NHS Fdn Trust, W Midlands Publ Hlth Lab, Birmingham B9 5SS, W Midlands, England.	Peter.Hawkey@heartofengland.nhs.uk	Staves, Peter/C-8219-2014					Berthoin K, 2010, J ANTIMICROB CHEMOTH, V65, P1073, DOI 10.1093/jac/dkq044; Carmeli Y, 2011, DIAGN MICR INFEC DIS, V70, P367, DOI 10.1016/j.diagmicrobio.2011.03.009; Chastre J, 2008, CRIT CARE MED, V36, P1089, DOI 10.1097/CCM.0b013e3181691b99; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Cunha BA, 2008, J CHEMOTHERAPY, V20, P233, DOI 10.1179/joc.2008.20.2.233; Dellinger EP, 2007, ANN SURG, V245, P674, DOI 10.1097/01.sla.0000250414.09255.84; Edwards SJ, 2005, CURR MED RES OPIN, V21, P785, DOI 10.1185/030079905X46223; Edwards SJ, 2012, EUR J HEALTH ECON, V13, P181, DOI 10.1007/s10198-011-0296-0; Frumin J, 2009, ANN PHARMACOTHER, V43, P304, DOI 10.1345/aph.1L486; Giakoupi P, 2009, EUROSURVEILLANCE, V14, P69; Goldstein EJC, 2009, ANTIMICROB AGENTS CH, V53, P5122, DOI 10.1128/AAC.00064-09; Gu J, 2009, AM J GERIATR PHARMAC, V7, P26, DOI 10.1016/j.amjopharm.2009.02.005; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hawser S, 2011, EUR J CLIN MICROBIOL, V30, P173, DOI 10.1007/s10096-010-1066-0; Health Protection Agency, 2011, CARB PROD ENT UK, V5; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Livermore DM, 2009, DIAGN MICR INFEC DIS, V63, P455, DOI 10.1016/j.diagmicrobio.2009.02.012; Martin-Canal G, 2010, INT J ANTIMICROB AG, V35, P301, DOI 10.1016/j.ijantimicag.2009.11.012; Masterton RG, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.023; Metzger R, 2010, ANN SURG, V251, P722, DOI 10.1097/SLA.0b013e3181c1ce3d; Miller AD, 2011, PHARMACOTHERAPY, V31, P408, DOI 10.1592/phco.31.4.408; Patel G, 2011, EXPERT REV ANTI-INFE, V9, P555, DOI [10.1586/eri.11.28, 10.1586/ERI.11.28]; Perrott J, 2010, ANN PHARMACOTHER, V44, P557, DOI 10.1345/aph.1M339; Prescott WA, 2007, PHARMACOTHERAPY, V27, P137, DOI 10.1592/phco.27.1.137; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6994; US Food and Drug Administration, 2010, TYG TIG LAB CHANG MO; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006	31	63	66	3	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3236	10.1136/bmj.e3236	http://dx.doi.org/10.1136/bmj.e3236			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22654063				2022-12-28	WOS:000304857000001
J	Kohstall, C; Zaccanti, M; Jag, M; Trenkwalder, A; Massignan, P; Bruun, GM; Schreck, F; Grimm, R				Kohstall, C.; Zaccanti, M.; Jag, M.; Trenkwalder, A.; Massignan, P.; Bruun, G. M.; Schreck, F.; Grimm, R.			Metastability and coherence of repulsive polarons in a strongly interacting Fermi mixture	NATURE			English	Article							ULTRACOLD GASES; FERROMAGNETISM; ATOMS	Ultracold Fermi gases with tunable interactions provide a test bed for exploring the many-body physics of strongly interacting quantum systems(1-4). Over the past decade, experiments have investigated many intriguing phenomena, and precise measurements of ground-state properties have provided benchmarks for the development of theoretical descriptions. Metastable states in Fermi gases with strong repulsive interactions(5-11) represent an exciting area of development. The realization of such systems is challenging, because a strong repulsive interaction in an atomic quantum gas implies the existence of a weakly bound molecular state, which makes the system intrinsically unstable against decay. Here we use radio-frequency spectroscopy to measure the complete excitation spectrum of fermionic K-40 impurities resonantly interacting with a Fermi sea of Li-6 atoms. In particular, we show that a well-defined quasiparticle exists for strongly repulsive interactions. We measure the energy and the lifetime of this 'repulsive polaron'(9,12,13), and probe its coherence properties by measuring the quasiparticle residue. The results are well described by a theoretical approach that takes into account the finite effective range of the interaction in our system. We find that when the effective range is of the order of the interparticle spacing, there is a substantial increase in the lifetime of the quasiparticles. The existence of such a long-lived, metastable many-body state offers intriguing prospects for the creation of exotic quantum phases in ultracold, repulsively interacting Fermi gases.	[Kohstall, C.; Zaccanti, M.; Jag, M.; Trenkwalder, A.; Schreck, F.; Grimm, R.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Kohstall, C.; Jag, M.; Grimm, R.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Kohstall, C.; Jag, M.; Grimm, R.] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Massignan, P.] Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Bruun, G. M.] Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Austrian Academy of Sciences; University of Innsbruck; University of Innsbruck; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Aarhus University	Zaccanti, M (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria.	matteo.zaccanti@oeaw.ac.at	Zaccanti, Matteo/D-2474-2014; Schreck, Florian/C-9206-2009; Massignan, Pietro/A-4429-2009; Grimm, Rudolf/D-2864-2009	Zaccanti, Matteo/0000-0001-6214-4921; Schreck, Florian/0000-0001-8225-8803; Massignan, Pietro/0000-0003-1545-792X; Grimm, Rudolf/0000-0003-1085-5558; Trenkwalder, Andreas/0000-0002-3066-5025; Bruun, Georg/0000-0003-4764-1668	Austrian Science Fund FWF through the SFB FoQuS; Lise Meitner programme of the FWF; ERC	Austrian Science Fund FWF through the SFB FoQuS(Austrian Science Fund (FWF)); Lise Meitner programme of the FWF; ERC(European Research Council (ERC)European Commission)	We thank A. Sidorov for contributions in the early stage of the experiments, and T. Enss, S. Giorgini, W. Ketterle, J. Levinsen, C. Lobo, D. Petrov, A. Recati, R. Schmidt, J. Song, C. Trefzger, P. Zoller, W. Zwerger, M. Zwierlein and, in particular, M. Baranov for many discussions. We acknowledge support from the Austrian Science Fund FWF through the SFB FoQuS. M.Z. is supported by the Lise Meitner programme of the FWF. P. M. is indebted to M. Lewenstein for support through the ERC Advanced Grant QUAGATUA.	Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Chang SY, 2011, P NATL ACAD SCI USA, V108, P51, DOI [10.1073/pnas.1011990108, 10.1073/pnas.1012291108]; Chevy F, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/112401; Chin C, 2004, SCIENCE, V305, P1128, DOI 10.1126/science.1100818; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Combescot R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.180402; Conduit GJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207201; Gezerlis A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.060403; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; KASEVICH M, 1992, PHYS REV LETT, V69, P1741, DOI 10.1103/PhysRevLett.69.1741; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; LeBlanc LJ, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013607; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Massignan P, 2011, EUR PHYS J D, V65, P83, DOI 10.1140/epjd/e2011-20084-5; Naik D, 2011, EUR PHYS J D, V65, P55, DOI 10.1140/epjd/e2010-10591-2; Nascimbene S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215303; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; Navon N, 2010, SCIENCE, V328, P729, DOI 10.1126/science.1187582; Pekker D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.050402; Petrov DS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.143201; Pilati S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.030405; Prokof'ev N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020408; Punk M, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.053605; Radzihovsky L, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076501; Sadeghzadeh K, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055011; Sanner C., 2012, CORRELATIONS PAIR FO; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Schmidt R, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063620; Shin Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.090403; Spiegelhalder FM, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.043637; Stewart JT, 2008, NATURE, V454, P744, DOI 10.1038/nature07172; Trenkwalder A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.115304	34	327	331	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					615	+		10.1038/nature11065	http://dx.doi.org/10.1038/nature11065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660321	Green Submitted			2022-12-28	WOS:000304608000042
J	Zheng, JK; Umikawa, M; Cui, CH; Li, JY; Chen, XL; Zhang, CZ; Hyunh, HD; Kang, XL; Silvany, R; Wan, X; Ye, JX; Canto, AP; Chen, SH; Wang, HY; Ward, ES; Zhang, CC				Zheng, Junke; Umikawa, Masato; Cui, Changhao; Li, Jiyuan; Chen, Xiaoli; Zhang, Chaozheng; Hyunh, HoangDinh; Kang, Xunlei; Silvany, Robert; Wan, Xuan; Ye, Jingxiao; Canto, Alberto Puig; Chen, Shu-Hsia; Wang, Huan-You; Ward, E. Sally; Zhang, Cheng Cheng			Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development	NATURE			English	Article							EX-VIVO EXPANSION; TRANSFORMATION; PROTEINS; PIRB	How environmental cues regulate adult stem cell and cancer cell activity through surface receptors is poorly understood. Angiopoietin-like proteins (ANGPTLs), a family of seven secreted glycoproteins, are known to support the activity of haematopoietic stem cells (HSCs) in vitro and in vivo(1-10). ANGPTLs also have important roles in lipid metabolism, angiogenesis and inflammation, but were considered 'orphan ligands' because no receptors were identified(3,11,12). Here we show that the immune-inhibitory receptor human leukocyte immunoglobulin-like receptor B2 (LILRB2) and its mouse orthologue paired immunoglobulin-like receptor (PIRB) are receptors for several ANGPTLs. LILRB2 and PIRB are expressed on human and mouse HSCs, respectively, and the binding of ANGPTLs to these receptors supported ex vivo expansion of HSCs. In mouse transplantation acute myeloid leukaemia models, a deficiency in intracellular signalling of PIRB resulted in increased differentiation of leukaemia cells, revealing that PIRB supports leukaemia development. Our study indicates an unexpected functional significance of classical immune-inhibitory receptors in maintenance of stemness of normal adult stem cells and in support of cancer development.	[Zheng, Junke; Umikawa, Masato; Cui, Changhao; Li, Jiyuan; Chen, Xiaoli; Zhang, Chaozheng; Hyunh, HoangDinh; Kang, Xunlei; Silvany, Robert; Wan, Xuan; Ye, Jingxiao; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zheng, Junke; Umikawa, Masato; Cui, Changhao; Li, Jiyuan; Chen, Xiaoli; Zhang, Chaozheng; Hyunh, HoangDinh; Kang, Xunlei; Silvany, Robert; Wan, Xuan; Ye, Jingxiao; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zheng, Junke] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis Chinese Min, Shanghai 200025, Peoples R China; [Umikawa, Masato] Univ Ryukyus, Dept Med Biochem, Okinawa 9030215, Japan; [Canto, Alberto Puig; Ward, E. Sally] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Chen, Shu-Hsia] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Wang, Huan-You] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shanghai Jiao Tong University; University of the Ryukyus; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Alec.Zhang@UTsouthwestern.edu	Zhang, Chaozheng/HGT-7826-2022; Zhang, Cheng/GRS-8698-2022	Ward, E. Sally/0000-0003-3232-7238; Kang, Xunlei/0000-0003-1853-1881	NIH [K01 CA 120099]; American Society of Hematology; March of Dimes; DOD [PR093256]; CPRIT [RP100402]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [R01CA109322, R01CA127483, K01CA120099, R01CA172268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; March of Dimes(March of Dimes); DOD(United States Department of Defense); CPRIT; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Armstrong for the MSCV-MLL-AF9-IRES-YFP construct, H. Hobbs for the CMV-ANGPTL6-Flag plasmid, T. Takai for providing the PIRB knockout mice to S.-H.C., X.-J. Xie for binding analysis, and UTSW Genomics and Microarray Core facility for DNA array experiments. S.-H.C. thanks support from NIH. C.C.Z. was supported by NIH grant K01 CA 120099, American Society of Hematology Junior Faculty Award, March of Dimes Basil O'Connor Scholar Award, DOD PR093256, CPRIT RP100402, and the Gabrielle's Angel Foundation.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2006, EXP HEMATOL, V34, P1230, DOI 10.1016/j.exphem.2006.04.017; Chou S, 2010, P NATL ACAD SCI USA, V107, P7799, DOI 10.1073/pnas.1003586107; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Khoury M, 2011, STEM CELLS DEV, V20, P1371, DOI 10.1089/scd.2010.0456; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lin M., 2008, AM SOC HEM 50 ANN M, V729, P186; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Luo Y, 2009, MABS-AUSTIN, V1, P491, DOI 10.4161/mabs.1.5.9631; Ma G, 2011, IMMUNITY, V34, P385, DOI 10.1016/j.immuni.2011.02.004; Meyaard L, 2010, IMMUNOL LETT, V128, P26, DOI 10.1016/j.imlet.2009.09.014; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takai T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/275302; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhang CC, 1999, MOL ENDOCRINOL, V13, P632, DOI 10.1210/me.13.4.632; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	37	169	189	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					656	+		10.1038/nature11095	http://dx.doi.org/10.1038/nature11095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660330	Green Accepted			2022-12-28	WOS:000304608000051
J	Chiel, HJ; Gill, JP; McManus, JM; Shaw, KM				Chiel, Hillel J.; Gill, Jeffrey P.; McManus, Jeffrey M.; Shaw, Kendrick M.			Learning Biology by Recreating and Extending Mathematical Models	SCIENCE			English	Editorial Material									[Chiel, Hillel J.; Gill, Jeffrey P.; McManus, Jeffrey M.; Shaw, Kendrick M.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Chiel, Hillel J.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Chiel, Hillel J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Chiel, HJ (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	hjc@case.edu		Chiel, Hillel/0000-0002-1750-8500	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1010434] Funding Source: National Science Foundation; NIGMS NIH HHS [T32-GM007250] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chiel HJ, 2010, CBE-LIFE SCI EDUC, V9, P248, DOI 10.1187/cbe.10-03-0022; Chiel HJ, 2009, J NEUROSCI, V29, P12807, DOI 10.1523/JNEUROSCI.3338-09.2009; Deb K., 2001, MULTIOBJECTIVE OPTIM, DOI 10.1109/tevc.2002.804322; Dorigo, 2007, SCHOLARPEDIA, V2, DOI DOI 10.4249/SCHOLARPEDIA.1462; Keller Evelyn Fox, 1983, FEELING ORGANISM LIF; Smith LM, 2010, NATURE, V465, P167, DOI 10.1038/465167a	6	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					993	994		10.1126/science.1214192	http://dx.doi.org/10.1126/science.1214192			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628646				2022-12-28	WOS:000304406800033
J	Ku, CJ; Wang, YQ; Weiner, OD; Altschuler, SJ; Wu, LNF				Ku, Chin-Jen; Wang, Yanqin; Weiner, Orion D.; Altschuler, Steven J.; Wu, Lani F.			Network Crosstalk Dynamically Changes during Neutrophil Polarization	CELL			English	Article							RHOA ACTIVITY; SIGNALING NETWORKS; CHEMOTAXIS; POLARITY; MICROTUBULES; CELLS; ACTIVATION; MIGRATION; TALK; ADAPTATION	How complex signaling networks shape highly coordinated, multistep cellular responses is poorly understood. Here, we made use of a network-perturbation approach to investigate causal influences, or "crosstalk,'' among signaling modules involved in the cytoskeletal response of neutrophils to chemoattractant. We quantified the intensity and polarity of cytoskeletal marker proteins over time to characterize stereotyped cellular responses. Analyzing the effects of network disruptions revealed that, not only does crosstalk evolve rapidly during polarization, but also that intensity and polarity responses are influenced by different patterns of crosstalk. Interestingly, persistent crosstalk is arranged in a surprisingly simple circuit: a linear cascade from front to back to microtubules influences intensities, and a feed-forward network in the reverse direction influences polarity. Our approach provided a rational strategy for decomposing a complex, dynamically evolving signaling system and revealed evolving paths of causal influence that shape the neutrophil polarization response.	[Ku, Chin-Jen; Wang, Yanqin; Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Simmons Canc Ctr, Dallas, TX 75390 USA; [Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Altschuler, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Simmons Canc Ctr, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	NIH [GM084040, GM081549, GM071794]; Searle Scholars Foundation; UTSW Medical Center; Welch Foundation [I-1644, I-1619]; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040, R01GM081549, R01GM071794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Foundation; UTSW Medical Center; Welch Foundation(The Welch Foundation); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Neal Alto, Al Gilman, Sasha Jilkine, David Mangelsdorf, Benjamin Pavie, Rama Ranganathan, Mike Rosen, and all other members of the Altschuler, Weiner, and Wu labs. O.D.W. was supported by NIH GM084040 and the Searle Scholars Foundation. L.F.W. and S.J.A. were supported by the Endowed Scholars Program at UTSW Medical Center. L.F.W. was supported by NIH GM081549 and the Welch Foundation I-1644. S.J.A. was supported by NIH GM071794, the Welch Foundation I-1619, and the Rita Allen Foundation.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Ku CJ, 2010, I S BIOMED IMAGING, P1029, DOI 10.1109/ISBI.2010.5490165; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Rasband W., 2006, IMAGEJ; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHLIWA M, 1982, CELL, V31, P705, DOI 10.1016/0092-8674(82)90325-7; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585; ZIGMOND SH, 1979, J CELL BIOL, V82, P517, DOI 10.1083/jcb.82.2.517	46	39	40	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1073	1083		10.1016/j.cell.2012.03.044	http://dx.doi.org/10.1016/j.cell.2012.03.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632971	Green Accepted, Bronze			2022-12-28	WOS:000304453900013
J	Teh, J; Kambouroglou, G; Newton, J				Teh, James; Kambouroglou, Gregoris; Newton, Julia			RATIONAL IMAGING Investigation of acute knee injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RADIOGRAPHY; CT		[Teh, James] Oxford Univ Hosp NHS Trust, Nuffield Orthopaed Ctr, Dept Radiol, Oxford OX3 7LD, England; [Kambouroglou, Gregoris] Oxford Univ Hosp NHS Trust, John Radcliffe Hosp, Trauma Serv, Oxford OX3 9DU, England	Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Teh, J (corresponding author), Oxford Univ Hosp NHS Trust, Nuffield Orthopaed Ctr, Dept Radiol, Oxford OX3 7LD, England.	jamesteh1@googlemail.com		Teh, James/0000-0002-6111-4269; Newton, Julia/0000-0002-1249-5253				Cosgrave CH, 2012, EMERG MED J, V29, P846, DOI 10.1136/emermed-2011-200356; Jackson JL, 2003, ANN INTERN MED, V139, P575, DOI 10.7326/0003-4819-139-7-200310070-00010; Jung JY, 2009, RADIOLOGY, V253, P780, DOI 10.1148/radiol.2533090457; Mackenzie R, 1996, CLIN RADIOL, V51, P245, DOI 10.1016/S0009-9260(96)80340-0; Mui LW, 2007, SKELETAL RADIOL, V36, P145, DOI 10.1007/s00256-006-0216-z; Mustonen AOT, 2005, ACTA RADIOL, V46, P866, DOI 10.1080/02841850500335135; Oei EHG, 2003, RADIOLOGY, V226, P837, DOI 10.1148/radiol.2263011892; STIELL IG, 1995, ACAD EMERG MED, V2, P966, DOI 10.1111/j.1553-2712.1995.tb03123.x; STIELL IG, 1995, ANN EMERG MED, V26, P405, DOI 10.1016/S0196-0644(95)70106-0; Wang CY, 2007, ARCH PHYS MED REHAB, V88, P984, DOI 10.1016/j.apmr.2007.04.008; Wicky S, 2000, EUR RADIOL, V10, P1227, DOI 10.1007/s003300000326	11	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2012	344								e3167	10.1136/bmj.e3167	http://dx.doi.org/10.1136/bmj.e3167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QV	22636383				2022-12-28	WOS:000304591800002
J	Winner, B; Peipert, JF; Zhao, QH; Buckel, C; Madden, T; Allsworth, JE; Secura, GM				Winner, Brooke; Peipert, Jeffrey F.; Zhao, Qiuhong; Buckel, Christina; Madden, Tessa; Allsworth, Jenifer E.; Secura, Gina M.			Effectiveness of Long-Acting Reversible Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNINTENDED PREGNANCY; INTRAUTERINE-DEVICES; NATIONAL-SURVEY; UNITED-STATES; DISPARITIES; FAILURE; RATES	BACKGROUND The rate of unintended pregnancy in the United States is much higher than in other developed nations. Approximately half of unintended pregnancies are due to contraceptive failure, largely owing to inconsistent or incorrect use. METHODS We designed a large prospective cohort study to promote the use of long-acting reversible contraceptive methods as a means of reducing unintended pregnancies in our region. Participants were provided with reversible contraception of their choice at no cost. We compared the rate of failure of long-acting reversible contraception (intrauterine devices [IUDs] and implants) with other commonly prescribed contraceptive methods (oral contraceptive pills, transdermal patch, contraceptive vaginal ring, and depot medroxyprogesterone acetate [DMPA] injection) in the overall cohort and in groups stratified according to age (less than 21 years of age vs. 21 years or older). RESULTS Among the 7486 participants included in this analysis, we identified 334 unintended pregnancies. The contraceptive failure rate among participants using pills, patch, or ring was 4.55 per 100 participant-years, as compared with 0.27 among participants using long-acting reversible contraception (hazard ratio after adjustment for age, educational level, and history with respect to unintended pregnancy, 21.8; 95% confidence interval, 13.7 to 34.9). Among participants who used pills, patch, or ring, those who were less than 21 years of age had a risk of unintended pregnancy that was almost twice as high as the risk among older participants. Rates of unintended pregnancy were similarly low among participants using DMPA injection and those using an IUD or implant, regardless of age. CONCLUSIONS The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills, patch, or ring and is not altered in adolescents and young women. (Funded by the Susan Thompson Buffet Foundation.)	[Peipert, Jeffrey F.] Washington Univ, Sch Med St Louis, Dept Obstet & Gynecol, Div Clin Res, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Peipert, JF (corresponding author), Washington Univ, Sch Med St Louis, Dept Obstet & Gynecol, Div Clin Res, 4533 Clayton Ave,Campus Box 8219, St Louis, MO 63110 USA.	peipertj@wustl.edu	Allsworth, Jenifer/J-2475-2019	Allsworth, Jenifer/0000-0001-6559-8638; Madden, Tessa/0000-0001-9455-1943	Susan Thompson Buffet Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD070979] Funding Source: NIH RePORTER	Susan Thompson Buffet Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Susan Thompson Buffet Foundation.	American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1493; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Brown S.S., 1995, BEST INTENTIONS UNIN; Cleland K, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1104373; Davis AJ, 2011, CURR OPIN PEDIATR, V23, P557, DOI 10.1097/MOP.0b013e32834a99d8; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Frost Jennifer J, 2008, Issues Brief (Alan Guttmacher Inst), P1; Fu HS, 1999, FAM PLANN PERSPECT, V31, P56, DOI 10.2307/2991640; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Mansour D, 2008, EUR J CONTRACEP REPR, V13, P13, DOI 10.1080/13625180801959931; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mosher William D, 2010, Vital Health Stat 23, P1; Peipert JF, 2011, OBSTET GYNECOL, V117, P1105, DOI 10.1097/AOG.0b013e31821188ad; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2007, CONTRACEPTIVE TECHNO, P747; Ventura Stephanie J, 2009, Natl Vital Stat Rep, V58, P1; Woods JL, 2006, J ADOLESCENT HEALTH, V39, P381, DOI 10.1016/j.jadohealth.2005.12.014	19	760	772	6	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1998	2007		10.1056/nejmoa1110855	http://dx.doi.org/10.1056/nejmoa1110855			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621627	Green Published, Bronze			2022-12-28	WOS:000304353000010
J	Watts, G				Watts, Geoff			Why the exclusion of older people from clinical research must stop	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						European Forum for Good Clinical Practice, GER RES GUID; Kee YYK, 2009, POSTGRAD MED J, V85, P115, DOI 10.1136/pgmj.2008.070607; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; Pallis AG, 2011, ANN ONCOL, V22, P1922, DOI 10.1093/annonc/mdq687; PREDICT, CHART RIGHTS OLD PEO; PREDICT, 2008, LIT REV	6	46	51	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 21	2012	344								e3445	10.1136/bmj.e3445	http://dx.doi.org/10.1136/bmj.e3445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QQ	22613873				2022-12-28	WOS:000304591200002
J	Johnson, DJ; Beaulieu, WT; Bever, JD; Clay, K				Johnson, Daniel J.; Beaulieu, Wesley T.; Bever, James D.; Clay, Keith			Conspecific Negative Density Dependence and Forest Diversity	SCIENCE			English	Article							PLANT-SOIL FEEDBACKS; TROPICAL FORESTS; SPECIES COEXISTENCE; TEMPERATE TREE; COMMUNITY; PATTERNS; ABUNDANCES; MORTALITY; SEEDLINGS	Conspecific negative density-dependent establishment, in which local abundance negatively affects establishment of conspecific seedlings through host-specific enemies, can influence species diversity of plant communities, but the generality of this process is not well understood. We tested the strength of density dependence using the United States Forest Service's Forest Inventory and Analysis database containing 151 species from more than 200,000 forest plots spanning 4,000,000 square kilometers. We found that most species experienced conspecific negative density dependence (CNDD), but there was little effect of heterospecific density. Additionally, abundant species exhibited weaker CNDD than rarer species, and species-rich regions exhibited stronger CNDD than species-poor regions. Collectively, our results provide evidence that CNDD is a pervasive mechanism driving diversity across a gradient from boreal to subtropical forests.	[Johnson, Daniel J.; Beaulieu, Wesley T.; Bever, James D.; Clay, Keith] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Johnson, DJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dj4@indiana.edu	Johnson, Daniel J./L-4899-2019; Beaulieu, Wesley T/A-9298-2013; Johnson, Daniel/K-8661-2012; Clay, Keith/C-8730-2012	Johnson, Daniel J./0000-0002-8585-2143; Beaulieu, Wesley T/0000-0002-0082-1242; 				Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clay Keith, 2008, P145; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Connell H., 1971, DYNAMICS POPULATIONS, P298; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	278	290	16	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					904	907		10.1126/science.1220269	http://dx.doi.org/10.1126/science.1220269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605774				2022-12-28	WOS:000304145600062
J	Brody, H				Brody, Herb			Untitled	NATURE			English	Editorial Material																			0	19	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S1	S1		10.1038/485S1a	http://dx.doi.org/10.1038/485S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616093	Bronze			2022-12-28	WOS:000305950100001
J	Greenbaum, C				Greenbaum, Carla			Rethink the immune connection	NATURE			English	Editorial Material							TYPE-1 DIABETES-MELLITUS; CONTROLLED-TRIAL; DOUBLE-BLIND; INSULIN		Benaroya Res Inst, Diabet program, Seattle, WA USA	Benaroya Research Institute	Greenbaum, C (corresponding author), Benaroya Res Inst, Diabet program, Seattle, WA USA.	cjgreen@benaroyaresearch.org						Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kimmelman J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001010; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568	6	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S9	S9		10.1038/485S9a	http://dx.doi.org/10.1038/485S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968AT	22616097	Bronze			2022-12-28	WOS:000305950100004
J	Das, M; Drake, T; Wiley, DJ; Buchwald, P; Vavylonis, D; Verde, F				Das, Maitreyi; Drake, Tyler; Wiley, David J.; Buchwald, Peter; Vavylonis, Dimitrios; Verde, Fulvia			Oscillatory Dynamics of Cdc42 GTPase in the Control of Polarized Growth	SCIENCE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; CELL POLARITY; PROTEIN SCD2; SYMMETRY-BREAKING; EXCHANGE FACTOR; RHO GTPASES; IN-VIVO; KINASE; MORPHOGENESIS	Cells promote polarized growth by activation of Rho-family protein Cdc42 at the cell membrane. We combined experiments and modeling to study bipolar growth initiation in fission yeast. Concentrations of a fluorescent marker for active Cdc42, Cdc42 protein, Cdc42-activator Scd1, and scaffold protein Scd2 exhibited anticorrelated fluctuations and oscillations with a 5-minute average period at polarized cell tips. These dynamics indicate competition for active Cdc42 or its regulators and the presence of positive and delayed negative feedbacks. Cdc42 oscillations and spatial distribution were sensitive to the amounts of Cdc42-activator Gef1 and to the activity of Cdc42-dependent kinase Pak1, a negative regulator. Feedbacks regulating Cdc42 oscillations and spatial self-organization appear to provide a flexible mechanism for fission yeast cells to explore polarization states and to control their morphology.	[Das, Maitreyi; Wiley, David J.; Buchwald, Peter; Verde, Fulvia] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol R 189, Miami, FL 33101 USA; [Drake, Tyler; Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Verde, Fulvia] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Miami; Lehigh University; Marine Biological Laboratory - Woods Hole	Verde, F (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol R 189, POB 016189, Miami, FL 33101 USA.	fverde@med.miami.edu	Buchwald, Peter/G-4275-2010	Buchwald, Peter/0000-0003-2732-8180; Das, Maitreyi/0000-0001-9164-0158	NSF [0745129]; NIH [1R01GM095867, R21GM083928]; University of Miami NSF ADVANCE award [0820128]; Lehigh University; Sigma Xi; Div Of Molecular and Cellular Bioscience [0745129] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM083928, R01GM095867] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami NSF ADVANCE award; Lehigh University; Sigma Xi; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Karsenti, C. Luetje, S. Lemmon, G. D'Urso, and T. K. Harris for critically reading the manuscript; M. Ioannidou and K. Zhang for help with data analysis; B. Skibbens and Yi Hu for facilitating experiments; and K. Shiozaki, P. Perez, and S. Martin for various strains. This work was supported by NSF grant 0745129, NIH grant 1R01GM095867, and a University of Miami NSF ADVANCE award 0820128 to F. V., and by NIH grant R21GM083928 and a Lehigh University Class of 68 Faculty Fellowship to D. V. T. D. was supported by a Sigma Xi grant-in-aid and as a Graduate Assistance in Areas of National Need Fellow through the U. S. Department of Education.	Chang E, 1999, MOL CELL BIOL, V19, P8066; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Csikasz-Nagy A, 2008, YEAST, V25, P59, DOI 10.1002/yea.1571; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kelly FD, 2011, MOL BIOL CELL, V22, P3801, DOI 10.1091/mbc.E11-01-0057; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; MITCHISON JM, 1985, J CELL SCI, V75, P357; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wheatley E, 2005, BIOCHEM J, V388, P177, DOI 10.1042/BJ20041838	28	104	104	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					239	243		10.1126/science.1218377	http://dx.doi.org/10.1126/science.1218377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22604726	Green Accepted			2022-12-28	WOS:000306323500060
J	Stehling, O; Vashisht, AA; Mascarenhas, J; Jonsson, ZO; Sharma, T; Netz, DJA; Pierik, AJ; Wohlschlegel, JA; Lill, R				Stehling, Oliver; Vashisht, Ajay A.; Mascarenhas, Judita; Jonsson, Zophonias O.; Sharma, Tanu; Netz, Daili J. A.; Pierik, Antonio J.; Wohlschlegel, James A.; Lill, Roland			MMS19 Assembles Iron-Sulfur Proteins Required for DNA Metabolism and Genomic Integrity	SCIENCE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; CLUSTER; DAMAGE; HOMEOSTASIS; BIOGENESIS; TFIIH; INSTABILITY; MATURATION; HELICASES	Instability of the nuclear genome is a hallmark of cancer and aging. MMS19 protein has been linked to maintenance of genomic integrity, but the molecular basis of this connection is unknown. Here, we identify MMS19 as a member of the cytosolic iron-sulfur protein assembly (CIA) machinery. MMS19 functions as part of the CIA targeting complex that specifically interacts with and facilitates iron-sulfur cluster insertion into apoproteins involved in methionine biosynthesis, DNA replication, DNA repair, and telomere maintenance. MMS19 thus serves as an adapter between early-acting CIA components and a subset of cellular iron-sulfur proteins. The function of MMS19 in the maturation of crucial components of DNA metabolism may explain the sensitivity of MMS19 mutants to DNA damage and the presence of extended telomeres.	[Vashisht, Ajay A.; Jonsson, Zophonias O.; Sharma, Tanu; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Stehling, Oliver; Mascarenhas, Judita; Netz, Daili J. A.; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35033 Marburg, Germany; [Stehling, Oliver; Mascarenhas, Judita; Netz, Daili J. A.; Pierik, Antonio J.; Lill, Roland] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Philipps University Marburg; Max Planck Society	Wohlschlegel, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jwohl@mednet.ucla.edu; lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010; Jónsson, Zophonías/E-1960-2015; Jónsson, Zophonías Oddur/AAO-1354-2020	Pierik, Antonio J/0000-0002-1509-6370; Jónsson, Zophonías Oddur/0000-0001-5798-9647; Lill, Roland/0000-0002-8345-6518	Deutsche Forschungsgemeinschaft [SFB 593]; Gottfried-Wilhelm Leibniz program [GRK 1216]; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft; Feldberg Foundation; Fonds der chemischen Industrie; Rhon Klinikum AG; NIH [GM089778]; University of California Cancer Research Coordinating Committee; Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottfried-Wilhelm Leibniz program; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft(Max Planck Society); Feldberg Foundation; Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Rhon Klinikum AG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee(University of California System); Jonsson Cancer Center at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. R. Dean and D. E. Gottschling for fruitful discussions, and C. Dore, S. A. Freibert, M. Funke, G. Kopf, B. Niggemeyer, R. Rosser, M. Stumpfig, and H. Webert for experimental help. Supported by Deutsche Forschungsgemeinschaft grants (SFB 593), Gottfried-Wilhelm Leibniz program and GRK 1216, von Behring-Rontgen Stiftung, Max-Planck Gesellschaft, Feldberg Foundation, Fonds der chemischen Industrie (all to R. L.), Rhon Klinikum AG (A.J.P. and R. L.), NIH grant GM089778 (J.A.W.), the University of California Cancer Research Coordinating Committee (J.A.W.), and the Jonsson Cancer Center at UCLA (J.A.W.).	Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Benton MG, 2007, MUTAT RES-GEN TOX EN, V633, P21, DOI 10.1016/j.mrgentox.2007.05.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; McMurray MA, 2004, CURR OPIN MICROBIOL, V7, P673, DOI 10.1016/j.mib.2004.10.008; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; PRAKASH L, 1979, MOL GEN GENET, V176, P351, DOI 10.1007/BF00333097; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schnackerz KD, 2004, BBA-PROTEINS PROTEOM, V1701, P61, DOI 10.1016/j.bbapap.2004.06.009; Seroz T, 2000, NUCLEIC ACIDS RES, V28, P4506, DOI 10.1093/nar/28.22.4506; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Thierbach R, 2010, BIOCHEM J, V432, P165, DOI 10.1042/BJ20101116; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	37	190	200	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					195	199		10.1126/science.1219723	http://dx.doi.org/10.1126/science.1219723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22678362	Green Accepted			2022-12-28	WOS:000306323500049
J	Bricker, DK; Taylor, EB; Schell, JC; Orsak, T; Boutron, A; Chen, YC; Cox, JE; Cardon, CM; Van Vranken, JG; Dephoure, N; Redin, C; Boudina, S; Gygi, SP; Brivet, M; Thummel, CS; Rutter, J				Bricker, Daniel K.; Taylor, Eric B.; Schell, John C.; Orsak, Thomas; Boutron, Audrey; Chen, Yu-Chan; Cox, James E.; Cardon, Caleb M.; Van Vranken, Jonathan G.; Dephoure, Noah; Redin, Claire; Boudina, Sihem; Gygi, Steven P.; Brivet, Michele; Thummel, Carl S.; Rutter, Jared			A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans	SCIENCE			English	Article							RAT-LIVER; IDENTIFICATION; TRANSPORT; MECHANISM; COMPLEX	Pyruvate constitutes a critical branch point in cellular carbon metabolism. We have identified two proteins, Mpc1 and Mpc2, as essential for mitochondrial pyruvate transport in yeast, Drosophila, and humans. Mpc1 and Mpc2 associate to form an similar to 150-kilodalton complex in the inner mitochondrial membrane. Yeast and Drosophila mutants lacking MPC1 display impaired pyruvate metabolism, with an accumulation of upstream metabolites and a depletion of tricarboxylic acid cycle intermediates. Loss of yeast Mpc1 results in defective mitochondrial pyruvate uptake, and silencing of MPC1 or MPC2 in mammalian cells impairs pyruvate oxidation. A point mutation in MPC1 provides resistance to a known inhibitor of the mitochondrial pyruvate carrier. Human genetic studies of three families with children suffering from lactic acidosis and hyperpyruvatemia revealed a causal locus that mapped to MPC1, changing single amino acids that are conserved throughout eukaryotes. These data demonstrate that Mpc1 and Mpc2 form an essential part of the mitochondrial pyruvate carrier.	[Taylor, Eric B.; Schell, John C.; Orsak, Thomas; Chen, Yu-Chan; Cardon, Caleb M.; Van Vranken, Jonathan G.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Bricker, Daniel K.; Thummel, Carl S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Boutron, Audrey; Brivet, Michele] Hop Bicetre, AP HP, Biochim Lab, Le Kremlin Bicetre, France; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Redin, Claire] IGBMC, Strasbourg, France; [Boudina, Sihem] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Utah System of Higher Education; University of Utah	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; Taylor, Eric/0000-0003-4549-6567	NIH [R01GM083746, RC1DK086426, R24DK092784, T32GM007464, K99AR059190];  [P30DK072437]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR059190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071962, R24DK092784, P30DK072437, RC1DK086426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM094232, R01GM087346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rutter, Thummel, Winge, Stillman, Shaw, and Metzstein laboratories for helpful discussions. We thank the Shaw and Winge labs for the antibodies against Fzo1, Cyb2, and Mge1 and for the mito-RFP constructs. We thank J. M. Saudubray, L. Burglen, and H. Tevissen for referring patients and C. Thibault and J. L. Mandel (IGBMC, Strasbourg, France) for assistance in single-nucleotide polymorphism array hybridization. This research was supported by NIH grants R01GM083746 (J. R.), RC1DK086426 (C. S. T.), and R24DK092784 (J. R. and C. S. T.) and a pilot grant from P30DK072437 (J. R.). D. K. B. and C. M. C. were supported by the NIH Genetics Predoctoral Training Grant T32GM007464. E. B. T. was supported by NIH Pathway to Independence award K99AR059190. D. K. B., T.O., C. S. T., and J. R. are inventors on a patent application by the University of Utah covering the discovery of the MPC complex.	Boles E, 1998, J BACTERIOL, V180, P2875, DOI 10.1128/JB.180.11.2875-2882.1998; Brivet M, 2003, MOL GENET METAB, V78, P186, DOI 10.1016/S1096-7192(03)00016-7; DESTEENSMA HY, 1990, EUR J BIOCHEM, V191, P769, DOI 10.1111/j.1432-1033.1990.tb19186.x; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; Jiang MR, 2009, MOL BIOL REP, V36, P215, DOI 10.1007/s11033-007-9169-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAPA S, 1974, EUR J BIOCHEM, V49, P265, DOI 10.1111/j.1432-1033.1974.tb03831.x; ROGNSTAD R, 1983, INT J BIOCHEM, V15, P1417, DOI 10.1016/0020-711X(83)90073-3; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; THOMAS AP, 1981, BIOCHEM J, V196, P471, DOI 10.1042/bj1960471; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; ZWIEBEL FM, 1982, BIOCHEMISTRY-US, V21, P346, DOI 10.1021/bi00531a023	19	514	545	7	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					96	100		10.1126/science.1218099	http://dx.doi.org/10.1126/science.1218099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628558	Green Accepted			2022-12-28	WOS:000306053100052
J	Westfall, CS; Zubieta, C; Herrmann, J; Kapp, U; Nanao, MH; Jez, JM				Westfall, Corey S.; Zubieta, Chloe; Herrmann, Jonathan; Kapp, Ulrike; Nanao, Max H.; Jez, Joseph M.			Structural Basis for Prereceptor Modulation of Plant Hormones by GH3 Proteins	SCIENCE			English	Article							CONJUGATES AMINO-ACIDS; SALICYLIC-ACID; EVOLUTIONARY HISTORY; FAMILY; JASMONATE; AUXIN; HYPOCOTYL; RECEPTOR; MEMBER; ASSAY	Acyl acid amido synthetases of the GH3 family act as critical prereceptor modulators of plant hormone action; however, the molecular basis for their hormone selectivity is unclear. Here, we report the crystal structures of benzoate-specific Arabidopsis thaliana AtGH3.12/PBS3 and jasmonic acid-specific AtGH3.11/JAR1. These structures, combined with biochemical analysis, define features for the conjugation of amino acids to diverse acyl acid substrates and highlight the importance of conformational changes in the carboxyl-terminal domain for catalysis. We also identify residues forming the acyl acid binding site across the GH3 family and residues critical for amino acid recognition. Our results demonstrate how a highly adaptable three-dimensional scaffold is used for the evolution of promiscuous activity across an enzyme family for modulation of plant signaling molecules.	[Westfall, Corey S.; Herrmann, Jonathan; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zubieta, Chloe; Kapp, Ulrike] European Synchrotron Radiat Facil, F-38000 Grenoble, France; [Nanao, Max H.] European Mol Biol Lab, F-38042 Grenoble, France; [Nanao, Max H.] Univ Grenoble 1, CNRS, European Mol Biol Lab, Unit Virus Host Cell Interact, Grenoble, France	Washington University (WUSTL); European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Nanao, Max/ABA-9292-2021	Nanao, Max/0000-0002-6340-1376; Zubieta, Chloe/0000-0003-4558-9333	NSF [MCB-1157771]; U.S. Department of Agriculture-National Institute of Food and Agriculture [MOW-2010-05240]; American Society of Plant Biologists; Howard Hughes Medical Institute-Washington University; Direct For Biological Sciences [1157771] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); American Society of Plant Biologists; Howard Hughes Medical Institute-Washington University(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant MCB-1157771 to J.M.J. C. S. W. was supported by a U.S. Department of Agriculture-National Institute of Food and Agriculture predoctoral fellowship (MOW-2010-05240), and J.H. was supported by an American Society of Plant Biologists-Summer Undergraduate Research Fellowship award and the Howard Hughes Medical Institute-Washington University Summer Scholars Program in Biology and Biomedical Research. Portions of this research were carried out at the European Synchrotron Radiation Facility and the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the Univ. of Chicago for the U. S. Department of Energy Office of Biological and Environmental Research (DE-AC02-06CH11357). Atomic coordinates and structure factors have been deposited in the PDB (accession codes are noted in table S2).	Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Takase T, 2003, PLANT CELL PHYSIOL, V44, P1071, DOI 10.1093/pcp/pcg130; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	22	102	110	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1708	1711		10.1126/science.1221863	http://dx.doi.org/10.1126/science.1221863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22628555				2022-12-28	WOS:000305794500051
J	Morken, NH				Morken, Nils-Halvdan			Preterm birth: new data on a global health priority	LANCET			English	Editorial Material							GESTATIONAL-AGE; CONSEQUENCES; EPIDEMIOLOGY; WEIGHT; COST		[Morken, Nils-Halvdan] Univ Bergen, N-5021 Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, N-5021 Bergen, Norway	University of Bergen	Morken, NH (corresponding author), Univ Bergen, N-5021 Bergen, Norway.	nils-halvdan.morken@kk.uib.no						[Anonymous], 1970, World Health Organ Tech Rep Ser, V457, P1; [Anonymous], BORN TOO SOON GLOB A; Berhman R, 2006, PRETERM BIRTH CAUSES; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Gilbert WM, 2003, OBSTET GYNECOL, V102, P488, DOI 10.1016/S0029-7844(03)00617-3; Jones J Stephen, 2002, Manag Care, V11, P42; LUMLEY J, 1993, BAILLIERE CLIN OB GY, V7, P477, DOI 10.1016/S0950-3552(05)80445-6; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Petrou S, 2003, BJOG-INT J OBSTET GY, V110, P17, DOI 10.1016/S1470-0328(03)00013-2; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; SAVITZ DA, 1991, AM J OBSTET GYNECOL, V164, P467, DOI 10.1016/S0002-9378(11)80001-3; St John EB, 2000, AM J OBSTET GYNECOL, V182, P170, DOI 10.1016/S0002-9378(00)70509-6; Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866	14	22	23	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2128	2130		10.1016/S0140-6736(12)60857-5	http://dx.doi.org/10.1016/S0140-6736(12)60857-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22682451				2022-12-28	WOS:000304990900009
J	Hock, AK; Vousden, KH				Hock, Andreas K.; Vousden, Karen H.			Tumor Suppression by p53: Fall of the Triumvirate?	CELL			English	Editorial Material							P53-INDUCIBLE REGULATOR; DNA-DAMAGE; APOPTOSIS	p53 is a key tumor suppressor protein that has numerous functions. Its primary mode of action has generally been ascribed to the induction of cell-cycle arrest, apoptosis, or senescence upon stress. Li et al. challenge this dogma with evidence that all three of these programs are dispensable for p53's tumor suppressive role.	[Hock, Andreas K.; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk						Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	11	32	36	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1183	1185		10.1016/j.cell.2012.05.024	http://dx.doi.org/10.1016/j.cell.2012.05.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682240	Bronze			2022-12-28	WOS:000305119600003
J	Xiao, S; Xie, D; Cao, XY; Yu, PF; Xing, XY; Chen, CC; Musselman, M; Xie, MC; West, FD; Lewin, HA; Wang, T; Zhong, S				Xiao, Shu; Xie, Dan; Cao, Xiaoyi; Yu, Pengfei; Xing, Xiaoyun; Chen, Chieh-Chun; Musselman, Meagan; Xie, Mingchao; West, Franklin D.; Lewin, Harris A.; Wang, Ting; Zhong, Sheng			Comparative Epigenomic Annotation of Regulatory DNA	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE VARIANT H2A.Z; GENE-EXPRESSION; CHROMATIN; GENOME; PLURIPOTENT; MARKS; DIFFERENTIATION; METHYLATION; VERTEBRATE	Despite the explosive growth of genomic data, functional annotation of regulatory sequences remains difficult. Here, we introduce "comparative epigenomics''-interspecies comparison of DNA and histone modifications-as an approach for annotation of the regulatory genome. We measured in human, mouse, and pig pluripotent stem cells the genomic distributions of cytosine methylation, H2A.Z, H3K4me1/2/3, H3K9me3, H3K27me3, H3K27ac, H3K36me3, transcribed RNAs, and P300, TAF1, OCT4, and NANOG binding. We observed that epigenomic conservation was strong in both rapidly evolving and slowly evolving DNA sequences, but not in neutrally evolving sequences. In contrast, evolutionary changes of the epigenome and the transcriptome exhibited a linear correlation. We suggest that the conserved colocalization of different epigenomic marks can be used to discover regulatory sequences. Indeed, seven pairs of epigenomic marks identified exhibited regulatory functions during differentiation of embryonic stem cells into mesendoderm cells. Thus, comparative epigenomics reveals regulatory features of the genome that cannot be discerned from sequence comparisons alone.	[Xiao, Shu; Xie, Dan; Chen, Chieh-Chun; Musselman, Meagan; Zhong, Sheng] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Xiao, Shu; Xie, Dan; Cao, Xiaoyi; Yu, Pengfei; Chen, Chieh-Chun; Lewin, Harris A.; Zhong, Sheng] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cao, Xiaoyi; Yu, Pengfei; Zhong, Sheng] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [West, Franklin D.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Xing, Xiaoyun; Xie, Mingchao; Wang, Ting] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia; Washington University (WUSTL)	Zhong, S (corresponding author), Univ Illinois, Dept Bioengn, 1304 W Springfield Ave, Urbana, IL 61801 USA.	szhong@illinois.edu	Xiao, Shu/H-1007-2014; Cao, Xiaoyi/D-4646-2017; Cao, Xiaoyi/Q-4157-2019; LEWIN, HARRIS/HGC-6543-2022	Cao, Xiaoyi/0000-0001-7222-5450; Cao, Xiaoyi/0000-0001-7222-5450; LEWIN, HARRIS/0000-0002-1043-7287	NIH [DP2-OD007417, 5U01ES017154]; NSF [DBI 09-60583]; Sloan Research Fellowship; March of Dimes Foundation; Edward Jr. Mallinckrodt Foundation; DDRCC [P30DK52574]; Siteman Cancer Center [P50CA134254]; NATIONAL CANCER INSTITUTE [P50CA134254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); March of Dimes Foundation(March of Dimes); Edward Jr. Mallinckrodt Foundation; DDRCC; Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH DP2-OD007417, NSF DBI 09-60583, and Sloan Research Fellowship to S.Z.; and by NIH 5U01ES017154, March of Dimes Foundation, Edward Jr. Mallinckrodt Foundation, DDRCC P30DK52574, and Siteman Cancer Center P50CA134254 to T.W. The authors thank Wei Huang and Darina McDee and Drs. Lisa Stubbs, Tetsuya Tanaka, Phillip Newmark, Rex Gaskins, Gene Robinson, David Clayton, Nigel Goldenfeld, Fei Wang, and Taekjip Ha for useful discussions.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jiang CZ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-316; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	39	136	138	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1381	1392		10.1016/j.cell.2012.04.029	http://dx.doi.org/10.1016/j.cell.2012.04.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682255	Green Accepted, Bronze			2022-12-28	WOS:000305119600020
J	Chhaya, V; Gupta, S				Chhaya, Vivek; Gupta, Sanjay			A farmer with fever and right upper quadrant pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN CYSTIC ECHINOCOCCOSIS; HYDATID-DISEASE; PERCUTANEOUS DRAINAGE; ALBENDAZOLE; CHEMOTHERAPY; PRAZIQUANTEL; DIAGNOSIS; ALVEOLAR		[Chhaya, Vivek; Gupta, Sanjay] Croydon Univ Hosp, Croydon, Vic CR7 7YE, Australia	Croydon University Hospital	Gupta, S (corresponding author), Croydon Univ Hosp, Croydon, Vic CR7 7YE, Australia.	sanjay.gupta@mayday.nhs.uk						AKINOGLU A, 1991, AM J TROP MED HYG, V45, P182, DOI 10.4269/ajtmh.1991.45.182; Centers for Disease Control and Prevention, LIF CYCL ECH GRAN; Cobo F, 1998, TROP MED INT HEALTH, V3, P462; DAVIS A, 1989, B WORLD HEALTH ORGAN, V67, P503; El-On J, 2003, ACTA TROP, V85, P243, DOI 10.1016/S0001-706X(02)00217-6; Filice C, 1997, ACTA TROP, V64, P95, DOI 10.1016/S0001-706X(96)00642-0; HIRA PR, 1988, LANCET, V2, P655; HORTON RJ, 1989, T ROY SOC TROP MED H, V83, P97, DOI 10.1016/0035-9203(89)90724-4; KAMMERER WS, 1993, INFECT DIS CLIN N AM, V7, P605; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; KHUROO MS, 1993, GASTROENTEROLOGY, V104, P1452, DOI 10.1016/0016-5085(93)90355-G; MARANI SAD, 1990, RADIOLOGY, V175, P701, DOI 10.1148/radiology.175.3.2343117; McManus DP, 2003, PARASITOLOGY, V127, pS37, DOI 10.1017/S0031182003003524; MILICEVIC M., 1994, SURG LIVER BILIARY T, V2, P1121; Mohamed AE, 1998, HEPATO-GASTROENTEROL, V45, P1690; Moro PL, 2006, ANN TROP MED PARASIT, V100, P703, DOI 10.1179/136485906X112257; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Pawlowski ZS, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P20; Smego RA, 2005, INT J INFECT DIS, V9, P69, DOI 10.1016/j.ijid.2004.08.001; Smego RA, 2003, CLIN INFECT DIS, V37, P1073, DOI 10.1086/378275; Thompson R. C. A., 1995, P1; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; TODOROV T, 1992, B WORLD HEALTH ORGAN, V70, P347; Yang YR, 2006, B WORLD HEALTH ORGAN, V84, P714, DOI 10.2471/BLT.05.025718; Zhang WB, 2006, FEMS IMMUNOL MED MIC, V47, P24, DOI 10.1111/j.1574-695X.2006.00060.x	25	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 1	2012	344								e3426	10.1136/bmj.e3426	http://dx.doi.org/10.1136/bmj.e3426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HK	22661721				2022-12-28	WOS:000304857600001
J	Dai, L; Vorselen, D; Korolev, KS; Gore, J				Dai, Lei; Vorselen, Daan; Korolev, Kirill S.; Gore, Jeff			Generic Indicators for Loss of Resilience Before a Tipping Point Leading to Population Collapse	SCIENCE			English	Article							EARLY-WARNING SIGNALS; REGIME SHIFTS; THRESHOLDS; ECOSYSTEMS; RECOVERY; CONSEQUENCES; TRANSITIONS; EXTINCTION; MANAGEMENT; DYNAMICS	Theory predicts that the approach of catastrophic thresholds in natural systems (e. g., ecosystems, the climate) may result in an increasingly slow recovery from small perturbations, a phenomenon called critical slowing down. We used replicate laboratory populations of the budding yeast Saccharomyces cerevisiae for direct observation of critical slowing down before population collapse. We mapped the bifurcation diagram experimentally and found that the populations became more vulnerable to disturbance closer to the tipping point. Fluctuations of population density increased in size and duration near the tipping point, in agreement with the theory. Our results suggest that indicators of critical slowing down can provide advance warning of catastrophic thresholds and loss of resilience in a variety of dynamical systems.	[Dai, Lei; Korolev, Kirill S.; Gore, Jeff] MIT, Dept Phys, Cambridge, MA 02139 USA; [Vorselen, Daan] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); Vrije Universiteit Amsterdam	Gore, J (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	gore@mit.edu	Korolev, Kirill/J-7957-2012		Pappalardo Fellowship; NIH; NSF; Sloan Research Fellowship; Pew Scholars Program; NATIONAL INSTITUTE ON AGING [DP2AG044279] Funding Source: NIH RePORTER	Pappalardo Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Pew Scholars Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Gore lab for valuable suggestions on the manuscript. Supported by a Pappalardo Fellowship (K. S. K.), an NIH R00 Pathways to Independence Award, an NSF CAREER Award, a Sloan Research Fellowship, and the Pew Scholars Program. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.p2481134).	Allee W., 1949, PRINCIPLES ANIMAL EC; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hines P. D. H., 2011, 2011 44 HAW INT C SY, P1, DOI DOI 10.1109/HICSS.2011.444; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHOLZ JP, 1987, PHYS LETT A, V123, P390, DOI 10.1016/0375-9601(87)90038-7; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	29	393	403	16	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1175	1177		10.1126/science.1219805	http://dx.doi.org/10.1126/science.1219805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654061				2022-12-28	WOS:000304647900054
J	Graham-Rowe, D				Graham-Rowe, Duncan			RISK ANALYSIS A dense issue	NATURE			English	Editorial Material																		Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173; Boyd N, 2009, CANCER EPIDEM BIOMAR, V18, P1754, DOI 10.1158/1055-9965.EPI-09-0107; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843	6	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S60	S61		10.1038/485S60a	http://dx.doi.org/10.1038/485S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648502	Bronze			2022-12-28	WOS:000304608000006
J	Maxmen, A				Maxmen, Amy			THE HARD FACTS	NATURE			English	Editorial Material																			0	40	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S50	S51		10.1038/485S50a	http://dx.doi.org/10.1038/485S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648497	Bronze			2022-12-28	WOS:000304608000001
J	Kates, J; Michaud, J				Kates, Jennifer; Michaud, Josh			The US Global Health Initiative: where does it stand?	LANCET			English	Editorial Material									[Kates, Jennifer; Michaud, Josh] Kaiser Family Fdn, Washington, DC 20005 USA		Kates, J (corresponding author), Kaiser Family Fdn, Washington, DC 20005 USA.	jkates@kff.org						Altman, 2012, PULLING IT TOGETHER; Donnelly J, 2011, GLOBAL POST     0509; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; Global Health Initiative, GHI COUNTR; Kaiser Family Foundation, WOM GIRLS G IN PRESS; Kaiser Family Foundation, PUBL OP POLLS GLOB H; Kaiser Family Foundation, 2012, US FUND GLOB HLTH IN; Kaiser Family Foundation, 2009, US GOV GLOB HLTH POL; Kaiser Family Foundation, 2011, US GLOB HLTH IN COUN; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; U.S. Department of State, 2010, LEAD CIV POW 1 QUADR; US Government Global Health Initiative, 2011, STRAT DOC US GOV GLO	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 26	2012	379	9830					1925	1926		10.1016/S0140-6736(12)60783-1	http://dx.doi.org/10.1016/S0140-6736(12)60783-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951YV	22633022				2022-12-28	WOS:000304757700006
J	Nik-Zainal, S; Van Loo, P; Wedge, DC; Alexandrov, LB; Greenman, CD; Lau, KW; Raine, K; Jones, D; Marshall, J; Ramakrishna, M; Shlien, A; Cooke, SL; Hinton, J; Menzies, A; Stebbings, LA; Leroy, C; Jia, MM; Rance, R; Mudie, LJ; Gamble, SJ; Stephens, PJ; McLaren, S; Tarpey, PS; Papaemmanuil, E; Davies, HR; Varela, I; McBride, DJ; Bignell, GR; Leung, K; Butler, AP; Teague, JW; Martin, S; Jonsson, G; Mariani, O; Boyault, S; Miron, P; Fatima, A; Langerod, A; Aparicio, SAJR; Tutt, A; Sieuwerts, AM; Borg, A; Thomas, G; Salomon, AV; Richardson, AL; Borresen-Dale, AL; Futreal, PA; Stratton, MR; Campbell, PJ				Nik-Zainal, Serena; Van Loo, Peter; Wedge, David C.; Alexandrov, Ludmil B.; Greenman, Christopher D.; Lau, King Wai; Raine, Keiran; Jones, David; Marshall, John; Ramakrishna, Manasa; Shlien, Adam; Cooke, Susanna L.; Hinton, Jonathan; Menzies, Andrew; Stebbings, Lucy A.; Leroy, Catherine; Jia, Mingming; Rance, Richard; Mudie, Laura J.; Gamble, Stephen J.; Stephens, Philip J.; McLaren, Stuart; Tarpey, Patrick S.; Papaemmanuil, Elli; Davies, Helen R.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Leung, Kenric; Butler, Adam P.; Teague, Jon W.; Martin, Sancha; Joensson, Goran; Mariani, Odette; Boyault, Sandrine; Miron, Penelope; Fatima, Aquila; Langerod, Anita; Aparicio, Samuel A. J. R.; Tutt, Andrew; Sieuwerts, Anieta M.; Borg, Ake; Thomas, Gilles; Salomon, Anne Vincent; Richardson, Andrea L.; Borresen-Dale, Anne-Lise; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.		Int Canc Genome Consortium	The Life History of 21 Breast Cancers	CELL			English	Article							GENOMIC REARRANGEMENT; EVOLUTION; MUTATIONS; PATTERNS; INSTABILITY; METASTASIS; SIGNATURES	Cancer evolves dynamically as clonal expansions supersede one another driven by shifting selective pressures, mutational processes, and disrupted cancer genes. These processes mark the genome, such that a cancer's life history is encrypted in the somatic mutations present. We developed algorithms to decipher this narrative and applied them to 21 breast cancers. Mutational processes evolve across a cancer's lifespan, with many emerging late but contributing extensive genetic variation. Subclonal diversification is prominent, and most mutations are found in just a fraction of tumor cells. Every tumor has a dominant subclonal lineage, representing more than 50% of tumor cells. Minimal expansion of these subclones occurs until many hundreds to thousands of mutations have accumulated, implying the existence of long-lived, quiescent cell lineages capable of substantial proliferation upon acquisition of enabling genomic changes. Expansion of the dominant subclone to an appreciable mass may therefore represent the final rate-limiting step in a breast cancer's development, triggering diagnosis.	[Nik-Zainal, Serena; Van Loo, Peter; Wedge, David C.; Alexandrov, Ludmil B.; Greenman, Christopher D.; Lau, King Wai; Raine, Keiran; Jones, David; Marshall, John; Ramakrishna, Manasa; Shlien, Adam; Cooke, Susanna L.; Hinton, Jonathan; Menzies, Andrew; Stebbings, Lucy A.; Leroy, Catherine; Jia, Mingming; Rance, Richard; Mudie, Laura J.; Gamble, Stephen J.; Stephens, Philip J.; McLaren, Stuart; Tarpey, Patrick S.; Papaemmanuil, Elli; Davies, Helen R.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Leung, Kenric; Butler, Adam P.; Teague, Jon W.; Martin, Sancha; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Greenman, Christopher D.] Univ E Anglia, Dept Comp, Norwich NR4 7TJ, Norfolk, England; [Greenman, Christopher D.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Joensson, Goran; Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Mariani, Odette; Salomon, Anne Vincent] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Boyault, Sandrine; Thomas, Gilles] Univ Lyon 1, Ctr Leon Berard, INCa Synergie, Lyon 08, France; [Miron, Penelope; Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Langerod, Anita; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Sieuwerts, Anieta M.] Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Borg, Ake] Lund Univ, Dept Oncol, SE-22184 Lund, Sweden; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0310 Oslo, Norway; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of London; King's College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Harvard University; Dana-Farber Cancer Institute; University of Oslo; University of British Columbia; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/AAS-1454-2021; Gamble, Stephen/D-1417-2011; Varela, Ignacio/AAA-7680-2021; Alexandrov, Ludmil/B-6582-2014; Jönsson, Göran/D-1212-2014; Van Loo, Peter/A-3287-2012; Varela, Ignacio/G-1699-2016; Nik-Zainal, Serena/ABD-4437-2020	Alexandrov, Ludmil/0000-0003-3596-4515; Gamble, Stephen/0000-0002-0867-3723; Varela, Ignacio/0000-0002-0969-506X; Alexandrov, Ludmil/0000-0003-3596-4515; Varela, Ignacio/0000-0002-0969-506X; Tutt, Andrew/0000-0001-8715-2901; Nik-Zainal, Serena/0000-0001-5054-1727; Aparicio, Samuel/0000-0002-0487-9599; Van Loo, Peter/0000-0003-0292-1949; Wedge, David/0000-0002-7572-3196; Martin, Sancha/0000-0001-6213-5259; Raine, Keiran/0000-0002-5634-1539	Wellcome Trust [098051]; Breakthrough Breast Cancer Research [ICGC 08/09]; National Research Council Canada; EMBO; International Human Frontier Science Program Organization; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO); Norwegian Research Council; Norwegian Cancer Society; Radium Hospital Foundation; Health Region South-East; European Community [242006]; National Cancer Institute Specialized Program Of Research Excellence [CA089393]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; St Thomas' NHS Foundation Trust; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer Research; National Research Council Canada; EMBO(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Radium Hospital Foundation; Health Region South-East; European Community(European Commission); National Cancer Institute Specialized Program Of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 098051) and Breakthrough Breast Cancer Research (ICGC 08/09). S. N.-Z. is a Wellcome Trust Clinical Research Training Fellow. P.J.C. is a Wellcome Trust Senior Clinical Research Fellow (WT088340MA). P.V.L. is a postdoctoral researcher of the Research Foundation-Flanders. A.S. is supported by the HL Holmes Award from the National Research Council Canada and a Fellowship from EMBO. I.V. is supported by a fellowship from the International Human Frontier Science Program Organization. J.W.M.M. is funded in part by a research grant from the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). A.-L.B.-D. and A.L. are funded by the Norwegian Research Council, Norwegian Cancer Society, Radium Hospital Foundation and Health Region South-East. S. M. is funded by the BASIS project through the European Community's FP7/2010-2014 under grant agreement 242006. We acknowledge the Core Sequencing Facility and IT groups of the Wellcome Trust Sanger Institute, support for samples, sample banking, and processing from the Breakthrough Breast Cancer Unit, members of the ICGC Breast Cancer Working Group, the Pathology Review subgroup of the Breast Cancer Working Group, the OSBREAC Consortium of The Oslo University Hospital and the National Cancer Institute Specialized Program Of Research Excellence (grant reference CA089393). We also acknowledge Dr. Peter Watson, the BCCA Tumour Tissue Repository, and the Centre for Translational Genomics. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Burrell RA, 2010, J CELL BIOCHEM, V111, P782, DOI 10.1002/jcb.22781; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dunson D. B., 2010, BAYESIAN NONPARAMETR; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornsby C, 2007, LANCET ONCOL, V8, P1030, DOI 10.1016/S1470-2045(07)70343-1; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	910	931	2	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5								10.1016/j.cell.2012.04.023	http://dx.doi.org/10.1016/j.cell.2012.04.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22608083	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000304453900007
J	Stute, A; Casabone, B; Schindler, P; Monz, T; Schmidt, PO; Brandstatter, B; Northup, TE; Blatt, R				Stute, A.; Casabone, B.; Schindler, P.; Monz, T.; Schmidt, P. O.; Brandstaetter, B.; Northup, T. E.; Blatt, R.			Tunable ion-photon entanglement in an optical cavity	NATURE			English	Article							SINGLE-PHOTON; DETERMINISTIC GENERATION; QUANTUM TELEPORTATION; TRAPPED IONS; ONE-ATOM; STATE; QUBITS; MATTER	Proposed quantum networks require both a quantum interface between light and matter and the coherent control of quantum states(1,2). A quantum interface can be realized by entangling the state of a single photon with the state of an atomic or solid-state quantum memory, as demonstrated in recent experiments with trapped ions(3,4), neutral atoms(5,6), atomic ensembles(7,8) and nitrogen-vacancy spins(9). The entangling interaction couples an initial quantum memory state to two possible light-matter states, and the atomic level structure of the memory determines the available coupling paths. In previous work, the transition parameters of these paths determined the phase and amplitude of the final entangled state, unless the memory was initially prepared in a superposition state(4) (a step that requires coherent control). Here we report fully tunable entanglement between a single Ca-40(+) ion and the polarization state of a single photon within an optical resonator. Our method, based on a bichromatic, cavity-mediated Raman transition, allows us to select two coupling paths and adjust their relative phase and amplitude. The cavity setting enables intrinsically deterministic, high-fidelity generation of any two-qubit entangled state. This approach is applicable to a broad range of candidate systems and thus is a promising method for distributing information within quantum networks.	[Stute, A.; Casabone, B.; Schindler, P.; Monz, T.; Brandstaetter, B.; Northup, T. E.; Blatt, R.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Schmidt, P. O.] Phys Tech Bundesanstalt, QUEST Inst Expt Quantum Metrol, D-38116 Braunschweig, Germany; [Schmidt, P. O.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany; [Blatt, R.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; Physikalisch-Technische Bundesanstalt (PTB); Leibniz University Hannover; Austrian Academy of Sciences	Northup, TE (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	tracy.northup@uibk.ac.at	Northup, Tracy E./N-1439-2017; Schindler, Philipp/AAB-4803-2019; Monz, Thomas/E-1285-2017; Schmidt, Piet/F-6384-2011; casabone, bernardo/R-7156-2019; Schindler, Philipp/E-1485-2017; Blatt, Rainer/H-9527-2014	Northup, Tracy E./0000-0002-1071-2218; Schindler, Philipp/0000-0002-9461-9650; Schmidt, Piet/0000-0003-0773-5889; casabone, bernardo/0000-0002-3695-7539; Schindler, Philipp/0000-0002-9461-9650; Monz, Thomas/0000-0001-7410-4804	Austrian Science Fund (FWF); European Commission (AQUTE); Institut fur Quanteninformation GmbH; Marie Curie International Incoming Fellowship within the 7th European Framework Program	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Commission (AQUTE)(European CommissionEuropean Commission Joint Research Centre); Institut fur Quanteninformation GmbH; Marie Curie International Incoming Fellowship within the 7th European Framework Program	We thank J. Barreiro, D. Nigg, K. Hammerer and W. Rosenfeld for discussions. This work was supported by the Austrian Science Fund (FWF), the European Commission (AQUTE), the Institut fur Quanteninformation GmbH, and a Marie Curie International Incoming Fellowship within the 7th European Framework Program.	Barros HG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103004; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Davison AC, 1997, BOOTSTRAP METHODS TH; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Jezek M, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012305; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Law CK, 1997, J MOD OPTIC, V44, P2067, DOI 10.1080/095003497152357; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Maunz P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.250502; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Rosenfeld W, 2009, ADV SCI LETT, V2, P469, DOI 10.1166/asl.2009.1059; Russo C, 2009, APPL PHYS B-LASERS O, V95, P205, DOI 10.1007/s00340-009-3430-2; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Shore B.W., 1990, THEORY COHERENT ATOM; Stute A., APPL PHYS B; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Weber B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030501; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245	30	148	150	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					482	U89		10.1038/nature11120	http://dx.doi.org/10.1038/nature11120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622573	Green Accepted, Green Submitted			2022-12-28	WOS:000304344500038
J	Volpp, KG; Loewenstein, G; Asch, DA				Volpp, Kevin G.; Loewenstein, George; Asch, David A.			Assessing Value in Health Care Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Volpp, Kevin G.; Asch, David A.] Univ Penn Sch, Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Loewenstein, George; Asch, David A.] Univ Penn, Penn CMU Roybal Ctr Behav Econ & Hlth P30, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Loewenstein, George; Asch, David A.] Univ Penn, Leonard Davis Inst Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Dept Hlth Care Management, Wharton Sch Decis Sci, Philadelphia, PA 19104 USA; [Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Carnegie Mellon University	Volpp, KG (corresponding author), Univ Penn Sch, Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, 1120 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X	NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG034546] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Garber A, 2007, HEALTH AFFAIR, V26, P1545, DOI 10.1377/hlthaff.26.6.1545; Jonsen A R, 1986, Law Med Health Care, V14, P172; Pollack Andrew, 2011, NEW YORK TIMES, pB1; RITOV I, 1992, J RISK UNCERTAINTY, V5, P49; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Stein R, 2011, WASHINGTON POST 1118; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	9	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2153	2154		10.1001/jama.2012.3619	http://dx.doi.org/10.1001/jama.2012.3619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945YX	22618919	Green Accepted, Green Published			2022-12-28	WOS:000304315200021
J	Lane, JD; Keenan, NG; Bouloux, P; Rogers, D				Lane, Jem D.; Keenan, Niall G.; Bouloux, Pierre; Rogers, Dominic			A heart without hormones	LANCET			English	Editorial Material									[Lane, Jem D.; Keenan, Niall G.; Rogers, Dominic] Royal Free Hosp, Dept Cardiol, London NW3 2QG, England; [Bouloux, Pierre] Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Rogers, D (corresponding author), Royal Free Hosp, Dept Cardiol, Pond St, London NW3 2QG, England.	dominic.rogers@nhs.net	Keenan, Niall/AAG-3376-2020	Keenan, Niall/0000-0002-0841-6989				Ellis CR, 2008, J CARDIOVASC ELECTR, V19, P1105, DOI 10.1111/j.1540-8167.2008.01154.x; Giraldi FP, 2011, OBESITY, V19, P2015, DOI 10.1038/oby.2011.33; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Le Bouter S, 2003, CIRC RES, V92, P234, DOI 10.1161/01.RES.0000053185.75505.8E; Nishizawa S, 2009, AM J EMERG MED, V27, p[e1, e3]	5	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1922	1922		10.1016/S0140-6736(12)60314-6	http://dx.doi.org/10.1016/S0140-6736(12)60314-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22608340				2022-12-28	WOS:000304194200034
J	Winzer, T; Gazda, V; He, Z; Kaminski, F; Kern, M; Larson, TR; Li, Y; Meade, F; Teodor, R; Vaistij, FE; Walker, C; Bowser, TA; Graham, IA				Winzer, Thilo; Gazda, Valeria; He, Zhesi; Kaminski, Filip; Kern, Marcelo; Larson, Tony R.; Li, Yi; Meade, Fergus; Teodor, Roxana; Vaistij, Fabian E.; Walker, Carol; Bowser, Tim A.; Graham, Ian A.			A Papaver somniferum 10-Gene Cluster for Synthesis of the Anticancer Alkaloid Noscapine	SCIENCE			English	Article							METABOLIC GENE CLUSTERS; MORPHINE BIOSYNTHESIS; OPIUM POPPY; MOLECULAR-CLONING; COPTIS-JAPONICA; ENZYME; CELLS; IDENTIFICATION; APOPTOSIS; PLANTS	Noscapine is an antitumor alkaloid from opium poppy that binds tubulin, arrests metaphase, and induces apoptosis in dividing human cells. Elucidation of the biosynthetic pathway will enable improvement in the commercial production of noscapine and related bioactive molecules. Transcriptomic analysis revealed the exclusive expression of 10 genes encoding five distinct enzyme classes in a high noscapine-producing poppy variety, HN1. Analysis of an F-2 mapping population indicated that these genes are tightly linked in HN1, and bacterial artificial chromosome sequencing confirmed that they exist as a complex gene cluster for plant alkaloids. Virus-induced gene silencing resulted in accumulation of pathway intermediates, allowing gene function to be linked to noscapine synthesis and a novel biosynthetic pathway to be proposed.	[Winzer, Thilo; Gazda, Valeria; He, Zhesi; Kaminski, Filip; Kern, Marcelo; Larson, Tony R.; Li, Yi; Meade, Fergus; Teodor, Roxana; Vaistij, Fabian E.; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Walker, Carol; Bowser, Tim A.] GlaxoSmithKline, Boronia, Vic 3155, Australia	University of York - UK; GlaxoSmithKline	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ian.graham@york.ac.uk	TEODOR, Roxana/R-6929-2018; Teodor, Roxana/I-3952-2012; Larson, Tony/AAI-4782-2020	TEODOR, Roxana/0000-0003-2652-1894; Larson, Tony/0000-0003-1337-3482; Bowser, Tim/0000-0002-2126-8538; Meade, Fergus/0000-0001-9242-3622; Vaistij, Fabian E./0000-0002-1469-0589	GlaxoSmithKline Australia; Garfield Weston Foundation for the Centre for Novel Agricultural Products; Biotechnology and Biological Sciences Research Council [1098027] Funding Source: researchfish	GlaxoSmithKline Australia(GlaxoSmithKline); Garfield Weston Foundation for the Centre for Novel Agricultural Products; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the laboratory and field staff at GlaxoSmithKline Australia for valuable technical assistance and J. Mitchell for administrative support. Supported by GlaxoSmithKline Australia and by the Garfield Weston Foundation for the Centre for Novel Agricultural Products. The identities of three of the P450s and the methyltransferase genes associated with noscapine production have been disclosed in PCT patent applications WO2011/161431 and WO2012/010872, respectively. The sequences of four BAC clones and genomic sequences of the 10 genes are available through the National Centre for Biotechnology Information under GenBank accession nos. JQ659009 to JQ659012 and JQ658999 to JQ659008. HN1, HM1, and HT1 are available from GSK Australia for experimental purposes, subject to a material transfer agreement.	Apuya NR, 2008, PLANT BIOTECHNOL J, V6, P160, DOI 10.1111/j.1467-7652.2007.00302.x; BATTERSBY AR, 1968, J CHEM SOC C, P2163, DOI 10.1039/j39680002163; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j; KONZETT H., 1954, EXPERIENTIA, V10, P472, DOI 10.1007/BF02170409; Landen JW, 2002, CANCER RES, V62, P4109; Lenz R, 1995, J BIOL CHEM, V270, P31091, DOI 10.1074/jbc.270.52.31091; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Robiquet P. -J., 1817, ANN CHIM PHYS, V5, P275; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	31	217	266	4	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1704	1708		10.1126/science.1220757	http://dx.doi.org/10.1126/science.1220757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22653730				2022-12-28	WOS:000305794500050
J	Liu, K; Ding, S				Liu, Kai; Ding, Sheng			Target Practice: Modeling Tumors with Stem Cells	CELL			English	Editorial Material							IDENTIFICATION	A variant neoplastic line of human pluripotent stem cell (hPSC) displays unique tumorigenic properties, including enhanced self-renewal and survival, and aberrant blockade in differentiation. Sachlos et al. adopted a neoplastic hPSC differentiation platform to screen small molecules that selectively induce differentiation of cancer stem cells.	[Liu, Kai; Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Liu, Kai; Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Ding, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu						Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516	10	4	5	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1185	1187		10.1016/j.cell.2012.05.019	http://dx.doi.org/10.1016/j.cell.2012.05.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682241	Bronze			2022-12-28	WOS:000305119600004
J	Reymann, AC; Boujemaa-Paterski, R; Martiel, JL; Guerin, C; Cao, WX; Chin, HF; De La Cruz, EM; Thery, M; Blanchoin, L				Reymann, Anne-Cecile; Boujemaa-Paterski, Rajaa; Martiel, Jean-Louis; Guerin, Christophe; Cao, Wenxiang; Chin, Harvey F.; De La Cruz, Enrique M.; Thery, Manuel; Blanchoin, Laurent			Actin Network Architecture Can Determine Myosin Motor Activity	SCIENCE			English	Article							FILAMENT BUNDLES; MOLECULAR MOTORS; CELL-SIZE; FIBROBLASTS; MECHANISM; RING	The organization of actin filaments into higher-ordered structures governs eukaryotic cell shape and movement. Global actin network size and architecture are maintained in a dynamic steady state through regulated assembly and disassembly. Here, we used experimentally defined actin structures in vitro to investigate how the activity of myosin motors depends on network architecture. Direct visualization of filaments revealed myosin-induced actin network deformation. During this reorganization, myosins selectively contracted and disassembled antiparallel actin structures, while parallel actin bundles remained unaffected. The local distribution of nucleation sites and the resulting orientation of actin filaments appeared to regulate the scalability of the contraction process. This "orientation selection" mechanism for selective contraction and disassembly suggests how the dynamics of the cellular actin cytoskeleton can be spatially controlled by actomyosin contractility.	[Reymann, Anne-Cecile; Boujemaa-Paterski, Rajaa; Martiel, Jean-Louis; Guerin, Christophe; Thery, Manuel; Blanchoin, Laurent] Univ Grenoble 1, Commissariat Energie Atom & Energies Alternat CEA, Inst Rech Technol & Sci Vivant iRTSV, Lab Physiol Cellulaire & Vegetale,CNRS,INRA, F-38054 Grenoble, France; [Cao, Wenxiang; Chin, Harvey F.; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Yale University	Thery, M (corresponding author), Univ Grenoble 1, Commissariat Energie Atom & Energies Alternat CEA, Inst Rech Technol & Sci Vivant iRTSV, Lab Physiol Cellulaire & Vegetale,CNRS,INRA, F-38054 Grenoble, France.	manuel.thery@cea.fr; laurent.blanchoin@cea.fr	Martiel, Jean-Louis/N-5250-2018; Martiel, Jean-Louis/M-7181-2014	Martiel, Jean-Louis/0000-0001-8638-7207; Reymann, Anne-Cecile/0000-0002-0517-5083	Human Frontier Science Program [RGP0004/2011]; Agence Nationale de la Recherche [ANR-08-BLANC-0012]; Institut National du Cancer [INCA-2011-141]; NIH [GM097348]; CEA; NSF [MCB-0546353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEA(French Atomic Energy Commission); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Sykes and J. Faix for muscle myosin II protein, F. Senger for image analysis, and K. John for discussions regarding the computational model. This work was supported by grants from Human Frontier Science Program (RGP0004/2011 awarded to L.B. and E.M.D.L.C.), Agence Nationale de la Recherche (ANR-08-BLANC-0012 awarded to L.B.), Institut National du Cancer (INCA-2011-141 awarded to M.T.), NIH (GM097348 awarded to E.M.D.L.C.), and a Ph.D. Fellowship from the Irtelis program of the CEA (awarded to A.C.R.). E.M.D.L.C. is an American Heart Association Established Investigator, an NSF Career Award recipient (MCB-0546353), and a Hellman Family Fellow. The use of micropatterned substrates to control actin network self-assembly is protected by patent EP2011/063676. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials.	Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; Calvert MEK, 2011, J CELL BIOL, V195, P799, DOI 10.1083/jcb.201101055; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Veigel C, 2011, NAT REV MOL CELL BIO, V12, P163, DOI 10.1038/nrm3062; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994	15	218	219	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1310	1314		10.1126/science.1221708	http://dx.doi.org/10.1126/science.1221708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679097	Green Accepted			2022-12-28	WOS:000304905300048
J	Sachlos, E; Risueno, RM; Laronde, S; Shapovalova, Z; Lee, JH; Russell, J; Malig, M; McNicol, JD; Fiebig-Comyn, A; Graham, M; Levadoux-Martin, M; Lee, JB; Giacomelli, AO; Hassell, JA; Fischer-Russell, D; Trus, MR; Foley, R; Leber, B; Xenocostas, A; Brown, ED; Collins, TJ; Bhatia, M				Sachlos, Eleftherios; Risueno, Ruth M.; Laronde, Sarah; Shapovalova, Zoya; Lee, Jong-Hee; Russell, Jennifer; Malig, Monika; McNicol, Jamie D.; Fiebig-Comyn, Aline; Graham, Monica; Levadoux-Martin, Marilyne; Lee, Jung Bok; Giacomelli, Andrew O.; Hassell, John A.; Fischer-Russell, Daniela; Trus, Michael R.; Foley, Ronan; Leber, Brian; Xenocostas, Anargyros; Brown, Eric D.; Collins, Tony J.; Bhatia, Mickie			Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; DIFFERENTIATION; EXPRESSION; INDUCTION; FEATURES; COHORT	Selective targeting of cancer stem cells (CSCs) offers promise for a new generation of therapeutics. However, assays for both human CSCs and normal stem cells that are amenable to robust biological screens are limited. Using a discovery platform that reveals differences between neoplastic and normal human pluripotent stem cells (hPSC), we identify small molecules from libraries of known compounds that induce differentiation to overcome neoplastic self-renewal. Surprisingly, thioridazine, an antipsychotic drug, selectively targets the neoplastic cells, and impairs human somatic CSCs capable of in vivo leukemic disease initiation while having no effect on normal blood SCs. The drug antagonizes dopamine receptors that are expressed on CSCs and on breast cancer cells as well. These results suggest that dopamine receptors may serve as a biomarker for diverse malignancies, demonstrate the utility of using neoplastic hPSCs for identifying CSC-targeting drugs, and provide support for the use of differentiation as a therapeutic strategy.	[Sachlos, Eleftherios; Risueno, Ruth M.; Laronde, Sarah; Shapovalova, Zoya; Lee, Jong-Hee; Russell, Jennifer; Malig, Monika; McNicol, Jamie D.; Fiebig-Comyn, Aline; Graham, Monica; Levadoux-Martin, Marilyne; Lee, Jung Bok; Fischer-Russell, Daniela; Collins, Tony J.; Bhatia, Mickie] McMaster Univ, Fac Hlth Sci, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada; [Giacomelli, Andrew O.; Hassell, John A.; Brown, Eric D.; Bhatia, Mickie] McMaster Univ, Fac Hlth Sci, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Trus, Michael R.; Foley, Ronan; Leber, Brian] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Xenocostas, Anargyros] Univ Western Ontario, Dept Med, Div Hematol, Schulich Sch Med, London, ON N6A 3K7, Canada	McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Fac Hlth Sci, McMaster Stem Cell & Canc Res Inst, 1280 Main St W,MDCL 5029, Hamilton, ON L8S 4L8, Canada.	mbhatia@mcmaster.ca	Xenocostas, Anargyros/G-3358-2011; Risueño, Ruth Muñoz/G-9969-2015	Risueño, Ruth Muñoz/0000-0003-4048-9536; Leber, Brian/0000-0001-5502-1480	Canadian Institute of Health Research; Canadian Cancer Society Research Institute (CCSRI); Ontario Ministry of Economic Development; Innovation's Ontario Consortium for Regeneration inducing Therapeutics; Canadian Chair; CCS-TFF	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Ontario Ministry of Economic Development; Innovation's Ontario Consortium for Regeneration inducing Therapeutics; Canadian Chair; CCS-TFF	This work was supported by grants from the Canadian Institute of Health Research, Canadian Cancer Society Research Institute (CCSRI) to M.B, and foremost by the Ontario Ministry of Economic Development and Innovation's Ontario Consortium for Regeneration inducing Therapeutics. M.B. is supported by the Canadian Chair Program and holds the Canada Research Chair in human stem cell biology. R.M.R is supported by a CCS-TFF fellowship. The McMaster University Animal Care Council approved all in vivo procedures and protocols. We thank Ryan Mitchell, Dr. Tamra Werbowetski-Ogilvie, and Dr. DongCheng Wu from the Bhatia lab for technical assistance and constructive input; Dr. Mark D. Minden of the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada, for providing AML cell lines (OCI-AML2, OCI-AML3); and members of the Labour and Delivery clinic at the McMaster Children's Hospital for supplying cord blood samples. We also thank Peter Cmorej and Robin Hallet from Dr. John Hassell's lab for technical assistance in breast tumor preparation and guidance with breast tumor biology, respectively; Dr. Eric Brown, Jan Blanchard, and staff of the McMaster HTS laboratory and Centre for Microbial Chemical Biology for supplying a portion of the Canadian Compound Collection library; Dr. Rima Al-war from the Ontario Institute of Cancer Research for supplying the OICR kinase library; Dr. Ahmed Aman from the Al-war lab for assistance with HPLC analysis; Dr. Gerry Wright from the Institute for Infectious Disease Research, McMaster University, and Dr. Geoff Tranmer and Inga Kireeva from the Wright lab for their assistance with NMR and HRMS analysis. E.S and R.M.R. designed and performed experiments, analyzed data, and wrote the paper; S.L, Z.S, J.H.L, J.R, M.M, J.M designed and performed experiments and analyzed data; A.F and M.G performed experiments; M.L.M. sorted samples and assisted with flow cytometry analysis; M.T, R.F and B.L supplied AML samples; A.O.G and J.A.H supplied breast tumor samples. T.J.C and D.F.R designed experiments, analyzed data, and wrote the paper. M.B. designed experiments, analyzed data, supervised the project and wrote the paper.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Carlo RD, 1986, ANN NY ACAD SCI, V464, P559, DOI DOI 10.1111/J.1749-6632.1986.TB16068.X; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Dalton SO, 2005, SCHIZOPHR RES, V75, P315, DOI 10.1016/j.schres.2004.11.009; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Estey EH, 1999, BLOOD, V93, P2478, DOI 10.1182/blood.V93.8.2478.408k04_2478_2484; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SACHS L, 1978, NATURE, V274, P535, DOI 10.1038/274535a0; SEEMAN P, 1983, EUR J PHARMACOL, V94, P145, DOI 10.1016/0014-2999(83)90452-1; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida H, 1996, CANCER RES, V56, P2945; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zheng R, 2002, BLOOD, V100, P4154, DOI 10.1182/blood-2002-03-0936	43	364	405	0	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1284	1297		10.1016/j.cell.2012.03.049	http://dx.doi.org/10.1016/j.cell.2012.03.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22632761	Bronze			2022-12-28	WOS:000305119600013
J	Schrauben, JN; Hayoun, R; Valdez, CN; Braten, M; Fridley, L; Mayer, JM				Schrauben, Joel N.; Hayoun, Rebecca; Valdez, Carolyn N.; Braten, Miles; Fridley, Lila; Mayer, James M.			Titanium and Zinc Oxide Nanoparticles Are Proton-Coupled Electron Transfer Agents	SCIENCE			English	Article							POLYCRYSTALLINE TIO2 ELECTRODES; HYDROGEN-ATOM TRANSFER; FLAT-BAND POTENTIALS; SPECTROSCOPIC DETERMINATION; COMPLEXES; PHOTOCATALYSIS; INTERCALATION; ABSORPTION; INTERFACES; ENERGETICS	Oxidation/reduction reactions at metal oxide surfaces are important to emerging solar energy conversion processes, photocatalysis, and geochemical transformations. Here we show that the usual description of these reactions as electron transfers is incomplete. Reduced TiO2 and ZnO nanoparticles in solution can transfer an electron and a proton to phenoxyl and nitroxyl radicals, indicating that e(-) and H+ are coupled in this interfacial reaction. These proton-coupled electron transfer (PCET) reactions are rapid and quantitative. The identification of metal oxide surfaces as PCET reagents has implications for the understanding and development of chemical energy technologies, which will rely on e(-)/H+ coupling.	[Schrauben, Joel N.; Hayoun, Rebecca; Valdez, Carolyn N.; Braten, Miles; Fridley, Lila; Mayer, James M.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mayer, JM (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	mayer@chem.washington.edu			University of Washington; American Chemical Society [51178-ND3]; U.S. NSF [CHE-1151726]; Department of Energy Office of Science [DE-AC05-06OR23100]; NSF Center for Enabling New Technologies through Catalysis; Division Of Chemistry [1151726] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023100] Funding Source: NIH RePORTER	University of Washington(University of Washington); American Chemical Society(American Chemical Society); U.S. NSF(National Science Foundation (NSF)); Department of Energy Office of Science(United States Department of Energy (DOE)); NSF Center for Enabling New Technologies through Catalysis; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Materials and methods and additional figures are presented in the supplementary materials on Science Online. We are grateful for financial support from the University of Washington, the American Chemical Society Petroleum Research Fund (51178-ND3), and the U.S. NSF (CHE-1151726). This research is also supported in part by the Department of Energy Office of Science Graduate Fellowship Program, made possible in part by the American Recovery and Reinvestment Act of 2009, administered by Oak Ridge Institute for Science and Education-Oak Ridge Associated Universities under contract no. DE-AC05-06OR23100, and in part by the NSF Center for Enabling New Technologies through Catalysis. We especially thank D. Gamelin, members of the Gamelin laboratory, and L. Maibaum for very valuable discussions.	Ardo S, 2009, CHEM SOC REV, V38, P115, DOI 10.1039/b804321n; BAHNEMANN D, 1984, J PHYS CHEM-US, V88, P709, DOI 10.1021/j150648a018; Bard AJ, 2010, J AM CHEM SOC, V132, P7559, DOI 10.1021/ja101578m; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Chen XB, 2011, SCIENCE, V331, P746, DOI 10.1126/science.1200448; Costentin C, 2008, CHEM REV, V108, P2145, DOI 10.1021/cr068065t; Cozzoli PD, 2003, J AM CHEM SOC, V125, P14539, DOI 10.1021/ja036505h; ENRIGHT B, 1994, J PHYS CHEM-US, V98, P6195, DOI 10.1021/j100075a023; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Germeau A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.097401; Hammes-Schiffer S, 2010, CHEM REV, V110, P6937, DOI 10.1021/cr100367q; Jin J, 2008, J ORG CHEM, V73, P7901, DOI 10.1021/jo801869r; Kamat PV, 2011, J PHYS CHEM LETT, V2, P839, DOI 10.1021/jz2002953; KOLLE U, 1985, INORG CHEM, V24, P2253; Liu WK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186804; LYON LA, 1995, J PHYS CHEM-US, V99, P15718, DOI 10.1021/j100043a005; Lyon LA, 1999, J PHYS CHEM B, V103, P4623, DOI 10.1021/jp9908404; Mahanthappa MK, 2004, ORGANOMETALLICS, V23, P836, DOI 10.1021/om034096s; Mahanthappa MK, 2002, CHEM COMMUN, P502, DOI 10.1039/b110147a; Marken F, 2004, ELECTROCHEM COMMUN, V6, P1153, DOI 10.1016/j.elecom.2004.09.006; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Minguzzi A, 2012, CHEM SCI, V3, P217, DOI 10.1039/c1sc00516b; Mohamed HH, 2011, J PHYS CHEM A, V115, P2139, DOI 10.1021/jp108958w; Morrison S.R., 1980, ELECTROCHEMISTRY SEM; O'Regan BC, 2009, ACCOUNTS CHEM RES, V42, P1799, DOI 10.1021/ar900145z; Park JK, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3561775; Petek H, 2010, CHEM REV, V110, P7082, DOI 10.1021/cr1001595; Pourbaix M., 1966, ATLAS ELECTROCHEMICA, Vfirst English; REDMOND G, 1993, J PHYS CHEM-US, V97, P1426, DOI 10.1021/j100109a029; Ren Y, 2010, ANGEW CHEM INT EDIT, V49, P2570, DOI 10.1002/anie.200907099; Schroder K, 2008, ORGANOMETALLICS, V27, P1859, DOI 10.1021/om7012293; Schwartz DA, 2003, P SOC PHOTO-OPT INS, V5224, P1, DOI 10.1117/12.508665; Shkrob IA, 2009, J PHYS CHEM C, V113, P17138, DOI 10.1021/jp906250w; Venkataraman C, 2010, J PHYS CHEM C, V114, P487, DOI 10.1021/jp908798n; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Zou XX, 2010, CHEM COMMUN, V46, P2112, DOI 10.1039/b924840d; Zukalova M, 2005, CHEM MATER, V17, P1248, DOI 10.1021/cm048249t	37	287	292	17	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1298	1301		10.1126/science.1220234	http://dx.doi.org/10.1126/science.1220234			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679095				2022-12-28	WOS:000304905300044
J	Tavakkoli, KGA; Gotrik, KW; Hannon, AF; Alexander-Katz, A; Ross, CA; Berggren, KK				Tavakkoli, A. K. G.; Gotrik, K. W.; Hannon, A. F.; Alexander-Katz, A.; Ross, C. A.; Berggren, K. K.			Templating Three-Dimensional Self-Assembled Structures in Bilayer Block Copolymer Films	SCIENCE			English	Article							THIN-FILMS; SURFACES; ARRAYS; NANOLITHOGRAPHY; GRAPHOEPITAXY; REGISTRATION; LITHOGRAPHY; ORIENTATION; GEOMETRIES; PATTERNS	The registration and alignment of a monolayer of microdomains in a self-assembled block copolymer thin film can be controlled by chemical or physical templating methods. Although planar patterns are useful for nanoscale device fabrication, three-dimensional multilevel structures are required for some applications. We found that a bilayer film of a cylindrical-morphology block copolymer, templated by an array of posts functionalized with a brush attractive to the majority block, can form a rich variety of three-dimensional structures consisting of cylinder arrays with controllable angles, bends, and junctions whose geometry is controlled by the template periodicity and arrangement. This technique allows control of microdomain patterns and the ability to route and connect microdomains in specific directions.	[Gotrik, K. W.; Hannon, A. F.; Alexander-Katz, A.; Ross, C. A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Tavakkoli, A. K. G.; Berggren, K. K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Tavakkoli, A. K. G.] NUS Grad Sch Integrat Sci & Engn NGS, Singapore 117456, Singapore	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National University of Singapore	Ross, CA (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	caross@mit.edu; berggren@mit.edu	Hannon, Adam/P-4848-2014	Hannon, Adam/0000-0002-7015-6858	NGS Singapore; Semiconductor Research Corporation; Center on Functional Engineered and Nano Architectonics; Nanoelectronics Research Initiative; Singapore-MIT Alliance; Tokyo Electron; Taiwan Semiconductor Manufacturing Company	NGS Singapore; Semiconductor Research Corporation; Center on Functional Engineered and Nano Architectonics; Nanoelectronics Research Initiative; Singapore-MIT Alliance; Tokyo Electron; Taiwan Semiconductor Manufacturing Company	Supported by a fellowship from NGS Singapore (A.T.K.G.), the Semiconductor Research Corporation, the Center on Functional Engineered and Nano Architectonics, Nanoelectronics Research Initiative, Singapore-MIT Alliance, Tokyo Electron, and Taiwan Semiconductor Manufacturing Company. We thank M. Mondol and J. Daley for technical assistance. A.T.K.G. would like to express his profound gratitude to T. C. Chong and S. N. Piramanayagam for their support. The Research Laboratory of Electronics Scanning-Electron-Beam Lithography Facility at MIT provided facilities for this work. A patent titled "Removable Templates for Directed Self-Assembly" has been filed with MIT.	Bita I, 2008, SCIENCE, V321, P939, DOI 10.1126/science.1159352; Black CT, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2112191; Black CT, 2004, IEEE T NANOTECHNOL, V3, P412, DOI 10.1109/TNANO.2004.834160; Cheng JY, 2008, ADV MATER, V20, P3155, DOI 10.1002/adma.200800826; Cheng JY, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064417; Cheng JY, 2003, ADV MATER, V15, P1599, DOI 10.1002/adma.200305244; Daoulas KC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036104; HENKEE CS, 1988, J MATER SCI, V23, P1685, DOI 10.1007/BF01115708; Ji SX, 2011, ADV MATER, V23, P3692, DOI 10.1002/adma.201101813; Jung H, 2011, ACS NANO, V5, P6164, DOI 10.1021/nn2006943; Jung YS, 2008, NANO LETT, V8, P3776, DOI 10.1021/nl802099k; Kim E, 2008, SOFT MATTER, V4, P475, DOI 10.1039/b717903k; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Milliron DJ, 2007, NAT MATER, V6, P352, DOI 10.1038/nmat1887; Naito K, 2002, IEEE T MAGN, V38, P1949, DOI 10.1109/TMAG.2002.802847; Park SM, 2007, MACROMOLECULES, V40, P5084, DOI 10.1021/ma0702344; Park SM, 2008, MACROMOLECULES, V41, P9124, DOI 10.1021/ma801039v; Park S, 2009, SCIENCE, V323, P1030, DOI 10.1126/science.1168108; Peng Q, 2011, ACS NANO, V5, P4600, DOI 10.1021/nn2003234; Phillip WA, 2010, MACROMOLECULES, V43, P7763, DOI 10.1021/ma1012946; Rockford L, 1999, PHYS REV LETT, V82, P2602, DOI 10.1103/PhysRevLett.82.2602; Rose F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/3/035603; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; Ruiz R, 2007, ADV MATER, V19, P587, DOI 10.1002/adma.200600287; Ruiz R, 2011, ACS NANO, V5, P79, DOI 10.1021/nn101561p; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Shin K, 2004, SCIENCE, V306, P76, DOI 10.1126/science.1100090; Stoykovich MP, 2007, ACS NANO, V1, P168, DOI 10.1021/nn700164p; Stoykovich MP, 2005, SCIENCE, V308, P1442, DOI 10.1126/science.1111041; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Wu YY, 2004, NAT MATER, V3, P816, DOI 10.1038/nmat1230; Yang JKW, 2010, NAT NANOTECHNOL, V5, P256, DOI [10.1038/NNANO.2010.30, 10.1038/nnano.2010.30]; Yu B, 2011, SOFT MATTER, V7, P10227, DOI 10.1039/c1sm05947e	33	215	232	5	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1294	1298		10.1126/science.1218437	http://dx.doi.org/10.1126/science.1218437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679094	Green Submitted			2022-12-28	WOS:000304905300043
J	Weber, SC; Brangwynne, CP				Weber, Stephanie C.; Brangwynne, Clifford P.			Getting RNA and Protein in Phase	CELL			English	Review							CELL-FREE FORMATION; BINDING PROTEINS; GRANULES; HYDROGELS; BODIES; FORM	Nonmembrane-bound organelles such as RNA granules behave like dynamic droplets, but the molecular details of their assembly are poorly understood. Several recent papers identify structural features that drive granule assembly, shedding light on how phase transitions functionally organize the cell and may lead to pathological protein aggregation.	[Weber, Stephanie C.; Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	cbrangwy@princeton.edu		Weber, Stephanie C./0000-0002-7297-2875	NIGMS NIH HHS [DP2 GM105437] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105437] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Vekilov PG, 2010, SOFT MATTER, V6, P5254, DOI 10.1039/c0sm00215a	20	339	342	2	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1188	1191		10.1016/j.cell.2012.05.022	http://dx.doi.org/10.1016/j.cell.2012.05.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682242	Bronze			2022-12-28	WOS:000305119600005
J	Cardinale, BJ; Duffy, JE; Gonzalez, A; Hooper, DU; Perrings, C; Venail, P; Narwani, A; Mace, GM; Tilman, D; Wardle, DA; Kinzig, AP; Daily, GC; Loreau, M; Grace, JB; Larigauderie, A; Srivastava, DS; Naeem, S				Cardinale, Bradley J.; Duffy, J. Emmett; Gonzalez, Andrew; Hooper, David U.; Perrings, Charles; Venail, Patrick; Narwani, Anita; Mace, Georgina M.; Tilman, David; Wardle, David A.; Kinzig, Ann P.; Daily, Gretchen C.; Loreau, Michel; Grace, James B.; Larigauderie, Anne; Srivastava, Diane S.; Naeem, Shahid			Biodiversity loss and its impact on humanity	NATURE			English	Review							ECOSYSTEM SERVICES SCIENCE; PLANT DIVERSITY; SPECIES RICHNESS; FUNCTIONAL-ROLE; PRODUCTIVITY; COMMUNITIES; STABILITY; NICHE; WATER; SUPPRESSION	The most unique feature of Earth is the existence of life, and the most extraordinary feature of life is its diversity. Approximately 9 million types of plants, animals, protists and fungi inhabit the Earth. So, too, do 7 billion people. Two decades ago, at the first Earth Summit, the vast majority of the world's nations declared that human actions were dismantling the Earth's ecosystems, eliminating genes, species and biological traits at an alarming rate. This observation led to the question of how such loss of biological diversity will alter the functioning of ecosystems and their ability to provide society with the goods and services needed to prosper.	[Cardinale, Bradley J.; Venail, Patrick; Narwani, Anita] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Duffy, J. Emmett] Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Hooper, David U.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Perrings, Charles; Kinzig, Ann P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Daily, Gretchen C.] Stanford Univ, Woods Inst, Stanford, CA 94305 USA; [Loreau, Michel] CNRS, Stn Ecol Expt, F-09200 Moulis, France; [Grace, James B.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA; [Larigauderie, Anne] Museum Natl Hist Nat, F-75231 Paris 05, France; [Srivastava, Diane S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Naeem, Shahid] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	University of Michigan System; University of Michigan; William & Mary; Virginia Institute of Marine Science; McGill University; Western Washington University; Arizona State University; Arizona State University-Tempe; Imperial College London; University of Minnesota System; University of Minnesota Twin Cities; Swedish University of Agricultural Sciences; Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); United States Department of the Interior; United States Geological Survey; Museum National d'Histoire Naturelle (MNHN); University of British Columbia; Columbia University	Cardinale, BJ (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	bradcard@umich.edu	Grace, James/B-8472-2009; Cardinale, Bradley J/I-7076-2013; Venail, Patrick/D-2968-2018; Gonzalez, Andrew/F-2247-2010; Duffy, J. Emmett/ABF-9200-2020; Wardle, David A./F-6031-2011; Tilman, David/ABD-5309-2021; Mace, Georgina M/I-3072-2016	Grace, James/0000-0001-6374-4726; Venail, Patrick/0000-0003-1126-280X; Gonzalez, Andrew/0000-0001-6075-8081; Duffy, J. Emmett/0000-0001-8595-6391; Wardle, David A./0000-0002-0476-7335; Mace, Georgina M/0000-0001-8965-5211; Narwani, Anita/0000-0003-4561-0163	National Center for Ecological Analysis and Synthesis; National Science Foundation (NSF) [EF-0553768]; University of California, Santa Barbara; State of California; NFS [DEB-104612]; Biodiversity and Ecosystem Services Research Training Network (BESTNet) (NSF) [0639252]; NERC [ESPA010001] Funding Source: UKRI; Natural Environment Research Council [ESPA010001] Funding Source: researchfish; Division Of Environmental Biology [1046121] Funding Source: National Science Foundation; Division Of Ocean Sciences [1031061] Funding Source: National Science Foundation	National Center for Ecological Analysis and Synthesis; National Science Foundation (NSF)(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; NFS; Biodiversity and Ecosystem Services Research Training Network (BESTNet) (NSF); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was conceived as a part of the working group, Biodiversity and the Functioning of Ecosystems: Translating Model Experiments into Functional Reality, supported by the National Center for Ecological Analysis and Synthesis, a Center funded by the National Science Foundation (NSF Grant EF-0553768), the University of California, Santa Barbara, and the State of California. Additional funds were provided by NFS' DIMENSIONS of Biodiversity program to BJC (DEB-104612), and by the Biodiversity and Ecosystem Services Research Training Network (BESTNet) (NSF Grant 0639252). The use of trade names is for descriptive purposes only and does not imply endorsement by the US Government.	[Anonymous], 1995, GLOBAL BIODIVERSITY; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale Bradley, 2009, P105; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carroll IT, 2011, ECOLOGY, V92, P1157; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Denoth M, 2002, BIOL CONTROL, V24, P20, DOI 10.1016/S1049-9644(02)00002-6; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fox JW, 2012, OIKOS, V121, P290, DOI 10.1111/j.1600-0706.2011.19656.x; Goldman-Benner RL, 2012, ORYX, V46, P55, DOI 10.1017/S0030605311001050; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Griffin John n., 2009, P78; Heal G.M., 2005, VALUING ECOSYSTEM SE; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper D. U., 2012, NATURE; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houghton J. T., 2007, CLIMATE CHANGE IPCC; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Kinzig AP, 2012, SCIENCE, V335, P656, DOI 10.1126/science.335.6069.656-b; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Latta LC, 2011, EVOL ECOL, V25, P1107, DOI 10.1007/s10682-010-9457-3; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M., 2010, POPULATIONS ECOSYSTE; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Loreau M., 2002, 1 DIVERSITAS; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; O'Gorman EJ, 2010, J ANIM ECOL, V79, P682, DOI 10.1111/j.1365-2656.2009.01658.x; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; PERRINGS C, 1992, AMBIO, V21, P201; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Quijas S, 2010, BASIC APPL ECOL, V11, P582, DOI 10.1016/j.baae.2010.06.009; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schmid Bernhard, 2009, P14; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Schulze E.D., 1993, BIODIVERSITY ECOSYST; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D., P NATL ACAD IN PRESS; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Venail PA, 2010, P ROY SOC B-BIOL SCI, V277, P2339, DOI 10.1098/rspb.2009.2104; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Wood SA, 2010, ECOL LETT, V13, P1160, DOI 10.1111/j.1461-0248.2010.01508.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	100	3644	3831	300	4922	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					59	67		10.1038/nature11148	http://dx.doi.org/10.1038/nature11148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678280	Green Accepted			2022-12-28	WOS:000304854000027
J	Tang, JY; Mackay-Wiggan, JM; Aszterbaum, M; Yauch, RL; Lindgren, J; Chang, K; Coppola, C; Chanana, AM; Marji, J; Bickers, DR; Epstein, EH				Tang, Jean Y.; Mackay-Wiggan, Julian M.; Aszterbaum, Michelle; Yauch, Robert L.; Lindgren, Joselyn; Chang, Kris; Coppola, Carol; Chanana, Anita M.; Marji, Jackleen; Bickers, David R.; Epstein, Ervin H., Jr.			Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARCINOMA SYNDROME; HUMAN HOMOLOG; CANCER; MUTATIONS; GENE; RESISTANCE; SKIN; AMPLIFICATION; TUMORIGENESIS	BACKGROUND Dysregulated hedgehog signaling is the pivotal molecular abnormality underlying basal-cell carcinomas. Vismodegib is a new orally administered hedgehog-pathway inhibitor that produces objective responses in locally advanced and metastatic basal-cell carcinomas. METHODS We tested the anti-basal-cell carcinoma efficacy of vismodegib in a randomized, double-blind, placebo-controlled trial in patients with the basal-cell nevus syndrome at three clinical centers from September 2009 through January 2011. The primary end point was reduction in the incidence of new basal-cell carcinomas that were eligible for surgical resection (surgically eligible) with vismodegib versus placebo after 3 months; secondary end points included reduction in the size of existing basal-cell carcinomas. RESULTS In 41 patients followed for a mean of 8 months (range, 1 to 15) after enrollment, the per-patient rate of new surgically eligible basal-cell carcinomas was lower with vismodegib than with placebo (2 vs. 29 cases per group per year, P<0.001), as was the size (percent change from baseline in the sum of the longest diameter) of existing clinically significant basal-cell carcinomas (-65% vs. -11%, P=0.003). In some patients, all basal-cell carcinomas clinically regressed. No tumors progressed during treatment with vismodegib. Patients receiving vismodegib routinely had grade 1 or 2 adverse events of loss of taste, muscle cramps, hair loss, and weight loss. Overall, 54% of patients (14 of 26) receiving vismodegib discontinued drug treatment owing to adverse events. At 1 month, vismodegib use had reduced the hedgehog target-gene expression by basal-cell carcinoma by 90% (P<0.001) and diminished tumor-cell proliferation, but apoptosis was not affected. No residual basal-cell carcinoma was detectable in 83% of biopsy samples taken from sites of clinically regressed basal-cell carcinomas. CONCLUSIONS Vismodegib reduces the basal-cell carcinoma tumor burden and blocks growth of new basal-cell carcinomas in patients with the basal-cell nevus syndrome. The adverse events associated with treatment led to discontinuation in over half of treated patients. (Funded by Genentech and others; ClinicalTrials.gov number, NCT00957229.)	[Tang, Jean Y.; Lindgren, Joselyn; Chang, Kris; Chanana, Anita M.; Epstein, Ervin H., Jr.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Tang, Jean Y.] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Aszterbaum, Michelle] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Yauch, Robert L.] Genentech Inc, San Francisco, CA 94080 USA; [Mackay-Wiggan, Julian M.; Coppola, Carol; Marji, Jackleen; Bickers, David R.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Mackay-Wiggan, Julian M.; Coppola, Carol; Marji, Jackleen; Bickers, David R.] Columbia Univ, Dept Dermatol, Med Ctr, New York, NY 10027 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Stanford University; University of California System; University of California Irvine; Roche Holding; Genentech; Columbia University; Columbia University	Epstein, EH (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr, Oakland, CA 94609 USA.	eepstein@chori.org		Tang, Jean/0000-0002-5510-6502	Genentech; National Institutes of Health [UL1RR02413]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5P30AR044535-11, 1K23AR056736]; National Cancer Institute [R01CA109584]; Damon Runyon Cancer Research Foundation [CI-54-11]; Swim across America Foundation; Michael J. Rainen Family Foundation; NATIONAL CANCER INSTITUTE [R01CA109584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR056736, P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079953] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Swim across America Foundation; Michael J. Rainen Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Genentech, a Clinical and Translational Science Award from the National Institutes of Health (UL1RR02413), grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30AR044535-11, to Dr. Bickers; 1K23AR056736, to Dr. Tang) and the National Cancer Institute (R01CA109584, to Dr. Epstein), a Damon Runyon Cancer Research Foundation Clinical Investigator Award (CI-54-11, to Dr. Tang), and funding from the Swim across America Foundation and the Michael J. Rainen Family Foundation.	Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Baselga J, 2010, 2010 ANN M AM SOC CL; Blackburn EH, 2011, CANCER PREV RES, V4, P787, DOI 10.1158/1940-6207.CAPR-11-0195; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Davari P, 2010, CARCINOGENESIS, V31, P968, DOI 10.1093/carcin/bgp309; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Ling G, 2001, ONCOGENE, V20, P7770, DOI 10.1038/sj.onc.1204946; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Reifenberger J, 1998, CANCER RES, V58, P1798; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Takezaki T, 2011, CANCER SCI, V102, P1306, DOI 10.1111/j.1349-7006.2011.01943.x; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhao C, 2009, NATURE, V460, P652, DOI 10.1038/nature08255	25	397	406	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2180	2188						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22670904	Green Accepted			2022-12-28	WOS:000304863400007
J	Li, PX; McElligott, S; Bergquist, H; Schwartz, JS; Doshi, JA				Li, Pengxiang; McElligott, Sean; Bergquist, Henry; Schwartz, J. Sanford; Doshi, Jalpa A.			Effect of the Medicare Part D Coverage Gap on Medication Use Among Patients With Hypertension and Hyperlipidemia	ANNALS OF INTERNAL MEDICINE			English	Article							PROTON PUMP INHIBITORS; PHARMACY RECORDS; DRUG COVERAGE; BENEFICIARIES; ADHERENCE; THERAPY; RESPONSES; BENEFITS; OVERUSE; RISK	Background: Prior studies of the Medicare Part D coverage gap are limited in generalizability and scope. Objective: To determine the effect of the coverage gap on drugs used for asymptomatic (antihypertensive and lipid-lowering drugs) and symptomatic (pain relievers, acid suppressants, and antidepressants) conditions in elderly patients with hypertension and hyperlipidemia. Design: Quasi-experimental study using pre-post design and contemporaneous control group. Setting: Medicare claims files from 2005 and 2006 for 5% random sample of Medicare beneficiaries. Patients: Part D plan enrollees with hypertension or hyperlipidemia aged 65 years or older who had no coverage, generic-only coverage, or both brand-name and generic coverage during the gap in 2006. Patients who were fully eligible for the low-income subsidy served as the control group. Measurements: Monthly 30-day supply prescriptions available, medication adherence, and continuous medication gaps of 30 days or more for antihypertensive or lipid-lowering drugs; monthly 30-day supply prescriptions available for pain relievers, acid suppressants, or antidepressants before and after coverage gap entry. Results: Patients with no gap coverage had a decrease in monthly antihypertensive and lipid-lowering drug prescriptions during the coverage gap. Nonadherence also increased in this group (anti-hypertensives: odds ratio [OR], 1.60 [95% CI, 1.50 to 1.71]; lipid-lowering drugs: OR, 1.59 [CI, 1.50 to 1.68]). The proportion of patients with no gap coverage who had continuous medication gaps in lipid-lowering medication use and antihypertensive use increased by an absolute 7.3% (OR, 1.38 [CI, 1.29 to 1.46]) and 3.2% (OR, 1.35 [CI, 1.25 to 1.45]), respectively, because of the coverage gap. Decreases in use were smaller for pain relievers and antidepressants and larger for acid suppressants in patients with no gap coverage. Patients with generic-only coverage had decreased use of cardiovascular medications but no change in use of drugs for symptomatic conditions. No measures changed in the brand-name and generic coverage groups. Results of sensitivity analyses were consistent with the main findings. Limitation: Because this study was nonrandomized, unobserved differences may still exist between study groups. Conclusion: The Part D coverage gap was associated with decreased use of medications for hypertension and hyperlipidemia in patients with no gap coverage and generic-only gap coverage. The proposed phasing out of the gap by 2020 will benefit such patients; however, use of low-value medications may also increase.	[Doshi, Jalpa A.] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Doshi, JA (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, Blockley Hall,Room 1222, Philadelphia, PA 19104 USA.	jdoshi@mail.med.upenn.edu			Penn-Pfizer Alliance; American Heart Association	Penn-Pfizer Alliance; American Heart Association(American Heart Association)	Primary Funding Source: Penn-Pfizer Alliance and American Heart Association.	Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; [Anonymous], 2001, ECONOMETRIC ANAL CRO; Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; Campbell DT, 1965, EXPT QUASIEXPERIMENT; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Cronk A, 2008, AM J HEALTH-SYST PH, V65, P1062, DOI 10.2146/ajhp070478; Doshi Jalpa A, 2004, Health Aff (Millwood), VSuppl Web Exclusives, pW4; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fendrick AM, 2001, AM J MANAG CARE, V7, P861; Fung V, 2010, HEALTH SERV RES, V45, P355, DOI 10.1111/j.1475-6773.2009.01071.x; Glew CM, 2007, J AM MED DIR ASSOC, V8, P607, DOI 10.1016/j.jamda.2007.07.001; Gu QA, 2010, AM J MANAG CARE, V16, P911; Gupta R, 2010, SOUTH MED J, V103, P207, DOI 10.1097/SMJ.0b013e3181ce0e7a; Heidelbaugh JJ, 2009, AM J GASTROENTEROL, V104, pS27, DOI 10.1038/ajg.2009.49; Hoadley J, 2009, MEDICARE D; Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Kaiser Family Foundation, 2010, EXPL HLTH CAR REF D; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Pedan A, 2009, AM J MANAG CARE, V15, P323; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Piette JD, 2006, SOC SCI MED, V62, P846, DOI 10.1016/j.socscimed.2005.06.045; Raebel MA, 2008, MED CARE, V46, P1116, DOI 10.1097/MLR.0b013e318185cddd; Robst J, 2007, HEALTH CARE FINANC R, V28, P15; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; Saftlas H, 2007, IND SURVEYS HEALTHCA; Schneeweiss S, 2007, CIRCULATION, V115, P2128, DOI 10.1161/CIRCULATIONAHA.106.665992; Schneeweiss S, 2009, HEALTH AFFAIR, V28, pW305, DOI 10.1377/hlthaff.28.2.w305; Sikka R, 2005, AM J MANAG CARE, V11, P453; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stuart BC, 2009, HEALTH SERV RES, V44, P128, DOI 10.1111/j.1475-6773.2008.00897.x; Sun Shawn X, 2007, Manag Care Interface, V20, P51; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Zhang Y, 2009, HEALTH AFFAIR, V28, pW317, DOI 10.1377/hlthaff.28.2.w317; Zink DA, 2005, ALIMENT PHARM THERAP, V21, P1203, DOI 10.1111/j.1365-2036.2005.02454.x	37	51	51	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					776	+		10.7326/0003-4819-156-11-201206050-00004	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00004			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	954ZK	22665815				2022-12-28	WOS:000304986500003
J	Brick, K; Smagulova, F; Khil, P; Camerini-Otero, RD; Petukhova, GV				Brick, Kevin; Smagulova, Fatima; Khil, Pavel; Camerini-Otero, R. Daniel; Petukhova, Galina V.			Genetic recombination is directed away from functional genomic elements in mice	NATURE			English	Article							HISTONE H3 METHYLTRANSFERASE; MEIOTIC RECOMBINATION; PRDM9; INITIATION; HOTSPOTS; SITES; MOUSE; IDENTIFICATION; LANDSCAPE; MEIOSIS	Genetic recombination occurs during meiosis, the key developmental programme of gametogenesis. Recombination in mammals has been recently linked to the activity of a histone H3 methyltransferase, PR domain containing 9 (PRDM9)(1-6), the product of the only known speciation-associated gene in mammals(7). PRDM9 is thought to determine the preferred recombination sites-recombination hotspots-through sequence-specific binding of its highly polymorphic multi-Zn-finger domain(8). Nevertheless, Prdm9 knockout mice are proficient at initiating recombination(9). Here we map and analyse the genome-wide distribution of recombination initiation sites in Prdm9 knockout mice and in two mouse strains with different Prdm9 alleles and their F-1 hybrid. We show that PRDM9 determines the positions of practically all hotspots in the mouse genome, with the exception of the pseudo-autosomal region (PAR)-the only area of the genome that undergoes recombination in 100% of cells(10). Surprisingly, hotspots are still observed in Prdm9 knockout mice, and as in wild type, these hotspots are found at H3 lysine 4 (H3K4) trimethylation marks. However, in the absence of PRDM9, most recombination is initiated at promoters and at other sites of PRDM9-independent H3K4 trimethylation. Such sites are rarely targeted in wild-type mice, indicating an unexpected role of the PRDM9 protein in sequestering the recombination machinery away from gene-promoter regions and other functional genomic elements.	[Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] Natl Inst Diabet Digest & Kidney Dis, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	rdcamerini@mail.nih.gov; gpetukhova@usuhs.mil	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Khil, Pavel/0000-0002-4903-8777; Smagulova, Fatima/0000-0001-6883-1968	NIDDK; March of Dimes Foundation [5-FY07-667]; NIH from NIGMS [1R01GM084104-01A1]; USUHS [FS71HU, R071HU, CS71HU]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); March of Dimes Foundation(March of Dimes); NIH from NIGMS; USUHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Sharmeen and H. Smith for assistance with high-throughput sequencing. We also thank M. Lichten and P. Hsieh for critical discussion of the manuscript. This research was supported by the NIDDK Intramural Research Program; Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-667 from the March of Dimes Foundation (G.V.P.); NIH grant 1R01GM084104-01A1 from NIGMS (G.V.P.); and New Investigator Start-up Grants FS71HU, R071HU and CS71HU from USUHS (G.V.P.).	Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Khil P. P., 2012, GENOME RES; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	255	257	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					642	645		10.1038/nature11089	http://dx.doi.org/10.1038/nature11089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660327	Green Accepted			2022-12-28	WOS:000304608000048
J	Heath, I				Heath, Iona			What's wrong with assisted dying	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						Carrere E, 2012, OTHER LIVES MINE; Rieff D, 2008, SWIMMING SEA GRIEF S	2	10	10	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3755	10.1136/bmj.e3755	http://dx.doi.org/10.1136/bmj.e3755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645214				2022-12-28	WOS:000304855700020
J	Setlur, SR; Lee, C				Setlur, Sunita R.; Lee, Charles			Tumor Archaeology Reveals that Mutations Love Company	CELL			English	Editorial Material							CANCER; GENOME	Two studies by Nik-Zainal et al. and a study by Roberts et al. now provide new insights into the life span of human tumors and the mutational processes that shape the cancer genome. The bulk of a tumor's life span is shown to involve the development of subclones, many of which harbor mutations that are clustered in subchromosomal regions and appear to result from catastrophic mutational events.	[Setlur, Sunita R.; Lee, Charles] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu						ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943	9	9	9	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					959	961		10.1016/j.cell.2012.05.010	http://dx.doi.org/10.1016/j.cell.2012.05.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632962	Bronze			2022-12-28	WOS:000304453900001
J	Dolgin, E				Dolgin, Elie			Managed by machine	NATURE			English	Editorial Material																			0	18	19	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S6	S8		10.1038/485S6a	http://dx.doi.org/10.1038/485S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616096	Bronze			2022-12-28	WOS:000305950100003
J	Gostin, LO				Gostin, Lawrence O.			A Framework Convention on Global Health Health for All, Justice for All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Health inequalities represent perhaps the most consequential global health challenge and yet they persist despite increased funding and innovative programs. The United Nations is revising the Millennium Development Goals (MDGs) that will shape the world for many years to come. What would a transformative post-MDG framework for global health justice look like? A global coalition of civil society and academics-the Joint Action and Learning Initiative on National and Global Responsibilities for Health (JALI)-has formed an international campaign to advocate for a Framework Convention on Global Health (FCGH). Recently endorsed by the UN Secretary-General, the FCGH would reimagine global governance for health, offering a new post-MDG vision. This Special Communication describes the key modalities of an FCGH to illustrate how it would improve health and reduce inequalities. The modalities would include defining national responsibilities for the population's health; defining international responsibilities for reliable, sustainable funding; setting global health priorities; coordinating fragmented activities; reshaping global governance for health; and providing strong global health leadership through the World Health Organization. JAMA. 2012;307(19):2087-2092	Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Africa Steering Group, 2008, ACH MILL DEV GOALS A; [Anonymous], 2009, MOR MON HLTH MOR HLT; [Anonymous], 2001, OAUSPSABUJA3; [Anonymous], 2010, AUDECL115; [Anonymous], FIN GLOB HLTH 2010 D; [Anonymous], 2008, COMM SOC DET HLTH FI; Bloland P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001199; Bloom D.E., 2007, FINANC DEV, V44, P31; BUSE KENT, 2009, MAKING SENSE GLOBAL; Epstein SB, 2011, FOREIGN OPERATIONS R; Fidler DP, 2010, CHALLENGES GLOBAL HL; Foster M., 2005, FISCAL SPACE SUSTAIN; Garay J, 2012, GLOBAL HLTH GH GH EQ; GARRETT L, 2007, MIDWAY JOURNEY PROMO; Gostin LO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001031; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Johnson T, 2009, WORLD HLTH ORG; Kates J, 2011, DONOR FUNDING HLTH L; Leach-Kemon K, 2012, HLTH AFF, DOI 10.1377/hlthaff.2011.1154; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Marmot M., 2009, LANCET, V374, P1231; McColl K, 2008, LANCET, V371, P2072, DOI 10.1016/S0140-6736(08)60901-0; Organisation for Economic Cooperation and Development, 2008, ACCR AG ACT; Organization WH, 2016, GLOBAL STATUS REPORT; Ottersen OP, 2011, LANCET, V378, P1612, DOI 10.1016/S0140-6736(11)61617-6; Paris Declaration on Aid Effectiveness, 2005, OWN HARM AL RES MUT; Rosenberg ML, 2010, CAL MILBANK BOOK HEA, V20, P1; Ruger JP, 2009, GLOBAL HLTH GOVERNAN; Savedoff W, 2010, ANTICORRUPTION HLTH; Sridhar D, 2011, JAMA-J AM MED ASSOC, V305, P1585, DOI 10.1001/jama.2011.418; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, 25 BOARD M ACCR GHAN; UN Secretary General, 2011, A65797 UN SECR GEN; UNICEF, LEV TRENDS CHILD MOR; United Nations, 2011, MILL DEV GOALS REP 2; United Nations Development Programme, HUM DEV REP 2011 SUS; WHO, 2010, WOR HEALT REP, P1; WHO, 2009, PROP PROGR BUDG 2010; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2007, EV BUS STRENGTH HLTH; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; WHO (World Health Organization), 2011, EBSS22 WHO, V2; World Health Organization, 2011, WORLD HLTH STAT 2011	44	43	44	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2087	2092		10.1001/jama.2012.4395	http://dx.doi.org/10.1001/jama.2012.4395			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665108				2022-12-28	WOS:000304048200028
J	Harrison, SC; Holmes, MV; Humphries, SE				Harrison, Seamus C.; Holmes, Michael V.; Humphries, Steve E.			Mendelian randomisation, lipids, and cardiovascular disease	LANCET			English	Editorial Material							CORONARY-DISEASE; HEART-DISEASE; RISK; ASSOCIATION; CHOLESTEROL; PATHWAYS; PROTEIN; HDL		[Harrison, Seamus C.; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, BHF Labs, London WC1E 6JJ, England; [Holmes, Michael V.] UCL, Inst Epidemiol & Hlth Care, Res Dept Epidemiol & Publ Hlth, London WC1E 6JJ, England	University of London; University College London; University of London; University College London	Humphries, SE (corresponding author), UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, BHF Labs, London WC1E 6JJ, England.	rmhaseh@ucl.ac.uk		Humphries, Stephen E/0000-0002-8221-6547	MRC [G0802432] Funding Source: UKRI; British Heart Foundation [FS/11/16/28696, RG/08/008/25291] Funding Source: Medline; Medical Research Council [G0802432] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Haase CL, 2010, J CLIN ENDOCR METAB, V95, pE500, DOI 10.1210/jc.2010-0450; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548	14	22	22	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 11	2012	380	9841					543	545		10.1016/S0140-6736(12)60481-4	http://dx.doi.org/10.1016/S0140-6736(12)60481-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22607824				2022-12-28	WOS:000307511400006
J	Prince, M; Acosta, D; Ferri, CP; Guerra, M; Huang, YQ; Rodriguez, JJL; Salas, A; Sosa, AL; Williams, JD; Dewey, ME; Acosta, I; Jotheeswaran, AT; Liu, ZR				Prince, Martin; Acosta, Daisy; Ferri, Cleusa P.; Guerra, Mariella; Huang, Yueqin; Rodriguez, Juan J. Llibre; Salas, Aquiles; Sosa, Ana Luisa; Williams, Joseph D.; Dewey, Michael E.; Acosta, Isaac; Jotheeswaran, Amuthavalli T.; Liu, Zhaorui			Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study	LANCET			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DWELLING BRAZILIAN POPULATION; EDGE-PALM TEST; ALZHEIMERS-DISEASE; CONSTRUCT-VALIDITY; VERBAL FLUENCY; COMMUNITY; VALIDATION; DIAGNOSIS; HEALTH	Background Results of the few cohort studies from countries with low incomes or middle incomes suggest a lower incidence of dementia than in high-income countries. We assessed incidence of dementia according to criteria from the 10/66 Dementia Research Group and Diagnostic and Statistical Manual of Mental Disorders (DSM) IV, the effect of dementia at baseline on mortality, and the independent effects of age, sex, socioeconomic position, and indicators of cognitive reserve. Methods We did a population-based cohort study of all people aged 65 years and older living in urban sites in Cuba, the Dominican Republic, and Venezuela, and rural and urban sites in Peru, Mexico, and China, with ascertainment of incident 10/66 and DSM-IV dementia 3-5 years after cohort inception. We used questionnaires to obtain information about age in years, sex, educational level, literacy, occupational attainment, and number of household assets. We obtained information about mortality from all sites. For participants who had died, we interviewed a friend or relative to ascertain the likelihood that they had dementia before death. Findings 12 887 participants were interviewed at baseline. 11 718 were free of dementia, of whom 8137 (69%) were reinterviewed, contributing 34 718 person-years of follow-up. Incidence for 10/66 dementia varied between 18.2 and 30.4 per 1000 person-years, and were 1.4-2.7 times higher than were those for DSM-IV dementia (9.9-15.7 per 1000 person-years). Mortality hazards were 1.56-5.69 times higher in individuals with dementia at baseline than in those who were dementia-free. Informant reports suggested a high incidence of dementia before death; overall incidence might be 4-19% higher if these data were included. 10/66 dementia incidence was independently associated with increased age (HR 1.67; 95% CI 1.56-1.79), female sex (0.72; 0.61-0.84), and low education (0.89; 0.81-0.97), but not with occupational attainment (1.04; 0.95-1.13). Interpretation Our results provide supportive evidence for the cognitive reserve hypothesis, showing that in middle-income countries as in high-income countries, education, literacy, verbal fluency, and motor sequencing confer substantial protection against the onset of dementia.	[Prince, Martin; Ferri, Cleusa P.; Dewey, Michael E.] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth, London SE5 8AF, England; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Inst Memoria & Desordenes Relacionados, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Rodriguez, Juan J. Llibre] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Hop Univ Caracas, Dept Med, Caracas, Venezuela; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Sosa, Ana Luisa; Acosta, Isaac] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Williams, Joseph D.] Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Jotheeswaran, Amuthavalli T.] Publ Hlth Fdn India, New Delhi, India	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; University of Central Venezuela; Universidad Nacional Autonoma de Mexico; Public Health Foundation of India	Prince, M (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth, London SE5 8AF, England.	martin.prince@kcl.ac.uk	Dewey, Michael E/E-2049-2010; Castillo, Gilberto Isaac Acosta/CAA-2728-2022; Rodriguez, Juan J Llibre/D-2380-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Ferri, Cleusa Pinheiro/B-2922-2010; Castillo, Gilberto Isaac Acosta/AAY-5476-2020; Prince, Martin J/A-9170-2010	Dewey, Michael E/0000-0002-7522-3677; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Prince, Martin J/0000-0003-1379-7146; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Liu, Zhaorui/0000-0002-6536-7503; Guerra, Mariella/0000-0001-8923-349X	Wellcome Trust Health Consequences of Population Change Programme; WHO; US Alzheimer's Association; FONACIT/CDCH/UCV; Wellcome Trust Health Consequences of Population Change Programme [GR066133, GR08002]; WHO (India); WHO (Dominican Republic); WHO (China); US Alzheimer's Association [IIRG-04-1286-Peru]; FONACIT/CDCH/UCV (Venezuela)	Wellcome Trust Health Consequences of Population Change Programme(Wellcome Trust); WHO(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Wellcome Trust Health Consequences of Population Change Programme(Wellcome Trust); WHO (India)(World Health Organization); WHO (Dominican Republic); WHO (China); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV (Venezuela)	Wellcome Trust Health Consequences of Population Change Programme, WHO, US Alzheimer's Association, FONACIT/CDCH/UCV; The 10/66 Dementia Research Group's research has been funded by the Wellcome Trust Health Consequences of Population Change Programme (GR066133-Prevalence phase in Cuba and Brazil; GR08002-Incidence phase in Peru, Mexico, Argentina, Cuba, Dominican Republic, Venezuela, and China), WHO (India, Dominican Republic, and China), the US Alzheimer's Association (IIRG-04-1286-Peru, Mexico and Argentina), and FONACIT/CDCH/UCV (Venezuela). The Rockefeller Foundation supported our dissemination meeting at their Bellagio Centre. ADI has provided support for networking and infrastructure.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Auriacombe S, 2006, DEMENT GERIATR COGN, V21, P260, DOI 10.1159/000091407; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Chan RCK, 2006, NEUROSCI LETT, V398, P189, DOI 10.1016/j.neulet.2006.01.014; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; Clark LJ, 2009, AM J ALZHEIMERS DIS, V24, P461, DOI 10.1177/1533317509345154; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; DAVIS PB, 1991, ARCH NEUROL-CHICAGO, V48, P613, DOI 10.1001/archneur.1991.00530180069019; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P912, DOI 10.1002/gps.446; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Hermsdorfer J, 2007, NEUROIMAGE, V36, pT109, DOI 10.1016/j.neuroimage.2007.03.037; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jones RA, 2011, JUNGIAN AND DIALOGICAL SELF PERSPECTIVES, P1; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Jotheeswaran AT, 2010, ALZ DIS ASSOC DIS, V24, P296, DOI 10.1097/WAD.0b013e3181d5e540; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LI G, 1991, ACTA PSYCHIAT SCAND, V83, P99, DOI 10.1111/j.1600-0447.1991.tb07373.x; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Nitrini R, 2005, COGN BEHAV NEUROL, V18, P211, DOI 10.1097/01.wnn.0000195292.48422.d5; Nitrini R, 2005, INT J GERIATR PSYCH, V20, P247, DOI 10.1002/gps.1274; Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241; Perkins AJ, 2002, INT J GERIATR PSYCH, V17, P566, DOI 10.1002/gps.643; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Saxton J, 2004, NEUROLOGY, V63, P2341, DOI 10.1212/01.WNL.0000147470.58328.50; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; Umetsu A, 2002, NEUROIMAGE, V17, P385, DOI 10.1006/nimg.2002.1218; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264	37	168	188	0	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2012	380	9836					50	58		10.1016/S0140-6736(12)60399-7	http://dx.doi.org/10.1016/S0140-6736(12)60399-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22626851	Green Published			2022-12-28	WOS:000306115900033
J	Bhalerao, S; Clandinin, TR				Bhalerao, Sheetal; Clandinin, Thomas R.			Vitamin K-2 Takes Charge	SCIENCE			English	Editorial Material							PARKIN; DROSOPHILA-PINK1; MUTANTS		[Bhalerao, Sheetal; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Bhalerao, S (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu						Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Dam H, 1935, BIOCHEM J, V29, P1273, DOI 10.1042/bj0291273; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; HADDOCK BA, 1977, BACTERIOL REV, V41, P47, DOI 10.1128/MMBR.41.1.47-99.1977; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0	14	29	32	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1241	1242		10.1126/science.1223812	http://dx.doi.org/10.1126/science.1223812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22679087				2022-12-28	WOS:000304905300026
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY From rags to riches: the atrial fibrillation story Irregularly irregular	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Christie B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1644; Herper M, 2010, FORBES          1115; Hunter RJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d897; Lafuente-Lafuente C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5216; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Watts G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1020	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2012	344								e3871	10.1136/bmj.e3871	http://dx.doi.org/10.1136/bmj.e3871			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957TG	22677533				2022-12-28	WOS:000305185200007
J	Chalder, M; Wiles, NJ; Campbell, J; Hollinghurst, SP; Haase, AM; Taylor, AH; Fox, KR; Costelloe, C; Searle, A; Baxter, H; Winder, R; Wright, C; Turner, KM; Calnan, M; Lawlor, DA; Peters, TJ; Sharp, DJ; Montgomery, AA; Lewis, G				Chalder, Melanie; Wiles, Nicola J.; Campbell, John; Hollinghurst, Sandra P.; Haase, Anne M.; Taylor, Adrian H.; Fox, Kenneth R.; Costelloe, Ceire; Searle, Aidan; Baxter, Helen; Winder, Rachel; Wright, Christine; Turner, Katrina M.; Calnan, Michael; Lawlor, Deborah A.; Peters, Tim J.; Sharp, Deborah J.; Montgomery, Alan A.; Lewis, Glyn			Facilitated physical activity as a treatment for depressed adults: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHIATRIC-DISORDER; CLINICAL-TRIALS; PRIMARY-CARE; EXERCISE; SCALE	Objective To investigate the effectiveness of facilitated physical activity as an adjunctive treatment for adults with depression presenting in primary care. Design Pragmatic, multicentre, two arm parallel randomised controlled trial. Setting General practices in Bristol and Exeter. Participants 361 adults aged 18-69 who had recently consulted their general practitioner with symptoms of depression. All those randomised had a diagnosis of an episode of depression as assessed by the clinical interview schedule-revised and a Beck depression inventory score of 14 or more. Interventions In addition to usual care, intervention participants were offered up to three face to face sessions and 10 telephone calls with a trained physical activity facilitator over eight months. The intervention was based on theory and aimed to provide individually tailored support and encouragement to engage in physical activity. Main outcome measures The primary outcome was self reported symptoms of depression, assessed with the Beck depression inventory at four months post-randomisation. Secondary outcomes included use of antidepressants and physical activity at the four, eight, and 12 month follow-up points, and symptoms of depression at eight and 12 month follow-up. Results There was no evidence that participants offered the physical activity intervention reported improvement in mood by the four month follow-up point compared with those in the usual care group; adjusted between group difference in mean Beck depression inventory score -0.54 (95% confidence interval -3.06 to 1.99; P=0.68). Similarly, there was no evidence that the intervention group reported a change in mood by the eight and 12 month follow-up points. Nor was there evidence that the intervention reduced antidepressant use compared with usual care (adjusted odds ratio 0.63, 95% confidence interval 0.19 to 2.06; P=0.44) over the duration of the trial. However, participants allocated to the intervention group reported more physical activity during the follow-up period than those allocated to the usual care group (adjusted odds ratio 2.27, 95% confidence interval 1.32 to 3.89; P=0.003). Conclusions The addition of a facilitated physical activity intervention to usual care did not improve depression outcome or reduce use of antidepressants compared with usual care alone.	[Chalder, Melanie; Wiles, Nicola J.; Hollinghurst, Sandra P.; Costelloe, Ceire; Searle, Aidan; Baxter, Helen; Turner, Katrina M.; Lawlor, Deborah A.; Sharp, Deborah J.; Montgomery, Alan A.; Lewis, Glyn] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Campbell, John; Winder, Rachel; Wright, Christine] Peninsula Med Sch, Primary Care Res Grp, Exeter, Devon, England; [Haase, Anne M.; Fox, Kenneth R.] Univ Bristol, Sch Policy Studies, Bristol BS8 2BN, Avon, England; [Taylor, Adrian H.] Univ Exeter, Exeter, Devon, England; [Calnan, Michael] Univ Kent, Sch Social Policy, Canterbury, Kent, England; [Peters, Tim J.] Univ Bristol, Sch Clin Sci, Bristol BS8 2BN, Avon, England	University of Bristol; University of Exeter; University of Bristol; University of Exeter; University of Kent; University of Bristol	Chalder, M (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England.	melanie.chalder@bristol.ac.uk	Taylor, Adrian/GME-5077-2022; Lewis, Glyn/E-9944-2012; Campbell, John/A-5792-2011; Fox, Kenneth/B-5897-2014	Taylor, Adrian/0000-0003-2701-9468; Lewis, Glyn/0000-0001-5205-8245; Campbell, John/0000-0002-6752-3493; sharp, deborah/0000-0003-3071-9860; Lawlor, Debbie A/0000-0002-6793-2262; Baxter, Helen/0000-0002-3320-2915; Winder, Rachel/0000-0002-9926-1280; Montgomery, Alan/0000-0003-0450-1606; Haase, Anne M/0000-0001-8556-2165; Chalder, Melanie/0000-0003-1964-2815; Turner, Katrina/0000-0002-6375-2918; Peters, Tim/0000-0003-2881-4180; Fox, Kenneth/0000-0003-2216-4287; Wiles, Nicola/0000-0002-5250-3553	Department of Health as part of the National Institute for Health Research; Medical Research Council [G0600705, G0800800] Funding Source: researchfish; National Institute for Health Research [03/45/07] Funding Source: researchfish; MRC [G0600705, G0800800] Funding Source: UKRI	Department of Health as part of the National Institute for Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was carried out independently by the University of Bristol, University of Exeter and the Peninsula Medical School. It is funded by the Department of Health as part of the National Institute for Health Research Health Technology Assessment programme.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Baxter H, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-105; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Chalder M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16100; Deci E.L., 1985, INTRINSIC MOTIVATION; Department of Health, 2011, START ACT STAY ACT R; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Haase AM, 2010, MENT HEALTH PHYS ACT, V3, P85, DOI DOI 10.1016/J.MHPA.2010.09.004; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Hyde J, 2005, BRIT J GEN PRACT, V55, P755; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Krogh J, 2011, J CLIN PSYCHIAT, V72, P529, DOI 10.4088/JCP.08r04913blu; LEWIS G, 1994, J EPIDEMIOL COMMUN H, V48, P207, DOI 10.1136/jech.48.2.207; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lewis G, 2011, BRIT J PSYCHIAT, V198, P464, DOI 10.1192/bjp.bp.110.082727; McCrone PR., 2008, PAYING PRICE COST ME; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; National Institute for Health and Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Pavey TG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6462; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Searle A, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567054; StataCorp, 2010, STAT STAT SOFTW REL; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007	29	127	127	1	125	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2012	344								e2758	10.1136/bmj.e2758	http://dx.doi.org/10.1136/bmj.e2758			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957TC	22674921	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000305184700002
J	Toledano, H; D'Alterio, C; Czech, B; Levine, E; Jones, DL				Toledano, Hila; D'Alterio, Cecilia; Czech, Benjamin; Levine, Erel; Jones, D. Leanne			The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche	NATURE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; SELF-RENEWAL; MICRORNA; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; CONTRIBUTES; LIBRARY; REGION	Adult stem cells support tissue homeostasis and repair throughout the life of an individual. During ageing, numerous intrinsic and extrinsic changes occur that result in altered stem-cell behaviour and reduced tissue maintenance and regeneration. In the Drosophila testis, ageing results in a marked decrease in the self-renewal factor Unpaired (Upd), leading to a concomitant loss of germline stem cells. Here we demonstrate that IGF-II messenger RNA binding protein (Imp) counteracts endogenous small interfering RNAs to stabilize upd (also known as os) RNA. However, similar to upd, Imp expression decreases in the hub cells of older males, which is due to the targeting of Imp by the heterochronic microRNA let-7. In the absence of Imp, upd mRNA therefore becomes unprotected and susceptible to degradation. Understanding the mechanistic basis for ageing-related changes in stem-cell behaviour will lead to the development of strategies to treat age-onset diseases and facilitate stem-cell-based therapies in older individuals.	[Toledano, Hila; D'Alterio, Cecilia; Jones, D. Leanne] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Czech, Benjamin] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Levine, Erel] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Levine, Erel] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Salk Institute; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Harvard University	Jones, DL (corresponding author), Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	ljones@salk.edu	Toledano, Hila/AGY-6574-2022; Czech, Benjamin/AAJ-8592-2020	Czech, Benjamin/0000-0001-8471-0007; Toledano, Hila/0000-0001-9409-7728	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation; Emerald Foundation; American Federation for Aging Research; National Institutes of Health; Boehringer Ingelheim Fonds; National Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG040288, R01AG028092] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Emerald Foundation; American Federation for Aging Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to D. St Johnston, W. Chia, P. Macdonald, R. Carthew, E. Bach, D. Harrison, T. Volk, U. Heberlein, A. Spradling, J. Kadonaga, G. Hannon, T. Hays, N. Sokol, H. Siomi and P. Lasko for reagents and fly stocks, to C. Doe, R. Hans, G. Volohonsky, T. Juven-Gershon, A. Pasquinelli, R. Zhou and S. Aigner for guidance on methods used in this manuscript, to O. Tam for computational support, and to C. Koehler for technical assistance. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Ellison Medical Foundation, the Emerald Foundation, the American Federation for Aging Research, and the National Institutes of Health (to D. L. J.). B. C. is supported by a PhD fellowship from the Boehringer Ingelheim Fonds. E. L. is supported by the National Science Foundation.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Boylan KLM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040036; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Caldwell JC, 2007, FLY, V1, P146, DOI 10.4161/fly.4562; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fabrizio JJ, 2008, FLY, V2, P47, DOI 10.4161/fly.5659; Fuller Margaret T., 1993, P71; Geng CY, 2006, MOL CELL BIOL, V26, P9508, DOI 10.1128/MCB.01136-06; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hime GR, 1996, J CELL SCI, V109, P2779; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wang L, 2011, EXP GERONTOL, V46, P340, DOI 10.1016/j.exger.2010.10.005; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	45	121	130	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					605	+		10.1038/nature11061	http://dx.doi.org/10.1038/nature11061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660319	Green Accepted			2022-12-28	WOS:000304608000040
J	Song, YH; Smith, RW; To, BJ; Millar, AJ; Imaizumi, T				Song, Young Hun; Smith, Robert W.; To, Benjamin J.; Millar, Andrew J.; Imaizumi, Takato			FKF1 Conveys Timing Information for CONSTANS Stabilization in Photoperiodic Flowering	SCIENCE			English	Article							LOCUS-T; ARABIDOPSIS; PROTEIN; COMPLEX; TIME	Plants use day-length information to coordinate flowering time with the appropriate season to maximize reproduction. In Arabidopsis, the long day-specific expression of CONSTANS (CO) protein is crucial for flowering induction. Although light signaling regulates CO protein stability, the mechanism by which CO is stabilized in the long-day afternoon has remained elusive. Here, we demonstrate that FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1) protein stabilizes CO protein in the afternoon in long days. FKF1 interacts with CO through its LOV domain, and blue light enhances this interaction. In addition, FKF1 simultaneously removes CYCLING DOF FACTOR 1 (CDF1), which represses CO and FLOWERING LOCUS T (FT) transcription. Together with CO transcriptional regulation, FKF1 protein controls robust FT mRNA induction through multiple feedforward mechanisms that accurately control flowering timing.	[Song, Young Hun; To, Benjamin J.; Imaizumi, Takato] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Smith, Robert W.; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci & SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland	University of Washington; University of Washington Seattle; University of Edinburgh	Imaizumi, T (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	takato@u.washington.edu	Millar, Andrew J/G-2423-2012	Millar, Andrew J/0000-0003-1756-3654	SSAC [PJ008109]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F59011/1, BB/F005237/1]; NIH [GM079712]; BBSRC [BB/G019621]; UK Engineering and Physical Sciences Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079712] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F005237/1] Funding Source: researchfish; BBSRC [BB/F005237/1] Funding Source: UKRI	SSAC; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Harmer, K. Torii, D. Nusinow, S. Ito, and H. Kinmonth-Schultz for critical reading of the manuscript and G. Coupland for providing cdf quadruple mutant. Supported by the Next Generation Biogreen 21 program (SSAC grant PJ008109) (Y.H.S.), UK Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/F59011/1 and BB/F005237/1 (R. W. S.), and NIH grant GM079712 (T. I.). SynthSys is partly supported by BBSRC grant BB/G019621 and by the UK Engineering and Physical Sciences Research Council.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fukamatsu Y, 2005, PLANT CELL PHYSIOL, V46, P1340, DOI 10.1093/pcp/pci144; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Thomas B., 1997, PHOTOPERIODISM PLANT; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	18	308	347	6	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1045	1049		10.1126/science.1219644	http://dx.doi.org/10.1126/science.1219644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628657	Green Accepted, Green Submitted			2022-12-28	WOS:000304406800048
J	Funfschilling, U; Supplie, LM; Mahad, D; Boretius, S; Saab, AS; Edgar, J; Brinkmann, BG; Kassmann, CM; Tzvetanova, ID; Mobius, W; Diaz, F; Meijer, D; Suter, U; Hamprecht, B; Sereda, MW; Moraes, CT; Frahm, J; Goebbels, S; Nave, KA				Fuenfschilling, Ursula; Supplie, Lotti M.; Mahad, Don; Boretius, Susann; Saab, Aiman S.; Edgar, Julia; Brinkmann, Bastian G.; Kassmann, Celia M.; Tzvetanova, Iva D.; Moebius, Wiebke; Diaz, Francisca; Meijer, Dies; Suter, Ueli; Hamprecht, Bernd; Sereda, Michael W.; Moraes, Carlos T.; Frahm, Jens; Goebbels, Sandra; Nave, Klaus-Armin			Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MICE LACKING; RAT OLIGODENDROCYTES; CELL-DEVELOPMENT; OPTIC-NERVE; MOUSE MODEL; LACTATE; GLUCOSE; BRAIN; DEFICIENCY	Oligodendrocytes, the myelin-forming glial cells of the central nervous system, maintain long-term axonal integrity(1-3). However, the underlying support mechanisms are not understood(4). Here we identify a metabolic component of axon-glia interactions by generating conditional Cox10 (protoheme IX farnesyltransferase) mutant mice, in which oligodendrocytes and Schwann cells fail to assemble stable mitochondrial cytochrome c oxidase (COX, also known as mitochondrial complex IV). In the peripheral nervous system, Cox10 conditional mutants exhibit severe neuropathy with dysmyelination, abnormal Remak bundles, muscle atrophy and paralysis. Notably, perturbing mitochondrial respiration did not cause glial cell death. In the adult central nervous system, we found no signs of demyelination, axonal degeneration or secondary inflammation. Unlike cultured oligodendrocytes, which are sensitive to COX inhibitors(5), post-myelination oligodendrocytes survive well in the absence of COX activity. More importantly, by in vivo magnetic resonance spectroscopy, brain lactate concentrations in mutants were increased compared with controls, but were detectable only in mice exposed to volatile anaesthetics. This indicates that aerobic glycolysis products derived from oligodendrocytes are rapidly metabolized within white matter tracts. Because myelinated axons can use lactate when energy-deprived(6), our findings suggest a model in which axon-glia metabolic coupling serves a physiological function.	[Fuenfschilling, Ursula; Supplie, Lotti M.; Saab, Aiman S.; Edgar, Julia; Brinkmann, Bastian G.; Kassmann, Celia M.; Tzvetanova, Iva D.; Moebius, Wiebke; Hamprecht, Bernd; Sereda, Michael W.; Goebbels, Sandra; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Mahad, Don] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Boretius, Susann; Frahm, Jens] Max Planck Inst Biophys Chem, Biomed NMR Forsch GmbH, D-37070 Gottingen, Germany; [Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol & Cell Biol & Anat, Miami, FL 33136 USA; [Meijer, Dies] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Suter, Ueli] ETH Honggerberg, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Sereda, Michael W.] Univ Gottingen UMG, Dept Clin Neurophysiol, D-37075 Gottingen, Germany	Max Planck Society; Newcastle University - UK; Max Planck Society; University of Miami; Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	nave@em.mpg.de	Edgar, Julia M/U-8456-2019; Edgar, Julia M/G-3275-2012; Moraes, Carlos/AAT-3818-2021; Suter, Ueli/A-1624-2010; Meijer, Dies/C-7786-2012; Boretius, Susann/ABF-4993-2021	Edgar, Julia M/0000-0002-3869-0962; Meijer, Dies/0000-0002-8461-6341; Boretius, Susann/0000-0003-2792-7423; Saab, Aiman S./0000-0003-3886-8369; /0000-0002-2902-7165	BMBF (Leukonet); DFG (CMPB); EU; Oliver's Army; Swiss National Science Foundation; National Center 'Neural Plasticity and Repair'; Swiss National Science Foundation [PAOOA-117479/1]; European Leukodystrophy Association	BMBF (Leukonet)(Federal Ministry of Education & Research (BMBF)); DFG (CMPB)(German Research Foundation (DFG)); EU(European Commission); Oliver's Army; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center 'Neural Plasticity and Repair'; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Leukodystrophy Association	We thank C. Stiles for the OLIG2 antibodies, A. Fahrenholz, U. Bode, T. Ruhwedel, and R. Tammer for technical support, and members of the Nave laboratory for discussions. We acknowledge grant support from the BMBF (Leukonet), DFG (CMPB), EU-FP7 programs (NGIDD, Leukotreat) and Oliver's Army. U. S. is supported by the Swiss National Science Foundation and the National Center 'Neural Plasticity and Repair'. U. F. was supported by fellowships from the EU-FP7 (Marie- Curie), the Swiss National Science Foundation (PAOOA-117479/1) and the European Leukodystrophy Association. K.-A.N. holds an ERC Advanced Grant.	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Brown AM, 2001, J NEUROSCI RES, V66, P839, DOI 10.1002/jnr.10081; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; LEVEILLE PJ, 1980, BRAIN RES, V196, P287, DOI 10.1016/0006-8993(80)90397-2; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Michaelis T, 2009, PROG NUCL MAG RES SP, V55, P1, DOI 10.1016/j.pnmrs.2008.11.001; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moreland C., 1990, NEUROCHEM INT, V50, P703; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	32	862	881	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					517	U130		10.1038/nature11007	http://dx.doi.org/10.1038/nature11007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622581	Green Accepted			2022-12-28	WOS:000304344500046
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WALES PROSPECTIVE DERIVATION; HIP FRACTURE; EXTERNAL VALIDATION; CARDIOVASCULAR RISK; OLDER-PEOPLE; MISSING DATA; WOMEN; MEN; IMPUTATION; SMOKING	Objective To develop and validate an updated version of the QFracture algorithm for estimating the risk of a patient sustaining an osteoporotic fracture or hip fracture in a primary care population. Design Prospective open cohort study using routinely collected data from 420 general practices in the United Kingdom to develop updated QFracture scores and 207 practices to validate scores. Cox's proportional hazards model was used in the derivation cohort to derive risk equations using several explanatory variables. We calculated measures of calibration and discrimination using the validation cohort. Participants 3 142 673 patients in derivation cohort and 1 583 373 in validation cohort, aged 30-100 years, who contributed 23 608 337 and 11 732 106 person years of observation, respectively. We identified 59 772 incident diagnoses of osteoporotic fracture in the derivation cohort and 28 685 in the validation cohort. Outcomes Incident diagnosis of osteoporotic fracture (vertebral, distal radius, proximal humerus, or hip) and incident hip fracture recorded in general practice records or linked cause of death records. Results We found significant independent associations with overall fracture risk in women for age, body mass index, ethnic origin, alcohol intake, smoking status, chronic obstructive pulmonary disease or asthma, any cancer, cardiovascular disease, dementia, diagnosis or treatment for epilepsy, history of falls, chronic liver disease, Parkinson's disease, rheumatoid arthritis or systemic lupus erythematosus, chronic renal disease, type 1 diabetes, type 2 diabetes, previous fracture, endocrine disorders, gastrointestinal malabsorption, any antidepressants, corticosteroids, unopposed hormone replacement therapy, and parental history of osteoporosis. Risk factors for hip fracture in women were similar except for gastrointestinal malabsorption and parental history of hip fracture. Risk factors for men were largely the same as those for women but also included care home residence. The updated hip fracture algorithm explained 71.7% (95% confidence interval 71.1% to 72.3%) of the variation in women and 70.4% (69.3% to 71.5%) in men. D statistic values for hip fracture were high for women (3.26, 3.21 to 3.31) and men 3.15, 3.06 to 3.24), and higher than for osteoporotic fracture. Values for the area under the receiver operating characteristics curves for hip fracture were 0.89 for women and 0.88 for men, compared with 0.79 and 0.71 for osteoporotic fracture, respectively. The updated algorithms performed better than the 2009 algorithms. Conclusions Two QFracture algorithms were updated to predict risk of osteoporotic and hip fracture in primary care populations to include ethnic origin, all classes of antidepressants, chronic obstructive pulmonary disease, epilepsy, dementia, Parkinson's disease, cancer, systemic lupus erythematosus, chronic renal disease, type 1 diabetes, previous fragility fracture, and care home residence. These updated algorithms showed improved performance compared with previous QFracture algorithms reported in 2009.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chen YY, 2012, PARKINSONISM RELAT D, V18, P506, DOI 10.1016/j.parkreldis.2012.01.014; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3651; Cornuz J, 1999, AM J MED, V106, P311, DOI 10.1016/S0002-9343(99)00022-4; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Diaz MN, 1997, BONE, V20, P145, DOI 10.1016/S8756-3282(96)00331-6; Godden S, 2001, HEALTH SOC CARE COMM, V9, P367, DOI 10.1046/j.1365-2524.2001.00314.x; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOLLENBACH KA, 1993, AM J PUBLIC HEALTH, V83, P1265, DOI 10.2105/AJPH.83.9.1265; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jette N, 2011, ARCH NEUROL-CHICAGO, V68, P107, DOI 10.1001/archneurol.2010.341; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kush RD, 2008, NEW ENGL J MED, V358, P1738, DOI 10.1056/NEJMsb0800209; McCann M, 2009, AGE AGEING, V38, P711, DOI 10.1093/ageing/afp173; Miao JM, 2005, DIABETES CARE, V28, P2850, DOI 10.2337/diacare.28.12.2850; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; National Institute for Health and Clinical Excellence, 2008, SYST REV CLIN EFF PR, P205; National Institute for Health and Clinical Excellence, 2012, OST FRAG FRACT RISK, P90; National Osteoporosis Guideline Group, 2008, GUID DIAGN MAN OST P, P12; Nitsch D, 2009, NEPHROL DIAL TRANSPL, V24, P1539, DOI 10.1093/ndt/gfn678; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SPECTOR TD, 1993, BRIT MED J, V306, P558, DOI 10.1136/bmj.306.6877.558; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x	45	200	205	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2012	344								e3427	10.1136/bmj.e3427	http://dx.doi.org/10.1136/bmj.e3427			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QS	22619194	hybrid			2022-12-28	WOS:000304591400007
J	Yasuoka, H; Koutroulakis, G; Chudo, H; Richmond, S; Veirs, DK; Smith, AI; Bauer, ED; Thompson, JD; Jarvinen, GD; Clark, DL				Yasuoka, H.; Koutroulakis, G.; Chudo, H.; Richmond, S.; Veirs, D. K.; Smith, A. I.; Bauer, E. D.; Thompson, J. D.; Jarvinen, G. D.; Clark, D. L.			Observation of Pu-239 Nuclear Magnetic Resonance	SCIENCE			English	Article							SUSCEPTIBILITY; MOMENT	In principle, the spin-1/2 plutonium-239 (Pu-239) nucleus should be active in nuclear magnetic resonance spectroscopy. However, its signal has eluded detection for the past 50 years. Here, we report observation of a Pu-239 resonance from a solid sample of plutonium dioxide (PuO2) subjected to a wide scan of external magnetic field values (3 to 8 tesla) at a temperature of 4 kelvin. By mapping the external field dependence of the measured resonance frequency, we determined the nuclear gyromagnetic ratio (239)gamma n(PuO2)/2 pi to be 2.856 +/- 0.001 megahertz per tesla (MHz/T). Assuming a free-ion value for the Pu4+ hyperfine coupling constant, we estimated a bare (239)gamma n/2 pi value of similar to 2.29 MHz/T, corresponding to a nuclear magnetic moment of mu(n) approximate to 0.15 mu(N) (where mu(N) is the nuclear magneton).	[Yasuoka, H.; Koutroulakis, G.; Chudo, H.; Richmond, S.; Veirs, D. K.; Smith, A. I.; Bauer, E. D.; Thompson, J. D.; Jarvinen, G. D.; Clark, D. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Yasuoka, H.; Chudo, H.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan	United States Department of Energy (DOE); Los Alamos National Laboratory; Japan Atomic Energy Agency	Koutroulakis, G (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	gkoutrou@lanl.gov	Clark, David L/A-9729-2011	Clark, David L/0000-0001-8043-7517; Bauer, Eric/0000-0003-0017-1937; Richmond, Scott/0000-0003-3899-0372; Smith, Alice I./0000-0002-4727-1487; Veirs, Douglas/0000-0001-6163-374X	Glenn T. Seaborg Institute; Los Alamos Laboratory Directed Research and Development (LDRD); Chemical Sciences, Geosciences, and Biosciences Division; Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy (DOE); DOE [EM-33, DE-AC52-06NA25396]	Glenn T. Seaborg Institute; Los Alamos Laboratory Directed Research and Development (LDRD)(United States Department of Energy (DOE)Los Alamos National Laboratory); Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	H.Y. thanks the Glenn T. Seaborg Institute and the Los Alamos Laboratory Directed Research and Development (LDRD) program for financial support. This work was supported by the Chemical Sciences, Geosciences, and Biosciences Division and by the Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy (DOE). High-purity plutonium oxide was provided by the Surveillance and Monitoring Program at LANL supported by DOE Nuclear Materials Disposition EM-33. LANL is operated by Los Alamos National Security for the National Nuclear Security Administration of DOE under contract DE-AC52-06NA25396.	Abragam A., 1961, PRINCIPLES NUCL MAGN; ARROTT A, 1957, PHYS REV, V108, P948, DOI 10.1103/PhysRev.108.948; BLEANEY B, 1954, PHILOS MAG, V45, P991; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; CHAMPEAU RJ, 1960, CR HEBD ACAD SCI, V251, P352; CLARK D.L., 2006, CHEM ACTINIDE TRANSA, DOI DOI 10.1007/1-4020-3598-5_7; Dunlap B. D., 1974, ACTINIDES ELECTRONIC, V1, P237; DUNLAP BD, 1974, PHYS REV LETT, V33, P1046, DOI 10.1103/PhysRevLett.33.1046; FABER J, 1976, PHYS REV B, V14, P1151, DOI 10.1103/PhysRevB.14.1151; FAUST J, 1965, PHYS LETT, V16, P71, DOI 10.1016/0031-9163(65)90407-5; Fradin F. Y., 1974, ACTINIDES ELECTRONIC, V1, P181; Ikushima K, 1998, J PHYS SOC JPN, V67, P65, DOI 10.1143/JPSJ.67.65; Kern S, 1999, PHYS REV B, V59, P104, DOI 10.1103/PhysRevB.59.104; KOLBE W, 1971, PHYS REV B-SOLID ST, V4, P2869, DOI 10.1103/PhysRevB.4.2869; LEBAIL H, 1983, J PHYS LETT-PARIS, V44, P1017, DOI 10.1051/jphyslet:0198300440240101700; PURCELL EM, 1946, PHYS REV, V69, P681; RAPHAEL G, 1968, SOLID STATE COMMUN, V6, P383, DOI 10.1016/0038-1098(68)90162-2; ROSS JW, 1967, J APPL PHYS, V38, P1451, DOI 10.1063/1.1709662	18	45	45	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					901	904		10.1126/science.1220801	http://dx.doi.org/10.1126/science.1220801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605773				2022-12-28	WOS:000304145600061
J	Berwanger, O; Guimaraes, HP; Laranjeira, LN; Cavalcanti, AB; Kodama, AA; Zazula, AD; Santucci, EV; Victor, E; Tenuta, M; Carvalho, V; Mira, VL; Pieper, KS; Weber, B; Mota, LH; Peterson, ED; Lopes, RD				Berwanger, Otavio; Guimaraes, Helio P.; Laranjeira, Ligia N.; Cavalcanti, Alexandre B.; Kodama, Alessandra A.; Zazula, Ana Denise; Santucci, Eliana V.; Victor, Elivane; Tenuta, Marcos; Carvalho, Vitor; Mira, Vera Lucia; Pieper, Karen S.; Weber, Bernardete; Mota, Luiz Henrique; Peterson, Eric D.; Lopes, Renato D.		BRIDGE-ACS Investigators	Effect of a Multifaceted Intervention on Use of Evidence-Based Therapies in Patients With Acute Coronary Syndromes in Brazil The BRIDGE-ACS Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY IMPROVEMENT PROGRAM; GLOBAL BURDEN; IMPLEMENTATION STRATEGIES; CARDIOVASCULAR-DISEASES; PRACTICE GUIDELINES; CLINICAL-PRACTICE; FOCUSED UPDATE; RISK-FACTORS; EQUIP-ACS	Context Studies have found that patients with acute coronary syndromes (ACS) often do not receive evidence-based therapies in community practice. This is particularly true in low- and middle-income countries. Objective To evaluate whether a multifaceted quality improvement (QI) intervention can improve the use of evidence-based therapies and reduce the incidence of major cardiovascular events among patients with ACS in a middle-income country. Design, Setting, and Participants The BRIDGE-ACS (Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes) trial, a cluster-randomized (concealed allocation) trial conducted among 34 clusters (public hospitals) in Brazil and enrolling a total of 1150 patients with ACS from March 15, 2011, through November 2, 2011, with follow-up through January 27, 2012. Intervention Multifaceted QI intervention including educational materials for clinicians, reminders, algorithms, and case manager training, vs routine practice (control). Main Outcome Measures Primary end point was the percentage of eligible patients who received all evidence-based therapies (aspirin, clopidogrel, anticoagulants, and statins) during the first 24 hours in patients without contraindications. Results Mean age of the patients enrolled was 62 (SD, 13) years; 68.6% were men, and 40% presented with ST-segment elevation myocardial infarction, 35.6% with non-ST-segment elevation myocardial infarction, and 23.6% with unstable angina. The randomized clusters included 79.5% teaching hospitals, all from major urban areas and 41.2% with 24-hour percutaneous coronary intervention capabilities. Among eligible patients (923/1150 [80.3%]), 67.9% in the intervention vs 49.5% in the control group received all eligible acute therapies (population average odds ratio [ORPA], 2.64 [95% CI, 1.28-5.45]). Similarly, among eligible patients (801/1150 [69.7%]), those in the intervention group were more likely to receive all eligible acute and discharge medications (50.9% vs 31.9%; ORPA,, 2.49 [95% CI, 1.08-5.74]). Overall composite adherence scores were higher in the intervention clusters (89% vs 81.4%; mean difference, 8.6% [95% CI, 2.2%-15.0%]). In-hospital cardiovascular event rates were 5.5% in the intervention group vs 7.0% in the control group (ORPA, 0.72 [95% CI, 0.36-1.43]); 30-day all-cause mortality was 7.0% vs 8.4% (ORPA, 0.79 [95% CI, 0.46-1.34]). Conclusion Among patients with ACS treated in Brazil, a multifaceted educational intervention resulted in significant improvement in the use of evidence-based therapies.	[Berwanger, Otavio; Guimaraes, Helio P.; Laranjeira, Ligia N.; Cavalcanti, Alexandre B.; Kodama, Alessandra A.; Zazula, Ana Denise; Santucci, Eliana V.; Victor, Elivane; Tenuta, Marcos; Carvalho, Vitor; Mira, Vera Lucia; Weber, Bernardete; Mota, Luiz Henrique] HCor Hosp Coracao, Res Inst, BR-04004030 Sao Paulo, Brazil; [Guimaraes, Helio P.; Lopes, Renato D.] Univ Fed Sao Paulo, Paulista Sch Med, Brazilian Clin Res Inst, Sao Paulo, Brazil; [Pieper, Karen S.; Peterson, Eric D.; Lopes, Renato D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Hospital do Coracao - HCor; Universidade Federal de Sao Paulo (UNIFESP); Duke University	Berwanger, O (corresponding author), HCor Hosp Coracao, Res Inst, Rua Abilio Soares 250,12th Floor, BR-04004030 Sao Paulo, Brazil.	oberwanger@hcor.com.br	Cavalcanti, Alexandre/K-5529-2013; Carvalho, Vitor Oliveira/CAH-3162-2022; Iats, Inct/K-2300-2013; Guimaraes, Helio Penna/AAD-8681-2019; Peterson, Eric David/ABF-5033-2021; Carvalho, Vitor Oliveira/C-7170-2012	Cavalcanti, Alexandre/0000-0003-2798-6263; carvalho, vitor/0000-0003-0007-2541	Brazilian Ministry of Health; Hospital do Coracao	Brazilian Ministry of Health; Hospital do Coracao	The study was funded by the Brazilian Ministry of Health in partnership with Hospital do Coracao-Programa Hospitais de Excelencia a Servico do SUS.	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Beek CA, 2005, JAMA-J AM MED ASSOC, V294, P309, DOI 10.1001/jama.294.3.309; Berwanger O, 2012, AM HEART J, V163, P323, DOI 10.1016/j.ahj.2012.02.004; Bonetti D, 2005, SOC SCI MED, V60, P2135, DOI 10.1016/j.socscimed.2004.08.072; Budaj A, 2003, AM HEART J, V146, P999, DOI 10.1016/S0002-8703(03)00509-X; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carlhed R, 2006, AM HEART J, V152, P1175, DOI 10.1016/j.ahj.2006.07.028; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Eapen ZJ, 2011, CIRC-CARDIOVASC QUAL, V4, P610, DOI 10.1161/CIRCOUTCOMES.111.961391; Flather M, 2006, WORLD C CARD SEPT 2; Flather MD, 2011, AM HEART J, V162, P700, DOI 10.1016/j.ahj.2011.07.027; Flather MD, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-5; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Grimshaw J, 2005, ANN AM ACAD POLIT SS, V599, P71, DOI 10.1177/0002716205274576; Grimshaw J, 2000, FAM PRACT, V17, pS11, DOI 10.1093/fampra/17.suppl_1.S11; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Grimshaw JM, 2001, MED CARE, V39, pII2; HALABI AR, 2001, CAN J CARDIOL, V17, pC152; Hayes RJ, 2009, INTERD STAT, P3; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kreuter F, 2011, STATA J S1, V7, P1; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Patel MR, 2007, AM J MED, V120, P40, DOI 10.1016/j.amjmed.2006.10.008; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Mattos LAPE, 2011, ARQ BRAS CARDIOL, V97, P94, DOI 10.1590/S0066-782X2011005000064; Polanczyk Carisi A, 2003, Crit Pathw Cardiol, V2, P222, DOI 10.1097/01.hpc.0000099742.69516.25; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Team RC., 2022, LANG ENV STAT COMP; Wenger NK, 2012, CLIN CARDIOL, V35, P3, DOI 10.1002/clc.20964; World Bank, WE CLASS COUNTR; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	47	62	64	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2041	2049		10.1001/jama.2012.413	http://dx.doi.org/10.1001/jama.2012.413			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665103	Bronze			2022-12-28	WOS:000304048200023
J	Raj, A; McDougal, L; Rusch, MLA				Raj, Anita; McDougal, Lotus; Rusch, Melanie L. A.			Changes in Prevalence of Girl Child Marriage in South Asia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Raj, Anita; Rusch, Melanie L. A.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [McDougal, Lotus] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Publ Hlth & Global Hlth, San Diego, CA 92103 USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Raj, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	anitaraj@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061115] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD061115] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armitage P., 2002, STAT METHODS MED RES; *MACR INC, MEASURE DHS STATCOMP; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rutstein SO, 2006, GUIDE DHS STAT; United Nations Childrens Fund (UNICEF), WORK COMM GOAL END C	6	31	31	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2027	2029		10.1001/jama.2012.3497	http://dx.doi.org/10.1001/jama.2012.3497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665097	Green Accepted, Bronze			2022-12-28	WOS:000304048200017
J	Kirby, T				Kirby, Tony			Alan Craft: a trailblazer in paediatric oncology	LANCET			English	Biographical-Item												tony@tonykirby.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					465	465		10.1016/S0140-6736(12)60915-5	http://dx.doi.org/10.1016/S0140-6736(12)60915-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983GY	22681859	Bronze			2022-12-28	WOS:000307109000013
J	Costello, EK; Stagaman, K; Dethlefsen, L; Bohannan, BJM; Relman, DA				Costello, Elizabeth K.; Stagaman, Keaton; Dethlefsen, Les; Bohannan, Brendan J. M.; Relman, David A.			The Application of Ecological Theory Toward an Understanding of the Human Microbiome	SCIENCE			English	Review							GUT MICROBIOME; INTESTINAL MICROBIOTA; COMMUNITY ECOLOGY; BACTERIAL COMMUNITIES; FECAL MICROBIOTA; INFECTION; INFANT; RESISTANCE; HISTORY; LIFE	The human-microbial ecosystem plays a variety of important roles in human health and disease. Each person can be viewed as an island-like "patch" of habitat occupied by microbial assemblages formed by the fundamental processes of community ecology: dispersal, local diversification, environmental selection, and ecological drift. Community assembly theory, and metacommunity theory in particular, provides a framework for understanding the ecological dynamics of the human microbiome, such as compositional variability within and between hosts. We explore three core scenarios of human microbiome assembly: development in infants, representing assembly in previously unoccupied habitats; recovery from antibiotics, representing assembly after disturbance; and invasion by pathogens, representing assembly in the context of invasive species. Judicious application of ecological theory may lead to improved strategies for restoring and maintaining the microbiota and the crucial health-associated ecosystem services that it provides.	[Costello, Elizabeth K.; Dethlefsen, Les; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Stagaman, Keaton; Bohannan, Brendan J. M.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Dethlefsen, Les; Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; University of Oregon; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	relman@stanford.edu	Bohannan, Brendan J. M./R-1582-2017; Dethlefsen, Les/R-2220-2018	Bohannan, Brendan J. M./0000-0003-2907-1016; Dethlefsen, Les/0000-0001-9622-1630; Relman, David A./0000-0001-8331-1354; Stagaman, Keaton/0000-0003-2815-4530	NIH [R01GM095385, DP1OD000964]; Doris Duke Charitable Trust; Stanford University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095385, T32GM007413] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964, R01OD011116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Trust(Doris Duke Charitable Foundation (DDCF)); Stanford University(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Relman and Bohannan laboratories, and in particular E. Bik, N. Qvit-Raz, G. Schmid, and K. Shelef (Stanford), and K. Guillemin, J. Green, Z. Stephens, and A. Burns (Oregon) for valuable ideas and critique. E.K.C. is a Walter V. and Idun Berry Postdoctoral Fellow. B.J.M.B. is supported by NIH grant R01GM095385. D.A.R. is supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Trust, NIH Pioneer Award DP1OD000964, and the Thomas C. and Joan M. Merigan Endowment at Stanford University. There are no conflicts of interest.	Allan C., 2009, ADAPTIVE ENV MANAGEM; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BENNET R, 1987, INFECTION, V15, P332, DOI 10.1007/BF01647733; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Daily G.C., 1997, ISSUES ECOLOGY, V1, P1; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Ellis AM, 2006, ECOLOGY, V87, P2582, DOI 10.1890/0012-9658(2006)87[2582:ETLMDO]2.0.CO;2; ESCHERICH T, 1988, REV INFECT DIS, V10, P1220; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Fukami Tadashi, 2010, P45; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hovatter SR, 2011, ECOLOGY, V92, P57, DOI 10.1890/10-0332.1; Hubbell Stephen P., 2001, V32, pi; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2012, IMMUNOL REV, V245, P132, DOI 10.1111/j.1600-065X.2011.01072.x; Mandar R, 1996, BIOL NEONATE, V69, P30; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Walker B, 2004, ECOL SOC, V9; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; YURDUSEV N, 1989, INFECT IMMUN, V57, P724, DOI 10.1128/IAI.57.3.724-731.1989	82	863	895	21	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1255	1262		10.1126/science.1224203	http://dx.doi.org/10.1126/science.1224203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22674335	Green Accepted			2022-12-28	WOS:000304905300034
J	Noor, E; Milo, R				Noor, Elad; Milo, Ron			Efficiency in Evolutionary Trade-Offs	SCIENCE			English	Editorial Material									[Noor, Elad; Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Noor, E (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	ron.milo@weizmann.ac.il	Noor, Elad/AAN-9042-2020; Milo, Hilla/C-8767-2016	Noor, Elad/0000-0001-8776-4799; Milo, Ron/0000-0003-1641-2299				GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; McGhee GR., 2007, GEOMETRY EVOLUTION A; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405	5	19	20	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1114	1115		10.1126/science.1223193	http://dx.doi.org/10.1126/science.1223193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654045				2022-12-28	WOS:000304647900032
J	Seliktar, D				Seliktar, Dror			Designing Cell-Compatible Hydrogels for Biomedical Applications	SCIENCE			English	Review							HYALURONIC-ACID; GROWTH-FACTORS; DRUG-DELIVERY; DIFFERENTIATION; MORPHOGENESIS; BIOMATERIALS; FIBRINOGEN; POLYMERS; PROTEIN	Hydrogels are polymeric materials distinguished by high water content and diverse physical properties. They can be engineered to resemble the extracellular environment of the body's tissues in ways that enable their use in medical implants, biosensors, and drug-delivery devices. Cell-compatible hydrogels are designed by using a strategy of coordinated control over physical properties and bioactivity to influence specific interactions with cellular systems, including spatial and temporal patterns of biochemical and biomechanical cues known to modulate cell behavior. Important new discoveries in stem cell research, cancer biology, and cellular morphogenesis have been realized with model hydrogel systems premised on these designs. Basic and clinical applications for hydrogels in cell therapy, tissue engineering, and biomedical research continue to drive design improvements using performance-based materials engineering paradigms.	Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Seliktar, D (corresponding author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.	dror@bm.technion.ac.il		Seliktar, Dror/0000-0001-6964-8567	European Union; Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering; Russell Berrie Nanotechnology Institute; Singapore National Research Foundation	European Union(European Commission); Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering; Russell Berrie Nanotechnology Institute; Singapore National Research Foundation(National Research Foundation, Singapore)	Support was provided by the European Union FP7 Program, the Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, the Russell Berrie Nanotechnology Institute, and the Singapore National Research Foundation. I thank I. Mironi-Harpaz, D. Yelin, O. Kossover, Y. Shachaf, R. Meller, and A. Wexler for helpful comments and support with the text and figures. I. Mironi-Harpaz and Y. Talmon are acknowledged for the scanning electron microscopy image in Fig. 2.	Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Griset AP, 2009, J AM CHEM SOC, V131, P2469, DOI 10.1021/ja807416t; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/j.addr.2012.09.009; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b; Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468; Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Khetan S, 2011, SOFT MATTER, V7, P830, DOI 10.1039/c0sm00852d; Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035; Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004; Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Messersmith P. B., 2010, BIOMATERIALS, V31, P420; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5; Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; van Dijk M, 2009, BIOCONJUGATE CHEM, V20, P2001, DOI 10.1021/bc900087a; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]; Young JL, 2011, BIOMATERIALS, V32, P1002, DOI 10.1016/j.biomaterials.2010.10.020	51	1313	1352	101	1703	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1124	1128		10.1126/science.1214804	http://dx.doi.org/10.1126/science.1214804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654050				2022-12-28	WOS:000304647900039
J	Frank, MC; Goodman, ND				Frank, Michael C.; Goodman, Noah D.			Predicting Pragmatic Reasoning in Language Games	SCIENCE			English	Article									[Frank, Michael C.; Goodman, Noah D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Frank, MC (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	mcfrank@stanford.edu		Frank, Michael/0000-0002-7551-4378				Benz A, 2006, PALG STUD PRAGM LANG, P1, DOI 10.1057/9780230285897; Clark H.H., 1996, USING LANGUAGE; DALE R, 1995, COGNITIVE SCI, V19, P233, DOI 10.1207/s15516709cog1902_3; Morgan J.L., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1163/9789004368811_003; ROSENBERG S, 1964, SCIENCE, V145, P1201, DOI 10.1126/science.145.3637.1201; Sperber Dan, 1995, RELEVANCE COMMUNICAT; Wittgenstein L., 1967, PHILOS INVESTIGATION; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245	9	283	285	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					998	998		10.1126/science.1218633	http://dx.doi.org/10.1126/science.1218633			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	947DK	22628647	Green Submitted			2022-12-28	WOS:000304406800035
J	Shetty, P				Shetty, Priya			India's diabetes time bomb	NATURE			English	Editorial Material																		HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Sachdev HPS, 2009, ARCH DIS CHILD, V94, P768, DOI 10.1136/adc.2008.140905	4	64	66	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S14	S16		10.1038/485S14a	http://dx.doi.org/10.1038/485S14a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616100				2022-12-28	WOS:000305950100007
J	Naito, AT; Sumida, T; Nomura, S; Liu, ML; Higo, T; Nakagawa, A; Okada, K; Sakai, T; Hashimoto, A; Hara, Y; Shimizu, I; Zhu, WD; Toko, H; Katada, A; Akazawa, H; Oka, T; Lee, JK; Minamino, T; Nagai, T; Walsh, K; Kikuchi, A; Matsumoto, M; Botto, M; Shiojima, I; Komuro, I				Naito, Atsuhiko T.; Sumida, Tomokazu; Nomura, Seitaro; Liu, Mei-Lan; Higo, Tomoaki; Nakagawa, Akito; Okada, Katsuki; Sakai, Taku; Hashimoto, Akihito; Hara, Yurina; Shimizu, Ippei; Zhu, Weidong; Toko, Haruhiro; Katada, Akemi; Akazawa, Hiroshi; Oka, Toru; Lee, Jong-Kook; Minamino, Tohru; Nagai, Toshio; Walsh, Kenneth; Kikuchi, Akira; Matsumoto, Misako; Botto, Marina; Shiojima, Ichiro; Komuro, Issei			Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes	CELL			English	Article							1ST COMPONENT; BETA-CATENIN; MECHANISM; RECEPTOR; PATHWAY; CELLS; SUBCOMPONENT; INHIBITION; PROTEINS; IMMUNITY	\ Wnt signaling plays critical roles in development of various organs and pathogenesis of many diseases, and augmented Wnt signaling has recently been implicated in mammalian aging and aging-related phenotypes. We here report that complement C1q activates canonical Wnt signaling and promotes aging-associated decline in tissue regeneration. Serum C1q concentration is increased with aging, and Wnt signaling activity is augmented during aging in the serum and in multiple tissues of wild-type mice, but not in those of C1qa-deficient mice. C1q activates canonical Wnt signaling by binding to Frizzled receptors and subsequently inducing C1s-dependent cleavage of the ectodomain of Wnt coreceptor low-density lipoprotein receptor-related protein 6. Skeletal muscle regeneration in young mice is inhibited by exogenous C1q treatment, whereas aging-associated impairment of muscle regeneration is restored by C1s inhibition or C1qa gene disruption. Our findings therefore suggest the unexpected role of complement C1q in Wnt signal transduction and modulation of mammalian aging.	[Naito, Atsuhiko T.; Higo, Tomoaki; Nakagawa, Akito; Okada, Katsuki; Sakai, Taku; Hashimoto, Akihito; Hara, Yurina; Akazawa, Hiroshi; Oka, Toru; Lee, Jong-Kook; Shiojima, Ichiro; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5650871, Japan; [Kikuchi, Akira] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Osaka 5650871, Japan; [Naito, Atsuhiko T.; Akazawa, Hiroshi; Oka, Toru; Lee, Jong-Kook; Shiojima, Ichiro; Komuro, Issei] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Sumida, Tomokazu; Nomura, Seitaro; Liu, Mei-Lan; Shimizu, Ippei; Zhu, Weidong; Toko, Haruhiro; Katada, Akemi; Minamino, Tohru; Nagai, Toshio; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan; [Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 0608638, Japan; [Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Complement & Inflammat Res, London SW7 2AZ, England	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Chiba University; Boston University; Hokkaido University; Imperial College London	Komuro, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5650871, Japan.	komuro-tky@umin.ac.jp	Okada, Katsuki/AGX-9515-2022; Minamino, Tohru/P-8145-2018; Nakagawa, Akito/AAQ-4631-2020	Okada, Katsuki/0000-0002-1725-781X; Minamino, Tohru/0000-0003-1627-6151; Nakagawa, Akito/0000-0001-8276-1505; Shimizu, Ippei/0000-0003-3333-8131; Sumida, Tomokazu/0000-0002-9806-2642; Akazawa, Hiroshi/0000-0002-3574-9607	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labour, and Welfare; Japan Science and Technology Agency; Japan Prize Foundation; Japan Foundation for Applied Enzymology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587, P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG015052, R01AG034972] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24659390, 23590558, 23390214, 23390213] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Prize Foundation(Japan Prize Foundation); Japan Foundation for Applied Enzymology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank X. He, R.T. Moon, C. Niehrs, and S. Aizawa for plasmids and A. Furuyama, M. Iiyama, M. Ikeda, M. Kikuchi, M. Naito, Y. Ohtsuki, and I. Sakamoto for technical support. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Ministry of Health, Labour, and Welfare; and Japan Science and Technology Agency (to I.K.). This work was also supported by Grant-in-Aid for Young Scientists (A), Grant-in-Aid for JSPS Fellows, Research Grant from the Japan Prize Foundation, and the Japan Foundation for Applied Enzymology (to A.T.N.).	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; BORQUE L, 1995, J CLIN LAB ANAL, V9, P302, DOI 10.1002/jcla.1860090505; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; ERIKSSON H, 1990, BIOCHIM BIOPHYS ACTA, V1037, P209, DOI 10.1016/0167-4838(90)90169-G; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; MATSUMOTO M, 1986, J IMMUNOL, V137, P2907; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nayak A, 2010, IMMUNOL LETT, V131, P139, DOI 10.1016/j.imlet.2010.03.012; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Pickering M C, 2000, Adv Immunol, V76, P227; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; White BD, 2007, CURR BIOL, V17, pR923, DOI 10.1016/j.cub.2007.08.062; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yamamoto A, 2005, CELL, V120, P223, DOI 10.1016/j.cell.2004.11.051; YONEMASU K, 1978, IMMUNOLOGY, V35, P523; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	40	200	209	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 8	2012	149	6					1298	1313		10.1016/j.cell.2012.03.047	http://dx.doi.org/10.1016/j.cell.2012.03.047			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22682250	Green Accepted, Bronze			2022-12-28	WOS:000305119600014
J	Barnosky, AD; Hadly, EA; Bascompte, J; Berlow, EL; Brown, JH; Fortelius, M; Getz, WM; Harte, J; Hastings, A; Marquet, PA; Martinez, ND; Mooers, A; Roopnarine, P; Vermeij, G; Williams, JW; Gillespie, R; Kitzes, J; Marshall, C; Matzke, N; Mindell, DP; Revilla, E; Smith, AB				Barnosky, Anthony D.; Hadly, Elizabeth A.; Bascompte, Jordi; Berlow, Eric L.; Brown, James H.; Fortelius, Mikael; Getz, Wayne M.; Harte, John; Hastings, Alan; Marquet, Pablo A.; Martinez, Neo D.; Mooers, Arne; Roopnarine, Peter; Vermeij, Geerat; Williams, John W.; Gillespie, Rosemary; Kitzes, Justin; Marshall, Charles; Matzke, Nicholas; Mindell, David P.; Revilla, Eloy; Smith, Adam B.			Approaching a state shift in Earth's biosphere	NATURE			English	Review							LATE-QUATERNARY VEGETATION; EARLY-WARNING SIGNALS; CLIMATE-CHANGE; INTERACTION STRENGTH; HUMAN APPROPRIATION; DIVERSITY LOSS; REGIME SHIFTS; EXTINCTION; BIODIVERSITY; TRANSFORMATION	Localized ecological systems are known to shift abruptly and irreversibly from one state to another when they are forced across critical thresholds. Here we review evidence that the global ecosystem as a whole can react in the same way and is approaching a planetary-scale critical transition as a result of human influence. The plausibility of a planetary-scale 'tipping point' highlights the need to improve biological forecasting by detecting early warning signs of critical transitions on global as well as local scales, and by detecting feedbacks that promote such transitions. It is also necessary to address root causes of how humans are forcing biological changes.	[Barnosky, Anthony D.; Marshall, Charles; Matzke, Nicholas] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.; Marshall, Charles] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Bascompte, Jordi] CSIC, Estn Biol Donana, Integrat Ecol Grp, Seville 41092, Spain; [Berlow, Eric L.] TRU N Labs, Berkeley, CA 94705 USA; [Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Fortelius, Mikael] Univ Helsinki, Dept Geosci & Geog, FI-00014 Helsinki, Finland; [Fortelius, Mikael] Univ Helsinki, Finnish Museum Nat Hist, FI-00014 Helsinki, Finland; [Getz, Wayne M.; Harte, John; Gillespie, Rosemary; Kitzes, Justin] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Harte, John] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Marquet, Pablo A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Marquet, Pablo A.] Inst Ecol & Biodiversidad, Santiago, Chile; [Marquet, Pablo A.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Martinez, Neo D.] Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA 94703 USA; [Mooers, Arne] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Roopnarine, Peter] Calif Acad Sci, San Francisco, CA 94118 USA; [Vermeij, Geerat] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Williams, John W.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Mindell, David P.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94102 USA; [Revilla, Eloy] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41092 Seville, Spain; [Smith, Adam B.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of New Mexico; University of Helsinki; University of Helsinki; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Simon Fraser University; California Academy of Sciences; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Missouri Botanical Gardens	Barnosky, AD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	barnosky@berkeley.edu	Hastings, Alan/O-6864-2019; Smith, Adam B./H-6906-2019; Gillespie, Rosemary/AAF-4244-2019; Matzke, Nicholas/L-4109-2015; Kitzes, Justin/D-1818-2011; Revilla, Eloy/B-5100-2008; Smith, Adam B/L-5111-2013; Marquet, Pablo A/B-7732-2009; Bascompte, Jordi/B-7596-2008; Getz, Wayne/I-4521-2013; Martinez, Neo/A-5312-2008	Hastings, Alan/0000-0002-0717-8026; Gillespie, Rosemary/0000-0003-0086-7424; Matzke, Nicholas/0000-0002-8698-7656; Kitzes, Justin/0000-0001-7839-3594; Revilla, Eloy/0000-0001-5534-5581; Smith, Adam B/0000-0002-6420-1659; Marquet, Pablo A/0000-0001-6369-9339; Bascompte, Jordi/0000-0002-0108-6411; Roopnarine, Peter/0000-0002-9811-1176; Getz, Wayne/0000-0001-8784-9354; Fortelius, Mikael/0000-0002-4851-783X; Martinez, Neo/0000-0002-1130-5550	University of California at Berkeley Office of the Vice Chancellor for Research under Berkeley Initiative for Global Change Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069801] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0956389] Funding Source: National Science Foundation	University of California at Berkeley Office of the Vice Chancellor for Research under Berkeley Initiative for Global Change Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research grew out of a workshop funded by The University of California at Berkeley Office of the Vice Chancellor for Research under the auspices of the Berkeley Initiative for Global Change Biology. We thank J. Jackson for discussions and Paul Ehrlich for comments.	Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; [Anonymous], 2011, WORLD POP PROSP 2010; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Barnosky AD, 2011, GEOL SOC SPEC PUBL, V358, P179, DOI 10.1144/SP358.12; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bradonjic M, 2007, LECT NOTES COMPUT SC, V4863, P209; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brown J.H., 1995, MACROECOLOGY; Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; CONVENTION ON BIOLOGICAL DIVERSITY, 2011, STRAT PLAN BIOD 2011; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Ellis EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030535; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Galaz V, 2012, CURR OPIN ENV SUST, V4, P80, DOI 10.1016/j.cosust.2012.01.006; Getz WM, 2011, ECOL LETT, V14, P113, DOI 10.1111/j.1461-0248.2010.01566.x; Getz WM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000209; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Graham RW, 1996, SCIENCE, V272, P1601; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hadly Elizabeth A., 2009, Paleontological Society Papers, V15, P39; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoek WZ, 2008, EPISODES, V31, P226, DOI 10.18814/epiiugs/2008/v31i2/007; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Kokkoris GD, 1999, ECOL LETT, V2, P70, DOI 10.1046/j.1461-0248.1999.22058.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Maurer Brian A., 1996, Biodiversity Letters, V3, P1, DOI 10.2307/2999702; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peters Debra P. C., 2009, P47, DOI 10.1007/978-0-387-77942-3_3; Polly PD, 2011, P ROY SOC B-BIOL SCI, V278, P1131, DOI 10.1098/rspb.2010.2233; Population Reference Bureau, 2012, POP PROJ 2050; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roopnarine P.D., 2010, PALEONTOL SOC PAP, V16, P143, DOI [10.1017/S1089332600001856, DOI 10.1017/S1089332600001856]; Sahasrabudhe S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1163; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shearer AW, 2005, FUTURES, V37, P445, DOI 10.1016/j.futures.2004.10.020; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; United Nations, 2004, WORLD POP 2300, P1; Vie J-C, 2009, WILDLIFE CHANGING WO, DOI [10.2305/IUCN.CH.2009.17.en, DOI 10.2305/IUCN.CH.2009.17.EN]; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Westley F, 2011, AMBIO, V40, P762, DOI 10.1007/s13280-011-0186-9; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P835, DOI 10.1098/rsta.2010.0339	99	1041	1084	27	1123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2012	486	7401					52	58		10.1038/nature11018	http://dx.doi.org/10.1038/nature11018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GD	22678279	Green Submitted			2022-12-28	WOS:000304854000026
J	Meyer, GS; Demehin, AA; Liu, X; Neuhauser, D				Meyer, Gregg S.; Demehin, Akinluwa A.; Liu, Xiu; Neuhauser, Duncan			Two Hundred Years of Hospital Costs and Mortality - MGH and Four Eras of Value in Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Meyer, Gregg S.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Demehin, Akinluwa A.] Natl Qual Forum, Washington, DC USA; [Liu, Xiu] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Neuhauser, Duncan] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Dartmouth College; Harvard University; Massachusetts General Hospital; Case Western Reserve University	Meyer, GS (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.							Holmes OW, 1892, COLLECTED ESSAYS 184; New York City Department of Health and Mental Hygiene Bureau of Vital Statistics, 2010, SUMM VIT STAT 2009, P106; Schactman D, 2003, HLTH AFF MILLWOOD, V22, P12; Shahian DM, 2011, NEW ENGL J MED, V364, P1382; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Stevens RA, 1996, HEALTH CARE FINANC R, V18, P11	6	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2147	2149		10.1056/NEJMp1202628	http://dx.doi.org/10.1056/NEJMp1202628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953JO	22670900				2022-12-28	WOS:000304863400003
J	Rydin, Y; Bleahu, A; Davies, M; Davila, JD; Friel, S; De Grandis, G; Groce, N; Hallal, PC; Hamilton, I; Howden-Chapman, P; Lai, KM; Lim, CJ; Martins, J; Osrin, D; Ridley, I; Scott, I; Taylor, M; Wilkinson, P; Wilson, J				Rydin, Yvonne; Bleahu, Ana; Davies, Michael; Davila, Julio D.; Friel, Sharon; De Grandis, Giovanni; Groce, Nora; Hallal, Pedro C.; Hamilton, Ian; Howden-Chapman, Philippa; Lai, Ka-Man; Lim, C. J.; Martins, Juliana; Osrin, David; Ridley, Ian; Scott, Ian; Taylor, Myfanwy; Wilkinson, Paul; Wilson, James			Shaping cities for health: complexity and the planning of urban environments in the 21st century	LANCET			English	Review							EPIDEMIOLOGIC TRANSITION THEORY; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; PUBLIC-HEALTH; DEVELOPING-COUNTRIES; INFECTIOUS-DISEASES; ANTHROPOGENIC HEAT; SLUDGE MANAGEMENT; CHANGING RELATION; WINTER MORTALITY		[Rydin, Yvonne] UCL, Bartlett Sch Planning, London WC1H 0QB, England; [Friel, Sharon] Australian Natl Univ, Canberra, ACT, Australia; [Hallal, Pedro C.] Univ Fed Pelotas, Pelotas, Brazil; [Howden-Chapman, Philippa] Univ Otago, Wellington, New Zealand; [Ridley, Ian] RMIT Univ, Melbourne, Vic, Australia; [Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; University College London; Australian National University; Universidade Federal de Pelotas; University of Otago; Royal Melbourne Institute of Technology (RMIT); University of London; London School of Hygiene & Tropical Medicine	Rydin, Y (corresponding author), UCL, Bartlett Sch Planning, Wates House,22 Gordon St, London WC1H 0QB, England.	y.rydin@ucl.ac.uk	Hamilton, Ian/O-6756-2019; Hallal, Pedro C/A-3249-2011; Bleahu, Ana/AAQ-8701-2020; Hamilton, Ian/O-6234-2014; Davies, Michael/GWV-2527-2022; Davila, Julio D/C-3257-2008; Lai, Ka Man/C-3259-2015	Hamilton, Ian/0000-0003-2582-2361; Hallal, Pedro C/0000-0003-1470-6461; Hamilton, Ian/0000-0003-2582-2361; Davila, Julio D/0000-0001-8319-2893; Lai, Ka Man/0000-0002-0037-792X; Martins, Juliana/0000-0002-2228-8274; Friel, Sharon/0000-0002-8345-5435; Osrin, David/0000-0001-9691-9684; Taylor, Myfanwy/0000-0003-2881-9192; Rydin, Yvonne/0000-0001-8283-9827; Wilkinson, Paul/0000-0001-7456-259X; Davies, Michael/0000-0003-2173-7063; RIDLEY, Ian Alexander/0000-0001-9240-5088; Wilson, James/0000-0002-0911-8510; Groce, Nora/0000-0002-7885-7042	UCL Alumni; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/G029881/1, EP/I02929X/1] Funding Source: researchfish; EPSRC [EP/I02929X/1, EP/G029881/1] Funding Source: UKRI	UCL Alumni; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the very insightful and constructive comments made by Anne Johnson, Hugh Montgomery, David Satterthwaite, and four anonymous reviewers. We are also grateful for financial support from UCL Alumni and the Engineering and Physical Sciences Research Council Crucible Programme.	Allen A., 2006, GOVERNANCE WATER SAN; Allen A, 2008, MOVING LADDER GOVERN; Allen PM., 1997, CITIES REGIONS SELF; Amorim TC, 2010, J PHYS ACT HEALTH, V7, pS204, DOI 10.1123/jpah.7.s2.s204; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2008, BBC NEWS; [Anonymous], 2008, PHARM ENV SOURCES FA, DOI DOI 10.1007/978-3-540-74664-5; [Anonymous], 2011, CIT CLIM CHANG; [Anonymous], INDICATOR S AFRICA, V13, P84; [Anonymous], 2002, NUTR TRANSITION DIET; [Anonymous], 2010, WORLD URB PROSP 2009; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Ashton J., 1986, Health Promotion, V1, P319, DOI 10.1093/heapro/1.3.319; Asomani-Boateng R, 1999, 3 WORLD PLAN REV, V4, P21; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Barnes DF, 2005, URBAN HOUSEHOLD ENER; Barnes DF, 1990, POPULATION GROWTH RE; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Barton H, 2006, J R SOC PROMO HEALTH, V126, P252, DOI 10.1177/1466424006070466; Barton H, 2009, LAND USE POLICY, V26, pS115, DOI 10.1016/j.landusepol.2009.09.008; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Baum FE, 2011, HEALTH PROMOT INT, V26, pII253, DOI 10.1093/heapro/dar078; Bauman A, 2005, J EPIDEMIOL COMMUN H, V59, P535, DOI 10.1136/jech.2004.032342; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Beitz Roma, 2004, J Br Menopause Soc, V10, P70, DOI 10.1258/136218004774202382; Bethany M, 2005, URBAN AGR REPORT REG; Bloom DE, 2007, INT J EPIDEMIOL, V36, P498, DOI 10.1093/ije/dym079; Bogota City Government, 2011, MOB; Bohnenstengel SI, 2011, Q J ROY METEOR SOC, V137, P1625, DOI 10.1002/qj.855; Boyce T, 2009, HLTH IMPACTS SPATIAL; Brand Peter, 2011, CITY, V15, P647, DOI DOI 10.1080/13604813.2011.609007; Braubach M., 2011, ENV BURD ENDISEASE A; Brook R., 2000, PERIURBAN INTERFACE; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Burns J, 2008, ENVIRON IMPACT ASSES, V28, P184, DOI 10.1016/j.eiar.2007.06.001; Burra S, 2003, ENVIRON URBAN, V15, P11, DOI 10.1177/095624780301500202; Burstrom B, 2005, AM J PUBLIC HEALTH, V95, P208, DOI 10.2105/AJPH.2003.034900; Butler EN, 2011, J PHYS ACT HEALTH, V8, pS91, DOI 10.1123/jpah.8.s1.s91; Button J, 1993, TRANSPORT ENV SUSTAI; Byrne J, 2009, J ENVIRON PLANN MAN, V52, P365, DOI 10.1080/09640560802703256; Caldwell J, 2002, ASIA PAC POPUL J, V17, P49; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Caldwell JC, 2001, B WORLD HEALTH ORGAN, V79, P159; Campbell HW, 2000, WATER SCI TECHNOL, V41, P1; Campbell M, 2009, SURVEY ALLOTMENT WAI; Capon AG, 2010, PLAN THEORY PRACT, V11, P109; Echeverry JC, 2005, ECONOMIA, V5, P151, DOI 10.1353/eco.2005.0014; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; CIEH, 2008, GOOD LEADS GOOD HLTH; City of Toronto, TOR FACTS TOR RAC DI; Cofie OO, 2005, RENEW AGR FOOD SYST, V20, P73, DOI 10.1079/RAF200491; Cohen ML, 1998, BRIT MED BULL, V54, P523; COHRE, 2008, WATERAID SDC UN HABI; Corcoran E., 2010, SICK WATER CENTRAL R; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Costongs C, 1997, EVALUATION, DOI 10. 1177/135638909700300306; Cotton A, 2000, SERVICES URBAN POOR; CSDH, 2008, CLOS GAP GEN HLTH EQ; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Davila JD, 2004, FORTALEZAS COLOMBIA, P417; Davila JD, 2009, ENVIRON URBAN, V21, P37, DOI 10.1177/0956247809103003; De Carbonnel E, CATASTROPHIC FALL GL; de Leeuw E, 2005, SOC SCI MED, V61, P1331, DOI 10.1016/j.socscimed.2005.01.028; De Leeuw E, 2009, HEALTH PROMOT INT, V24, P19, DOI 10.1093/heapro/dap052; De Sousa CA, 2003, LANDSCAPE URBAN PLAN, V62, P181, DOI 10.1016/S0169-2046(02)00149-4; Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710; Dennis K., 2009, CAR; Despommier D, 2008, VERTICAL FARM ESSAY; Diamond J, 2011, NATURE, V469, P478, DOI 10.1038/469478a; Drechsel P., 2010, WASTEWATER IRRIGATIO; Dryzek J., 1990, DISCURSIVE DEMOCRACY; Duhl L, 2005, BUILT ENV, V31, P356; Duhl L. J., 1986, HEALTH PROMOT INT, V1, P55; Enriquez LJ, 2000, 14 FOOD 1 I FOOD DEV; Feinleib M, 2008, ANN EPIDEMIOL, V18, P865, DOI 10.1016/j.annepidem.2008.08.004; Florindo AA, 2009, J PHYS ACT HEALTH, V6, P625, DOI 10.1123/jpah.6.5.625; Forester J., 1999, DELIBERATIVE PRACTIT; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frumkin H, 2002, PUBLIC HEALTH REP, V117, P201, DOI 10.1016/S0033-3549(04)50155-3; Gage TB, 2005, YEARB PHYS ANTHROPOL, V48, P96, DOI 10.1002/ajpa.20353; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Gerrits L, 2009, MANAGING COMPLEX GOV, P309; Gilbert A., 2002, CAPITAL CITY POLITIC, P29; Gilbert A, 2008, TRANSPORT REV, V28, P439, DOI 10.1080/01441640701785733; Giles-Corti B, 2006, J SCI MED SPORT, V9, P357, DOI 10.1016/j.jsams.2006.06.021; Glazier R, 2007, NEIGHBORHOOD ENV RES; Glouberman S, 2006, J URBAN HEALTH, V83, P325, DOI 10.1007/s11524-006-9034-9; Gomez LF, 2010, J PHYS ACT HEALTH, V7, pS196, DOI 10.1123/jpah.7.s2.s196; Goumans D, 1997, SOC SCI MED, V63, P179; Greater London Authority, 2011, MAN RISKS INCR RES M; Greater London Authority GL, 2009, LOND PLAN SPAT DEV S; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hallal PC, 2005, AM J PREV MED, V28, P156, DOI 10.1016/j.amepre.2004.10.012; Hallal Pedro Curi, 2006, Cad. Saúde Pública, V22, P1277, DOI 10.1590/S0102-311X2006000600017; Hamilton IG, 2013, PROC INST CIV ENG-U, V166, P164, DOI 10.1680/udap.10.00046; Hamilton IG, 2009, BUILD ENVIRON, V44, P807, DOI 10.1016/j.buildenv.2008.05.024; Hancock T, 1988, HLTH CITIES PROJECT; Hancock Trevor, 1993, Journal of Public Health Policy, V14, P5, DOI 10.2307/3342823; Hanna AK, 2000, B SCI TECHNOL SOC, V20, P207, DOI DOI 10.1177/027046760002000308; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Hardoy J., 1989, SQUATTER CITIZEN; Harpham T, 2001, HEALTH PROMOT INT, V16, P111, DOI 10.1093/heapro/16.2.111; Harpham T, 1996, URBAN HLTH RES DEV C; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Heuveline P, 2002, SOC SCI MED, V55, P313, DOI 10.1016/S0277-9536(01)00172-1; HM Government, 2013, APPR DOC F VENT 2010; Housing Stock CLG, 2010, ENGL DWELL STOCK EST; Howden-Chapman P, 2011, TACKLING COLD HOUSIN; Howden-Chapman P, 2009, ENERG POLICY, V37, P3387, DOI 10.1016/j.enpol.2008.12.023; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hughes BB, 2011, B WORLD HEALTH ORGAN, V89, P478, DOI 10.2471/BLT.10.083766; Ichinose T, 1999, ATMOS ENVIRON, V33, P3897, DOI 10.1016/S1352-2310(99)00132-6; Ingallinella AM, 2002, WATER SCI TECHNOL, V46, P285, DOI 10.2166/wst.2002.0355; Innes JE, 2018, PLANNING WITH COMPLEXITY: AN INTRODUCTION TO COLLABORATIVE RATIONALITY FOR PUBLIC POLICY, 2ND EDITION; International Energy Agency, 2008, WORLD EN OUTL; Jackson L., 2019, CLIMATE CHANGE FLOOD; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P1; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kenzer M, 1999, ENVIRON URBAN, V11, P201, DOI 10.1177/095624789901100103; Kickbusch Ilona, 2007, Promot Educ, VSuppl 2, P40; Kien CL, 2003, ARCH PEDIAT ADOL MED, V157, P811, DOI 10.1001/archpedi.157.8.811; Knowlton K, 2008, ADV GLOB CHANGE RES, V30, P143, DOI 10.1007/978-1-4020-6877-5_9; Kornov L, 2009, ENVIRON IMPACT ASSES, V29, P60, DOI 10.1016/j.eiar.2008.04.003; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kunitz SJ, 2007, INT J EPIDEMIOL, V36, P491, DOI 10.1093/ije/dym076; Lathrop Pack C, 2009, WAR GARDEN VICTORIOU; LEACH G, 1992, ENERG POLICY, V20, P116, DOI 10.1016/0301-4215(92)90105-B; Lim C. J., 2010, SMARTCITIES ECOWARRI; Lopez R, 2004, AM J PUBLIC HEALTH, V94, P1574, DOI 10.2105/AJPH.94.9.1574; MACKENBACH JP, 1994, J EPIDEMIOL COMMUN H, V48, P329, DOI 10.1136/jech.48.4.329-a; Majone G., 1989, EVIDENCE ARGUMENT PE; Maller C., 2002, HLTH PARKS HLTH PEOP; Marmot M, 2000, MARMOT REV STRATEGIC; Martinez J, 2008, HABITAT INT, V32, P86, DOI 10.1016/j.habitatint.2007.08.018; Mavrogianni A, 2011, BUILD SERV ENG RES T, V32, P35, DOI 10.1177/0143624410394530; Mayntz R, 1993, MODERN GOVERNANCE NE, P14; McFarlane C, 2008, ENVIRON PLANN A, V40, P88, DOI 10.1068/a39221; McGranahan G., 2001, CITIZENS RISK URBAN; McGranahan G, 2007, URBAN ENV WEALTH HLT; McKeown T., 1976, ROLE MED DREAM MIRAG; McKeown Thomas, 1976, MODERN RISE POPULATI; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Minkler M, 1998, COMMUNITY ORG COMMUN; Mogk J, 2010, URBAN AGR GOOD FOOD; Monteiro CA, 2002, NUTR TRANSITION DIET; Montes F, 2010, 5 M NETW CICL RECR M; Montgomery MR, 2009, URBAN POVERTY HLTH D; Morgan K, 2009, INT PLAN STUD, V14, P341, DOI 10.1080/13563471003642852; Murch S, 2009, VEGETABLE GARDENERS; Nickson A, 1997, INT REV ADM SCI, V63, P165, DOI 10.1177/002085239706300202; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064; Nugent R., 2000, IMPACT URBAN AGR HOU; O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122; Obosu-Mensah K., 2002, AFR STUD Q, V6, P19; Oikonomou E, BUILDING EN IN PRESS; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; OKE TR, 1995, NATO ADV SCI INST SE, V277, P81; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Olshansky SJ, 1997, POPUL BULL, V52, P2; OMRAN AR, 1983, J TROP PEDIATRICS, V29, P305, DOI 10.1093/tropej/29.6.305; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pachauri S, 2008, ENERG POLICY, V36, P4022, DOI 10.1016/j.enpol.2008.06.016; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Parra DC, 2010, PREV MED; Petersen A, 1996, HEALTH PLACE, V2, P157, DOI 10.1016/1353-8292(96)00008-1; Pinderhughes RR, 2000, URBAN AGR HAVANA CUB; Population Reference Bureau, 2010, 2010 WORLD POP DAT; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Prigogine I., 1977, SELF ORG NONEQUILIBR; Ramaraj R, 2008, AM J CARDIOL, V102, P102, DOI 10.1016/j.amjcard.2008.02.104; Reynolds L Raymond, 2004, Endocr Pract, V10, P153; Ritsatakis A, 2009, B WORLD HEALTH ORGAN, V12, P188; Ritsatakis A, 2009, HEALTH PROMOT INT, V24, P81, DOI 10.1093/heapro/dap058; ROGERS RG, 1987, SOC BIOL, V34, P234; Room G, 2011, COMPLEXITY I PUBLIC, P239; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Ross NA, 2007, AM J PUBLIC HEALTH, V97, P500, DOI 10.2105/AJPH.2004.060954; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sanderson I, 2006, POLICY POLIT, V34, P115, DOI 10.1332/030557306775212188; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Sarmiento OL, 2010, J PHYS ACT HEALTH, V7, pS181, DOI 10.1123/jpah.7.s2.s181; Satterthwaite D., 2007, IIED HUMAN SETTLEMEN; Satterthwaite DE, 2000, ENV HLTH URBAN POVER; Schaub-Jones D, 2006, SANITATION PARTNERSH; Schubeler P, 1996, 9 WORLD BANK SDC COL; Schwandt TA, 1997, EVALUATION, V3, P69; Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7; Scott P, 2011, THESIS U LOUGHBOROUG; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Sharp D, 2008, J URBAN HEALTH, V85, P1, DOI 10.1007/s11524-007-9242-y; Smallman-Raynor M, 1999, HEALTH PLACE, V5, P209, DOI 10.1016/S1353-8292(99)00010-6; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Sommers P., 1994, PROMOTING URBAN AGR; SPAHG, 2011, STEPS HLTH PLANN PRO; Stephens C, 1996, ENVIRON URBAN, V8, P9, DOI 10.1177/095624789600800211; Sterman J., 2010, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stern DI, 2001, J ENVIRON ECON MANAG, V41, P162, DOI 10.1006/jeem.2000.1132; Sverdlik A, 2011, ENVIRON URBAN, V23, P123, DOI 10.1177/0956247811398604; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; Szreter S., 2005, HLTH WEALTH STUDIES; Szreter Simon, 1988, SOCIAL SCI MED, V1, P1, DOI DOI 10.1145/1073943.1073950; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; Takano T, 2001, J EPIDEMIOL COMMUN H, V55, P263, DOI 10.1136/jech.55.4.263; Takano T., 2003, HLTH CITIES URBAN PO; The Energy and Climate Change Committee, 2010, 5 EN CLIM CHANG COMM; The World Bank, DAT URB POP; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Thompson WS, 1929, AM J SOCIOL, V34, P959, DOI 10.1086/214874; Troesken Werner., 2004, WATER RACE DIS; Tsouros A, 1990, HLTH CITIES PROJECT; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; UN, UN HAB 2011 CIT CLIM; UN Department of Economic and Social Affairs, ONL DAT URB RUR POP; UN Habitat, 2021, URBAN REGENERATION T; UN-Habitat, 2003, RENT HOUS ESS OPT UR; UN-Habitat, 2003, WAT SAN WORLDS CIT; UNDP, 2006, HUMAN DEV REPORT 200; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; van Ginkel HJA, 2007, MANAGING URBAN FUTUR; van Kamp I, 2003, LANDSCAPE URBAN PLAN, V65, P7; van Naerssen T, 2002, VANNAERSSEN BARTEN H; van Naerssen T, HLTH CITIES POLITICA; Wahdan M. H., 1996, Eastern Mediterranean Health Journal, V2, P8; Waliczek Tina M., 1999, Journal of Environmental Horticulture, V17, P180; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; Wang XD, 1999, ENVIRON SCI TECHNOL, V33, P3056, DOI 10.1021/es981360d; Water Utility Partnership (WUP), 2003, BETT WAT SAN URB POO; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; Wenger E., 2007, COMMUNITIES PRACTICE; Werna E, 1996, URBAN HLTH RES DEV C; Whitzman C, 2005, URBAN PLAN INT, V19, p[58, 121]; WHO, 2006, WHO GUID SAF US WAST; WHO, CONST WORLD HLTH ORG; WHO, 2011, HLTH GREEN EC HLTH C; WHO, 2004, WAT SAN HYG; WHO, 2010, 2010 URB HEART; WHO, 2009, MEG URB HLTH; WHO. Regional Office for Europe, 2008, CIT LEAD HLTH SUMM E, P20; WHO Regional Office for Europe, PHAS 5 2009 2013 WHO; WHO Regional Office for Europe, HLTH CIT WORLD OV HL; WHO Regional Office for Europe, HLTH CIT PROJ PHAS 3; WHO UNICEF, 2010, PROGR SAN DRINK WAT; WHO/World Bank, WORLD REP DIS; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Wilkinson P, 2001, COLD COMFORT SOCIAL; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Williams P, 2009 JOINT REV WINT; WolleswinkelVandenBosch JH, 1997, INT J EPIDEMIOL, V26, P772, DOI 10.1093/ije/26.4.772; Wood DM, 2004, CLIN SCI, V106, P527, DOI 10.1042/CS20030333; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; World Health Organization, 2006, WHO HOUS EN DAT; World Health Organization, TYP HLTH SETT; WRC. RPA, 2008, ENV EC SOC I 1 UNPUB; Wright L, 2004, RECLAIMING PUBLIC SP; WSP, PARTN COMM SUST SAN; WSP, 2006, MUMB SLUM SAN PROGR; WSP, 2004, CAS MARK SAN WAT SAN; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Yokohari M., 2005, LANDSC ECOL ENG, V1, P53, DOI DOI 10.1007/s11355-005-0012-2; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	275	418	435	39	368	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2079	2108		10.1016/S0140-6736(12)60435-8	http://dx.doi.org/10.1016/S0140-6736(12)60435-8			30	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22651973	Green Accepted			2022-12-28	WOS:000304759100033
J	Hauke, P; Tagliacozzo, L; Lewenstein, M				Hauke, Philipp; Tagliacozzo, Luca; Lewenstein, Maciej			Speeding Up Quantum Field Theories	SCIENCE			English	Editorial Material							SIMULATIONS; ALGORITHMS		[Hauke, Philipp; Tagliacozzo, Luca; Lewenstein, Maciej] Inst Ciencies Foton, Castelldefels 08860, Spain; [Lewenstein, Maciej] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Hauke, P (corresponding author), Inst Ciencies Foton, Castelldefels 08860, Spain.	philipp.hauke@icfo.es; luca.tagliacozzo@icfo.es; maciej.lewenstein@icfo.es	Lewenstein, Maciej/I-1337-2014; Hauke, Philipp/H-5304-2015; Tagliacozzo, Luca/D-5711-2011	Lewenstein, Maciej/0000-0002-0210-7800; Hauke, Philipp/0000-0002-0414-1754; Tagliacozzo, Luca/0000-0002-5858-1587	ICREA Funding Source: Custom	ICREA(ICREA)		Aspuru-Guzik A, 2012, NAT PHYS, V8, P285, DOI [10.1038/NPHYS2253, 10.1038/nphys2253]; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Cirac JI, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.104431; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Haegeman J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.251601; Houck AA, 2012, NAT PHYS, V8, P292, DOI [10.1038/nphys2251, 10.1038/NPHYS2251]; Laumann C. R., 2012, MODERN THEORIES MANY, P298; Lewenstein M, 2012, ULTRACOLD ATOMS IN OPTICAL LATTICES: SIMULATING QUANTUM MANY-BODY SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199573127.001.0001; Sachdev S., 2009, PHYSICS, V2, P90, DOI [10.1103/Physics.2.90, DOI 10.1103/PHYSICS.2.90]; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Vidal G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220405	14	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1122	1123		10.1126/science.1223010	http://dx.doi.org/10.1126/science.1223010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654049				2022-12-28	WOS:000304647900038
J	Spence, D				Spence, Des			That joke isn't funny any more	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3762	10.1136/bmj.e3762	http://dx.doi.org/10.1136/bmj.e3762			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645215				2022-12-28	WOS:000304855700021
J	Liao, HG; Cui, LK; Whitelam, S; Zheng, HM				Liao, Hong-Gang; Cui, Likun; Whitelam, Stephen; Zheng, Haimei			Real-Time Imaging of Pt3Fe Nanorod Growth in Solution	SCIENCE			English	Article							ORIENTED ATTACHMENT; ELECTRON-MICROSCOPY; FEPT NANOPARTICLES; NANOCRYSTALS; LIQUID; BIOMINERALIZATION; GENERATION; INTERFACE; NANOWIRES; FORCES	The growth of colloidal nanocrystal architectures by nanoparticle attachment is frequently reported as an alternative to the conventional growth by monomer attachment. However, the mechanism whereby nanoparticle attachment proceeds microscopically remains unclear. We report real-time transmission electron microscopy (TEM) imaging of the solution growth of Pt3Fe nanorods from nanoparticle building blocks. Observations revealed growth of winding polycrystalline nanoparticle chains by shape-directed nanoparticle attachment followed by straightening and orientation and shape corrections to yield single-crystal nanorods. Tracking nanoparticle growth trajectories allowed us to distinguish the force fields exerted by single nanoparticles and nanoparticle chains. Such quantification of nanoparticle interaction and understanding the growth pathways are important for the design of hierarchical nanomaterials and controlling nanocrystal self-assembly for functional devices.	[Liao, Hong-Gang; Cui, Likun; Whitelam, Stephen; Zheng, Haimei] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Whitelam, Stephen] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zheng, HM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	hmzheng@lbl.gov	Liao, Hong-Gang/T-2991-2019; Liao, hong-gang/M-2476-2015	Liao, Hong-Gang/0000-0003-2622-9842; Zheng, Haimei/0000-0003-3813-4170	Office of Science, Office of Basic Energy Sciences (BES), Scientific User Facilities Division of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U.S. DOE [DE-AC02-05CH11231]; U.S. DOE Office of Science; LDRD LBNL	Office of Science, Office of Basic Energy Sciences (BES), Scientific User Facilities Division of the U.S. Department of Energy (DOE); Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U.S. DOE(United States Department of Energy (DOE)); U.S. DOE Office of Science(United States Department of Energy (DOE)); LDRD LBNL	We thank P. Geissler (University of California, Berkeley) for helpful discussions. We are also grateful to the comments of B. Sadtler and G. Reinhard. This work was performed using the facility at National Center for Electron Microscopy (NCEM), Lawrence Berkeley National Laboratory (LBNL), and portions of this work were performed at the Molecular Foundry (MF), LBNL. NCEM and MF were supported by the Office of Science, Office of Basic Energy Sciences (BES), Scientific User Facilities Division of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. This project was supported by the Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, of the U.S. DOE under contract no. DE-AC02-05CH11231. H.-G. L. thanks J. Park for help on the initial experimental setup. H.Z. thanks the U.S. DOE Office of Science Early Career Research Program for support and gratefully acknowledges partial funding support from LDRD LBNL.	Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; de Jonge N, 2011, NAT NANOTECHNOL, V6, P695, DOI [10.1038/NNANO.2011.161, 10.1038/nnano.2011.161]; Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k; Ku JY, 2011, J AM CHEM SOC, V133, P838, DOI 10.1021/ja107138x; Li Z, 2008, COLLOID SURFACE A, V313, P40, DOI 10.1016/j.colsurfa.2007.04.069; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5; Panda AB, 2006, J AM CHEM SOC, V128, P2790, DOI 10.1021/ja058148b; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Schliehe C, 2010, SCIENCE, V329, P550, DOI 10.1126/science.1188035; Shukla N, 2003, J MAGN MAGN MATER, V266, P178, DOI 10.1016/S0304-8853(03)00469-4; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165; Zhang YW, 2008, J PHYS CHEM C, V112, P12092, DOI 10.1021/jp805788x; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	28	536	546	27	771	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1011	1014		10.1126/science.1219185	http://dx.doi.org/10.1126/science.1219185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628649				2022-12-28	WOS:000304406800039
J	Lewis, SL				Lewis, Simon L.			We must set planetary boundaries wisely	NATURE			English	Editorial Material									[Lewis, Simon L.] UCL, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, London WC1E 6BT, England.	s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851					0	53	61	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					417	417		10.1038/485417a	http://dx.doi.org/10.1038/485417a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622531	Bronze			2022-12-28	WOS:000304344500006
J	Weibel, L; Spinas, R				Weibel, Lisa; Spinas, Renate			Aquagenic Wrinkling of Palms in Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weibel, Lisa; Spinas, Renate] Univ Childrens Hosp Zurich, Zurich, Switzerland	University Children's Hospital Zurich	Weibel, L (corresponding author), Univ Childrens Hosp Zurich, Zurich, Switzerland.	lisa.weibel@kispi.uzh.ch		Weibel, Lisa/0000-0002-8696-8164					0	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					E32	E32						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22621642	Green Accepted			2022-12-28	WOS:000304353000001
J	Black, ME				Black, Mary E.			Fashion fads in global health	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 21	2012	344								e3525	10.1136/bmj.e3525	http://dx.doi.org/10.1136/bmj.e3525			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QQ	22613874				2022-12-28	WOS:000304591200004
J	Herzig, SJ; Rothberg, MB				Herzig, Shoshana J.; Rothberg, Michael B.			Prophylaxis rates for venous thromboembolism and gastrointestinal bleeding in general medical patients: too low or too high?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STRESS-ULCER PROPHYLAXIS; AMERICAN-COLLEGE; RISK; PREVENTION; PLACEBO; METAANALYSIS		[Herzig, Shoshana J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Herzig, Shoshana J.] Harvard Univ, Sch Med, Boston, MA USA; [Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med, Springfield, MA USA; [Rothberg, Michael B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Baystate Medical Center; Tufts University	Herzig, SJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA.	sherzig@bidmc.harvard.edu						ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Department of Health, 2010, US COMM QUAL INN CQU; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; Herzig SJ, 2011, ARCH INTERN MED, V171, P991, DOI 10.1001/archinternmed.2011.14; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Janicki T, 2007, J HOSP MED, V2, P86, DOI 10.1002/jhm.177; Joint Commission on the Accreditation of Healthcare Organizations, 2011, VEN THROMB VEN THROM; Lederle FA, 2011, ANN INTERN MED, V155, P602, DOI 10.7326/0003-4819-155-9-201111010-00008; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Maynard G, 2008, AHRQ PUBLICATION; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Rothberg MB, 2011, J HOSP MED, V6, P202, DOI 10.1002/jhm.888; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Sanofi UK, 2010, SPONS 2010; Straube S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-41; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Treasure T, 2010, J ROY SOC MED, V103, P210, DOI 10.1258/jrsm.2010.100086; Wein L, 2007, ARCH INTERN MED, V167, P1476, DOI 10.1001/archinte.167.14.1476	28	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2012	344								e3248	10.1136/bmj.e3248	http://dx.doi.org/10.1136/bmj.e3248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946NV	22611168				2022-12-28	WOS:000304359600003
J	Gravitz, L				Gravitz, Lauren			The critters within	NATURE			English	Editorial Material																		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7	4	26	42	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S12	S13		10.1038/485S12a	http://dx.doi.org/10.1038/485S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616099				2022-12-28	WOS:000305950100006
J	Chico, RM; Mayaud, P; Ariti, C; Mabey, D; Ronsmans, C; Chandramohan, D				Chico, R. Matthew; Mayaud, Philippe; Ariti, Cono; Mabey, David; Ronsmans, Carine; Chandramohan, Daniel			Prevalence of Malaria and Sexually Transmitted and Reproductive Tract Infections in Pregnancy in Sub-Saharan Africa A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTERMITTENT PREVENTIVE TREATMENT; PLASMODIUM-FALCIPARUM INFECTION; SINGLE-DOSE AZITHROMYCIN; PRETERM DELIVERY; TRICHOMONAS-VAGINALIS; CHLAMYDIA-TRACHOMATIS; BACTERIAL VAGINOSIS; RANDOMIZED TRIAL; BIRTH-WEIGHT; WOMEN	Context Malaria and sexually transmitted infections/reproductive tract infections (STIs/RTIs) in pregnancy are direct and indirect causes of stillbirth, prematurity, low birth weight, and maternal and neonatal morbidity and mortality. Objective To conduct a systematic review and meta-analysis of malaria and STI/RTI prevalence estimates among pregnant women attending antenatal care facilities in sub-Saharan Africa. Data Sources PubMed, MEDLINE, EMBASE, the World Health Organization International Clinical Trials Registry, and reference lists were searched for studies reporting malaria, syphilis, Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, or bacterial vaginosis among pregnant women attending antenatal care facilities in sub-Saharan Africa. Study Selection Included studies were conducted in 1990-2011 with open enrollment. Studies from South Africa, where malaria is no longer endemic, were excluded. Data Extraction Point prevalence estimates were corrected for diagnostic precision. A random-effects model meta-analysis was applied to produce pooled prevalence estimates. Results A total of 171 studies met inclusion criteria, providing 307 point prevalence estimates for malaria or STIs/RTIs and including a total of 340 904 women. The pooled prevalence estimates (with 95% CIs and number of women with positive diagnosis) among studies in 1990-2011 in East and Southern Africa were as follows: syphilis, 4.5%(3.9%-5.1%; n=8346 positive diagnoses), N gonorrhoeae, 3.7% (2.8%-4.6%; n=626), C trachomatis, 6.9% (5.1%-8.6%; n=350), T vaginalis, 29.1% (20.9%-37.2%; n=5502), bacterial vaginosis, 50.8% (43.3%-58.4%; n=4280), peripheral malaria, 32.0% (25.9%-38.0%; n=11 688), and placental malaria, 25.8% (19.7%-31.9%; n=1388). West and Central Africa prevalence estimates were as follows: syphilis, 3.5% (1.8%-5.2%; n=851), N gonorrhoeae, 2.7%(1.7%-3.7%; n=73), Ctrachomatis, 6.1%(4.0%-8.3%; n=357), Tvaginalis, 17.8%(12.4%-23.1%; n=822), bacterial vaginosis, 37.6%(18.0%-57.2%; n=1208), peripheral malaria, 38.2%(32.3%-44.1%; n=12 242), and placental malaria, 39.9%(34.2%-45.7%; n=4658). Conclusion The dual prevalence of malaria and STIs/RTIs in pregnancy among women who attend antenatal care facilities in sub-Saharan Africa is considerable, with the combined prevalence of curable STIs/RTIs being equal to, if not greater than, malaria. JAMA. 2012;307(19):2079-2086	[Chico, R. Matthew; Chandramohan, Daniel] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Mayaud, Philippe; Mabey, David] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Ariti, Cono] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Chico, R. Matthew; Mabey, David; Chandramohan, Daniel] Univ London London Sch Hyg & Trop Med, Malaria Ctr, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Chico, RM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St,Room 445, London WC1E 7HT, England.	matthew.chico@lshtm.ac.uk	Chico, R. Matthew/ABC-7601-2020	Mabey, David/0000-0002-0031-8276; MAYAUD, Philippe/0000-0001-5730-947X	Pfizer; Medicines for Malaria Venture	Pfizer(Pfizer); Medicines for Malaria Venture	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Chico reports having previously received funding as part of 2 studies co-financed by Pfizer and the Medicines for Malaria Venture that are investigating the use of azithromycin plus chloroquine in IPTp. No other disclosures were reported.	[Anonymous], 2010, REP GLOB AIDS EP 201; Ayisi JG, 2000, INT J STD AIDS, V11, P393, DOI 10.1258/0956462001916119; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Ayisi JG, 2003, AIDS, V17, P585, DOI 10.1097/00002030-200303070-00014; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Brabin BJ, 1991, RISKS SEVERITY MALAR; Chico RM, 2011, TROP MED INT HEALTH, V16, P774, DOI 10.1111/j.1365-3156.2011.02765.x; Chico RM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-255; Cot M, 1995, AM J TROP MED HYG, V53, P581, DOI 10.4269/ajtmh.1995.53.581; Daly CC, 1998, SEX TRANSM INFECT, V74, pS50; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dewsnap CH, 2006, INT J STD AIDS, V17, P357, DOI 10.1258/095646206777323418; Diallo MO, 1997, INT J STD AIDS, V8, P636, DOI 10.1258/0956462971918904; FOUTS AC, 1980, J INFECT DIS, V141, P137, DOI 10.1093/infdis/141.2.137; French JI, 2006, AM J OBSTET GYNECOL, V194, P1717, DOI 10.1016/j.ajog.2006.03.004; Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gray RH, 2001, AM J OBSTET GYNECOL, V185, P1209, DOI 10.1067/mob.2001.118158; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hammerschlag MR, 2011, CLIN INFECT DIS, V53, pS99, DOI 10.1093/cid/cir699; HANDSFIELD HH, 1994, SEX TRANSM DIS, V21, P107, DOI 10.1097/00007435-199403000-00010; Kalilani L, 2006, AM J TROP MED HYG, V75, P121; Kassam SN, 2006, INT J GYNECOL OBSTET, V93, P225, DOI 10.1016/j.ijgo.2006.02.021; Kelsey JL., 1996, METHODS OBSERVATIONA; Keou FXM, 1998, INT J STD AIDS, V9, P400, DOI 10.1258/0956462981922485; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Lujan J, 2008, SAMJ S AFR MED J, V98, P49; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; Mabey D, 2009, SEX TRANSM DIS, V36, P777, DOI 10.1097/OLQ.0b013e3181bd0fdd; MAHLER H, 1987, LANCET, V1, P668; Mankhambo L, 2002, J CLIN MICROBIOL, V40, P155, DOI 10.1128/JCM.40.1.155-158.2002; Mayaud P, 1997, GENITOURIN MED, V73, P33; Mayaud P, 1998, SEX TRANSM INFECT, V74, pS77; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McDonald HM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub3; Menendez Clara, 2010, Infect Dis Obstet Gynecol, V2010, DOI 10.1155/2010/609315; Menendez C, 2011, CLIN INFECT DIS, V52, P41, DOI 10.1093/cid/ciq049; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Ndyomugyenyi R, 1999, ANN TROP MED PARASIT, V93, P457, DOI 10.1080/00034989958195; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; OGBONNA C I C, 1991, Angewandte Parasitologie, V32, P198; Orroth KK, 2003, SEX TRANSM INFECT, V79, P98, DOI 10.1136/sti.79.2.98; Ortashi O M, 2004, J Obstet Gynaecol, V24, P513, DOI 10.1080/01443610410001722536; Peeling R, 2003, SEXUALLY TRANSMITTED; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; SCHACHTER J, 1986, JAMA-J AM MED ASSOC, V255, P3374, DOI 10.1001/jama.255.24.3374; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Sterne J. A. C., 2008, SYSTEMATIC REV HLTH, V323, P189, DOI [10.1002/9780470693926.ch11, DOI 10.1002/9780470693926.CH11]; Sterne J. A. C., 2009, METAANALYSIS STATA U; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Tann CJ, 2006, SEX TRANSM INFECT, V82, P285, DOI 10.1136/sti.2005.014845; van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191; van der Schee C, 1999, J CLIN MICROBIOL, V37, P4127, DOI 10.1128/JCM.37.12.4127-4130.1999; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; VANDYCK E, 1992, EUR J CLIN MICROBIOL, V11, P527; VUYLSTEKE B, 1993, GENITOURIN MED, V69, P427; VUYLSTEKE B, 1993, CLIN INFECT DIS, V17, P82, DOI 10.1093/clinids/17.1.82; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Wessel H F, 1998, Afr J Reprod Health, V2, P32; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Zhou Xia, 2010, Infect Dis Obstet Gynecol, V2010, P737425, DOI 10.1155/2010/737425	70	116	123	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2012	307	19					2079	2086		10.1001/jama.2012.3428	http://dx.doi.org/10.1001/jama.2012.3428			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942MM	22665107	Green Accepted			2022-12-28	WOS:000304048200027
J	Powell, K				Powell, Kendall			MOLECULAR ONCOLOGY The positive in the negative	NATURE			English	Editorial Material																		Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Shah S.P, 2012, NATURE          0404, DOI [10.1038/nature10933, DOI 10.1038/NATURE10933]; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242	6	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S52	S53		10.1038/nj7395-553a	http://dx.doi.org/10.1038/nj7395-553a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22548214	Bronze			2022-12-28	WOS:000304608000002
